CA2380549A1 - Secretory molecules - Google Patents
Secretory molecules Download PDFInfo
- Publication number
- CA2380549A1 CA2380549A1 CA002380549A CA2380549A CA2380549A1 CA 2380549 A1 CA2380549 A1 CA 2380549A1 CA 002380549 A CA002380549 A CA 002380549A CA 2380549 A CA2380549 A CA 2380549A CA 2380549 A1 CA2380549 A1 CA 2380549A1
- Authority
- CA
- Canada
- Prior art keywords
- polynucleotide
- sptm
- sequence
- sequences
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000003248 secreting effect Effects 0.000 title claims abstract description 34
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 183
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 183
- 239000002157 polynucleotide Substances 0.000 claims abstract description 183
- 238000000034 method Methods 0.000 claims abstract description 147
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 120
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 94
- 229920001184 polypeptide Polymers 0.000 claims abstract description 84
- 230000014509 gene expression Effects 0.000 claims abstract description 75
- 239000012634 fragment Substances 0.000 claims abstract description 64
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- 238000002493 microarray Methods 0.000 claims abstract description 21
- 239000000523 sample Substances 0.000 claims description 89
- 239000002773 nucleotide Substances 0.000 claims description 60
- 125000003729 nucleotide group Chemical group 0.000 claims description 60
- 238000009396 hybridization Methods 0.000 claims description 51
- 230000000295 complement effect Effects 0.000 claims description 39
- 230000027455 binding Effects 0.000 claims description 29
- 238000012360 testing method Methods 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 238000002372 labelling Methods 0.000 claims description 11
- 238000012216 screening Methods 0.000 claims description 10
- 239000012472 biological sample Substances 0.000 claims description 9
- 230000009261 transgenic effect Effects 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 6
- 238000012408 PCR amplification Methods 0.000 claims description 3
- 231100000041 toxicology testing Toxicity 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 2
- 230000008791 toxic response Effects 0.000 claims description 2
- 239000013598 vector Substances 0.000 abstract description 44
- 108091034117 Oligonucleotide Proteins 0.000 abstract description 22
- 238000003556 assay Methods 0.000 abstract description 20
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract description 16
- 210000004027 cell Anatomy 0.000 description 148
- 108090000623 proteins and genes Proteins 0.000 description 112
- 108020004414 DNA Proteins 0.000 description 80
- 150000007523 nucleic acids Chemical group 0.000 description 71
- 210000001519 tissue Anatomy 0.000 description 55
- 241000282414 Homo sapiens Species 0.000 description 54
- 239000002299 complementary DNA Substances 0.000 description 54
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 54
- 102000004169 proteins and genes Human genes 0.000 description 53
- 235000018102 proteins Nutrition 0.000 description 47
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 40
- 239000013615 primer Substances 0.000 description 40
- 108091028043 Nucleic acid sequence Proteins 0.000 description 39
- 201000010099 disease Diseases 0.000 description 37
- 108010076504 Protein Sorting Signals Proteins 0.000 description 32
- 238000004458 analytical method Methods 0.000 description 32
- 230000000694 effects Effects 0.000 description 29
- 238000005516 engineering process Methods 0.000 description 28
- 238000002869 basic local alignment search tool Methods 0.000 description 26
- 102000039446 nucleic acids Human genes 0.000 description 26
- 108020004707 nucleic acids Proteins 0.000 description 26
- 230000000692 anti-sense effect Effects 0.000 description 25
- 238000003752 polymerase chain reaction Methods 0.000 description 25
- 235000001014 amino acid Nutrition 0.000 description 23
- 229940024606 amino acid Drugs 0.000 description 22
- 239000013612 plasmid Substances 0.000 description 22
- 150000001413 amino acids Chemical class 0.000 description 21
- 230000002068 genetic effect Effects 0.000 description 21
- 239000012528 membrane Substances 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 19
- 208000035475 disorder Diseases 0.000 description 17
- 238000012163 sequencing technique Methods 0.000 description 17
- 238000011282 treatment Methods 0.000 description 16
- 239000013604 expression vector Substances 0.000 description 15
- 238000000746 purification Methods 0.000 description 15
- 125000003275 alpha amino acid group Chemical group 0.000 description 14
- 230000000875 corresponding effect Effects 0.000 description 14
- 108020004999 messenger RNA Proteins 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 102000005962 receptors Human genes 0.000 description 14
- 108020003175 receptors Proteins 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 238000006467 substitution reaction Methods 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 238000004422 calculation algorithm Methods 0.000 description 12
- 238000010276 construction Methods 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 230000032258 transport Effects 0.000 description 12
- 239000000427 antigen Substances 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 210000000349 chromosome Anatomy 0.000 description 11
- 238000013507 mapping Methods 0.000 description 11
- -1 vasomediators Proteins 0.000 description 11
- 230000003321 amplification Effects 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 10
- 230000005754 cellular signaling Effects 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 230000002759 chromosomal effect Effects 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 238000001415 gene therapy Methods 0.000 description 10
- 239000003102 growth factor Substances 0.000 description 10
- 238000003199 nucleic acid amplification method Methods 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 241001430294 unidentified retrovirus Species 0.000 description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- 241000700584 Simplexvirus Species 0.000 description 9
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 9
- 210000000170 cell membrane Anatomy 0.000 description 9
- 230000004069 differentiation Effects 0.000 description 9
- 229940088597 hormone Drugs 0.000 description 9
- 239000005556 hormone Substances 0.000 description 9
- 238000013518 transcription Methods 0.000 description 9
- 230000035897 transcription Effects 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 241000710929 Alphavirus Species 0.000 description 8
- 108020004635 Complementary DNA Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 108060003393 Granulin Proteins 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 150000002500 ions Chemical class 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 239000002987 primer (paints) Substances 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 108010078791 Carrier Proteins Proteins 0.000 description 7
- 108091026890 Coding region Proteins 0.000 description 7
- 108091035707 Consensus sequence Proteins 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 230000002596 correlated effect Effects 0.000 description 7
- 239000005090 green fluorescent protein Substances 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 230000001404 mediated effect Effects 0.000 description 7
- 239000008177 pharmaceutical agent Substances 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 238000013519 translation Methods 0.000 description 7
- 102000004127 Cytokines Human genes 0.000 description 6
- 108090000695 Cytokines Proteins 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 108091005804 Peptidases Proteins 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 230000002788 anti-peptide Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 238000001890 transfection Methods 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 108010083687 Ion Pumps Proteins 0.000 description 5
- 102000006391 Ion Pumps Human genes 0.000 description 5
- 108010052285 Membrane Proteins Proteins 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 102000035195 Peptidases Human genes 0.000 description 5
- 108091093037 Peptide nucleic acid Proteins 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 230000000890 antigenic effect Effects 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000004590 computer program Methods 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 230000003394 haemopoietic effect Effects 0.000 description 5
- 230000028993 immune response Effects 0.000 description 5
- 210000000987 immune system Anatomy 0.000 description 5
- 238000003119 immunoblot Methods 0.000 description 5
- 229940027941 immunoglobulin g Drugs 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 5
- 238000003127 radioimmunoassay Methods 0.000 description 5
- 230000010076 replication Effects 0.000 description 5
- 238000010839 reverse transcription Methods 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 241000701161 unidentified adenovirus Species 0.000 description 5
- 241000701447 unidentified baculovirus Species 0.000 description 5
- 241001529453 unidentified herpesvirus Species 0.000 description 5
- 239000003155 DNA primer Substances 0.000 description 4
- 238000001712 DNA sequencing Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 4
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 4
- 102000005720 Glutathione transferase Human genes 0.000 description 4
- 108010070675 Glutathione transferase Proteins 0.000 description 4
- 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 4
- 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 4
- 108090000862 Ion Channels Proteins 0.000 description 4
- 102000004310 Ion Channels Human genes 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 102000018697 Membrane Proteins Human genes 0.000 description 4
- 208000003250 Mixed connective tissue disease Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 108090000189 Neuropeptides Proteins 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 239000013592 cell lysate Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 230000001086 cytosolic effect Effects 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 238000000684 flow cytometry Methods 0.000 description 4
- 230000006801 homologous recombination Effects 0.000 description 4
- 238000002744 homologous recombination Methods 0.000 description 4
- 210000004408 hybridoma Anatomy 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000005304 joining Methods 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 239000002502 liposome Substances 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 238000000329 molecular dynamics simulation Methods 0.000 description 4
- 239000003068 molecular probe Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 210000000496 pancreas Anatomy 0.000 description 4
- 102000054765 polymorphisms of proteins Human genes 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 108700028369 Alleles Proteins 0.000 description 3
- 108091023043 Alu Element Proteins 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 102000019034 Chemokines Human genes 0.000 description 3
- 108010012236 Chemokines Proteins 0.000 description 3
- 241000701022 Cytomegalovirus Species 0.000 description 3
- 241001635598 Enicostema Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 241000725303 Human immunodeficiency virus Species 0.000 description 3
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010025323 Lymphomas Diseases 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 3
- ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 3
- 241000710961 Semliki Forest virus Species 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 238000012300 Sequence Analysis Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108010006785 Taq Polymerase Proteins 0.000 description 3
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 3
- 108010004977 Vasopressins Proteins 0.000 description 3
- 102000002852 Vasopressins Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 3
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 210000002459 blastocyst Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 230000006037 cell lysis Effects 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 210000000688 human artificial chromosome Anatomy 0.000 description 3
- 210000005260 human cell Anatomy 0.000 description 3
- 210000003917 human chromosome Anatomy 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000005847 immunogenicity Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 230000003278 mimic effect Effects 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000004929 secretory organelle Anatomy 0.000 description 3
- 238000002864 sequence alignment Methods 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 238000010361 transduction Methods 0.000 description 3
- 230000026683 transduction Effects 0.000 description 3
- 108091005703 transmembrane proteins Proteins 0.000 description 3
- 229960003726 vasopressin Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 2
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 2
- 108091006112 ATPases Proteins 0.000 description 2
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 2
- 102000055025 Adenosine deaminases Human genes 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 208000007887 Alphavirus Infections Diseases 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 102000003669 Antiporters Human genes 0.000 description 2
- 108090000084 Antiporters Proteins 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 102000001733 Basic Amino Acid Transport Systems Human genes 0.000 description 2
- 108010015087 Basic Amino Acid Transport Systems Proteins 0.000 description 2
- 108010051479 Bombesin Proteins 0.000 description 2
- 102000013585 Bombesin Human genes 0.000 description 2
- 206010006811 Bursitis Diseases 0.000 description 2
- 102000055006 Calcitonin Human genes 0.000 description 2
- 108060001064 Calcitonin Proteins 0.000 description 2
- 108090000565 Capsid Proteins Proteins 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 2
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 2
- 102100023321 Ceruloplasmin Human genes 0.000 description 2
- 108010062745 Chloride Channels Proteins 0.000 description 2
- 102000011045 Chloride Channels Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102100025841 Cholecystokinin Human genes 0.000 description 2
- 101800001982 Cholecystokinin Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 2
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 2
- 206010010099 Combined immunodeficiency Diseases 0.000 description 2
- 201000003883 Cystic fibrosis Diseases 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 102000002045 Endothelin Human genes 0.000 description 2
- 108050009340 Endothelin Proteins 0.000 description 2
- 208000032027 Essential Thrombocythemia Diseases 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108050001049 Extracellular proteins Proteins 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
- 108091006027 G proteins Proteins 0.000 description 2
- 102000030782 GTP binding Human genes 0.000 description 2
- 108091000058 GTP-Binding Proteins 0.000 description 2
- 102400000921 Gastrin Human genes 0.000 description 2
- 108010052343 Gastrins Proteins 0.000 description 2
- 102400000321 Glucagon Human genes 0.000 description 2
- 108060003199 Glucagon Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000009465 Growth Factor Receptors Human genes 0.000 description 2
- 108010009202 Growth Factor Receptors Proteins 0.000 description 2
- 208000030836 Hashimoto thyroiditis Diseases 0.000 description 2
- 208000009292 Hemophilia A Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 102100034349 Integrase Human genes 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 102400000050 Oxytocin Human genes 0.000 description 2
- 101800000989 Oxytocin Proteins 0.000 description 2
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 101710182846 Polyhedrin Proteins 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 241000714474 Rous sarcoma virus Species 0.000 description 2
- 241000710960 Sindbis virus Species 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 108091027544 Subgenomic mRNA Proteins 0.000 description 2
- 102000003673 Symporters Human genes 0.000 description 2
- 108090000088 Symporters Proteins 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 102000006601 Thymidine Kinase Human genes 0.000 description 2
- 108020004440 Thymidine kinase Proteins 0.000 description 2
- 241000723873 Tobacco mosaic virus Species 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000700618 Vaccinia virus Species 0.000 description 2
- 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 2
- 102400000015 Vasoactive intestinal peptide Human genes 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 208000017733 acquired polycythemia vera Diseases 0.000 description 2
- 208000009621 actinic keratosis Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 210000000625 blastula Anatomy 0.000 description 2
- DNDCVAGJPBKION-DOPDSADYSA-N bombesin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 229960004015 calcitonin Drugs 0.000 description 2
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 2
- 229940107137 cholecystokinin Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000003200 chromosome mapping Methods 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 229940047120 colony stimulating factors Drugs 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000003398 denaturant Substances 0.000 description 2
- 201000001981 dermatomyositis Diseases 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 210000000750 endocrine system Anatomy 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 108700004025 env Genes Proteins 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 210000001723 extracellular space Anatomy 0.000 description 2
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 2
- 229940028334 follicle stimulating hormone Drugs 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000001476 gene delivery Methods 0.000 description 2
- 102000054767 gene variant Human genes 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 2
- 229960004666 glucagon Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 210000002288 golgi apparatus Anatomy 0.000 description 2
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 238000001114 immunoprecipitation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000003712 lysosome Anatomy 0.000 description 2
- 230000001868 lysosomic effect Effects 0.000 description 2
- 230000005291 magnetic effect Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000005060 membrane bound organelle Anatomy 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 201000006417 multiple sclerosis Diseases 0.000 description 2
- 206010028417 myasthenia gravis Diseases 0.000 description 2
- 206010028537 myelofibrosis Diseases 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 2
- 229960001723 oxytocin Drugs 0.000 description 2
- 239000000813 peptide hormone Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 208000037244 polycythemia vera Diseases 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 208000005987 polymyositis Diseases 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 230000004853 protein function Effects 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010188 recombinant method Methods 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 208000012672 seasonal affective disease Diseases 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 208000001608 teratocarcinoma Diseases 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 230000005945 translocation Effects 0.000 description 2
- 102000035160 transmembrane proteins Human genes 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 239000013603 viral vector Substances 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 238000001086 yeast two-hybrid system Methods 0.000 description 2
- LLXVXPPXELIDGQ-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(2,5-dioxopyrrol-1-yl)benzoate Chemical compound C=1C=CC(N2C(C=CC2=O)=O)=CC=1C(=O)ON1C(=O)CCC1=O LLXVXPPXELIDGQ-UHFFFAOYSA-N 0.000 description 1
- KYRUKRFVOACELK-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(4-hydroxyphenyl)propanoate Chemical compound C1=CC(O)=CC=C1CCC(=O)ON1C(=O)CCC1=O KYRUKRFVOACELK-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- CUKWUWBLQQDQAC-VEQWQPCFSA-N (3s)-3-amino-4-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s,3s)-1-[[(2s)-1-[(2s)-2-[[(1s)-1-carboxyethyl]carbamoyl]pyrrolidin-1-yl]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-ox Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 CUKWUWBLQQDQAC-VEQWQPCFSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 1
- PFCLMNDDPTZJHQ-XLPZGREQSA-N 2-amino-7-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PFCLMNDDPTZJHQ-XLPZGREQSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- ZPZDIFSPRVHGIF-UHFFFAOYSA-N 3-aminopropylsilicon Chemical compound NCCC[Si] ZPZDIFSPRVHGIF-UHFFFAOYSA-N 0.000 description 1
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
- 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
- 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 208000026872 Addison Disease Diseases 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000034263 Amino acid transporters Human genes 0.000 description 1
- 108050005273 Amino acid transporters Proteins 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 108010089414 Anaphylatoxins Proteins 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 102400000345 Angiotensin-2 Human genes 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 108090000672 Annexin A5 Proteins 0.000 description 1
- 102000004121 Annexin A5 Human genes 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010003594 Ataxia telangiectasia Diseases 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 1
- 208000012219 Autonomic Nervous System disease Diseases 0.000 description 1
- WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
- 208000023328 Basedow disease Diseases 0.000 description 1
- OGBVRMYSNSKIEF-UHFFFAOYSA-N Benzylphosphonic acid Chemical class OP(O)(=O)CC1=CC=CC=C1 OGBVRMYSNSKIEF-UHFFFAOYSA-N 0.000 description 1
- 101000800130 Bos taurus Thyroglobulin Proteins 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 208000004020 Brain Abscess Diseases 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 210000004366 CD4-positive T-lymphocyte Anatomy 0.000 description 1
- 102000000905 Cadherin Human genes 0.000 description 1
- 108050007957 Cadherin Proteins 0.000 description 1
- 102000004612 Calcium-Transporting ATPases Human genes 0.000 description 1
- 108010017954 Calcium-Transporting ATPases Proteins 0.000 description 1
- 241000173351 Camvirus Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000016918 Complement C3 Human genes 0.000 description 1
- 108010028780 Complement C3 Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 208000019736 Cranial nerve disease Diseases 0.000 description 1
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 1
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- RDFLLVCQYHQOBU-GPGGJFNDSA-O Cyanin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@H](CO)O1)c1c(-c2cc(O)c(O)cc2)[o+]c2c(c(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)cc(O)c2)c1 RDFLLVCQYHQOBU-GPGGJFNDSA-O 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000016192 Demyelinating disease Diseases 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 102000012545 EGF-like domains Human genes 0.000 description 1
- 108050002150 EGF-like domains Proteins 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241000701867 Enterobacteria phage T7 Species 0.000 description 1
- 101710091045 Envelope protein Proteins 0.000 description 1
- 206010014950 Eosinophilia Diseases 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 206010015226 Erythema nodosum Diseases 0.000 description 1
- 206010015251 Erythroblastosis foetalis Diseases 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 206010061846 Extradural abscess Diseases 0.000 description 1
- 108010054218 Factor VIII Proteins 0.000 description 1
- 102000001690 Factor VIII Human genes 0.000 description 1
- 201000003542 Factor VIII deficiency Diseases 0.000 description 1
- 241000282323 Felidae Species 0.000 description 1
- LLQPHQFNMLZJMP-UHFFFAOYSA-N Fentrazamide Chemical compound N1=NN(C=2C(=CC=CC=2)Cl)C(=O)N1C(=O)N(CC)C1CCCCC1 LLQPHQFNMLZJMP-UHFFFAOYSA-N 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 241000724791 Filamentous phage Species 0.000 description 1
- 201000011240 Frontotemporal dementia Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102400001370 Galanin Human genes 0.000 description 1
- 101800002068 Galanin Proteins 0.000 description 1
- 102000007563 Galectins Human genes 0.000 description 1
- 108010046569 Galectins Proteins 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 208000003736 Gerstmann-Straussler-Scheinker Disease Diseases 0.000 description 1
- 206010072075 Gerstmann-Straussler-Scheinker syndrome Diseases 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- SAEBUDRWKUXLOM-ACZMJKKPSA-N Glu-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O SAEBUDRWKUXLOM-ACZMJKKPSA-N 0.000 description 1
- QXDXIXFSFHUYAX-MNXVOIDGSA-N Glu-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O QXDXIXFSFHUYAX-MNXVOIDGSA-N 0.000 description 1
- CBEUFCJRFNZMCU-SRVKXCTJSA-N Glu-Met-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O CBEUFCJRFNZMCU-SRVKXCTJSA-N 0.000 description 1
- 102000042092 Glucose transporter family Human genes 0.000 description 1
- 108091052347 Glucose transporter family Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
- 208000024869 Goodpasture syndrome Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000015023 Graves' disease Diseases 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- WSDOHRLQDGAOGU-BQBZGAKWSA-N His-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 WSDOHRLQDGAOGU-BQBZGAKWSA-N 0.000 description 1
- WZOGEMJIZBNFBK-CIUDSAMLSA-N His-Asp-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O WZOGEMJIZBNFBK-CIUDSAMLSA-N 0.000 description 1
- SDTPKSOWFXBACN-GUBZILKMSA-N His-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O SDTPKSOWFXBACN-GUBZILKMSA-N 0.000 description 1
- YADRBUZBKHHDAO-XPUUQOCRSA-N His-Gly-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](C)C(O)=O YADRBUZBKHHDAO-XPUUQOCRSA-N 0.000 description 1
- 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
- 101001042049 Human herpesvirus 1 (strain 17) Transcriptional regulator ICP22 Proteins 0.000 description 1
- 101000999690 Human herpesvirus 2 (strain HG52) E3 ubiquitin ligase ICP22 Proteins 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 101150027427 ICP4 gene Proteins 0.000 description 1
- USXAYNCLFSUSBA-MGHWNKPDSA-N Ile-Phe-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N USXAYNCLFSUSBA-MGHWNKPDSA-N 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 102000016844 Immunoglobulin-like domains Human genes 0.000 description 1
- 108050006430 Immunoglobulin-like domains Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 108700005090 Lethal Genes Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 206010025327 Lymphopenia Diseases 0.000 description 1
- 108010062166 Lys-Asn-Asp Proteins 0.000 description 1
- BYPMOIFBQPEWOH-CIUDSAMLSA-N Lys-Asn-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BYPMOIFBQPEWOH-CIUDSAMLSA-N 0.000 description 1
- 108091054437 MHC class I family Proteins 0.000 description 1
- 108010008364 Melanocortins Proteins 0.000 description 1
- 101710151321 Melanostatin Proteins 0.000 description 1
- 206010027202 Meningitis bacterial Diseases 0.000 description 1
- 206010027260 Meningitis viral Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 206010068836 Metabolic myopathy Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 206010048723 Multiple-drug resistance Diseases 0.000 description 1
- 208000003926 Myelitis Diseases 0.000 description 1
- 206010028643 Myopathy endocrine Diseases 0.000 description 1
- 206010028648 Myopathy toxic Diseases 0.000 description 1
- 208000023137 Myotoxicity Diseases 0.000 description 1
- 108010008211 N-Formylmethionine Leucyl-Phenylalanine Proteins 0.000 description 1
- 206010061309 Neoplasm progression Diseases 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000009905 Neurofibromatoses Diseases 0.000 description 1
- 102400001104 Neuromedin N Human genes 0.000 description 1
- 101800001607 Neuromedin N Proteins 0.000 description 1
- 102400000064 Neuropeptide Y Human genes 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 102400001103 Neurotensin Human genes 0.000 description 1
- 101800001814 Neurotensin Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 241000526686 Paracoccidioides brasiliensis Species 0.000 description 1
- 208000027099 Paranoid disease Diseases 0.000 description 1
- 208000000733 Paroxysmal Hemoglobinuria Diseases 0.000 description 1
- 241000237988 Patellidae Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 102100036050 Phosphatidylinositol N-acetylglucosaminyltransferase subunit A Human genes 0.000 description 1
- 208000000609 Pick Disease of the Brain Diseases 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 108010003541 Platelet Activating Factor Proteins 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 241000881705 Porcine endogenous retrovirus Species 0.000 description 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 208000024777 Prion disease Diseases 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 101710188315 Protein X Proteins 0.000 description 1
- 101710193937 Protein hit Proteins 0.000 description 1
- 102000052575 Proto-Oncogene Human genes 0.000 description 1
- 108700020978 Proto-Oncogene Proteins 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 206010037779 Radiculopathy Diseases 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 208000033464 Reiter syndrome Diseases 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241000242677 Schistosoma japonicum Species 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- VQBLHWSPVYYZTB-DCAQKATOSA-N Ser-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N VQBLHWSPVYYZTB-DCAQKATOSA-N 0.000 description 1
- CDVFZMOFNJPUDD-ACZMJKKPSA-N Ser-Gln-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CDVFZMOFNJPUDD-ACZMJKKPSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102400000099 Somatomedin-B Human genes 0.000 description 1
- 101800004225 Somatomedin-B Proteins 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- 102000005157 Somatostatin Human genes 0.000 description 1
- 208000029033 Spinal Cord disease Diseases 0.000 description 1
- 208000010112 Spinocerebellar Degenerations Diseases 0.000 description 1
- 241000256248 Spodoptera Species 0.000 description 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042265 Sturge-Weber Syndrome Diseases 0.000 description 1
- 201000000002 Subdural Empyema Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 201000009594 Systemic Scleroderma Diseases 0.000 description 1
- 206010042953 Systemic sclerosis Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000003141 Tachykinin Human genes 0.000 description 1
- 206010043118 Tardive Dyskinesia Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 208000002903 Thalassemia Diseases 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
- 102000009843 Thyroglobulin Human genes 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 208000000323 Tourette Syndrome Diseases 0.000 description 1
- 208000016620 Tourette disease Diseases 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 208000026911 Tuberous sclerosis complex Diseases 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 102000014384 Type C Phospholipases Human genes 0.000 description 1
- 108010079194 Type C Phospholipases Proteins 0.000 description 1
- KWKJGBHDYJOVCR-SRVKXCTJSA-N Tyr-Ser-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O KWKJGBHDYJOVCR-SRVKXCTJSA-N 0.000 description 1
- AFWXOGHZEKARFH-ACRUOGEOSA-N Tyr-Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=C(O)C=C1 AFWXOGHZEKARFH-ACRUOGEOSA-N 0.000 description 1
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 102000050488 Urotensin II Human genes 0.000 description 1
- 108010018369 Urotensin II Proteins 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
- LZRWTJSPTJSWDN-FKBYEOEOSA-N Val-Trp-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N LZRWTJSPTJSWDN-FKBYEOEOSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- 201000011032 Werner Syndrome Diseases 0.000 description 1
- 108700029631 X-Linked Genes Proteins 0.000 description 1
- 208000028247 X-linked inheritance Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 102000019997 adhesion receptor Human genes 0.000 description 1
- 108010013985 adhesion receptor Proteins 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 208000024447 adrenal gland neoplasm Diseases 0.000 description 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 206010002022 amyloidosis Diseases 0.000 description 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 201000009904 bacterial meningitis Diseases 0.000 description 1
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
- 208000018300 basal ganglia disease Diseases 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229950004398 broxuridine Drugs 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 206010007776 catatonia Diseases 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 230000023549 cell-cell signaling Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000005081 chemiluminescent agent Substances 0.000 description 1
- 239000002975 chemoattractant Substances 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 208000014826 cranial nerve neuropathy Diseases 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- RDFLLVCQYHQOBU-ZOTFFYTFSA-O cyanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=[O+]C1=CC(O)=C2)C=3C=C(O)C(O)=CC=3)=CC1=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 RDFLLVCQYHQOBU-ZOTFFYTFSA-O 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 229940095074 cyclic amp Drugs 0.000 description 1
- 108091007930 cytoplasmic receptors Proteins 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 208000010118 dystonia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000004795 endocrine process Effects 0.000 description 1
- 210000001900 endoderm Anatomy 0.000 description 1
- 210000001163 endosome Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 201000000165 epidural abscess Diseases 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000001667 episodic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003499 exocrine gland Anatomy 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960000301 factor viii Drugs 0.000 description 1
- 201000006061 fatal familial insomnia Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 208000001031 fetal erythroblastosis Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 238000002825 functional assay Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000000609 ganglia Anatomy 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 230000009395 genetic defect Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000012254 genetic linkage analysis Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 108010040856 glutamyl-cysteinyl-alanine Proteins 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930004094 glycosylphosphatidylinositol Natural products 0.000 description 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
- 229940035638 gonadotropin-releasing hormone Drugs 0.000 description 1
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 201000001505 hemoglobinuria Diseases 0.000 description 1
- 208000009429 hemophilia B Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 229940098197 human immunoglobulin g Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 230000035992 intercellular communication Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 244000000056 intracellular parasite Species 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 206010023497 kuru Diseases 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 230000029226 lipidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 231100001023 lymphopenia Toxicity 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 101710130522 mRNA export factor Proteins 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000002865 melanocortin Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 229960003248 mifepristone Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- SLZIZIJTGAYEKK-CIJSCKBQSA-N molport-023-220-247 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CNC=N1 SLZIZIJTGAYEKK-CIJSCKBQSA-N 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 208000005264 motor neuron disease Diseases 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 208000018389 neoplasm of cerebral hemisphere Diseases 0.000 description 1
- 230000010309 neoplastic transformation Effects 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 208000029986 neuroepithelioma Diseases 0.000 description 1
- 201000004931 neurofibromatosis Diseases 0.000 description 1
- RZMLVIHXZGQADB-YLUGYNJDSA-N neuromedin n Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C1=CC=C(O)C=C1 RZMLVIHXZGQADB-YLUGYNJDSA-N 0.000 description 1
- 208000018360 neuromuscular disease Diseases 0.000 description 1
- PCJGZPGTCUMMOT-ISULXFBGSA-N neurotensin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 PCJGZPGTCUMMOT-ISULXFBGSA-N 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 108020004017 nuclear receptors Proteins 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 108091008819 oncoproteins Proteins 0.000 description 1
- 102000027450 oncoproteins Human genes 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 230000014306 paracrine signaling Effects 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000000849 parathyroid Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 201000003045 paroxysmal nocturnal hemoglobinuria Diseases 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 208000029308 periodic paralysis Diseases 0.000 description 1
- 208000027232 peripheral nervous system disease Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000018491 positive regulation of cytokine secretion Effects 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 244000000040 protozoan parasite Species 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 206010061928 radiculitis Diseases 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 208000002574 reactive arthritis Diseases 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000008458 response to injury Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 208000002491 severe combined immunodeficiency Diseases 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000013179 statistical model Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000001548 stomatognathic system Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 108060008037 tachykinin Proteins 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 229960002175 thyroglobulin Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 208000009999 tuberous sclerosis Diseases 0.000 description 1
- 230000005751 tumor progression Effects 0.000 description 1
- 238000010396 two-hybrid screening Methods 0.000 description 1
- 108010087967 type I signal peptidase Proteins 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- HFNHAPQMXICKCF-USJMABIRSA-N urotensin-ii Chemical compound N([C@@H](CC(O)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@@H](C(C)C)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)[C@@H](C)O HFNHAPQMXICKCF-USJMABIRSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 201000010044 viral meningitis Diseases 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention provides purified secretory polynucleotides (sptm). Also encompassed are the polypeptides (SPTM) encoded by sptm. The invention also provides for the use of sptm, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing sptm for the expression of SPTM. The invention additionally provides for the use of isolated and purified SPTM to induce antibodies and to screen libraries of compounds and the use of anti-SPTM
antibodies in diagnostic assays. Also provided are microarrays containing sptm and methods of use.
antibodies in diagnostic assays. Also provided are microarrays containing sptm and methods of use.
Description
SECRETORY MOLECULES
TECHNICAL FIELD
The present invention relates to secretory molecules and to the use of these sequences in the s diagnosis, study, prevention, and treatment of diseases associated with cell signaling.
BACKGROUND OF THE INVENTION
Protein transport and secretion are essential for cellular function. Protein transport is mediated by a signal peptide located at the amino terminus of the protein to be transported or so secreted. The signal peptide is comprised of about ten to twenty hydrophobic amino acids which target the nascent protein from the ribosome to a particular membrane bound compartment such as the endoplasmic reticulum (ER). Proteins targeted to the ER may either proceed through the secretory pathway or remain in any of the secretory organelles such as the ER, Golgi apparatus, or lysosomes.
Proteins that transit through the secretory pathway are either secreted into the extracellular space or is retained in the plasma membrane. Proteins that are retained in the plasma membrane contain one or more transmembrane domains, each comprised of about 20 hydrophobic amino acid residues.
Proteins that are secreted from the cell are generally synthesized as inactive precursors that are activated by post-translational processing events during transit through the secretory pathway. Such events include glycosylation, proteolysis, and removal of the signal peptide by a signal peptidase.
2o Other events that may occur during protein transport include chaperone-dependent unfolding and folding of the nascent protein and interaction of the protein with a receptor or pore complex.
Examples of secretory proteins with amino terminal signal peptides are discussed below and include proteins with important roles in cell-to-cell signaling. Such proteins include transmembrane receptors and cell surface markers, extracellular matrix molecules, cytokines, hormones, growth and 2 s differentiation factors, neuropeptides, vasomediators, ion channels, transporters/pumps, and proteases. (Reviewed in Alberts, B. et al. (1994) Molecular Biology of The Cell, Garland Publishing, New York, NY, pp. 557-560, 582-592.) G-protein coupled receptors (GPCRs) comprise a superfamily of integral membrane proteins which transduce extracellular signals. Not all GPCRs contain N-terminal signal peptides. GPCRs 3 o include receptors for biogenic amines such as dopamine, epinephrine, histamine, glutamate (metabotropic-type), acetylcholine (muscarinic-type), and serotonin; for lipid mediators of inflammation such as prostaglandins, platelet activating factor, and leukotrienes; far peptide hormones such as calcitonin, CSa anaphylatoxin, follicle stimulating hormone, gonadotropin releasing hormone, neurokinin, oxytocin, and thrombin; and for sensory signal mediators such as retinal 35 photopigments and olfactory stimulatory molecules. The structure of these highly conserved receptors consists of seven hydrophobic transmembrane regions, cysteine disulfide bridges between the second and third extracellular loops, an extracellular N-terminus, and a cytoplasmic C-ternunus.
The N-terminus interacts with ligands, the disulfide bridges interact with agonists and antagonists, and the large third intracellular loop interacts with G proteins to activate second messengers such as cyclic AMP, phospholipase C, inositol triphosphate, or ion channels. (Reviewed in Watson, S. and Arkinstall, S. ( 1994) The G-protein Linked Receptor Facts Book, Academic Press, San Diego, CA, pp. 2-6; and Bolander, F.F. (1994) Molecular Endocrinolosy, Academic Press, San Diego, CA, pp.
162-176.) Other types of receptors include cell surface antigens identified on leukocytic cells of the immune system. These antigens have been identified using systematic, monoclonal antibody (mAb)-lo based "shot gun" techniques. These techniques have resulted in the production of hundreds of mAbs directed against unknown cell surface leukocytic antigens. These antigens have been grouped into "clusters of differentiation" based on common immunocytochemical localization patterns in various differentiated and undifferentiated leukocytic cell types. Antigens in a given cluster are presumed to identify a single cell surface protein and are assigned a "cluster of differentiation" or "CD"
designation. Some of the genes encoding proteins identified by CD antigens have been cloned and verified by standard molecular biology techniques. CD antigens have been characterized as both transmembrane proteins and cell surface proteins anchored to the plasma membrane via covalent attachment to fatty acid-containing glycolipids such as glycosylphosphatidylinositol (GPn.
(Reviewed in Barclay, A. N. et al. (1995) The Leucocyte Antigen Facts Book, Academic Press, San zo Diego, CA, pp. 17-20.) Matrix proteins (MPs) are transmembrane and extracellular proteins which function in formation, growth, remodeling, and maintenance of tissues and as important mediators and regulators of the inflammatory response. The expression and balance of MPs may be perturbed by biochemical changes that result from congenital, epigenetic, or infectious diseases. In addition, MPs affect z s leukocyte migration, proliferation, differentiation, and activation in the immune response. MPs are frequently characterized by the presence of one or more domains which may include collagen-like domains, EGF-like domains, immunoglobulin-like domains, and fibronectin-like domains. In addition, MPs may be heavily glycosylated and may contain an Arginine-Glycine-Aspartate (RGD) tripeptide motif which may play a role in adhesive interactions. MPs include extracellular proteins 3o such as fibronectin, collagen, galectin, vitronectin and its proteolytic derivative somatomedin B; and cell adhesion receptors such as cell adhesion molecules (CAMs), cadherins, and integrins. (Reviewed in Ayad, S. et al. (1994) The Extracellular Matrix Facts Book, Academic Press, San Diego, CA, pp. 2-16; Ruoslahti, E. (1997) Kidney Int. 51:1413-1417; Sjaastad, M.D. and Nelson, W.J. (1997) BioEssays 19:47-55.) 35 Cytokines are secreted by hematopoietic cells in response to injury or infection. Interleukins, neurotrophins, growth factors, interferons, and chemokines all define cytokine families that work in conjunction with cellular receptors to regulate cell proliferation and differentiation. In addition, cytokines effect activities such as leukocyte migration and function, hematopoietic cell proliferation, temperature regulation, acute response to infection, tissue remodeling, and apoptosis.
Chemokines, in particular, are small chemoattractant cytokines involved in inflammation, s leukocyte proliferation and migration, angiogenesis and angiostasis, regulation of hematopoiesis, HIV
infectivity, and stimulation of cytokine secretion. Chemokines generally contain 70-100 amino acids and are subdivided into four subfamilies based on the presence of conserved cysteine-based motifs.
(Callard, R. and Gearing, A. (1994) The Cytokine Facts Book, Academic Press, New York, NY, pp.
181-190, 210-213, 223-227.) to Growth and differentiation factors are secreted proteins which function in intercellular communication. Some factors require oligomerization or association with MPs for activity. Complex interactions among these factors and their receptors trigger intracellular signal transduction pathways that stimulate or inhibit cell division, cell differentiation, cell signaling, and cell motility. Most growth and differentiation factors act on cells in their local environment (paracrine signaling). There is are three broad classes of growth and differentiation factors. The first class includes the large polypeptide growth factors such as epidermal growth factor, fibroblast growth factor, transforming growth factor, insulin-like growth factor, and platelet-derived growth factor.
The second class includes the hematopoietic growth factors such as the colony stimulating factors (CSFs).
Hematopoietic growth factors stimulate the proliferation and differentiation of blood cells such as B-20 lymphocytes, T-lymphocytes, erythrocytes, platelets, eosinophils, basophils, neutrophils, macrophages, and their stem cell precursors. The third class includes small peptide factors such as bombesin, vasopressin, oxytocin, endothelin, transferrin, angiotensin II, vasoactive intestinal peptide, and bradykinin which function as hormones to regulate cellular functions other than proliferation.
Growth and differentiation factors play critical roles in neoplastic transformation of cells in 2s vitro and in tumor progression in vivo. Inappropriate expression of growth factors by tumor cells may contribute to vascularization and metastasis of tumors. During hematopoiesis, growth factor misregulation can result in anemias, leukemias, and lymphomas. Certain growth factors such as interferon are cytotoxic to tumor cells both in vivo and in vitro. Moreover, some growth factors and growth factor receptors are related both structurally and functionally to oncoproteins. In addition, 3o growth factors affect transcriptional regulation of both proto-oncogenes and oncosuppressor genes.
(Reviewed in Pimentel, E. (1994) Handbook of Growth Factors, CRC Press, Ann Arbor, MI, pp. 1-9.) Proteolytic enzymes or proteases either activate or deactivate proteins by hydrolyzing peptide bonds. Proteases are found in the cytosol, in membrane-bound compartments, and in the extracellular space. The major families are the zinc, serine, cysteine, thiol, and carboxyl proteases.
3s Ion channels, ion pumps, and transport proteins mediate the transport of molecules across cellular membranes. Transport can occur by a passive, concentration-dependent mechanism or can be linked to an energy source such as ATP hydrolysis. Symporters and antiporters transport ions and small molecules such as amino acids, glucose, and drugs. Symporters transport molecules and ions unidirectionally, and antiporters transport molecules and ions bidirectionally. Transporter superfamilies include facilitative transporters and active ATP-binding cassette transporters which are s involved in multiple-drug resistance and the targeting of antigenic peptides to MHC Class I
molecules. These transporters bind to a specific ion or other molecule and undergo a conformational change in order to transfer the ion or molecule across the membrane. (Reviewed in Alberts, B. et al.
(1994) Molecular Biology of The Cell, Garland Publishing, New York, NY, pp.
523-546.) Ion channels are formed by transmembrane proteins which create a lined passageway across to the membrane through which water and ions, such as Na+, K+, Ca2+, and Cl-, enter and exit the cell.
For example, chloride channels are involved in the regulation of the membrane electric potential as well as absorption and secretion of ions across the membrane. Chloride channels also regulate the internal pH of membrane-bound organelles.
Ion pumps are ATPases which actively maintain membrane gradients. Ion pumps are is classified as P, V, or F according to their structure and function. All have one or more binding sites for ATP in their cytosolic domains. The P-class ion pumps include Ca2+ ATPase and Na'/K+ ATPase and function in transporting H+, Na+, K+, and Caz+ ions. P-class pumps consist of two a and two [3 transmembrane subunits. The V- and F-class ion pumps have similar structures but transport only H+.
F class H+ pumps mediate transport across the membranes of mitochondria and chloroplasts, while V-2 o class H+ pumps regulate acidity inside lysosomes, endosomes, and plant vacuoles.
A family of structurally related intrinsic membrane proteins known as facilitative glucose transporters catalyze the movement of glucose and other selected sugars across the plasma membrane.
The proteins in this family contain a highly conserved, large transmembrane domain comprised of 12 a-helices, and several weakly conserved, cytoplasmic and exoplasmic domains.
(Pessin, J. E., and 2s Bell, G.I. (1992) Annu. Rev. Physiol. 54:911-930.) Amino acid transport is mediated by Na+ dependent amino acid transporters.
These transporters are involved in gastrointestinal and renal uptake of dietary and cellular amino acids and in neuronal reuptake of neurotransmitters. Transport of cationic amino acids is mediated by the system y+ family and the cationic amino acid transporter (CAT) family. Members of the CAT family 3o share a high degree of sequence homology, and each contains 12-14 putative transmembrane domains. (Ito, K. and Groudine, M. (1997) J. Biol. Chem. 272:26780-26786.) Hormones are secreted molecules that travel through the circulation and bind to specific receptors on the surface of, or within, target cells. Although they have diverse biochemical compositions and mechanisms of action, hormones can be grouped into two categories. One category 35 includes small lipophilic hormones that diffuse through the plasma membrane of target cells, bind to cytosolic or nuclear receptors, and form a complex that alters gene expression. Examples of these molecules include retinoic acid, thyroxine, and the cholesterol-derived steroid hormones such as progesterone, estrogen, testosterone, cortisol, and aldosterone. The second category includes hydrophilic hormones that function by binding to cell surface receptors that transduce signals across the plasma membrane. Examples of such hormones include amino acid derivatives such as s catecholamines and peptide hormones such as glucagon, insulin, gastrin, secretin, cholecystokinin, adrenocorticotropic hormone, follicle stimulating hormone, luteinizing hormone, thyroid stimulating hormone, and vasopressin. (See, for example, Lodish et al. (1995) Molecular Cell BioloQV, Scientific American Books Inc., New York, NY, pp. 856-864.) Neuropeptides and vasomediators (NP/VM) comprise a large family of endogenous signaling to molecules. Included in this family are neuropeptides and neuropeptide hormones such as bombesin, neuropeptide Y, neurotensin, neuromedin N, melanocortins, opioids, galanin, somatostatin, tachykinins, urotensin II and related peptides involved in smooth muscle stimulation, vasopressin, vasoactive intestinal peptide, and circulatory system-borne signaling molecules such as angiotensin, complement, calcitonin, endothelins, formyl-methionyl peptides, glucagon, cholecystokinin and 15 gastrin. NP/VMs can transduce signals directly, modulate the activity or release of other neurotransmitters and hormones, and act as catalytic enzymes in cascades. The effects of NP/VMs range from extremely brief to long-lasting. (Reviewed in Martin, C. R. et al.
(1985) Endocrine Physiology, Oxford University Press, New York, NY, pp. 57-62.) The discovery of new secretory molecules satisfies a need in the art by providing new 2o compositions which are useful in the diagnosis, study, prevention, and treatment of diseases associated with cell signaling.
SUMMARY OF THE INVENTION
The present invention relates to nucleic acid sequences comprising human polynucleotides 2s encoding secretory polypeptides that contain signal peptides and/or transmembrane domains. These human polynucleotides (sptm) as presented in the Sequence Listing uniquely identify genes encoding structural, functional, and regulatory polypeptides (SPTM) involved in cell signaling.
The invention provides an isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting 30 of SEQ )D NO:1-26; b) a naturally occurring polynucleotide sequence having at least 90°1o sequence identity to a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; c) a polynucleotide sequence complementary to a); d) a polynucleotide sequence complementary to b);
and e) an RNA equivalent of a) through d). In one alternative, the polynucleotide comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26.
In another 35 alternative, the polynucleotide comprises at least 60 contiguous nucleotides of a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; b) a naturally occurring polynucleotide sequence having at least 90%
sequence identity to a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; c) a polynucleotide sequence complementary to a); d) a polynucleotide sequence complementary to b); and e) an RNA equivalent of a) through d). The invention further provides a composition for s the detection of expression of secretory polynucleotides comprising at least one isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26;
b) a naturally occurring polynucleotide sequence having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ >D NO:1-26; c) a polynucleotide sequence to complementary to a); d) a polynucleotide sequence complementary to b); and e) an RNA equivalent of a) through d); and a detectable label.
The invention also provides a method for detecting a target polynucleotide in a sample, said target polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ )D NO:1-26;
b) a naturally 15 occurnng polynucleotide sequence having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; c) a polynucleotide sequence complementary to a); d) a polynucleotide sequence complementary to b); and e) an RNA equivalent of a) through d). The method comprises a) hybridizing the sample with a probe comprising at least 20 contiguous nucleotides comprising a sequence complementary to said target polynucleotide in the 2o sample, and which probe specifically hybridizes to said target polynucleotide, under conditions whereby a hybridization complex is formed between said probe and said target polynucleotide, and b) detecting the presence or absence of said hybridization complex, and, optionally, if present, the amount thereof. In one alternative, the probe comprises at least 30 contiguous nucleotides. In another alternative, the probe comprises at least 60 contiguous nucleotides.
z 5 The invention further provides a recombinant polynucleotide comprising a promoter sequence operably linked to an isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; b) a naturally occurring polynucleotide sequence having at least 90%
sequence identity to a polynucleotide sequence selected from the group consisting of SEQ )D NO:1-26;
c) a polynucleotide 3o sequence complementary to a); d) a polynucleotide sequence complementary to b); and e) an RNA
equivalent of a) through d). In one alternative, the invention provides a cell transformed with the recombinant polynucleotide. In another alternative, the invention provides a transgenic organism comprising the recombinant polynucleotide. In a further alternative, the invention provides a method for producing a secretory polypeptide, the method comprising a) culturing a cell under conditions 35 suitable for expression of the secretory polypeptide, wherein said cell is transformed with the recombinant polynucleotide, and b) recovering the secretory polypeptide so expressed.
The invention also provides a purified secretory polypeptide (SPTM) encoded by at least one polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ 1D
NO:1-26. Additionally, the invention provides an isolated antibody which specifically binds to the secretory polypeptide. The invention further provides a method of identifying a test compound which specifically binds to the secretory polypeptide, the method comprising the steps of a) providing a test compound; b) combining the secretory polypeptide with the test compound for a sufficient time and under suitable conditions for binding; and c) detecting binding of the secretory polypeptide to the test compound, thereby identifying the test compound which specifically binds the secretory polypeptide.
The invention further provides a microarray wherein at least one element of the microarray is to an isolated polynucleotide comprising at least 60 contiguous nucleotides of a polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ )D NO:1-26; b) a naturally occurring polynucleotide sequence having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ )D NO:1-26; c) a polynucleotide sequence complementary to a); d) is a polynucleotide sequence complementary to b); and e) an RNA equivalent of a) through d). The invention also provides a method for generating a transcript image of a sample which contains polynucleotides. The method comprises a) labeling the polynucleotides of the sample, b) contacting the elements of the microarray with the labeled polynucleotides of the sample under conditions suitable for the formation of a hybridization complex, and c) quantifying the expression of the 2o polynucleotides in the sample.
Additionally, the invention provides a method for screening a compound for effectiveness in altering expression of a target polynucleotide, wherein said target polynucleotide comprises a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ 1D NO:1-26; b) a naturally occurnng polynucleotide sequence 25 having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ >D NO:1-26; c) a polynucleotide sequence complementary to a); d) a polynucleotide sequence complementary to b); and e) an RNA equivalent of a) through d). The method comprises a) exposing a sample comprising the target polynucleotide to a compound, and b) detecting altered expression of the target polynucleotide.
3o The invention further provides a method for detecting a target polynucleotide in a sample for toxicity testing of a compound, said target polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ 1D NO:1-26; b) a naturally occurring polynucleotide sequence having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; c) a 35 polynucleotide sequence complementary to a); d) a polynucleotide sequence complementary to b);
and e) an RNA equivalent of a) through d). The method comprises a) hybridizing the sample with a probe comprising at least 20 contiguous nucleotides comprising a sequence complementary to said target polynucleotide in the sample, and which probe specifically hybridizes to said target polynucleotide, under conditions whereby a hybridization complex is formed between said probe and said target polynucleotide, b) detecting the presence or absence of said hybridization complex, and, optionally, if present, the amount thereof, and c) comparing the presence, absence or amount of said target polynucleotide in a first biological sample and a second biological sample, wherein said first biological sample has been contacted with said compound, and said second sample is a control, whereby a change in presence, absence or amount of said target polynucleotide in said first sample, as compared with said second sample, is indicative of toxic response to said compound.
to DESCRIPTION OF THE TABLES
Table 1 shows the sequence identification numbers (SEQ ID NOa) and template identification numbers (template IDs) corresponding to the polynucleotides of the present invention, along with their GenBank hits (GI Numbers), probability scores, and functional annotations is corresponding to the GenBank hits.
Table 2 shows the sequence identification numbers (SEQ >D NOa) and template identification numbers (template IDs) corresponding to the polynucleotides of the present invention, along with polynucleotide segments of each template sequence as defined by the indicated "start" and "stop" nucleotide positions. The reading frames of the polynucleotide segments are shown, and the 2 o polypeptides encoded by the polynucleotide segments constitute either signal peptide (SP) or transmembrane (TM) domains, as indicated.
Table 3 shows the sequence identification numbers (SEQ )D NOa) and template identification numbers (template IDs) corresponding to the polynucleotides of the present invention, along with component sequence identification numbers (component IDs) corresponding to each 2 s template. The component sequences, which were used to assemble the template sequences, are defined by the indicated "start" and "stop" nucleotide positions along each template.
Table 4 summarizes the bioinformatics tools which are useful for analysis of the polynucleotides of the present invention. The first column of Table 4 lists analytical tools, programs, and algorithms, the second column provides brief descriptions thereof, the third column presents 3 o appropriate references, all of which are incorporated by reference herein in their entirety, and the fourth column presents, where applicable, the scores, probability values, and other parameters used to evaluate the strength of a match between two sequences (the higher the score, the greater the homology between two sequences).
Before the nucleic acid sequences and methods are presented, it is to be understood that this invention is not limited to the particular machines, methods, and materials described. Although particular embodiments are described, machines, methods, and materials similar or equivalent to these embodiments may be used to practice the invention. The preferred machines, methods, and materials set forth are not intended to limit the scope of the invention which is limited only by the s appended claims.
The singular forms "a", "an", and "the" include plural reference unless the context clearly dictates otherwise. All technical and scientific terms have the meanings commonly understood by one of ordinary skill in the art. All publications are incorporated by reference for the purpose of describing and disclosing the cell lines, vectors, and methodologies which are presented and which to might be used in connection with the invention. Nothing in the specification is to be construed as an admission that the invention is not entitled to antedate such disclosure by virtue of prior invention.
Definitions As used herein, the lower case "sptm" refers to a nucleic acid sequence, while the upper case 15 "SPTM" refers to an amino acid sequence encoded by sptm. A "full-length"
sptm refers to a nucleic acid sequence containing the entire coding region of a gene endogenously expressed in human tissue.
"Adjuvants" are materials such as Freund's adjuvant, mineral gels (aluminum hydroxide), and' surface active substances (lysolecithin, pluronic polyols, polyanions, peptides" oil emulsions, keyhole limpet hemocyanin, and dinitrophenol) which may be administered to increase a host's 2 o immunological response.
"Allele" refers to an alternative form of a nucleic acid sequence. Alleles result from a "mutation," a change or an alternative reading of the genetic code. Any given gene may have none, one, or many allelic forms. Mutations which give rise to alleles include deletions, additions, or substitutions of nucleotides. Each of these changes may occur alone, or in combination with the 25 others, one or more times in a given nucleic acid sequence. The present invention encompasses allelic sptm.
"Amino acid sequence" refers to a peptide, a polypeptide, or a protein of either natural or synthetic origin. The amino acid sequence is not limited to the complete, endogenous amino acid sequence and may be a fragment, epitope, variant, or derivative of a protein expressed by a nucleic 3 o acid sequence.
"Amplification" refers to the production of additional copies of a sequence and is carried out using polymerase chain reaction (PCR) technologies well known in the art.
"Antibody" refers to intact molecules as well as to fragments thereof, such as Fab, F(ab')2, and Fv fragments, which are capable of binding the epitopic determinant.
Antibodies that bind SPTM
35 polypeptides can be prepared using intact polypeptides or using fragments containing small peptides of interest as the immunizing antigen. The polypeptide or peptide used to immunize an animal (e.g., a mouse, a rat, or a rabbit) can be derived from the translation of RNA, or synthesized chemically, and can be conjugated to a carrier protein if desired. Commonly used Garners that are chemically coupled to peptides include bovine serum albumin, thyroglobulin, and keyhole limpet hemocyanin (KLH).
The coupled peptide is then used to immunize the animal.
"Antisense sequence" refers to a sequence capable of specifically hybridizing to a target sequence. The antisense sequence may include DNA, RNA, or any nucleic acid mimic or analog such as peptide nucleic acid (PNA); oligonucleotides having modified backbone linkages such as phosphorothioates, methylphosphonates, or benzylphosphonates; oligonucleotides having modified sugar groups such as 2'-methoxyethyl sugars or 2'-methoxyethoxy sugars; or oligonucleotides having to modified bases such as 5-methyl cytosine, 2'-deoxyuracil, or 7-deaza-2'-deoxyguanosine.
"Antisense sequence" refers to a sequence capable of specifically hybridizing to a target sequence. The antisense sequence can be DNA, RNA, or any nucleic acid mimic or analog.
"Antisense technology" refers to any technology which relies on the specific hybridization of an antisense sequence to a target sequence.
A "bin" is a portion of computer memory space used by a computer program for storage of data, and bounded in such a manner that data stored in a bin may be retrieved by the program.
"Biologically active" refers to an amino acid sequence having a structural, regulatory, or biochemical function of a naturally occurring amino acid sequence.
"Clone joining" is a process for combining gene bins based upon the bins' containing 2 o sequence information from the same clone. The sequences may assemble into a primary gene transcript as well as one or more splice variants.
"Complementary" describes the relationship between two single-stranded nucleic acid sequences that anneal by base-pairing (5'-A-G-T-3' pairs with its complement 3'-T-C-A-5').
A "component sequence" is a nucleic acid sequence selected by a computer program such as PHRED and used to assemble a consensus or template sequence from one or more component sequences.
A "consensus sequence" or "template sequence" is a nucleic acid sequence which has been assembled from overlapping sequences, using a computer program for fragment assembly such as the GELVIEW fragment assembly system (Genetics Computer Group (GCG), Madison WI) or using a 3o relational database management system (RDMS).
"Conservative amino acid substitutions" are those substitutions that, when made, least interfere with the properties of the original protein, i.e., the structure and especially the function of the protein is conserved and not significantly changed by such substitutions.
The table below shows amino acids which may be substituted for an original amino acid in a protein and which are regarded as conservative substitutions.
Original Residue Conservative Substitution Ala Gly, Ser Arg His, Lys Asn Asp, Gln, His Asp Asn, Glu Cys Ala, Ser Gln Asn, Glu, His Glu Asp, Gln, His Gly Ala to His Asn, Arg, Gln, Glu Ile Leu, Val Leu Ile, Val Lys Arg, Gln, Glu Met Leu, Ile Phe His, Met, Leu, Trp, Tyr Ser Cys, Thr Thr Ser, Val Trp Phe, Tyr Tyr His, Phe, Trp 2o Val Ile, Leu, Thr Conservative substitutions generally maintain (a) the structure of the polypeptide backbone in the area of the substitution, for example, as a beta sheet or alpha helical conformation, (b) the charge or hydrophobicity of the molecule at the target site, or (c) the bulk of the side chain.
"Deletion" refers to a change in either a nucleic or amino acid sequence in which at least one nucleotide or amino acid residue, respectively, is absent.
"Derivative" refers to the chemical modification of a nucleic acid sequence, such as by replacement of hydrogen by an alkyl, acyl, amino, hydroxyl, or other group.
3 o The terms "element" and "array element" refer to a polynucleotide, polypeptide, or other chemical compound having a unique and defined position on a microarray.
"E-value" refers to the statistical probability that a match between two sequences occurred by chance.
A "fragment" is a unique portion of sptm or SPTM which is identical in sequence to but shorter in length than the parent sequence. A fragment may comprise up to the entire length of the defined sequence, minus one nucleotidelamino acid residue. For example, a fragment may comprise from 10 to 1000 contiguous amino acid residues or nucleotides. A fragment used as a probe, primer, antigen, therapeutic molecule, or for other purposes, may be at least 5, 10, 15, 16, 20, 25, 30, 40, 50, 60, 75, 100, 150, 250 or at least 500 contiguous amino acid residues or nucleotides in length.
4o Fragments may be preferentially selected from certain regions of a molecule. For example, a polypeptide fragment may comprise a certain length of contiguous amino acids selected from the first 250 or 500 amino acids (or first 25% or 50%) of a polypeptide as shown in a certain defined sequence. Clearly these lengths are exemplary, and any length that is supported by the specification, including the Sequence Listing and the figures, may be encompassed by the present embodiments.
A fragment of sptm comprises a region of unique polynucleotide sequence that specifically identifies sptm, for example, as distinct from any other sequence in the same genome. A fragment of sptm is useful, for example, in hybridization and amplification technologies and in analogous methods that distinguish sptm from related polynucleotide sequences. The precise length of a fragment of sptm and the region of sptm to which the fragment corresponds are routinely determinable by one of ordinary skill in the art based on the intended purpose for the fragment.
A fragment of SPTM is encoded by a fragment of sptm. A fragment of SPTM
comprises a 1o region of unique amino acid sequence that specifically identifies SPTM. For example, a fragment of SPTM is useful as an immunogenic peptide for the development of antibodies that specifically recognize SPTM. The precise length of a fragment of SPTM and the region of SPTM to which the fragment corresponds are routinely determinable by one of ordinary skill in the art based on the intended purpose for the fragment.
A "full length" nucleotide sequence is one containing at least a start site for translation to a protein sequence, followed by an open reading frame and a stop site, and encoding a "full length"
polypeptide.
"Hit" refers to a sequence whose annotation will be used to describe a given template.
Criteria for selecting the top hit are as follows: if the template has one or more exact nucleic acid 2 o matches, the top hit is the exact match with highest percent identity. If the template has no exact matches but has significant protein hits, the top hit is the protein hit with the lowest E-value. If the template has no significant protein hits, but does have significant non-exact nucleotide hits, the top hit is the nucleotide hit with the lowest E-value.
"Homology" refers to sequence similarity either between a reference nucleic acid sequence 2 5 and at least a fragment of an sptm or between a reference amino acid sequence and a fragment of an SPTM.
"Hybridization" refers to the process by which a strand of nucleotides anneals with a complementary strand through base pairing. Specific hybridization is an indication that two nucleic acid sequences share a high degree of identity. Specific hybridization complexes form under defined 3 o annealing conditions, and remain hybridized after the "washing" step. The defined hybridization conditions include the annealing conditions and the washing step(s), the latter of which is particularly important in determining the stringency of the hybridization process, with more stringent conditions allowing less non-specific binding, i.e., binding between pairs of nucleic acid probes that are not perfectly matched. Permissive conditions for annealing of nucleic acid sequences are routinely 35 determinable and may be consistent among hybridization experiments, whereas wash conditions may be varied among experiments to achieve the desired stringency.
Generally, stringency of hybridization is expressed with reference to the temperature under which the wash step is carried out. Generally, such wash temperatures are selected to be about 5°C to 20°C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. The T", is the temperature (under defined ionic strength and pH) at which 50% of the target s sequence hybridizes to a perfectly matched probe. An equation for calculating Tm and conditions for nucleic acid hybridization is well known and can be found in Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, 2°° ed., vol. 1-3, Cold Spring Harbor Press, Plainview NY;
specifically see volume 2, chapter 9.
High stringency conditions for hybridization between polynucleotides of the present to invention include wash conditions of 68°C in the presence of about 0.2 x SSC and about 0.1% SDS, for 1 hour. Alternatively, temperatures of about 65°C, 60°C, or 55°C may be used. SSC
concentration may be varied from about 0.2 to 2 x SSC, with SDS being present at about 0.1 %.
Typically, blocking reagents are used to block non-specific hybridization.
Such blocking reagents include, for instance, denatured salmon sperm DNA at about 100-200 pg/ml.
Useful variations on 15 these conditions will be readily apparent to those skilled in the art.
Hybridization, particularly under high stringency conditions, may be suggestive of evolutionary similarity between the nucleotides.
Such similarity is strongly indicative of a similar role for the nucleotides and their resultant proteins.
Other parameters, such as temperature, salt concentration, and detergent concentration may be varied to achieve the desired stringency. Denaturants, such as formanude at a concentration of 2o about 35-50% v/v, may also be used under particular circumstances, such as RNA:DNA
hybridizations. Appropriate hybridization conditions are routinely determinable by one of ordinary skill in the art.
"Immunogenic" describes the potential for a natural, recombinant, or synthetic peptide, epitope, polypeptide, or protein to induce antibody production in appropriate animals, cells, or cell 25 lines.
"Insertion" or "addition" refers to a change in either a nucleic or amino acid sequence in which at least one nucleotide or residue, respectively, is added to the sequence.
"Labeling" refers to the covalent or noncovalent joining of a polynucleotide, polypeptide, or antibody with a reporter molecule capable of producing a detectable or measurable signal.
30 "Microarray" is any arrangement of nucleic acids, amino acids, antibodies, etc., on a substrate. The substrate may be a solid support such as beads, glass, paper, nitrocellulose, nylon, or an appropriate membrane.
"Linkers" are short stretches of nucleotide sequence which may be added to a vector or an sptm to create restriction endonuclease sites to facilitate cloning.
"Polylinkers" are engineered to 35 incorporate multiple restriction enzyme sites and to provide for the use of enzymes which leave 5' or 3' overhangs (e.g., BamHI, EcoRI, and HindII>] and those which provide blunt ends (e.g., EcoRV, SnaBI, and Stun.
"Naturally occurring" refers to an endogenous polynucleotide or polypeptide that may be isolated from viruses or prokaryotic or eukaryotic cells.
"Nucleic acid sequence" refers to the specific order of nucleotides joined by phosphodiester bonds in a linear, polymeric arrangement. Depending on the number of nucleotides, the nucleic acid sequence can be considered an oligomer, oligonucleotide, or polynucleotide.
The nucleic acid can be DNA, RNA, or any nucleic acid analog, such as PNA, may be of genomic or synthetic origin, may be either double-stranded or single-stranded, and can represent either the sense or antisense i o (complementary) strand.
"Oligomer" refers to a nucleic acid sequence of at least about 6 nucleotides and as many as about 60 nucleotides, preferably about 15 to 40 nucleotides, and most preferably between about 20 and 30 nucleotides, that may be used in hybridization or amplification technologies. Oligomers may be used as, e.g., primers for PCR, and are usually chemically synthesized.
"Operably linked" refers to the situation in which a first nucleic acid sequence is placed in a functional relationship with the second nucleic acid sequence. For instance, a promoter is operably linked to a coding sequence if the promoter affects the transcription or expression of the coding sequence. Generally, operably linked DNA sequences may be in close proxinuty or contiguous and, where necessary to join two protein coding regions, in the same reading frame.
"Peptide nucleic acid" (PNA) refers to a DNA mimic in which nucleotide bases are attached to a pseudopeptide backbone to increase stability. PNAs, also designated antigene agents, can prevent gene expression by targeting complementary messenger RNA.
The phrases "percent identity" and "% identity", as applied to polynucleotide sequences, refer to the percentage of residue matches between at least two polynucleotide sequences aligned using a standardized algorithm. Such an algorithm may insert, in a standardized and reproducible way, gaps in the sequences being compared in order to optimize alignment between two sequences, and therefore achieve a more meaningful comparison of the two sequences.
Percent identity between polynucleotide sequences may be determined using the default parameters of the CLUSTAL V algorithm as incorporated into the MEGALIGN
version 3.12e 3o sequence alignment program. This program is part of the LASERGENE software package, a suite of molecular biological analysis programs (DNASTAR, Madison WI). CLUSTAL V is described in Higgins, D.G. and Sharp, P.M. (1989) CABIOS 5:151-153 and in Higgins, D.G. et al. (1992) CABIOS 8:189-191. For pairwise alignments of polynucleotide sequences, the default parameters are set as follows: Ktuple=2, gap penalty=5, window=4, and "diagonals saved"=4.
The "weighted"
residue weight table is selected as the default. Percent identity is reported by CLUSTAL V as the "percent similarity" between aligned polynucleotide sequence pairs.
Alternatively, a suite of commonly used and freely available sequence comparison algorithms is provided by the National Center for Biotechnology Information (NCBI) Basic Local Alignment Search Tool (BLAST) (Altschul, S.F. et al. (1990) J. Mol. Biol. 215:403-410), which is available from several sources, including the NCBI, Bethesda, MD, and on the Internet at http://www.ncbi.nlm.nih.gov/BLAST/. The BLAST software suite includes various sequence analysis programs including "blastn," that is used to determine alignment between a known polynucleotide sequence and other sequences on a variety of databases. Also available is a tool called "BLAST 2 Sequences" that is used for direct pairwise comparison of two nucleotide sequences.
"BLAST 2 Sequences" can be accessed and used interactively at to http:/lwww.ncbi.nlm.nih.govlgorf/b12/. The "BLAST 2 Sequences" tool can be used for both blastn and blastp (discussed below). BLAST programs are commonly used with gap and other parameters set to default settings. For example, to compare two nucleotide sequences, one may use blastn with the "BLAST 2 Sequences" tool Version 2Ø9 (May-07-1999) set at default parameters. Such default parameters may be, for example:
Matrix: BLOSUM62 Reward for match: 1 Penalty for mismatch: -2 Open Gap: S and Extension Gap: 2 penalties Gap x drop-off.' SO
z o Expect: 70 Word Size: J I
Filter: on Percent identity may be measured over the length of an entire defined sequence, for example, as defined by a particular SEQ ID number, or may be measured over a shorter length, for example, over the length of a fragment taken from a larger, defined sequence, for instance, a fragment of at least 20, at least 30, at least 40, at least 50, at least 70, at least 100, or at least 200 contiguous nucleotides. Such lengths are exemplary only, and it is understood that any fragment length supported by the sequences shown herein, in figures or Sequence Listings, may be used to describe a length over which percentage identity may be measured.
3 o Nucleic acid sequences that do not show a high degree of identity may nevertheless encode similar amino acid sequences due to the degeneracy of the genetic code. It is understood that changes in nucleic acid sequence can be made using this degeneracy to produce multiple nucleic acid sequences that all encode substantially the same protein.
The phrases "percent identity" and "°!o identity", as applied to polypeptide sequences, refer to the percentage of residue matches between at least two polypeptide sequences aligned using a standardized algorithm. Methods of polypeptide sequence alignment are well-known. Some alignment methods take into account conservative amino acid substitutions.
Such conservative substitutions, explained in more detail above, generally preserve the hydrophobicity and acidity of the substituted residue, thus preserving the structure (and therefore function) of the folded polypeptide.
Percent identity between polypeptide sequences may be determined using the default parameters of the CLUSTAL V algorithm as incorporated into the MEGALIGN
version 3.12e sequence alignment program (described and referenced above). For pairwise alignments of polypeptide sequences using CLUSTAL V, the default parameters are set as follows: Ktuple=1, gap penalty=3, window=5, and "diagonals saved"=5. The PAM250 matrix is selected as the default residue weight table. As with polynucleotide alignments, the percent identity is reported by 1o CLUSTAL V as the "percent similarity" between aligned polypeptide sequence pairs.
Alternatively the NCBI BLAST software suite may be used. For example, for a pairwise comparison of two polypeptide sequences, one may use the "BLAST 2 Sequences"
tool Version 2Ø9 (May-07-1999) with blastp set at default parameters. Such default parameters may be, for example:
Matrix: BLOSUM62 Open Gap: 1l and Extension Gap: l penalty Cap x drop-off.' S0 Expect: 10 Word Size: 3 Filter: on 2o Percent identity may be measured over the length of an entire defined polypeptide sequence, for example, as defined by a particular SEQ ID number, or may be measured over a shorter length, for example, over the length of a fragment taken from a larger, defined polypeptide sequence, for instance, a fragment of at least 15, at least 20, at least 30, at least 40, at least 50, at least 70 or at least 150 contiguous residues. Such lengths are exemplary only, and it is understood that any fragment length supported by the sequences shown herein, in figures or Sequence Listings, may be used to describe a length over which percentage identity may be measured.
"Post-translational modification" of an SPTM may involve lipidation, glycosylation, phosphorylation, acetylation, racemization, proteolytic cleavage, and other modifications known in the art. These processes may occur synthetically or biochemically. Biochemical modifications will 3 o vary by cell type depending on the enzymatic milieu and the SPTM.
"Probe" refers to sptm or fragments thereof, which are used to detect identical, allelic or related nucleic acid sequences. Probes are isolated oligonucleotides or polynucleotides attached to a detectable label or reporter molecule. Typical labels include radioactive isotopes, ligands, chemiluminescent agents, and enzymes. "Primers" are short nucleic acids, usually DNA
oligonucleotides, which may be annealed to a target polynucleotide by complementary base-pairing.
The primer may then be extended along the target DNA strand by a DNA
polymerase enzyme.
Primer pairs can be used for amplification (and identification) of a nucleic acid sequence, e.g., by the polymerase chain reaction (PCR).
Probes and primers as used in the present invention typically comprise at least 15 contiguous nucleotides of a known sequence. In order to enhance specificity, longer probes and primers may also be employed, such as probes and primers that comprise at least 20, 30, 40, 50, 60, 70, 80, 90, 100, or at least 150 consecutive nucleotides of the disclosed nucleic acid sequences.
Probes and primers may be considerably longer than these examples, and it is understood that any length supported by the specification, including the figures and Sequence Listing, may be used.
Methods for preparing and using probes and primers are described in the references, for to example Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, 2"d ed., vol. 1-3, Cold Spring Harbor Press, Plainview NY; Ausubel et a1.,1987, Current Protocols in Molecular Biology, Greene Publ. Assoc. & Wiley-Intersciences, New York NY; Innis et al., 1990, PCR Protocols, A
Guide to Methods and Applications, Academic Press, San Diego CA. PCR primer pairs can be derived from a known sequence, for example, by using computer programs intended for that purpose such as Primer (Version 0.5, 1991, Whitehead Institute for Biomedical Research, Cambridge MA).
Oligonucleotides for use as primers are selected using software known in the art for such purpose. For example, OLIGO 4.06 software is useful for the selection of PCR
primer pairs of up to 100 nucleotides each, and for the analysis of oligonucleotides and larger polynucleotides of up to 5,000 nucleotides from an input polynucleotide sequence of up to 32 kilobases.
Similar primer 2 o selection programs have incorporated additional features for expanded capabilities. For example, the PrimOU primer selection program (available to the public from the Genome Center at University of Texas South West Medical Center, Dallas TX) is capable of choosing specific primers from megabase sequences and is thus useful for designing primers on a genome-wide scope. The Primer3 primer selection program (available to the public from the Whitehead Institute/MIT Center for 2 s Genome Research, Cambridge MA) allows the user to input a "mispriming library," in which sequences to avoid as primer binding sites are user-specified. Primer3 is useful, in particular, for the selection of oligonucleotides for microarrays. (The source code for the latter two primer selection programs may also be obtained from their respective sources and modified to meet the user's specific needs.) The PrimeGen program (available to the public from the UK Human Genome Mapping 3o Project Resource Centre, Cambridge UK) designs primers based on multiple sequence alignments, thereby allowing selection of primers that hybridize to either the most conserved or least conserved regions of aligned nucleic acid sequences. Hence, this program is useful for identification of both unique and conserved oligonucleotides and polynucleotide fragments. The oligonucleotides and polynucleotide fragments identified by any of the above selection methods are useful in hybridization 3 s technologies, for example, as PCR or sequencing primers, microarray elements, or specific probes to identify fully or partially complementary polynucleotides in a sample of nucleic acids. Methods of oligonucleotide selection are not limited to those described above.
"Purified" refers to molecules, either polynucleotides or polypeptides that are isolated or separated from their natural environment and are at least 60% free, preferably at least 75% free, and most preferably at least 90% free from other compounds with which they are naturally associated.
A "recombinant nucleic acid" is a sequence that is not naturally occurnng or has a sequence that is made by an artificial combination of two or more otherwise separated segments of sequence.
This artificial combination is often accomplished by chemical synthesis or, more commonly, by the artificial manipulation of isolated segments of nucleic acids, e.g., by genetic engineering techniques to such as those described in Sambrook, supra. The term recombinant includes nucleic acids that have been altered solely by addition, substitution, or deletion of a portion of the nucleic acid. Frequently, a recombinant nucleic acid may include a nucleic acid sequence operably linked to a promoter sequence. Such a recombinant nucleic acid may be part of a vector that is used, for example, to transform a cell.
Alternatively, such recombinant nucleic acids may be part of a viral vector, e.g., based on a vaccinia virus, that could be use to vaccinate a mammal wherein the recombinant nucleic acid is expressed, inducing a protective immunological response in the mammal.
"Regulatory element" refers to a nucleic acid sequence from nontranslated regions of a gene, and includes enhancers, promoters, introns, and 3' untranslated regions, which interact with host 2 o proteins to carry out or regulate transcription or translation.
"Reporter" molecules are chemical or biochemical moieties used for labeling a nucleic acid, an amino acid, or an antibody. They include radionuclides; enzymes;
fluorescent, chemiluminescent, or chromogenic agents; substrates; cofactors; inhibitors; magnetic particles;
and other moieties known in the art.
An "RNA equivalent," in reference to a DNA sequence, is composed of the same linear sequence of nucleotides as the reference DNA sequence with the exception that all occurrences of the nitrogenous base thymine are replaced with uracil, and the sugar backbone is composed of ribose instead of deoxyribose.
"Sample" is used in its broadest sense. Samples may contain nucleic or amino acids, 3o antibodies, or other materials, and may be derived from any source (e.g., bodily fluids including, but not limited to, saliva, blood, and urine; chromosome(s), organelles, or membranes isolated from a cell; genomic DNA, RNA, or cDNA in solution or bound to a substrate; and cleared cells or tissues or blots or imprints from such cells or tissues).
"Specific binding" or "specifically binding" refers to the interaction between a protein or peptide and its agonist, antibody, antagonist, or other binding partner. The interaction is dependent upon the presence of a particular structure of the protein, e.g., the antigenic determinant or epitope, recognized by the binding molecule. For example, if an antibody is specific for epitope "A," the presence of a polypeptide containing epitope A, or the presence of free unlabeled A, in a reaction containing free labeled A and the antibody will reduce the amount of labeled A
that binds to the antibody.
"Substitution" refers to the replacement of at least one nucleotide or amino acid by a different nucleotide or anuno acid.
"Substrate" refers to any suitable rigid or semi-rigid support including, e.g., membranes, filters, chips, slides, wafers, fibers, magnetic or nonmagnetic beads, gels, tubing, plates, polymers, microparticles or capillaries. The substrate can have a variety of surface forms, such as wells, Zo trenches, pins, channels and pores, to which polynucleotides or polypeptides are bound.
A "transcript image" refers to the collective pattern of gene expression by a particular tissue or cell type under given conditions at a given time.
"Transformation" refers to a process by which exogenous DNA enters a recipient cell.
Transformation may occur under natural or artificial conditions using various methods well known in i5 the art. Transformation may rely on any known method for the insertion of foreign nucleic acid sequences into a prokaryotic or eukaryotic host cell. The method is selected based on the host cell being transformed.
"Transformants" include stably transformed cells in which the inserted DNA is capable of replication either as an autonomously replicating plasmid or as part of the host chromosome, as well zo as cells which transiently express inserted DNA or RNA.
A "transgenic organism," as used herein, is any organism, including but not limited to animals and plants, in which one or more of the cells of the organism contains heterologous nucleic acid introduced by way of human intervention, such as by transgenic techniques well known in the art.
The nucleic acid is introduced into the cell, directly or indirectly by introduction into a precursor of 25 the cell, by way of deliberate genetic manipulation, such as by microinjection or by infection with a recombinant virus. The term genetic manipulation does not include classical cross-breeding, or in vitro fertilization, but rather is directed to the introduction of a recombinant DNA molecule. The transgenic organisms contemplated in accordance with the present invention include bacteria, cyanobacteria, fungi, and plants and animals. The isolated DNA of the present invention can be s o introduced into the host by methods known in the art, for example infection, transfection, transformation or transconjugation. Techniques for transferring the DNA of the present invention into such organisms are widely known and provided in references such as Sambrook et al. (1989), supra.
A "variant" of a particular nucleic acid sequence is defined as a nucleic acid sequence having 35 at least 25% sequence identity to the particular nucleic acid sequence over a certain length of one of the nucleic acid sequences using blastn with the "BLAST 2 Sequences" tool Version 2Ø9 (May-07-1999) set at default parameters. Such a pair of nucleic acids may show, for example, at least 30%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95% or even at least 98% or greater sequence identity over a certain defined length. The variant may result in "conservative"
amino acid changes which do not affect structural and/or chemical properties.
A variant may be described as, for example, an "allelic" (as defined above), "splice,"
"species," or "polymorphic"
variant. A splice variant may have significant identity to a reference molecule, but will generally have a greater or lesser number of polynucleotides due to alternate splicing of exons during mRNA
processing. The corresponding polypeptide may possess additional functional domains or lack domains that are present in the reference molecule. Species variants are polynucleotide sequences to that vary from one species to another. The resulting polypeptides generally will have significant amino acid identity relative to each other. A polymorphic variant is a variation in the polynucleotide sequence of a particular gene between individuals of a given species.
Polymorphic variants also may encompass "single nucleotide polymorphisms" (SNPs) in which the polynucleotide sequence varies by one base. The presence of SNPs may be indicative of, for example, a certain population, a disease is state, or a propensity for a disease state.
In an alternative, variants of the polynucleotides of the present invention may be generated through recombinant methods. One possible method is a DNA shuffling technique such as MOLECULARBREEDING (Maxygen Inc., Santa Clara CA; described in U.S. Patent Number 5,837,458; Chang, C.-C. et al. (1999) Nat. Biotechnol. 17:793-797; Christians, F.C. et al. (1999) Nat.
2o Biotechnol. 17:259-264; and Crameri, A. et al. (1996) Nat. Biotechnol.
14:315-319) to alter or improve the biological properties of SPTM, such as its biological or enzymatic activity or its ability to bind to other molecules or compounds. DNA shuffling is a process by which a library of gene variants is produced using PCR-mediated recombination of gene fragments. The library is then subjected to selection or screening procedures that identify those gene variants with the desired 25 properties. These preferred variants may then be pooled and further subjected to recursive rounds of DNA shuffling and selectionlscreening. Thus, genetic diversity is created through "artificial"
breeding and rapid molecular evolution. For example, fragments of a single gene containing random point mutations may be recombined, screened, and then reshuffled until the desired properties are optimized. Alternatively, fragments of a given gene may be recombined with fragments of 3 o homologous genes in the same gene fanuly, either from the same or different species, thereby maximizing the genetic diversity of multiple naturally occurring genes in a directed and controllable manner.
A "variant" of a particular polypeptide sequence is defined as a polypeptide sequence having at least 40% sequence identity to the particular polypeptide sequence over a certain length of one of 35 the polypeptide sequences using blastp with the "BLAST 2 Sequences" tool Version 2Ø9 (May-07-1999) set at default parameters. Such a pair of polypeptides may show, for example, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, or at least 98% or greater sequence identity over a certain defined length of one of the polypeptides.
THE INVENTION
In a particular embodiment, cDNA sequences derived from human tissues and cell lines were aligned based on nucleotide sequence identity and assembled into "consensus"
or "template"
sequences which are designated by the template identification numbers (template IDs) in column 2 of Table 1. The sequence identification numbers (SEQ ID NOa) corresponding to the template IDs are shown in column 1. The template sequences have similarity to GenBank sequences, or "hits," as to designated by the GI Numbers in column 3. The statistical probability of each GenBank hit is indicated by a probability score in column 4, and the functional annotation corresponding to each GenBank hit is listed in column 5.
Segments of each template sequences are defined by the "start" and "stop"
nucleotide positions listed in columns 3 and 4 of Table 2. These segments, when translated in the reading frames i5 indicated in column 5, have similarity to signal peptide (SP) or transmembrane (TM) domain consensus sequences, as indicated in column 6.
The invention incorporates the nucleic acid sequences of these templates as disclosed in the Sequence Listing and the use of these sequences in the diagnosis and treatment of disease states characterized by defects in cell signaling. The invention further utilizes these sequences in 2o hybridization and amplification technologies, and in particular, in technologies which assess gene expression patterns correlated with specific cells or tissues and their responses in vivo or in vitro to pharmaceutical agents, toxins, and other treatments. In this manner, the sequences of the present invention are used to develop a transcript image for a particular cell or tissue.
z s Derivation of Nucleic Acid Sequences cDNA was isolated from libraries constructed using RNA derived from normal and diseased human tissues and cell lines. The human tissues and cell lines used for cDNA
library construction were selected from a broad range of sources to provide a diverse population of cDNAs representative of gene transcription throughout the human body. Descriptions of the human tissues and cell lines 3 o used for cDNA library construction are provided in the LIFESEQ database (Incyte Genomics, Inc.
(Incyte), Palo Alto CA). Human tissues were broadly selected from, for example, cardiovascular, dermatologic, endocrine, gastrointestinal, hematopoietic/immune system, musculoskeletal, neural, reproductive, and urologic sources.
Cell lines used for cDNA library construction were derived from, for example, leukemic 35 cells, teratocarcinomas, neuroepitheliomas, cervical carcinoma, lung fibroblasts, and endothelial cells.
Such cell lines include, for example, THP-1, Jurkat, HUVEC, hNT2, WI38, HeLa, and other cell lines commonly used and available from public depositories (American Type Culture Collection, Manassas VA). Prior to mRNA isolation, cell lines were untreated, treated with a pharmaceutical agent such as 5 =aza-2'-deoxycytidine, treated with an activating agent such as lipopolysaccharide in the case of leukocytic cell lines, or, in the case of endothelial cell lines, subjected to shear stress.
Sepuencin~ of the cDNAs Methods for DNA sequencing are well known in the art. Conventional enzymatic methods employ the Klenow fragment of DNA polymerase I, SEQUENASE DNA polymerase (U.S.
Biochemical Corporation, Cleveland OH), Taq polymerase (PE Biosystems, Foster City CA), to thermostable T7 polymerase (Amersham Pharmacia Biotech, Inc. (Amersham Pharmacia Biotech), Piscataway NJ), or combinations of polymerases and proofreading exonucleases such as those found in the ELONGASE amplification system (Life Technologies Inc. (Life Technologies), Gaithersburg MD), to extend the nucleic acid sequence from an oligonucleotide primer annealed to the DNA
template of interest. Methods have been developed for the use of both single-stranded and double-ts stranded templates. Chain termination reaction products may be electrophoresed on urea-polyacrylamide gels and detected either by autoradiography (for radioisotope-labeled nucleotides) or by fluorescence (for fluorophore-labeled nucleotides). Automated methods for mechanized reaction preparation, sequencing, and analysis using fluorescence detection methods have been developed.
Machines used to prepare cDNAs for sequencing can include the MICROLAB 2200 liquid transfer 2 o system (Hamilton Company (Hamilton), Reno NV), Pettier thermal cycler (PTC200; MJ Research, Inc. (MJ Research), Watertown MA), and ABI CATALYST 800 thermal cycler (PE
Biosystems).
Sequencing can be carried out using, for example, the ABI 373 or 377 (PE
Biosystems) or MEGABACE 1000 (Molecular Dynamics, Inc. (Molecular Dynamics), Sunnyvale CA) DNA
sequencing systems, or other automated and manual sequencing systems well known in the art.
25 The nucleotide sequences of the Sequence Listing have been prepared by current, state-of the-art, automated methods and, as such, may contain occasional sequencing errors or unidentified nucleotides. Such unidentified nucleotides are designated by an N. These infrequent unidentified bases do not represent a hindrance to practicing the invention for those skilled in the art. Several methods employing standard recombinant techniques may be used to correct errors and complete the 3o missing sequence information. (See, e.g., those described in Ausubel, F.M.
et al. (1997) Short Protocols in Molecular Biolo~y, John Wiley & Sons, New York NY; and Sambrook, J. et al. (1989) Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Press, Plainview NY.) Assembly of cDNA Sequences 35 Human polynucleotide sequences may be assembled using programs or algorithms well known in the art. Sequences to be assembled are related, wholly or in part, and may be derived from a single or many different transcripts. Assembly of the sequences can be performed using such programs as PHRAP (Phils Revised Assembly Program) and the GELVIEW fragment assembly system (GCG), or other methods known in the art.
Alternatively, cDNA sequences are used as "component" sequences that are assembled into s "template" or "consensus" sequences as follows. Sequence chromatograms are processed, verified, and quality scores are obtained using PHRED. Raw sequences are edited using an editing pathway known as Block 1 (See, e.g., the LIFESEQ Assembled User Guide, Incyte Genomics, Palo Alto, CA).
A series of BLAST comparisons is performed and low-information segments and repetitive elements (e.g., dinucleotide repeats, Alu repeats, etc.) are replaced by "n's", or masked, to prevent spurious to matches. Mitochondria) and ribosomal RNA sequences are also removed. The processed sequences are then loaded into a relational database management system (RDMS) which assigns edited sequences to existing templates, if available. When additional sequences are added into the RDMS, a process is initiated which modifies existing templates or creates new templates from works in progress (i.e., nonfinal assembled sequences) containing queued sequences or the sequences 15 themselves. After the new sequences have been assigned to templates, the templates can be merged into bins. If multiple templates exist in one bin, the bin can be split and the templates reannotated.
Once gene bins have been generated based upon sequence alignments, bins are "clone joined"
based upon clone information. Clone joining occurs when the S' sequence of one clone is present in one bin and the 3' sequence from the same clone is present in a different bin, indicating that the two 2o bins should be merged into a single bin. Only bins which share at least two different clones are merged.
A resultant template sequence may contain either a partial or a full length open reading frame, or all or part of a genetic regulatory element. This variation is due in part to the fact that the full length cDNAs of many genes are several hundred, and sometimes several thousand, bases in 25 length. With current technology, cDNAs comprising the coding regions of large genes cannot be cloned because of vector limitations, incomplete reverse transcription of the mRNA, or incomplete "second strand" synthesis. Template sequences may be extended to include additional contiguous sequences derived from the parent RNA transcript using a variety of methods known to those of skill in the art. Extension may thus be used to achieve the full length coding sequence of a gene.
Analysis of the cDNA Sequences The cDNA sequences are analyzed using a variety of programs and algorithms which are well known in the art. (See, e.g., Ausubel, 1997, supra, Chapter 7.7; Meyers, R.A.
(Ed.) (1995) Molecular Biology and Biotechnology, Wiley VCH, New York NY, pp. 856-853; and Table 4.) These analyses comprise both reading frame determinations, e.g., based on triplet codon periodicity for particular organisms (Fickett, J.W. (1982) Nucleic Acids Res. 10:5303-5318); analyses of potential start and stop codons; and homology searches.
Computer programs known to those of skill in the art for performing computer-assisted searches for amino acid and nucleic acid sequence similarity, include, for example, Basic Local s Alignment Search Tool (BLAST; Altschul, S.F. (1993) J. Mol. Evol. 36:290-300; Altschul, S.F. et al.
(1990) J. Mol. Biol. 215:403-410). BLAST is especially useful in determining exact matches and comparing two sequence fragments of arbitrary but equal lengths, whose alignment is locally maximal and for which the alignment score meets or exceeds a threshold or cutoff score set by the user (Karlin, S. et al. ( 1988) Proc. Natl. Acad. Sci. USA 85:841-845). Using an appropriate search io tool (e.g., BLAST or HMM), GenBank, SwissProt, BLOCKS, PFAM and other databases may be searched for sequences containing regions of homology to a query sptm or SPTM
of the present invention.
Other approaches to the identification, assembly, storage, and display of nucleotide and polypeptide sequences are provided in "Relational Database for Storing Biomolecule Information,"
15 U.S.S.N. 08/947,845, filed October 9, 1997; "Project-Based Full-Length Biomolecular Sequence Database," U.S.S.N. 08/811,758, filed March 6, 1997; and "Relational Database and System for Storing Information Relating to Biomolecular Sequences," U.S.S.N. 09/034,807, filed March 4, 1998, all of which are incorporated by reference herein in their entirety.
Protein hierarchies can be assigned to the putative encoded polypeptide based on, e.g., motif, 2o BLAST, or biological analysis. Methods for assigning these hierarchies are described, for example, in "Database System Employing Protein Function Hierarchies for Viewing Biomolecular Sequence Data," U.S.S.N. 08/812,290, filed March 6, 1997, incorporated herein by reference.
Se9uences of Human Secretory Molecules z s The sptm of the present invention may be used for a variety of diagnostic and therapeutic purposes. For example, an sptm may be used to diagnose a particular condition, disease, or disorder associated with cell signaling. Such conditions, diseases, and disorders include, but are not limited to, a cell proliferative disorder such as actinic keratosis, arteriosclerosis, atherosclerosis, bursitis, cirrhosis, hepatitis, mixed connective tissue disease (MCTD), myelofibrosis, paroxysmal nocturnal 3o hemoglobinuria, polycythemia vera, psoriasis, primary thrombocythemia, and cancers including adenocarcinoma, leukemia, lymphoma, melanoma, myeloma, sarcoma, teratocarcinoma, and, in particular, a cancer of the adrenal gland, bladder, bone, bone marrow, brain, breast, cervix, gall bladder, ganglia, gastrointestinal tract, heart, kidney, liver, lung, muscle, ovary, pancreas, parathyroid, penis, prostate, salivary glands, skin, spleen, testis, thymus, thyroid, and uterus; an immune system 3s disorder such as such as inflammation, actinic keratosis, acquired immunodeficiency syndrome (AmS), Addison's disease, adult respiratory distress syndrome, allergies, ankylosing spondylitis, amyloidosis, anemia, arteriosclerosis, asthma, atherosclerosis, autoimmune hemolytic anemia, autoimmune thyroiditis, bronchitis, bursitis, cholecystitis, cirrhosis, contact dermatitis, Crohn's disease, atopic dermatitis, dermatomyositis, diabetes mellitus, emphysema, erythroblastosis fetalis, erythema nodosum, atrophic gastritis, glomerulonephritis, Goodpasture's syndrome, gout, Graves' disease, Hashimoto's thyroiditis, paroxysmal nocturnal hemoglobinuria, hepatitis, hypereosinophilia, irritable bowel syndrome, episodic lymphopenia with lymphocytotoxins, mixed connective tissue disease (MCTD), multiple sclerosis, myasthenia gravis, myocardial or pericardial inflanunation, myelofibrosis, osteoarthritis, osteoporosis, pancreatitis, polycythemia vera, polymyositis, psoriasis, Reiter's syndrome, rheumatoid arthritis, scleroderma, Sjogren's syndrome, systemic anaphylaxis, to systemic lupus erythematosus, systemic sclerosis, primary thrombocythemia, thrombocytopenic purpura, ulcerative colitis, uveitis, Werner syndrome, complications of cancer, hemodialysis, and extracorporeal circulation, trauma, and hematopoietic cancer including lymphoma, leukemia, and myeloma; and a neurological disorder such as epilepsy, ischemic cerebrovascular disease, stroke, cerebral neoplasms, Alzheimer's disease, Pick's disease, Huntington's disease, dementia, Parkinson's i5 disease and other extrapyramidal disorders, amyotrophic lateral sclerosis and other motor neuron disorders, progressive neural muscular atrophy, retinitis pigmentosa, hereditary ataxias, multiple sclerosis and other demyelinating diseases, bacterial and viral meningitis, brain abscess, subdural empyema, epidural abscess, suppurative intracranial thrombophlebitis, myelitis and radiculitis, viral central nervous system disease, prion diseases including kuru, Creutzfeldt-Jakob disease, and 2o Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, nutritional and metabolic diseases of the nervous system, neurofibromatosis, tuberous sclerosis, cerebelloretinal hemangioblastomatosis, encephalotrigeminal syndrome, mental retardation and other developmental disorder of the central nervous system, cerebral palsy, a neuroskeletal disorder, an autonomic nervous system disorder, a cranial nerve disorder, a spinal cord disease, muscular dystrophy and other neuromuscular disorder, a 25 peripheral nervous system disorder, dermatomyositis and polymyositis, inherited, metabolic, endocrine, and toxic myopathy, myasthenia gravis, periodic paralysis, a mental disorder including mood, anxiety, and schizophrenic disorder, seasonal affective disorder (SAD), akathesia, amnesia, catatonia, diabetic neuropathy, tardive dyskinesia, dystonias, paranoid psychoses, postherpetic neuralgia, and Tourette's disorder. The sptm can be used to detect the presence of, or to quantify the 3 o amount of, an sptm-related polynucleotide in a sample. This information is then compared to information obtained from appropriate reference samples, and a diagnosis is established.
Alternatively, a polynucleotide complementary to a given sptm can inhibit or inactivate a therapeutically relevant gene related to the sptm.
Analysis of sntm Expression Patterns The expression of sptm may be routinely assessed by hybridization-based methods to determine, for example, the tissue-specificity, disease-specificity, or developmental stage-specificity of sptm expression. For example, the level of expression of sptm may be compared among different cell types or tissues, among diseased and normal cell types or tissues, among cell types or tissues at different developmental stages, or among cell types or tissues undergoing various treatments. This type of analysis is useful, for example, to assess the relative levels of sptm expression in fully or partially differentiated cells or tissues, to determine if changes in sptm expression levels are correlated with the development or progression of specific disease states, and to assess the response to of a cell or tissue to a specific therapy, for example, in pharmacological or toxicological studies.
Methods for the analysis of sptm expression are based on hybridization and amplification technologies and include membrane-based procedures such as northern blot analysis, high-throughput procedures that utilize, for example, microarrays, and PCR-based procedures.
Hybridization and Genetic Analysis The sptm, their fragments, or complementary sequences, may be used to identify the presence of and/or to determine the degree of sinvlarity between two (or more) nucleic acid sequences. The sptm may be hybridized to naturally occurnng or recombinant nucleic acid sequences under appropriately selected temperatures and salt concentrations. Hybridization with a probe based on the 2 o nucleic acid sequence of at least one of the sptm allows for the detection of nucleic acid sequences, including genomic sequences, which are identical or related to the sptm of the Sequence Listing.
Probes may be selected from non-conserved or unique regions of at least one of the polynucleotides of SEQ ID NO:1-26 and tested for their ability to identify or amplify the target nucleic acid sequence using standard protocols.
z5 Polynucleotide sequences that are capable of hybridizing, in particular, to those shown in SEQ m NO:1-26 and fragments thereof, can be identified using various conditions of stringency.
(See, e.g., Wahl, G.M. and S.L. Berger (1987) Methods Enzymol. 152:399-407;
Kimmel, A.R. (1987) Methods Enzymol. 152:507-511.) Hybridization conditions are discussed in "Definitions."
A probe for use in Southern or northern hybridization may be derived from a fragment of an 3 o sptm sequence, or its complement, that is up to several hundred nucleotides in length and is either single-stranded or double-stranded. Such probes may be hybridized in solution to biological materials such as plasmids, bacterial, yeast, or human artificial chromosomes, cleared or sectioned tissues, or to artificial substrates containing sptm. Microarrays are particularly suitable for identifying the presence of and detecting the level of expression for multiple genes of interest by examining gene 35 expression correlated with, e.g., various stages of development, treatment with a drug or compound, or disease progression. An array analogous to a dot or slot blot may be used to arrange and link polynucleotides to the surface of a substrate using one or more of the following: mechanical (vacuum), chemical, thermal, or UV bonding procedures. Such an array may contain any number of sptm and may be produced by hand or by using available devices, materials, and machines.
Microarrays may be prepared, used, and analyzed using methods known in the art. (See, e.g., s Brennan, T.M. et al. (1995) U.S. Patent No. 5,474,796; Schena, M. et al.
(1996) Proc. Natl. Acad. Sci.
USA 93:10614-10619; Baldeschweiler et al. (1995) PCT application W0951251 l 16; Shalon, D. et al.
(1995) PCT application W095/35505; Heller, R.A. et al. (1997) Proc. Natl.
Acad. Sci. USA 94:2150 2155; and Heller, M.J. et al. (1997) U.S. Patent No. 5,605,662.) Probes may be labeled by either PCR or enzymatic techniques using a variety of to commercially available reporter molecules. For example, commercial kits are available for radioactive and chemiluminescent labeling (Amersham Pharmacia Biotech) and for alkaline phosphatase labeling (Life Technologies). Alternatively, sptm may be cloned into commercially available vectors for the production of RNA probes. Such probes may be transcribed in the presence of at least one labeled nucleotide (e.g.,'ZP-ATP, Amersham Pharmacia Biotech).
is Additionally the polynucleotides of SEQ )D NO:1-26 or suitable fragments thereof can be used to isolate full length cDNA sequences utilizing hybridization and/or amplification procedures well known in the art, e.g., cDNA library screening, PCR amplification, etc.
The molecular cloning of such full length cDNA sequences may employ the method of cDNA library screening with probes using the hybridization, stringency, washing, and probing strategies described above and in Ausubel, 2o supra, Chapters 3, 5, and 6. These procedures may also be employed with genomic libraries to isolate genomic sequences of sptm in order to analyze, e.g., regulatory elements.
Genetic Mapping Gene identification and mapping are important in the investigation and treatment of almost all z5 conditions, diseases, and disorders. Cancer, cardiovascular disease, Alzheimer's disease, arthritis, diabetes,,and mental illnesses are of particular interest. Each of these conditions is more complex than the single gene defects of sickle cell anemia or cystic fibrosis, with select groups of genes being predictive of predisposition for a particular condition, disease, or disorder.
For example, cardiovascular disease may result from malfunctioning receptor molecules that fail to clear 3 o cholesterol from the bloodstream, and diabetes may result when a particular individual's immune system is activated by an infection and attacks the insulin-producing cells of the pancreas. In some studies, Alzheimer s disease has been linked to a gene on chromosome 21; other studies predict a different gene and location. Mapping of disease genes is a complex and reiterative process and generally proceeds from genetic linkage analysis to physical mapping.
35 As a condition is noted among members of a family, a genetic linkage map traces parts of chromosomes that are inherited in the same pattern as the condition.
Statistics link the inheritance of particular conditions to particular regions of chromosomes, as defined by RFLP
or other markers.
(See, for example, Lander, E. S. and Botstein, D. (1986) Proc. Natl. Acad.
Sci. USA 83:7353-7357.) Occasionally, genetic markers and their locations are known from previous studies. More often, however, the markers are simply stretches of DNA that differ among individuals. Examples of genetic linkage maps can be found in various scientific journals or at the Online Mendelian Inheritance in Man (OMIM) World Wide Web site.
In another embodiment of the invention, sptm sequences may be used to generate hybridization probes useful in chromosomal mapping of naturally occurring genomic sequences.
Either coding or noncoding sequences of sptm may be used, and in some instances, noncoding to sequences may be preferable over coding sequences. For example, conservation of an sptm coding sequence among members of a mufti-gene family may potentially cause undesired cross hybridization during chromosomal mapping. The sequences may be mapped to a particular chromosome, to a specific region of a chromosome, or to artificial chromosome constructions, e.g., human artificial chromosomes (HACs), yeast artificial chromosomes (YACs), bacterial artificial chromosomes (BACs), bacterial P1 constructions, or single chromosome cDNA libraries. (See, e.g., Harrington, J.J.
et al. (1997) Nat. Genet. 15:345-355; Price, C.M. (1993) Blood Rev. 7:127-134;
and Trask, B.J.
(1991) Trends Genet. 7:149-154.) Fluorescent in situ hybridization (FISH) may be correlated with other physical chromosome mapping techniques and genetic map data. (See, e.g., Meyers, supra, pp. 965-968.) Correlation 2o between the location of sptm on a physical chromosomal map and a specific disorder, or a predisposition to a specific disorder, may help define the region of DNA
associated with that disorder. The sptm sequences may also be used to detect polymorphisms that are genetically linked to the inheritance of a particular condition, disease, or disorder.
In situ hybridization of chromosomal preparations and genetic mapping techniques, such as z5 linkage analysis using established chromosomal markers, may be used for extending existing genetic maps. Often the placement of a gene on the chromosome of another mammalian species, such as mouse, may reveal associated markers even if the number or arm of the corresponding human chromosome is not known. These new marker sequences can be mapped to human chromosomes and may provide valuable information to investigators searching for disease genes using positional 3o cloning or other gene discovery techniques. Once a disease or syndrome has been crudely correlated by genetic linkage with a particular genomic region, e.g., ataxia-telangiectasia to l 1q22-23, any sequences mapping to that area may represent associated or regulatory genes for further investigation.
(See, e.g., Gatti, R.A. et al. (1988) Nature 336:577-580.) The nucleotide sequences of the subject invention may also be used to detect differences in chromosomal architecture due to translocation, 35 inversion, etc., among normal, carrier, or affected individuals.
Once a disease-associated gene is mapped to a chromosomal region, the gene must be cloned in order to identify mutations or other alterations (e.g., translocations or inversions) that may be correlated with disease. This process requires a physical map of the chromosomal region containing the disease-gene of interest along with associated markers. A physical map is necessary for s determining the nucleotide sequence of and order of marker genes on a particular chromosomal region. Physical mapping techniques are well known in the art and require the generation of overlapping sets of cloned DNA fragments from a particular organelle, chromosome, or genome.
These clones are analyzed to reconstruct and catalog their order. Once the position of a marker is determined, the DNA from that region is obtained by consulting the catalog and selecting clones from io that region. The gene of interest is located through positional cloning techniques using hybridization or similar methods.
Diagnostic Uses The sptm of the present invention may be used to design probes useful in diagnostic assays.
i5 Such assays, well known to those skilled in the art, may be used to detect or confirm conditions, disorders, or diseases associated with abnormal levels of sptm expression.
Labeled probes developed from sptm sequences are added to a sample under hybridizing conditions of desired stringency. In some instances, sptm, or fragments or oligonucleotides derived from sptm, may be used as primers in amplification steps prior to hybridization. The amount of hybridization complex formed is quantified 2o and compared with standards for that cell or tissue. If sptm expression varies significantly from the standard, the assay indicates the presence of the condition, disorder, or disease. Qualitative or quantitative diagnostic methods may include northern, dot blot, or other membrane or dip-stick based technologies or multiple-sample format technologies such as PCR, enzyme-linked immunosorbent assay (ELISA)-like, pin, or chip-based assays.
z5 The probes described above may also be used to monitor the progress of conditions, disorders, or diseases associated with abnormal levels of sptm expression, or to evaluate the efficacy of a particular therapeutic treatment. The candidate probe may be identified from the sptm that are specific to a given human tissue and have not been observed in GenBank or other genome databases.
Such a probe may be used in animal studies, preclinical tests, clinical trials, or in monitoring the 3 o treatment of an individual patient. In a typical process, standard expression is established by methods well known in the art for use as a basis of comparison, samples from patients affected by the disorder or disease are combined with the probe to evaluate any deviation from the standard profile, and a therapeutic agent is administered and effects are monitored to generate a treatment profile. Efficacy is evaluated by determining whether the expression progresses toward or returns to the standard 35 normal pattern. Treatment profiles may be generated over a period of several days or several months.
Statistical methods well known to those skilled in the art may be use to determine the significance of such therapeutic agents.
The polynucleotides are also useful for identifying individuals from minute biological samples, for example, by matching the RFLP pattern of a sample's DNA to that of an individual's s DNA. The polynucleotides of the present invention can also be used to determine the actual base-by-base DNA sequence of selected portions of an individual's genome.
These sequences can be used to prepare PCR primers for amplifying and isolating such selected DNA, which can then be sequenced. Using this technique, an individual can be identified through a unique set of DNA
sequences. Once a unique ID database is established for an individual, positive identification of that to individual can be made from extremely small tissue samples.
In a particular aspect, oligonucleotide primers derived from the sptm of the invention may be used to detect single nucleotide polymorphisms (SNPs). SNPs are substitutions, insertions and deletions that are a frequent cause of inherited or acquired genetic disease in humans. Methods of SNP detection include, but are not limited to, single-stranded conformation polymorphism (SSCP) is and fluorescent SSCP (fSSCP) methods. In SSCP, oligonucleotide primers derived from sptm are used to amplify DNA using the polymerase chain reaction (PCR). The DNA may be derived, for example, from diseased or normal tissue, biopsy samples, bodily fluids, and the like. SNPs in the DNA cause differences in the secondary and tertiary structures of PCR products in single-stranded form, and these differences are detectable using gel electrophoresis in non-denaturing gels. In 2o fSCCP, the oligonucleotide primers are fluorescently labeled, which allows detection of the amplimers in high-throughput equipment such as DNA sequencing machines.
Additionally, sequence database analysis methods, termed in silico SNP (isSNP), are capable of identifying polymorphisms by comparing the sequences of individual overlapping DNA fragments which assemble into a common consensus sequence. These computer-based methods filter out sequence variations due to 25 laboratory preparation of DNA and sequencing errors using statistical models and automated analyses of DNA sequence chromatograms. In the alternative, SNPs may be detected and characterized by mass spectrometry using, for example, the high throughput MASSARRAY system (Sequenom, Inc., San Diego CA).
DNA-based identification techniques are critical in forensic technology. DNA
sequences 3 o taken from very small biological samples such as tissues, e.g., hair or skin, or body fluids, e.g., blood, saliva, semen, etc., can be amplified using, e.g., PCR, to identify individuals. (See, e.g., Erlich, H.
(1992) PCR TechnoloQV, Freeman and Co., New York, NY). Similarly, polynucleotides of the present invention can be used as polymorphic markers.
There is also a need for reagents capable of identifying the source of a particular tissue.
3 5 Appropriate reagents can comprise, for example, DNA probes or primers prepared from the sequences of the present invention that are specific for particular tissues.
Panels of such reagents can identify tissue by species and/or by organ type. In a similar fashion, these reagents can be used to screen tissue cultures for contamination.
The polynucleotides of the present invention can also be used as molecular weight markers on nucleic acid gels or Southern blots, as diagnostic probes for the presence of a specific mRNA in a particular cell type, in the creation of subtracted cDNA libraries which aid in the discovery of novel polynucleotides, in selection and synthesis of oligomers for attachment to an array or other support, and as an antigen to elicit an immune response.
Disease Model Svstems Using-sptm The sptm of the invention or their mammalian homologs may be "knocked out" in an animal to model system using homologous recombination in embryonic stem (ES) cells.
Such techniques are well known in the art and are useful for the generation of animal models of human disease. (See, e.g., U.S. Patent Number 5,175,383 and U.S. Patent Number 5,767,337.) For example, mouse ES cells, such as the mouse 129/SvJ cell line, are derived from the early mouse embryo and grown in culture.
The ES cells are transformed with a vector containing the gene of interest disrupted by a marker gene, e.g., the neomycin phosphotransferase gene (neo; Capecchi, M.R. (1989) Science 244:1288-1292).
The vector integrates into the corresponding region of the host genome by homologous recombination. Alternatively, homologous recombination takes place using the Cre-IoxP system to knockout a gene of interest in a tissue- or developmental stage-specific manner (March, J.D. (1996) Clin. Invest. 97:1999-2002; Wagner, K.U. et al. (1997) Nucleic Acids Res.
25:4323-4330).
2o Transformed ES cells are identified and nucroinjected into mouse cell blastocysts such as those from the C57BL/6 mouse strain. The blastocysts are surgically transferred to pseudopregnant dams, and the resulting chimeric progeny are genotyped and bred to produce heterozygous or homozygous strains. Transgenic animals thus generated may be tested with potential therapeutic or toxic agents.
The sptm of the invention may also be manipulated in vitro in ES cells derived from human blastocysts. Human ES cells have the potential to differentiate into at least eight separate cell lineages including endoderm, mesoderm, and ectodermal cell types. These cell lineages differentiate into, for example, neural cells, hematopoietic lineages, and cardiomyocytes (Thomson, J.A. et al.
(1998) Science 282:1145-1147).
The sptm of the invention can also be used to create "knockin" humanized animals (pigs) or 3o transgenic animals (mice or rats) to model human disease. With knockin technology, a region of sptm is injected into animal ES cells, and the injected sequence integrates into the animal cell genome.
Transformed cells are injected into blastulae, and the blastulae are implanted as described above.
Transgenic progeny or inbred lines are studied and treated with potential pharmaceutical agents to obtain information on treatment of a human disease. Alternatively, a mammal inbred to overexpress sptm, resulting, e.g., in the secretion of SPTM in its milk, may also serve as a convenient source of that protein (Janne, J. et al. ( 1998) Biotechnol. Annu. Rev. 4:55-74).
Screening Assays SPTM encoded by polynucleotides of the present invention may be used to screen for molecules that bind to or are bound by the encoded polypeptides. The binding of the polypeptide and the molecule may activate (agonist), increase, inhibit (antagonist), or decrease activity of the polypeptide or the bound molecule. Examples of such molecules include antibodies, oligonucleotides, proteins (e.g., receptors), or small molecules.
Preferably, the molecule is closely related to the natural ligand of the polypeptide, e.g., a ligand or fragment thereof, a natural substrate, or a structural or functional mimetic. (See, Coligan et al., (1991) Current Protocols in Immunology 1(2): Chapter 5.) Similarly, the molecule can be closely to related to the natural receptor to which the polypeptide binds, or to at least a fragment of the receptor, e.g., the active site. In either case, the molecule can be rationally designed using known techniques.
Preferably, the screening for these molecules involves producing appropriate cells which express the polypeptide, either as a secreted protein or on the cell membrane. Preferred cells include cells from mammals, yeast, Drosophila, or E. coli. Cells expressing the polypeptide or cell membrane fractions i5 which contain the expressed polypeptide are then contacted with a test compound and binding, stimulation, or inhibition of activity of either the polypeptide or the molecule is analyzed.
An assay may simply test binding of a candidate compound to the polypeptide, wherein binding is detected by a fluorophore, radioisotope, enzyme conjugate, or other detectable label.
Alternatively, the assay may assess binding in the presence of a labeled competitor.
2o Additionally, the assay can be carried out using cell-free preparations, polypeptide/molecule affixed to a solid support, chemical libraries, or natural product mixtures.
The assay may also simply comprise the steps of mixing a candidate compound with a solution containing a polypeptide, measuring polypeptide/molecule activity or binding, and comparing the polypeptide/molecule activity or binding to a standard.
25 Preferably, an ELISA assay using, e.g., a monoclonal or polyclonal antibody, can measure polypeptide level in a sample. The antibody can measure polypeptide level by either binding, directly or indirectly, to the polypeptide or by competing with the polypeptide for a substrate.
All of the above assays can be used in a diagnostic or prognostic context. The molecules discovered using these assays can be used to treat disease or to bring about a particular result in a 3o patient (e.g., blood vessel growth) by activating or inhibiting the polypeptide/molecule. Moreover, the assays can discover agents which may inhibit or enhance the production of the polypeptide from suitably manipulated cells or tissues.
Transcript Imaging Another embodiment relates to the use of sptm to develop a transcript image of a tissue or s5 cell type. A transcript image is the collective pattern of gene expression by a particular tissue or cell type under given conditions and at a given time. This pattern of gene expression is defined by the number of expressed genes, their abundance, and their function. Thus the sptm of the present invention may be used to develop a transcript image of a tissue or cell type by hybridizing, preferably in a microarray format, the sptm of the present invention to the totality of transcripts or reverse transcripts of a tissue or cell type. The resultant transcript image would provide a profile of gene activity pertaining to cell signaling.
Transcript images which profile sptm expression may be generated using transcripts isolated from tissues, cell lines, biopsies, or other biological samples. The transcript image may thus reflect sptm expression in vivo, as in the case of a tissue or biopsy sample, or in vitro, as in the case of a cell line. Transcript images may be used to profile sptm expression in distinct tissue types. This process to can be used to determine cell signaling activity in a particular tissue type relative to this activity in a different tissue type. Transcript images may be used to generate a profile of sptm expression characteristic of diseased tissue. Transcript images of tissues before and after treatment may be used for diagnostic purposes, to monitor the progression of disease, and to monitor the efficacy of drug treatments for diseases which affect cell signaling.
Transcript images which profile sptm expression may also be used in conjunction with in vitro model systems and preclinical evaluation of pharmaceuticals. Transcript images of cell lines can be used to assess cell signaling activity and/or to identify cell lines that lack or nusregulate this activity. Such cell lines may then be treated with pharmaceutical agents, and a transcript image following treatment may indicate the efficacy of these agents in restoring desired levels of this 2 o activity. A similar approach may be used to assess the toxicity of pharmaceutical agents as reflected by undesirable changes in cell signaling. Candidate pharmaceutical agents may be evaluated by comparing their associated transcript images with those of pharmaceutical agents of known effectiveness.
Antisense Molecules 2 5 The polynucleotides of the present invention are useful in antisense technology. Antisense technology or therapy relies on the modulation of expression of a target protein through the specific binding of an antisense sequence to a target sequence encoding the target protein or directing its expression. (See, e.g., Agrawal, S., ed. (1996) Antisense Therapeutics, Humana Press Inc., Totawa NJ; Alama, A. et al. (1997) Pharmacol. Res. 36(3):171-178; Crooke, S.T. (1997) Adv. Pharmacol.
30 40:1-49; Sharma, H.W. and R. Narayanan (1995) Bioessays 17(12):1055-1063;
and Lavrosky, Y. et al. (1997) Biochem. Mol. Med. 62(1):11-22.) An antisense sequence is a polynucleotide sequence capable of specifically hybridizing to at least a portion of the target sequence. Antisense sequences bind to cellular mRNA and/or genomic DNA, affecting translation and/or transcription. Antisense sequences can be DNA, RNA, or nucleic acid mimics and analogs. (See, e.g., Rossi, J.J. et al. (1991) 35 Antisense Res. Dev. 1(3):285-288; Lee, R. et al. (1998) Biochemistry 37(3):900-1010; Pardridge, W.M. et al. (1995) Proc. Natl. Acad. Sci. USA 92(12):5592-5596; and Nielsen, P. E. and Haaima, G.
(1997) Chem. Soc. Rev. 96:73-78.) Typically, the binding which results in modulation of expression occurs through hybridization or binding of complementary base pairs. Antisense sequences can also bind to DNA duplexes through specific interactions in the major groove of the double helix.
The polynucleotides of the present invention and fragments thereof can be used as antisense sequences to modify the expression of the polypeptide encoded by sptm. The antisense sequences can be produced ex vivo, such as by using any of the ABI nucleic acid synthesizer series (PE
Biosystems) or other automated systems known in the art. Antisense sequences can also be produced biologically, such as by transforming an appropriate host cell with an expression vector containing the sequence of interest. (See, e.g., Agrawal, su ra.) to In therapeutic use, any gene delivery system suitable for introduction of the antisense sequences into appropriate target cells can be used. Antisense sequences can be delivered intracellularly in the form of an expression plasmid which, upon transcription, produces a sequence complementary to at least a portion of the cellular sequence encoding the target protein. (See, e.g., Slater, J.E., et al. (1998) J. Allergy Clin. Immunol. 102(3):469-475; and Scanlon, K.J., et al. (1995) 9(13):1288-1296.) Antisense sequences can also be introduced intracellularly through the use of viral vectors, such as retrovirus and adeno-associated virus vectors. (See, e.g., Miller, A.D. (1990) Blood 76:271; Ausubel, F.M. et al. (1995) Current Protocols in Molecular BioloQV, John Wiley &
Sons, New York NY; Uckert, W. and W. Walther (1994) Pharmacol. Ther. 63(3):323-347.) Other gene delivery mechanisms include liposome-derived systems, artificial viral envelopes, and other 2o systems known in the art. (See> e.g., Rossi> J.J. (1995) Br. Med. Bull.
51(1):217-225; Boado, R.J. et al. (1998) J. Pharm. Sci. 87(11):1308-1315; and Morris> M.C. et al. (1997) Nucleic Acids Res.
25( 14):2730-2736.) Expression In order to express a biologically active SPTM, the nucleotide sequences encoding SPTM or z5 fragments thereof may be inserted into an appropriate expression vector, 1.e., a vector which contains the necessary elements for transcriptional and translational control of the inserted coding sequence in a suitable host. Methods which are well known to those skilled in the art may be used to construct expression vectors containing sequences encoding SPTM and appropriate transcriptional and translational control elements. These methods include in vitro recombinant DNA
techniques, 3o synthetic techniques, and in vivo genetic recombination. (See, e.g., Sambrook, supra, Chapters 4, 8, 16, and 17; and Ausubel, supra, Chapters 9, I0, 13, and 16.) A variety of expression vector/host systems may be utilized to contain and express sequences encoding SPTM. These include, but are not linuted to, nucroorganisms such as bacteria transformed with recombinant bacteriophage, plasmid, or cosmid DNA expression vectors;
yeast transformed 35 with yeast expression vectors; insect cell systems infected with viral expression vectors (e.g., baculovirus); plant cell systems transformed with viral expression vectors (e.g., cauliflower mosaic virus, CaMV, or tobacco mosaic virus, TMV) or with bacterial expression vectors (e.g., Ti or pBR322 plasmids); or animal (mammalian) cell systems. (See, e.g., Sambrook, su ra; Ausubel, 1995, su~a, Van Heeke, G. and S.M. Schuster (1989) J. Biol. Chem. 264:5503-5509; Bitter, G.A. et al. (1987) Methods Enzymol. 153:516-544; Scorer, C.A. et al. (1994) Bio/Technology 12:181-184;
s Engelhard, E.K. et al. (1994) Proc. Natl. Acad. Sci. USA 91:3224-3227;
Sandig, V. et al. (1996) Hum. Gene Ther. 7:1937-1945; Takamatsu, N. (1987) EMBO J. 6:307-311; Coruzzi, G. et al. (1984) EMBO J. 3:1671-1680; Brogue, R. et al. (1984) Science 224:838-843; Winter, J.
et al. (1991) Results Probl. Cell Differ. 17:85-105; The McGraw Hill Yearbook of Science and TechnoloQy (1992) McGraw Hill, New York NY, pp. 191-196; Logan, J. and T. Shenk (1984) Proc. Natl. Acad.
to Sci. USA 81:3655-3659; and Harrington, J.J. et al. (1997) Nat. Genet.
15:345-355.) Expression vectors derived from retroviruses, adenoviruses, or herpes or vaccinia viruses, or from various bacterial plasmids, may be used for delivery of nucleotide sequences to the targeted organ, tissue, or cell population. (See, e.g., Di Nicola, M. et al. (1998) Cancer Gen. Ther.
5(6):350-356; Yu, M. et al., (1993) Proc. Natl. Acad. Sci. USA 90(13):6340-6344; Buller, R.M. et al. (1985) Nature 15 317(6040):813-815; McGregor, D.P. et al. (1994) Mol. Immunol. 31(3):219-226; and Verma, LM.
and N. Somia (1997) Nature 389:239-242.) The invention is not limited by the host cell employed.
For long term production of recombinant proteins in mammalian systems, stable expression of SPTM in cell lines is preferred. For example, sequences encoding SPTM can be transformed into cell lines using expression vectors which may contain viral origins of replication and/or endogenous zo expression elements and a selectable marker gene on the same or on a separate vector. Any number of selection systems may be used to recover transformed cell lines. (See, e.g., Wigler, M. et al.
(1977) Cell 11:223-232; Lowy, I. et al. (1980) Cell 22:817-823.; Wigler, M. et al. (1980) Proc. Natl.
Acad. Sci. USA 77:3567-3570; Colbere-Garapin, F. et al. (1981) J. Mol. Biol.
150:1-14; Hartman, S.C. and R.C.Mulligan (1988) Proc. Natl. Acad. Sci. USA 85:8047-8051; Rhodes, C.A. (1995) z5 Methods Mol. Biol. 55:121-131.) Therapeutic Uses of sptm The sptm of the invention may be used for somatic or germline gene therapy.
Gene therapy may be performed to (i) correct a genetic deficiency (e.g., in the cases of severe combined immunodeficiency (SCID)-X1 disease characterized by X-linked inheritance (Cavazzana-Calvo, M.
3 o et al. (2000) Science 288:669-672), severe combined immunodeficiency syndrome associated with an inherited adenosine deaminase (ADA) deficiency (Blaese, R.M. et al. ( 1995) Science 270:475-480;
Bordignon, C. et al. (1995) Science 270:470-475), cystic fibrosis (Zabner, J.
et al. (1993) Cell 75:207-216; Crystal, R.G. et al. (1995) Hum. Gene Therapy 6:643-666; Crystal, R.G. et al. (1995) Hum. Gene Therapy 6:667-703), thalassemias, familial hypercholesterolenva, and hemophilia 35 resulting from Factor VIII or Factor IX deficiencies (Crystal, R.G. (1995) Science 270:404-410;
Verma, LM. and Somia, N. ( 1997) Nature 389:239-242)), (ii) express a conditionally lethal gene product (e.g., in the case of cancers which result from unregulated cell proliferation), or (iii) express a protein which affords protection against intracellular parasites (e.g., against human retroviruses, such as human immunodeficiency virus (HIV) (Baltimore, D. (1988) Nature 335:395-396; Poeschla, E. et al. (1996) Proc. Natl. Acad. Sci. USA. 93:11395-11399), hepatitis B or C
virus (HBV, HCV);
s fungal parasites, such as Candida albicans and Paracoccidioides brasiliensis; and protozoan parasites such as Plasmodium falciparum and Trvnanosoma cruzi). In the case where a genetic deficiency in sptm expression or regulation causes disease, the expression of sptm from an appropriate population of transduced cells may alleviate the clinical manifestations caused by the genetic deficiency.
In a further embodiment of the invention, diseases or disorders caused by deficiencies in to sptm are treated by constructing mammalian expression vectors comprising sptm and introducing these vectors by mechanical means into sptm-deficient cells. Mechanical transfer technologies for use with cells in vivo or ex vitro include (i) direct DNA microinjection into individual cells, (ii) ballistic gold particle delivery, (iii) liposome-mediated transfection, (iv) receptor-mediated gene transfer, and (v) the use of DNA transposons (Morgan, R.A. and Anderson, W.F.
(1993) Annu. Rev.
15 Biochem. 62:191-217; Ivics, Z. (1997) Cell 91:501-510; Boulay, J-L. and Recipon, H. (1998) Curr.
Opin. Biotechnol. 9:445-450).
Expression vectors that may be effective for the expression of sptm include, but are not limited to, the PCDNA 3.1, EPTTAG, PRCCMV2, PREP, PVAX vectors (Invitrogen, Carlsbad CA), PCMV-SCRIPT, PCMV-TAG, PEGSH/PERV (Stratagene, La Jolla CA), and PTET-OFF, 2o PTET-ON, PTRE2, PTRE2-LUC, PTK-HYG (Clontech, Palo Alto CA). The sptm of the invention may be expressed using (i) a constitutively active promoter, (e.g., from cytomegalovirus (CMV), Rous sarcoma virus (RSV), SV40 virus, thymidine kinase (TK), or ~i-actin genes), (ii) an inducible promoter (e.g., the tetracycline-regulated promoter (Gossen, M. and Bujard, H.
(1992) Proc. Natl.
Acad. Sci. U.S.A. 89:5547-5551; Gossen, M. et al., (1995) Science 268:1766-1769; Rossi, F.M.V.
2s and Blau, H.M. (1998) Curr. Opin. Biotechnol. 9:451-456), commercially available in the T-REX
plasmid (Invitrogen)); the ecdysone-inducible promoter (available in the plasmids PVGRXR and PIND; Invitrogen); the FK506/rapamycin inducible promoter; or the RU486/mifepristone inducible promoter (Rossi, F.M.V. and Blau, H.M. su ra)), or (iii) a tissue-specific promoter or the native promoter of the endogenous gene encoding SPTM from a normal individual.
3 o Commercially available liposome transformation kits (e.g., the PERFECT
TRANSFECTION KIT, available from Invitrogen) allow one with ordinary skill in the art to deliver polynucleotides to target cells in culture and require minimal effort to optimize experimental parameters. In the alternative, transformation is performed using the calcium phosphate method (Graham, F.L. and Eb, A.J. (1973) Virology 52:456-467), or by electroporation (Neumann, E. et al.
35 (1982) EMBO J. 1:841-845). The introduction of DNA to primary cells requires modification of these standardized mammalian transfection protocols.
In another embodiment of the invention, diseases or disorders caused by genetic defects with respect to sptm expression are treated by constructing a retrovirus vector consisting of (i) sptm under the control of an independent promoter or the retrovirus long terminal repeat (LTR) promoter, (ii) appropriate RNA packaging signals, and (iii) a Rev-responsive element (RRE) along with additional retrovirus cis-acting RNA sequences and coding sequences required for efficient vector propagation.
Retrovirus vectors (e.g., PFB and PFBNEO) are commercially available (Stratagene) and are based on published data (Riviere, I. et al. (1995) Proc. Natl. Acad. Sci. U.S.A.
92:6733-6737), incorporated by reference herein. The vector is propagated in an appropriate vector producing cell line (VPCL) that expresses an envelope gene with a tropism for receptors on the target cells or a promiscuous 1o envelope protein such as VSVg (Armentano, D. et al. (1987) J. Virol.
61:1647-1650; Bender, M.A. et al. (1987) J. Virol. 61:1639-1646; Adam, M.A. and Miller, A.D. (1988) J.
Virol. 62:3802-3806; Dull, T. et al. (1998) J. Virol. 72:8463-8471; Zufferey, R. et al. (1998) J. Virol.
72:9873-9880). U.S.
Patent Number 5,910,434 to Rigg ("Method for obtaining retrovirus packaging cell lines producing high transducing efficiency retroviral supernatant") discloses a method for obtaining retrovirus packaging cell lines and is hereby incorporated by reference. Propagation of retrovirus vectors, transduction of a population of cells (e.g., CD4+ T-cells), and the return of transduced cells to a patient are procedures well known to persons skilled in the art of gene therapy and have been well documented (Ranga, U. et al. (1997) J. Virol. 71:7020-7029; Bauer, G. et al.
(1997) Blood 89:2259-2267; Bonyhadi, M.L. (1997) J. Virol. 71:4707-4716; Ranga, U. et al. (1998) Proc. Natl. Acad. Sci.
2o U.S.A. 95:1201-1206; Su, L. (1997) Blood 89:2283-2290).
In the alternative, an adenovirus-based gene therapy delivery system is used to deliver sptm to cells which have one or more genetic abnormalities with respect to the expression of sptm. The construction and packaging of adenovirus-based vectors are well known to those with ordinary skill in the art. Replication defective adenovirus vectors have proven to be versatile for importing genes z5 encoding imrnunoregulatory proteins into intact islets in the pancreas (Csete, M.E. et al. (1995) Transplantation 27:263-268). Potentially useful adenoviral vectors are described in U.S. Patent Number 5,707,618 to Armentano ("Adenovirus vectors for gene therapy"), hereby incorporated by reference. For adenoviral vectors, see also Antinozzi, P.A. et al. (1999) Annu. Rev. Nutr.
19:511-544 and Verma, LM. and Somia, N. (1997) Nature 18:389:239-242, both incorporated by 3 o reference herein.
In another alternative, a herpes-based, gene therapy delivery system is used to deliver sptm to target cells which have one or more genetic abnormalities with respect to the expression of sptm.
The use of herpes simplex virus (HSV)-based vectors may be especially valuable for introducing sptm to cells of the central nervous system, for which HSV has a tropism. The construction and 35 packaging of herpes-based vectors are well known to those with ordinary skill in the art. A
replication-competent herpes simplex virus (HSV) type 1-based vector has been used to deliver a reporter gene to the eyes of primates (Liu, X. et al. (1999) Exp. Eye Res.169:385-395). The construction of a HSV-1 virus vector has also been disclosed in detail in U.S.
Patent Number 5,804,413 to DeLuca ("Herpes simplex virus strains for gene transfer"), which is hereby incorporated by reference. U.S. Patent Number 5,804,413 teaches the use of recombinant HSV
d92 which consists of a genome containing at least one exogenous gene to be transferred to a cell under the control of the appropriate promoter for purposes including human gene therapy.
Also taught by this patent are the construction and use of recombinant HSV strains deleted for ICP4, ICP27 and ICP22.
For HSV vectors, see also Goins, W. F. et al. 1999 J. Virol. 73:519-532 and Xu, H. et al., (1994) Dev. Biol. 163:152-161, hereby incorporated by reference. The manipulation of cloned herpesvirus to sequences, the generation of recombinant virus following the transfection of multiple plasmids , containing different segments of the large herpesvirus genomes, the growth and propagation of herpesvirus, and the infection of cells with herpesvirus are techniques well known to those of ordinary skill in the art.
In another alternative, an alphavirus (positive, single-stranded RNA virus) vector is used to deliver sptm to target cells. The biology of the prototypic alphavirus, Semliki Forest Virus (SFV), has been studied extensively and gene transfer vectors have been based on the SFV genome (Garoff, H. and Li, K-J. (1998) Curr. Opin. Biotech. 9:464-469). During alphavirus RNA
replication, a subgenomic RNA is generated that normally encodes the viral capsid proteins.
This subgenomic RNA replicates to higher levels than the full-length genomic RNA, resulting in the overproduction of 2o capsid proteins relative to the viral proteins with enzymatic activity (e.g., protease and polymerase).
Similarly, inserting sptm into the alphavirus genome in place of the capsid-coding region results in the production of a large number of sptm RNAs and the synthesis of high levels of SPTM in vector transduced cells. While alphavirus infection is typically associated with cell lysis within a few days, the ability to establish a persistent infection in hamster normal kidney cells (BHK-21) with a variant of Sindbis virus (SIN) indicates that the lytic replication of alphaviruses can be altered to suit the needs of the gene therapy application (Dryga, S.A. et al. (1997) Virology 228:74-83). The wide host range of alphaviruses will allow the introduction of SPTM into a variety of cell types. The specific transduction of a subset of cells in a population may require the sorting of cells prior to transduction.
The methods of manipulating infectious cDNA clones of alphaviruses, performing alphavirus cDNA
3o and RNA transfections, and performing alphavirus infections, are well known to those with ordinary skill in the art.
Antibodies Anti-SPTM antibodies may be used to analyze protein expression levels. Such antibodies include, but are not limited to, polyclonal, monoclonal, chimeric, single chain, and Fab fragments.
For descriptions of and protocols of antibody technologies, see, e.g., Pound J.D. ( 1998) Immunochemical Protocols, Humana Press, Totowa, NJ.
The amino acid sequence encoded by the sptm of the Sequence Listing may be analyzed by appropriate software (e.g., LASERGENE NAVIGATOR software, DNASTAR) to determine regions s of high immunogenicity. The optimal sequences for immunization are selected from the C-terminus, the N-terminus, and those intervening, hydrophilic regions of the polypeptide which are likely to be exposed to the external environment when the polypeptide is in its natural conformation. Analysis used to select appropriate epitopes is also described by Ausubel (1997, supra, Chapter 11.7).
Peptides used for antibody induction do not need to have biological activity;
however, they must be to antigenic. Peptides used to induce specific antibodies may have an amino acid sequence consisting of at five amino acids, preferably at least 10 amino acids, and most preferably l5 amino acids. A
peptide which mimics an antigenic fragment of the natural polypeptide may be fused with another protein such as keyhole limpet cyanin (KLH; Sigma, St. Louis MO) for antibody production. A
peptide encompassing an antigenic region may be expressed from an sptm, synthesized as described 15 above, or purified from human cells.
Procedures well known in the art may be used for the production of antibodies.
Various hosts including mice, goats, and rabbits, may be immunized by injection with a peptide. Depending on the host species, various adjuvants may be used to increase immunological response.
In one procedure, peptides about 15 residues in length may be synthesized using an ABI
zo 431A peptide synthesizer (PE Biosystems) using fmoc-chemistry and coupled to KLH (Sigma) by reaction with M-maleimidobenzoyl-N-hydroxysuccinimide ester (Ausubel, 1995, su ra . Rabbits are immunized with the peptide-KLH complex in complete Freund's adjuvant. The resulting antisera are tested for antipeptide activity by binding the peptide to plastic, blocking with 1 % bovine serum albumin (BSA), reacting with rabbit antisera, washing, and reacting with radioiodinated goat anti-25 rabbit IgG. Antisera with antipeptide activity are tested for anti-SPTM
activity using protocols well known in the art, including ELISA, radioimmunoassay (RIA), and immunoblotting.
In another procedure, isolated and purified peptide may be used to immunize mice (about 100 pg of peptide) or rabbits (about 1 mg of peptide). Subsequently, the peptide is radioiodinated and used to screen the immunized animals' B-lymphocytes for production of antipeptide antibodies.
3o Positive cells are then used to produce hybridomas using standard techniques. About 20 mg of peptide is sufficient for labeling and screening several thousand clones.
Hybridomas of interest are detected by screening with radioiodinated peptide to identify those fusions producing peptide-specific monoclonal antibody. In a typical protocol, wells of a multi-well plate (FAST, Becton-Dickinson, Palo Alto, CA) are coated with affinity-purified, specific rabbit-anti-mouse (or suitable 35 anti-species IgG) antibodies at 10 mg/ml. The coated wells are blocked with 1 % BSA and washed and exposed to supernatants from hybridomas. After incubation, the wells are exposed to radiolabeled peptide at 1 mg/ml.
Clones producing antibodies bind a quantity of labeled peptide that is detectable above background. Such clones are expanded and subjected to 2 cycles of cloning.
Cloned hybridomas are injected into pristane-treated mice to produce ascites, and monoclonal antibody is purified from the ascitic fluid by affinity chromatography on protein A (Amersham Pharmacia Biotech). Several procedures for the production of monoclonal antibodies, including in vitro production, are described in Pound su ra). Monoclonal antibodies with antipeptide activity are tested for anti-SPTM activity using protocols well known in the art, including ELISA, RIA, and immunoblotting.
to Antibody fragments containing specific binding sites for an epitope may also be generated.
For example, such fragments include, but are not limited to, the F(ab~2 fragments produced by pepsin digestion of the antibody molecule, and the Fab fragments generated by reducing the disulfide bridges of the F(ab~2 fragments. Alternatively, construction of Fab expression libraries in filamentous bacteriophage allows rapid and easy identification of monoclonal fragments with desired specificity (Pound, supra, Chaps. 45-47). Antibodies generated against polypeptide encoded by sptm can be used to purify and characterize full-length SPTM protein and its activity, binding partners, etc.
Assays Using Antibodies Anti-SPTM antibodies may be used in assays to quantify the amount of SPTM
found in a 2o particular human cell. Such assays include methods utilizing the antibody and a label to detect expression level under normal or disease conditions. The peptides and antibodies of the invention may be used with or without modification or labeled by joining them, either covalently or noncovalently, with a reporter molecule.
Protocols for detecting and measuring protein expression using either polyclonal or monoclonal antibodies are well known in the art. Examples include ELISA, RIA, and fluorescent activated cell sorting (FACS). Such immunoassays typically involve the formation of complexes between the SPTM and its specific antibody and the measurement of such complexes. These and other assays are described in Pound (su ra).
Without further elaboration, it is believed that one skilled in the art can, using the preceding 3o description, utilize the present invention to its fullest extent. The following preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.
The disclosures of all patents, applications, and publications mentioned above and below, in particular U.S. Ser. No. 60/147,501, and U.S. Ser. No. 60/147,500 are hereby expressly incorporated by reference.
EXAMPLES
I. Construction of cDNA Libraries RNA was purchased from CLONTECH Laboratories, Inc. (Palo Alto CA) or isolated from various tissues. Some tissues were homogenized and lysed in guanidinium isothiocyanate, while others were homogenized and lysed in phenol or in a suitable mixture of denaturants, such as TRIZOL (Life Technologies), a monophasic solution of phenol and guanidine isothiocyanate. The resulting lysates were centrifuged over CsCI cushions or extracted with chloroform. RNA was precipitated with either isopropanol or sodium acetate and ethanol, or by other routine methods.
Phenol extraction and precipitation of RNA were repeated as necessary to increase RNA
to purity. In most cases, RNA was treated with DNase. For most libraries, poly(A+) RNA was isolated using oligo d(T)-coupled paramagnetic particles (Promega Corporation (Promega), Madison WI), OLIGOTEX latex particles (QIAGEN, Inc. (QIAGEN), Valencia CA), or an OLIGOTEX
mRNA
purification kit (QIAGEN). Alternatively, RNA was isolated directly from tissue lysates using other RNA isolation kits, e.g., the POLY(A)PURE mRNA purification kit (Ambion, Inc., Austin TX).
In some cases, Stratagene was provided with RNA and constructed the corresponding cDNA
libraries. Otherwise, cDNA was synthesized and cDNA libraries were constructed with the UNIZAP
vector system (Stratagene Cloning Systems, Inc. (Stratagene), La Jolla CA) or SUPERSCRIPT
plasmid system (Life Technologies), using the recommended procedures or similar methods known in the art. (See, e.g., Ausubel, 1997, supra, Chapters 5.1 through 6.6.) Reverse transcription was 2o initiated using oligo d(T) or random primers. Synthetic oligonucleotide adapters were ligated to double stranded cDNA, and the cDNA was digested with the appropriate restriction enzyme or enzymes. For most libraries, the cDNA was size-selected (300-1000 bp) using SEPHACRYL SI000, SEPHAROSE CL2B, or SEPHAROSE CL4B column chromatography (Amersham Pharmacia Biotech) or preparative agarose gel electrophoresis. cDNAs were ligated into compatible restriction enzyme sites of the polylinker of a suitable plasmid, e.g., PBLUESCRIPT
plasmid (Stratagene), pSPORTI plasmid (Life Technologies), or pINCY (Incyte). Recombinant plasmids were transformed into competent E. coli cells including XL1-Blue, XL1-BIueMRF, or SOLR from Stratagene or DHSa, DHlOB, or ElectroMAX DH10B from Life Technologies.
3 o II. Isolation of cDNA Clones Plasmids were recovered from host cells by in vivo excision using the UNIZAP
vector system (Stratagene) or by cell lysis. Plasmids were purified using at least one of the following: the Magic or WIZARD Minipreps DNA purification system (Promega); the AGTC Miniprep purification kit (Edge BioSystems, Gaithersburg MD); and the QIAWELL 8, QIAWELL 8 Plus, and QIAWELL 8 Ultra plasmid purification systems or the R.E.A.L. PREP 96 plasmid purification kit (QIAGEN). Following precipitation, plasmids were resuspended in 0.1 ml of distilled water and stored, with or without lyophilization, at 4°C.
Alternatively, plasmid DNA was amplified from host cell lysates using direct link PCR in a high-throughput format. (Rao, V.B. (1994) Anal. Biochem. 216:1-14.) Host cell lysis and thermal cycling steps were carried out in a single reaction mixture. Samples were processed and stored in 384-well plates, and the concentration of amplified plasmid DNA was quantified fluorometrically using PICOGREEN dye (Molecular Probes, Inc. (Molecular Probes), Eugene OR) and a FLUOROSKAN II fluorescence scanner (Labsystems Oy, Helsinki, Finland).
to III. Sequencing and Analysis cDNA sequencing reactions were processed using standard methods or high-throughput instrumentation such as the ABI CATALYST 800 thermal cycler (PE Biosystems) or the PTC-200 thermal cycler (MJ Research) in conjunction with the HYDRA microdispenser (Robbins Scientific Corp., Sunnyvale CA) or the MICROLAB 2200 liquid transfer system (Hamilton).
cDNA
i5 sequencing reactions were prepared using reagents provided by Amersham Pharmacia Biotech or supplied in ABI sequencing kits such as the ABI PRISM BIGDYE Terminator cycle sequencing ready reaction kit (PE Biosystems). Electrophoretic separation of cDNA
sequencing reactions and detection of labeled polynucleotides were carried out using the MEGABACE 1000 DNA sequencing system (Molecular Dynamics); the ABI PRISM 373 or 377 sequencing system (PE
Biosystems) in 2 o conjunction with standard ABI protocols and base calling software; or other sequence analysis systems known in the art. Reading frames within the cDNA sequences were identified using standard methods (reviewed in Ausubel, 1997, supra, Chapter 7.7). Some of the cDNA sequences were selected for extension using the techniques disclosed in Example VIII.
2 s IV. Assembly and Analysis of Sequences Component sequences from chromatograms were subject to PHRED analysis and assigned a quality score. The sequences having at least a required quality score were subject to various pre-processing editing pathways to eliminate, e.g., low quality 3' ends, vector and linker sequences, polyA tails, Alu repeats, mitochondrial and ribosomal sequences, bacterial contamination sequences, 3 o and sequences smaller than 50 base pairs. In particular, low-information sequences and repetitive elements (e.g., dinucleotide repeats, Alu repeats, etc.) were replaced by "n's", or masked, to prevent spurious matches.
Processed sequences were then subject to assembly procedures in which the sequences were assigned to gene bins (bins). Each sequence could only belong to one bin.
Sequences in each gene 35 bin were assembled to produce consensus sequences (templates). Subsequent new sequences were added to existing bins using BLASTn (v.1.4 WashU) and CROSSMATCH. Candidate pairs were identified as all BLAST hits having a quality score greater than or equal to 150. Alignments of at least 82% local identity were accepted into the bin. The component sequences from each bin were assembled using a version of PHRAP. Bins with several overlapping component sequences were assembled using DEEP PHRAP. The orientation (sense or antisense) of each assembled template was determined based on the number and orientation of its component sequences.
Template sequences as disclosed in the sequence listing correspond to sense strand sequences (the "forward"
reading frames), to the best determination. The complementary (antisense) strands are inherently disclosed herein. The component sequences which were used to assemble each template consensus sequence are listed in Table 3, along with their positions along the template nucleotide sequences.
to Bins were compared against each other and those having local similarity of at least 82%
were combined and reassembled. Reassembled bins having templates of insufficient overlap (less than 95% local identity) were re-split. Assembled templates were also subject to analysis by STITCHER/EXON MAPPER algorithms which analyze the probabilities of the presence of splice variants, alternatively spliced exons, splice junctions, differential expression of alternative spliced is genes across tissue types or disease states, etc. These resulting bins were subject to several rounds of the above assembly procedures.
Once gene bins were generated based upon sequence alignments, bins were clone joined based upon clone information. If the S' sequence of one clone was present in one bin and the 3' sequence from the same clone was present in a different bin, it was likely that the two bins actually 2 o belonged together in a single bin. The resulting combined bins underwent assembly procedures to regenerate the consensus sequences.
The final assembled templates were subsequently annotated using the following procedure.
Template sequences were analyzed using BLASTn (v2.0, NCBI) versus gbpri (GenBank version 116). "Hits" were defined as an exact match having from 95% local identity over 200 base pairs 25 through 100% local identity over 100 base pairs, or a homolog match having an E-value, i.e. a probability score, of s 1 x 10-g. The hits were subject to frameshift FASTx versus GENPEPT
(GenBank version 116). (See Table 4). In this analysis, a homolog match was defined as having an E-value of <_ 1 x 10-8. The assembly method used above was described in "System and Methods for Analyzing Biomolecular Sequences," U.S.S.N. 09/276,534, filed March 25, 1999, and the LIFESEQ
3 o Gold user manual (Incyte) both incorporated by reference herein.
Following assembly, template sequences were subjected to motif, BLAST, and functional analyses, and categorized in protein hierarchies using methods described in, e.g., "Database System Employing Protein Function Hierarchies for Viewing Biomolecular Sequence Data," U.S.S.N.
08/812,290, filed March 6, 1997; "Relational Database for Storing Biomolecule Information,"
35 U.S.S.N. 08/947,845, filed October 9, 1997; "Project-Based Full-Length Biomolecular Sequence Database," U.S.S.N. 08/811,758, filed March 6, 1997; and "Relational Database and System for Storing Information Relating to Biomolecular Sequences," U.S.S.N. 09/034,807, filed March 4, 1998, all of which are incorporated by reference herein.
The template sequences are further analyzed by translating each template in all three forward reading frames and searching each translation against the Pfam database of hidden Markov model-s based protein families and domains using the HMMER software package (available to the public from Washington University School of Medicine, St. Louis MO). (See also World Wide Web site http://pfam.wustl.edu/ for detailed descriptions of Pfam protein domains and families.) Additionally, the template sequences were translated in all three forward reading frames and each translation was searched against hidden Markov models for signal peptide and transmembrane to domains using the HMMER software package. Construction of hidden Markov models and their usage in sequence analysis has been described. (See, for example, Eddy, S.R.
(1996) Curr. Opin. Str.
Biol. 6:361-365.) Segments of templates which, when translated, contain similarity to signal peptide or transmembrane domain consensus sequences are reported in Table 2. Only those signal peptide or transmembrane hits with a cutoff score of 11 bits or greater are reported. A
cutoff score of 11 bits or 15 greater corresponds to at least about 91-94% true-positives in signal peptide prediction, and at least about 75% true-positives in transmembrane domain prediction.
The results of BLAST analysis as reported in Table 1 may support the results of HMMER
analysis as reported in Table 2 or may suggest alternative or additional properties of template-encoded secretory polypeptides not previously uncovered by HMMER or other analyses.
2o Template sequences are further analyzed using the bioinformatics tools listed in Table 4, or using sequence analysis software known in the art such as MACDNASIS PRO
software (Hitachi Software Engineering, South San Francisco CA) and LASERGENE software (DNASTAR).
Template sequences may be further queried against public databases such as the GenBank rodent, mammalian, vertebrate, prokaryote, and eukaryote databases.
V. Analysis of Polynucleotide Expression Northern analysis is a laboratory technique used to detect the presence of a transcript of a gene and involves the hybridization of a labeled nucleotide sequence to a membrane on which RNAs from a particular cell type or tissue have been bound. (See, e.g., Sambrook, s. unra, ch. 7; Ausubel, 1995, supra, ch. 4 and 16.) Analogous computer techniques applying BLAST are used to search for identical or related molecules in cDNA databases such as GenBank or LIFESEQ (Incyte Pharmaceuticals). This analysis is much faster than multiple membrane-based hybridizations. In addition, the sensitivity of the computer search can be modified to determine whether any particular match is categorized as exact or similar. The basis of the search is the product score, which is defined as:
BLAST Score x Percent Identity x minimum { length(Seq. 1 ), length(Seq. 2) }
The product score takes into account both the degree of similarity between two sequences and the 5 length of the sequence match. The product score is a normalized value between 0 and 100, and is calculated as follows: the BLAST score is multiplied by the percent nucleotide identity and the product is divided by (5 times the length of the shorter of the two sequences). The BLAST score is calculated by assigning a score of +5 for every base that matches in a high-scoring segment pair (HSP), and -4 for every mismatch. Two sequences may share more than one HSP
(separated by to gaps). If there is more than one HSP, then the pair with the highest BLAST
score is used to calculate the product score. The product score represents a balance between fractional overlap and quality in a BLAST alignment. For example, a product score of 100 is produced only for 100%
identity over the entire length of the shorter of the two sequences being compared. A product score of 70 is produced either by 100% identity and 70% overlap at one end, or by 88% identity and 100% overlap at the i5 other. A product score of 50 is produced either by 100% identity and SO%
overlap at one end, or 79% identity and 100% overlap.
VI. Tissue Distribution Profiling A tissue distribution profile is determined for each template by compiling the cDNA library 2o tissue classifications of its component cDNA sequences. Each component sequence, is derived from a cDNA library constructed from a human tissue. Each human tissue is classified into one of the following categories: cardiovascular system; connective tissue; digestive system; embryonic structures; endocrine system; exocrine glands; genitalia, female; genitalia, male; germ cells; heroic and immune system; liver; musculoskeletal system; nervous system; pancreas;
respiratory system;
25 sense organs; skin; stomatognathic system; unclassified/mixed; or urinary tract. Template sequences, component sequences, and cDNA library/tissue information are found in the LIFESEQ
GOLD database (Incyte Genomics, Palo Alto CA).
VII. Transcript Image Analysis 3o Transcript images are generated as described in Seilhamer et al., "Comparative Gene Transcript Analysis," U.S. Patent Number 5,840,484, incorporated herein by reference.
VIII. Extension of Polynucleotide Sequences and Isolation of a Full-length cDNA
Oligonucleotide primers designed using an sptm of the Sequence Listing are used to extend 35 the nucleic acid sequence. One primer is synthesized to initiate 5' extension of the template, and the other primer, to initiate 3' extension of the template. The initial primers may be designed using OLIGO 4.06 software (National Biosciences, Inc. (National Biosciences), Plymouth MN), or another appropriate program, to be about 22 to 30 nucleotides in length, to have a GC
content of about 50%
or more, and to anneal to the target sequence at temperatures of about 68°C to about 72°C. Any stretch of nucleotides which would result in hairpin structures and primer-primer dimerizations are avoided. Selected human cDNA libraries are used to extend the sequence. If more than one extension is necessary or desired, additional or nested sets of primers are designed.
High fidelity amplification is obtained by PCR using methods well known in the art. PCR is performed in 96-well plates using the PTC-200 thermal cycler (MJ Research).
The reaction mix contains DNA template, 200 nmol of each primer, reaction buffer containing Mg2+, (NH4)zS04, and to B-mercaptoethanol, Taq DNA polymerase (Amersham Pharmacia Biotech), ELONGASE enzyme (Life Technologies), and Pfu DNA polymerase (Stratagene), with the following parameters for primer pair PCI A and PCI B: Step 1: 94°C, 3 min; Step 2: 94°C, 15 sec; Step 3: 60°C, 1 min; Step 4: 68°C, 2 min; Step 5: Steps 2, 3, and 4 repeated 20 times; Step 6:
68°C, 5 min; Step 7: storage at 4°C. In the alternative, the parameters for primer pair T7 and SK+ are as follows: Step 1: 94°C, 3 15 min; Step 2: 94°C, 15 sec; Step 3: 57°C, 1 min; Step 4:
68°C, 2 min; Step 5: Steps 2, 3, and 4 repeated 20 times; Step 6: 68°C, 5 min; Step 7: storage at 4°C.
The concentration of DNA in each well is determined by dispensing 100 p1 PICOGREEN
quantitation reagent (0.25% (v/v); Molecular Probes) dissolved in 1X Tris-EDTA
(TE) and 0.5 p1 of undiluted PCR product into each well of an opaque fluorimeter plate (Corning Incorporated 20 (Corning), Corning NY), allowing the DNA to bind to the reagent. The plate is scanned in a FLUOROSKAN II (Labsystems Oy) to measure the fluorescence of the sample and to quantify the concentration of DNA. A 5 p1 to 10 p1 aliquot of the reaction nuxture is analyzed by electrophoresis on a 1 % agarose nuni-gel to determine which reactions are successful in extending the sequence.
The extended nucleotides are desalted and concentrated, transferred to 384-well plates, 2s digested with CviJI cholera virus endonuclease (Molecular Biology Research, Madison WI), and sonicated or sheared prior to religation into pUC 18 vector (Amersham Pharmacia Biotech). For shotgun sequencing, the digested nucleotides are separated on low concentration (0.6 to 0.8%) agarose gels, fragments are excised, and agar digested with AGAR ACE
(Promega). Extended clones are religated using T4 ligase (New England Biolabs, Inc., Beverly MA) into pUC 18 vector 30 (Amersham Pharmacia Biotech), treated with Pfu DNA polymerase (Stratagene) to fill-in restriction site overhangs, and transfected into competent E. coli cells. Transformed cells are selected on antibiotic-containing media, individual colonies are picked and cultured overnight at 37°C in 384-well plates in LB/2x carbenicillin liquid media.
The cells are lysed, and DNA is amplified by PCR using Taq DNA polymerase (Amersham 35 Pharmacia Biotech) and Pfu DNA polymerase (Stratagene) with the following parameters: Step 1:
94°C, 3 min; Step 2: 94°C, IS sec; Step 3: 60°C, 1 min;
Step 4: 72°C, 2 min; Step 5: steps 2, 3, and 4 repeated 29 times; Step 6: 72°C, 5 min; Step 7: storage at 4°C. DNA is quantified by PICOGREEN reagent (Molecular Probes) as described above. Samples with low DNA
recoveries are reamplified using the same conditions as described above. Samples are diluted with 20%
dimethysulfoxide (1:2, v/v), and sequenced using DYENAMIC energy transfer sequencing primers and the DYENAMIC DIRECT kit (Amersham Pharmacia Biotech) or the ABI PRISM
BIGDYE
Terminator cycle sequencing ready reaction kit (PE Biosystems).
In like manner, the sptm is used to obtain regulatory sequences (promoters, introns, and enhancers) using the procedure above, oligonucleotides designed for such extension, and an appropriate genomic library.
IX. Labeling of Probes and Southern Hybridization Analyses Hybridization probes derived from the sptm of the Sequence Listing are employed for screening cDNAs, mRNAs, or genomic DNA. The labeling of probe nucleotides between 100 and 1000 nucleotides in length is specifically described, but essentially the same procedure may be used is with larger cDNA fragments. Probe sequences are labeled at room temperature for 30 minutes using a T4 polynucleotide kinase, y3zP-ATP, and O.SX One-Phor-All Plus (Amersham Pharmacia Biotech) buffer and purified using a ProbeQuant G-50 Microcolumn (Amersham Pharmacia Biotech). The probe mixture is diluted to 10' dpm/pg/ml hybridization buffer and used in a typical membrane-based hybridization analysis.
2 o The DNA is digested with a restriction endonuclease such as Eco RV and is electrophoresed through a 0.7% agarose gel. The DNA fragments are transferred from the agarose to nylon membrane (NYTRAN Plus, Schleicher & Schuell, Inc., Keene NH) using procedures specified by the manufacturer of the membrane. Prehybridization is carried out for three or more hours at 68°C, and hybridization is carried out overnight at 68°C. To remove non-specific signals, blots are 25 sequentially washed at room temperature under increasingly stringent conditions, up to O. lx saline sodium citrate (SSC) and 0.5% sodium dodecyl sulfate. After the blots are placed in a PHOSPHORIMAGER cassette (Molecular Dynamics) or are exposed to autoradiography film, hybridization patterns of standard and experimental lanes are compared.
Essentially the same procedure is employed when screening RNA.
X. Chromosome Mapping of sptm The cDNA sequences which were used to assemble SEQ ID NO:1-26 are compared with sequences from the Incyte LIFESEQ database and public domain databases using BLAST and other implementations of the Smith-Waterman algorithm. Sequences from these databases that match SEQ
ID NO:1-26 are assembled into clusters of contiguous and overlapping sequences using assembly algorithms such as PHRAP (Table 4). Radiation hybrid and genetic mapping data available from public resources such as the Stanford Human Genome Center (SHGC), Whitehead Institute for Genome Research (WIGR), and Genethon are used to determine if any of the clustered sequences have been previously mapped. Inclusion of a mapped sequence in a cluster will result in the assignment of all sequences of that cluster, including its particular SEQ ID
NO:, to that map location.
The genetic map locations of SEQ ID NO:1-26 are described as ranges, or intervals, of human chromosomes. The map position of an interval, in centiMorgans, is measured relative to the terminus of the chromosome's p-arm. (The centiMorgan (cM) is a unit of measurement based on recombination frequencies between chromosomal markers. On average, 1 cM is roughly equivalent to 1 megabase (Mb) of DNA in humans, although this can vary widely due to hot and cold spots of to recombination.) The cM distances are based on genetic markers mapped by Genethon which provide boundaries for radiation hybrid markers whose sequences were included in each of the clusters.
XI. Microarray Analysis Probe Preparation from Tissue or Cell Samples is Total RNA is isolated from tissue samples using the guanidinium thiocyanate method and polyA+ RNA is purified using the oligo (dT) cellulose method. Each polyA+ RNA
sample is reverse transcribed using MMLV reverse-transcriptase, 0.05 pg/lrl oligo-dT primer (2lmer), 1X first strand buffer, 0.03 units/pl RNase inhibitor, 500 NM dATP, 500 pM dGTP, 5001rM dTTP, 40 pM dCTP, 40 pM dCTP-Cy3 (BDS) or dCTP-Cy5 (Amersham Pharmacia Biotech). The reverse transcription 2o reaction is performed in a 25 ml volume containing 200 ng polyA+ RNA with GEMBRIGHT kits (Incyte). Specific control polyA+ RNAs are synthesized by in vitro transcription from non-coding yeast genomic DNA (W. Lei, unpublished). As quantitative controls, the control mRNAs at 0.002 ng, 0.02 ng, 0.2 ng, and 2 ng are diluted into reverse transcription reaction at ratios of 1:100,000, 1:10,000, 1:1000, I :100 (w1w) to sample mRNA respectively. The control mRNAs are diluted into 25 reverse transcription reaction at ratios of 1:3, 3:1, 1:10, 10:1, 1:25, 25:1 (w/w) to sample mRNA
differential expression patterns. After incubation at 37° C for 2 hr, each reaction sample (one with Cy3 and another with Cy5 labeling) is treated with 2.5 ml of 0.5M sodium hydroxide and incubated for 20 minutes at 85°C to the stop the reaction and degrade the RNA.
Probes are purified using two successive CHROMA SPIN 30 gel filtration spin columns (CLONTECH Laboratories, Inc.
so (CLONTECH), Palo Alto CA) and after combining, both reaction samples are ethanol precipitated using 1 ml of glycogen (1 mg/ml), 60 ml sodium acetate, and 300 ml of 100%
ethanol. The probe is then dried to completion using a SpeedVAC (Savant Instruments Inc., Holbrook NY) and resuspended in 14 p1 5X SSC/0.2% SDS.
Microarray Preparation 35 Sequences of the present invention are used to generate array elements.
Each array element is amplified from bacterial cells containing vectors with cloned cDNA inserts.
PCR amplification uses primers complementary to the vector sequences flanking the cDNA insert.
Array elements are amplified in thirty cycles of PCR from an initial quantity of 1-2 ng to a final quantity greater than 5 pg. Amplified array elements are then purified using SEPHACRYL-400 (Amersham Pharmacia Biotech).
s Purified array elements are immobilized on polymer-coated glass slides.
Glass microscope slides (Corning) are cleaned by ultrasound in 0.1% SDS and acetone, with extensive distilled water washes between and after treatments. Glass slides are etched in 4%
hydrofluoric acid (VWR
Scientific Products Corporation (VWR), West Chester, PA), washed extensively in distilled water, and coated with 0.05% aminopropyl silane (Sigma) in 95% ethanol. Coated slides are cured in a l0 110°C oven.
Array elements are applied to the coated glass substrate using a procedure described in US
Patent No. 5,807,522, incorporated herein by reference. 1 p1 of the array element DNA, at an average concentration of 100 ng/pl, is loaded into the open capillary printing element by a high-speed robotic apparatus. The apparatus then deposits about 5 n1 of array element sample per slide.
15 Microarrays are UV-crosslinked using a STRATALINKER UV-crosslinker (Stratagene).
Microarrays are washed at room temperature once in 0.2% SDS and three times in distilled water.
Non-specific binding sites are blocked by incubation of microarrays in 0.2%
casein in phosphate buffered saline (PBS) (Tropix, Inc., Bedford, MA) for 30 minutes at 60°C followed by washes in 0.2% SDS and distilled water as before.
2 o Hybridization Hybridization reactions contain 9 p1 of probe mixture consisting of 0.2 pg each of Cy3 and Cy5 labeled cDNA synthesis products in 5X SSC, 0.2% SDS hybridization buffer.
The probe mixture is heated to 65°C for 5 minutes and is aliquoted onto the microarray surface and covered with an 1.8 cmz coverslip. The arrays are transferred to a waterproof chamber having a cavity just 25 slightly larger than a microscope slide. The chamber is kept at 100%
humidity internally by the addition of 140 p1 of Sx SSC in a comer of the chamber. The chamber containing the arrays is incubated for about 6.5 hours at 60° C. The arrays are washed for 10 min at 45° C in a first wash buffer (1X SSC, 0.1% SDS), three times for 10 minutes each at 45°C in a second wash buffer (0.1X
SSC), and dried.
3o Detection Reporter-labeled hybridization complexes are detected with a microscope equipped with an Innova 70 mixed gas 10 W laser (Coherent, Inc., Santa Clara CA) capable of generating spectral lines at 488 nm for excitation of Cy3 and at 632 nm for excitation of CyS. The excitation laser light is focused on the array using a 20X microscope objective (Nikon, Inc., Melville NY). The slide 35 containing the array is placed on a computer-controlled X-Y stage on the microscope and raster-scanned past the objective. The 1.8 cm x 1.8 cm array used in the present example is scanned with a resolution of 20 micrometers..
In two separate scans, a mixed gas multiline laser excites the two fluorophores sequentially.
Emitted light is split, based on wavelength, into two photomultiplier tube detectors (PMT 81477, s Hamamatsu Photonics Systems, Bridgewater NJ) corresponding to the two fluorophores.
Appropriate filters positioned between the array and the photomultiplier tubes are used to filter the signals. The emission maxima of the fluorophores used are 565 nm for Cy3 and 650 nm for CyS.
Each array is typically scanned twice, one scan per fluorophore using the appropriate filters at the laser source, although the apparatus is capable of recording the spectra from both fluorophores to simultaneously.
The sensitivity of the scans is typically calibrated using the signal intensity generated by a cDNA control species added to the probe mix at a known concentration. A
specific location on the array contains a complementary DNA sequence, allowing the intensity of the signal at that location to be correlated with a weight ratio of hybridizing species of 1:100,000. When two probes from 15 different sources (e.g., representing test and control cells), each labeled with a different fluorophore, are hybridized to a single array for the purpose of identifying genes that are differentially expressed, the calibration is done by labeling samples of the calibrating cDNA with the two fluorophores and adding identical amounts of each to the hybridization mixture.
The output of the photomultiplier tube is digitized using a 12-bit RTI-835H
analog-to-digital 20 (A/D) conversion board (Analog Devices, Inc., Norwood, MA) installed in an IBM-compatible PC
computer. The digitized data are displayed as an image where the signal intensity is mapped using a linear 20-color transformation to a pseudocolor scale ranging from blue (low signal) to red (high signal). The data is also analyzed quantitatively. Where two different fluorophores are excited and measured simultaneously, the data are first corrected for optical crosstalk (due to overlapping 2 s emission spectra) between the fluorophores using each fluorophore's emission spectrum.
A grid is superimposed over the fluorescence signal image such that the signal from each spot is centered in each element of the grid. The fluorescence signal within each element is then integrated to obtain a numerical value corresponding to the average intensity of the signal. The software used for signal analysis is the GEMTOOLS gene expression analysis program (Incyte).
XII. Complementary Nucleic Acids Sequences complementary to the sptm are used to detect, decrease, or inhibit expression of the naturally occurnng nucleotide. The use of oligonucleotides comprising from about 15 to 30 base pairs is typical in the art. However, smaller or larger sequence fragments can also be used.
Appropriate oligonucleotides are designed from the sptm using OLIGO 4.06 software (National Biosciences) or other appropriate programs and are synthesized using methods standard in the art or ordered from a commercial supplier. To inhibit transcription, a complementary oligonucleotide is designed from the most unique 5'sequence and used to prevent transcription factor binding to the promoter sequence. To inhibit translation, a complementary oligonucleotide is designed to prevent ribosomal binding and processing of the transcript.
XIII. Expression of SPTM
Expression and purification of SPTM is accomplished using bacterial or virus-based expression systems. For expression of SPTM in bacteria, cDNA is subcloned into an appropriate vector containing an antibiotic resistance gene and an inducible promoter that directs high levels of to cDNA transcription. Examples of such promoters include, but are not limited to, the trp-lac (tac) hybrid promoter and the TS or T7 bacteriophage promoter in conjunction with the lac operator regulatory element. Recombinant vectors are transformed into suitable bacterial hosts, e.g., BL21(DE3). Antibiotic resistant bacteria express SPTM upon induction with isopropyl beta-D-thiogalactopyranoside (IPTG). Expression of SPTM in eukaryotic cells is achieved by infecting 15 insect or mammalian cell lines with recombinant Autogranhica californica nuclear polyhedrosis virus (AcMNPV), commonly known as baculovirus. The nonessential polyhedrin gene of baculovirus is replaced with cDNA encoding SPTM by either homologous recombination or bacterial-mediated transposition involving transfer plasmid intermediates. Viral infectivity is maintained and the strong polyhedrin promoter drives high levels of cDNA transcription. Recombinant baculovirus is used to zo infect Spodoptera fru>yiperda (Sf9) insect cells in most cases, or human hepatocytes, in some cases.
Infection of the latter requires additional genetic modifications to baculovirus. (See e.g., Engelhard, suvra; and Sandig, supra.) In most expression systems, SPTM is synthesized as a fusion protein with, e.g., glutathione S-transferase (GST) or a peptide epitope tag, such as FLAG or 6-His, permitting rapid, single-step, zs affinity-based purification of recombinant fusion protein from crude cell lysates. GST, a 26 kilodalton enzyme from Schistosoma japonicum, enables the purification of fusion proteins on immobilized glutathione under conditions that maintain protein activity and antigenicity (Amersham Pharmacia Biotech). Following purification, the GST moiety can be proteolytically cleaved from SPTM at specifically engineered sites. FLAG, an 8-amino acid peptide, enables immunoaffinity 3o purification using commercially available monoclonal and polyclonal anti-FLAG antibodies (Eastman Kodak Company, Rochester NY). 6-His, a stretch of six consecutive histidine residues, enables purification on metal-chelate resins (QIAGEN). Methods for protein expression and purification are discussed in Ausubel (1995, su ra, Chapters 10 and 16).
Purified SPTM obtained by these methods can be used directly in the following activity assay.
XIV. Demonstration of SPTM Activity An assay for SPTM activity measures the expression of SPTM on the cell surface. cDNA
encoding SPTM is subcloned into an appropriate mammalian expression vector suitable for high levels of cDNA expression. The resulting construct is transfected into a nonhuman cell line such as s NIH3T3. Cell surface proteins are labeled with biotin using methods known in the art.
Immunoprecipitations are performed using SPTM-specific antibodies, and immunoprecipitated samples are analyzed using SDS-PAGE and immunoblotting techniques. The ratio of labeled immunoprecipitant to unlabeled immunoprecipitant is proportional to the amount of SPTM
expressed on the cell surface.
1o Alternatively, an assay for SPTM activity measures the amount of SPTM in secretory, membrane-bound organelles. Transfected cells as described above are harvested and lysed. The lysate is fractionated using methods known to those of skill in the art, for example, sucrose gradient ultracentrifugation. Such methods allow the isolation of subcellular components such as the Golgi apparatus, ER, small membrane-bound vesicles, and other secretory organelles.
is Immunoprecipitations from fractionated and total cell lysates are performed using SPTM-specific antibodies, and immunoprecipitated samples are analyzed using SDS-PAGE and immunoblotting techniques. The concentration of SPTM in secretory organelles relative to SPTM
in total cell lysate is proportional to the amount of SPTM in transit through the secretory pathway.
2 o XV. Functional Assays SPTM function is assessed by expressing sptm at physiologically elevated levels in manunalian cell culture systems. cDNA is subcloned into a mammalian expression vector containing a strong promoter that drives high levels of cDNA expression. Vectors of choice include pCMV
SPORT (Life Technologies) and pCR3.1 (Invitrogen Corporation, Carlsbad CA), both of which 2 s contain the cytomegalovirus promoter. 5-10 pg of recombinant vector are transiently transfected into a human cell line, preferably of endothelial or hematopoietic origin, using either liposome formulations or electroporation. 1-2 pg of an additional plasmid containing sequences encoding a marker protein are co-transfected.
Expression of a marker protein provides a means to distinguish transfected cells from s o nontransfected cells and is a reliable predictor of cDNA expression from the recombinant vector.
Marker proteins of choice include, e.g., Green Fluorescent Protein (GFP;
CLONTECH), CD64, or a CD64-GFP fusion protein. Flow cytometry (FCM), an automated laser optics-based technique, is used to identify transfected cells expressing GFP or CD64-GFP and to evaluate the apoptotic state of the cells and other cellular properties.
35 FCM detects and quantifies the uptake of fluorescent molecules that diagnose events preceding or coincident with cell death. These events include changes in nuclear DNA content as measured by staining of DNA with propidium iodide; changes in cell size and granularity as measured by forward light scatter and 90 degree side light scatter; down-regulation of DNA synthesis as measured by decrease in bromodeoxyuridine uptake; alterations in expression of cell surface and intracellular proteins as measured by reactivity with specific antibodies; and alterations in plasma membrane composition as measured by the binding of fluorescein-conjugated Annexin V protein to the cell surface. Methods in flow cytometry are discussed in Ormerod, M. G. ( 1994) Flow Ctometry, Oxford, New York NY.
The influence of SPTM on gene expression can be assessed using highly purified populations of cells transfected with sequences encoding SPTM and either CD64 or CD64-GFP.
to CD64 and CD64-GFP are expressed on the surface of transfected cells and bind to conserved regions of human immunoglobulin G (IgG). Transfected cells are efficiently separated from nontransfected cells using magnetic beads coated with either human IgG or antibody against CD64 (DYNAL, Inc., Lake Success NY). mRNA can be purified from the cells using methods well known by those of skill in the art. Expression of mRNA encoding SPTM and other genes of interest can be analyzed by northern analysis or microarray techniques.
XVI. Production of Antibodies SPTM substantially purified using polyacrylamide gel electrophoresis (PAGE;
see, e.g., Harrington, M.G. (1990) Methods Enzymol. 182:488-495), or other purification techniques, is used 2o to immunize rabbits and to produce antibodies using standard protocols.
Alternatively, the SPTM amino acid sequence is analyzed using LASERGENE
software (DNASTAR) to determine regions of high immunogenicity, and a corresponding peptide is synthesized and used to raise antibodies by means known to those of skill in the art. Methods for selection of appropriate epitopes, such as those near the C-terminus or in hydrophilic regions are well described in the art. (See, e.g., Ausubel, 1995, supra, Chapter 11.) Typically, peptides 15 residues in length are synthesized using an ABI 431A
peptide synthesizer (PE Biosystems) using fmoc-chemistry and coupled to KLH (Sigma) by reaction with N-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) to increase immunogenicity.
(See, e.g., Ausubel, supra.) Rabbits are immunized with the peptide-KL,H complex in complete Freund's 3 o adjuvant. Resulting antisera are tested for antipeptide activity by, for example, binding the peptide to plastic, blocking with 1 % BSA, reacting with rabbit antisera, washing, and reacting with radio-iodinated goat anti-rabbit IgG. Antisera with antipeptide activity are tested for anti-SPTM activity using protocols well known in the art, including ELISA, RIA, and immunoblotting.
XVII. Purification of Naturally Occurring SPTM Using Specific Antibodies Naturally occurring or recombinant SPTM is substantially purified by immunoaffinity chromatography using antibodies specific for SPTM. An immunoaffinity column is constructed by covalently coupling anti-SPTM antibody to an activated chromatographic resin, such as s CNBr-activated SEPHAROSE (Amersham Pharmacia Biotech). After the coupling, the resin is blocked and washed according to the manufacturer's instructions.
Media containing SPTM are passed over the immunoaffinity column, and the column is washed under conditions that allow the preferential absorbance of SPTM (e.g., high ionic strength buffers in the presence of detergent). The column is eluted under conditions that disrupt to antibody/SPTM binding (e.g., a buffer of pH 2 to pH 3, or a high concentration of a chaotrope, such as urea or thiocyanate ion), and SPTM is collected.
XVIII. Identification of Molecules Which Interact with SPTM
SPTM, or biologically active fragments thereof, are labeled with'ZSI Bolton-Hunter reagent.
is (See, e.g., Bolton, A.E. and W.M. Hunter (1973) Biochem. J. 133:529-539.) Candidate molecules previously arrayed in the wells of a multi-well plate are incubated with the labeled SPTM, washed, and any wells with labeled SPTM complex are assayed. Data obtained using different concentrations of SPTM are used to calculate values for the number, affinity, and association of SPTM with the candidate molecules.
2o Alternatively, molecules interacting with SPTM are analyzed using the yeast two-hybrid system as described in Fields, S. and O. Song (1989) Nature 340:245-246, or using commercially available kits based on the two-hybrid system, such as the MATCHMAKER system (CLONTECH).
SPTM may also be used in the PATHCALLING process (CuraGen Corp., New Haven CT) which employs the yeast two-hybrid system in a high-throughput manner to determine all 2 s interactions between the proteins encoded by two large libraries of genes (Nandabalan, K. et al.
(2000) U.S. Patent No. 6,057,101).
All publications and patents mentioned in the above specification are herein incorporated by reference. Various modifications and variations of the described method and system of the invention 3o will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the above-described modes for carrying out the invention which are obvious to those skilled in the field of molecular biology or 35 related fields are intended to be within the scope of the following claims.
o Q °' E za vU ,. °~~ o ~
Q r ~" c Q ~ C N ~E
O N M O N ~"
Y ~ ~ ~ O O O ~ N E !_ N C U ~ h Q ~ O ~
-O ~ N E Q O U ,c~
Q. _N p ~ 'O N p;
p o o ~ ~ a o ~ N 3 Y ~ ~n ~ -Q o vU ~ o a a ~ ~ p E
Q ~ o °' ~ ~ o ~? o ~ ~ v ~ aU
~n O 'D
"' LpU~ E ~ ~ Q O ~ "',~>. Q uyU
O v~~ ~ ~ ~ h Q ~ ~ . Z C p ~' E ~ M ~.~u O Q ~7 O
C v C ~ U ~ ~ Z ~ p ~ L" ~ U ~ vi .~ ~ U Q U p 'i' t O ~ pU n C U O E O N vi ~ 'O " N J z Q U ~ Q
Q N O ~ v U >- v~ M ~ U E C N U ~ U U M ~ m O Z
C ii Q C ~ Q d ~ ~ v~ C U ~ N p E ~ U Lv cY N o -~,~z ~ o a o 0 0~ ~ ~ a~ a~Q °~ ai E o,~~' o~~_a~ z o= o QQ ~ a~g a~ d~ ~ ~ a'~ a o--~ Z Qw N o o~ E N .C ~ s N ~ o o Q z Q ~ ~ ~ E M
U p U rn N = U C O Q p U ~ L" Z =' N ~n O V
C OZ~~~o°oC0 OUN~U~ Qp E~~ O~pMOQ
Qa~~°~pa~o°=~o c°_'Qa_Ez~ ~Q '~ ~o Q~NoN
O U ~ ° -o N U ~ N ~ c a N .Q N U N ~ C E ~ p ~ r- ~, ~ N o ~ Y
U ~ Q~ U ~ ~. ~ ~ w ~ ~ ~ p ~ j N E ~ ~ U QcG ~ ~ ~ ~ p ~ O
~ O O O ~ O ~ O ~ ~ D N m O ~ 0 ~ ° Z ~ N O O
~ o U~ o E a~ ° ~ ~ E a s N C O Q o o ~ ~ ~ C9 U~ o 0 E QU U~U ~~ >~-=~QO ~U o v~ > a_ E U ~~~c ~~~; E
Q c N c c c ~.~ ~z ~~oho a o C c C c c ~ c c ~ c -~ ~' ~ c p ~ "' c N N N Q O ~ ~ ~ r Z O N O N ~ N N (~ ~ ~ N Q N
-Q. -Q. 'a -Q. o U ~o D -o ~ -p E ~Q. ,o -a ~a -a -a o a ~ ~j L ~a Q- ~ z -a a~D~~~~?~~tNZ<~.,LDra~~~a~~°~mo~3~pUa or o 0 0 ~ aQ o o ~a~o 0 0 oQ ~ o o ao ~~ ~ o oQ o Eo E E E~~z ~Qo c~ > E~_ E EN aE E E E ~~ ~ E~z c E
z °m z z i ~ ~~ ~ ~ z ~ Y z z U z z ~ ~ z z ~ i aw U z ~
a~
M M N ~ ~ O O~ n ~ ~ r ~ N
i i i i i i i i i i ~ i UJ LV UJ UJ ' UJ UJ UJ UJ UJ UJ UJ UJ
- O O O O O O ~ O O O O O O O O O O O O O O O O
Q O O O O p O O O O O O O O
N ~O ~ ~ ~ ~ N r h U ~ ~O CV
O
d N O~ ~ ~ ~O c0 W M O O V c0 O, ~O ~_ N a0 V_ _ C~ O
O~ r ~O U_ O~ V ~O O N O ~ M ~_ ~O O~ U ~ c0 N
O~ ~ ~ h h N o0 ~ h N ~O ~O ~O u7 O~ ~O ~
E h h O~ O M h ~O h ~ O~ N h ~O U ~O O ~ U P O h O
7 O V N U N O ~ ~O ~ ~_ O O a0 O ~O a0 N h ~ h ~ c0 c0 U P ~O O~ h ~O CO ~O h h ~ ~O h ~ 00 U c~ ~O ~ CG ~
~O r V ~O ~f7 r X17 ~ r ~O M r V ~ ~O ~O V V M ~O M V
~ ~ ~ ° ° ~ ~ ~ ~ ° ~
D
M r M N ~ M N ~ Q M r ~O r N h ~O r N ~ ~ h U V O~ ~O V O M h ' ~O ~ u7 ~ M V V U V
O a0 a0 ~ a0 N ~ ~O V O- M ~ M ~ fw0 ~ ~ 00 c0 h d' V
h o0 h O ~ c0 c0 h N O N a0 O- r N ~ V ~ ~O
Q U ~ ~OO N M a0 U ~ ~ ~ tn N N h ~- ~ h U O
E~N°NNNN N NNNNNNNN NN c~c~ c~m'7c~M
N
Z
D ~ N M V ~ ~O h OD O~ ~ r ~ M ~ ~ ~ ~ M ~' O N M
N N N N
UJ
M
r:
O
Q
N
Y
N
C
O
U "' O 'd 47 ~ ~ U
a7 O Q
00 ~ E
C Q Q O
Q- ~ Z
Y
_C_ Q _N _O
O O_ U Q- Q
Z Q
C
U
Vl N fn N f~ N
O O O
O O O
O.
U
~O O O
O
.Q
O
d U N O O
~ c~ O
oD ~ CV
Z ~ ~ ~
D
M
P_ ~ n O r P N
O- O O
~ V d' H
O
Z
N N N
w TABLE 2.
SEQ Template Start Stop Frame Domain ID ID Type NO:
1 1978.1 401 478 forward TM
2 2588.4 362 454 forward SP
2 2588.4 1552 1626 forward TM
3 201759,3 926 1009 forward SP
4 208184,1 1438 1533 forward SP
4 208184.1 159 242 forward SP
4 208184,1 1194 1271 forward TM
212029,3 128 208 forward SP
b 213446,2 944 1021 forward SP
b 213446.2 614 718 forward SP
b 213446,2 934 1020 forward TM
7 228864,4 1600 1680 forward SP
7 228864.4 116 229 forward SP
7 228864.4 543 638 forward SP
8 229840.3 2861 2938 forward TM
9 231793.2 730 810 forward SP
234137.5 708 806 forward SP
11 234671.14 557 634 forward TM
12 241236.3 1397 1501 forward SP
13 245014.1 1326 1412 forward TM
14 245251.6 826 909 forward SP
252875.1 2388 2468 forward TM
16 252964.2 2954 3037 forward TM
17 267153.7 746 829 forward SP
18 331244.6 413 493 forward TM
19 335484.1 1977 2060 forward TM
19 335484.1 2805 2888 forward TM
337489.2 bbb 746 forward TM
21 359574.5 2571 2657 forward SP
21 359574.5 1845 1931 forward SP
21 359574.5 1665 1760 forward SP
22 360645.5 415 495 forward SP
23 404145.7 2141 2248 forward SP
23 404145.7 Ebb 785 forward SP
24 480119.1 1181 1267 forward SP
24 480119.1 413 499 forward SP
480951.5 2523 2606 forward TM
2b 481257.3 2774 2860 forward TM
S'7 SEQ ID NO: TemplateComponent Start Stop ID ID
1 1978.1 g 1855482 1 217 1 1978,1 3137104H1 1 272 1 1978.1 3137104F6 1 381 1 1978.1 3526040H1 11 304 1 1978.1 3523774H1 11 357 1 1978.1 g 1267790 148 605 1 1978.1 g1267782 148 522 1 1978.1 g1958606 164 580 1 1978.1 3031854H1 269 571 1 1978.1 4832441H1 339 597 1 1978,1 g1775794 353 418 1 1978.1 4142134H1 553 758 1 1978.1 1600481H1 605 800 1 1978.1 1600481F6 605 966 1 1978.1 4379163H1 653 915 1 1978.1 2901551H1 668 927 1 1978.1 1678677H1 677 909 1 1978.1 3842809H1 736 1043 1 1978.1 1793709H1 755 1050 1 1978.1 2773028H1 755 1009 1 1978.1 3602828H1 860 1155 1 1978.1 1610720H1 934 1142 1 1978,1 2366358H1 976 1193 1 1978.1 5497064H1 1036 1265 1 1978,1 3742273H1 1063 1273 1 1978.1 5261375H1 1113 1334 1 1978,1 1378352F1 1149 1688 1 1978.1 1378352H1 1149 1386 1 1978,1 1281776F6 1190 1796 1 1978,1 1281776H1 1190 1453 1 1978.1 2097593H1 1199 1380 1 1978.1 2098893H1 1199 1445 1 1978.1 g714966 1208 1550 1 1978.1 3929766H1 1219 1504 1 1978.1 g1425881 1230 1639 1 1978.1 g989565 1249 1465 1 1978.1 1369088H1 1249 1478 1 1978.1 627100H1 1249 1491 1 1978.1 815413H1 1269 1522 1 1978.1 4505379H1 1271 1473 1 1978.1 128177676 1348 1957 1 1978.1 g1860340 1388 1801 1 1978.1 g1959763 1438 1931 1 1978.1 160048176 1439 1962 1 1978.1 313710476 1467 1961 1 1978.1 g3231943 1542 1999 1 1978.1 5195075H1 1543 1772 1 1978.1 g3231851 1547 1999 1 1978.1 g3539313 1559 2000 1 1978.1 g3539311 1559 2001 SE6~ Template Component Start Stop ID NO: ID ID
1 1978.1 764088H1 1571 1866 1 1978.1 765817H1 1571 1820 1 1978.1 76581786 1571 1972 1 1978.1 765817T6 1571 1964 1 1978.1 81860995 1588 2012 1 1978.1 84068873 1592 2000 1 1978.1 82787512 1594 2000 1 1978.1 81202822 1605 2000 1 1978.1 g 1425795 1639 2004 1 1978.1 2202630T6 1656 1956 1 1978.1 2202630H1 1664 1911 1 1978.1 2202630F6 1664 1996 1 1978.1 g 1775688 1702 1969 1 1978.1 8714967 1724 2012 1 1978.1 2290116H1 1725 1992 1 1978.1 2127226H1 1725 1998 1 1978.1 3815472H1 1739 2000 1 1978.1 8989478 1752 1987 1 1978.1 83043215 1787 2005 1 1978.1 2413731H1 1868 2004 2 2588.4 3502438H1 2224 2533 2 2588.4 82786213 2248 2674 2 2588.4 83277689 2254 2669 2 2588.4 2366762H1 2248 2486 2 2588.4 1910722H1 2255 2499 2 2588.4 84286541 2256 2664 2 2588.4 83052444 2260 2670 2 2588.4 832051T6 2268 2624 2 2588.4 82873700 2274 2671 2 2588.4 82876032 2276 2668 2 2588.4 2663178H1 2278 2519 2 2588.4 81482457 2282 2670 2 2588.4 2868714H1 2290 2577 2 2588.4 83239166 2301 2671 2 2588.4 83700567 2302 2669 2 2588.4 4595434H1 2361 2549 2 2588.4 g 1118566 2382 2669 2 2588.4 81693563 2384 2670 2 2588.4 81920095 2390 2675 2 2588.4 2370688H1 2416 2519 2 2588.4 g 1952447 2420 2676 2 2588.4 81124041 2428 2669 2 2588.4 8787440 2432 2669 2 2588.4 82322889 2432 2803 2 2588.4 g 1885881 2434 2677 2 2588.4 81267377 2451 2817 2 2588.4 g 1119118 2466 2669 2 2588.4 81218402 2474 2669 2 2588.4 2768580Th 2481 2630 2 2588.4 82102824 2482 2892 SEQ ID Template Component Start Stop NO: ID ID
2 2588.4 1844326H1 2483 2669 2 2588.4 2768580H1 2488 2670 2 2588.4 2768580F6 2488 2670 2 2588.4 82457806 2514 2667 2 2588.4 1854244H1 2530 2669 2 2588.4 1830904Th 2533 2622 2 2588.4 1854244Th 2533 2630 2 2588.4 g 1484958 2560 2670 2 2588.4 35b5846H1 2565 2885 2 2588.4 8845861 2570 2688 2 2588.4 2094b84H1 2574 2669 2 2588.4 4157557H1 2598 2867 2 2588.4 3412843H1 2640 2859 2 2588.4 2467396Th 2734 3206 2 2588.4 2467396Fb 2741 . 3192 2 2588.4 2467396H1 2741 2978 2 2588.4 31486bOH1 2882 2992 2 2588.4 82435914 2884 3178 2 2588.4 2832630F6 2918 3237 2 2588.4 2832b30H1 2918 3174 2 2588.4 2832630Th 2922 3199 2 2588.4 81154518 2999 3296 2 2588.4 8845812 3031 3245 2 2588.4 4118483H1 3044 3213 2 2588.4 g 1123141 3054 3244 2 2588.4 2268209Th 761 1105 2 2588.4 2672328F6 1 357 2 2588.4 2590094H2 1 227 2 2588.4 2b72328H1 1 227 2 2588.4 2672248H1 1 227 2 2588.4 2159193H1 1 149 2 2588.4 2660709H1 5 253 2 2588.4 3046945H1 14 316 2 2588.4 20476b1H1 30 315 2 2588.4 81957845 31 476 2 2588.4 82210487 57 387 2 2588.4 3b98574H1 308 459 2 2588.4 5633547H1 440 637 2 2588.4 2892108H1 440 708 2 2588.4 3496131H1 490 777 2 2588.4 3111455H1 513 783 2 2588.4 2536480H1 550 792 2 2588.4 4971550H1 560 817 2 2588.4 226820986 570 955 2 2588.4 2268209H1 571 833 2 2588.4 1259305F1 611 1189 2 2588.4 3773508H1 612 930 2 2588.4 1259305H1 611 838 2 2588.4 82534bH1 685 983 2 2588.4 212237bH1 702 955 SE6~ Template Component Start Stop ID NO: ID ID
2 2588.4 3108360H1 743 1017 2 2588.4 g2210429 769 1039 2 2588.4 5188115H1 895 1068 2 2588.4 646258H1 907 1068 2 2588.4 4564951H1 961 1217 2 2588.4 661278H1 999 1263 2 2588.4 660712H1 999 1267 2 2588.4 634487H1 987 1238 2 2588.4 82037676 1040 1244 2 2588.4 5035180H1 1074 1347 2 2588.4 66127886 999 1563 2 2588.4 5035211H1 1074 1324 2 2588.4 81523090 1093 1462 2 2588.4 3523389H1 1113 1352 2 2588.4 81192612 1099 1470 2 2588.4 1450413H1 1129 1376 2 2588.4 4346111H1 1138 1389 2 2588.4 4346627H1 1138 1401 2 2588.4 3174422H1 1139 1381 2 2588.4 2645913H1 1158 1420 2 2588.4 4959350H1 1163 1408 2 2588.4 2632516H1 1170 1408 2 2588.4 2995782H1 1187 1446 2 2588.4 81950525 1257 1594 2 2588.4 5501962H1 1295 1527 2 2588.4 2866753H1 1313 1647 2 2588.4 81920346 1372 1779 2 2588.4 g 1950552 1426 1678 2 2588.4 1990742H1 1432 1677 2 2588.4 82102880 1453 1926 2 2588.4 2108316H1 1491 1762 2 2588.4 4323533H1 1493 1761 2 2588.4 2326875H1 1498 1749 2 2588.4 2326664H1 1498 1726 2 2588.4 5117484H1 1534 1793 2 2588.4 1794995H1 1560 1832 2 2588.4 3203064H1 1561 1846 2 2588.4 2406583H1 1576 1709 2 2588.4 4144701H1 1594 1773 2 2588.4 3605515H1 1621 1861 2 2588.4 2715994H1 1641 1885 2 2588.4 3141136H1 1644 1889 2 2588.4 3687001H1 1650 1947 2 2588.4 8900018 1654 1998 2 2588.4 81639521 1672 1916 2 2588.4 2860261H1 1690 1969 2 2588.4 3254658H1 1699 1932 2 2588.4 3095495H1 1712 1995 2 2588.4 2660751H1 1768 2016 2 2588.4 83205186 1804 2094 SE6~ Template Component Start Stop ID NO: ID ID
2 2588.4 1812964H1 1804 2036 2 2588.4 832051H1 1804 2072 2 2588.4 1812964F6 1805 2328 2 2588.4 2900724H1 1812 2115 2 2588.4 1496448H1 1817 2058 2 2588.4 g2912624 1840 2122 2 ' 2588.4 g2879636 1844 2122 2 2588.4 g2191548 1846 2122 2 2588.4 5506884H1 1863 2096 2 2588.4 2203126H1 1903 2157 2 2588.4 4159080H1 1906 2135 2 2588.4 1857148H1 1916 2161 2 2588.4 5099926H1 1925 2212 2 2588.4 g787181 1953 2177 2 2588.4 3327731H1 1983 2283 2 2588.4 5572386H1 1994 2106 2 2588.4 4986441H1 2004 2303 2 2588.4 3110534H1 2004 2279 2 2588.4 5396265T1 2047 2631 2 2588.4 2189071T6 2070 2626 2 2588.4 2189071H1 2072 2357 2 2588.4 2189071F6 2072 2492 2 2588.4 2783063H1 2074 2365 2 2588.4 539637571 2081 2633 2 2588.4 4862535H1 2082 2244 2 2588.4 267232876 2092 2636 2 2588.4 1972459H1 2094 2376 2 2588.4 3786773H1 2114 2409 2 2588.4 66127876 2145 2631 2 2588,4 3994175H 2158 2450 2 2588.4 3995990H1 2160 2411 2 2588.4 5137950H2 2208 2487 2 2588,4 g1523038 2213 2669 2 2588.4 2664705H1 2212 2338 2 2588.4 g3308729 2218 2673 3 201759.3 83662481 823 1315 3 201759,3 039821H1 861 1031 3 201759.3 5278457H1 871 1132 3 201759.3 836624H1 872 1143 3 201759.3 836632H1 873 1140 3 201759.3 4299787H1 879 1057 3 201759.3 263784H1 898 1265 3 201759.3 g2017411 900 1347 3 201759.3 82619981 904 1553 3 201759.3 826199H1 904 1190 3 201759,3 g1463426 908 1456 3 201759.3 2011073H1 914 1130 3 201759.3 4203594H1 917 1203 3 201759.3 2021844H1 918 1180 3 201759.3 4861150H1 919 1199 b2 SEQ ID Template Component Starf Stop NO: ID ID
3 201759.3 1494424H1 958 1173 3 201759.3 3697752H1 970 1290 3 201759.3 81049651 984 1332 3 201759.3 3015055H1 987 1320 3 201759.3 1857956H1 990 1165 3 201759.3 1857956F6 990 1530 3 201759.3 5112648H1 997 1334 3 201759.3 535858H1 1000 1099 3 201759.3 5091726H1 1015 1322 3 201759.3 1952952H1 1015 1309 3 201759.3 1257476H1 1016 1281 3 201759.3 4585955H1 1017 1309 3 201759.3 5836690H1 1018 1270 3 201759.3 4648947H1 1027 1197 3 201759.3 958699H1 1029 1339 3 201759.3 3960850H2 1028 1325 3 201759.3 691887H1 1030 1258 3 201759.3 g 1240155 1040 1284 3 201759.3 81025462 1053 1335 3 201759.3 g 1264434 1053 1450 3 201759.3 3354080H1 1065 1243 3 201759.3 8863516 1067 1324 3 201759.3 5428281H1 1073 1362 3 201759.3 1236418H1 1075 1290 3 201759.3 3525638H1 1085 1444 3 201759.3 4086966H1 1102 1398 3 201759,3 2921953H1 1116 1433 3 201759.3 2370849H1 1117 1402 3 201759.3 1649210H1 1117 1383 3 201759.3 4159589H1 1126 1416 3 201759.3 83919705 1134 1658 3 201759.3 2840735H1 1139 1417 3 201759.3 1401895H1 1140 1414 3 201759,3 82110825 1140 1652 3 201759.3 3807071H1 1141 1491 3 201759,3 4112417H1 1144 1251 3 201759.3 3843828H1 1143 1465 3 201759.3 83238572 1144 1668 3 201759.3 82347672 1147 1665 3 201759,3 82930046 1147 1665 3 201759,3 83238573 1150 1668 3 201759.3 82742072 1171 1658 3 201759.3 83595471 1176 1658 3 201759.3 83988715 1176 1658 3 201759.3 83644962 1177 1668 3 201759.3 3466714H1 1177 1467 3 201759.3 81384561 1180 1673 3 201759.3 83446683 1181 1670 3 201759.3 83679958 1184 1664 3 201759.3 g 13321 1190 1663 b5 b3 SE6~ Template Component Start Stop ID NO: ID ID
3 201759.3 3600088H1 1200 1528 3 201759.3 2542561T6 1207 1633 3 201759.3 900346H1 1225 1325 3 201759.3 90034681 1225 1658 3 201759.3 8848629 1225 1571 3 201759.3 5056168H1 1225 1530 3 201759.3 3112117H1 1233 1546 3 201759.3 82524963 1240 1658 3 201759.3 84332204 1241 1665 3 201759.3 3366929H1 1244 1517 3 201759.3 83432662 1244 1666 3 201759,3 82806722 1246 1661 3 201759.3 83931304 1247 1667 3 201759.3 83601403 1248 1663 3 201759.3 83238932 1252 1665 3 201759.3 83931309 1258 1667 3 201759.3 2293916H1 1261 1529 3 201759.3 2399275H1 1272 1541 3 201759.3 82557656 1281 1663 3 201759.3 82617892 1281 1659 3 201759.3 82463986 1286 1668 3 201759.3 82457535 1288 1646 3 201759.3 83416543 1292 1643 3 201759.3 83095258 1297 1665 3 201759.3 82669541 1297 1658 3 201759.3 3467486H1 1311 1579 3 201759.3 82198192 1314 1665 3 201759.3 g 749662 1313 1659 3 201759.3 8752157 1313 1580 3 201759.3 82188331 1324 1670 3 201759.3 83308655 1325 1658 3 201759.3 82156163 1331 1835 3 201759.3 83229304 1342 1668 3 201759.3 82969733 1349 1665 3 201759.3 2664494Th 1352 1622 3 201759.3 81049959 1369 1670 3 201759.3 82243211 1366 1668 3 201759.3 8863517 1371 1642 3 201759.3 8784617 1372 1665 3 201759.3 81614677 1368 1658 3 201759.3 84148476 1369 1665 3 201759.3 81294977 1369 1658 3 201759.3 82955119 1373 1667 3 201759.3 81448860 1373 1658 3 201759.3 g 29581 1395 1658 b 1 3 201759.3 83233016 1401 1663 3 201759.3 4640182H1 1401 1660 3 201759.3 83884622 1404 1670 3 201759.3 83431226 1406 1658 3 201759.3 83843156 1407 1658 b4 SEQ ID Template Component ~ Start Stop NO: ID ID
3 201759.3 2101118H1 1413 1655 3 201759.3 2044357H1 1428 1688 3 201759.3 3573519Th 1432 1996 3 201759.3 1695963T6 1432 1995 3 201759.3 2351137H1 1458 1662 3 201759.3 1901951H1 1468 1763 3 201759.3 2505488H2 1468 1721 3 201759.3 2052204H1 1486 1761 3 201759.3 2016130H1 1 95 3 201759.3 5373386H1 24 184 3 201759.3 6026840H1 51 139 3 201759.3 2598924H1 87 375 3 201759.3 2598924F6 88 598 3 201759.3 1318607H1 88 321 3 201759.3 3450621H1 93 257 3 201759.3 2664494H1 96 332 3 201759.3 2664494F6 96 652 3 201759.3 3573519F6 98 681 3 201759.3 3573519H1 98 405 3 201759.3 4177617H1 102 371 3 201759.3 4920283H1 101 194 3 201759.3 4843441H1 104 378 3 201759.3 3069036H1 104 395 3 201759.3 3374007H1 109 376 3 201759.3 4662762H1 109 366 3 201759.3 2160985H1 109 364 3 201759.3 2964373H1 109 423 3 201759,3 3561542H1 110 405 3 201759.3 3579440H1 110 414 3 201759.3 1571030H1 110 302 3 201759.3 3595416H1 112 234 3 201759.3 2133581H1 113 395 3 201759.3 3281108H1 112 376 3 201759.3 3658478H1 112 394 3 201759.3 3359378H1 117 395 3 201759.3 g1962636 119 523 3 201759.3 3373501H1 119 374 3 201759,3 899120H1 123 209 3 201759.3 2913242H1 123 383 3 201759.3 4974963H1 123 215 3 201759.3 81813092 125 514 3 201759.3 1531710H1 126 327 3 201759.3 4270743H1 163 428 3 201759.3 4522315H1 170 429 3 201759.3 2647741H1 176 428 3 201759.3 3031088H1 194 497 3 201759,3 82163335 192 565 3 201759.3 3895133H1 205 527 3 201759,3 3950958H1 272 434 3 201759,3 5538554H2 305 502 b5 SEQ ID Template Component Start Stop NO: ID ID
3 201759.3 1911718H1 323 482 3 201759.3 g4084676 346 828 3 201759.3 5713320H1 362 659 3 201759.3 583652bH1 363 651 3 201759.3 5833621H1 3b3 651 3 201759.3 2858391H1 367 b31 3 201759.3 2859193H1 367 b22 3 201759.3 g2255078 377 819 3 201759.3 273057bH1 423 698 3 ~ 201759.3 1695963Fb 433 907 3 201759.3 4548b39H1 433 676 3 201759.3 2674195H1 433 678 3 201759.3 1695963H1 433 685 3 201759.3 g21 b317b 461 890 3 201759.3 3422493H1 470 700 3 201759.3 597747H1 475 712 3 201759.3 436190H1 489 747 3 201759.3 g761512 496 878 3 201759.3 g 1799100 496 1022 3 201759.3 1707486H1 506 730 3 201759.3 3758616H1 511 639 3 201759.3 173498H1 523 720 3 201759.3 g883464 549 959 3 201759,3 4299747H1 566 794 3 201759.3 4301171H1 5bb 775 3 201759.3 g788509 576 853 3 201759.3 39b857bH1 586 911 3 201759.3 173498F1 593 1035 3 201759.3 3624367H1 611 886 3 201759.3 5811130H1 618 916 3 201759.3 2480172H1 620 957 3 201759.3 3233075H1 626 934 3 201759.3 1376454H1 629 872 3 201759.3 1376454F1 629 1103 3 201759.3 4824995H1 633 903 3 201759,3 1611033H1 638 856 3 201759.3 1b110b4H1 638 840 3 201759.3 85064981 639 1297 3 201759.3 850b49H1 639 901 3 201759,3 280397H1 640 1029 3 201759.3 3608679H1 639 848 3 201759.3 3502463H1 644 9bb 3 201759.3 4302480H1 646 950 3 201759.3 166390H1 652 925 3 201759,3 465154H1 675 922 3 201759,3 2471187H1 696 946 3 201759.3 81332164 698 1205 3 201759.3 81988555 704 1008 3 201759.3 167885H1 704 1055 3 201759.3 167849H1 705 1059 bb SE6~ Template Component Start Stop ID NO: ID ID
3 201759.3 087337H1 707 954 3 201759.3 1482767H1 724 988 3 201759.3 81614676 733 862 3 201759.3 8874674 740 1147 3 201759.3 8877795 740 1099 3 201759.3 668420H1 739 986 3 201759.3 061003H1 741 915 3 201759.3 81448859 753 1297 3 201759.3 5861969H1 754 1038 3 201759.3 2961324H1 754 1072 3 201759.3 2545528H1 760 1023 3 201759.3 030800H1 761 1060 3 201759.3 3599778H1 779 1014 3 201759.3 4886074H1 790 1073 3 201759.3 2702328H1 790 1054 3 201759.3 4724311H1 797 910 3 201759.3 1674833H1 802 1024 3 201759.3 81055891 803 1147 3 201759.3 4425751H1 817 1097 3 201759.3 700809H1 819 1111 3 201759.3 700858H1 819 1108 3 201759,3 81406784 1492 1915 3 201759.3 83307726 1501 1658 3 201759.3 83405773 1505 1969 3 201759.3 1007491H1 1541 1848 3 201759.3 83841579 1547 1665 3 201759.3 5906115H1 1549 1665 3 201759.3 83016169 1550 1658 3 201759.3 82967986 1558 1658 3 201759.3 1416494H1 1560 1811 3 201759.3 2111952H1 1560 1859 3 201759.3 82265647 1572 2043 3 201759.3 82106597 1571 1674 3 201759.3 040426H1 1577 1834 3 201759.3 8314936 1600 2038 3 201759.3 83872004 1609 2038 3 201759.3 82112437 1613 2047 3 201759.3 81382965 1616 2039 3 201759.3 82930234 1617 2039 3 201759.3 82559360 1619 2038 3 201759.3 1602514Th 1630 1972 3 201759.3 5022224H1 1637 1919 3 201759.3 1602514F6 1638 1821 3 201759.3 1602514H1 1638 1841 3 201759.3 g 1813014 1642 2039 3 201759.3 82107167 1647 2047 3 201759.3 1857956T6 1653 2000 3 201759.3 83770498 1655 2040 3 201759.3 8518019 1702 2038 3 201759.3 8883358 1708 2046 SEQ ID Template Component Start Stop NO: ID ID
3 201759.3 8678008 1717 2038 3 201759.3 83777972 1726 2041 3 201759.3 165551076 1743 1998 3 201759.3 1655510H1 1751 2003 3 201759.3 1655502H1 1751 1999 3 201759.3 81211514 1750 2039 3 201759.3 1655510F6 1751 2038 3 201759.3 84270201 1753 2046 3 201759.3 g 1025463 1758 2033 3 201759.3 2410391H1 1760 1986 3 201759.3 4565053H1 1763 2014 3 201759.3 8874588 - 1768 2062 3 201759.3 82836530 1783 2039 3 201759.3 82620460 1787 2038 3 201759.3 502222471 1794 1995 3 201759.3 8848545 1797 2010 3 201759.3 82269911 1826 2038 3 201759.3 81202659 1857 2052 3 201759.3 5597773H1 1869 2043 3 201759.3 8869167 1874 2062 3 201759.3 1818223H1 1896 2045 3 201759.3 82658131 1898 2347 3 201759.3 83595015 1910 2346 3 201759.3 5059857H1 1942 2004 3 201759.3 4654185H1 1959 2242 3 201759.3 3489630H1 1968 2039 3 201759.3 8750011 2022 2358 3 201759.3 84194527 2035 2346 3 201759.3 83843200 2039 2347 3 201759,3 82658236 2054 2347 3 201759.3 2844058F6 2078 2347 3 201759.3 2844058H1 2078 2350 3 201759.3 8752055 2137 2322 3 201759.3 83433471 2136 2345 4 208184.1 5329975H1 1526 1795 4 208184.1 3962839H1 1531 1848 4 208184.1 3963078H1 1531 1837 4 208184.1 832955H1 1393 1484 4 208184.1 150072176 1405 1942 4 208184.1 2360410H1 1406 1679 4 208184.1 2360557H1 1406 1539 4 208184.1 82023641 1411 1756 4 208184,1 2271884H1 1421 1705 4 208184.1 378111H1 1459 1630 4 208184.1 273132H1 1478 1606 4 208184.1 84313046 1518 1980 4 208184,1 2130933H1 1526 1810 4 208184.1 2833701H1 990 1243 4 208184.1 1357760H1 994 1258 4 208184.1 4753736H1 1001 1285 b8 SEQ ID Template Component Start Stop NO: ID ID
4 208184,1 84327798 1 405 4 208184.1 83146292 2 336 4 208184.1 1837725H1 44 324 4 208184.1 82466840 92 456 4 208184,1 467394H1 159 367 4 208184,1 2343544H1 267 506 4 208184.1 5942721H1 311 616 4 208184.1 2655870F6 521 1093 4 208184,1 1258044H1 521 758 4 208184.1 2655870H1 521 830 4 208184.1 1787374H1 560 844 4 208184.1 2479769H1 605 845 4 208184.1 3630251H1 607 894 4 208184.1 5589572H1 708 955 4 208184.1 2642468H1 777 1015 4 208184.1 2792888F6 782 1199 4 208184.1 3158506H1 869 1142 4 208184.1 830940H1 900 972 4 208184.1 2586835H ~ 928 1167 4 208184.1 3658943H1 938 1227 4 208184.1 647769H1 945 1164 4 208184.1 3330172H1 1542 1710 4 208184.1 82968814 1552 1974 4 208184.1 3663020H1 1592 1883 4 208184.1 3662752H1 1593 1893 4 208184.1 1629365H1 1628 1855 4 208184.1 1629361H1 1628 1841 4 208184.1 393609F1 1631 1981 4 208184.1 39360981 1631 1981 4 208184.1 83145605 1636 1983 4 208184.1 82318373 1640 1978 4 208184.1 2986775H1 1697 1990 4 208184.1 473722H1 1701 1933 4 208184.1 82941595 1703 2001 4 208184.1 888824H1 1706 1955 4 208184.1 4132772H2 1734 1979 4 208184.1 81378655 1744 1991 4 208184.1 83174115 1744 2011 4 208184.1 84327773 1775 1985 4 208184.1 8783328 1798 1975 4 208184.1 81444361 1802 1975 4 208184.1 2352377H1 1802 1985 4 208184.1 83837531 1924 1990 4 208184,1 700181H1 1378 1668 4 208184,1 2154043H1 1242 1524 4 208184.1 1500721H1 1248 1431 4 208184.1 1500721F6 1257 1748 4 208184,1 81378654 1267 1587 4 208184,1 3051269H1 1274 1560 4 208184.1 81296126 1279 1723 SEQ ID Template Component Start Stop NO: ID ID
4 208184.1 g842860 1356 1604 4 208184.1 372793471 1363 1936 4 208184.1 279288876 1362 1938 4 208184.1 265587076 1366 1922 4 208184.1 64296781 1368 1913 4 208184.1 642967H1 1369 1601 4 208184.1 645668H 1369 1615 4 208184,1 86932581 1143 1734 4 208184.1 73441481 1172 1674 4 208184.1 734414H1 1172 1393 4 208184.1 515633H1 1009 1322 4 208184.1 g783327 1028 1265 4 208184.1 3167476H1 1039 1316 4 208184.1 2726328H1 1048 1300 4 208184.1 3578247H1 1055 1320 4 208184.1 1330851H1 1055 1296 4 208184.1 g 1939112 1082 1314 4 208184.1 g1939111 1082 1322 4 208184,1 5426183H1 1105 1366 4 208184.1 1740885H1 1106 1341 4 208184,1 3727934H1 1117 1417 4 208184.1 869325H1 1143 1415 212029.3 1908946F6 1264 1619 5 212029.3 1908946H1 1264 1511 5 212029.3 g1958480 1322 1542 5 212029,3 227098486 1388 1847 5 212029.3 2270975H1 1388 1625 5 212029.3 2270984H1 1388 1617 5 212029.3 g850966 1509 1772 5 212029.3 987831 H 1587 1785 1, 5 212029.3 g2069455 1 405 5 212029.3 1597036H1 1 218 5 212029,3 4013148H1 178 464 5 212029.3 g2064597 257 606 5 212029.3 3296932H 313 565 5 212029.3 3296932F6 313 956 5 212029,3 5839392H1 316 547 5 212029.3 1254055H1 422 641 5 212029.3 3527901H1 436 710 5 212029.3 3402996H1 551 701 5 212029.3 3503954F6 617 1009 5 212029.3 3503954H1 618 921 5 212029.3 3985708H1 625 818 5 212029.3 3620240H1 773 982 5 212029,3 5912238H1 878 1073 5 212029.3 1961296H1 971 1244 5 212029.3 3406891F6 1033 1594 5 212029.3 3406891H1 1033 1273 5 212029.3 329693276 1256 1880 5 212029.3 4367370H2 1260 1508 SEQ ID Template Component Start Stop NO: ID ID
b 213446.2 4544305H1 1 149 b 213446.2 5522542H1 30 291 6 213446.2 5522550H1 30 292 b 213446.2 1750451H1 - 95 304 6 213446.2 5328728H1 94 357 b 213446.2 1750451F6 94 648 b 213446.2 3359386H1 96 358 b 213446.2 79633586 96 586 b 213446,2 3150909H1 97 331 b 213446.2 79633581 96 644 6 213446.2 796335H1 96 329 b 213446.2 5424323H1 98 249 b 213446.2 3057114H1 96 297 b 213446.2 4673642H1 99 375 b 213446.2 4675219H1 99 220 b 213446.2 4673443H1 99 230 6 213446.2 603462H1 103 357 6 213446.2 60346281 103 712 b 213446.2 4890190H1 144 432 b 213446.2 3456603H1 394 643 b 213446.2 5159788H1 438 bbl b 213446.2 5096622H2 502 780 6 213446.2 3369950H1 627 914 b 213446.2 1487733H1 632 923 b 213446.2 82321939 697 1107 6 213446,2 84080503 832 1304 b 213446.2 5182853F6 856 1172 6 213446.2 5182853H1 856 1015 6 213446.2 5182853T6 859 1342 6 213446.2 82656754 949 1317 6 213446.2 890504H1 1069 1263 6 213446.2 84123800 1095 1321 7 228864.4 5865075H1 109 391 7 228864.4 1616880H1 109 333 7 228864.4 8774507 118 458 7 228864,4 4155366H1 120 391 7 228864.4 2362950H1 120 282 7 228864.4 2106089H1 120 368 7 228864.4 2362976H1 120 279 7 228864.4 1444952H1 120 400 7 228864.4 5697362H1 123 391 7 228864.4 8830103 122 525 7 228864.4 2503761H1 145 416 7 228864.4 3796285H1 145 479 7 228864,4 3079081H1 147 235 7 228864.4 869160H1 159 421 7 228864.4 86916081 159 796 7 228864.4 3183023H1 177 496 7 228864.4 4560714H1 198 479 7 228864.4 1258418H1 207 449 SE6~ Template Component Start Stop ID NO: ID ID
7 228864.4 g389913 216 646 7 228864.4 3770688H1 222 367 7 228864.4 2533191H2 240 481 7 228864.4 3930940H1 268 571 7 228864.4 3537668H1 329 559 7 228864.4 2442003H1 ' 330 520 7 228864.4 1319657H1 347 595 7 228864.4 2629730H1 357 612 7 228864.4 3481103H1 371 651 7 228864.4 3497710H1 384 685 7 228864.4 1873990H1 390 677 7 228864.4 5161918H1 404 682 7 228864.4 5263240H1 407 478 7 228864.4 2308843H1 419 526 7 228864.4 2743121H1 419 684 7 228864.4 3080645H1 426 726 7 228864.4 g 1991438 427 704 7 228864.4 g 1990985 427 788 7 228864.4 4078219H1 429 727 7 228864.4 5386816H1 433 716 7 228864.4 g613059 433 723 7 228864.4 lb1bb45H1 435 683 7 228864,4 1616645F6 435 949 7 228864.4 g879155 457 630 7 228864,4 g907965 457 745 7 228864.4 698631H1 460 709 7 228864.4 495118H1 468 730 7 228864.4 495134H1 468 729 7 228864.4 1514782H1 485 705 7 228864.4 3296938H1 490 750 7 228864.4 4352776H1 494 706 7 228864.4 3480107H1 507 765 7 228864.4 1290794F6 517 877 7 228864.4 1290794H1 517 772 7 228864.4 4588579H1 521 805 7 228864,4 3107341H1 540 847 7 228864.4 4606551H1 541 812 7 228864,4 1463995H1 562 787 7 228864.4 8844939 592 867 7 228864,4 4752023H1 600 885 7 228864,4 2422049H1 603 836 7 228864,4 2620147H1 606 877 7 228864.4 739668H1 620 758 7 228864.4 1522232H1 618 812 7 228864.4 1519746H1 618 785 7 228864.4 73966881 629 1119 7 228864.4 2309713H1 630 883 7 228864.4 3146554H1 640 978 7 228864.4 878372H1 643 912 7 228864.4 3457194H1 649 909 SEQ ID Template Component Start Stop NO: ID ID
7 228864.4 3782086H1 661 989 7 228864.4 4567913H1 670 958 7 228864.4 1363758F1 670 1143 7 228864.4 4125731H1 670 950 7 228864.4 1363758H1 670 863 7 228864.4 1357005H1 670 951 7 228864.4 4045988H1 675 963 7 228864.4 g1886674 675 1127 7 228864.4 4775601H1 688 975 7 228864.4 5900350H1 717 870 7 228864.4 472426H1 734 904 7 228864.4 82206480 738 912 7 228864,4 3153075H1 741 1034 7 228864,4 5841024H2 745 1038 7 228864.4 4574294H1 751 1023 7 228864.4 3784538H1 783 1107 7 228864.4 81694080 789 1126 7 228864.4 4308240H1 788 1140 7 228864.4 3406691H1 789 1052 7 228864.4 3409828H1 803 1086 7 228864.4 82032612 810 1160 7 228864.4 4255552H1 824 ll04 7 228864.4 2956312H1 852 1180 7 228864,4 4379248H1 851 1140 7 228864.4 4378894H1 851 1027 7 228864.4 2411619H1 856 1103 7 228864,4 3504691H1 860 1153 7 228864.4 2642410H1 863 1121 7 228864.4 623141H1 868 1139 7 228864.4 2592655H1 867 1119 7 228864.4 4194450H1 867 1041 7 228864.4 2225947H1 867 1111 7 228864.4 81186186 872 1088 7 228864.4 81799037 874 1310 7 228864.4 1596221H1 874 1112 7 228864.4 4567877H1 878 1047 7 228864,4 2920003H1 876 1165 7 228864.4 2655503H1 880 1209 7 228864.4 264850H1 881 981 7 228864.4 6023806H1 883 1224 7 228864.4 1986159H1 883 1134 7 228864.4 1986159R6 883 1119 7 228864.4 2416335H1 883 1134 7 228864,4 3824142H1 894 1186 7 228864.4 5206556H1 895 1099 7 228864.4 4625676H1 901 1185 7 228864.4 171937H1 907 1124 7 228864.4 8888919 907 1190 7 228864,4 677587H1 918 1200 7 228864.4 2290038H1 919 1198 SE6Z Template Component Start Stop ID NO: ID ID ~
7 228864.4 5023768H1 928 1238 7 228864.4 82001495 928 1282 7 228864.4 5183168H1 937 1205 7 228864.4 5879286H1 945 1240 7 228864.4 4184443H1 945 1150 7 228864.4 4211129H1 944 1240 7 228864.4 3272214H1 968 1249 7 228864.4 2572116H1 981 1288 7 228864.4 5112704H1 985 1308 7 228864.4 1911846H1 1003 1113 7 228864.4 83307374 1444 1932 7 228864.4 84111085 1450 1961 7 228864.4 1368277H1 1454 1710 7 228864.4 5261924H1 1459 1712 7 228864.4 536879H1 1462 1752 7 228864.4 1959881T6 1458 1920 7 228864.4 82038223 1460 1768 7 228864.4 670986H1 1460 1801 7 228864.4 2372786H1 1460 1722 7 228864.4 1477817H1 1467 1738 7 228864.4 503758H1 1467 1751 7 228864.4 82139339 1472 1967 7 228864.4 2415457H1 1478 1767 7 228864.4 83429630 1483 1963 7 228864.4 1991354H1 1487 1804 7 228864.4 2508710H1 1499 1787 7 228864.4 83087298 1500 1968 7 228864.4 82354234 1502 1961 7 228864.4 83250205 1507 1973 7 228864.4 82264116 1507 1932 7 228864.4 83245152 1514 1970 7 228864,4 82526470 1515 1961 7 228864.4 81860066 1517 1958 7 228864.4 1906229H1 1520 1845 7 228864.4 82210895 1521 1947 7 228864,4 83593403 1521 1970 7 228864,4 3107177H1 1526 1866 7 228864.4 5978491H1 1529 1857 7 228864.4 3350739H1 1534 1854 7 228864.4 1341266H1 1534 1843 7 228864.4 82205403 1535 1974 7 228864.4 516461H1 1537 1798 7 228864.4 4253927H1 1544 1841 7 228864.4 82805846 1543 1963 7 228864.4 2413301H1 1543 1800 7 228864.4 82206749 1545 1964 7 228864.4 82881920 1553 1967 7 228864.4 83765236 1555 1972 7 228864.4 g 1693975 1561 1962 7 228864.4 81692741 1561 1973 SEQ ID Template Component Start Stop NO: ID ID
7 228864.4 83422186 1562 1968 7 228864,4 82206375 1569 1961 7 228864.4 82238997 1571 1984 7 228864.4 82269218 1571 1961 7 228864,4 81422987 1574 1958 ' 7 228864.4 1366917H1 1576 1829 7 228864.4 136691781 1576 1937 7 228864.4 136691771 1576 1930 7 228864.4 84509876 1576 1961 7 228864.4 82840643 1576 1969 7 228864.4 87327571 1577 1923 7 228864.4 873275H1 1577 1857 7 228864.4 87327581 1577 1961 7 228864.4 943941H1 1582 1944 7 228864.4 94394171 1581 1923 7 228864.4 553126H1 1590 1847 7 228864.4 82955909 1587 1969 7 228864.4 82141313 1592 1961 7 228864,4 841913H1 1595 1876 7 228864.4 1269237H1 1601 1895 7 228864.4 2240562H1 1600 1899 7 228864.4 1269229F6 1601 1961 7 228864,4 3173222H1 1601 1891 7 228864.4 126922976 1604 1921 7 228864.4 2569601H1 1605 1887 7 228864.4 008331H1 1607 1912 7 228864.4 82410907 1607 1967 7 228864.4 83870805 1607 1962 7 228864.4 8830045 1616 1978 7 228864.4 84110296 1612 1976 7 228864.4 4595257H1 1618 1841 7 228864.4 8825912 1622 1973 7 228864.4 g 1164606 1632 1961 7 228864.4 751050H1 1637 1898 7 228864.4 81479705 1638 1961 7 228864.4 1257103F1 1642 1967 7 228864.4 1257103H1 1642 1924 7 228864.4 8519500 1644 1967 7 228864.4 2915847H1 1642 1944 7 228864,4 5427111H1 1646 1939 7 228864,4 210895H1 1646 1898 7 228864.4 83050237 1647 1967 7 228864.4 2491624H1 1650 1906 7 228864,4 83754764 1654 1966 7 228864,4 8858236 1661 1945 7 228864,4 8888828 1663 1967 7 228864.4 8832518 1669 1974 7 228864.4 3793365H1 1666 1961 7 228864.4 4424104H1 1670 1953 7 228864.4 8907936 1673 1946 SEQ ID Template Component Start Stop NO: ID ID
7 228864.4 82264098 1673 1933 7 228864.4 82167663 1673 1966 7 228864.4 81886251 1684 1964 7 228864.4 83750664 1690 1961 7 228864.4 81443124 1693 1967 7 228864.4 8889394 1695 1979 7 228864.4 8519496 1697 1967 7 228864.4 8614232 1699 1967 7 228864,4 2101758H1 1700 1967 7 228864.4 8994586 1701 1957 7 228864.4 8845833 1701 1967 7 228864.4 8810610 1701 1960 7 228864.4 81067419 1701 1943 7 228864.4 1215929H1 1703 1857 7 228864.4 8872749 1706 1976 7 228864.4 8614200 1706 1961 7 228864.4 8566599 1710 1967 7 228864.4 8888655 1712 1968 7 228864.4 4425257H1 1715 1980 7 228864.4 240542H1 1716 1869 7 228864.4 82058861 1715 1967 7 228864.4 82335948 1720 1961 7 228864.4 82322019 1726 1966 7 228864.4 530442H1 1741 1961 7 228864.4 8670640 1752 1967 7 228864.4 2245477H1 1755 1961 7 228864,4 5580560H1 1766 1929 7 228864.4 g 1494073 1764 1961 7 228864.4 4194132H1 1766 1967 7 228864.4 82986422 1785 1967 7 228864.4 84123826 1797 1963 7 228864.4 1397558H1 1808 1961 7 228864.4 81479653 1806 1961 7 228864.4 2258238H1 1808 1961 7 228864.4 1370863H1 1809 1967 7 228864.4 82280375 1810 1967 7 228864,4 8916819 1817 1961 7 228864.4 82739855 1840 1965 7 228864.4 83038015 1842 1961 7 228864.4 82841777 1852 1961 7 228864,4 84372871 1855 1963 7 228864.4 1264942H1 1007 1273 7 228864.4 1264942R1 1007 1444 7 228864,4 405391R6 1014 1553 7 228864.4 5683210H1 1021 1289 7 228864.4 3541340H1 1019 1330 7 228864.4 215013H1 1035 1158 7 228864.4 81928459 1047 1478 7 228864.4 1228283H1 1058 1320 7 228864.4 531728R6 1066 1706 7b SEQ ID Template Component Start Stop NO: ID ID
7 228864.4 531728H1 1066 1371 7 228864.4 4092970H1 1066 1375 7 228864.4 5693116H1 1066 1331 7 228864.4 8614233 1077 1412 7 228864.4 5101746H1 1084 1332 7 228864,4 4642390H1 1105 1337 7 228864.4 866916H1 1109 1379 7 228864.4 866916R1 1109 1766 7 228864.4 1693363H1 1110 1207 7 228864.4 8810713 1114 1454 7 228864.4 8845887 1115 1544 7 228864.4 2214177H1 1118 1388 7 228864,4 1365249H1 1118 1190 7 228864.4 3853462H1 1118 1440 7 228864.4 81940874 1119 1688 7 228864,4 3493702H1 1124 1439 7 228864,4 5004632H1 1128 1400 7 228864.4 3992620H1 1132 1456 7 228864,4 2874610H1 1130 1466 7 228864,4 1340384H1 1134 1308 7 228864,4 5184044H1 1142 1429 7 228864.4 5107670H1 1141 1413 7 228864.4 4425962H1 1142 1416 7 228864.4 2246674H1 1144 1434 7 228864.4 82139112 1154 1646 7 228864.4 3663704H1 1155 1493 7 228864.4 2079688H1 1154 1447 7 228864.4 3591083H1 1154 1346 7 228864.4 3814383H1 1155 1476 7 228864.4 1681877H1 1154 1412 7 228864.4 2108278H1 1154 1458 7 228864.4 515405H1 1155 1403 7 228864.4 8858032 1157 1435 7 . 228864.41789187H1 1164 1422 7 228864.4 1788136H1 1164 1450 7 228864.4 4327161H1 1164 1437 7 228864.4 5832891H1 1184 1490 7 228864,4 276693H1 1181 1469 7 228864.4 81521765 1194 1542 7 228864.4 5404066H1 1195 1483 7 228864.4 5404004H1 1195 1317 7 228864.4 1394880H1 1199 1488 7 228864.4 8922893 1204 1539 7 228864.4 8889937 1204 1539 7 228864.4 8889393 1205 1573 7 228864.4 8888654 1205 1448 7 228864.4 1917625H1 1209 1482 7 228864.4 2630585H1 1211 1488 7 228864.4 133967H1 1218 1422 7 228864.4 1616645T6 1227 1921 SE9 ID Template Component Start Stop NO: ID ID
7 228864.4 8884600 1235 1593 7 228864.4 5840548H2 1241 1529 7 228864.4 4311468H1 1244 1447 7 228864.4 631129H1 1244 1534 7 228864.4 2130838H1 1244 1531 7 228864.4 81692842 1243 1822 7 228864.4 75204681 1254 1877 7 228864.4 2659504H1 1254 1562 7 228864.4 81954716 1264 1577 7 228864.4 1538114H1 1268 1454 7 228864.4 4852290H1 1279 1549 7 228864.4 1950908H1 1283 1565 7 228864.4 112889H1 1293 1544 7 228864.4 2707203H1 1297 1577 7 228864.4 4317110H1 1298 1622 7 228864.4 531728Th 1302 1923 7 228864.4 405391T6 1302 1921 7 228864.4 112890H1 1306 1522 7 228864.4 81961047 1306 1789 7 228864.4 6209217H1 1307 1670 7 228864.4 5106358H1 1308 1596 7 228864.4 1986159Th 1309 1922 7 228864,4 204430H1 1315 1474 7 228864.4 2220564H1 1317 1590 7 228864.4 81973608 1327 1661 7 228864,4 5100480H1 1337 1447 7 228864,4 1886806H1 1340 1662 7 228864.4 81576711 1341 1526 7 228864.4 82069223 1343 1823 7 228864.4 137261H1 1343 1539 7 228864.4 81423026 1343 1774 7 228864.4 604541H1 1343 1604 7 228864.4 3469340H1 1343 1631 7 228864.4 2438735H1 1351 1605 7 228864.4 82069954 1351 1817 7 228864.4 2438390H1 1351 1627 7 228864.4 3126373H1 1354 1711 7 228864.4 2422970H1 1361 1653 7 228864.4 82206156 1360 1739 7 228864.4 2316643H1 1370 1667 7 228864.4 2373160H1 1386 1695 7 228864.4 2364835H1 1386 1645 7 228864.4 1290794Th 1389 1952 7 228864.4 137894H1 1392 1604 7 228864.4 2627275H1 1392 1716 7 228864.4 4839445H1 1392 1726 7 228864.4 82930378 1395 1970 7 228864.4 739668F1 1400 1961 7 228864.4 3251281H1 1399 1792 7 228864.4 2666633H1 1404 1692 SE6~ Template Component Start Stop ID NO: ID ID
7 228864,4 5834458H1 1409 1606 7 228864.4 3692921H1 1412 1754 7 228864.4 g2360187 1411 1932 7 228864.4 g2953905 1412 1964 7 228864.4 1489882H1 1415 1731 7 228864.4 3269028H1 1419 1599 7 228864.4 g1960172 1419 1961 7 228864.4 1346630H1 1419 1703 7 228864.4 g2051175 1421 1872 7 228864.4 2561963H1 1422 1759 7 228864.4 566676H1 1426 1766 7 228864.4 g2728469 1424 1970 7 228864.4 g3162592 1421 1945 7 228864.4 4536759H1 1427 1718 7 228864.4 g3665710 1430 1965 7 228864.4 1453494H1 1432 1717 7 228864.4 g3162610 1435 1945 7 228864.4 g4313225 1442 1951 7 228864.4 g4328835 1440 1970 7 228864.4 g888982 1882 1968 7 228864.4 1443349F6 1 514 7 228864.4 1739557H1 55 293 7 228864.4 3541425H1 b3 374 7 228864.4 1594648H1 65 293 7 228864.4 868282H1 70 328 7 228864.4 4693320H2 76 177 7 228864.4 2437341H1 76 316 7 228864.4 1258508H1 79 348 7 228864.4 g677259 79 344 7 228864,4 2661646H1 82 327 7 228864.4 1992251H1 83 309 7 228864.4 2502018H1 83 356 7 228864.4 3700420H1 85 398 7 228864.4 1578634H1 87 320 7 228864.4 3601285H1 91 398 7 228864.4 3419979H1 91 366 7 228864.4 3394860H1 91 384 7 228864.4 3487463H1 91 397 7 228864.4 3323182H1 90 377 7 228864.4 3761644H1 92 455 7 228864.4 2190393H1 90 370 7 228864.4 2477729H1 91 320 7 228864.4 2925245H1 91 358 7 228864,4 3394839H1 91 359 7 228864.4 3394843H1 91 359 7 228864,4 660322H1 91 377 7 228864.4 2380023H1 91 329 7 228864.4 1687157H1 91 302 7 228864.4 3452490H1 91 264 7 228864,4 1959881H1 91 343 SEQ ID Template Component Start Stop NO: ID ID
7 228864.4 660994H1 91 375 7 228864.4 2663372H1 91 340 7 228864.4 3496054H1 91 407 7 228864.4 1749148H1 91 374 7 228864.4 2797721H1 91 351 7 228864,4 2370507H1 91 388 7 228864.4 8872854 87 439 7 228864.4 3251075H1 91 419 7 228864.4 195988186 91 406 7 228864.4 3359733H1 92 390 7 228864.4 3557086H1 93 408 7 228864.4 2660652H1 95 349 7 228864.4 1875407H1 95 381 7 228864.4 5778376H1 98 388 7 228864.4 4839236H1 96 410 7 228864.4 4873821H1 97 392 7 228864.4 2267072H1 98 373 7 228864.4 4563807H1 102 187 7 228864.4 4697375H1 101 328 7 228864.4 8574327 101 473 7 228864.4 2457949H1 101 355 7 228864.4 81959304 101 454 7 228864.4 4399256H1 101 258 7 228864.4 2525904H1 102 376 7 228864.4 750617H1 102 347 7 228864.4 4873985H1 102 367 7 228864.4 3296104H1 102 376 7 228864.4 2963248H1 101 426 7 228864.4 75061781 102 654 7 228864.4 8826028 103 438 7 228864.4 4753330H1 104 385 7 228864.4 3466388H1 104 374 7 228864.4 3372760H1 104 385 7 228864.4 8831794 103 419 7 228864,4 3581563H1 105 406 7 228864.4 835615H1 105 348 7 228864,4 3239308H1 105 373 7 228864,4 73272481 106 721 7 228864,4 732724H1 106 348 7 228864.4 3248690H1 106 424 .
7 228864,4 5919227H1 104 432 7 228864.4 5985820H1 108 389 8 229840.3 83921683 2848 3070 8 229840.3 82985904 2858 3072 8 229840.3 5909792H1 2693 2987 8 229840.3 84189001 2712 3069 8 229840.3 82882752 2717 3065 8 229840.3 84073312 2728 3073 8 229840.3 84264530 2733 3065 8 229840.3 84325751 2738 3069 SEQ ID Template Component Start Stop NO: ID ID
8 229840.3 81148915 2739 3065 8 229840.3 83836479 2744 3073 8 229840.3 145458076 2838 3037 8 229840.3 1454581H1 2838 3066 8 229840.3 1454581F1 2838 3065 8 229840.3 145458176 2838 3040 8 229840.3 82782503 2842 3069 8 229840.3 3034701H1 2838 3063 8 229840.3 3000391H1 1647 1951 8 229840.3 5375263H1 1665 1869 8 229840.3 5375650H1 1665 1924 8 229840.3 4140779H1 1675 1982 8 229840.3 288084576 1739 2019 8 229840.3 785393H1 1796 2090 8 229840.3 1664014H1 1827 2057 8 229840.3 83807773 1832 2305 8 229840.3 3323431H1 1888 2170 8 229840.3 4852173H1 3 263 8 229840.3 157321276 1903 2287 8 229840.3 4549830H1 1993 2265 8 229840.3 4995409H1 1944 2202 8 229840.3 2747040H1 1964 2208 .
8 229840.3 3878345H1 2032 2327 8 229840.3 3413323H1 2042 2290 8 229840.3 040203H1 2070 2308 8 229840.3 83094583 456 932 8 229840.3 83869975 473 933 8 229840.3 134898876 502 887 8 229840.3 82398144 503 931 8 229840.3 84069464 504 929 8 229840.3 300112276 565 905 8 229840.3 3001122H1 572 876 8 229840.3 3001122F6 573 932 8 229840.3 83213774 588 935 8 229840.3 82210579 6b2 941 8 229840.3 84190109 681 929 8 229840.3 3002524H1 692 886 8 229840.3 5637815H1 748 1014 8 229840.3 84327917 751 892 8 229840.3 3605342H1 760 1069 8 229840.3 1573212H1 872 1111 8 229840.3 1573212F6 872 1159 8 229840.3 5867496H1 913 1192 8 229840.3 5525935H2 972 1224 8 229840.3 5525917H2 972 1200 8 229840.3 82210630 52 237 8 229840.3 2882517H1 55 320 8 229840.3 1348984H1 132 393 8 229840.3 1348988F6 132 569 8 229840.3 230345776 338 895 SEQ ID Template Component Start Stop NO: ID ID
8 229840.3 252533776 394 899 8 229840.3 254803876 414 900 8 229840.3 4776015H1 16 291 8 229840.3 384074H1 22 310 8 229840.3 3201803H1 23 230 8 229840.3 2587779H1 34 280 8 229840.3 4358685H1 34 317 8 229840.3 4308bOlHl 34 325 8 229840.3 4308648H1 35 383 8 229840.3 426170H1 43 265 8 229840.3 828194H1 2400 2661 8 229840.3 138331876 2407 3027 8 229840.3 1487404H1 2412 2666 8 229840.3 87854281 2428 3032 8 229840.3 878542H1 2428 2664 8 229840.3 87854271 2428 3027 8 229840.3 2255908H1 2449 2735 8 229840.3 042254H1 2495 2695 8 229840.3 1676510H1 1463 1673 8 229840.3 3351180H1 1474 1763 8 229840.3 3164210H1 1482 1773 8 229840.3 6024893H1 1487 1789 8 229840.3 3294678H1 1513 1799 8 229840.3 3555380H1 1517 1822 8 229840.3 4370762H1 1551 1815 8 229840.3 3561882H1 1559 1860 8 229840.3 166401476 1570 2019 8 229840.3 2664716H1 1598 1827 8 229840.3 82553076 1599 2055 8 229840.3 1664014F6 1603 2057 8 229840.3 8843066 1608 1908 8 229840.3 2811115H1 1619 1892 8 229840.3 1383318F6 1630 2128 8 229840.3 1383318H1 1630 1873 8 229840.3 939387H1 2858 3065 8 229840.3 960688H1 2858 2999 8 229840.3 g 1784633 2858 3069 8 229840.3 82987896 2858 3072 8 229840.3 454983071 2858 3026 8 229840.3 83096610 2858 3069 8 229840.3 81761395 2866 3042 8 229840.3 902367H1 2878 3064 8 229840.3 90236771 2878 3036 8 229840.3 1370625H1 2883 3063 8 229840.3 1752509H1 2545 2763 8 229840.3 217456976 2550 3027 8 229840.3 3720838H1 2568 2887 8 229840.3 5680448H1 2580 2815 8 229840.3 84189079 2584 3067 8 229840.3 83927421 2595 3065 SEQ ID Template Component Start Stop NO; ID ID
8 229840.3 1903055H1 2609 2815 8 229840.3 83679709 2616 3074 8 229840.3 2133162H1 2660 2931 8 229840.3 779163H1 2685 2941 8 229840.3 4354675H1 2686 2815 8 229840.3 82264632 2495 2815 8 229840.3 82267837 2496 2838 8 229840.3 275005H1 2497 2653 8 229840.3 5076984H1 2508 2801 8 229840.3 1829765H1 2508 2744 8 229840.3 5076985H1 2509 2801 8 229840.3 1829765F6 2508 3038 8 229840.3 3995183H1 2514 2782 8 229840.3 1829765Th 2530 3023 8 229840.3 3519322H1 2082 2459 8 229840.3 2635539H1 2092 2363 8 229840.3 085879H1 2097 2364 8 229840.3 4852717H1 2096 2355 8 229840.3 3201459H1 2118 2314 8 229840.3 4980057H 2124 2385 8 229840.3 81785255 2144 2573 8 229840.3 3491811H1 2154 2423 8 229840.3 2471395H1 2215 2437 8 229840.3 3162006H1 2226 2511 8 229840.3 4996246H1 2229 2504 8 229840.3 81761571 2288 2651 8 229840.3 2694820H1 2308 2482 8 229840.3 2622173H1 2326 2606 8 229840.3 81925233 2364 2594 8 229840.3 828194T1 2400 3030 8 229840.3 82819481 2400 2953 8 229840.3 82540041 2946 3067 8 229840.3 82539934 2959 3067 8 229840.3 83055680 2978 3070 8 229840.3 2349363H1 2980 3069 8 229840.3 81925117 2981 3066 8 229840.3 2880845F6 1118 1558 8 229840.3 2880845H1 1118 1415 8 229840.3 2174569F6 1251 1727 8 229840.3 2174569H1 1251 1475 8 229840.3 4872808H1 1284 1561 8 229840.3 838790H1 1299 1568 8 229840.3 2845321H1 1333 1592 8 229840.3 3389695H1 1346 1632 8 229840.3 2267707H1 1380 1630 8 229840.3 1549249H1 1442 1632 8 229840.3 3749030H1 1 191 8 229840.3 2548038F6 10 548 8 229840.3 2539058F6 10 624 8 229840.3 4561642H1 10 264 SEQ ID Template Component Start Stop NO: ID ID
8 229840.3 2548038H1 10 261 8 229840.3 2303457H1 14 267 8 229840.3 230345786 14 487 8 229840.3 3714222H1 17 314 9 231793.2 3743582H1 1 301 9 231793.2 3490362H1 3 201 9 231793.2 3355002H1 21 304 9 231793.2 1522723H1 22 218 9 231793.2 2790244H2 30 337 9 231793.2 1866779F6 33 415 9 231793.2 1866779H1 33 315 9 231793.2 1311083H1 81 300 9 231793,2 3236153H1 112 360 9 231793.2 5158979H1 204 429 9 231793.2 1390212H1 289 447 9 231793.2 1390306H1 289 541 9 231793.2 100112686 326 885 9 231793.2 4049712H1 369 641 9 231793.2 3767101H1 536 651 9 231793.2 2791795H1 512 801 9 231793.2 4576054H1 565 824 9 231793.2 5593839H1 735 994 9 231793.2 5052279H1 837 971 9 231793.2 198660386 867 1390 9 231793.2 1986603H1 867 1148 9 231793.2 1991005H1 919 1076 9 231793.2 3962341H1 972 1262 9 231793.2 3673817H1 1007 1289 9 231793.2 2488457H1 1180 1409 9 231793,2 2623858H1 1187 1437 9 231793.2 262385886 1187 1501 9 231793.2 4650753H1 1351 1495 9 231793.2 2793766H1 1368 1667 9 231793,2 1803565H1 1553 1837 9 231793.2 5281570H2 1575 1847 9 231793.2 4731704H1 1578 1869 9 231793.2 158289H1 1659 1835 9 231793.2 4048712H1 1710 1992 9 231793.2 1707686H1 1780 1971 9 231793.2 5296093H1 1783 2004 9 231793.2 g 1979679 1792 2097 9 231793.2 g2277027 1844 2232 9 231793.2 2673033F6 1878 2419 9 231793.2 2673033H1 1878 2118 9 231793.2 977810H1 1886 2105 9 231793.2 5027277H1 1892 2169 9 231793.2 3803405H1 1935 2246 9 231793.2 5095560H1 1943 2126 9 231793.2 4213438H1 1971 2181 9 231793.2 198660376 1984 2479 SE9 ID Template Component Start Stop NO; ID ID
9 231793.2 100112676 1992 2477 9 231793.2 180356576 2006 2466 9 231793.2 4170673H1 2050 2319 9 231793.2 3406618H1 2052 2313 9 231793.2 186677977 2068 2484 9 231793.2 g3765637 2072 2541 9 231793.2 5094942H1 2071 2324 9 231793.2 121429376 2088 2483 9 231793,2 1214293R6 2089 2496 9 231793.2 1214293H1 2099 2319 9 231793.2 1214167H1 2100 2353 9 231793.2 g2347914 2126 2520 9 ~ 231793.25084768H1 2127 2351 9 231793.2 1914969H1 2130 2392 9 231793.2 g3049752 2143 2523 9 231793.2 170768676 2151 2476 9 231793.2 5048501H1 2163 2459 9 231793.2 267303376 2179 2484 9 231793.2 g2556740 2194 2521 9 231793.2 g4078219 2241 2545 9 231793.2 288397076 2276 2504 9 231793.2 3512992H1 2276 2482 9 231793.2 g2322181 2353 2523 9 231793.2 130206777 2358 2481 9 231793.2 1302517H1 2365 2521 9 231793.2 1302517F6 2365 2521 9 231793.2 134723H1 2380 2521 9 231793.2 g1195715 2479 2529 234137,5 1832689R6 409 751 10 234137.5 1711521H1 413 622 10 234137,5 3317846H1 475 733 10 234137.5 g1616066 508 785 10 234137.5 2185641H1 526 792 10 234137,5 1618067H1 569 786 10 234137.5 1255603F6 593 951 10 234137.5 1255603H1 593 840 10 234137.5 5518712H1 592 827 10 234137.5 1944240H1 206 468 10 234137.5 g814646 194 490 10 234137.5 3746685H1 207 493 10 234137.5 2486355H1 212 459 10 234137.5 2888507H1 194 257 10 234137.5 2500535H1 212 454 10 234137.5 3511080H1 198 505 10 234137.5 2503636H1 258 508 10 234137.5 698952H1 275 372 10 234137.5 699726H1 275 547 10 234137.5 699737H1 275 542 10 234137.5 5190833H2 287 547 10 234137.5 2723787H1 285 555 SEQ ID Template Component Start Stop NO: ID ID
234137.5 4880881H1 289 506 10 234137.5 1742695H1 1192 1399 10 234137.5 g1004759 1193 1454 10 234137.5 3051736H1 1198 1493 10 234137.5 3789688H1 1215 1430 10 234137.5 389357H1 1221 1370 10 234137.5 4000387H1 1237 1509 10 234137.5 535718H1 1253 1466 10 234137.5 45436581 1440 1754 10 234137.5 2419654H1 316 571 10 234137.5 1993760H1 317 548 10 234137.5 3506477H1 317 624 10 234137.5 g991858 324 495 10 234137.5 84152671 380 748 10 234137.5 3327435H1 381 647 10 234137.5 1832689H1 409 689 10 234137.5 211077786 1 348 10 234137.5 2110777H1 1 190 10 234137.5 714010H1 26 224 10 234137.5 8706051 26 417 10 234137.5 8674497 27 384 10 234137.5 6026756H1 34 308 10 234137.5 3530615H1 141 458 10 234137,5 4171108H1 155 454 10 234137.5 8615415 154 412 10 234137,5 3156905H1 lbl 328 10 234137.5 81815065 164 624 10 234137.5 8884950 1b8 595 10 234137.5 3331405H1 173 444 10 234137.5 3458347H1 183 429 10 234137.5 3672287H1 177 400 10 234137.5 2816025H1 181 495 10 234137.5 4077622H1 178 467 10 234137.5 905762H1 180 395 10 234137.5 8953765 180 561 10 234137.5 1602692H1 183 396 10 234137,5 1602692F6 183 487 10 234137,5 8775373 184 485 10 234137.5 1482169H1 182 462 10 234137.5 82141035 183 625 10 234137.5 4159960H1 186 452 10 234137.5 8616022 185 46b 10 234137.5 8705506 186 492 10 234137.5 8705505 186 460 10 234137.5 8868789 190 488 10 234137.5 8831177 190 564 10 234137.5 8574383 189 529 10 234137.5 81516946 192 619 10 234137.5 8390441 190 506 10 234137.5 3243071H1 194 448 SEQ ID Template Component Start Stop NO: ID ID
234137.5 2888320H1 194 481 10 234137.5 2180954H1 778 935 10 234137.5 90150081 614 1145 10 234137.5 4230253H1 1101 1384 10 234137.5 901600H1 614 922 10 234137.5 589607H1 1148 1398 10 234137.5 901500H1 614 907 10 234137.5 901744H1 614 815 10 234137.5 2287212H1 1189 1422 10 234137.5 5591962H1 633 765 10 234137.5 3424013H1 1190 1460 10 234137.5 1742570H1 1192 1478 10 234137.5 g4394560 1660 2001 10 234137.5 g4224234 1598 2008 11 234671.14 4638731H1 73 352 11 234671.14 2525135H1 71 327 11 234671.14 4510615H1 90 235 11 234671.14 2805957H1 91 423 11 234671.14 5912661H1 90 401 11 234671.14 2016655H1 93 419 11 234671.14 3202510H1 95 401 11 234671.14 4608993H1 95 350 11 234671.14 725bObHl 95 408 11 234671.14 5030359H1 94 349 11 234671.14 1499350H1 95 308 ~
11 234671.14 4849095H2 101 299 11 234671.14 2916364H1 100 405 11 234671.14 2071479H1 100 380 11 234671.14 4294695H1 105 191 11 234671.14 1480701H1 100 313 11 234671.14 2845388H1 103 388 11 234671.14 3916903H1 104 433 11 234671.14 4974316H1 104 402 11 234671.14 2865203H1 104 214 11 234671.14 916311H1 105 433 11 234671.14 915496H1 105 392 11 w 234671.14222004876 106 668 11 234671.14 g 1799327 103 346 11 234671.14 8735496 108 456 11 234671.14 2521203H1 108 377 11 234671.14 2820807H1 109 330 11 234671.14 5302702H1 111 380 11 234671.14 2367817H1 115 386 11 234671.14 2660131H1 116 374 11 234671.14 81962046 115 562 11 234671.14 2220048F6 118 622 11 234671.14 5622009H1 115 475 11 234671.14 088730H1 119 393 11 234671.14 82036474 120 433 11 234671.14 3978238H1 121 442 SE6~ ID NO. TemplateComponent Start Stop ID ID
11 234671,14 4744991H1 121 397 11 234671,14 3529614H1 122 458 11 234671.14 g1697240 122 306 11 234671.14 g1721900 122 613 11 234671.14 3928785H1 122 406 11 234671.14 4626904H1 122 396 11 234671.14 3928677H1 122 305 11 234671.14 g1516296 122 603 11 234671.14 2074823H1 122 270 11 234671.14 2135894H1 122 418 11 234671.14 3115158H1 123 430 11 234671.14 2135876H1 122 420 11 234671.14 575915H1 126 291 11 234671.14 4975637H1 126 419 11 234671.14 1463657H1 131 349 11 234671.14 g1317142 132 626 11 234671.14 146365771 131 669 11 234671.14 5278514H1 131 296 11 234671,14 1914942H1 132 399 11 234671.14 2479730H1 132 391 11 234671.14 3148758H1 132 461 11 234671.14 2912447H 132 425 11 234671.14 5857652H1 134 429 11 234671.14 2451454H1 134 392 11 234671.14 5664881H1 135 444 11 234671.14 4981466H1 136 420 11 234671.14 2968710H1 136 486 11 234671.14 4981166H1 136 419 11 234671.14 3013140H1 136 389 11 234671.14 2551737H1 136 422 11 234671.14 2284544H1 136 397 11 234671.14 102120H1 136 407 11 234671.14 3461073H1 136 399 11 234671.14 4822658H1 139 441 11 234671.14 4166805H1 136 467 11 234671.14 2707011H1 137 428 11 234671.14 4974307H1 139 436 11 234671.14 1468622H1 139 275 11 234671.14 1467020H1~ 139 345 11 234671.14 2541676H1 139 415 11 234671.14 1470317H1 139 341 11 234671.14 3733432H1 141 464 11 234671.14 g901576 143 487 11 234671.14 2766646H1 143 411 11 234671,14 082496H1 149 367 11 234671,14 2476615H1 148 390 11 234671.14 2905015H1 149 325 11 234671,14 3760125H1 156 272 11 234671,14 3297065H1 160 435 11 234671.14 6141029H1 159 505 SE6~ ID NO: TemplateComponent Start Stop ID ID
11 234671.14 2818173H1 161 414 11 234671.14 4701519H1 1b3 457 11 234671.14 2371480H1 165 412 11 234671.14 2448051H1 165 429 11 234671.14 2026733H1 165 446 11 234671.14 086299H1 165 447 11 234671.14 4553646H1 167 446 11 234671.14 3236203H1 170 447 11 234671.14 2625102H1 170 425 11 234671.14 g 1639954 171 396 11 234671.14 81447865 190 407 11 234671.14 8889618 204 571 11 234671.14 3292442F6 1 493 11 234671.14 3292442H1 1 261 11 234671.14 2787149H1 22 144 11 234671.14 4845874H1 64 251 11 234671.14 5217923H1 b9 348 11 234671.14 329244276 204 689 11 234671.14 8889628 204 548 11 234671.14 5509259H1 218 458 11 234671.14 3035317H1 223 544 11 234671.14 3035317F6 223 561 11 234671.14 84329558 240 715 11 234671.14 84111623 244 720 11 234671.14 83404679 245 707 11 234671.14 84112201 246 707 11 234671.14 82929715 248 707 11 234671.14 83401096 253 710 11 234671.14 4206791H1 273 465 11 234671,14 82268964 287 706 11 234671.14 419449H1 292 516 11 234671.14 276343376 293 678 11 234671.14 81516236 295 718 11 234671.14 1999242H1 310 512 11 234671.14 8504586 313 710 11 234671.14 81721788 314 716 11 234671.14 4372931H1 321 579 11 234671.14 1353392F1 323 760 11 234671.14 1353392H1 323 599 11 234671.14 83797245 334 707 11 234671.14 81728570 340 716 11 234671.14 4711787H1 383 484 11 234671.14 8735497 401 718 11 234671.14 2534033H1 406 647 11 234671.14 347531H1 412 659 11 234671.14 498396H1 419 637 11 234671.14 82327885 426 722 11 234671.14 83048289 426 915 11 234671.14 83756898 428 714 11 234671.14 5408101H1 428 529 SEQ ID Template Component Start Stop NO: ID ID
11 234671.14 83202140 430 720 11 234671.14 82875495 436 750 11 234671.14 84194406 439 715 11 234671.14 83600863 461 915 11 234671.14 548974H1 498 715 11 234671.14 83180704 511 572 11 234671.14 001841H1 517 911 11 234671.14 82904348 534 918 11 234671,14 81300605 535 712 11 234671,14 83843537 558 920 11 234671,14 82716778 564 715 11 234671.14 4704563H1 567 707 11 234671,14 5094769H1 613 856 1 1 234671,14 g 1147845 641 923 11 234671.14 3774346H1 676 970 11 234671,14 3237695H1 694 853 11 234671.14 3549570H1 731 986 11 234671.14 1306053F6 737 1223 11 234671.14 6104976H1 853 1149 11 234671.14 534062H1 914 1164 11 234671.14 2673834H1 931 1145 11 234671.14 84292281 998 1448 11 234671.14 1306053H1 994 1223 11 234671.14 83803923 1028 1448 11 234671.14 82768559 1065 1453 11 234671.14 83415483 1115 1459 11 234671.14 65982186 1144 1458 11 234671.14 65982176 1143 1410 11 234671.14 659821H1 1144 1407 11 234671.14 83659045 1159 1406 11 234671.14 82344002 1193 1447 11 234671.14 8889629 1209 1385 11 234671.14 8889619 1254 1401 11 234671.14 8901577 1258 1448 11 234671.14 8908490 1258 1402 11 234671.14 2374770H1 1344 1458 12 241236,3 84083561 1571 2017 12 241236,3 2491474H1 1570 1818 12 241236,3 84222338 1572 2016 12 241236.3 488351476 1574 1994 12 241236.3 84082140 1581 1953 12 241236.3 2129206H1 1590 1898 12 241236.3 82177776 1593 2016 12 241236.3 84077506 1605 2010 12 241236.3 145625381 1613 2014 12 241236.3 2752225H1 1623 1900 12 241236.3 84189365 1624 2019 12 241236.3 83144764 1626 2014 12 241236.3 82539525 1650 2013 12 241236.3 82986682 1666 2017 SE6~ Template Component Start Stop ID NO: ID ID
12 241236.3 g2273603 1701 2012 12 241236.3 2989623T6 1740 1966 12 241236.3 2625824H1 1750 1989 12 241236.3 2625824Th 1758 1956 12 241236.3 2625824F6 1750 2010 12 241236.3 g3756824 1 393 12 241236.3 5376769H1 1 249 12 241236.3 3473825H1 115 374 12 241236.3 1675287H1 134 303 12 241236.3 1675845H1 135 314 12 241236.3 2047281F6 271 810 12 241236.3 2047281H1 271 482 12 241236.3 3724339H1 352 632 12 241236.3 5733241H1 404 664 12 241236,3 4909488H1 408 664 12 241236.3 1857844H1 412 667 12 241236.3 3078885H1 467 776 12 241236.3 4883514F6 529 963 12 241236.3 4883514H1 529 815 12 241236.3 g1023658 566 798 12 241236.3 1222879H1 644 871 12 241236.3 3400427H1 661 890 12 241236.3 1702383H1 664 880 12 241236.3 4902281H1 687 953 12 241236.3 4380777H1 697 956 12 241236.3 868686H1 702 954 12 241236.3 2598561H1 706 994 12 241236.3 3672519H1 718 995 12 241236.3 5811931H1 729 1048 12 241236.3 4863967H 7b9 1059 12 241236.3 1534650H1 780 979 12 241236.3 4852733H1 780 1034 12 241236.3 1532438H1 780 987 12 241236.3 3407892H1 791 1049 12 241236,3 4173535H1 841 1129 12 241236.3 736762H1 845 1073 12 241236.3 987503H1 867 1107 12 241236,3 3591339H1 899 1203 12 241236.3 1600224H1 907 1096 12 241236,3 1680682H1 924 1117 12 241236.3 98487681 967 1431 12 241236.3 5022045H1 967 1235 12 241236.3 984876H1 967 1272 12 241236.3 2394790H1 995 1238 12 241236.3 3105586H1 1029 1318 12 241236.3 2116090H1 1029 1295 12 241236.3 g3894545 1045 1441 12 241236.3 1665126H1 1048 1280 12 241236.3 2812429H1 1096 1416 12 241236.3 3099677H1 1102 1419 SEQ ID Template Component Start Stop NO; ID ID
12 241236.3 3323472H1 1109 1397 12 241236,3 3806144H1 1111 1421 12 241236.3 1967610H1 1112 1402 12 241236.3 2967854H1 1112 1426 12 241236.3 g1627157 1114 1405 12 241236.3 3812578H1 1117 1273 12 241236.3 2808537H1 1122 1393 12 241236.3 2265394H1 1125 1400 12 241236.3 5573683H1 1130 1367 12 241236.3 603729H1 1139 1413 12 241236.3 2594490H1 1151 1408 12 241236.3 2083413H1 1153 1440 12 241236.3 606483H1 1210 1377 12 241236.3 336504H1 1227 1467 12 241236.3 g 1114699 1226 1411 12 241236.3 4903237H1 1276 1552 12 241236.3 1976619F6 1276 1737 12 241236.3 1976619H1 1276 1544 12 241236.3 1738833H1 1299 1487 12 241236.3 1738865F6 1299 1601 12 241236.3 4240709H1 1343 1407 12 241236.3 4240711H1 1343 1709 12 241236.3 g853461 1360 1657 12 241236.3 2123125H1 1368 1658 12 241236.3 5451102H1 1372 1637 12 241236.3 2191211H1 1382 1653 12 241236.3 g1792059 1408 1780 12 241236.3 543835H1 1412 1649 12 241236.3 197713076 1425 1965 12 241236.3 1633344H1 1427 1669 12 241236,3 4505552H1 1428 1707 12 241236.3 197661976 1433 1970 12 241236.3 502204571 1438 1972 12 241236.3 173886576 1441 1967 12 241236.3 1981924H1 1459 1759 12 241236.3 2803121H1 1495 1769 12 241236.3 2260917H1 1503 1771 .
12 241236.3 3014105H1 1509 1829 12 241236,3 1994356H1 1513 1799 12 241236.3 5568339H1 1525 1765 12 241236,3 3186679H1 1537 1873 12 241236,3 4828122H1 1544 1837 12 241236.3 4828623H1 1544 1807 12 241236.3 g3595120 1549 2018 12 241236,3 g2177775 1559 2016 12 241236,3 1456253H1 1562 1841 12 241236.3 1000028H1 1564 1808 12 241236.3 3791315H1 1567 1881 12 241236.3 g4392232 1568 2013 12 241236.3 g2968124 1767 2016 SEQ ID Template Component Start Stop NO: ID ID
12 241236.3 4115186H1 1773 2017 12 241236.3 3392646H1 1783 2058 12 241236.3 g3239075 1838 2014 12 241236.3 g3808002 1848 2016 12 241236.3 84072387 1848 2014 12 241236.3 3781961H1 1848 2169 12 241236.3 83754629 1851 2016 12 241236.3 84006032 1860 2015 12 241236.3 84073569 1860 2010 12 241236.3 84005900 1870 2007 12 241236.3 83321490 1862 2009 12 241236.3 84006303 1870 2007 12 241236.3 84087154 1871 2010 12 241236.3 83862359 1871 2010 12 241236.3 83322077 1862 2015 12 241236.3 84005537 1871 2010 12 241236.3 83846653 1871 2010 12 241236.3 84077466 1862 2010 12 241236.3 84080249 1871 2011 12 241236.3 83862436 1871 2010 12 241236.3 84018950 1863 2007 12 241236.3 84077665 1871 2010 12 241236.3 83989227 1871 2010 12 241236.3 83806894 1864 2014 12 241236.3 83932638 1871 2011 12 241236.3 83862447 1871 2010 12 241236.3 83847853 1871 2010 12 241236.3 83989984 1871 2010 12 241236.3 83890144 1871 2011 12 241236.3 83989001 1871 2010 12 241236.3 84071839 1871 2008 12 241236.3 83847054 1871 2008 12 241236.3 83989318 1871 2016 12 241236.3 83890413 1871 2016 12 241236.3 83848056 1871 2007 12 241236.3 84282452 1871 2007 12 241236.3 84018579 1871 2014 12 241236.3 83990148 1871 2014 12 241236.3 83890229 1871 2010 12 241236.3 83847713 1871 2010 12 241236.3 504961H1 1872 2018 12 241236.3 2475277H1 1872 2017 12 241236.3 83149294 1964 ~ 2016 13 245014.1 168004H1 1773 2112 13 245014.1 16800486 1777 2032 13 245014.1 3444984H1 1854 2115 13 245014.1 963645H1 1859 2101 13 245014.1 96364582 1859 2354 13 245014.1 83095484 1869 1985 13 245014.1 2278942H1 1903 2171 SEQ ID Template Component Start Stop NO: ID ID
13 245014.1 3993577H1 1907 2200 13 245014.1 3518094H1 1918 2179 13 245014.1 5696350H1 1918 2173 13 245014.1 4507976H1 1924 2192 13 245014.1 3020932H1 1924 2204 13 245014.1 4400157H1 1949 2191 13 245014.1 3248110H1 1949 2229 13 245014.1 2855006H1 1949 2041 13 245014.1 5399133H1 1 213 13 245014.1 345036186 68 543 13 245014.1 3450361H1 68 327 13 245014.1 2731452F6 81 421 13 245014.1 2731452H1 81 320 13 245014.1 263691H1 94 428 13 245014.1 5674201H1 106 347 13 245014.1 2645021H1 207 460 13 245014.1 8895569 346 512 13 245014.1 1923470Th 2455 2704 13 245014.1 192347086 2469 2742 13 245014.1 1923470H1 2469 2740 13 245014.1 81874511 2471 2748 13 245014.1 83179513 2407 2746 13 245014.1 g 1153232 241 b 2748 13 245014.1 2285748H1 2426 2679 13 245014.1 2875652H1 2477 2743 13 245014.1 8878521 2504 2740 13 245014.1 82810267 2508 2751 13 245014.1 84457618 2512 2745 13 245014.1 186006176 2430 2701 13 245014.1 1636359H1 2527 2620 13 245014.1 974331H1 2439 2619 13 245014.1 81548974 2445 2740 13 245014.1 4802874H1 2527 2633 13 245014.1 2785026H1 2528 2716 13 245014.1 82209561 2448 2743 13 245014.1 2862743H1 2558 2742 13 245014.1 82208300 2452 2740 13 245014.1 82987537 2624 2751 13 245014.1 3318766H1 1684 1957 13 245014.1 4825016H1 1699 1982 13 245014.1 3776745H1 1732 2032 13 245014.1 4368674H1 1746 2008 13 245014.1 2650579H1 1749 1945 13 245014.1 5062862H1 1764 2021 13 245014.1 5062961H2 1766 2004 13 245014.1 4089945H1 1770 1847 13 245014.1 263180276 2246 2706 13 245014.1 4863733H1 2264 2562 13 245014.1 5328806H1 2261 2544 13 245014.1 83917411 2269 2748 SEQ ID Template Component Start Stop NO. ID ID
13 245014.1 82838934 2255 2747 13 245014.1 3166548H1 2273 2559 13 245014.1 82818702 2280 2690 13 245014.1 83693781 2261 2742 13 245014.1 81068825 2306 2659 13 245014.1 83016160 2306 2749 13 245014.1 607473H1 2309 2584 13 245014.1 3558364H1 2329 2637 13 245014.1 84329144 2346 2738 13 245014.1 81941347 2347 2733 13 245014.1 4302681H1 2356 2591 13 245014.1 83182104 2369 2745 13 245014.1 1299474Th 2371 2705 13 245014.1 1299474F6 2377 2742 13 245014.1 82003283 2377 2742 13 245014.1 1302005H1 2380 2722 13 245014.1 81219422 2396 2743 13 245014.1 178082H1 1590 1829 13 245014.1 064892H1 1591 1750 13 245014.1 963385H1 1595 1896 13 245014.1 96338582 1595 1972 13 245014.1 81068873 1463 1775 13 245014.1 2280635H1 1470 1750 13 245014.1 14562381 1453 1886 13 245014.1 960167H1 1546 1671 13 245014.1 81166309 1456 1851 13 245014.1 3638263H1 1553 1845 13 245014.1 5423560H1 1615 1861 13 245014.1 1495185H1 1633 1857 13 245014.1 82209742 1636 2103 13 245014.1 927457H1 1650 1930 13 245014.1 722266H1 1650 1917 13 245014.1 929020H1 1650 1913 13 245014.1 92745781 1650 2180 13 245014.1 81874627 1666 1896 13 245014.1 81920695 1632 1830 13 245014.1 637604H1 1672 1906 13 245014.1 81958169 1678 1988 13 245014.1 8959179 1452 1761 13 245014.1 3038691H1 1453 1545 13 245014.1 3398816H1 1453 1567 13 245014.1 4212104H1 937 1209 13 245014.1 5500792H1 976 1201 13 245014.1 6012320H1 996 1270 13 245014.1 2675268H1 1000 1244 13 245014.1 2675268F6 1000 1405 13 245014.1 3724087H1 1035 1309 13 245014.1 3069566H1 1096 1395 13 245014.1 5508358H1 1126 1346 13 245014.1 5592345H1 1278 1487 SEQ ID Template Component Start Stop NO: ID ID
13 245014.1 141058H1 1278 1534 13 245014,1 3714983H1 1373 1661 13 245014.1 3515644H1 1417 1647 13 245014.1 4797535H1 360 650 13 245014.1 81128352 373 613 13 245014.1 82003284 456 712 13 245014.1 4164512H1 367 675 13 245014.1 8878573 547 871 13 245014.1 2749018H1 576 825 13 245014.1 3450361T6 593 1156 13 245014.1 2910268H1 610 873 13 245014.1 4372565H1 613 915 13 245014.1 133005H1 618 801 13 245014.1 13300586 618 1056 13 245014.1 4972429H1 693 985 13 245014.1 4435621H1 735 1012 13 245014.1 83446618 746 1207 13 245014.1 3275925H1 745 986 13 245014.1 5299476H1 746 899 13 245014.1 82541414 754 1204 13 245014,1 3629224H1 1987 2293 13 245014.1 160092H1 2017 2421 13 245014.1 3256601H1 2029 2284 13 245014.1 5091829H1 1988 2256 13 245014.1 3489772H1 2057 2357 13 245014.1 82057259 2087 2423 13 245014,1 8395755 2096 2414 13 245014.1 218809H1 2112 2381 13 245014.1 3493510H1 2011 2285 13 245014.1 217964H1 2112 2345 13 245014.1 1376993F1 2115 2581 13 245014.1 1376993H1 2115 2356 13 245014.1 113469H1 2014 2268 13 245014.1 1860061F6 2124 2549 13 245014.1 1860061H1 2124 2428 13 245014.1 3806342H1 2014 2255 13 245014.1 828638H1 2137 2406 13 245014,1 82863881 2137 2607 13 245014.1 5710216H2 2171 2422 13 245014,1 344609H1 2015 2226 13 245014.1 4121876H1 2174 2394 13 245014,1 4416742H1 2176 2434 13 245014.1 133005Th 2176 2707 13 245014,1 145623F1 2183 2740 13 245014,1 5500510H1 2192 2451 13 245014,1 82444538 2195 2559 13 245014.1 82163904 2198 2658 13 245014.1 004038H1 2203 2582 13 245014.1 003770H1 2203 2566 13 245014.1 003808H1 2203 2532 SE6~ Template Component Start Stop ID NO: ID ID
13 245014.1 4356958H1 2221 2498 13 245014,1 168004Th 2222 2703 13 245014.1 3858354H1 2235 2426 13 245014.1 3858174H1 2236 2531 13 245014.1 4602871H1 768 1018 13 245014.1 2884645H1 776 1041 13 245014.1 4196193H1 873 1007 13 245014.1 g2139409 887 1282 13 245014.1 2872604H1 890 1150 13 245014.1 4548678H1 890 1121 13 245014.1 g 1953042 915 11 b5 13 245014.1 3438285H1 1440 1656 13 245014.1 2462626H1 1448 1680 13 245014.1 3491523H1 1440 1685 14 245251.6 g3806445 1422 1590 14 245251.6 g3806467 1422 1590 14 245251,6 g3848606 1422 1590 14 245251.6 g3849478 1422 1590 14 245251.6 g3845826 1422 1590 14 245251.6 g3806471 1422 1590 14 245251.6 g3846603 1422 1590 14 245251.6 g4034496 1422 1594 14 245251.6 g3807003 1422 1591 14 245251.6 g3806382 1422 1593 14 245251.6 83847027 1422 1587 14 245251.6 83989330 1422 1587 14 245251.6 83861794 1422 1587 14 245251.6 84018012 1422 1593 14 245251.6 83847094 1422 1591 14 245251.6 83807437 1422 1593 14 245251.6 83846856 1422 1592 14 245251.6 84284777 1422 1586 14 245251.6 83847587 1422 1593 14 245251,6 84186360 1422 1593 14 245251.6 83990433 1422 1593 14 245251.6 83807539 1422 1593 14 245251,6 83990700 1422 1593 14 245251.6 84071417 1422 1593 ~
14 245251.6 83806276 1422 1592 14 245251,6 83806906 1422 1592 14 245251,6 83847511 1422 1592 14 245251,6 83842268 1422 1593 14 245251.6 83846164 1422 1592 14 245251.6 83846151 1422 1592 14 245251,6 84077836 1422 1594 14 245251.6 83862401 1422 1593 14 245251.6 84082235 1422 1593 14 245251.6 83847852 1422 1593 14 245251.6 83842306 1422 1591 14 245251.6 84074675 1422 1591 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 83861509 1422 1593 14 245251.6 83989299 1422 1593 14 245251.6 84074633 1422 1591 14 245251.6 83848075 1422 1593 14 245251,6 83847601 1422 1596 14 245251.6 83846659 1422 1591 14 245251.6 83807971 1422 1593 14 245251.6 83862373 1422 1592 14 245251.6 83846613 1422 1594 14 245251.6 83842371 1422 1593 14 245251.6 84150319 1422 1593 14 245251.6 83848195 1422 1593 14 245251.6 84186335 1422 1593 14 245251.6 84071420 1422 1590 14 245251.6 83845843 1422 1590 14 245251.6 271945H1 1423 1592 14 245251.6 4860092H1 1425 1549 14 245251.6 3025205H1 1425 1591 14 245251.6 81329015 1110 1592 14 245251.6 1708907H1 1110 1392 14 245251,6 2356035H1 1113 1395 14 245251.6 83321637 1412 1593 14 245251.6 83321397 1412 1591 14 245251.6 83990361 1412 1594 14 245251.6 83321297 1412 1594 14 245251.6 83321613 1412 1590 14 245251.6 83321619 1412 1590 14 245251,6 83321346 1412 1590 14 245251,6 83321642 1412 1592 14 245251,6 83322073 1412 1593 14 245251,6 83322037 1412 1579 14 245251,6 83321904 1412 1591 14 245251.6 83322057 1412 1594 14 245251,6 84086504 1412 1593 14 245251.6 83321689 1412 1593 14 245251.6 83322072 1412 1594 14 245251.6 290509H1 1413 1593 14 245251.6 83842429 1413 1595 14 245251.6 83321374 141 b 1590 14 245251.6 2715779H1 1417 1590 14 245251.6 83841465 1420 1590 14 245251.6 83847930 1421 1590 14 245251.6 83847580 1421 1592 14 245251.6 84187012 1421 1590 14 245251.6 83806657 1421 1586 14 245251.6 83846129 1421 1590 14 245251.6 84005749 1421 1592 14 245251.6 84005487 1421 1590 14 245251.6 83665836 1422 1590 14 245251.6 83848560 1422 1590 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 83845838 1422 1590 14 245251.6 83848559 1422 1590 14 245251.6 703105H1 1113 1417 14 245251.6 81501582 1117 1592 14 245251.6 83255080 1119 1602 14 245251.6 84081903 1119 1598 14 245251.6 81948394 1156 1590 14 245251.6 2411955H1 1117 1414 14 245251.6 4569146H1 1120 1459 14 245251.6 027069H1 1165 1412 14 245251.6 1538171H1 1120 1407 14 245251.6 83279555 1127 1593 14 245251.6 84114349 1128 1594 14 245251.6 83740354 1131 1592 14 245251.6 82279150 1132 1590 14 245251.6 84533152 1132 1592 14 245251.6 83962173 1132 1596 14 245251.6 887316H1 1138 1466 14 245251.6 82397876 1165 1592 14 245251.6 82360627 1138 1598 14 245251.6 82714133 1137 1590 14 245251.6 83016485 1165 1596 14 245251.6 82464368 1139 1594 14 245251.6 82552766 1146 1590 14 245251.6 2962133H1 1150 1496 14 245251.6 82464621 1152 1589 14 245251.6 537878H1 1150 1446 14 245251.6 1359957H1 1148 1419 14 245251.6 1963987H1 1155 1496 14 245251.6 83253832 1165 1593 14 245251.6 82913751 1168 1593 14 245251.6 82932949 1173 1602 14 245251.6 83735276 1178 1602 14 245251.6 863137H1 1181 1466 14 245251.6 84269459 1181 1590 14 245251.6 82563609 1183 1590 14 245251.6 2418779H1 1185 1471 14 245251.6 84113654 1188 1590 14 245251.6 81641703 1188 1586 14 245251.6 1551309H1 1190 1448 14 245251.6 83840122 1192 1597 14 245251.6 82705424 1200 1589 14 245251.6 2286469H1 1200 1498 14 245251.6 82566862 1209 1593 14 245251.6 82435745 1212 1361 14 245251.6 2088012H1 1215 1517 14 245251.6 1312225H1 1215 1472 14 245251.6 82270163 1215 1592 14 245251.6 2288870H1 1215 1497 14 245251.6 8864236 1220 1591 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 83597473 1220 1598 14 245251.6 81972695 1223 1595 14 245251.6 83322133 1231 1594 14 245251.6 81148477 1231 1598 14 245251.6 83960762 1244 1590 14 245251.6 272932H1 1248 1590 14 245251.6 3334564H1 1248 1581 14 245251.6 1355971H1 1248 1540 14 245251.6 1907330H1 1248 1548 14 245251.6 81774782 1253 ~ 1594 14 . 245251.6 8927896 1244 1592 14 245251.6 82279391 1256 1596 14 245251.6 83280855 1259 1597 14 245251.6 981518H1 1265 1598 14 245251.6 83070488 1267 1596 14 245251.6 84269675 1271 1593 14 245251.6 83127594 1273 1545 14 245251.6 84297922 1273 1593 14 245251.6 81527256 1274 1590 14 245251.6 83215022 1273 1593 14 245251.6 81927427 1278 1590 14 245251.6 81618008 1279 1599 14 245251.6 8651970 1270 1597 14 245251,6 1926049H1 1279 1543 14 245251.6 82053209 1281 1601 14 245251.6 770417H1 1425 1593 14 245251.6 83321693 1426 1590 14 245251.6 544220H1 1464 1596 14 245251.6 83886402 1465 1859 14 245251.6 422119H1 1493 1594 14 245251.6 4832225H1 721 877 14 245251.6 063120H1 727 876 14 245251,6 3228413H1 720 863 14 245251.6 81927545 717 883 14 245251.6 1255835H1 754 894 14 245251,6 3226250H1 699 837 14 245251,6 4323801H1 746 909 14 245251,6 4510868H1 704 796 14 245251.6 4800865H1 700 891 14 245251.6 3715312H1 697 900 14 245251.6 1428725H1 696 883 14 245251.6 2106521H1 480 642 14 245251.6 5100266H1 695 785 14 245251.6 1222560H1 693 907 14 245251.6 360061H1 701 914 14 245251.6 2388047H1 692 901 14 245251.6 81527303 817 919 14 245251.6 1708351H1 699 916 14 245251.6 4563631H1 839 920 14 245251.6 4337368H1 720 919 SEQ ID Template Component Start Stop NO; ID ID
14 245251.6 3284155H1 811 915 14 245251.6 1573816H1 427 644 14 245251.6 g2017060 687 914 14 245251.6 g2992991 687 808 14 245251.6 5945233H1 692 816 14 245251.6 142800H1 686 921 14 245251.6 1611073H1 686 892 14 245251.6 1612960H1 686 871 14 245251,6 5182909H1 686 922 14 245251.6 4675087H1 686 868 14 245251.6 2175031H1 686 917 14 245251.6 1674874H1 686 901 14 245251.6 748598H1 699 925 14 245251.6 g698473 1 375 14 245251.6 g2750955 3 322 14 245251.6 4711779H1 41 296 14 245251.6 2468527H1 173 531 14 245251.6 3674073H1 243 527 14 245251.6 g2015374 251 676 14 245251.6 4710904H1 283 582 14 245251.6 3674243H1 289 527 14 245251,6 5112393H1 314 606 14 245251.6 1960508H1 317 627 14 245251,6 4043372H1 322 607 14 245251.6 2017147H1 341 444 14 245251,6 1725960H1 376 , 592 14 245251,6 1573484H1 377 596 14 245251.6 310542H1 382 643 14 245251.6 3205850H1 400 693 14 245251.6 1726232H1 403 592 14 245251.6 310938H1 407 646 14 245251.6 1877685H1 417 704 14 245251.6 2598596H1 416 704 14 245251.6 3090278H1 416 704 14 245251.6 4128553H1 426 699 14 245251,6 g2030260 426 715 14 245251.6 5538163H1 448 647 14 245251.6 2502707H1 450 699 14 245251.6 1800655H1 462 705 14 245251.6 4899818H1 465 705 14 245251.6 3858619H1 464 724 14 245251.6 2111517H1 478 729 14 245251.6 310488H1 476 642 14 245251.6 1686443H1 491 731 14 245251.6 1425427H1 584 837 14 245251.6 1490475H1 584 812 14 245251.6 4853210H1 586 806 14 245251.6 g3846065 1396 1590 14 245251.6 g4304887 1396 1593 14 245251.6 g4006580 1396 1590 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 84085914 1396 1590 14 245251.6 84005760 1396 1592 14 245251,6 83931547 1396 1593 14 245251.6 83842208 1396 1590 14 245251.6 84082237 1399 1590 14 245251.6 83848014 1403 1590 14 245251.6 83322137 1406 1590 14 245251.6 83883898 1407 1587 14 245251.6 84086951 1407 1590 14 245251.6 84033921 1408 1590 14 245251.6 84077315 1409 1590 14 245251.6 83849422 1409 1587 14 245251.6 83322163 1409 1590 14 245251.6 84005466 1410 1596 14 245251.6 84189675 1409 1587 14 245251.6 83842222 1410 1593 14 245251.6 84073579 1410 1593 14 245251.6 84071991 1410 1593 14 245251.6 83848782 1410 1590 14 245251.6 83842461 1410 1590 14 245251.6 83890086 1410 1589 14 245251.6 84073751 1410 1587 14 245251.6 84072155 1410 1587 14 245251.6 84005762 1410 1587 14 245251.6 84017767 1410 1586 14 245251.6 84082225 1410 1633 14 245251.6 84150699 1410 1587 14 245251.6 83849075 1410 1590 14 245251.6 83842220 1410 1590 14 245251,6 84034488 1410 1592 14 245251,6 84018592 1410 1590 14 245251.6 84071488 1410 1590 14 245251,6 83990408 1410 1584 14 245251.6 84006140 1410 1587 14 245251,6 84148813 1410 1592 14 245251.6 83665905 1410 1591 14 245251.6 84189666 1410 1586 14 245251.6 83842450 1410 1590 14 245251.6 84006752 1410 1593 14 245251.6 83665891 1410 1595 14 245251.6 83848888 1410 1590 14 245251.6 84393782 1410 1590 14 245251.6 83927687 1410 1594 14 245251.6 83931504 1410 1589 14 245251.6 83922922 1411 1589 14 245251.6 83321965 1412 1590 14 245251.6 83321608 1412 1591 14 245251.6 83321192 1412 1590 14 245251.6 83321212 1412 1593 14 245251.6 83848884 1412 1631 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 83321780 1412 1590 14 245251.6 83321859 1412 1590 14 245251.6 83322187 1412 1596 14 245251,6 83846123 1412 1587 14 245251.6 83321441 1412 1590 14 245251.6 83322011 1412 1591 14 245251.6 83754224 1049 1606 14 245251,6 83425292 1050 1595 14 245251.6 4996361H1 1014 1361 14 245251.6 4546463H1 1019 1337 14 245251,6 83117255 1018 1545 14 245251.6 82357822 1020 1592 14 245251,6 1853257H1 1021 1384 14 245251.6 g 1722623 1022 1593 .
14 245251.6 82566601 1026 1486 14 245251,6 81328830 1031 1601 14 245251.6 82824176 1029 1592 14 245251.6 84124629 1041 1595 14 245251,6 82269348 1044 1592 14 245251.6 84217707 1045 1593 14 245251.6 84070671 1048 1601 14 245251.6 2240628H1 1047 1379 14 245251.6 84524298 3 185 14 245251.6 84005797 8 142 14 245251.6 813528H1 686 905 14 245251.6 83807474 1283 1416 14 245251.6 84327570 1238 1419 14, 245251.6 1645004H1 451 672 14 245251.6 1312584H1 697 963 14 245251.6 3471164H1 720 993 14 245251.6 4998559H1 722 1004 14 245251.6 83890267 1283 1418 14 245251.6 4351329H1 686 824 14 245251.6 1672134H1 1233 1423 14 245251.6 83848850 1283 1415 14 245251.6 1517530H1 462 672 14 245251,6 82037443 332 608 14 245251.6 3315274H1 739 996 14 245251.6 83990415 1283 1419 14 245251.6 83849121 1283 1415 14 245251.6 3272177H1 680 917 14 245251.6 5913406H1 686 954 14 245251.6 83848236 1283 1417 14 245251.6 052757H1 756 994 14 245251.6 4708284H1 686 930 14 245251.6 83848935 1283 1416 14 245251.6 83890340 8 142 14 245251.6 82025954 684 995 14 245251.6 1990122H1 581 672 14 245251.6 1436841H1 686 906 SEQ ID Template Component Start Stop NO: ID ID
14 245251,6 g 1301526 726 979 14 245251.6 83990448 1283 1417 14 245251.6 5902523H1 694 996 14 245251,6 2154086H1 740 1016 14 245251.6 917108H1 686 847 14 245251.6 2767517H1 686 922 14 245251.6 83862612 1283 1419 14 245251,6 83848684 6 142 14 245251.6 1814125H1 1258 1419 14 ~ 245251,6 3682120H1 697 991 14 245251.6 2053508H1 751 1005 14 245251,6 3291620H1 686 907 14 245251.6 83862415 1283 1419 14 245251.6 545078H1 734 994 14 245251.6 3280782H1 759 1005 14 245251.6 5376980H1 475 673 14 245251.6 3749492H1 686 950 14 245251.6 83847665 10 142 14 245251.6 1469717H1 864 1150 14 245251.6 2442618H1 869 1184 14 245251.6 516105076 873 1570 14 245251.6 281458376 874 1553 14 245251.6 5216384H1 888 1183 14 245251.6 g 1313327 885 1234 14 245251.6 506895H1 887 1161 14 245251.6 2246148H1 888 1183 14 245251.6 82032570 892 1215 14 245251.6 82033061 892 1312 14 245251.6 6105423H1 892 1228 14 245251.6 1212338H1 894 1249 14 245251.6 2681270H1 894 1239 14 245251.6 2408072H1 894 1201 14 245251.6 774022H1 894 1152 14 245251.6 4667376H1 894 1218 14 245251.6 2629364H1 894 1225 14 245251.6 2260118H1 894 1198 14 245251.6 4372704H1 895 1264 14 245251.6 464993H1 896 1176 14 245251.6 3027714H1 896 1274 14 245251.6 1856953H1 911 1241 14 245251.6 2410246H1 911 1181 14 245251,6 4750638H2 911 1243 14 245251.6 1294624H1 913 1179 14 245251,6 738970H1 921 1241 14 245251.6 g 1775058 924 1381 14 245251,6 81618108 929 1261 14 245251.6 82336997 938 1260 14 245251,6 1979648H1 940 1271 14 245251.6 1990936H1 941 1143 14 245251.6 966663H1 946 1300 104 .
SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 4371102H1 955 1331 14 245251.6 81315094 957 1239 14 245251.6 4369280H1 963 1293 14 245251.6 1905865H1 993 1281 14 245251.6 81972974 997 1364 14 245251.6 4068060H1 1006 1188 14 245251.6 83597449 1007 1595 14 245251.6 1657456H1 1009 1264 14 245251.6 4996367H1 1014 1326 14 245251.6 81758102 1094 1593 14 245251.6 81623171 1100 1594 14 245251.6 82824662 1099 1590 14 245251.6 82526734 1101 1590 14 245251.6 84108545 1103 1592 14 245251.6 82328692 1105 1593 14 245251.6 814904H1 1104 1425 14 245251.6 2870889H1 1108 1460 14 245251.6 5295918H1 686 922 14 245251.6 83890756 1283 1419 14 245251.6 3086975H1 686 955 14 245251.6 83990539 1283 1416 14 245251.6 83847105 1283 1417 14 245251.6 83989389 6 142 14 245251.6 1333963H1 686 884 14 245251.6 84077443 9 142 14 245251.6 3180014H1 686 913 14 245251.6 83849458 8 142 14 245251.6 4619650H1 686 907 14 245251.6 83989412 1283 1416 14 245251.6 491316H1 686 911 14 245251.6 84077428 7 142 14 245251.6 1647829H1 686 881 14 245251.6 83848848 1283 1416 14 245251.6 705929H1 686 889 14 245251.6 83806474 1283 1418 14 245251.6 2540850H1 686 937 14 245251.6 2301130H1 715 965 14 245251.6 83849235 1283 1411 14 245251.6 127489H1 686 893 14 245251.6 83848866 1283 1419 14 245251.6 1876624H1 383 664 14 245251.6 84085932 9 142 14 245251.6 84077334 1283 1419 14 245251.6 83890303 1283 1415 14 245251.6 3384767H1 725 969 14 245251.6 3688995H1 686 945 14 245251.6 1215027H1 839 975 14 245251.6 83847032 1283 1416 14 245251.6 83807516 8 142 14 245251.6 5102970H1 686 941 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 1802892H1 736 973 14 245251.6 g3842338 7 142 14 245251.6 3286343H2 719 969 14 245251.6 1874116H1 374 653 14 245251.6 g3806912 1283 1416 14 245251.6 g3847485 6 142 14 245251.6 619293H1 687 930 14 245251.6 1258505H1 720 968 14 245251.6 g3989388 1283 1411 14 245251.6 6007911H1 686 974 14 245251.6 2149173H1 686 956 14 245251.6 g3848208 1283 1419 14 245251.6 2992493H1 686 946 14 245251.6 650586H1 379 638 14 245251,6 g3849247 1283 1416 14 245251.6 5910613H1 686 972 14 245251,6 g4077711 1283 1419 14 245251.6 4510726H1 704 973 14 245251,6 g3848062 1283 1417 14 245251,6 6106933H1 686 919 14 245251,6 5115225H1 697 970 14 245251,6 g3846901 6 142 14 245251,6 2513695H2 686 907 14 245251,6 g4326234 1283 1419 14 245251.6 3158887H1 686 935 14 245251.6 2706363H1 756 1102 14 245251.6 g4535116 756 1070 14 245251,6 3883004H1 760 1087 14 245251.6 5301496H1 760 1055 14 245251.6 4096707H1 760 1122 14 245251.6 2863619H1 763 1162 14 245251.6 2867319H1 763 1102 14 245251.6 g1281850 767 1331 14 245251.6 g1576704 773 1232 14 245251.6 g1298432 777 1130 14 245251.6 3837476H1 784 1091 14 245251.6 3010150H1 785 1128 14 245251.6 3010801H1 785 1123 14 245251.6 g2204501 790 1201 14 245251.6 g2217814 791 1325 14 245251.6 g1060431 795 1137 14 245251.6 3918458H1 803 1125 14 245251.6 5697844H1 803 1122 14 245251.6 g2591145 815 1249 14 245251,6 4573806H1 818 1102 14 245251.6 4914643H1 820 1142 14 245251.6 908962H1 833 1192 14 245251.6 2132022T6 833 1548 14 245251.6 4628839H1 832 1120 14 245251.6 3550659H1 835 1213 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 g674861 839 1124 14 245251.6 706061H1 843 1165 14 245251,6 2061068H1 851 1161 14 245251.6 5264515F6 853 1331 14 245251.6 g2539208 854 1344 14 245251,6 2408850H1 856 1132 14 245251,6 6006938H1 863 1213 14 245251.6 6007037H1 863 1228 14 245251.6 3171466H1 866 1199 14 245251.6 g1124148 1283 1592 14 245251.6 g3803160 1285 1600 14 245251.6 g2942025 1286 1598 14 245251.6 3160175H1 1288 1592 14 245251.6 g1740568 1300 1593 14 245251.6 2300048H1 1302 1557 14 245251.6 82877399 1307 1594 14 245251.6 82728321 1309 1591 14 245251.6 1491834H1 1310 1593 14 245251.6 2862613H1 1317 1592 14 245251.6 945012H1 1322 1598 14 245251.6 88471 b8 1313 1593 14 245251.6 84327571 1325 1590 14 245251.6 1507186H1 1330 1569 14 245251,6 3970589H1 1334 1595 14 245251.6 209179H1 1334 1535 14 245251.6 207014H1 1334 1582 14 245251.6 3967178H1 1335 1590 14 245251.6 83058131 1337 1592 14 245251.6 3967462H1 1335 1591 14 245251.6 82787682 1337 1594 14 245251.6 83154417 1337 1594 14 245251.6 2361006H1 1338 1590 14 245251.6 2362930H1 1339 1590 14 245251.6 83001273 1339 1590 14 245251.6 83960768 1341 1592 14 245251.6 942262H1 1345 1592 14 245251.6 902954H1 1349 1593 14 245251.6 4506855H1 1353 1590 14 245251.6 81265337 1360 1599 14 245251.6 1419110H1 1365 1590 14 245251.6 81264701 1373 1599 14 245251.6 81227017 1374 1600 14 245251.6 83884934 1385 1589 14 245251.6 83884396 1388 1590 14 245251.6 83884926 1390 1587 14 245251.6 83846626 1390 1593 14 245251,6 83849105 1390 1541 14 245251.6 83884831 1391 1593 14 245251,6 83842214 1391 1590 14 245251.6 83846730 1393 1590 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 83846909 1393 1586 14 245251.6 82657904 1087 1590 14 245251.6 84525345 1090 1592 14 245251.6 83239030 1088 1599 14 245251.6 870032H1 1092 1407 14 245251.6 5597455H1 1093 1365 14 245251.6 1898558H1 697 967 14 245251.6 84071850 1283 1419 14 245251.6 2452174H1 686 897 14 245251.6 2842830H1 380 650 14 245251.6 3686824H1 686 972 14 245251.6 84077526 9 142 14 245251.6 3782176H1 686 945 14 245251.6 1535425H1 861 972 14 245251.6 83848055 1283 1419 14 245251.6 3119950H1 699 977 14 245251.6 3884464H1 686 806 14 245251.6 83842568 6 142 14 245251.6 3507042H1 695 977 14 245251.6 2512439H1 686 909 14 245251.6 84085946 1283 1416 14 245251.6 4405615H1 686 943 14 245251.6 5896519H1 694 977 14 245251.6 83845926 1283 1419 14 245251.6 3330695H1 686 929 14 245251.6 83847726 1283 1416 14 245251.6 3157747H1 693 975 14 245251.6 1622382H1 686 909 14 245251.6 83862513 1283 1419 14 245251,6 1656661H1 686 873 14 245251.6 83845948 8 142 14 245251.6 3028871H1 686 967 14 245251.6 3809687H1 686 977 14 245251.6 83990041 1283 1417 14 245251,6 2451959H1 573 669 14 245251.6 4551365H 699 976 1 .
14 245251.6 83847599 6 142 14 245251.6 5172386H1 721 980 14 245251.6 83845822 1283 1416 14 245251.6 4824541H1 726 980 14 245251.6 83931555 1283 1418 14 245251.6 84006049 9 142 14 245251.6 2481849H1 686 907 14 245251.6 6026544H1 686 978 14 245251.6 83862408 1283 1416 14 245251.6 5893562H1 694 984 14 245251.6 3141501H1 686 935 14 245251.6 82899544 48 137 14 245251.6 83842538 9 142 14 245251.6 1897745H1 686 935 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 g3807515 10 142 14 245251.6 3698231H1 686 964 14 245251.6 1680096H1 454 670 14 245251.6 3575006H1 686 976 14 245251.6 3945268H1 696 980 14 245251.6 g3990060 1283 1418 14 245251.6 1630619H1 740 961 14 245251.6 6026541H1 686 983 14 245251.6 282261H1 821 987 14 245251.6 83989332 1283 1416 14 245251.6 82714757 6 127 14 245251.6 83848017 1283 1418 14 245251.6 4909050H1 691 864 14 245251.6 84077616 1283 1419 14 245251.6 5016694H1 709 985 14 245251.6 82715675 1342 1421 14 245251.6 83890469 1283 1415 14 245251.6 82020485 727 976 14 245251.6 81548162 1304 1422 14 245251.6 84086845 1283 1419 14 245251.6 3095012H1 686 984 14 245251.6 83990363 1283 1416 14 245251.6 4012002H1 686 964 14 245251.6 82198225 1301 1421 14 245251.6 83989049 10 142 14 245251.6 2960954H1 686 985 14 245251.6 84189209 1283 1419 14 245251.6 4268413H1 686 983 14 245251.6 850512H1 756 961 14 245251.6 4238523H1 696 976 14 245251.6 83989140 1283 1419 14 245251.6 8715951 690 981 14 245251.6 83736535 1367 1423 14 245251.6 2512088H1 686 984 14 245251.6 84284258 9 142 14 245251.6 4379339H1 686 936 14 245251.6 83890461 1283 1419 14 245251.6 3182012H1 687 981 14 245251.6 4706886H1 686 932 14 245251.6 83846611 1283 1415 14 245251.6 2322530H1 736 987 14 245251.6 83990086 7 142 14 245251.6 3839096H1 686 938 14 245251.6 321302H1 765 984 14 245251.6 83989015 1283 1416 14 245251.6 1990623H1 686 928 14 245251.6 3683615H1 696 987 14 245251.6 84086491 1283 1416 14 245251.6 1619567H1 686 866 14 245251.6 3078410H1 686 986 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 84080312 9 142 14 245251.6 2908167H1 686 987 14 245251.6 3671767H1 686 892 14 245251.6 82037878 686 961 14 245251.6 84077435 1283 1416 14 245251.6 1603854H1 686 878 14 245251.6 81199063 686 987 14 245251.6 84017782 1283 1419 14 245251.6 1347327H1 686 907 14 245251.6 8927989 359 637 14 245251.6 3324035H1 697 990 14 245251.6 84086445 7 142 14 245251,6 2546965H2 686 862 14 245251.6 4343132H1 873 997 14 245251.6 84077453 1283 1419 14 245251.6 4334622H1 686 944 14 245251.6 8847231 356 637 14 245251.6 83846130 1283 1416 14 245251.6 84018630 1283 1416 14 245251.6 2101272H1 4 114 14 245251,6 2587234H1 686 903 14 245251.6 3574372H1 686 979 14 245251,6 83694286 1050 1590 14 245251,6 81315095 1061 1599 14 245251.6 210059H1 1053 1331 14 245251.6 83279541 1055 1598 14 245251.6 83736864 1055 1595 14 245251,6 4974349H1 1056 1417 14 245251.6 83665039 1061 1592 14 245251.6 3888183H1 1063 1401 14 245251.6 1530540H1 1063 1345 14 245251.6 81274050 1076 1590 14 245251.6 002239H1 1065 1548 14 245251.6 1297924H1 1065 1381 14 245251.6 3479370H1 1065 1328 14 245251.6 1312352H1 1068 1333 14 245251.6 506800H1 1068 1356 14 245251.6 81364437 1077 1592 14 245251.6 82214112 1072 1591 14 245251.6 1267456H1 1074 1366 14 245251.6 82820951 1079 1594 14 245251.6 1311167H1 1082 1398 14 245251.6 82401841 1080 1593 14 245251.6 83735785 1082 1596 14 245251.6 82217605 1083 1595 14 245251.6 g 1576739 1085 1592 14 245251.6 8674787 1092 1587 14 245251.6 4010641H1 697 1030 14 245251.6 2506513H1 697 956 14 245251.6 795092H1 697 957 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 5221852H2 697 979 14 245251.6 5687479H1 697 979 14 245251.6 1483887H1 697 973 14 245251.6 1449209H1 697 917 14 245251.6 3747027H1 697 1031 14 245251.6 1594015H1 697 942 14 245251.6 1455584H1 697 966 14 245251.6 1593886H1 697 922 14 245251.6 3379095H1 699 975 14 245251.6 526768H1 699 978 14 245251.6 g1970187 700 1120 14 245251.6 5913596H1 699 1013 14 245251.6 g1997336 702 1120 14 245251.6 g864282 704 1088 14 245251.6 4307655H1 702 1087 14 245251.6 3766134H1 702 1031 14 245251.6 4545031H1 705 1032 14 245251.6 g 1501684 705 1219 14 245251.6 g 1321292 707 1229 14 245251.6 2496344H1 705 1103 14 245251.6 4675111H1 705 964 14 245251.6 3482217H1 705 1067 14 245251.6 4070047H1 705 1031 14 245251.6 2997014H1 706 1031 14 245251.6 g1623223 711 1097 14 245251.6 5164521H1 709 999 14 245251.6 4196137H1 686 806 14 245251.6 358653H1 701 923 14 245251.6 1370775H1 686 823 14 245251.6 3759039H1 686 907 14 245251.6 600085H1 422 656 14 245251.6 1575013H1 686 897 14 245251.6 1000003H1 686 925 14 245251.6 2049730H1 686 925 14 245251.6 5282003H1 686 919 14 245251.6 5161050H1 557 657 14 245251.6 2134833H1 696 928 14 245251,6 4667193H1 689 928 14 245251,6 1593935H1 686 898 14 245251.6 1786467H1 686 919 14 245251,6 1299188H1 686 917 14 245251.6 2616796H1 686 913 14 245251,6 5699823H1 686 928 14 245251.6 4833390H1 691 907 14 245251.6 2450956H1 686 913 14 245251,6 1416169H1 686 927 14 245251.6 4902593H1 686 853 14 245251.6 685823H1 686 795 14 245251.6 1378622H1 686 892 14 245251.6 2203295H1 686 912 SEQ ID Template Component Start Stop NO: ID ID
14 245251,6 4873526H1 686 906 14 245251.6 1567661H1 686 889 14 245251.6 4265241H1 554 660 14 245251.6 4565002H1 686 930 14 245251.6 5028562H1 686 931 14 245251.6 3315321H2 686 916 14 245251.6 179704H1 686 857 14 245251.6 5043044H1 691 923 14 245251.6 3272310H1 686 923 14 245251.6 5590795H1 686 871 14 245251.6 4374880H1 686 930 14 245251.6 2942376H1 722 932 14 245251.6 2669414H1 686 932 14 245251.6 2051081H1 686 932 14 245251.6 778957H1 686 836 14 245251.6 3383437H1 686 924 14 245251.6 2502860H1 702 939 14 245251.6 g1548213 686 828 14 245251.6 1558658H1 686 895 14 245251.6 2742568H1 693 934 14 245251.6 5844527H1 686 928 14 245251.6 3237925H1 413 660 14 245251.6 1654956H1 686 903 14 245251.6 1212747H1 686 906 14 245251.6 2110510H1 695 937 14 245251,6 2670483H1 697 937 14 245251.6 3887565H1 686 937 14 245251.6 2278236H1 692 939 14 245251.6 1549915H1 686 880 14 245251.6 1915263H1 686 926 14 245251.6 3174435H1 686 912 14 245251,6 931246H1 686 925 14 245251.6 1524019H1 724 944 14 245251,6 2630203H1 686 914 14 245251.6 6063419H1 686 867 14 245251.6 1557962H1 686 876 14 245251,6 1519653H1 686 820 14 245251,6 g1970343 686 927 14 245251,6 1643982H1 686 870 14 245251.6 2636948H1 686 944 14 245251.6 3236095H1 686 910 14 ~ 245251.63290990H1 695 944 14 245251.6 2916653H1 439 664 14 245251.6 2347442H1 686 901 14 245251.6 2160657H1 705 942 14 245251.6 1612904H1 686 861 14 245251.6 1602311H1 686 865 14 245251.6 2479177H1 686 940 14 245251.6 3276325H1 686 942 14 245251,6 3342181H1 686 942 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 3414248H1 700 942 14 245251.6 4244690H1 424 664 14 245251.6 1657385H1 686 887 14 245251.6 2060168H1 686 942 14 245251.6 2724864H1 686 940 14 245251.6 2507348H1 718 943 14 245251.6 3439967H1 686 916 14 245251.6 3875717H1 712 946 14 245251.6 3930892H1 686 944 14 245251.6 2876429H1 686 930 14 245251.6 1663347H1 686 897 14 245251.6 745654H1 715 946 14 245251.6 5714032H1 402 bbl 14 245251.6 6013561H1 686 939 14 245251.6 3368428H1 687 945 14 245251.6 4673619H1 686 945 14 245251.6 4356555H1 686 921 14 245251.6 2984258H1 691 943 14 245251.6 6073987H1 686 945 14 245251.6 2435338H1 686 881 14 245251.6 3416993H1 698 943 14 245251.6 4108736H1 686 944 14 245251.6 1793902H1 686 938 14 245251.6 3429779H1 686 943 14 245251.6 1522075H1 468 664 14 245251.6 3282589H1 701 946 14 245251.6 5781877H1 686 925 14 245251.6 1311376H1 686 946 14 245251.6 2478308H1 686 912 14 245251.6 476523H1 1305 1419 14 245251.6 3406437H1 . 6 108 14 245251.6 4998161H1 686 936 14 245251.6 1759883H1 686 943 14 245251.6 2426656H1 686 918 14 245251.6 2357554H1 686 898 14 245251.6 911731H1 686 947 14 245251.6 3361812H1 686 947 14 245251.6 4349129H1 686 875 14 245251.6 4847891H1 686 922 14 245251.6 929615H1 686 943 14 245251.6 4593502H1 686 938 14 245251.6 g1956732 701 948 14 245251.6 3325687H2 554 664 14 245251.6 1504636H1 699 951 14 245251.6 3357413H1 686 931 14 245251.6 2093969H1 7 120 14 245251.6 3888045H1 686 917 14 245251.6 4400406H1 704 949 14 245251.6 4675188H1 686 895 14 245251.6 1833267H1 696 949 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 3531646H1 1290 1419 14 245251.6 4675103H1 686 823 14 245251.6 612029H1 686 948 14 245251.6 83861897 1283 1417 14 245251.6 83861915 10 142 14 245251.6 4585634H1 ' 686 807 14 245251.6 81187227 736 954 14 245251.6 83806416 6 142 14 245251.6 8809795 688 920 14 245251.6 83806236 1283 1417 14 245251.6 5184838H1 686 929 14 245251.6 83806383 9 142 14 245251.6 83862381 6 142 14 245251.6 5102972H1 686 938 14 245251.6 83806305 1283 1416 14 245251.6 4049171H1 686 952 14 245251.6 5399585H1 686 806 14 245251.6 83806377 8 142 14 245251.6 1609289H1 686 ' 861 14 245251.6 81985106 688 952 14 245251.6 1631116H1 740 958 14 245251.6 83846850 1283 1419 14 245251.6 3371627H1 686 934 14 245251.6 83842256 1283 1415 14 245251.6 81948393 686 952 14 245251.6 83849535 8 142 14 245251.6 1353725H1 686 906 14 245251.6 3811303H1 395 637 14 245251.6 83849274 1283 1417 14 245251.6 770658H1 692 958 14 245251.6 1709346H1 686 889 14 245251.6 83923055 1283 1416 14 245251.6 1351272H1 686 917 14 245251.6 2497443H1 686 952 14 245251.6 6007158H1 686 958 14 245251.6 84086359 1283 1419 14 245251.6 83849526 1283 1419 14 245251.6 5905094H1 686 959 14 245251.6 83847515 1283 1417 14 245251.6 3040561H1 686 954 14 245251.6 1886946H1 686 956 14 245251.6 4764852H1 686 958 14 245251.6 83847084 1283 1417 14 245251.6 83845943 1283 1419 14 245251.6 5685528H1 686 956 14 245251.6 83846660 9 142 14 245251.6 83845949 1283 1419 14 245251.6 3400315H1 688 927 14 245251.6 81953701 688 939 14 245251.6 5833060H1 686 954 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 83989265 1283 1417 14 245251.6 4049178H1 686 954 14 245251.6 82038078 686 957 14 245251.6 212969H1 686 851 14 245251,6 84074607 9 142 14 245251.6 83990111 1283 1419 14 245251.6 4265942H1 688 945 14 245251.6 83990156 1283 1415 14 245251,6 1859765H1 446 666 14 245251.6 83847576 9 142 14 245251.6 81320366 594 1041 14 245251.6 2039935H1 596 882 14 245251.6 5299657H1 601 870 14 245251.6 4947763H1 623 800 14 245251.6 799795H1 640 890 14 245251.6 81957419 644 1200 14 245251.6 1503008H1 669 974 14 245251.6 1503133H1 669 1024 14 245251,6 1703102H1 670 907 14 245251.6 5945265H1 671 9b5 14 245251.6 4154972H1 672 973 14 245251.6 4783070H1 677 947 14 245251.6 2729061H1 680 956 14 245251.6 4817713H1 683 981 14 245251.6 2604603H1 685 958 14 245251,6 2300089H1 685 963 14 245251,6 3647926H1 689 1020 14 245251.6 5120725H1 690 1026 14 245251,6 083810H1 692 952 14 245251,6 4409416H1 694 881 14 245251,6 4057228H1 694 996 14 245251.6 5395048H1 696 1005 14 245251.6 3481334H1 693 1055 14 245251.6 4218418H1 694 988 14 245251.6 4820226H1 695 855 14 245251.6 4073954H1 694 1017 14 245251.6 1315458H1 695 975 14 245251.6 3600571H1 696 1025 14 245251.6 3776260H1 696 1029 14 245251.6 3588749H1 695 1055 14 245251,6 2814583F6 696 1360 14 245251.6 1229362H1 696 948 14 245251.6 5732270H1 695 982 14 245251.6 g 1727842 696 1088 14 245251.6 3660326H1 696 915 14 245251.6 4198443H1 697 808 14 245251.6 1455236H1 695 976 14 245251.6 2343111H1 696 992 14 245251.6 3513953H1 696 992 14 245251.6 4999458H1 696 993 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 2261362H1 696 975 14 245251.6 3029907H1 696 1017 14 245251.6 5121569H1 696 1011 14 245251.6 4537506H1 695 979 14 245251.6 3321759H1 696 1013 14 245251.6 2307802H1 697 981 14 245251.6 2307804H1 697 979 14 245251.6 3012456H1 697 951 14 245251.6 2504610H1 697 952 14 245251.6 3362687H1 697 990 14 245251.6 3748602H1 696 901 14 245251.6 3316419H1 697 990 14 245251,6 2814582H1 696 992 14 245251.6 2272892H1 697 993 14 245251.6 1807854H1 696 976 14 245251.6 g2466185 697 1219 14 245251.6 2132022H1 697 996 14 245251.6 213202286 697 1408 14 245251.6 3073883H1 697 997 14 245251.6 2125224H1 697 1003 14 245251.6 2269903H1 697 816 14 245251.6 1459722H1 697 922 14 245251.6 4562893H1 697 981 14 245251.6 1496792H1 696 922 14 245251.6 5221884H2 697 975 ~
14 245251.6 5572366H1 697 928 14 245251,6 2771241H1 697 967 14 245251.6 1573610H1 697 974 14 245251.6 1867126H1 697 1002 14 245251.6 1507375H1 697 928 14 245251,6 1573473H1 697 932 14 245251.6 3267774H1 697 1002 14 245251,6 3163705H1 697 973 14 245251,6 3272193H1 696 970 14 245251,6 2985313H1 697 1009 14 245251.6 3495519H1 697 1014 14 245251.6 3943155H1 697 981 14 245251.6 3812545H1 697 1032 14 245251.6 2708787H1 697 1024 14 24 ~51.b 3639075H 697 1030 14 245251.6 81940776 733 1099 14 245251.6 8908409 734 1122 14 245251.6 5865030H1 736 1078 14 245251.6 4050960H1 736 1049 14 245251.6 3819250H1 751 1088 14 245251.6 g 1761139 757 1219 14 245251.6 g 1967349 756 1382 14 245251.6 81618353 729 1108 14 245251.6 g 1364436 729 1251 14 245251.6 81727492 715 1095 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 g1968929 710 1184 14 245251.6 5161050F6 712 1306 14 245251.6 g1959923 712 1159 14 245251.6 g 1757908 715 1152 14 245251.6 1229535H1 721 817 14 245251.6 1844975H1 725 1044 14 245251.6 g1295958 729 1461 14 245251.6 358108H1 712 839 14 245251.6 2903511H1 712 1072 14 245251.6 3087812H1 712 1032 14 245251.6 g1440940 728 1227 15 252875.1 2931079H1 2777 3055 15 252875.1 1917962H1 2777 2996 15 252875.1 827946H1 2777 3031 15 252875.1 g 1494002 2777 2956 15 252875.1 1452450H1 2777 2989 15 252875.1 g28465 2777 2913 15 252875.1 g2046620 2785 3270 15 252875.1 g897974 2789 3046 15 252875.1 4584285H1 2789 3086 15 252875,1 g897962 2789 3132 15 252875.1 5518734H1 2797 3022 15 252875.1 g1157691 2797 3093 15 252875.1 5587262H1 2798 3081 15 252875.1 1547554H1 2800 2940 15 252875.1 2169571H1 2840 3091 15 252875.1 5449334H1 2849 3116 15 252875.1 4340677H1 2859 3171 15 252875.1 3015019H1 2858 3160 15 252875.1 406486H1 2859 3107 15 252875.1 3556907H1 2862 3187 15 252875.1 2651443H1 2871 3120 15 252875,1 2444851H1 2875 3115 15 252875.1 373627H1 2876 3096 15 252875.1 2172734H1 2879 3083 15 252875.1 5875371H1 2881 3171 15 252875.1 g 1690763 2890 3247 15 252875,1 g1506919 2890 3158 15 252875.1 3842658H1 2897 3209 15 252875.1 4435381H1 2895 3130 15 252875.1 2799807H1 2897 3164 15 252875.1 2909321H1 2904 3055 15 252875.1 3093958H1 2913 3222 15 252875.1 4644257H1 2913 3192 15 252875.1 2594951H1 2918 3182 15 252875.1 720109H1 2928 3197 15 252875.1 531590H1 2932 3153 15 252875.1 5497370H1 2938 3133 15 252875.1 4741744H1 2940 3237 15 252875.1 2850778H1 2951 3229 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 2420169H1 2950 3197 15 252875.1 2227025H1 2953 3202 15 252875.1 1948888H1 2953 3118 15 252875.1 96767181 2957 3598 15 252875.1 2682662H1 2956 3270 15 252875.1 967671H1 2957 3272 15 252875.1 g1303166 2964 3269 15 252875.1 4323462H1 2975 3231 15 252875.1 3774157H1 2982 3300 15 252875.1 2384295H2 2984 3216 15 252875.1 4156648H1 2992 3290 15 252875.1 5373633H1 2994 3209 15 252875.1 190297H1 3005 3261 15 252875.1 19029781 3005 3659 15 252875.1 3222225H1 3006 3362 15 252875.1 2197579H1 3012 3284 15 252875.1 4334641H1 3016 3321 15 252875.1 1739115H1 3031 3225 15 252875.1 2076112H1 3031 3345 15 252875.1 4588978H1 3031 3144 15 252875.1 1929325H1 3033 3287 15 252875.1 1698356H1 3044 3278 15 252875.1 774049H1 3044 3278 15 252875.1 3201988H1 3045 3229 15 252875.1 g 1165436 3045 3537 15 252875,1 4079815H1 3046 3338 15 252875.1 546658H1 3054 3386 15 252875,1 3243004H1 3061 3315 15 252875.1 2285730H1 3074 3327 15 252875.1 4957381H1 3075 3353 15 252875,1 g1165609 3101 3371 15 252875.1 548503H1 3112 3289 15 252875,1 434752H1 3117 3345 15 252875.1 1665374H1 3115 3374 15 252875,1 3766307H1 3116 3255 15 252875.1 5301677H1 3118 3294 15 252875.1 619409H1 3124 3411 15 252875.1 2134475H1 3129 3401 15 252875.1 1328119H1 3134 3432 15 252875.1 g835219 3135 3529 15 252875.1 3414825H1 3663 3915 15 252875.1 g4285757 3666 3843 15 252875.1 3992325H1 3673 3977 15 252875.1 1684593H1 3674 3906 15 252875.1 g1690764 3683 3831 15 252875.1 507054H1 3693 3932 15 252875.1 g 1493946 3705 3840 15 252875.1 2113227H1 3709 4000 15 252875.1 g4457753 3711 3844 15 252875.1 1601661H1 3712 3926 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 5860245H1 3714 4016 15 252875.1 g897528 3724 3841 15 252875,1 g1149324 3726 3877 15 252875.1 731353H1 3733 3998 15 252875,1 5219557H1 3737 3928 15 252875.1 g1194254 3752 4014 15 252875.1 g1976483 3768 4129 15 252875.1 g1194793 3775 3940 15 252875.1 3806345H1 3781 4050 15 252875.1 2603535H1 3783 4049 15 252875.1 47bb3bOH1 3785 4070 15 252875.1 1833291H1 3783 4043 15 252875.1 3450113H1 3790 4072 15 252875.1 5120311H1 634 940 15 252875.1 2866935H1 741 1043 15 252875.1 638818H1 752 1017 15 252875.1 3435566H1 812 1068 15 252875.1 2169234H1 833 1056 15 252875.1 2169234F6 833 1253 15 252875.1 5636183H1 906 1181 15 252875.1 4267043H1 961 1243 15 252875.1 3416556H1 985 1240 15 252875.1 5502666H1 1070 1287 15 252875.1 g1384448 1072 1421 15 252875.1 4b983bbHl 1099 1361 15 252875.1 2477291H1 1137 1358 15 252875.1 1274557F6 1172 1609 15 252875.1 1274557H1 1172 1419 15 252875.1 g3845885 1226 1585 15 252875.1 2746276H1 1241 1484 15 252875.1 3488583H1 1249 1508 15 252875.1 g2557990 1259 1550 15 252875.1 g3412243 1271 1590 15 252875,1 g2013979 1289 1524 15 252875.1 g2217748 4188 4593 15 252875.1 1336165H1 4186 4455 15 252875.1 2803030H1 4193 4486 15 252875.1 3728371H1 4193 4534 15 252875.1 g2195154 4193 4593 15 252875.1 372837171 4203 4554 15 252875.1 g1192650 4206 4590 15 252875,1 g2279223 4215 4590 15 252875.1 2718529H1 4217 4515 15 252875.1 83229683 4218 4587 15 252875.1 83144363 4227 4593 15 252875.1 81891729 4233 4590 15 252875.1 83666365 4234 4594 15 252875.1 83742308 4240 4593 15 252875.1 709764H1 4243 4529 15 252875.1 83237786 4245 4587 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 g1545463 4245 4602 15 252875.1 g2840952 4251 4587 15 252875.1 g2883750 4267 4608 15 252875.1 224311H1 4280 4486 15 252875.1 224311F1 4280 4587 15 252875.1 226928H1 4280 4545 15 252875.1 229979H1 4280 4508 15 252875.1 4091574H1 4282 4578 15 252875.1 2887836H1 4282 4576 15 252875.1 g4326366 4283 4593 15 252875.1 g 1139072 4293 4594 15 252875.1 g3434294 4294 4587 15 252875.1 174025986 4294 4587 15 252875.1 1740259H1 4294 4532 15 252875.1 1740259Th 4294 4553 15 252875.1 3470373H1 4300 4587 15 252875.1 g4149411 4304 4593 15 252875.1 659699H1 4310 4590 15 252875.1 731353F1 4156 4587 15 252875.1 g1846732 4157 4593 15 252875.1 g3214922 4160 4594 15 252875.1 g3416272 4325 4587 15 252875.1 g4525092 4330 4596 15 252875.1 4423707H1 4332 4587 15 252875.1 g3428976 4162 4595 15 252875.1 g3895874 4162 4596 15 252875.1 22431181 4177 4587 15 252875.1 g2753953 4168 4587 15 252875.1 g1626194 4171 4595 15 252875.1 g3146324 4171 4542 15 252875.1 g2779866 4172 4504 15 252875.1 g2054706 3495 3840 15 252875.1 3837481H1 3497 3712 15 252875.1 3512137H1 3510 3600 15 252875,1 g566011 3510 3833 15 252875.1 3325564H1 3518 3685 15 252875,1 g2537480 3527 4057 15 252875.1 2586362H1 3531 3819 15 252875.1 1265894H1 3534 3772 15 252875.1 1265894F1 3534 4149 15 252875.1 g1271274 3538 3812 15 252875.1 4339850H1 3540 3823 15 252875.1 5014329H1 3540 3807 15 252875.1 84333060 3540 3830 15 252875.1 83899484 3542 3840 15 252875.1 4019833H1 3553 3873 15 252875.1 3930433H1 3553 3868 15 252875.1 1394247H1 3557 3830 15 252875.1 8670185 3558 3833 15 252875.1 8897537 3565 3831 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 2313534H1 3569 3818 15 252875.1 1258470F1 3572 4196 15 252875.1 84304393 3571 3842 15 252875.1 2692250H1 3572 3831 15 252875.1 1258470H1 3572 3836 15 252875.1 81275416 3572 4230 15 252875.1 3809069H1 3582 3895 15 252875.1 81152594 3583 3840 15 252875.1 82321801 3588 3838 15 252875.1 8835206 3590 3840 15 252875.1 2808212H1 3607 3935 15 252875.1 1916784H1 3616 3905 15 252875.1 1251826H1 3619 3778 15 252875.1 1251826F1 3619 3830 15 252875.1 83920452 2265 2604 15 252875.1 2457404H1 2267 2520 15 252875.1 5216436H1 2268 2523 15 252875.1 8572819 2271 2614 15 252875.1 2685979H1 2291 2546 15 252875.1 4311421H1 2289 2413 15 252875.1 1387882H1 2291 2569 15 252875.1 1994174H1 2291 2402 15 252875.1 1386461H1 2291 2425 15 252875.1 3296980H1 2293 2560 15 252875.1 3742330H1 2307 2605 15 252875.1 2839295H1 2309 2585 15 252875.1 2615762H1 2321 2606 15 252875.1 2115669H1 2327 2594 15 252875.1 3248377H1 2331 2428 15 252875.1 1892380H1 2352 2493 15 252875.1 82217857 2382 2726 15 252875.1 3425510H1 2390 2665 15 252875.1 3666290H1 2391 2590 15 252875.1 3133325H1 2392 2667 15 252875.1 g 1897668 2395 2756 15 252875.1 034289H1 2400 2657 15 252875.1 g 1062015 2406 2733 15 252875.1 3542538H1 2407 2673 15 252875.1 3542586H1 2407 2668 15 252875.1 2969209H1 2424 2686 15 252875.1 4358014H1 2434 2716 15 252875.1 3657619H1 2435 2724 15 252875.1 82930924 2236 2642 15 252875.1 031953H1 2440 2723 15 252875.1 030691H1 2440 2652 15 252875.1 81154198 2441 2728 15 252875.1 2069257Th 2441 2867 15 252875.1 2744591H1 2441 2699 15 252875.1 81062277 2451 2739 15 252875.1 1945843H1 2476 2722 SE9 ID Template Component Start Stop NO: ID ID
15 252875.1 5135194H1 2479 2749 15 252875.1 4173923H1 2497 2797 15 252875.1 1853266H1 2497 2756 15 252875.1 5542442H1 2499 2719 15 252875.1 5497660H1 2514 2768 15 252875.1 84086589 2517 2925 15 252875.1 5878048H1 2521 2830 15 252875.1 81320612 2521 2852 15 252875.1 3891146H1 2524 2756 15 252875.1 2073038H1 2529 2756 15 252875.1 5834734H1 2544 2775 15 252875.1 5512348H1 2569 2872 15 252875.1 5512133H1 2569 2756 15 252875.1 199654386 2578 3088 15 252875.1 1996543H1 2578 2842 15 252875.1 3940668H1 2587 2874 15 252875.1 Ob0574H1 2591 2756 15 252875.1 4151473H1 2591 2870 15 252875.1 5196676H1 2591 2860 15 252875.1 030354H1 2599 2860 15 252875,1 4196058H1 2603 2923 15 252875.1 1450989F1 2621 2982 15 252875.1 1450989H1 2621 2901 15 252875.1 82218312 2632 3002 15 252875.1 g 1383259 2632 3083 15 252875.1 82617741 2633 2835 15 252875.1 8791689 2635 2874 15 252875.1 4933134H1 2648 2964 15 252875.1 2797213H1 2678 2953 15 252875.1 4864853H1 2678 2935 15 252875.1 2798634H1 2678 2946 15 252875.1 633892H1 2688 2918 15 252875.1 8880789 2705 3081 15 252875.1 2807841H1 2737 3068 15 252875,1 81182637 2746 3090 15 252875.1 81125575 2753 3131 15 252875.1 81295159 2765 3081 15 252875.1 4265522H1 2774 3018 15 25.2875.1 90022281 2775 3209 15 252875.1 900222H1 2775 3120 15 252875.1 4410765H1 2777 2983 15 252875.1 3468239H1 2777 2966 15 252875.1 2551180H1 2777 2970 15 252875.1 3813780H1 2777 3065 15 252875.1 81506871 3620 3830 15 252875.1 8791584 3621 3848 15 252875.1 2407631H1 3621 3840 15 252875.1 8835220 3629 3841 15 252875.1 83038977 3629 3783 15 252875.1 81062367 3637 3823 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 310441H1 3639 3825 15 252875.1 31044186 3640 3924 15 252875.1 4080535H1 3641 3961 15 252875.1 1740495H1 3641 3892 15 252875.1 4647311H1 3642 3919 15 252875.1 388848H1 3647 3848 15 252875.1 81332310 3651 4188 15 252875.1 81332258 3651 4126 15 252875.1 g 1524775 3653 4182 15 252875.1 81443183 3652 3840 15 252875.1 g 1891789 3654 4121 15 252875.1 400845H1 3659 3849 15 252875.1 2639596H1 1369 1429 15 252875.1 2874502F6 1406 1784 15 252875.1 2169234T6 1331 1696 15 252875.1 2874502H1 1407 1686 15 252875.1 2746872H1 1408 1674 15 252875.1 81984049 1443 1765 15 252875.1 5264513F6 1452 1772 15 252875.1 82526630 1461 1904 15 252875.1 2877577H1 1498 1668 15 252875.1 2871627H1 1498 1758 15 252875.1 4768331H1 1519 1790 15 252875.1 2762166H1 1536 1793 15 252875.1 82010681 1598 1898 15 252875.1 5370588H1 1609 1832 15 252875.1 3725509H1 1646 1936 15 252875.1 4714478H1 1664 1929 15 252875.1 1950683H1 1674 1901 15 252875.1 82006648 1675 1920 15 252875.1 82027521 1714 2070 15 252875.1 3825837H1 1735 2021 15 252875.1 84511067 1738 2020 15 252875.1 653234H1 1780 2029 15 252875.1 2170628H1 1806 2054 15 252875.1 2170628F6 1806 2302 15 252875.1 1665096H1 1845 2078 15 252875.1 5695708H1 1860 2097 15 252875.1 8573675 1919 2227 15 252875.1 5638872H1 1975 2241 15 252875.1 5086872H1 1983 2207 15 252875.1 1689519H1 1988 2112 15 252875.1 4833076H1 1999 2262 15 252875.1 3370367H1 2005 2286 15 252875.1 2354679H1 2006 2135 15 252875.1 82011403 2014 2239 15 252875.1 4820085H1 2037 2264 ' 15 252875.1 6063612H1 2037 2310 15 252875.1 2170628Th 2050 2471 15 252875.1 83676979 2051 2516 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 4346524H1 2081 2351 15 252875.1 2650068H1 2081 2333 15 252875.1 059589H1 2091 2303 15 252875.1 g2335474 2135 2520 15 252875.1 g616509 2166 2506 15 252875.1 4993749H1 2166 2461 15 252875.1 729898H1 2167 2371 15 252875.1 72989886 2167 2582 15 252875.1 73091586 2167 2686 15 252875.1 72989881 2167 2512 15 252875.1 350527H1 2181 2315 15 252875.1 1486345H1 2211 2463 15 252875.1 1486345F6 2211 2586 15 252875.1 5450622H1 2228 2489 15 252875.1 4553123H1 3172 3443 15 252875.1 3629790H1 3181 3496 15 252875.1 402268H1 3188 3407 15 252875.1 1509841H1 3195 3397 15 252875.1 1509833H1 3195 3399 15 252875.1 4919221H1 3206 3499 15 252875.1 g835205 3135 3437 15 252875.1 4073386H1 3142 3458 15 252875.1 2445427H1 3156 3414 15 252875.1 2041560H1 3157 3451 15 252875.1 5013650H1 3219 3526 15 252875.1 1876087H1 3222 3480 15 252875.1 2401949H1 3222 3494 15 252875.1 5875179H1 3223 3506 15 252875.1 5518081H1 3236 3414 15 252875.1 3163335H1 3239 3533 15 252875.1 5636648H1 3241 3536 15 252875.1 3076681H1 3247 3407 15 252875.1 g3850466 3246 3697 15 252875.1 1876575H1 3254 3547 15 252875.1 g1367750 3257 3843 15 252875.1 4931430H1 3264 3545 15 252875.1 1958432H1 3269 3585 15 252875.1 627261H1 3274 3529 15 252875.1 3786347H1 3281 3554 15 252875.1 1730878H1 3283 3539 15 252875.1 1730895H1 3283 3490 15 252875.1 1730824H1 3283 3492 15 252875.1 2874502T6 3290 3797 15 252875.1 469285H1 3293 3550 15 252875.1 2058867H1 3298 3571 15 252875.1 205886786 3298 3699 15 252875.1 5733018H1 3300 3592 15 252875.1 1261341H1 3301 3574 15 252875.1 2878759H1 3307 3607 15 252875.1 1398976H1 3310 3559 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 81751344 3316 3586 15 252875.1 720109F1 3317 3840 15 252875.1 82945397 3332 3840 15 252875.1 5778084H1 3336 3617 15 252875.1 8767808 3337 3845 15 252875.1 5777985H1 3337 3574 15 252875.1 1337062H1 3340 3594 15 252875.1 83280387 3347 3842 15 252875.1 2289425H1 3347 3610 15 252875.1 83675613 3354 3840 15 252875.1 3801180H1 3355 3524 15 252875.1 2876933H1 3367 3502 15 252875.1 84269890 3369 3846 15 252875.1 95279271 3382 3758 15 252875.1 2409980H1 3383 3623 15 252875.1 83446123 3389 3840 15 252875.1 82930114 3390 3850 15 252875.1 81157245 3394 3841 15 252875.1 1880890H1 3392 3654 15 252875.1 95279281 3394 3843 15 252875.1 952792H1 3396 3588 15 252875.1 83988283 3397 3840 15 252875.1 1813653H1 3396 3598 15 252875.1 1213928H1 3398 3638 15 252875,1 121392871 3398 3797 15 252875.1 83872611 3405 3840 15 252875.1 2505231H1 3406 3652 15 252875.1 84452830 3407 3840 15 252875.1 84523040 3407 3840 15 252875.1 81897843 3408 3844 15 252875.1 4715628H1 3411 3673 15 252875.1 2994530H1 3411 3680 15 252875.1 66100186 3412 3843 15 252875.1 83422408 3412 3840 15 252875,1 660905H1 3412 3685 15 252875.1 83870520 3412 3840 15 252875,1 66100176 3412 3798 15 252875.1 660690H1 3412 3692 15 252875.1 1740390H1 3414 3649 15 252875.1 3773806H1 3416 3738 15 252875.1 81324229 3421 3969 15 252875.1 83433983 3430 3849 15 252875,1 81440537 3440 3737 15 252875.1 81545520 3441 3877 15 252875.1 82264856 3445 3842 15 252875.1 82968893 3446 3844 15 252875.1 3972857H1 3449 3612 15 252875.1 3521680H1 3446 3813 15 252875.1 475000H1 3459 3741 15 252875.1 1369528H1 3462 3711 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 4716618H1 3464 3764 15 252875.1 5402888H1 3470 3744 15 252875.1 737350H1 3473 3678 15 252875.1 149929H1 3479 3686 15 252875.1 14992981 3478 4058 15 252875.1 2746121H1 3479 3733 15 252875.1 g 1060820 3490 3824 15 252875.1 86252381 3492 4121 15 252875.1 862523H1 3492 3770 15 252875.1 1741284H1 3492 3722 15 252875.1 1578142H1 3496 3744 15 252875.1 1962956H1 3795 4112 15 252875.1 5186635H1 3795 4047 15 252875.1 2110916H1 3795 3950 15 252875.1 2870075H1 3798 4092 15 252875.1 87279481 3800 4322 15 252875.1 872794H1 3800 4089 15 252875.1 3560953H1 3801 4004 15 252875.1 3623917H1 3811 3995 15 252875.1 4176710H1 3809 4014 15 252875.1 2364402H1 3813 3996 15 252875.1 2017186H1 3822 4091 15 252875.1 2806941H1 3825 4141 15 252875.1 136474881 3836 4363 15 252875.1 1364748H1 3836 4115 15 252875.1 2126618H1 3840 4142 15 252875.1 205886776 3849 4554 15 252875.1 1268579H1 3853 4104 15 252875.1 2420031H1 3861 4111 15 252875.1 867120H1 3861 4022 15 252875.1 3471449H1 3865 4144 15 252875.1 31044176 3890 4550 15 252875.1 687562H1 3894 4173 15 252875.1 502213071 3901 4543 15 252875.1 4995018H1 3907 4179 15 252875.1 5022130H1 3906 4031 15 252875.1 5401446H1 3913 4169 15 252875.1 3279479H1 3926 4204 15 252875.1 1517039H1 3926 4149 15 252875.1 1517087H1 3926 4130 15 252875.1 2072072H1 3934 4206 15 252875.1 3781502H1 3941 4286 15 252875.1 1548234H1 3941 4170 15 252875.1 5390212H1 3942 4216 15 252875.1 g 1321347 3949 4364 15 252875.1 3092282H1 3956 4209 15 252875.1 320547H1 3969 4394 15 252875.1 4436308H1 3979 4256 15 252875.1 1901926H1 3988 4270 15 252875.1 3051460H1 3988 4292 SE6~ Template Component Start Stop ID NO: ID ID
15 252875.1 3836484H1 4000 4290 15 252875.1 2423168H1 4010 4263 15 252875.1 4122620H1 4011 4292 15 252875.1 149929F1 4015 4587 15 252875.1 1590154H1 4014 4284 15 252875.1 779159H1 4016 4273 15 252875.1 77915981 4016 4586 ~
15 252875.1 4718944H1 4016 4296 15 252875.1 4981471H1 4019 4227 15 252875.1 2128923H1 4025 4308 15 252875.1 3859444H1 4027 4310 15 252875.1 3856453H1 4027 4286 15 252875,1 2564780H1 4029 4155 15 252875,1 5911630H1 4042 4395 15 252875.1 730915Th 4045 4555 15 252875.1 g2619417 4049 4327 15 252875,1 g2619632 4050 4332 15 252875,1 729898Th 4065 4551 15 252875.1 1667393H1 4074 4312 15 252875,1 4339273H1 4072 4385 15 252875,1 1666593H1 4074 4303 15 252875.1 1667396H1 4074 4312 15 252875,1 g 1846687 4080 4520 15 252875.1 g4108324 4089 4587 15 252875.1 2736196H1 4093 4366 15 252875,1 2736715H1 4093 4373 15 252875.1 3879868H1 4100 4235 15 252875.1 g3675575 4102 4587 15 252875.1 g1332311 4107 4604 15 252875.1 g4329975 4102 4587 15 252875.1 g1524714 4104 4600 15 252875.1 g3278422 4104 4587 15 252875.1 g3596503 4106 4587 15 252875.1 g2656299 4107 4592 15 252875.1 1759044H1 4108 4370 15 252875.1 3951189H1 4107 4428 15 252875.1 g4393268 4109 4596 15 252875.1 g3920837 4110 4593 15 252875.1 3559291H1 4111 4437 15 252875.1 g3644402 4116 4596 15 252875.1 5683481H1 4117 4371 15 252875.1 g3238075 4121 4587 15 252875.1 g1219850 4128 4589 15 252875.1 2599386H1 4126 4428 15 252875.1 g2217641 4128 4592 15 252875.1 g4394253 4129 4587 15 252875.1 g4267736 4136 4589 15 252875.1 g4453805 4139 4593 15 252875.1 g4522737 4140 4593 15 252875.1 g 1332201 4155 4593 SES~ Template -.Component Start Stop ID NO: ID ID
15 252875.1 g4509608 4154 4593 15 252875.1 5614003H1 4156 4396 15 252875.1 g4243557 4155 4593 15 252875.1 2754555H1 4338 4593 15 252875.1 g879867 4365 4600 15 252875.1 g1266259 4368 4594 15 252875.1 3327329H1 4370 4597 15 252875.1 4248607H1 4392 4609 15 252875.1 g4186572 4402 4587 15 252875.1 1351626H1 4411 4567 15 252875.1 1351626F1 4411 4587 15 252875.1 302767H1 4412 4588 15 252875.1 1968509H1 4412 4594 15 252875.1 5876201H1 4413 4603 15 252875.1 g2433592 4416 4598 15 252875.1 2969615H1 4419 4563 15 252875.1 g2942070 4469 4587 15 252875.1 g 1267224 4474 4593 15 252875.1 2043678H1 4475 4587 15 252875.1 g2986396 4477 4587 15 252875.1 3373314H1 1 112 15 252875.1 3077972H1 5 316 15 252875.1 2069257H1 42 277 15 252875.1 3073491H1 42 295 15 252875.1 2069257F6 47 450 15 252875.1 482316H1 49 258 15 252875.1 3036127H1 49 267 15 252875.1 3607250H1 49 197 15 252875.1 3343670H1 49 258 15 252875.1 3394626H1 49 291 15 252875.1 5522114H1 68 242 15 252875.1 3419860H1 176 401 15 252875.1 3199647H1 305 401 15 252875.1 g1984204 369 786 15 252875.1 3536255H1 386 662 15 252875.1 3528024H1 563 799 16 252964.2 4178741H1 3001 3238 16 252964.2 830538H1 3012 3108 16 252964.2 830538T1 3012 3198 16 252964.2 83053881 3012 3238 1b 252964.2 g3057275 3033 3241 1b 252964.2 g1164549 3040 3238 1b 252964.2 g1894136 3044 3243 16 252964.2 747073H1 3055 3313 16 252964.2 4074768H1 3099 3217 16 252964.2 g863600 3102 3226 16 252964.2 g1060375 3108 3215 16 252964.2 g1892056 3109 3241 16 252964.2 g2620960 3140 3245 1b 252964.2 g3805026 3150 3252 SE6~ Template Component Start Stop ID NO. ID ID
16 252964.2 2939591H1 2679 2990 16 252964.2 1993076T6 2681 3200 1b 252964.2 221873H1 2702 2925 16 252964.2 2853281H1 2711 3001 16 252964.2 2260511H1 2723 2995 16 . 252964.2 5289957H1 2723 3020 1 b 252964.2 8868647 2723 , 3063 16 252964.2 83108721 2731 3238 16 252964.2 4381077H1 2740 3027 16 252964.2 5272939H1 2740 3013 16 252964.2 82161092 2743 3241 16 252964.2 3223031H1 2758 2944 16 252964.2 1843518H1 2758 3072 16 252964.2 2245609H1 2779 3073 16 252964.2 88201 b2 2779 3063 16 252964.2 83033754 2784 3244 16 252964.2 4642653H1 2785 3057 16 252964.2 83900624 2787 3243 16 252964.2 84267231 2793 3238 16 252964.2 83919071 2794 3238 16 252964.2 2188192H1 2810 3110 16 252964.2 2369459Th 2816 3198 1b 252964.2 450871T6 2828 3200 1b 252964.2 661201H1 2842 3123 16 252964.2 5594903H1 2842 3112 16 252964.2 2736768H1 2850 3140 16 252964.2 83870375 2856 3243 16 252964.2 3805033H1 2856 3172 16 252964.2 84330626 2857 3238 16 252964.2 84112946 2862 3238 16 252964.2 4540882H1 2889 3156 16 252964.2 82207247 2889 3238 1b 252964.2 82218580 2889 3250 1b 252964.2 81719392 2892 3239 1b 252964.2 1833491H1 2896 3197 16 252964.2 911307H1 2899 3168 16 252964.2 619933H1 2906 3185 16 252964.2 83960791 2916 3238 16 252964.2 84391406 2917 3247 16 252964.2 82715745 2919 3238 16 252964.2 84268192 2920 3241 16 252964.2 84267270 2921 3244 16 252964.2 83644389 2922 3247 16 252964.2 928993H1 2924 3085 16 252964.2 82903695 2930 3238 16 252964.2 8566929 2935 3238 16 252964.2 81153963 2967 3238 1b 252964.2 3116982H1 2660 2957 16 252964.2 84070514 2973 3243 1b 252964.2 2792353H1 2660 2757 SE6~ Template Component Start Stop ID NO: ID ID
16 252964.2 g3778735 2983 3238 16 252964.2 053091H1 2997 3206 16 252964.2 497154H1 2999 3190 16 252964.2 500461H1 2999 3218 16 252964.2 2673105H1 1792 2031 16 252964.2 5855988H1 1793 2040 16 252964.2 5118330H1 1803 2082 16 252964.2 2866056H1 1860 2172 16 252964.2 4851249H1 1893 2144 16 252964.2 5007337H1 1898 2151 1 b 252964.2 g 1719391 1899 2291 1b 252964.2 2227319H1 1903 2148 16 252964.2 5926595H1 1920 2214 16 252964.2 g1060485 1945 2361 1b 252964.2 2845135H1 1958 2191 16 252964.2 1913383H1 2031 2290 16 252964.2 3481001H1 2073 2222 16 252964.2 5403224H1 2075 2379 16 252964.2 2370791H1 2076 2304 16 252964.2 2370791F6 2076 2562 1b 252964.2 3234460H1 2083 2331 16 252964.2 g1273052 2102 2564 1b 252964.2 4849809H1 2102 2386 16 252964.2 3551288H1 2110 2331 16 252964.2 6065193H1 2112 2375 16 252964.2 80568781 2130 2640 1b 252964.2 805687H1 2140 2339 16 252964.2 4818872H1 2168 2338 16 252964.2 445589H1 2169 2424 16 252964.2 3534641H1 2170 2472 16 252964.2 4932921H1 2228 2496 1 b 252964.2 g 1187975 2229 2592 1b 252964.2 925326H1 2237 2551 16 252964.2 925389H1 2237 2337 16 252964.2 92532681 2238 2597 16 252964.2 1984547H1 2246 2523 16 252964.2 198454786 2246 2718 16 252964.2 822651H1 2256 2524 16 252964.2 82265181 2256 2803 16 252964.2 2960302H1 2287 2582 16 252964.2 2745337H1 2311 2556 16 252964.2 2745683H1 2311 2554 16 252964.2 5015696H1 2321 2422 16 252964.2 5552559H1 2322 2586 16 252964.2 3469448H1 2323 2579 16 252964.2 4834907H1 2329 2586 16 252964.2 785664H1 2331 2633 16 252964.2 78566486 2331 2771 16 252964.2 78525781 2331 2862 16 252964.2 785257H1 2331 2582 SE6~ Template Component Start Stop ID NO. ID ID
16 252964.2 4266319H1 2385 2565 16 252964.2 g2161091 2394 2814 16 252964.2 3021996H1 2395 2694 16 252964.2 4795127H1 2428 2695 16 252964.2 1427976H1 2443 2707 16 252964.2 1427976F6 2443 3025 1b 252964.2 002126H1 2461 2923 16 252964.2 g1783079 2462 2847 1 b 252964.2 g 1892162 2462 2884 16 252964.2 4593447H1 2479 2737 16 252964.2 4416604H1 2486 2723 16 252964.2 313687H1 2491 2731 16 252964.2 374457H1 2492 2707 16 252964.2 1231088H1 2511 2737 16 252964,2 1427976T6 2510 3060 1b 252964.2 2421408H1 2535 2775 16 252964.2 1237191H1 2545 2782 16 252964.2 1237191F1 2545 3125 16 252964.2 2564135H1 2568 2835 16 252964.2 1364705H1 2569 2836 16 252964.2 1364705R1 2569 2936 16 252964,2 2570283H1 2569 2830 16 252964.2 3811167H1 2577 2851 16 252964,2 g3958470 2603 3096 1b 252964.2 785664T6 2611 3198 16 252964,2 6103263H1 2623 2913 16 252964,2 g2207504 2652 3049 16 252964.2 2820307H1 2657 3013 16 252964.2 2820510H1 2657 2994 16 252964.2 3620806H1 596 894 16 252964.2 450871R6 789 1191 16 252964.2 2367753T6 820 1282 16 252964.2 6336 11 831 1087 16 252964.2 2791431H1 860 1136 16 252964.2 3233115H1 649 894 16 252964.2 746957H1 919 1176 16 252964.2 1839028H1 1018 1185 16 252964.2 g4394691 686 1065 16 252964.2 1838057H1 1018 1320 16 252964.2 g1993698 1033 1347 16 252964.2 4292134H1 1058 1315 16 252964.2 g869109 1093 1386 1b 252964.2 g792911 1095 1358 16 252964.2 g2269330 700 1066 1b 252964.2 g2444529 1098 1482 1b 252964.2 452142H1 1120 1366 16 252964.2 4239190H1 740 1007 16 252964.2 4046046H1 1134 1403 16 252964.2 1993076F6 1136 1449 1b 252964.2 1993076H1 1136 1292 SEQ ID Template Component Start Stop NO: ID ID
16 252964.2 94548886 1173 1668 1b 252964.2 945488H1 1172 1463 16 252964.2 5434372H1 1176 1384 16 252964.2 2701918H1 1267 1540 16 252964.2 997219H1 1312 1504 16 252964.2 99721982 1312 1842 1b 252964.2 596014H1 1363 1597 16 252964.2 160577H1 1398 1597 16 252964.2 8573332 1426 1787 16 252964.2 8677613 1426 1779 16 252964.2 81998633 783 1161 16 252964.2 5193886H1 1448 1687 16 252964.2 82052933 1483 1589 16 252964.2 5192721H1 1589 1859 16 252964.2 82218358 1592 1916 16 252964.2 4108761H1 1608 1895 16 252964.2 81165576 1619 1872 16 252964.2 3285590H1 1701 1945 16 252964.2 5713371H1 1715 2000 16 252964.2 1877915H1 1767 1928 16 252964.2 450871H1 789 1015 16 252964.2 1877915F6 1767 2150 1b 252964.2 5615447H1 1 281 16 252964.2 1871935F6 8 479 1b 252964.2 1871935H1 8 ~ 263 16 252964.2 1871835H1 8 247 16 252964.2 2787027H1 101 429 16 252964.2 3770821H1 319 618 16 252964.2 5291758H1 346 547 16 252964,2 81545134 439 843 16 252964.2 81063095 439 811 16 252964,2 8272283 469 804 1b 252964.2 2670348T6 493 1024 16 252964.2 1871935Th 528 1019 1b 252964.2 2367753F6 563 974 1b 252964.2 2367753H1 563 788 17 267153.7 2580428F6 1 424 17 267153.7 5780256H1 7 197 17 267153.7 1927531H1 1 104 17 267153.7 5542321H1 1 86 17 267153.7 2580428H1 1 211 17 267153.7 82033888 656 925 17 267153.7 82033889 65b 842 17 267153.7 82034039 656 1001 17 267153.7 82034000 656 969 17 267153.7 82033922 656 925 17 267153.7 556169H1 663 808 17 267153.7 55616986 663 1220 17 267153.7 553115H1 663 885 17 267153.7 986072H1 693 802 SE9 ID Template Component Start Stop NO; ID ID
17 267153.7 4180466H1 1166 1393 17 267153.7 4180466F6 1166 1456 17 267153.7 1416069H1 1351 1620 17 267153.7 3047572F6 1402 1874 17 267153.7 3047572H1 1403 1708 17 267153,7 5422118H1 1463 1711 17 267153.7 3241209H1 1499 1736 17 267153.7 3577671H1 18 193 17 267153.7 5636615H1 18 164 17 267153.7 5322669H1 29 285 17 267153.7 5321675H1 29 298 17 267153.7 3227664F6 31 402 17 267153.7 3406115H1 31 290 17 267153.7 3799455H1 31 255 17 267153.7 3227664H1 33 322 17 267153.7 3146326H1 35 333 17 267153,7 4760440H1 45 149 17 267153.7 3378285H1 54 286 17 267153,7 3799580H1 69 370 17 267153.7 3366109H1 109 317 17 267153,7 g2229557 110 441 17 267153.7 6078201H1 381 715 17 267153.7 g923914 419 670 17 267153,7 g274698 464 842 17 267153.7 g781645 644 877 18 331244.6 g2037184 293 666 18 331244.6 3703079H1 295 604 18 331244.6 4355792H1 298 664 18 331244.6 5205414H2 299 581 18 331244.6 5662744H1 307 557 18 331244.6 1818166H1 312 602 18 331244.6 1428020F6 313 . 785 18 331244.6 2867856H1 314 547 18 331244.6 2534359H2 315 500 18 331244.6 2852946H1 315 629 18 331244.6 4909270H1 315 593 18 331244.6 5895948H1 321 625 18 331244.6 5902265H1 322 603 18 331244.6 g1970235 332 646 18 331244.6 4700222H1 335 620 18 331244.6 3367010H1 336 601 18 331244.6 g2103204 351 812 18 331244.6 3929559H1 352 Ebb 18 331244.6 036372H1 353 586 18 331244.6 058809H1 358 537 18 331244.6 2726788H1 358 614 18 331244.6 g 1110314 362 671 18 331244.6 351602H1 363 604 18 331244.6 1352253H1 1 254 18 331244.6 1352253F1 1 575 SE9 ID Template Component Start Stop NO: ID ID
18 331244.6 1352253F6 1 465 18 331244.6 2600773H1 363 680 18 331244.6 4718931H1 42 313 18 331244.6 2656868H1 363 576 18 331244.6 2605832H1 363 595 18 331244.6 3436228H1 363 598 18 331244.6 5118860H1 364 653 18 331244.6 2024732H1 366 624 18 331244.6 4371963H1 371 641 18 331244.6 100587H1 43 245 18 331244.6 1867334H1 49 224 18 331244.6 3597304H1 48 367 18 331244.6 2451902H1 50 289 18 331244.6 2738608H1 50 294 18 331244.6 g771569 51 434 18 331244.6 g1803076 53 131 18 331244.6 4718914H1 61 332 18 331244.6 4719022H 62 170 18 331244.6 4373837H1 371 652 18 331244.6 043783H1 381 689 18 331244.6 g1678313 381 800 18 331244.6 841019H1 387 650 18 331244.6 84101981 387 1002 18 331244.6 199510286 400 826 18 331244.6 1995102H1 400 695 18 331244.6 3855550H1 404 726 18 331244.6 g766559 115 361 18 331244,6 g2034844 121 481 18 331244.6 g880214 204 609 18 331244.6 g751349 253 587 18 331244.6 535267H1 280 511 18 331244.6 1428020H1 282 477 18 331244.6 1427648H1 282 560 18 331244.6 3450701H1 286 545 18 331244.6 1718398H1 455 670 18 331244.6 3025271H1 478 761 18 331244.6 3057108H1 481 665 18 331244.6 4773103H1 518 829 18 331244.6 94286281 528 983 18 331244.6 942862H1 528 778 18 331244.6 1302039H1 552 849 18 331244.6 4981303H1 560 837 18 331244.6 2101923H1 645 907 18 331244.6 3972632H1 696 975 18 331244.6 2327160H1 712 967 18 331244.6 2232654H1 731 975 18 331244.6 3818861H1 732 1029 18 331244.6 1609537H1 732 933 18 331244.6 1609517H1 732 920 18 331244.6 4710176H1 734 896 SE6~ Template Component Start Stop ID NO: ID ID
18 331244.6 4710284H1 734 1011 18 331244.6 82595082 755 945 18 331244.6 4049284H1 772 1069 18 331244.6 1538495H1 798 999 18 331244.6 1228870H1 844 1094 18 331244.6 2628877H1 861 1098 18 331244.6 4995618H1 875 1144 18 331244.6 199510276 877 1530 18 331244.6 2043991H1 884 1126 18 331244.6 3516482H1 915 1177 18 331244.6 199637476 922 1532 18 331244.6 199637486 939 1439 18 331244.6 1996374H1 939 1206 18 331244.6 1549444H1 939 1164 18 331244.6 4324734H1 945 1185 18 331244.6 336097H1 1003 1259 18 331244.6 82017702 1007 1387 18 331244.6 2425889H1 1035 1298 18 331244.6 3411191H1 1036 1202 18 331244.6 3078834H1 1103 1417 18 331244.6 480272H1 1113 1369 18 331244.6 82103137 1128 1585 18 331244.6 8712162 1138 1574 18 331244.6 84525329 1137 1571 18 331244.6 549094H1 1146 1442 18 331244.6 2579048H2 1154 1442 18 331244.6 1414589F6 1177 1583 18 331244.6 1414589H1 1177 1439 18 331244.6 83841570 1187 1575 18 331244.6 8794847 1206 1589 18 331244,6 4640449H1 1219 1507 18 331244.6 83840885 1222 1571 18 331244.6 8819967 1280 1581 18 331244.6 8751350 1272 1573 18 331244.6 4367801H1 1281 1528 18 331244.6 8519529 1293 1571 18 331244.6 8618115 1361 1575 19 335484,1 2626409H1 2774 3005 19 335484.1 2626409F6 2774 3290 19 335484.1 2626025H1 2774 3030 19 335484.1 1418291H1 . 2841 3077 19 335484.1 82397783 2874 3259 19 335484,1 2746883H1 2914 3175 19 335484.1 262640976 3031 3264 19 335484.1 84270950 3127 3574 19 335484.1 82899058 3132 3575 19 335484.1 2521894F6 148 bbl 19 335484.1 2521894H1 148 407 19 335484.1 5538378H1 264 471 19 335484.1 3465291H1 316 642 SEQ ID Template Component Start Stop NO: ID ID
19 335484.1 g1623573 318 650 19 335484.1 g715634 78 309 19 335484.1 5386328H1 330 594 19 335484.1 g764148 79 353 19 335484.1 g2012728 369 603 19 335484.1 5854480H1 414 711 19 335484.1 2671282F6 1138 1680 19 335484.1 3115951F6 1497 1895 19 335484.1 3115951H1 1498 1773 19 335484.1 g570994 1528 1910 19 335484.1 g672096 1529 1865 19 335484.1 g677051 1529 1830 19 335484.1 g781962 1542 1799 19 335484.1 g668551 1542 1803 19 335484.1 4010291H1 1563 1839 19 335484,1 2401422H1 1728 1969 19 335484.1 3695649H1 2034 2334 19 335484.1 g3240345 1869 2245 19 335484.1 3293772F6 2059 2440 19 335484.1 3293772H1 2059 2332 19 335484.1 116622H1 2085 2321 19 335484.1 11662281 2085 2558 19 335484,1 5171287H1 2170 2380 19 335484.1 5175487H1 2170 2442 19 335484.1 267128276 2172 2748 19 335484.1 5098225H1 419 697 19 335484.1 5677977H1 969 1230 19 335484.1 g1626824 970 1275 19 335484.1 5098225F6 419 691 19 335484.1 509822576 432 1048 19 335484.1 g2694430 439 905 19 335484.1 g2357857 995 1365 19 335484.1 g1289722 522 916 19 335484.1 5645168H1 633 884 19 335484.1 g715547 802 902 19 335484.1 g3239654 843 1073 19 335484.1 1978183H1 1014 1276 19 335484.1 5834795H1 1067 1-337 19 335484.1 2671282H1 1138 1379 19 335484.1 g1321140 1 418 19 335484.1 3448433H1 1 238 19 335484.1 4380511H1 16 285 19 335484,1 3576080H1 40 293 19 335484.1 3463823H1 64 314 19 335484.1 311595176 2174 2742 19 335484.1 116622F1 2216 2785 19 335484.1 4172444H1 2216 2512 19 335484.1 3721925H1 2298 2603 19 335484.1 g2902979 2336 2799 19 335484.1 g822642 2488 2802 SEQ ID Template Component Start Stop NO: ID ID
19 335484.1 g5b2bb2 2502 2785 19 335484.1 293b989H1 2520 2782 19 335484.1 867138b 2547 2785 19 335484.1 8646350 2577 2785 19 335484.1 864511b 2579 2785 19 335484.1 82805833 2664 2797 19 335484.1 3293772Tb 2748 3218 20 337489.2 49457b4H1 1 263 20 337489.2 81985316 1 217 20 337489.2 3247865H1 11 317 20 337489.2 4180529H1 15 112 20 337489.2 385371H1 166 429 20 337489.2 g 1624554 389 725 20 337489.2 3078832F6 392 796 20 337489.2 3078832H1 392 697 20 337489.2 3294510H1 650 824 20 337489.2 8395753 669 1006 20 337489.2 821843b4 816 1265 20 337489.2 b075740H1 885 1174 20 337489.2 6075772H1 903 1168 20 337489.2 3078832Tb 1009 1457 21 359574.5 82398327 1 343 21 359574.5 82629710 1 421 21 359574.5 3338142H1 1 233 21 359574.5 3b85831H1 30 171 21 359574.5 2993588H1 40 306 21 359574.5 1906768Fb 41 453 21 359574.5 190b7b8H1 41 118 21 359574.5 3172672H1 46 229 21 359574.5 3436865H1 47 289 21 359574.5 1818045H1 47 342 21 359574.5 81781952 bb 480 21 359574.5 3982668H1 72 264 21 359574.5 1b72722H1 75 282 21 359574.5 3036287H1 107 372 21 359574.5 81578363 103 345 21 359574.5 8827499 106 477 21 359574.5 4054942H1 123 423 21 359574.5 3340967H1 132 397 21 359574.5 3433495H1 132 218 21 359574.5 817357b9 158 554 21 359574.5 1390555H1 188 376 21 359574.5 1390555F6 188 565 21 359574.5 987088H1 190 476 21 359574.5 5850596H1 204 395 21 359574.5 2204622H1 326 591 21 359574.5 2204b22F6 326 853 21 359574.5 g 1961866 385 793 21 359574.5 1967881H1 396 690 21 359574.5 5059229H1 397 672 SEQ ID Template Component Start Stop NO: ID ID
21 359574.5 3199313H1 463 561 21 359574.5 1006996H1 511 748 21 359574.5 3054689H ' 547 838 21 359574.5 1965560H1 692 968 21 359574.5 5544945H1 716 949 21 359574.5 3376272H1 741 918 21 359574.5 8899846 882 1212 21 359574.5 8389140 910 1319 21 359574,5 8616300 914 1190 21 359574.5 5636083H1 920 1214 21 359574.5 83769768 924 1005 21 359574.5 3804657H1 943 1272 21 359574.5 1347412H1 967 1224 21 359574.5 270746H1 974 1326 21 359574.5 493004H1 977 1377 21 359574.5 4915149H1 979 1259 21 359574,5 3289817H1 1044 1181 21 359574.5 74741181 1057 1741 21 359574.5 747411H1 1057 1300 21 359574.5 1902775F6 1102 1593 21 359574,5 1902775H1 1102 1380 21 359574.5 3331792H1 1170 1463 21 359574.5 4787713H1 1231 1489 21 359574.5 5101264H1 1240 1501 21 359574.5 81578064 2292 2727 21 359574.5 045454H1 2294 2533 21 359574,5 82063879 2309 2770 21 359574.5 8848870 2314 2662 21 359574.5 8848899 2314 2632 21 359574.5 4731068H1 2312 2586 21 359574.5 8848913 2322 2712 21 359574.5 3494155H1 2327 2593 21 359574.5 4180013Th 2338 2792 21 359574.5 413579H1 2342 2590 21 359574.5 415164H1 2342 2589 21 359574.5 2905578Th 2345 2775 21 359574.5 1841356Th 2347 2748 21 359574.5 1713137Th 2345 2762 21 359574.5 83109931 2355 2819 21 359574.5 82705028 2359 2817 21 359574.5 82752959 2359 2815 21 359574.5 83752541 2360 2815 21 359574.5 81578272 2370 2817 21 359574.5 81941192 2370 2820 21 359574.5 82001627 2385 2815 21 359574.5 84114546 2380 2815 21 359574.5 3866784H1 2380 2664 21 359574.5 981891H1 2383 2661 21 359574.5 1500830Th 2387 2773 21 359574.5 82883824 2389 2818 SEQ ID Template Component Start Stop NO: ID ID
21 359574.5 g 1741113 2392 2814 21 359574.5 g 1815396 2394 2816 21 359574.5 83921165 2402 2815 21 359574.5 83277950 2404 2821 21 359574.5 83777806 2405 2780 21 359574.5 84389617 2405 2815 21 359574.5 84394654 2408 2816 21 359574.5 5161988H1 2412 2686 21 359574.5 819400b4 2414 2820 21 359574.5 831904b0 2418 2815 21 359574.5 82159890 2419 2819 21 359574.5 8848914 2422 2821 21 359574.5 83280154 2423 2818 21 359574.5 82063754 2428 2816 21 359574.5 81010758 2429 2828 21 359574.5 74413881 2433 2815 21 359574.5 81940045 2433 2820 21 359574.5 744138H1 2433 2681 21 359574.5 98558881 2441 2815 21 359574.5 98558871 2441 2772 21 359574.5 985588H1 2441 2703 21 359574.5 8848871 2450 2815 21 359574.5 8848900 2461 2792 21 359574.5 8519499 2467 2815 21 359574.5 83801239 2477 2818 21 359574.5 8890240 2479 2795 21 359574.5 83245088 2483 2820 21 359574.5 84308927 2485 2815 21 359574.5 8712131 2490 2816 21 359574.5 676177H1 2497 2753 21 359574,5 674403H1 2497 2775 21 359574,5 677641H1 2497 2780 21 359574.5 82955368 2508 2823 21 359574.5 1306109F6 2513 2815 21 359574.5 130610976 2515 2787 21 359574.5 82985090 2523 2815 21 359574.5 4509027H1 2523 2796 21 359574.5 3482667H1 2525 2773 21 359574.5 81781898 2533 2819 21 359574.5 83843043 2548 2816 21 359574.5 84088596 2553 2815 21 359574.5 3203278H1 2562 2772 21 359574.5 83862263 2579 2818 21 359574.5 82783892 2589 2813 21 359574.5 81241936 2605 2815 21 359574.5 82968846 2752 2815 21 359574.5 121182H1 1243 1366 21 359574.5 3929693H1 1258 1451 21 359574.5 3929728H1 1258 1553 21 359574.5 3929244H1 1258 1542 SEQ ID Template Component Start Stop NO: ID ID
21 359574.5 2583640H1 1299 1548 21 359574.5 3720446H1 1302 1550 21 359574.5 701602H1 1304 1583 21 359574.5 1533449H1 1349 1556 21 359574.5 3778291H1 1382 1674 21 359574.5 3444913H1 1400 1687 21 359574.5 3444961H1 1400 1679 21 359574.5 8958359 1426 1664 21 359574.5 4754535H1 1428 1647 21 359574.5 5413181H1 1438 1592 21 359574.5 4198550H1 1443 1721 21 359574.5 2310430H1 1479 1764 21 359574.5 4027760H1 1489 1759 21 359574.5 4016122H1 1535 1836 21 359574.5 8869879 1540 1599 21 359574.5 3442527H1 1567 1817 21 359574.5 4885815H1 1582 1849 21 359574.5 81275597 1609 1963 21 359574.5 4695180H1 1619 1885 21 359574.5 4695474H1 1620 1894 21 359574.5 8901597 1664 2045 21 359574.5 1007934H1 1689 2008 21 359574.5 4822784H1 1699 1898 21 359574.5 533880H1 1726 2009 21 359574.5 5273871H1 1733 1997 21 359574.5 1822559H1 1733 1991 21 359574.5 4771544H1 1736 2019 21 359574,5 957505H1 1739 1874 21 359574.5 1419462H1 1764 2012 21 359574.5 1419438H1 1764 2023 21 359574.5 5377747H1 1767 2042 21 359574,5 3090935H1 1767 2048 21 359574.5 2578414H1 1767 2041 ~
21 359574,5 3055886H 1777 1996 21 359574,5 4307872H1 1798 1913 21 359574.5 5888134H1 1809 2090 21 359574.5 5881810H1 1809 2029 21 359574.5 5881543H1 1809 2092 21 359574.5 5885336H1 1809 2092 21 359574.5 1756055H1 1832 2078 21 359574.5 175607086 1832 2190 21 359574.5 669694H1 1851 2139 21 359574.5 2819291H1 1851 2162 21 359574.5 669348H1 1851 2136 21 359574.5 4376341H1 1872 2139 21 359574.5 81815577 1876 2377 21 359574.5 5272067H1 1880 2149 21 359574.5 1713137F6 1887 2285 21 359574.5 1713137H1 1889 2114 21 359574.5 3457357H1 1894 2156 SEQ ID Template Component Start Stop NO: ID ID
21 359574.5 173730H1 1910 2114 21 359574.5 5897973H1 1917 2178 21 359574.5 5902784H1 1917 2216 21 359574.5 359622H1 1919 2162 21 359574.5 96061481 1945 2549 21 359574.5 960614H1 1945 2236 21 359574.5 1811654F6 1965 2504 21 359574.5 1811654H1 1965 2193 21 359574.5 2244848H1 2044 2311 21 359574.5 108439H 2050 2312 21 359574.5 5055320H1 2113 2403 21 359574.5 4168527H1 2115 2416 21 359574.5 993418H1 2116 2352 21 359574.5 4175578H1 2134 2428 21 359574.5 3121162H1 2142 2427 21 359574.5 1663986H1 2147 2381 21 359574.5 175607076 2173 2775 21 359574.5 2744396H1 2182 2464 21 359574.5 5052765H1 2187 2452 21 359574.5 269785776 2207 2773 21 359574.5 2597236H1 2219 2487 21 359574.5 g890239 2240 2516 21 359574.5 g944471 2245 2444 21 359574.5 g1940156 2246 2668 21 359574.5 g1940137 2246 2687 21 359574.5 345599H1 2246 2484 21 359574.5 g1941570 2246 2712 21 359574,5 34559981 2246 2815 21 359574.5 34559976 2246 2773 21 359574.5 34559986 2246 2711 21 359574,5 g944601 2257 2495 21 359574.5 337627276 2263 2783 21 359574.5 2875472H1 2286 2576 21 359574,5 5263385H1 2291 2476 21 359574,5 5263484H1 2291 2570 22 360645,5 3292408H1 459 712 22 360645.5 3316570H1 482 745 22 360645.5 2419778H1 627 854 22 360645.5 2069602F6 718 1133 22 360645.5 2069602H1 718 1005 22 360645.5 g1989917 895 1120 22 360645.5 2741388H1 919 1046 22 360645.5 3870739H1 928 1208 22 360645.5 g793668 936 1225 22 360645.5 4328833H1 949 1209 22 360645.5 g810427 1514 1829 22 360645.5 3337383H1 1563 1830 22 360645.5 4544819H1 1572 1859 22 360645.5 755269H1 1493 1731 22 360645.5 5674837H1 1503 1781 SE6~ Template Component Start Stop ID NO: ID ID
22 360645.5 4370282H1 1672 1936 22 360645,5 5622513H1 1718 1985 22 360645.5 1655614Th 1751 2297 22 360645.5 3943544H1 1865 2133 22 360645.5 5114825H1 2045 2300 22 360645.5 4003719H1 58 111 22 360645.5 3246721H1 68 332 22 360645.5 84307092 100 560 22 360645.5 1532088H1 108 298 22 360645,5 1532088F6 108 498 22 360645.5 5016056H1 116 341 22 360645.5 5730961H1 957 1236 22 360645.5 8928494 968 1138 22 360645.5 3945858H1 988 1262 22 360645.5 2757979H1 1000 1280 22 360645.5 853610H1 1008 1266 22 360645.5 858390H1 1008 1228 22 360645.5 83932189 137 556 22 360645.5 4862779H1 142 426 22 360645,5 4988340H1 237 514 22 360645.5 3460296H1 131 357 22 360645.5 750638H1 237 461 22 360645.5 4141768H1 386 657 22 360645,5 2607858Th 2162 2289 22 360645.5 492034H1 1 112 22 360645.5 3433917H1 1 243 22 360645.5 928400R6 9 371 22 360645.5 2607858H1 29 288 22 360645.5 2607858F6 29 372 22 360645.5 3111874H1 33 168 22 360645,5 3286166H2 33 137 22 360645.5 3346552H1 33 146 22 360645.5 928400H1 35 296 22 360645.5 3392281H1 40 321 22 360645.5 2562696H1 1447 1749 22 360645.5 2562696R6 1447 1930 22 360645.5 1655614F6 1468 2026 22 360645,5 1655614H1 1468 1602 22 360645.5 3780371H1 1479 1725 22 360645.5 3674986H1 1482 1626 22 360645.5 4294260H1 1490 1738 22 360645.5 5424404H1 1492 1695 22 360645,5 4118032H1 1010 1193 22 360645.5 3484111H1 1011 1329 22 360645.5 3749318H1 1089 1394 22 360645.5 82139442 1114 1465 22 360645.5 8813345 1194 1462 22 360645.5 2185958F6 1196 1667 22 360645.5 2185958H1 1196 1475 22 360645.5 5471220H1 1268 1469 SE9 ID Template Component Start Stop NO: ID ID
22 360645.5 4907477H1 1282 1514 22 360645.5 4931374H1 1291 1569 22 360645.5 5554128H1 1307 1579 22 360645.5 3852884H1 1316 1599 22 360645.5 2605946H1 1430 1682 22 360645.5 2605946F6 1430 1850 23 404145.7 1226940T6 2019 2668 23 404145.7 1384452H1 2040 2300 23 404145.7 g2849417 2162 2715 23 404145.7 g823503 2173 2683 23 404145.7 3406347H1 2172 2452 23 404145,7 999039Th 2184 2670 23 404145.7 1540442H1 2182 2421 23 404145.7 g982396 2199 2455 23 404145,7 g712667 2199 2485 23 404145.7 g1981065 2198 2524 23 404145.7 515954H1 2206 2479 23 404145.7 1422474H1 2212 2431 23 404145.7 1422482H1 2212 2425 23 404145.7 2059115H1 2218 2298 23 404145.7 5675554H1 2212 2487 23 404145.7 4296263H1 2231 2519 23 404145.7 g3958774 2305 2714 23 404145.7 g3848380 2304 2711 23 404145.7 g2254693 2310 2711 23 404145.7 3461604H1 1327 1395 23 404145.7 4695473H1 1331 1607 23 404145.7 4874584H1 1350 1628 23 404145.7 4787505H1 1176 1448 23 404145.7 255532H1 1351 1453 23 404145.7 2634636H1 1355 1622 23 404145.7 g832545 1379 1449 23 404145.7 4115082H1 1181 1460 23 404145.7 3782056H1 1386 1713 23 404145.7 g706330 1182 1437 23 404145,7 g2156249 1209 1450 23 404145.7 g567479 1209 1446 23 404145,7 g4327617 1215 1446 23 404145,7 3453995H1 1439 1718 23 404145.7 5085837H1 1440 1592 23 404145.7 g868972 1221 1465 23 404145.7 1623692H1 1263 1452 23 404145.7 388050H1 1276 1448 23 404145.7 494624H1 1454 1689 ' 23 404145.7 1209507H1 1458 1685 23 404145.7 g573709 1284 1576 23 404145.7 g872902 1297 1625 23 404145.7 g2156298 1300 1447 23 404145.7 120950781 1458 2035 23 404145.7 5849810H1 1322 1615 SEQ ID Template Component Start Stop NO: ID ID
23 404145.7 2716195H1 1460 1573 23 404145,7 4854635H1 1326 1576 23 404145.7 3875565H1 1477 1783 23 404145.7 4764440H1 1487 1750 23 404145,7 4764803H1 1487 1776 23 404145.7 504658H1 1492 1716 23 404145.7 2245901H1 1492 1745 23 404145.7 1554072H1 1522 1749 23 404145.7 4306748H1 1522 1648 23 404145.7 681646H1 1599 1730 23 404145.7 3397784H1 1660 1877 23 404145.7 4775418H1 1709 1991 23 404145.7 4320445H1 1743 2009 23 404145.7 5516752H1 1748 1890 23 404145.7 g1300713 1768 1930 23 404145.7 g2022370 1777 2020 23 404145.7 3573326H1 1779 2074 23 404145.7 2365670F6 983 1446 23 404145.7 4080981H1 990 1144 23 404145.7 g3694292 989 1450 23 404145.7 2365670H1 983 1211 23 404145.7 g4187437 990 1449 23 404145.7 197970176 989 1407 23 404145.7 g1941609 991 1450 23 404145.7 1979701H1 989 1100 23 404145.7 g2401947 999 1447 23 404145.7 g4175914 1010 1446 23 404145.7 g4186516 1012 1446 23 404145.7 5903586H1 243 372 23 404145.7 5895277H1 243 542 23 404145.7 713562H1 264 456 23 404145.7 1859327H1 283 553 23 404145.7 g2240756 298 640 23 404145.7 3802569H1 377 675 23 404145.7 3801769H1 376 685 23 404145.7 4160262H1 403 663 23 404145.7 3386012H1 417 669 23 404145.7 3672136H1 430 701 23 404145.7 3225464H1 446 551 23 404145.7 g1376475 496 934 23 404145,7 4125118H1 555 694 23 404145.7 2957060H1 594 885 23 404145.7 3615068H1 595 900 23 404145,7 5290436H1 596 868 23 404145.7 3035696F6 601 1194 23 404145.7 3035696H1 601 897 23 404145.7 2538441H1 650 866 23 404145.7 1927342H1 658 924 23 404145.7 3760928H1 664 986 23 404145.7 192734276 753 1404 SEQ ID Template Component Start Stop NO: ID ID
23 404145.7 4895377H1 762 1007 23 404145.7 2956245H1 792 1071 23 404145.7 3343627H1 800 1065 23 404145.7 3535153H1 804 1024 23 404145.7 g2558289 815 1224 23 404145.7 231872F1 894 1446 23 404145.7 g2080439 930 1431 23 404145.7 86685681 953 1577 23 404145.7 866856H1 954 1267 23 404145.7 g3230192 957 1458 23 404145.7 g4076020 965 1450 23 404145.7 g2080362 964 1449 23 404145.7 2775965H1 973 1254 23 404145.7 3729250H1 973 1309 23 404145.7 g4453632 976 1446 23 404145.7 g4137344 977 1446 23 404145.7 2365670T6 976 1402 23 404145.7 2208265H1 981 1247 23 404145.7 5067178H1 973 1228 23 404145.7 2258456H1 983 1254 23 404145.7 1809649F6 1 446 23 404145.7 1809649H1 1 236 23 404145.7 g868971 18 380 23 404145.7 g766530 18 261 23 404145,7 3753077H1 69 380 23 404145,7 3212973H1 103 385 23 404145,7 3504947H1 110 414 23 404145.7 5287655H1 184 359 23 404145.7 92991481 220 782 23 404145.7 929914H1 220 443 23 404145.7 4615617H1 1909 2168 23 404145,7 1304785H1 1912 2125 23 404145.7 5832281H1 1844 2103 23 404145.7 809035H1 1989 2155 23 404145.7 179371686 1996 2294 23 404145.7 1793716H1 1996 2260 23 404145.7 2562614H1 2007 2225 23 404145.7 2952424H1 1876 2161 23 404145.7 3282561H1 2012 2272 23 404145.7 2955893H1 1876 2137 23 404145.7 122694086 2014 2233 23 404145.7 1226940H1 2014 2270 23 404145.7 674047H 2017 2299 23 404145.7 675500H1 2017 2292 23 404145.7 g982397 2454 2704 23 404145.7 83003541 2472 2708 23 404145.7 8566129 2520 2706 23 404145.7 82022554 2549 2711 23 404145.7 808819H1 2625 2711 23 404145.7 1719821H1 2323 2479 SEQ ID Template Component Start Stop NO: ID ID
23 404145.7 83849700 2323 2720 23 404145.7 1652087Th 2323 2672 23 404145.7 1719821F6 2323 2673 23 404145.7 914198H1 2330 2630 23 404145.7 5779135H1 2329 2596 23 404145.7 83895240 2356 2712 23 404145.7 3410322H1 2369 2613 23 404145.7 82254107 2370 2712 23 404145.7 3035696Th 2372 2673 23 404145.7 8872903 2394 2719 23 404145.7 83899723 2414 2712 23 404145.7 81754350 2415 2704 23 404145.7 84451440 2429 2712 23 404145.7 3105351H1 2437 2704 23 404145.7 82278302 1017 1445 23 404145.7 84264482 1018 1446 23 404145.7 82167436 1016 1446 23 404145.7 82569624 1016 1446 23 404145.7 83785423 1022 1446 23 404145.7 83446161 1023 1446 23 404145.7 83757074 1031 1453 23 404145.7 4894986H1 1036 1338 23 404145.7 g 1332103 1031 1454 23 404145.7 84108387 1032 1446 23 404145.7 8674079 1041 1448 23 404145.7 4605744H1 1063 1335 23 404145.7 4605666H1 1063 1339 23 404145.7 3270540H1 1068 1326 23 404145.7 1624105H1 1083 1264 23 404145.7 81376427 1088 1447 23 404145.7 82809882 1103 1446 23 404145.7 1339468H1 1128 1390 23 404145.7 1340790H1 1128 1360 23 404145.7 3272590H1 1128 1397 23 404145.7 4583083H1 1135 1407 23 404145.7 84077930 1135 1453 23 404145.7 8817212 1153 1450 24 480119.1 2352304H1 739 946 24 480119.1 3758378H1 1117 1297 24 480119.1 2094276H1 900 1179 24 480119.1 3280967H1 806 1056 24 480119.1 342432H1 940 1165 24 480119.1 2082987H1 906 1175 24 480119.1 5499718H1 1123 1223 24 480119.1 3374480H1 972 1247 24 480119.1 2715270H1 734 1001 24 480119.1 670230H1 802 1052 24 480119.1 2860379H1 964 1231 24 480119.1 3792137H1 848 1151 24 480119.1 2860343H1 964 1210 SE9 ID Template Component Start Stop NO: ID ID
24 480119.1 997621H1 959 1209 24 480119.1 3055163H1 949 1191 24 480119.1 998148H1 1 280 24 480119.1 1908860F6 121 498 24 480119.1 1908860H1 121 226 24 480119.1 5639607H1 455 586 24 480119.1 3003224H1 516 790 24 480119.1 1229820H1 711 819 24 480119,1 g4307656 724 1062 24 480119.1 g3336553 744 1112 24 480119.1 3153981H1 806 1078 24 480119.1 669605H1 807 1071 24 480119.1 3376935H1 849 1097 24 480119.1 1636772F6 855 1316 24 480119.1 2579416H1 863 1102 24 480119,1 668857H1 967 1069 24 480119,1 4252513H1 968 1126 24 480119.1 163677276 1135 1336 24 480119.1 4066993H1 757 1016 24 480119,1 1945549H1 591 817 24 480119.1 1672355H1 994 1205 25 480951.5 3507776H1 1269 1599 25 480951.5 4822022H1 1279 1597 25 480951.5 g1980640 1281 1642 25 480951.5 g1227074 1282 1672 25 480951.5 635081H1 1281 1577 25 480951.5 g2525370 1282 1667 25 480951.5 g2224141 1287 1673 25 480951.5 633976H1 1295 1566 25 480951.5 g 1813260 1304 1683 25 480951.5 g3673968 1303 1667 25 480951.5 g1141351 1306 1674 25 480951.5 5733042H1 1306 1556 25 480951.5 4115350H1 1306 1589 25 480951.5 500639H1 1307 1589 25 480951.5 g3891298 1311 1670 25 480951.5 g1718633 1315 1675 25 480951.5 g1401801 1316 1669 25 480951.5 g989254 1317 1682 25 480951.5 g2070629 1318 1684 25 480951.5 g698987 1325 1714 25 480951.5 g698871 1325 1642 25 480951.5 g 1319182 1325 1781 25 480951.5 g2898680 1325 1767 25 480951.5 g2806772 1327 1547 25 480951.5 3359017H1 1249 1564 25 480951,5 g4089542 1255 1669 25 480951.5 765793H1 1260 1536 25 480951.5 3492863H1 1327 1629 25 480951.5 g2779619 1327 1667 SE9 ID Template Component Start Stop NO. ID ID
25 480951.5 686048H1 1327 1620 25 480951.5 g2617638 1261 1655 25 480951.5 g3677064 1263 1673 25 480951.5 3398923H1 1263 1523 25 480951.5 4729307H1 1267 1545 25 480951.5 5217308H1 1261 1532 25 480951.5 1221016H1 1328 1583 25 480951.5 2447883H1 1338 1603 25 480951.5 g1102813 1338 1697 25 480951.5 g2669446 1351 1670 25 480951.5 2048112H1 1369 1667 25 480951.5 2790672H1 1372 1695 25 480951.5 2234076H1 1375 1672 25 480951.5 3862273H1 1376 1622 25 480951.5 4247109H1 1377 1675 25 480951.5 4880414H1 1378 1671 25 480951.5 g1670201 1384 1667 25 480951.5 5077294H1 1391 1667 25 480951.5 g782958 1396 1672 25 480951.5 3142143H1 1393 1693 25 480951.5 Ob9b55H1 1400 1600 25 480951.5 g4089195 1401 1676 25 480951.5 2360852H1 1405 1684 25 480951,5 1220650H1 1416 1672 25 480951.5 g981974 1416 1648 25 480951.5 g2035110 1427 1667 25 480951,5 497474H1 1433 1647 25 480951,5 g2751121 1433 1670 25 480951.5 g 1998201 1463 1848 25 480951.5 g1996178 1463 1769 25 480951.5 2284547H1 1463 1725 25 480951.5 6013816H1 1488 1667 25 480951.5 g1067287 1496 1852 25 480951.5 g1401911 776 1312 25 480951,5 2423201H1 2372 2629 25 480951.5 g884922 2375 2737 25 480951.5 122603H1 2383 2588 25 480951.5 114097F1 2383 2736 25 480951.5 g1547877 2387 2736 25 480951.5 533580H1 2387 2655 25 480951.5 g1625895 2388 2744 25 480951.5 g892913 2389 2745 25 480951.5 4760035H1 2411 2725 25 480951.5 2029001H1 2411 2700 25 480951.5 5978765H1 2410 2729 25 480951.5 g3076031 2412 2739 25 480951.5 1288402H1 2417 2690 25 480951.5 g 1240606 2425 2736 25 480951,5 3729607H1 2426 2723 25 480951.5 g1740278 2437 2742 SEQ ID Template Component Start Stop NO: ID ID
25 480951.5 g 1690726 2453 2737 25 480951.5 g1070677 2455 2736 25 480951.5 g1505473 2455 2736 25 480951.5 565823H1 2457 2695 25 480951.5 564237H1 2457 2719 25 480951.5 g3784617 2458 2739 25 480951.5 g4292869 2458 2723 25 480951.5 501474H1 2457 2680 25 480951.5 532322H1 2463 2744 25 480951.5 g1114717 2474 2739 25 480951.5 g990510 2478 2730 25 480951.5 g 1271273 2490 2741 25 480951,5 g796298 2493 2745 25 480951.5 g4137432 2508 2737 25 480951,5 2907345H1 2514 2736 25 480951.5 g4389704 2523 2736 25 480951,5 865791T1 2543 3032 25 480951,5 865791H1 2543 2787 25 480951,5 2042379H1 2589 2733 25 480951.5 2412014H1 2608 2736 25 480951.5 3934970H1 2609 2742 25 480951.5 g4532798 2613 2736 25 480951.5 g3919950 2618 2736 25 480951.5 2108271H1 2638 2736 25 480951.5 5921804H1 2644 2736 25 480951.5 4020876H1 2665 2736 25 480951.5 g2070432 724 1019 25 480951.5 3579019H1 740 1053 25 480951.5 376204H1 747 1026 25 480951.5 1672679H1 751 878 25 480951.5 2839053H1 753 1032 25 480951,5 4192530H1 763 1028 25 480951.5 5283432H1 763 1029 25 480951.5 4575886H1 774 1052 25 480951.5 3750596H1 1 163 25 480951.5 g2056998 1 224 25 480951.5 2613688H1 9 250 25 480951.5 3541978H1 19 226 25 480951.5 3395818H1 39 330 25 480951.5 3395687H1 38 285 25 480951.5 3117868H1 70 261 25 480951.5 g2057109 161 443 25 480951.5 g2229512 237 678 25 480951.5 5542378H1 251 438 25 480951.5 3451601H1 298 471 25 480951.5 3243270H1 308 566 25 480951.5 4199125H1 308 bll 25 480951.5 466549H1 331 540 25 480951.5 3571943H1 331 479 25 480951.5 2943245H2 2145 2471 SEQ ID Template Component Start Stop NO: ID ID
25 480951.5 536022H1 2145 2426 25 480951.5 2961678H1 2154 2478 25 480951.5 2099720H1 2160 2467 25 480951.5 5875882H1 2164 2467 25 480951.5 2531822H1 2174 2510 25 480951.5 772953F1 2178 2736 25 480951.5 82820897 2184 2741 25 480951.5 1710502H1 2185 2468 25 480951.5 1291521H1 2190 2464 25 480951.5 8794676 2193 2517 25 480951.5 1916675H1 2191 2510 25 480951.5 8787672 2193 2560 25 480951.5 82204645 2197 2461 25 480951.5 82839081 2205 2711 ~
25 480951.5 2126621H1 2208 2531 25 480951.5 82156454 2210 2741 25 480951.5 82458421 2212 2739 25 480951.5 1834518H1 2217 2484 25 480951.5. 3816120H1 2219 2514 25 480951.5 82992797 2220 2736 25 480951.5 2158693H1 2224 2494 25 480951.5 81328891 2235 2746 25 480951.5 82221416 2227 2516 25 480951.5 81313752 2237 2746 25 480951.5 83648207 2237 2740 25 480951.5 708349H1 2241 2571 25 480951.5 5057841H1 2241 2545 25 480951,5 81313306 2257 2743 25 480951.5 81328885 2297 2746 25 480951,5 81319439 2304 2736 25 480951,5 82750733 2309 2725 25 480951,5 84308069 2319 2742 25 480951,5 82883660 2320 2743 25 480951,5 4698908H1 2320 2616 25 480951.5 83037326 2326 2738 25 480951.5 82162162 2337 2740 25 480951.5 3671211H1 2336 2687 25 480951.5 82051249 2337 2741 25 480951.5 3092677H1 2336 2643 25 480951.5 82841059 2337 2742 25 480951.5 5660220H1 2337 2544 25 480951.5 498999H1 2337 2551 25 480951.5 1633006H1 2337 2556 25 480951.5 3026659H1 2336 2662 25 480951.5 564552H1 2337 2576 25 480951.5 82177724 2337 2737 25 480951.5 82907272 2337 2738 25 480951.5 83427370 2337 2736 25 480951.5 83701416 2337 2735 25 480951.5 82713691 2337 2736 SEQ ID Template Component Start Stop NO: ID ID
25 480951.5 83677845 2337 2735.
25 480951.5 84137050 2337 2736 25 480951.5 84190652 2337 2736 25 480951.5 82410477 2337 2736 25 480951.5 82159482 2337 2725 25 480951.5 2024457H1 2337 2573 25 480951.5 497715H1 2338 2641 25 480951.5 4972011H1 2337 2572 25 480951.5 3889752H1 2337 2600 25 480951.5 84307373 2337 2737 25 480951.5 8923082 2341 2732 25 480951.5 g 1319066 2350 2742 25 480951.5 1369972H1 2367 2620 25 480951.5 168757H1 1502 1860 25 480951.5 146107H1 1517 1705 25 480951,5 4175742H1 1513 1829 25 480951.5 516463H1 1522 1773 25 480951.5 1837209H1 1541 1754 25 480951.5 5104267H1 1548 1851 25 480951.5 81493944 1549 1682 25 480951.5 4828067H1 1560 1843 25 480951.5 3626933H1 1560 1675 25 480951.5 4827669H1 1560 1763 25 480951.5 802254H1 1571 1839 25 480951.5 5733222H1 1573 1667 25 480951.5 1833804H1 1572 1840 25 480951.5 1834116H1 1599 1830 25 480951.5 1834116R6 1599 2021 25 480951.5 2267528H1 1600 1776 25 480951.5 82047293 1601 2121 25 480951.5 4316354H1 1601 1957 25 480951.5 2531080H1 1614 1859 25 480951.5 3549819H1 1626 1873 25 480951.5 4405261H1 1664 1936 25 480951.5 259520276 1667 2181 25 480951.5 2443532H1 1670 1916 25 480951.5 82205045 1689 2201 25 480951.5 4652128H1 1711 1862 25 480951.5 82178101 1716 2097 25 480951.5 4540165H1 1743 2004 25 480951.5 019674H1 1751 1969 25 480951.5 5777532H1 1751 2031 25 480951.5 4247819H1 1751 2025 25 480951.5 4244210H1 1751 2022 25 480951.5 139108H1 1751 2091 25 480951.5 136508781 1765 2020 25 480951.5 4872832H1 1766 2045 25 480951.5 4182858H1 1766 2029 25 480951.5 1365087H1 1766 2008 25 . 480951.5 2500845H1 1774 2016 SEB ID Template Component Start Stop NO; ID ID
25 480951.5 3270008H1 1787 2060 25 480951.5 3026939H1 1801 1902 25 480951.5 1970095F6 1808 2308 25 480951.5 1970095H1 1808 2104 25 480951.5 451299H1 1823 2050 25 480951.5 g 1367292 1825 2249 25 480951.5 3400713H1 1828 1918 25 480951.5 5035969H1 1856 2063 25 480951.5 g2986154 1859 2230 25 480951.5 77295381 1859 2460 25 480951.5 772953H1 1859 2099 25 480951.5 3478925H1 1862 2201 25 480951.5 499186H1 1864 1957 25 480951.5 497679H1 1871 2087 25 480951.5 499991H1 1871 2088 25 480951.5 5119583H1 1894 2180 25 480951.5 g3739696 1903 2235 25 480951.5 5013206H1 1910 2182 25 480951.5 2506884H1 1911 2150 25 480951.5 4728147H1 1911 2162 25 480951.5 2506516H1 1911 2154 25 480951.5 g922543 1923 2226 25 480951.5 g885013 1923 2312 25 480951.5 1220669H1 1928 2075 25 480951.5 3376313H1 1933 2196 25 480951.5 4816025H1 1934 2190 25 480951.5 g2208341 1941 2229 25 480951,5 633621H1 1947 2203 25 480951,5 g2005941 1953 2215 25 480951.5 3882972H1 1967 2274 25 480951,5 g3678005 1967 2227 25 480951,5 4881031H1 1967 2245 25 480951,5 g1102777 1976 2199 25 480951,5 2695882H1 1983 2290 25 480951.5 g2016849 1983 2261 25 480951.5 4607680H1 1986 2257 25 480951.5 3480738H1 1991 2125 25 480951.5 g1506305 2019 2162 25 480951.5 633694H1 2022 2300 25 480951.5 4210591H1 2027 2317 25 480951.5 4758948H1 2028 2334 25 480951.5 563634H1 2039 2256 25 480951.5 1541096H1 2049 2203 25 480951.5 4060004H1 2052 2340 25 480951.5 197009576 2057 2694 25 480951.5 183411676 2057 2689 25 480951.5 2594078H1 2062 2308 25 480951.5 2452635H1 2067 2319 25 480951,5 2134382H1 2082 2275 25 480951.5 4858857H1 2084 2408 SE6~ Template Component Start Stop ID NO: ID ID
25 480951.5 4767365H1 2083 2401 25 480951.5 2289353H1 2085 2322 25 480951.5 1818948H1 2085 2401 25 480951.5 1818322H1 2085 2308 25 480951.5 2972228H2 2086 2308 25 480951.5 2969484H1 2087 2415 25 480951.5 1720287H1 2095 2322 25 480951.5 81690725 2095 2526 25 480951.5 3702645H1 2105 2416 25 480951.5 625400H1 2105 2308 25 480951.5 3093179H1 2105 2407 25 480951.5 5375221H1 2142 2426 25 480951.5 3228787H1 2143 2261 25 480951.5 83959433 1122 1538 25 480951.5 5004750H1 1127 1317 25 480951.5 2508409H1 1131 1244 25 480951.5 2073090H1 1131 1460 25 480951.5 2875436H1 1130 1406 25 480951.5 5574295H1 1134 1401 25 480951.5 069957H1 1135 1359 25 480951.5 81720206 1141 1667 25 480951,5 82903027 1144 1664 25 480951.5 2964463H1 1147 1500 25 480951.5 81425708 1165 1667 25 480951.5 84152996 1175 1667 25 480951.5 83693187 1178 1667 25 480951.5 84152993 1178 1667 25 480951.5 679425H1 1181 1468 25 480951.5 630229H1 1186 1458 25 480951.5 82659963 1190 1609 25 480951.5 83678646 1190 1680 25 480951.5 4060761H1 1193 1488 25 480951,5 82161517 1193 1664 25 480951.5 2126237H1 1193 1470 25 480951.5 83366968 1197 1667 25 480951,5 84079071 1198 1676 25 480951.5 83675935 1199 1673 25 480951,5 83174345 1199 1672 25 480951,5 378369H1 1200 1467 25 480951,5 451941H1 1203 1427 25 480951.5 81126660 1203 1666 25 480951,5 82409946 1201 1665 25 480951.5 82836409 1204 1676 25 480951.5 4380896H1 1205 1426 25 480951.5 82167291 1205 1676 25 480951.5 8990603 1208 1624 25 480951.5 81721518 1208 1682 25 480951.5 82785589 1209 1667 25 480951.5 83884848 1214 1675 25 480951.5 82161366 1216 1667 SEQ ID Template Component Start Stop NO; ID ID
25 480951.5 82714918 1220 1607 25 480951.5 510978H1 1224 1467 25 480951.5 82741372 1226 1682 25 480951.5 1648008H1 1229 1467 25 480951.5 1648031H1 1229 1456 25 480951.5 2860452H1 1229 1532 25 480951.5 2044321H1 1230 1493 25 480951.5 4216861H1 1230 1528 25 480951.5 88026181 1246 1854 25 480951.5 880261H1 1246 1589 25 480951.5 497500H1 1247 1588 25 480951.5 562595H '\ 1247 1491 25 480951.5 390816H1 '1247 1513 25 480951.5 3336103H1 1248 1539 25 480951.5 85582881 655 1282 25 480951.5 855828H1 655 901 25 480951.5 l6bOl1bH1 662 903 25 480951.5 4459507H1 664 939 25 480951.5 8892912 664 1073 25 480951.5 1660036H1 662 807 25 480951.5 2737280H1 667 927 25 480951.5 2243455H1 666 953 25 480951.5 3051410H1 678 1002 25 480951.5 8892899 685 983 25 480951.5 1255907H1 715 969 25 480951.5 2687937H1 720 980 25 480951.5 2271346H1 722 999 25 480951,5 3373291H1 332 592 25 480951.5 5292779H2 332 602 25 480951.5 82013066 334 618 25 480951.5 2235148F6 335 829 25 480951.5 2235148H1 335 596 25 480951.5 82035111 335 522 25 480951.5 4891424H1 336 638 25 480951.5 5593759H1 338 591 25 480951.5 3390870H1 340 659 25 480951.5 1360005F1 342 875 25 480951.5 2913426H1 342 624 25 480951.5 4770833H1 341 626 25 480951.5 3250802H1 341 670 25 480951.5 1360005H1 342 601 25 480951.5 4023870H1 342 625 25 480951.5 81998895 343 510 25 480951.5 4161775H1 343 605 25 480951.5 4031302H1 342 614 25 480951.5 3778265H1 342 677 25 480951.5 4843784H1 345 640 25 480951.5 3533957H1 347 688 25 480951.5 451527H1 349 499 25 480951.5 4618672H1 349 614 SEQ ID Template Component Start Stop NO: ID ID
25 480951.5 g2669182 350 825 25 480951.5 g1277584 354 894 25 480951.5 3321371H1 354 659 25 480951.5 2581094H1 355 608 25 480951.5 4729423H1 355 520 25 480951.5 g1799076 359 866 25 480951.5 2457980H1 359 613 25 480951.5 5538138H1 361 523 25 480951.5 3123678H1 357 683 25 480951.5 3123878H1 357 553 25 480951.5 3591022H1 361 693 25 480951.5 3987391H1 362 656 25 480951.5 5391147H1 362 688 25 480951.5 3593512H1 362 715 25 480951.5 407591H1 363 527 25 480951.5 2650347H1 362 618 25 480951.5 1320037H1 362 652 25 480951.5 595420H1 362 628 25 480951.5 2719839H1 362 637 25 480951.5 2885143H1 364 649 25 480951.5 3538760H1 363 592 25 480951.5 4205158H1 362 667 25 480951.5 5064082H1 364 594 25 480951.5 4160969H1 364 672 25 480951.5 3394195H1 364 654 25 480951.5 5542680H1 363 598 25 480951.5 4067217H1 365 659 25 480951.5 1989538H1 367 723 25 480951.5 5395039H1 366 657 25 480951.5 3385558H1 367 659 25 480951.5 3574186H1 367 665 25 480951,5 3765155H1 367 711 25 480951.5 5538463H2 366 572 25 480951.5 1371886H1 367 607 25 480951,5 3291484H1 785 1029 25 480951,5 3984729H1 795 982 25 480951.5 g1303165 796 1092 25 480951,5 3678810H1 803 1029 25 480951.5 3441626H1 804 1029 25 480951.5 3674810H1 805 1005 25 480951.5 1909062H1 806 1029 25 480951.5 g782156 819 1142 25 480951.5 3322168H1 834 1141 25 480951.5 5661420H1 775 1049 25 480951.5 3825020H1 783 1029 25 480951.5 5538458H2 837 997 25 480951.5 754038H1 839 1029 25 480951.5 5516018H1 839 1029 25 480951.5 1727177H1 839 1029 25 480951.5 75403881 839 1469 SEQ ID Template Component Start Stop NO: ID ID
25 480951.5 999590H1 845 1029 25 480951.5 2780282H1 855 1029 25 480951.5 g2167709 862 1417 25 480951.5 2100719H1 876 1136 25 480951.5 3532184H1 890 1182 25 480951.5 2935763H1 890 1196 25 480951.5 g1844616 891 1232 25 480951.5 g1720287 892 1280 25 480951.5 5212745H1 895 1086 25 480951.5 g897017 902 1334 25 480951.5 341998H1 907 1167 25 480951.5 g2025152 911 1204 25 480951.5 083270H1 918 1140 25 480951,5 2435281H1 955 1204 25 480951.5 g1328982 969 1408 25 480951.5 3837044H1 970 1255 25 480951.5 1600531H1 973 1209 25 480951.5 2235148Th 1062 1629 25 480951.5 84234881 1062 1639 25 480951.5 2042383H1 1067 1375 25 480951.5 2376168H1 1069 1226 25 480951.5 2043947H1 1067 1363 25 480951.5 3217005H1 1069 1341 25 480951.5 2374982H1 1069 1266 25 480951.5 2376160H1 1069 1231 25 480951,5 5471168H1 1069 1273 25 480951,5 054106H1 1069 1255 25 480951,5 1719624H1 1069 1229 25 480951.5 842348H1 1069 1294 25 480951.5 2374615H1 1069 1261 25 480951,5 3170061H1 1069 1319 25 480951.5 5158959Th 1071 1642 25 480951.5 1330830H1 1090 1355 25 480951.5 2350109H1 1103 1315 25 480951,5 453412H1 1109 1211 25 480951.5 3421220H1 1115 1377 25 480951.5 507765H1 1118 1339 25 480951.5 1988757Th 1117 1617 25 480951.5 g1163670 451 632 25 480951.5 2779615H1 479 774 25 480951.5 3211910H1 481 620 25 480951.5 2232343H1 498 762 25 480951.5 g1494000 498 688 25 480951.5 g1670312 497 784 25 480951.5 2705619H1 498 797 25 480951.5 g1278591 498 665 25 480951.5 g1721860 498 940 25 480951.5 g989068 508 801 25 480951.5 g1809515 527 1029 25 480951.5 2944225H1 537 875 SE6~ Template Component Start Stop ID NO: ID ID
25 480951.5 2544567H2 534 828 25 480951.5 24994b8H1 541 840 25 480951.5 1592175H1 544 772 25 480951.5 1591703H1 544 770 25 480951.5 4176769H1 545 750 25 480951.5 8115b402 547 807 25 480951.5 3322962H1 554 866 25 480951.5 3331328H1 562 726 25 480951.5 3470714H1 560 853 25 480951.5 3214025H1 5b9 847 25 480951.5 037805H1 572 775 25 480951.5 5401247H1 576 884 25 480951.5 5410853H1 575 857 25 480951.5 5695792H1 620 892 25 480951.5 5294959H1 621 891 25 480951.5 84310946 625 1135 25 480951.5 83178543 627 1019 25 480951.5 452965H1 628 866 25 480951.5 3111016H1 632 748 25 480951.5 5208639H1 632 924 25 480951.5 84194092 641 990 25 480951.5 98678581 644 1138 25 480951.5 986785H1 644 883 25 480951.5 81687504 654 1111 25 480951.5 81064548 657 1032 25 480951.5 3504819H1 369 704 25 480951.5 3800372H1 3b7 682 25 480951.5 2448255H1 367 b21 25 480951.5 2599377H1 366 661 25 480951.5 274195bH1 367 640 25 480951.5 4374001H1 367 688 25 480951.5 2520140H1 369 622 25 480951.5 3751944H1 368 588 25 480951.5 4786273H2 368 5b1 25 480951:5 2878674H1 370 668 25 480951.5 3119978H1 370 667 25 480951.5 204764bH1 370 648 25 480951.5 4170133H1 370 679 25 480951.5 8981973 372 660 25 480951.5 2898280H1 371 596 25 480951,5 3363180H1 370 650 25 480951,5 82025536 372 690 25 480951,5 81198636 372 734 25 480951.5 3b49034H1 370 547 25 480951.5 3551711H1 372 703 25 480951.5 1346252H1 374 615 25 480951,5 2441829H1 375 601 25 480951.5 81974420 378 766 25 480951,5 81718741 379 696 25 480951.5 3745122H1 378 714 SE9 ID NO: Template Component Start Stop ID ID
25 480951.5 491592H1 380 540 25 480951.5 2921720H1 380 6b9 25 480951.5 650429H1 380 639 25 480951.5 5224b48H1 381 485 25 480951.5 3331491H1 382 646 25 480951.5 4770049H1 388 686 25 480951.5 82166364 390 811 25 480951.5 5589241H1 390 636 25 480951.5 5542605H1 392 629 25 480951.5 2742261H1 394 688 25 480951.5 5395040H1 393 688 25 480951.5 1579085H1 394 592 25 480951.5 81147442 397 762 25 480951.5 372b996H1 404 727 25 480951.5 81146694 404 792 25 480951.5 3647806H1 403 758 25 480951.5 2133705H1 402 688 25 480951.5 1423332H1 404 669 25 480951.5 2020306F6 404 842 25 480951.5 81978134 404 754 25 480951.5 81625996 404 807 25 480951.5 202030bH1 404 716 25 480951.5 810b8989 408 782 25 480951.5 3541b74H1 409 753 25 480951.5 2664883H1 407 682 25 480951.5 2535301H1 407 675 25 480951.5 81313751 408 760 25 480951.5 81367340 409 852 25 480951.5 81972153 411 675 25 480951.5 3247844H1 410 739 25 480951.5 5545462H1 410 629 25 480951.5 81425731 411 952 25 480951.5 3140608H1 410 727 25 480951.5 4415741H1 412 699 25 480951.5 5545632H1 413 665 25 480951.5 5041074H1 434 715 25 480951.5 1236401Fb 444 920 25 480951.5 123b075F1 444 1124 25 480951.5 123b075H1 444 724 25 480951.5 4747674H1 402 706 25 480951.5 35b5518H1 401 740 25 480951.5 4174839H1 402 717 25 480951.5 4418643H1 402 695 25 480951.5 2729711H1 403 690 25 480951.5 3326928H1 403 703 25 480951.5 4822b53H1 402 697 25 480951.5 198875786 404 842 25 480951.5 3758338H1 403 732 25 480951.5 1988757H1 404 722 25 480951.5 4842127H1 403 693 SEQ Template Component Start Stop ID ID ID
NO:
TECHNICAL FIELD
The present invention relates to secretory molecules and to the use of these sequences in the s diagnosis, study, prevention, and treatment of diseases associated with cell signaling.
BACKGROUND OF THE INVENTION
Protein transport and secretion are essential for cellular function. Protein transport is mediated by a signal peptide located at the amino terminus of the protein to be transported or so secreted. The signal peptide is comprised of about ten to twenty hydrophobic amino acids which target the nascent protein from the ribosome to a particular membrane bound compartment such as the endoplasmic reticulum (ER). Proteins targeted to the ER may either proceed through the secretory pathway or remain in any of the secretory organelles such as the ER, Golgi apparatus, or lysosomes.
Proteins that transit through the secretory pathway are either secreted into the extracellular space or is retained in the plasma membrane. Proteins that are retained in the plasma membrane contain one or more transmembrane domains, each comprised of about 20 hydrophobic amino acid residues.
Proteins that are secreted from the cell are generally synthesized as inactive precursors that are activated by post-translational processing events during transit through the secretory pathway. Such events include glycosylation, proteolysis, and removal of the signal peptide by a signal peptidase.
2o Other events that may occur during protein transport include chaperone-dependent unfolding and folding of the nascent protein and interaction of the protein with a receptor or pore complex.
Examples of secretory proteins with amino terminal signal peptides are discussed below and include proteins with important roles in cell-to-cell signaling. Such proteins include transmembrane receptors and cell surface markers, extracellular matrix molecules, cytokines, hormones, growth and 2 s differentiation factors, neuropeptides, vasomediators, ion channels, transporters/pumps, and proteases. (Reviewed in Alberts, B. et al. (1994) Molecular Biology of The Cell, Garland Publishing, New York, NY, pp. 557-560, 582-592.) G-protein coupled receptors (GPCRs) comprise a superfamily of integral membrane proteins which transduce extracellular signals. Not all GPCRs contain N-terminal signal peptides. GPCRs 3 o include receptors for biogenic amines such as dopamine, epinephrine, histamine, glutamate (metabotropic-type), acetylcholine (muscarinic-type), and serotonin; for lipid mediators of inflammation such as prostaglandins, platelet activating factor, and leukotrienes; far peptide hormones such as calcitonin, CSa anaphylatoxin, follicle stimulating hormone, gonadotropin releasing hormone, neurokinin, oxytocin, and thrombin; and for sensory signal mediators such as retinal 35 photopigments and olfactory stimulatory molecules. The structure of these highly conserved receptors consists of seven hydrophobic transmembrane regions, cysteine disulfide bridges between the second and third extracellular loops, an extracellular N-terminus, and a cytoplasmic C-ternunus.
The N-terminus interacts with ligands, the disulfide bridges interact with agonists and antagonists, and the large third intracellular loop interacts with G proteins to activate second messengers such as cyclic AMP, phospholipase C, inositol triphosphate, or ion channels. (Reviewed in Watson, S. and Arkinstall, S. ( 1994) The G-protein Linked Receptor Facts Book, Academic Press, San Diego, CA, pp. 2-6; and Bolander, F.F. (1994) Molecular Endocrinolosy, Academic Press, San Diego, CA, pp.
162-176.) Other types of receptors include cell surface antigens identified on leukocytic cells of the immune system. These antigens have been identified using systematic, monoclonal antibody (mAb)-lo based "shot gun" techniques. These techniques have resulted in the production of hundreds of mAbs directed against unknown cell surface leukocytic antigens. These antigens have been grouped into "clusters of differentiation" based on common immunocytochemical localization patterns in various differentiated and undifferentiated leukocytic cell types. Antigens in a given cluster are presumed to identify a single cell surface protein and are assigned a "cluster of differentiation" or "CD"
designation. Some of the genes encoding proteins identified by CD antigens have been cloned and verified by standard molecular biology techniques. CD antigens have been characterized as both transmembrane proteins and cell surface proteins anchored to the plasma membrane via covalent attachment to fatty acid-containing glycolipids such as glycosylphosphatidylinositol (GPn.
(Reviewed in Barclay, A. N. et al. (1995) The Leucocyte Antigen Facts Book, Academic Press, San zo Diego, CA, pp. 17-20.) Matrix proteins (MPs) are transmembrane and extracellular proteins which function in formation, growth, remodeling, and maintenance of tissues and as important mediators and regulators of the inflammatory response. The expression and balance of MPs may be perturbed by biochemical changes that result from congenital, epigenetic, or infectious diseases. In addition, MPs affect z s leukocyte migration, proliferation, differentiation, and activation in the immune response. MPs are frequently characterized by the presence of one or more domains which may include collagen-like domains, EGF-like domains, immunoglobulin-like domains, and fibronectin-like domains. In addition, MPs may be heavily glycosylated and may contain an Arginine-Glycine-Aspartate (RGD) tripeptide motif which may play a role in adhesive interactions. MPs include extracellular proteins 3o such as fibronectin, collagen, galectin, vitronectin and its proteolytic derivative somatomedin B; and cell adhesion receptors such as cell adhesion molecules (CAMs), cadherins, and integrins. (Reviewed in Ayad, S. et al. (1994) The Extracellular Matrix Facts Book, Academic Press, San Diego, CA, pp. 2-16; Ruoslahti, E. (1997) Kidney Int. 51:1413-1417; Sjaastad, M.D. and Nelson, W.J. (1997) BioEssays 19:47-55.) 35 Cytokines are secreted by hematopoietic cells in response to injury or infection. Interleukins, neurotrophins, growth factors, interferons, and chemokines all define cytokine families that work in conjunction with cellular receptors to regulate cell proliferation and differentiation. In addition, cytokines effect activities such as leukocyte migration and function, hematopoietic cell proliferation, temperature regulation, acute response to infection, tissue remodeling, and apoptosis.
Chemokines, in particular, are small chemoattractant cytokines involved in inflammation, s leukocyte proliferation and migration, angiogenesis and angiostasis, regulation of hematopoiesis, HIV
infectivity, and stimulation of cytokine secretion. Chemokines generally contain 70-100 amino acids and are subdivided into four subfamilies based on the presence of conserved cysteine-based motifs.
(Callard, R. and Gearing, A. (1994) The Cytokine Facts Book, Academic Press, New York, NY, pp.
181-190, 210-213, 223-227.) to Growth and differentiation factors are secreted proteins which function in intercellular communication. Some factors require oligomerization or association with MPs for activity. Complex interactions among these factors and their receptors trigger intracellular signal transduction pathways that stimulate or inhibit cell division, cell differentiation, cell signaling, and cell motility. Most growth and differentiation factors act on cells in their local environment (paracrine signaling). There is are three broad classes of growth and differentiation factors. The first class includes the large polypeptide growth factors such as epidermal growth factor, fibroblast growth factor, transforming growth factor, insulin-like growth factor, and platelet-derived growth factor.
The second class includes the hematopoietic growth factors such as the colony stimulating factors (CSFs).
Hematopoietic growth factors stimulate the proliferation and differentiation of blood cells such as B-20 lymphocytes, T-lymphocytes, erythrocytes, platelets, eosinophils, basophils, neutrophils, macrophages, and their stem cell precursors. The third class includes small peptide factors such as bombesin, vasopressin, oxytocin, endothelin, transferrin, angiotensin II, vasoactive intestinal peptide, and bradykinin which function as hormones to regulate cellular functions other than proliferation.
Growth and differentiation factors play critical roles in neoplastic transformation of cells in 2s vitro and in tumor progression in vivo. Inappropriate expression of growth factors by tumor cells may contribute to vascularization and metastasis of tumors. During hematopoiesis, growth factor misregulation can result in anemias, leukemias, and lymphomas. Certain growth factors such as interferon are cytotoxic to tumor cells both in vivo and in vitro. Moreover, some growth factors and growth factor receptors are related both structurally and functionally to oncoproteins. In addition, 3o growth factors affect transcriptional regulation of both proto-oncogenes and oncosuppressor genes.
(Reviewed in Pimentel, E. (1994) Handbook of Growth Factors, CRC Press, Ann Arbor, MI, pp. 1-9.) Proteolytic enzymes or proteases either activate or deactivate proteins by hydrolyzing peptide bonds. Proteases are found in the cytosol, in membrane-bound compartments, and in the extracellular space. The major families are the zinc, serine, cysteine, thiol, and carboxyl proteases.
3s Ion channels, ion pumps, and transport proteins mediate the transport of molecules across cellular membranes. Transport can occur by a passive, concentration-dependent mechanism or can be linked to an energy source such as ATP hydrolysis. Symporters and antiporters transport ions and small molecules such as amino acids, glucose, and drugs. Symporters transport molecules and ions unidirectionally, and antiporters transport molecules and ions bidirectionally. Transporter superfamilies include facilitative transporters and active ATP-binding cassette transporters which are s involved in multiple-drug resistance and the targeting of antigenic peptides to MHC Class I
molecules. These transporters bind to a specific ion or other molecule and undergo a conformational change in order to transfer the ion or molecule across the membrane. (Reviewed in Alberts, B. et al.
(1994) Molecular Biology of The Cell, Garland Publishing, New York, NY, pp.
523-546.) Ion channels are formed by transmembrane proteins which create a lined passageway across to the membrane through which water and ions, such as Na+, K+, Ca2+, and Cl-, enter and exit the cell.
For example, chloride channels are involved in the regulation of the membrane electric potential as well as absorption and secretion of ions across the membrane. Chloride channels also regulate the internal pH of membrane-bound organelles.
Ion pumps are ATPases which actively maintain membrane gradients. Ion pumps are is classified as P, V, or F according to their structure and function. All have one or more binding sites for ATP in their cytosolic domains. The P-class ion pumps include Ca2+ ATPase and Na'/K+ ATPase and function in transporting H+, Na+, K+, and Caz+ ions. P-class pumps consist of two a and two [3 transmembrane subunits. The V- and F-class ion pumps have similar structures but transport only H+.
F class H+ pumps mediate transport across the membranes of mitochondria and chloroplasts, while V-2 o class H+ pumps regulate acidity inside lysosomes, endosomes, and plant vacuoles.
A family of structurally related intrinsic membrane proteins known as facilitative glucose transporters catalyze the movement of glucose and other selected sugars across the plasma membrane.
The proteins in this family contain a highly conserved, large transmembrane domain comprised of 12 a-helices, and several weakly conserved, cytoplasmic and exoplasmic domains.
(Pessin, J. E., and 2s Bell, G.I. (1992) Annu. Rev. Physiol. 54:911-930.) Amino acid transport is mediated by Na+ dependent amino acid transporters.
These transporters are involved in gastrointestinal and renal uptake of dietary and cellular amino acids and in neuronal reuptake of neurotransmitters. Transport of cationic amino acids is mediated by the system y+ family and the cationic amino acid transporter (CAT) family. Members of the CAT family 3o share a high degree of sequence homology, and each contains 12-14 putative transmembrane domains. (Ito, K. and Groudine, M. (1997) J. Biol. Chem. 272:26780-26786.) Hormones are secreted molecules that travel through the circulation and bind to specific receptors on the surface of, or within, target cells. Although they have diverse biochemical compositions and mechanisms of action, hormones can be grouped into two categories. One category 35 includes small lipophilic hormones that diffuse through the plasma membrane of target cells, bind to cytosolic or nuclear receptors, and form a complex that alters gene expression. Examples of these molecules include retinoic acid, thyroxine, and the cholesterol-derived steroid hormones such as progesterone, estrogen, testosterone, cortisol, and aldosterone. The second category includes hydrophilic hormones that function by binding to cell surface receptors that transduce signals across the plasma membrane. Examples of such hormones include amino acid derivatives such as s catecholamines and peptide hormones such as glucagon, insulin, gastrin, secretin, cholecystokinin, adrenocorticotropic hormone, follicle stimulating hormone, luteinizing hormone, thyroid stimulating hormone, and vasopressin. (See, for example, Lodish et al. (1995) Molecular Cell BioloQV, Scientific American Books Inc., New York, NY, pp. 856-864.) Neuropeptides and vasomediators (NP/VM) comprise a large family of endogenous signaling to molecules. Included in this family are neuropeptides and neuropeptide hormones such as bombesin, neuropeptide Y, neurotensin, neuromedin N, melanocortins, opioids, galanin, somatostatin, tachykinins, urotensin II and related peptides involved in smooth muscle stimulation, vasopressin, vasoactive intestinal peptide, and circulatory system-borne signaling molecules such as angiotensin, complement, calcitonin, endothelins, formyl-methionyl peptides, glucagon, cholecystokinin and 15 gastrin. NP/VMs can transduce signals directly, modulate the activity or release of other neurotransmitters and hormones, and act as catalytic enzymes in cascades. The effects of NP/VMs range from extremely brief to long-lasting. (Reviewed in Martin, C. R. et al.
(1985) Endocrine Physiology, Oxford University Press, New York, NY, pp. 57-62.) The discovery of new secretory molecules satisfies a need in the art by providing new 2o compositions which are useful in the diagnosis, study, prevention, and treatment of diseases associated with cell signaling.
SUMMARY OF THE INVENTION
The present invention relates to nucleic acid sequences comprising human polynucleotides 2s encoding secretory polypeptides that contain signal peptides and/or transmembrane domains. These human polynucleotides (sptm) as presented in the Sequence Listing uniquely identify genes encoding structural, functional, and regulatory polypeptides (SPTM) involved in cell signaling.
The invention provides an isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting 30 of SEQ )D NO:1-26; b) a naturally occurring polynucleotide sequence having at least 90°1o sequence identity to a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; c) a polynucleotide sequence complementary to a); d) a polynucleotide sequence complementary to b);
and e) an RNA equivalent of a) through d). In one alternative, the polynucleotide comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26.
In another 35 alternative, the polynucleotide comprises at least 60 contiguous nucleotides of a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; b) a naturally occurring polynucleotide sequence having at least 90%
sequence identity to a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; c) a polynucleotide sequence complementary to a); d) a polynucleotide sequence complementary to b); and e) an RNA equivalent of a) through d). The invention further provides a composition for s the detection of expression of secretory polynucleotides comprising at least one isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26;
b) a naturally occurring polynucleotide sequence having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ >D NO:1-26; c) a polynucleotide sequence to complementary to a); d) a polynucleotide sequence complementary to b); and e) an RNA equivalent of a) through d); and a detectable label.
The invention also provides a method for detecting a target polynucleotide in a sample, said target polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ )D NO:1-26;
b) a naturally 15 occurnng polynucleotide sequence having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; c) a polynucleotide sequence complementary to a); d) a polynucleotide sequence complementary to b); and e) an RNA equivalent of a) through d). The method comprises a) hybridizing the sample with a probe comprising at least 20 contiguous nucleotides comprising a sequence complementary to said target polynucleotide in the 2o sample, and which probe specifically hybridizes to said target polynucleotide, under conditions whereby a hybridization complex is formed between said probe and said target polynucleotide, and b) detecting the presence or absence of said hybridization complex, and, optionally, if present, the amount thereof. In one alternative, the probe comprises at least 30 contiguous nucleotides. In another alternative, the probe comprises at least 60 contiguous nucleotides.
z 5 The invention further provides a recombinant polynucleotide comprising a promoter sequence operably linked to an isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; b) a naturally occurring polynucleotide sequence having at least 90%
sequence identity to a polynucleotide sequence selected from the group consisting of SEQ )D NO:1-26;
c) a polynucleotide 3o sequence complementary to a); d) a polynucleotide sequence complementary to b); and e) an RNA
equivalent of a) through d). In one alternative, the invention provides a cell transformed with the recombinant polynucleotide. In another alternative, the invention provides a transgenic organism comprising the recombinant polynucleotide. In a further alternative, the invention provides a method for producing a secretory polypeptide, the method comprising a) culturing a cell under conditions 35 suitable for expression of the secretory polypeptide, wherein said cell is transformed with the recombinant polynucleotide, and b) recovering the secretory polypeptide so expressed.
The invention also provides a purified secretory polypeptide (SPTM) encoded by at least one polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ 1D
NO:1-26. Additionally, the invention provides an isolated antibody which specifically binds to the secretory polypeptide. The invention further provides a method of identifying a test compound which specifically binds to the secretory polypeptide, the method comprising the steps of a) providing a test compound; b) combining the secretory polypeptide with the test compound for a sufficient time and under suitable conditions for binding; and c) detecting binding of the secretory polypeptide to the test compound, thereby identifying the test compound which specifically binds the secretory polypeptide.
The invention further provides a microarray wherein at least one element of the microarray is to an isolated polynucleotide comprising at least 60 contiguous nucleotides of a polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ )D NO:1-26; b) a naturally occurring polynucleotide sequence having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ )D NO:1-26; c) a polynucleotide sequence complementary to a); d) is a polynucleotide sequence complementary to b); and e) an RNA equivalent of a) through d). The invention also provides a method for generating a transcript image of a sample which contains polynucleotides. The method comprises a) labeling the polynucleotides of the sample, b) contacting the elements of the microarray with the labeled polynucleotides of the sample under conditions suitable for the formation of a hybridization complex, and c) quantifying the expression of the 2o polynucleotides in the sample.
Additionally, the invention provides a method for screening a compound for effectiveness in altering expression of a target polynucleotide, wherein said target polynucleotide comprises a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ 1D NO:1-26; b) a naturally occurnng polynucleotide sequence 25 having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ >D NO:1-26; c) a polynucleotide sequence complementary to a); d) a polynucleotide sequence complementary to b); and e) an RNA equivalent of a) through d). The method comprises a) exposing a sample comprising the target polynucleotide to a compound, and b) detecting altered expression of the target polynucleotide.
3o The invention further provides a method for detecting a target polynucleotide in a sample for toxicity testing of a compound, said target polynucleotide comprising a polynucleotide sequence selected from the group consisting of a) a polynucleotide sequence selected from the group consisting of SEQ 1D NO:1-26; b) a naturally occurring polynucleotide sequence having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26; c) a 35 polynucleotide sequence complementary to a); d) a polynucleotide sequence complementary to b);
and e) an RNA equivalent of a) through d). The method comprises a) hybridizing the sample with a probe comprising at least 20 contiguous nucleotides comprising a sequence complementary to said target polynucleotide in the sample, and which probe specifically hybridizes to said target polynucleotide, under conditions whereby a hybridization complex is formed between said probe and said target polynucleotide, b) detecting the presence or absence of said hybridization complex, and, optionally, if present, the amount thereof, and c) comparing the presence, absence or amount of said target polynucleotide in a first biological sample and a second biological sample, wherein said first biological sample has been contacted with said compound, and said second sample is a control, whereby a change in presence, absence or amount of said target polynucleotide in said first sample, as compared with said second sample, is indicative of toxic response to said compound.
to DESCRIPTION OF THE TABLES
Table 1 shows the sequence identification numbers (SEQ ID NOa) and template identification numbers (template IDs) corresponding to the polynucleotides of the present invention, along with their GenBank hits (GI Numbers), probability scores, and functional annotations is corresponding to the GenBank hits.
Table 2 shows the sequence identification numbers (SEQ >D NOa) and template identification numbers (template IDs) corresponding to the polynucleotides of the present invention, along with polynucleotide segments of each template sequence as defined by the indicated "start" and "stop" nucleotide positions. The reading frames of the polynucleotide segments are shown, and the 2 o polypeptides encoded by the polynucleotide segments constitute either signal peptide (SP) or transmembrane (TM) domains, as indicated.
Table 3 shows the sequence identification numbers (SEQ )D NOa) and template identification numbers (template IDs) corresponding to the polynucleotides of the present invention, along with component sequence identification numbers (component IDs) corresponding to each 2 s template. The component sequences, which were used to assemble the template sequences, are defined by the indicated "start" and "stop" nucleotide positions along each template.
Table 4 summarizes the bioinformatics tools which are useful for analysis of the polynucleotides of the present invention. The first column of Table 4 lists analytical tools, programs, and algorithms, the second column provides brief descriptions thereof, the third column presents 3 o appropriate references, all of which are incorporated by reference herein in their entirety, and the fourth column presents, where applicable, the scores, probability values, and other parameters used to evaluate the strength of a match between two sequences (the higher the score, the greater the homology between two sequences).
Before the nucleic acid sequences and methods are presented, it is to be understood that this invention is not limited to the particular machines, methods, and materials described. Although particular embodiments are described, machines, methods, and materials similar or equivalent to these embodiments may be used to practice the invention. The preferred machines, methods, and materials set forth are not intended to limit the scope of the invention which is limited only by the s appended claims.
The singular forms "a", "an", and "the" include plural reference unless the context clearly dictates otherwise. All technical and scientific terms have the meanings commonly understood by one of ordinary skill in the art. All publications are incorporated by reference for the purpose of describing and disclosing the cell lines, vectors, and methodologies which are presented and which to might be used in connection with the invention. Nothing in the specification is to be construed as an admission that the invention is not entitled to antedate such disclosure by virtue of prior invention.
Definitions As used herein, the lower case "sptm" refers to a nucleic acid sequence, while the upper case 15 "SPTM" refers to an amino acid sequence encoded by sptm. A "full-length"
sptm refers to a nucleic acid sequence containing the entire coding region of a gene endogenously expressed in human tissue.
"Adjuvants" are materials such as Freund's adjuvant, mineral gels (aluminum hydroxide), and' surface active substances (lysolecithin, pluronic polyols, polyanions, peptides" oil emulsions, keyhole limpet hemocyanin, and dinitrophenol) which may be administered to increase a host's 2 o immunological response.
"Allele" refers to an alternative form of a nucleic acid sequence. Alleles result from a "mutation," a change or an alternative reading of the genetic code. Any given gene may have none, one, or many allelic forms. Mutations which give rise to alleles include deletions, additions, or substitutions of nucleotides. Each of these changes may occur alone, or in combination with the 25 others, one or more times in a given nucleic acid sequence. The present invention encompasses allelic sptm.
"Amino acid sequence" refers to a peptide, a polypeptide, or a protein of either natural or synthetic origin. The amino acid sequence is not limited to the complete, endogenous amino acid sequence and may be a fragment, epitope, variant, or derivative of a protein expressed by a nucleic 3 o acid sequence.
"Amplification" refers to the production of additional copies of a sequence and is carried out using polymerase chain reaction (PCR) technologies well known in the art.
"Antibody" refers to intact molecules as well as to fragments thereof, such as Fab, F(ab')2, and Fv fragments, which are capable of binding the epitopic determinant.
Antibodies that bind SPTM
35 polypeptides can be prepared using intact polypeptides or using fragments containing small peptides of interest as the immunizing antigen. The polypeptide or peptide used to immunize an animal (e.g., a mouse, a rat, or a rabbit) can be derived from the translation of RNA, or synthesized chemically, and can be conjugated to a carrier protein if desired. Commonly used Garners that are chemically coupled to peptides include bovine serum albumin, thyroglobulin, and keyhole limpet hemocyanin (KLH).
The coupled peptide is then used to immunize the animal.
"Antisense sequence" refers to a sequence capable of specifically hybridizing to a target sequence. The antisense sequence may include DNA, RNA, or any nucleic acid mimic or analog such as peptide nucleic acid (PNA); oligonucleotides having modified backbone linkages such as phosphorothioates, methylphosphonates, or benzylphosphonates; oligonucleotides having modified sugar groups such as 2'-methoxyethyl sugars or 2'-methoxyethoxy sugars; or oligonucleotides having to modified bases such as 5-methyl cytosine, 2'-deoxyuracil, or 7-deaza-2'-deoxyguanosine.
"Antisense sequence" refers to a sequence capable of specifically hybridizing to a target sequence. The antisense sequence can be DNA, RNA, or any nucleic acid mimic or analog.
"Antisense technology" refers to any technology which relies on the specific hybridization of an antisense sequence to a target sequence.
A "bin" is a portion of computer memory space used by a computer program for storage of data, and bounded in such a manner that data stored in a bin may be retrieved by the program.
"Biologically active" refers to an amino acid sequence having a structural, regulatory, or biochemical function of a naturally occurring amino acid sequence.
"Clone joining" is a process for combining gene bins based upon the bins' containing 2 o sequence information from the same clone. The sequences may assemble into a primary gene transcript as well as one or more splice variants.
"Complementary" describes the relationship between two single-stranded nucleic acid sequences that anneal by base-pairing (5'-A-G-T-3' pairs with its complement 3'-T-C-A-5').
A "component sequence" is a nucleic acid sequence selected by a computer program such as PHRED and used to assemble a consensus or template sequence from one or more component sequences.
A "consensus sequence" or "template sequence" is a nucleic acid sequence which has been assembled from overlapping sequences, using a computer program for fragment assembly such as the GELVIEW fragment assembly system (Genetics Computer Group (GCG), Madison WI) or using a 3o relational database management system (RDMS).
"Conservative amino acid substitutions" are those substitutions that, when made, least interfere with the properties of the original protein, i.e., the structure and especially the function of the protein is conserved and not significantly changed by such substitutions.
The table below shows amino acids which may be substituted for an original amino acid in a protein and which are regarded as conservative substitutions.
Original Residue Conservative Substitution Ala Gly, Ser Arg His, Lys Asn Asp, Gln, His Asp Asn, Glu Cys Ala, Ser Gln Asn, Glu, His Glu Asp, Gln, His Gly Ala to His Asn, Arg, Gln, Glu Ile Leu, Val Leu Ile, Val Lys Arg, Gln, Glu Met Leu, Ile Phe His, Met, Leu, Trp, Tyr Ser Cys, Thr Thr Ser, Val Trp Phe, Tyr Tyr His, Phe, Trp 2o Val Ile, Leu, Thr Conservative substitutions generally maintain (a) the structure of the polypeptide backbone in the area of the substitution, for example, as a beta sheet or alpha helical conformation, (b) the charge or hydrophobicity of the molecule at the target site, or (c) the bulk of the side chain.
"Deletion" refers to a change in either a nucleic or amino acid sequence in which at least one nucleotide or amino acid residue, respectively, is absent.
"Derivative" refers to the chemical modification of a nucleic acid sequence, such as by replacement of hydrogen by an alkyl, acyl, amino, hydroxyl, or other group.
3 o The terms "element" and "array element" refer to a polynucleotide, polypeptide, or other chemical compound having a unique and defined position on a microarray.
"E-value" refers to the statistical probability that a match between two sequences occurred by chance.
A "fragment" is a unique portion of sptm or SPTM which is identical in sequence to but shorter in length than the parent sequence. A fragment may comprise up to the entire length of the defined sequence, minus one nucleotidelamino acid residue. For example, a fragment may comprise from 10 to 1000 contiguous amino acid residues or nucleotides. A fragment used as a probe, primer, antigen, therapeutic molecule, or for other purposes, may be at least 5, 10, 15, 16, 20, 25, 30, 40, 50, 60, 75, 100, 150, 250 or at least 500 contiguous amino acid residues or nucleotides in length.
4o Fragments may be preferentially selected from certain regions of a molecule. For example, a polypeptide fragment may comprise a certain length of contiguous amino acids selected from the first 250 or 500 amino acids (or first 25% or 50%) of a polypeptide as shown in a certain defined sequence. Clearly these lengths are exemplary, and any length that is supported by the specification, including the Sequence Listing and the figures, may be encompassed by the present embodiments.
A fragment of sptm comprises a region of unique polynucleotide sequence that specifically identifies sptm, for example, as distinct from any other sequence in the same genome. A fragment of sptm is useful, for example, in hybridization and amplification technologies and in analogous methods that distinguish sptm from related polynucleotide sequences. The precise length of a fragment of sptm and the region of sptm to which the fragment corresponds are routinely determinable by one of ordinary skill in the art based on the intended purpose for the fragment.
A fragment of SPTM is encoded by a fragment of sptm. A fragment of SPTM
comprises a 1o region of unique amino acid sequence that specifically identifies SPTM. For example, a fragment of SPTM is useful as an immunogenic peptide for the development of antibodies that specifically recognize SPTM. The precise length of a fragment of SPTM and the region of SPTM to which the fragment corresponds are routinely determinable by one of ordinary skill in the art based on the intended purpose for the fragment.
A "full length" nucleotide sequence is one containing at least a start site for translation to a protein sequence, followed by an open reading frame and a stop site, and encoding a "full length"
polypeptide.
"Hit" refers to a sequence whose annotation will be used to describe a given template.
Criteria for selecting the top hit are as follows: if the template has one or more exact nucleic acid 2 o matches, the top hit is the exact match with highest percent identity. If the template has no exact matches but has significant protein hits, the top hit is the protein hit with the lowest E-value. If the template has no significant protein hits, but does have significant non-exact nucleotide hits, the top hit is the nucleotide hit with the lowest E-value.
"Homology" refers to sequence similarity either between a reference nucleic acid sequence 2 5 and at least a fragment of an sptm or between a reference amino acid sequence and a fragment of an SPTM.
"Hybridization" refers to the process by which a strand of nucleotides anneals with a complementary strand through base pairing. Specific hybridization is an indication that two nucleic acid sequences share a high degree of identity. Specific hybridization complexes form under defined 3 o annealing conditions, and remain hybridized after the "washing" step. The defined hybridization conditions include the annealing conditions and the washing step(s), the latter of which is particularly important in determining the stringency of the hybridization process, with more stringent conditions allowing less non-specific binding, i.e., binding between pairs of nucleic acid probes that are not perfectly matched. Permissive conditions for annealing of nucleic acid sequences are routinely 35 determinable and may be consistent among hybridization experiments, whereas wash conditions may be varied among experiments to achieve the desired stringency.
Generally, stringency of hybridization is expressed with reference to the temperature under which the wash step is carried out. Generally, such wash temperatures are selected to be about 5°C to 20°C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. The T", is the temperature (under defined ionic strength and pH) at which 50% of the target s sequence hybridizes to a perfectly matched probe. An equation for calculating Tm and conditions for nucleic acid hybridization is well known and can be found in Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, 2°° ed., vol. 1-3, Cold Spring Harbor Press, Plainview NY;
specifically see volume 2, chapter 9.
High stringency conditions for hybridization between polynucleotides of the present to invention include wash conditions of 68°C in the presence of about 0.2 x SSC and about 0.1% SDS, for 1 hour. Alternatively, temperatures of about 65°C, 60°C, or 55°C may be used. SSC
concentration may be varied from about 0.2 to 2 x SSC, with SDS being present at about 0.1 %.
Typically, blocking reagents are used to block non-specific hybridization.
Such blocking reagents include, for instance, denatured salmon sperm DNA at about 100-200 pg/ml.
Useful variations on 15 these conditions will be readily apparent to those skilled in the art.
Hybridization, particularly under high stringency conditions, may be suggestive of evolutionary similarity between the nucleotides.
Such similarity is strongly indicative of a similar role for the nucleotides and their resultant proteins.
Other parameters, such as temperature, salt concentration, and detergent concentration may be varied to achieve the desired stringency. Denaturants, such as formanude at a concentration of 2o about 35-50% v/v, may also be used under particular circumstances, such as RNA:DNA
hybridizations. Appropriate hybridization conditions are routinely determinable by one of ordinary skill in the art.
"Immunogenic" describes the potential for a natural, recombinant, or synthetic peptide, epitope, polypeptide, or protein to induce antibody production in appropriate animals, cells, or cell 25 lines.
"Insertion" or "addition" refers to a change in either a nucleic or amino acid sequence in which at least one nucleotide or residue, respectively, is added to the sequence.
"Labeling" refers to the covalent or noncovalent joining of a polynucleotide, polypeptide, or antibody with a reporter molecule capable of producing a detectable or measurable signal.
30 "Microarray" is any arrangement of nucleic acids, amino acids, antibodies, etc., on a substrate. The substrate may be a solid support such as beads, glass, paper, nitrocellulose, nylon, or an appropriate membrane.
"Linkers" are short stretches of nucleotide sequence which may be added to a vector or an sptm to create restriction endonuclease sites to facilitate cloning.
"Polylinkers" are engineered to 35 incorporate multiple restriction enzyme sites and to provide for the use of enzymes which leave 5' or 3' overhangs (e.g., BamHI, EcoRI, and HindII>] and those which provide blunt ends (e.g., EcoRV, SnaBI, and Stun.
"Naturally occurring" refers to an endogenous polynucleotide or polypeptide that may be isolated from viruses or prokaryotic or eukaryotic cells.
"Nucleic acid sequence" refers to the specific order of nucleotides joined by phosphodiester bonds in a linear, polymeric arrangement. Depending on the number of nucleotides, the nucleic acid sequence can be considered an oligomer, oligonucleotide, or polynucleotide.
The nucleic acid can be DNA, RNA, or any nucleic acid analog, such as PNA, may be of genomic or synthetic origin, may be either double-stranded or single-stranded, and can represent either the sense or antisense i o (complementary) strand.
"Oligomer" refers to a nucleic acid sequence of at least about 6 nucleotides and as many as about 60 nucleotides, preferably about 15 to 40 nucleotides, and most preferably between about 20 and 30 nucleotides, that may be used in hybridization or amplification technologies. Oligomers may be used as, e.g., primers for PCR, and are usually chemically synthesized.
"Operably linked" refers to the situation in which a first nucleic acid sequence is placed in a functional relationship with the second nucleic acid sequence. For instance, a promoter is operably linked to a coding sequence if the promoter affects the transcription or expression of the coding sequence. Generally, operably linked DNA sequences may be in close proxinuty or contiguous and, where necessary to join two protein coding regions, in the same reading frame.
"Peptide nucleic acid" (PNA) refers to a DNA mimic in which nucleotide bases are attached to a pseudopeptide backbone to increase stability. PNAs, also designated antigene agents, can prevent gene expression by targeting complementary messenger RNA.
The phrases "percent identity" and "% identity", as applied to polynucleotide sequences, refer to the percentage of residue matches between at least two polynucleotide sequences aligned using a standardized algorithm. Such an algorithm may insert, in a standardized and reproducible way, gaps in the sequences being compared in order to optimize alignment between two sequences, and therefore achieve a more meaningful comparison of the two sequences.
Percent identity between polynucleotide sequences may be determined using the default parameters of the CLUSTAL V algorithm as incorporated into the MEGALIGN
version 3.12e 3o sequence alignment program. This program is part of the LASERGENE software package, a suite of molecular biological analysis programs (DNASTAR, Madison WI). CLUSTAL V is described in Higgins, D.G. and Sharp, P.M. (1989) CABIOS 5:151-153 and in Higgins, D.G. et al. (1992) CABIOS 8:189-191. For pairwise alignments of polynucleotide sequences, the default parameters are set as follows: Ktuple=2, gap penalty=5, window=4, and "diagonals saved"=4.
The "weighted"
residue weight table is selected as the default. Percent identity is reported by CLUSTAL V as the "percent similarity" between aligned polynucleotide sequence pairs.
Alternatively, a suite of commonly used and freely available sequence comparison algorithms is provided by the National Center for Biotechnology Information (NCBI) Basic Local Alignment Search Tool (BLAST) (Altschul, S.F. et al. (1990) J. Mol. Biol. 215:403-410), which is available from several sources, including the NCBI, Bethesda, MD, and on the Internet at http://www.ncbi.nlm.nih.gov/BLAST/. The BLAST software suite includes various sequence analysis programs including "blastn," that is used to determine alignment between a known polynucleotide sequence and other sequences on a variety of databases. Also available is a tool called "BLAST 2 Sequences" that is used for direct pairwise comparison of two nucleotide sequences.
"BLAST 2 Sequences" can be accessed and used interactively at to http:/lwww.ncbi.nlm.nih.govlgorf/b12/. The "BLAST 2 Sequences" tool can be used for both blastn and blastp (discussed below). BLAST programs are commonly used with gap and other parameters set to default settings. For example, to compare two nucleotide sequences, one may use blastn with the "BLAST 2 Sequences" tool Version 2Ø9 (May-07-1999) set at default parameters. Such default parameters may be, for example:
Matrix: BLOSUM62 Reward for match: 1 Penalty for mismatch: -2 Open Gap: S and Extension Gap: 2 penalties Gap x drop-off.' SO
z o Expect: 70 Word Size: J I
Filter: on Percent identity may be measured over the length of an entire defined sequence, for example, as defined by a particular SEQ ID number, or may be measured over a shorter length, for example, over the length of a fragment taken from a larger, defined sequence, for instance, a fragment of at least 20, at least 30, at least 40, at least 50, at least 70, at least 100, or at least 200 contiguous nucleotides. Such lengths are exemplary only, and it is understood that any fragment length supported by the sequences shown herein, in figures or Sequence Listings, may be used to describe a length over which percentage identity may be measured.
3 o Nucleic acid sequences that do not show a high degree of identity may nevertheless encode similar amino acid sequences due to the degeneracy of the genetic code. It is understood that changes in nucleic acid sequence can be made using this degeneracy to produce multiple nucleic acid sequences that all encode substantially the same protein.
The phrases "percent identity" and "°!o identity", as applied to polypeptide sequences, refer to the percentage of residue matches between at least two polypeptide sequences aligned using a standardized algorithm. Methods of polypeptide sequence alignment are well-known. Some alignment methods take into account conservative amino acid substitutions.
Such conservative substitutions, explained in more detail above, generally preserve the hydrophobicity and acidity of the substituted residue, thus preserving the structure (and therefore function) of the folded polypeptide.
Percent identity between polypeptide sequences may be determined using the default parameters of the CLUSTAL V algorithm as incorporated into the MEGALIGN
version 3.12e sequence alignment program (described and referenced above). For pairwise alignments of polypeptide sequences using CLUSTAL V, the default parameters are set as follows: Ktuple=1, gap penalty=3, window=5, and "diagonals saved"=5. The PAM250 matrix is selected as the default residue weight table. As with polynucleotide alignments, the percent identity is reported by 1o CLUSTAL V as the "percent similarity" between aligned polypeptide sequence pairs.
Alternatively the NCBI BLAST software suite may be used. For example, for a pairwise comparison of two polypeptide sequences, one may use the "BLAST 2 Sequences"
tool Version 2Ø9 (May-07-1999) with blastp set at default parameters. Such default parameters may be, for example:
Matrix: BLOSUM62 Open Gap: 1l and Extension Gap: l penalty Cap x drop-off.' S0 Expect: 10 Word Size: 3 Filter: on 2o Percent identity may be measured over the length of an entire defined polypeptide sequence, for example, as defined by a particular SEQ ID number, or may be measured over a shorter length, for example, over the length of a fragment taken from a larger, defined polypeptide sequence, for instance, a fragment of at least 15, at least 20, at least 30, at least 40, at least 50, at least 70 or at least 150 contiguous residues. Such lengths are exemplary only, and it is understood that any fragment length supported by the sequences shown herein, in figures or Sequence Listings, may be used to describe a length over which percentage identity may be measured.
"Post-translational modification" of an SPTM may involve lipidation, glycosylation, phosphorylation, acetylation, racemization, proteolytic cleavage, and other modifications known in the art. These processes may occur synthetically or biochemically. Biochemical modifications will 3 o vary by cell type depending on the enzymatic milieu and the SPTM.
"Probe" refers to sptm or fragments thereof, which are used to detect identical, allelic or related nucleic acid sequences. Probes are isolated oligonucleotides or polynucleotides attached to a detectable label or reporter molecule. Typical labels include radioactive isotopes, ligands, chemiluminescent agents, and enzymes. "Primers" are short nucleic acids, usually DNA
oligonucleotides, which may be annealed to a target polynucleotide by complementary base-pairing.
The primer may then be extended along the target DNA strand by a DNA
polymerase enzyme.
Primer pairs can be used for amplification (and identification) of a nucleic acid sequence, e.g., by the polymerase chain reaction (PCR).
Probes and primers as used in the present invention typically comprise at least 15 contiguous nucleotides of a known sequence. In order to enhance specificity, longer probes and primers may also be employed, such as probes and primers that comprise at least 20, 30, 40, 50, 60, 70, 80, 90, 100, or at least 150 consecutive nucleotides of the disclosed nucleic acid sequences.
Probes and primers may be considerably longer than these examples, and it is understood that any length supported by the specification, including the figures and Sequence Listing, may be used.
Methods for preparing and using probes and primers are described in the references, for to example Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, 2"d ed., vol. 1-3, Cold Spring Harbor Press, Plainview NY; Ausubel et a1.,1987, Current Protocols in Molecular Biology, Greene Publ. Assoc. & Wiley-Intersciences, New York NY; Innis et al., 1990, PCR Protocols, A
Guide to Methods and Applications, Academic Press, San Diego CA. PCR primer pairs can be derived from a known sequence, for example, by using computer programs intended for that purpose such as Primer (Version 0.5, 1991, Whitehead Institute for Biomedical Research, Cambridge MA).
Oligonucleotides for use as primers are selected using software known in the art for such purpose. For example, OLIGO 4.06 software is useful for the selection of PCR
primer pairs of up to 100 nucleotides each, and for the analysis of oligonucleotides and larger polynucleotides of up to 5,000 nucleotides from an input polynucleotide sequence of up to 32 kilobases.
Similar primer 2 o selection programs have incorporated additional features for expanded capabilities. For example, the PrimOU primer selection program (available to the public from the Genome Center at University of Texas South West Medical Center, Dallas TX) is capable of choosing specific primers from megabase sequences and is thus useful for designing primers on a genome-wide scope. The Primer3 primer selection program (available to the public from the Whitehead Institute/MIT Center for 2 s Genome Research, Cambridge MA) allows the user to input a "mispriming library," in which sequences to avoid as primer binding sites are user-specified. Primer3 is useful, in particular, for the selection of oligonucleotides for microarrays. (The source code for the latter two primer selection programs may also be obtained from their respective sources and modified to meet the user's specific needs.) The PrimeGen program (available to the public from the UK Human Genome Mapping 3o Project Resource Centre, Cambridge UK) designs primers based on multiple sequence alignments, thereby allowing selection of primers that hybridize to either the most conserved or least conserved regions of aligned nucleic acid sequences. Hence, this program is useful for identification of both unique and conserved oligonucleotides and polynucleotide fragments. The oligonucleotides and polynucleotide fragments identified by any of the above selection methods are useful in hybridization 3 s technologies, for example, as PCR or sequencing primers, microarray elements, or specific probes to identify fully or partially complementary polynucleotides in a sample of nucleic acids. Methods of oligonucleotide selection are not limited to those described above.
"Purified" refers to molecules, either polynucleotides or polypeptides that are isolated or separated from their natural environment and are at least 60% free, preferably at least 75% free, and most preferably at least 90% free from other compounds with which they are naturally associated.
A "recombinant nucleic acid" is a sequence that is not naturally occurnng or has a sequence that is made by an artificial combination of two or more otherwise separated segments of sequence.
This artificial combination is often accomplished by chemical synthesis or, more commonly, by the artificial manipulation of isolated segments of nucleic acids, e.g., by genetic engineering techniques to such as those described in Sambrook, supra. The term recombinant includes nucleic acids that have been altered solely by addition, substitution, or deletion of a portion of the nucleic acid. Frequently, a recombinant nucleic acid may include a nucleic acid sequence operably linked to a promoter sequence. Such a recombinant nucleic acid may be part of a vector that is used, for example, to transform a cell.
Alternatively, such recombinant nucleic acids may be part of a viral vector, e.g., based on a vaccinia virus, that could be use to vaccinate a mammal wherein the recombinant nucleic acid is expressed, inducing a protective immunological response in the mammal.
"Regulatory element" refers to a nucleic acid sequence from nontranslated regions of a gene, and includes enhancers, promoters, introns, and 3' untranslated regions, which interact with host 2 o proteins to carry out or regulate transcription or translation.
"Reporter" molecules are chemical or biochemical moieties used for labeling a nucleic acid, an amino acid, or an antibody. They include radionuclides; enzymes;
fluorescent, chemiluminescent, or chromogenic agents; substrates; cofactors; inhibitors; magnetic particles;
and other moieties known in the art.
An "RNA equivalent," in reference to a DNA sequence, is composed of the same linear sequence of nucleotides as the reference DNA sequence with the exception that all occurrences of the nitrogenous base thymine are replaced with uracil, and the sugar backbone is composed of ribose instead of deoxyribose.
"Sample" is used in its broadest sense. Samples may contain nucleic or amino acids, 3o antibodies, or other materials, and may be derived from any source (e.g., bodily fluids including, but not limited to, saliva, blood, and urine; chromosome(s), organelles, or membranes isolated from a cell; genomic DNA, RNA, or cDNA in solution or bound to a substrate; and cleared cells or tissues or blots or imprints from such cells or tissues).
"Specific binding" or "specifically binding" refers to the interaction between a protein or peptide and its agonist, antibody, antagonist, or other binding partner. The interaction is dependent upon the presence of a particular structure of the protein, e.g., the antigenic determinant or epitope, recognized by the binding molecule. For example, if an antibody is specific for epitope "A," the presence of a polypeptide containing epitope A, or the presence of free unlabeled A, in a reaction containing free labeled A and the antibody will reduce the amount of labeled A
that binds to the antibody.
"Substitution" refers to the replacement of at least one nucleotide or amino acid by a different nucleotide or anuno acid.
"Substrate" refers to any suitable rigid or semi-rigid support including, e.g., membranes, filters, chips, slides, wafers, fibers, magnetic or nonmagnetic beads, gels, tubing, plates, polymers, microparticles or capillaries. The substrate can have a variety of surface forms, such as wells, Zo trenches, pins, channels and pores, to which polynucleotides or polypeptides are bound.
A "transcript image" refers to the collective pattern of gene expression by a particular tissue or cell type under given conditions at a given time.
"Transformation" refers to a process by which exogenous DNA enters a recipient cell.
Transformation may occur under natural or artificial conditions using various methods well known in i5 the art. Transformation may rely on any known method for the insertion of foreign nucleic acid sequences into a prokaryotic or eukaryotic host cell. The method is selected based on the host cell being transformed.
"Transformants" include stably transformed cells in which the inserted DNA is capable of replication either as an autonomously replicating plasmid or as part of the host chromosome, as well zo as cells which transiently express inserted DNA or RNA.
A "transgenic organism," as used herein, is any organism, including but not limited to animals and plants, in which one or more of the cells of the organism contains heterologous nucleic acid introduced by way of human intervention, such as by transgenic techniques well known in the art.
The nucleic acid is introduced into the cell, directly or indirectly by introduction into a precursor of 25 the cell, by way of deliberate genetic manipulation, such as by microinjection or by infection with a recombinant virus. The term genetic manipulation does not include classical cross-breeding, or in vitro fertilization, but rather is directed to the introduction of a recombinant DNA molecule. The transgenic organisms contemplated in accordance with the present invention include bacteria, cyanobacteria, fungi, and plants and animals. The isolated DNA of the present invention can be s o introduced into the host by methods known in the art, for example infection, transfection, transformation or transconjugation. Techniques for transferring the DNA of the present invention into such organisms are widely known and provided in references such as Sambrook et al. (1989), supra.
A "variant" of a particular nucleic acid sequence is defined as a nucleic acid sequence having 35 at least 25% sequence identity to the particular nucleic acid sequence over a certain length of one of the nucleic acid sequences using blastn with the "BLAST 2 Sequences" tool Version 2Ø9 (May-07-1999) set at default parameters. Such a pair of nucleic acids may show, for example, at least 30%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95% or even at least 98% or greater sequence identity over a certain defined length. The variant may result in "conservative"
amino acid changes which do not affect structural and/or chemical properties.
A variant may be described as, for example, an "allelic" (as defined above), "splice,"
"species," or "polymorphic"
variant. A splice variant may have significant identity to a reference molecule, but will generally have a greater or lesser number of polynucleotides due to alternate splicing of exons during mRNA
processing. The corresponding polypeptide may possess additional functional domains or lack domains that are present in the reference molecule. Species variants are polynucleotide sequences to that vary from one species to another. The resulting polypeptides generally will have significant amino acid identity relative to each other. A polymorphic variant is a variation in the polynucleotide sequence of a particular gene between individuals of a given species.
Polymorphic variants also may encompass "single nucleotide polymorphisms" (SNPs) in which the polynucleotide sequence varies by one base. The presence of SNPs may be indicative of, for example, a certain population, a disease is state, or a propensity for a disease state.
In an alternative, variants of the polynucleotides of the present invention may be generated through recombinant methods. One possible method is a DNA shuffling technique such as MOLECULARBREEDING (Maxygen Inc., Santa Clara CA; described in U.S. Patent Number 5,837,458; Chang, C.-C. et al. (1999) Nat. Biotechnol. 17:793-797; Christians, F.C. et al. (1999) Nat.
2o Biotechnol. 17:259-264; and Crameri, A. et al. (1996) Nat. Biotechnol.
14:315-319) to alter or improve the biological properties of SPTM, such as its biological or enzymatic activity or its ability to bind to other molecules or compounds. DNA shuffling is a process by which a library of gene variants is produced using PCR-mediated recombination of gene fragments. The library is then subjected to selection or screening procedures that identify those gene variants with the desired 25 properties. These preferred variants may then be pooled and further subjected to recursive rounds of DNA shuffling and selectionlscreening. Thus, genetic diversity is created through "artificial"
breeding and rapid molecular evolution. For example, fragments of a single gene containing random point mutations may be recombined, screened, and then reshuffled until the desired properties are optimized. Alternatively, fragments of a given gene may be recombined with fragments of 3 o homologous genes in the same gene fanuly, either from the same or different species, thereby maximizing the genetic diversity of multiple naturally occurring genes in a directed and controllable manner.
A "variant" of a particular polypeptide sequence is defined as a polypeptide sequence having at least 40% sequence identity to the particular polypeptide sequence over a certain length of one of 35 the polypeptide sequences using blastp with the "BLAST 2 Sequences" tool Version 2Ø9 (May-07-1999) set at default parameters. Such a pair of polypeptides may show, for example, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, or at least 98% or greater sequence identity over a certain defined length of one of the polypeptides.
THE INVENTION
In a particular embodiment, cDNA sequences derived from human tissues and cell lines were aligned based on nucleotide sequence identity and assembled into "consensus"
or "template"
sequences which are designated by the template identification numbers (template IDs) in column 2 of Table 1. The sequence identification numbers (SEQ ID NOa) corresponding to the template IDs are shown in column 1. The template sequences have similarity to GenBank sequences, or "hits," as to designated by the GI Numbers in column 3. The statistical probability of each GenBank hit is indicated by a probability score in column 4, and the functional annotation corresponding to each GenBank hit is listed in column 5.
Segments of each template sequences are defined by the "start" and "stop"
nucleotide positions listed in columns 3 and 4 of Table 2. These segments, when translated in the reading frames i5 indicated in column 5, have similarity to signal peptide (SP) or transmembrane (TM) domain consensus sequences, as indicated in column 6.
The invention incorporates the nucleic acid sequences of these templates as disclosed in the Sequence Listing and the use of these sequences in the diagnosis and treatment of disease states characterized by defects in cell signaling. The invention further utilizes these sequences in 2o hybridization and amplification technologies, and in particular, in technologies which assess gene expression patterns correlated with specific cells or tissues and their responses in vivo or in vitro to pharmaceutical agents, toxins, and other treatments. In this manner, the sequences of the present invention are used to develop a transcript image for a particular cell or tissue.
z s Derivation of Nucleic Acid Sequences cDNA was isolated from libraries constructed using RNA derived from normal and diseased human tissues and cell lines. The human tissues and cell lines used for cDNA
library construction were selected from a broad range of sources to provide a diverse population of cDNAs representative of gene transcription throughout the human body. Descriptions of the human tissues and cell lines 3 o used for cDNA library construction are provided in the LIFESEQ database (Incyte Genomics, Inc.
(Incyte), Palo Alto CA). Human tissues were broadly selected from, for example, cardiovascular, dermatologic, endocrine, gastrointestinal, hematopoietic/immune system, musculoskeletal, neural, reproductive, and urologic sources.
Cell lines used for cDNA library construction were derived from, for example, leukemic 35 cells, teratocarcinomas, neuroepitheliomas, cervical carcinoma, lung fibroblasts, and endothelial cells.
Such cell lines include, for example, THP-1, Jurkat, HUVEC, hNT2, WI38, HeLa, and other cell lines commonly used and available from public depositories (American Type Culture Collection, Manassas VA). Prior to mRNA isolation, cell lines were untreated, treated with a pharmaceutical agent such as 5 =aza-2'-deoxycytidine, treated with an activating agent such as lipopolysaccharide in the case of leukocytic cell lines, or, in the case of endothelial cell lines, subjected to shear stress.
Sepuencin~ of the cDNAs Methods for DNA sequencing are well known in the art. Conventional enzymatic methods employ the Klenow fragment of DNA polymerase I, SEQUENASE DNA polymerase (U.S.
Biochemical Corporation, Cleveland OH), Taq polymerase (PE Biosystems, Foster City CA), to thermostable T7 polymerase (Amersham Pharmacia Biotech, Inc. (Amersham Pharmacia Biotech), Piscataway NJ), or combinations of polymerases and proofreading exonucleases such as those found in the ELONGASE amplification system (Life Technologies Inc. (Life Technologies), Gaithersburg MD), to extend the nucleic acid sequence from an oligonucleotide primer annealed to the DNA
template of interest. Methods have been developed for the use of both single-stranded and double-ts stranded templates. Chain termination reaction products may be electrophoresed on urea-polyacrylamide gels and detected either by autoradiography (for radioisotope-labeled nucleotides) or by fluorescence (for fluorophore-labeled nucleotides). Automated methods for mechanized reaction preparation, sequencing, and analysis using fluorescence detection methods have been developed.
Machines used to prepare cDNAs for sequencing can include the MICROLAB 2200 liquid transfer 2 o system (Hamilton Company (Hamilton), Reno NV), Pettier thermal cycler (PTC200; MJ Research, Inc. (MJ Research), Watertown MA), and ABI CATALYST 800 thermal cycler (PE
Biosystems).
Sequencing can be carried out using, for example, the ABI 373 or 377 (PE
Biosystems) or MEGABACE 1000 (Molecular Dynamics, Inc. (Molecular Dynamics), Sunnyvale CA) DNA
sequencing systems, or other automated and manual sequencing systems well known in the art.
25 The nucleotide sequences of the Sequence Listing have been prepared by current, state-of the-art, automated methods and, as such, may contain occasional sequencing errors or unidentified nucleotides. Such unidentified nucleotides are designated by an N. These infrequent unidentified bases do not represent a hindrance to practicing the invention for those skilled in the art. Several methods employing standard recombinant techniques may be used to correct errors and complete the 3o missing sequence information. (See, e.g., those described in Ausubel, F.M.
et al. (1997) Short Protocols in Molecular Biolo~y, John Wiley & Sons, New York NY; and Sambrook, J. et al. (1989) Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Press, Plainview NY.) Assembly of cDNA Sequences 35 Human polynucleotide sequences may be assembled using programs or algorithms well known in the art. Sequences to be assembled are related, wholly or in part, and may be derived from a single or many different transcripts. Assembly of the sequences can be performed using such programs as PHRAP (Phils Revised Assembly Program) and the GELVIEW fragment assembly system (GCG), or other methods known in the art.
Alternatively, cDNA sequences are used as "component" sequences that are assembled into s "template" or "consensus" sequences as follows. Sequence chromatograms are processed, verified, and quality scores are obtained using PHRED. Raw sequences are edited using an editing pathway known as Block 1 (See, e.g., the LIFESEQ Assembled User Guide, Incyte Genomics, Palo Alto, CA).
A series of BLAST comparisons is performed and low-information segments and repetitive elements (e.g., dinucleotide repeats, Alu repeats, etc.) are replaced by "n's", or masked, to prevent spurious to matches. Mitochondria) and ribosomal RNA sequences are also removed. The processed sequences are then loaded into a relational database management system (RDMS) which assigns edited sequences to existing templates, if available. When additional sequences are added into the RDMS, a process is initiated which modifies existing templates or creates new templates from works in progress (i.e., nonfinal assembled sequences) containing queued sequences or the sequences 15 themselves. After the new sequences have been assigned to templates, the templates can be merged into bins. If multiple templates exist in one bin, the bin can be split and the templates reannotated.
Once gene bins have been generated based upon sequence alignments, bins are "clone joined"
based upon clone information. Clone joining occurs when the S' sequence of one clone is present in one bin and the 3' sequence from the same clone is present in a different bin, indicating that the two 2o bins should be merged into a single bin. Only bins which share at least two different clones are merged.
A resultant template sequence may contain either a partial or a full length open reading frame, or all or part of a genetic regulatory element. This variation is due in part to the fact that the full length cDNAs of many genes are several hundred, and sometimes several thousand, bases in 25 length. With current technology, cDNAs comprising the coding regions of large genes cannot be cloned because of vector limitations, incomplete reverse transcription of the mRNA, or incomplete "second strand" synthesis. Template sequences may be extended to include additional contiguous sequences derived from the parent RNA transcript using a variety of methods known to those of skill in the art. Extension may thus be used to achieve the full length coding sequence of a gene.
Analysis of the cDNA Sequences The cDNA sequences are analyzed using a variety of programs and algorithms which are well known in the art. (See, e.g., Ausubel, 1997, supra, Chapter 7.7; Meyers, R.A.
(Ed.) (1995) Molecular Biology and Biotechnology, Wiley VCH, New York NY, pp. 856-853; and Table 4.) These analyses comprise both reading frame determinations, e.g., based on triplet codon periodicity for particular organisms (Fickett, J.W. (1982) Nucleic Acids Res. 10:5303-5318); analyses of potential start and stop codons; and homology searches.
Computer programs known to those of skill in the art for performing computer-assisted searches for amino acid and nucleic acid sequence similarity, include, for example, Basic Local s Alignment Search Tool (BLAST; Altschul, S.F. (1993) J. Mol. Evol. 36:290-300; Altschul, S.F. et al.
(1990) J. Mol. Biol. 215:403-410). BLAST is especially useful in determining exact matches and comparing two sequence fragments of arbitrary but equal lengths, whose alignment is locally maximal and for which the alignment score meets or exceeds a threshold or cutoff score set by the user (Karlin, S. et al. ( 1988) Proc. Natl. Acad. Sci. USA 85:841-845). Using an appropriate search io tool (e.g., BLAST or HMM), GenBank, SwissProt, BLOCKS, PFAM and other databases may be searched for sequences containing regions of homology to a query sptm or SPTM
of the present invention.
Other approaches to the identification, assembly, storage, and display of nucleotide and polypeptide sequences are provided in "Relational Database for Storing Biomolecule Information,"
15 U.S.S.N. 08/947,845, filed October 9, 1997; "Project-Based Full-Length Biomolecular Sequence Database," U.S.S.N. 08/811,758, filed March 6, 1997; and "Relational Database and System for Storing Information Relating to Biomolecular Sequences," U.S.S.N. 09/034,807, filed March 4, 1998, all of which are incorporated by reference herein in their entirety.
Protein hierarchies can be assigned to the putative encoded polypeptide based on, e.g., motif, 2o BLAST, or biological analysis. Methods for assigning these hierarchies are described, for example, in "Database System Employing Protein Function Hierarchies for Viewing Biomolecular Sequence Data," U.S.S.N. 08/812,290, filed March 6, 1997, incorporated herein by reference.
Se9uences of Human Secretory Molecules z s The sptm of the present invention may be used for a variety of diagnostic and therapeutic purposes. For example, an sptm may be used to diagnose a particular condition, disease, or disorder associated with cell signaling. Such conditions, diseases, and disorders include, but are not limited to, a cell proliferative disorder such as actinic keratosis, arteriosclerosis, atherosclerosis, bursitis, cirrhosis, hepatitis, mixed connective tissue disease (MCTD), myelofibrosis, paroxysmal nocturnal 3o hemoglobinuria, polycythemia vera, psoriasis, primary thrombocythemia, and cancers including adenocarcinoma, leukemia, lymphoma, melanoma, myeloma, sarcoma, teratocarcinoma, and, in particular, a cancer of the adrenal gland, bladder, bone, bone marrow, brain, breast, cervix, gall bladder, ganglia, gastrointestinal tract, heart, kidney, liver, lung, muscle, ovary, pancreas, parathyroid, penis, prostate, salivary glands, skin, spleen, testis, thymus, thyroid, and uterus; an immune system 3s disorder such as such as inflammation, actinic keratosis, acquired immunodeficiency syndrome (AmS), Addison's disease, adult respiratory distress syndrome, allergies, ankylosing spondylitis, amyloidosis, anemia, arteriosclerosis, asthma, atherosclerosis, autoimmune hemolytic anemia, autoimmune thyroiditis, bronchitis, bursitis, cholecystitis, cirrhosis, contact dermatitis, Crohn's disease, atopic dermatitis, dermatomyositis, diabetes mellitus, emphysema, erythroblastosis fetalis, erythema nodosum, atrophic gastritis, glomerulonephritis, Goodpasture's syndrome, gout, Graves' disease, Hashimoto's thyroiditis, paroxysmal nocturnal hemoglobinuria, hepatitis, hypereosinophilia, irritable bowel syndrome, episodic lymphopenia with lymphocytotoxins, mixed connective tissue disease (MCTD), multiple sclerosis, myasthenia gravis, myocardial or pericardial inflanunation, myelofibrosis, osteoarthritis, osteoporosis, pancreatitis, polycythemia vera, polymyositis, psoriasis, Reiter's syndrome, rheumatoid arthritis, scleroderma, Sjogren's syndrome, systemic anaphylaxis, to systemic lupus erythematosus, systemic sclerosis, primary thrombocythemia, thrombocytopenic purpura, ulcerative colitis, uveitis, Werner syndrome, complications of cancer, hemodialysis, and extracorporeal circulation, trauma, and hematopoietic cancer including lymphoma, leukemia, and myeloma; and a neurological disorder such as epilepsy, ischemic cerebrovascular disease, stroke, cerebral neoplasms, Alzheimer's disease, Pick's disease, Huntington's disease, dementia, Parkinson's i5 disease and other extrapyramidal disorders, amyotrophic lateral sclerosis and other motor neuron disorders, progressive neural muscular atrophy, retinitis pigmentosa, hereditary ataxias, multiple sclerosis and other demyelinating diseases, bacterial and viral meningitis, brain abscess, subdural empyema, epidural abscess, suppurative intracranial thrombophlebitis, myelitis and radiculitis, viral central nervous system disease, prion diseases including kuru, Creutzfeldt-Jakob disease, and 2o Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, nutritional and metabolic diseases of the nervous system, neurofibromatosis, tuberous sclerosis, cerebelloretinal hemangioblastomatosis, encephalotrigeminal syndrome, mental retardation and other developmental disorder of the central nervous system, cerebral palsy, a neuroskeletal disorder, an autonomic nervous system disorder, a cranial nerve disorder, a spinal cord disease, muscular dystrophy and other neuromuscular disorder, a 25 peripheral nervous system disorder, dermatomyositis and polymyositis, inherited, metabolic, endocrine, and toxic myopathy, myasthenia gravis, periodic paralysis, a mental disorder including mood, anxiety, and schizophrenic disorder, seasonal affective disorder (SAD), akathesia, amnesia, catatonia, diabetic neuropathy, tardive dyskinesia, dystonias, paranoid psychoses, postherpetic neuralgia, and Tourette's disorder. The sptm can be used to detect the presence of, or to quantify the 3 o amount of, an sptm-related polynucleotide in a sample. This information is then compared to information obtained from appropriate reference samples, and a diagnosis is established.
Alternatively, a polynucleotide complementary to a given sptm can inhibit or inactivate a therapeutically relevant gene related to the sptm.
Analysis of sntm Expression Patterns The expression of sptm may be routinely assessed by hybridization-based methods to determine, for example, the tissue-specificity, disease-specificity, or developmental stage-specificity of sptm expression. For example, the level of expression of sptm may be compared among different cell types or tissues, among diseased and normal cell types or tissues, among cell types or tissues at different developmental stages, or among cell types or tissues undergoing various treatments. This type of analysis is useful, for example, to assess the relative levels of sptm expression in fully or partially differentiated cells or tissues, to determine if changes in sptm expression levels are correlated with the development or progression of specific disease states, and to assess the response to of a cell or tissue to a specific therapy, for example, in pharmacological or toxicological studies.
Methods for the analysis of sptm expression are based on hybridization and amplification technologies and include membrane-based procedures such as northern blot analysis, high-throughput procedures that utilize, for example, microarrays, and PCR-based procedures.
Hybridization and Genetic Analysis The sptm, their fragments, or complementary sequences, may be used to identify the presence of and/or to determine the degree of sinvlarity between two (or more) nucleic acid sequences. The sptm may be hybridized to naturally occurnng or recombinant nucleic acid sequences under appropriately selected temperatures and salt concentrations. Hybridization with a probe based on the 2 o nucleic acid sequence of at least one of the sptm allows for the detection of nucleic acid sequences, including genomic sequences, which are identical or related to the sptm of the Sequence Listing.
Probes may be selected from non-conserved or unique regions of at least one of the polynucleotides of SEQ ID NO:1-26 and tested for their ability to identify or amplify the target nucleic acid sequence using standard protocols.
z5 Polynucleotide sequences that are capable of hybridizing, in particular, to those shown in SEQ m NO:1-26 and fragments thereof, can be identified using various conditions of stringency.
(See, e.g., Wahl, G.M. and S.L. Berger (1987) Methods Enzymol. 152:399-407;
Kimmel, A.R. (1987) Methods Enzymol. 152:507-511.) Hybridization conditions are discussed in "Definitions."
A probe for use in Southern or northern hybridization may be derived from a fragment of an 3 o sptm sequence, or its complement, that is up to several hundred nucleotides in length and is either single-stranded or double-stranded. Such probes may be hybridized in solution to biological materials such as plasmids, bacterial, yeast, or human artificial chromosomes, cleared or sectioned tissues, or to artificial substrates containing sptm. Microarrays are particularly suitable for identifying the presence of and detecting the level of expression for multiple genes of interest by examining gene 35 expression correlated with, e.g., various stages of development, treatment with a drug or compound, or disease progression. An array analogous to a dot or slot blot may be used to arrange and link polynucleotides to the surface of a substrate using one or more of the following: mechanical (vacuum), chemical, thermal, or UV bonding procedures. Such an array may contain any number of sptm and may be produced by hand or by using available devices, materials, and machines.
Microarrays may be prepared, used, and analyzed using methods known in the art. (See, e.g., s Brennan, T.M. et al. (1995) U.S. Patent No. 5,474,796; Schena, M. et al.
(1996) Proc. Natl. Acad. Sci.
USA 93:10614-10619; Baldeschweiler et al. (1995) PCT application W0951251 l 16; Shalon, D. et al.
(1995) PCT application W095/35505; Heller, R.A. et al. (1997) Proc. Natl.
Acad. Sci. USA 94:2150 2155; and Heller, M.J. et al. (1997) U.S. Patent No. 5,605,662.) Probes may be labeled by either PCR or enzymatic techniques using a variety of to commercially available reporter molecules. For example, commercial kits are available for radioactive and chemiluminescent labeling (Amersham Pharmacia Biotech) and for alkaline phosphatase labeling (Life Technologies). Alternatively, sptm may be cloned into commercially available vectors for the production of RNA probes. Such probes may be transcribed in the presence of at least one labeled nucleotide (e.g.,'ZP-ATP, Amersham Pharmacia Biotech).
is Additionally the polynucleotides of SEQ )D NO:1-26 or suitable fragments thereof can be used to isolate full length cDNA sequences utilizing hybridization and/or amplification procedures well known in the art, e.g., cDNA library screening, PCR amplification, etc.
The molecular cloning of such full length cDNA sequences may employ the method of cDNA library screening with probes using the hybridization, stringency, washing, and probing strategies described above and in Ausubel, 2o supra, Chapters 3, 5, and 6. These procedures may also be employed with genomic libraries to isolate genomic sequences of sptm in order to analyze, e.g., regulatory elements.
Genetic Mapping Gene identification and mapping are important in the investigation and treatment of almost all z5 conditions, diseases, and disorders. Cancer, cardiovascular disease, Alzheimer's disease, arthritis, diabetes,,and mental illnesses are of particular interest. Each of these conditions is more complex than the single gene defects of sickle cell anemia or cystic fibrosis, with select groups of genes being predictive of predisposition for a particular condition, disease, or disorder.
For example, cardiovascular disease may result from malfunctioning receptor molecules that fail to clear 3 o cholesterol from the bloodstream, and diabetes may result when a particular individual's immune system is activated by an infection and attacks the insulin-producing cells of the pancreas. In some studies, Alzheimer s disease has been linked to a gene on chromosome 21; other studies predict a different gene and location. Mapping of disease genes is a complex and reiterative process and generally proceeds from genetic linkage analysis to physical mapping.
35 As a condition is noted among members of a family, a genetic linkage map traces parts of chromosomes that are inherited in the same pattern as the condition.
Statistics link the inheritance of particular conditions to particular regions of chromosomes, as defined by RFLP
or other markers.
(See, for example, Lander, E. S. and Botstein, D. (1986) Proc. Natl. Acad.
Sci. USA 83:7353-7357.) Occasionally, genetic markers and their locations are known from previous studies. More often, however, the markers are simply stretches of DNA that differ among individuals. Examples of genetic linkage maps can be found in various scientific journals or at the Online Mendelian Inheritance in Man (OMIM) World Wide Web site.
In another embodiment of the invention, sptm sequences may be used to generate hybridization probes useful in chromosomal mapping of naturally occurring genomic sequences.
Either coding or noncoding sequences of sptm may be used, and in some instances, noncoding to sequences may be preferable over coding sequences. For example, conservation of an sptm coding sequence among members of a mufti-gene family may potentially cause undesired cross hybridization during chromosomal mapping. The sequences may be mapped to a particular chromosome, to a specific region of a chromosome, or to artificial chromosome constructions, e.g., human artificial chromosomes (HACs), yeast artificial chromosomes (YACs), bacterial artificial chromosomes (BACs), bacterial P1 constructions, or single chromosome cDNA libraries. (See, e.g., Harrington, J.J.
et al. (1997) Nat. Genet. 15:345-355; Price, C.M. (1993) Blood Rev. 7:127-134;
and Trask, B.J.
(1991) Trends Genet. 7:149-154.) Fluorescent in situ hybridization (FISH) may be correlated with other physical chromosome mapping techniques and genetic map data. (See, e.g., Meyers, supra, pp. 965-968.) Correlation 2o between the location of sptm on a physical chromosomal map and a specific disorder, or a predisposition to a specific disorder, may help define the region of DNA
associated with that disorder. The sptm sequences may also be used to detect polymorphisms that are genetically linked to the inheritance of a particular condition, disease, or disorder.
In situ hybridization of chromosomal preparations and genetic mapping techniques, such as z5 linkage analysis using established chromosomal markers, may be used for extending existing genetic maps. Often the placement of a gene on the chromosome of another mammalian species, such as mouse, may reveal associated markers even if the number or arm of the corresponding human chromosome is not known. These new marker sequences can be mapped to human chromosomes and may provide valuable information to investigators searching for disease genes using positional 3o cloning or other gene discovery techniques. Once a disease or syndrome has been crudely correlated by genetic linkage with a particular genomic region, e.g., ataxia-telangiectasia to l 1q22-23, any sequences mapping to that area may represent associated or regulatory genes for further investigation.
(See, e.g., Gatti, R.A. et al. (1988) Nature 336:577-580.) The nucleotide sequences of the subject invention may also be used to detect differences in chromosomal architecture due to translocation, 35 inversion, etc., among normal, carrier, or affected individuals.
Once a disease-associated gene is mapped to a chromosomal region, the gene must be cloned in order to identify mutations or other alterations (e.g., translocations or inversions) that may be correlated with disease. This process requires a physical map of the chromosomal region containing the disease-gene of interest along with associated markers. A physical map is necessary for s determining the nucleotide sequence of and order of marker genes on a particular chromosomal region. Physical mapping techniques are well known in the art and require the generation of overlapping sets of cloned DNA fragments from a particular organelle, chromosome, or genome.
These clones are analyzed to reconstruct and catalog their order. Once the position of a marker is determined, the DNA from that region is obtained by consulting the catalog and selecting clones from io that region. The gene of interest is located through positional cloning techniques using hybridization or similar methods.
Diagnostic Uses The sptm of the present invention may be used to design probes useful in diagnostic assays.
i5 Such assays, well known to those skilled in the art, may be used to detect or confirm conditions, disorders, or diseases associated with abnormal levels of sptm expression.
Labeled probes developed from sptm sequences are added to a sample under hybridizing conditions of desired stringency. In some instances, sptm, or fragments or oligonucleotides derived from sptm, may be used as primers in amplification steps prior to hybridization. The amount of hybridization complex formed is quantified 2o and compared with standards for that cell or tissue. If sptm expression varies significantly from the standard, the assay indicates the presence of the condition, disorder, or disease. Qualitative or quantitative diagnostic methods may include northern, dot blot, or other membrane or dip-stick based technologies or multiple-sample format technologies such as PCR, enzyme-linked immunosorbent assay (ELISA)-like, pin, or chip-based assays.
z5 The probes described above may also be used to monitor the progress of conditions, disorders, or diseases associated with abnormal levels of sptm expression, or to evaluate the efficacy of a particular therapeutic treatment. The candidate probe may be identified from the sptm that are specific to a given human tissue and have not been observed in GenBank or other genome databases.
Such a probe may be used in animal studies, preclinical tests, clinical trials, or in monitoring the 3 o treatment of an individual patient. In a typical process, standard expression is established by methods well known in the art for use as a basis of comparison, samples from patients affected by the disorder or disease are combined with the probe to evaluate any deviation from the standard profile, and a therapeutic agent is administered and effects are monitored to generate a treatment profile. Efficacy is evaluated by determining whether the expression progresses toward or returns to the standard 35 normal pattern. Treatment profiles may be generated over a period of several days or several months.
Statistical methods well known to those skilled in the art may be use to determine the significance of such therapeutic agents.
The polynucleotides are also useful for identifying individuals from minute biological samples, for example, by matching the RFLP pattern of a sample's DNA to that of an individual's s DNA. The polynucleotides of the present invention can also be used to determine the actual base-by-base DNA sequence of selected portions of an individual's genome.
These sequences can be used to prepare PCR primers for amplifying and isolating such selected DNA, which can then be sequenced. Using this technique, an individual can be identified through a unique set of DNA
sequences. Once a unique ID database is established for an individual, positive identification of that to individual can be made from extremely small tissue samples.
In a particular aspect, oligonucleotide primers derived from the sptm of the invention may be used to detect single nucleotide polymorphisms (SNPs). SNPs are substitutions, insertions and deletions that are a frequent cause of inherited or acquired genetic disease in humans. Methods of SNP detection include, but are not limited to, single-stranded conformation polymorphism (SSCP) is and fluorescent SSCP (fSSCP) methods. In SSCP, oligonucleotide primers derived from sptm are used to amplify DNA using the polymerase chain reaction (PCR). The DNA may be derived, for example, from diseased or normal tissue, biopsy samples, bodily fluids, and the like. SNPs in the DNA cause differences in the secondary and tertiary structures of PCR products in single-stranded form, and these differences are detectable using gel electrophoresis in non-denaturing gels. In 2o fSCCP, the oligonucleotide primers are fluorescently labeled, which allows detection of the amplimers in high-throughput equipment such as DNA sequencing machines.
Additionally, sequence database analysis methods, termed in silico SNP (isSNP), are capable of identifying polymorphisms by comparing the sequences of individual overlapping DNA fragments which assemble into a common consensus sequence. These computer-based methods filter out sequence variations due to 25 laboratory preparation of DNA and sequencing errors using statistical models and automated analyses of DNA sequence chromatograms. In the alternative, SNPs may be detected and characterized by mass spectrometry using, for example, the high throughput MASSARRAY system (Sequenom, Inc., San Diego CA).
DNA-based identification techniques are critical in forensic technology. DNA
sequences 3 o taken from very small biological samples such as tissues, e.g., hair or skin, or body fluids, e.g., blood, saliva, semen, etc., can be amplified using, e.g., PCR, to identify individuals. (See, e.g., Erlich, H.
(1992) PCR TechnoloQV, Freeman and Co., New York, NY). Similarly, polynucleotides of the present invention can be used as polymorphic markers.
There is also a need for reagents capable of identifying the source of a particular tissue.
3 5 Appropriate reagents can comprise, for example, DNA probes or primers prepared from the sequences of the present invention that are specific for particular tissues.
Panels of such reagents can identify tissue by species and/or by organ type. In a similar fashion, these reagents can be used to screen tissue cultures for contamination.
The polynucleotides of the present invention can also be used as molecular weight markers on nucleic acid gels or Southern blots, as diagnostic probes for the presence of a specific mRNA in a particular cell type, in the creation of subtracted cDNA libraries which aid in the discovery of novel polynucleotides, in selection and synthesis of oligomers for attachment to an array or other support, and as an antigen to elicit an immune response.
Disease Model Svstems Using-sptm The sptm of the invention or their mammalian homologs may be "knocked out" in an animal to model system using homologous recombination in embryonic stem (ES) cells.
Such techniques are well known in the art and are useful for the generation of animal models of human disease. (See, e.g., U.S. Patent Number 5,175,383 and U.S. Patent Number 5,767,337.) For example, mouse ES cells, such as the mouse 129/SvJ cell line, are derived from the early mouse embryo and grown in culture.
The ES cells are transformed with a vector containing the gene of interest disrupted by a marker gene, e.g., the neomycin phosphotransferase gene (neo; Capecchi, M.R. (1989) Science 244:1288-1292).
The vector integrates into the corresponding region of the host genome by homologous recombination. Alternatively, homologous recombination takes place using the Cre-IoxP system to knockout a gene of interest in a tissue- or developmental stage-specific manner (March, J.D. (1996) Clin. Invest. 97:1999-2002; Wagner, K.U. et al. (1997) Nucleic Acids Res.
25:4323-4330).
2o Transformed ES cells are identified and nucroinjected into mouse cell blastocysts such as those from the C57BL/6 mouse strain. The blastocysts are surgically transferred to pseudopregnant dams, and the resulting chimeric progeny are genotyped and bred to produce heterozygous or homozygous strains. Transgenic animals thus generated may be tested with potential therapeutic or toxic agents.
The sptm of the invention may also be manipulated in vitro in ES cells derived from human blastocysts. Human ES cells have the potential to differentiate into at least eight separate cell lineages including endoderm, mesoderm, and ectodermal cell types. These cell lineages differentiate into, for example, neural cells, hematopoietic lineages, and cardiomyocytes (Thomson, J.A. et al.
(1998) Science 282:1145-1147).
The sptm of the invention can also be used to create "knockin" humanized animals (pigs) or 3o transgenic animals (mice or rats) to model human disease. With knockin technology, a region of sptm is injected into animal ES cells, and the injected sequence integrates into the animal cell genome.
Transformed cells are injected into blastulae, and the blastulae are implanted as described above.
Transgenic progeny or inbred lines are studied and treated with potential pharmaceutical agents to obtain information on treatment of a human disease. Alternatively, a mammal inbred to overexpress sptm, resulting, e.g., in the secretion of SPTM in its milk, may also serve as a convenient source of that protein (Janne, J. et al. ( 1998) Biotechnol. Annu. Rev. 4:55-74).
Screening Assays SPTM encoded by polynucleotides of the present invention may be used to screen for molecules that bind to or are bound by the encoded polypeptides. The binding of the polypeptide and the molecule may activate (agonist), increase, inhibit (antagonist), or decrease activity of the polypeptide or the bound molecule. Examples of such molecules include antibodies, oligonucleotides, proteins (e.g., receptors), or small molecules.
Preferably, the molecule is closely related to the natural ligand of the polypeptide, e.g., a ligand or fragment thereof, a natural substrate, or a structural or functional mimetic. (See, Coligan et al., (1991) Current Protocols in Immunology 1(2): Chapter 5.) Similarly, the molecule can be closely to related to the natural receptor to which the polypeptide binds, or to at least a fragment of the receptor, e.g., the active site. In either case, the molecule can be rationally designed using known techniques.
Preferably, the screening for these molecules involves producing appropriate cells which express the polypeptide, either as a secreted protein or on the cell membrane. Preferred cells include cells from mammals, yeast, Drosophila, or E. coli. Cells expressing the polypeptide or cell membrane fractions i5 which contain the expressed polypeptide are then contacted with a test compound and binding, stimulation, or inhibition of activity of either the polypeptide or the molecule is analyzed.
An assay may simply test binding of a candidate compound to the polypeptide, wherein binding is detected by a fluorophore, radioisotope, enzyme conjugate, or other detectable label.
Alternatively, the assay may assess binding in the presence of a labeled competitor.
2o Additionally, the assay can be carried out using cell-free preparations, polypeptide/molecule affixed to a solid support, chemical libraries, or natural product mixtures.
The assay may also simply comprise the steps of mixing a candidate compound with a solution containing a polypeptide, measuring polypeptide/molecule activity or binding, and comparing the polypeptide/molecule activity or binding to a standard.
25 Preferably, an ELISA assay using, e.g., a monoclonal or polyclonal antibody, can measure polypeptide level in a sample. The antibody can measure polypeptide level by either binding, directly or indirectly, to the polypeptide or by competing with the polypeptide for a substrate.
All of the above assays can be used in a diagnostic or prognostic context. The molecules discovered using these assays can be used to treat disease or to bring about a particular result in a 3o patient (e.g., blood vessel growth) by activating or inhibiting the polypeptide/molecule. Moreover, the assays can discover agents which may inhibit or enhance the production of the polypeptide from suitably manipulated cells or tissues.
Transcript Imaging Another embodiment relates to the use of sptm to develop a transcript image of a tissue or s5 cell type. A transcript image is the collective pattern of gene expression by a particular tissue or cell type under given conditions and at a given time. This pattern of gene expression is defined by the number of expressed genes, their abundance, and their function. Thus the sptm of the present invention may be used to develop a transcript image of a tissue or cell type by hybridizing, preferably in a microarray format, the sptm of the present invention to the totality of transcripts or reverse transcripts of a tissue or cell type. The resultant transcript image would provide a profile of gene activity pertaining to cell signaling.
Transcript images which profile sptm expression may be generated using transcripts isolated from tissues, cell lines, biopsies, or other biological samples. The transcript image may thus reflect sptm expression in vivo, as in the case of a tissue or biopsy sample, or in vitro, as in the case of a cell line. Transcript images may be used to profile sptm expression in distinct tissue types. This process to can be used to determine cell signaling activity in a particular tissue type relative to this activity in a different tissue type. Transcript images may be used to generate a profile of sptm expression characteristic of diseased tissue. Transcript images of tissues before and after treatment may be used for diagnostic purposes, to monitor the progression of disease, and to monitor the efficacy of drug treatments for diseases which affect cell signaling.
Transcript images which profile sptm expression may also be used in conjunction with in vitro model systems and preclinical evaluation of pharmaceuticals. Transcript images of cell lines can be used to assess cell signaling activity and/or to identify cell lines that lack or nusregulate this activity. Such cell lines may then be treated with pharmaceutical agents, and a transcript image following treatment may indicate the efficacy of these agents in restoring desired levels of this 2 o activity. A similar approach may be used to assess the toxicity of pharmaceutical agents as reflected by undesirable changes in cell signaling. Candidate pharmaceutical agents may be evaluated by comparing their associated transcript images with those of pharmaceutical agents of known effectiveness.
Antisense Molecules 2 5 The polynucleotides of the present invention are useful in antisense technology. Antisense technology or therapy relies on the modulation of expression of a target protein through the specific binding of an antisense sequence to a target sequence encoding the target protein or directing its expression. (See, e.g., Agrawal, S., ed. (1996) Antisense Therapeutics, Humana Press Inc., Totawa NJ; Alama, A. et al. (1997) Pharmacol. Res. 36(3):171-178; Crooke, S.T. (1997) Adv. Pharmacol.
30 40:1-49; Sharma, H.W. and R. Narayanan (1995) Bioessays 17(12):1055-1063;
and Lavrosky, Y. et al. (1997) Biochem. Mol. Med. 62(1):11-22.) An antisense sequence is a polynucleotide sequence capable of specifically hybridizing to at least a portion of the target sequence. Antisense sequences bind to cellular mRNA and/or genomic DNA, affecting translation and/or transcription. Antisense sequences can be DNA, RNA, or nucleic acid mimics and analogs. (See, e.g., Rossi, J.J. et al. (1991) 35 Antisense Res. Dev. 1(3):285-288; Lee, R. et al. (1998) Biochemistry 37(3):900-1010; Pardridge, W.M. et al. (1995) Proc. Natl. Acad. Sci. USA 92(12):5592-5596; and Nielsen, P. E. and Haaima, G.
(1997) Chem. Soc. Rev. 96:73-78.) Typically, the binding which results in modulation of expression occurs through hybridization or binding of complementary base pairs. Antisense sequences can also bind to DNA duplexes through specific interactions in the major groove of the double helix.
The polynucleotides of the present invention and fragments thereof can be used as antisense sequences to modify the expression of the polypeptide encoded by sptm. The antisense sequences can be produced ex vivo, such as by using any of the ABI nucleic acid synthesizer series (PE
Biosystems) or other automated systems known in the art. Antisense sequences can also be produced biologically, such as by transforming an appropriate host cell with an expression vector containing the sequence of interest. (See, e.g., Agrawal, su ra.) to In therapeutic use, any gene delivery system suitable for introduction of the antisense sequences into appropriate target cells can be used. Antisense sequences can be delivered intracellularly in the form of an expression plasmid which, upon transcription, produces a sequence complementary to at least a portion of the cellular sequence encoding the target protein. (See, e.g., Slater, J.E., et al. (1998) J. Allergy Clin. Immunol. 102(3):469-475; and Scanlon, K.J., et al. (1995) 9(13):1288-1296.) Antisense sequences can also be introduced intracellularly through the use of viral vectors, such as retrovirus and adeno-associated virus vectors. (See, e.g., Miller, A.D. (1990) Blood 76:271; Ausubel, F.M. et al. (1995) Current Protocols in Molecular BioloQV, John Wiley &
Sons, New York NY; Uckert, W. and W. Walther (1994) Pharmacol. Ther. 63(3):323-347.) Other gene delivery mechanisms include liposome-derived systems, artificial viral envelopes, and other 2o systems known in the art. (See> e.g., Rossi> J.J. (1995) Br. Med. Bull.
51(1):217-225; Boado, R.J. et al. (1998) J. Pharm. Sci. 87(11):1308-1315; and Morris> M.C. et al. (1997) Nucleic Acids Res.
25( 14):2730-2736.) Expression In order to express a biologically active SPTM, the nucleotide sequences encoding SPTM or z5 fragments thereof may be inserted into an appropriate expression vector, 1.e., a vector which contains the necessary elements for transcriptional and translational control of the inserted coding sequence in a suitable host. Methods which are well known to those skilled in the art may be used to construct expression vectors containing sequences encoding SPTM and appropriate transcriptional and translational control elements. These methods include in vitro recombinant DNA
techniques, 3o synthetic techniques, and in vivo genetic recombination. (See, e.g., Sambrook, supra, Chapters 4, 8, 16, and 17; and Ausubel, supra, Chapters 9, I0, 13, and 16.) A variety of expression vector/host systems may be utilized to contain and express sequences encoding SPTM. These include, but are not linuted to, nucroorganisms such as bacteria transformed with recombinant bacteriophage, plasmid, or cosmid DNA expression vectors;
yeast transformed 35 with yeast expression vectors; insect cell systems infected with viral expression vectors (e.g., baculovirus); plant cell systems transformed with viral expression vectors (e.g., cauliflower mosaic virus, CaMV, or tobacco mosaic virus, TMV) or with bacterial expression vectors (e.g., Ti or pBR322 plasmids); or animal (mammalian) cell systems. (See, e.g., Sambrook, su ra; Ausubel, 1995, su~a, Van Heeke, G. and S.M. Schuster (1989) J. Biol. Chem. 264:5503-5509; Bitter, G.A. et al. (1987) Methods Enzymol. 153:516-544; Scorer, C.A. et al. (1994) Bio/Technology 12:181-184;
s Engelhard, E.K. et al. (1994) Proc. Natl. Acad. Sci. USA 91:3224-3227;
Sandig, V. et al. (1996) Hum. Gene Ther. 7:1937-1945; Takamatsu, N. (1987) EMBO J. 6:307-311; Coruzzi, G. et al. (1984) EMBO J. 3:1671-1680; Brogue, R. et al. (1984) Science 224:838-843; Winter, J.
et al. (1991) Results Probl. Cell Differ. 17:85-105; The McGraw Hill Yearbook of Science and TechnoloQy (1992) McGraw Hill, New York NY, pp. 191-196; Logan, J. and T. Shenk (1984) Proc. Natl. Acad.
to Sci. USA 81:3655-3659; and Harrington, J.J. et al. (1997) Nat. Genet.
15:345-355.) Expression vectors derived from retroviruses, adenoviruses, or herpes or vaccinia viruses, or from various bacterial plasmids, may be used for delivery of nucleotide sequences to the targeted organ, tissue, or cell population. (See, e.g., Di Nicola, M. et al. (1998) Cancer Gen. Ther.
5(6):350-356; Yu, M. et al., (1993) Proc. Natl. Acad. Sci. USA 90(13):6340-6344; Buller, R.M. et al. (1985) Nature 15 317(6040):813-815; McGregor, D.P. et al. (1994) Mol. Immunol. 31(3):219-226; and Verma, LM.
and N. Somia (1997) Nature 389:239-242.) The invention is not limited by the host cell employed.
For long term production of recombinant proteins in mammalian systems, stable expression of SPTM in cell lines is preferred. For example, sequences encoding SPTM can be transformed into cell lines using expression vectors which may contain viral origins of replication and/or endogenous zo expression elements and a selectable marker gene on the same or on a separate vector. Any number of selection systems may be used to recover transformed cell lines. (See, e.g., Wigler, M. et al.
(1977) Cell 11:223-232; Lowy, I. et al. (1980) Cell 22:817-823.; Wigler, M. et al. (1980) Proc. Natl.
Acad. Sci. USA 77:3567-3570; Colbere-Garapin, F. et al. (1981) J. Mol. Biol.
150:1-14; Hartman, S.C. and R.C.Mulligan (1988) Proc. Natl. Acad. Sci. USA 85:8047-8051; Rhodes, C.A. (1995) z5 Methods Mol. Biol. 55:121-131.) Therapeutic Uses of sptm The sptm of the invention may be used for somatic or germline gene therapy.
Gene therapy may be performed to (i) correct a genetic deficiency (e.g., in the cases of severe combined immunodeficiency (SCID)-X1 disease characterized by X-linked inheritance (Cavazzana-Calvo, M.
3 o et al. (2000) Science 288:669-672), severe combined immunodeficiency syndrome associated with an inherited adenosine deaminase (ADA) deficiency (Blaese, R.M. et al. ( 1995) Science 270:475-480;
Bordignon, C. et al. (1995) Science 270:470-475), cystic fibrosis (Zabner, J.
et al. (1993) Cell 75:207-216; Crystal, R.G. et al. (1995) Hum. Gene Therapy 6:643-666; Crystal, R.G. et al. (1995) Hum. Gene Therapy 6:667-703), thalassemias, familial hypercholesterolenva, and hemophilia 35 resulting from Factor VIII or Factor IX deficiencies (Crystal, R.G. (1995) Science 270:404-410;
Verma, LM. and Somia, N. ( 1997) Nature 389:239-242)), (ii) express a conditionally lethal gene product (e.g., in the case of cancers which result from unregulated cell proliferation), or (iii) express a protein which affords protection against intracellular parasites (e.g., against human retroviruses, such as human immunodeficiency virus (HIV) (Baltimore, D. (1988) Nature 335:395-396; Poeschla, E. et al. (1996) Proc. Natl. Acad. Sci. USA. 93:11395-11399), hepatitis B or C
virus (HBV, HCV);
s fungal parasites, such as Candida albicans and Paracoccidioides brasiliensis; and protozoan parasites such as Plasmodium falciparum and Trvnanosoma cruzi). In the case where a genetic deficiency in sptm expression or regulation causes disease, the expression of sptm from an appropriate population of transduced cells may alleviate the clinical manifestations caused by the genetic deficiency.
In a further embodiment of the invention, diseases or disorders caused by deficiencies in to sptm are treated by constructing mammalian expression vectors comprising sptm and introducing these vectors by mechanical means into sptm-deficient cells. Mechanical transfer technologies for use with cells in vivo or ex vitro include (i) direct DNA microinjection into individual cells, (ii) ballistic gold particle delivery, (iii) liposome-mediated transfection, (iv) receptor-mediated gene transfer, and (v) the use of DNA transposons (Morgan, R.A. and Anderson, W.F.
(1993) Annu. Rev.
15 Biochem. 62:191-217; Ivics, Z. (1997) Cell 91:501-510; Boulay, J-L. and Recipon, H. (1998) Curr.
Opin. Biotechnol. 9:445-450).
Expression vectors that may be effective for the expression of sptm include, but are not limited to, the PCDNA 3.1, EPTTAG, PRCCMV2, PREP, PVAX vectors (Invitrogen, Carlsbad CA), PCMV-SCRIPT, PCMV-TAG, PEGSH/PERV (Stratagene, La Jolla CA), and PTET-OFF, 2o PTET-ON, PTRE2, PTRE2-LUC, PTK-HYG (Clontech, Palo Alto CA). The sptm of the invention may be expressed using (i) a constitutively active promoter, (e.g., from cytomegalovirus (CMV), Rous sarcoma virus (RSV), SV40 virus, thymidine kinase (TK), or ~i-actin genes), (ii) an inducible promoter (e.g., the tetracycline-regulated promoter (Gossen, M. and Bujard, H.
(1992) Proc. Natl.
Acad. Sci. U.S.A. 89:5547-5551; Gossen, M. et al., (1995) Science 268:1766-1769; Rossi, F.M.V.
2s and Blau, H.M. (1998) Curr. Opin. Biotechnol. 9:451-456), commercially available in the T-REX
plasmid (Invitrogen)); the ecdysone-inducible promoter (available in the plasmids PVGRXR and PIND; Invitrogen); the FK506/rapamycin inducible promoter; or the RU486/mifepristone inducible promoter (Rossi, F.M.V. and Blau, H.M. su ra)), or (iii) a tissue-specific promoter or the native promoter of the endogenous gene encoding SPTM from a normal individual.
3 o Commercially available liposome transformation kits (e.g., the PERFECT
TRANSFECTION KIT, available from Invitrogen) allow one with ordinary skill in the art to deliver polynucleotides to target cells in culture and require minimal effort to optimize experimental parameters. In the alternative, transformation is performed using the calcium phosphate method (Graham, F.L. and Eb, A.J. (1973) Virology 52:456-467), or by electroporation (Neumann, E. et al.
35 (1982) EMBO J. 1:841-845). The introduction of DNA to primary cells requires modification of these standardized mammalian transfection protocols.
In another embodiment of the invention, diseases or disorders caused by genetic defects with respect to sptm expression are treated by constructing a retrovirus vector consisting of (i) sptm under the control of an independent promoter or the retrovirus long terminal repeat (LTR) promoter, (ii) appropriate RNA packaging signals, and (iii) a Rev-responsive element (RRE) along with additional retrovirus cis-acting RNA sequences and coding sequences required for efficient vector propagation.
Retrovirus vectors (e.g., PFB and PFBNEO) are commercially available (Stratagene) and are based on published data (Riviere, I. et al. (1995) Proc. Natl. Acad. Sci. U.S.A.
92:6733-6737), incorporated by reference herein. The vector is propagated in an appropriate vector producing cell line (VPCL) that expresses an envelope gene with a tropism for receptors on the target cells or a promiscuous 1o envelope protein such as VSVg (Armentano, D. et al. (1987) J. Virol.
61:1647-1650; Bender, M.A. et al. (1987) J. Virol. 61:1639-1646; Adam, M.A. and Miller, A.D. (1988) J.
Virol. 62:3802-3806; Dull, T. et al. (1998) J. Virol. 72:8463-8471; Zufferey, R. et al. (1998) J. Virol.
72:9873-9880). U.S.
Patent Number 5,910,434 to Rigg ("Method for obtaining retrovirus packaging cell lines producing high transducing efficiency retroviral supernatant") discloses a method for obtaining retrovirus packaging cell lines and is hereby incorporated by reference. Propagation of retrovirus vectors, transduction of a population of cells (e.g., CD4+ T-cells), and the return of transduced cells to a patient are procedures well known to persons skilled in the art of gene therapy and have been well documented (Ranga, U. et al. (1997) J. Virol. 71:7020-7029; Bauer, G. et al.
(1997) Blood 89:2259-2267; Bonyhadi, M.L. (1997) J. Virol. 71:4707-4716; Ranga, U. et al. (1998) Proc. Natl. Acad. Sci.
2o U.S.A. 95:1201-1206; Su, L. (1997) Blood 89:2283-2290).
In the alternative, an adenovirus-based gene therapy delivery system is used to deliver sptm to cells which have one or more genetic abnormalities with respect to the expression of sptm. The construction and packaging of adenovirus-based vectors are well known to those with ordinary skill in the art. Replication defective adenovirus vectors have proven to be versatile for importing genes z5 encoding imrnunoregulatory proteins into intact islets in the pancreas (Csete, M.E. et al. (1995) Transplantation 27:263-268). Potentially useful adenoviral vectors are described in U.S. Patent Number 5,707,618 to Armentano ("Adenovirus vectors for gene therapy"), hereby incorporated by reference. For adenoviral vectors, see also Antinozzi, P.A. et al. (1999) Annu. Rev. Nutr.
19:511-544 and Verma, LM. and Somia, N. (1997) Nature 18:389:239-242, both incorporated by 3 o reference herein.
In another alternative, a herpes-based, gene therapy delivery system is used to deliver sptm to target cells which have one or more genetic abnormalities with respect to the expression of sptm.
The use of herpes simplex virus (HSV)-based vectors may be especially valuable for introducing sptm to cells of the central nervous system, for which HSV has a tropism. The construction and 35 packaging of herpes-based vectors are well known to those with ordinary skill in the art. A
replication-competent herpes simplex virus (HSV) type 1-based vector has been used to deliver a reporter gene to the eyes of primates (Liu, X. et al. (1999) Exp. Eye Res.169:385-395). The construction of a HSV-1 virus vector has also been disclosed in detail in U.S.
Patent Number 5,804,413 to DeLuca ("Herpes simplex virus strains for gene transfer"), which is hereby incorporated by reference. U.S. Patent Number 5,804,413 teaches the use of recombinant HSV
d92 which consists of a genome containing at least one exogenous gene to be transferred to a cell under the control of the appropriate promoter for purposes including human gene therapy.
Also taught by this patent are the construction and use of recombinant HSV strains deleted for ICP4, ICP27 and ICP22.
For HSV vectors, see also Goins, W. F. et al. 1999 J. Virol. 73:519-532 and Xu, H. et al., (1994) Dev. Biol. 163:152-161, hereby incorporated by reference. The manipulation of cloned herpesvirus to sequences, the generation of recombinant virus following the transfection of multiple plasmids , containing different segments of the large herpesvirus genomes, the growth and propagation of herpesvirus, and the infection of cells with herpesvirus are techniques well known to those of ordinary skill in the art.
In another alternative, an alphavirus (positive, single-stranded RNA virus) vector is used to deliver sptm to target cells. The biology of the prototypic alphavirus, Semliki Forest Virus (SFV), has been studied extensively and gene transfer vectors have been based on the SFV genome (Garoff, H. and Li, K-J. (1998) Curr. Opin. Biotech. 9:464-469). During alphavirus RNA
replication, a subgenomic RNA is generated that normally encodes the viral capsid proteins.
This subgenomic RNA replicates to higher levels than the full-length genomic RNA, resulting in the overproduction of 2o capsid proteins relative to the viral proteins with enzymatic activity (e.g., protease and polymerase).
Similarly, inserting sptm into the alphavirus genome in place of the capsid-coding region results in the production of a large number of sptm RNAs and the synthesis of high levels of SPTM in vector transduced cells. While alphavirus infection is typically associated with cell lysis within a few days, the ability to establish a persistent infection in hamster normal kidney cells (BHK-21) with a variant of Sindbis virus (SIN) indicates that the lytic replication of alphaviruses can be altered to suit the needs of the gene therapy application (Dryga, S.A. et al. (1997) Virology 228:74-83). The wide host range of alphaviruses will allow the introduction of SPTM into a variety of cell types. The specific transduction of a subset of cells in a population may require the sorting of cells prior to transduction.
The methods of manipulating infectious cDNA clones of alphaviruses, performing alphavirus cDNA
3o and RNA transfections, and performing alphavirus infections, are well known to those with ordinary skill in the art.
Antibodies Anti-SPTM antibodies may be used to analyze protein expression levels. Such antibodies include, but are not limited to, polyclonal, monoclonal, chimeric, single chain, and Fab fragments.
For descriptions of and protocols of antibody technologies, see, e.g., Pound J.D. ( 1998) Immunochemical Protocols, Humana Press, Totowa, NJ.
The amino acid sequence encoded by the sptm of the Sequence Listing may be analyzed by appropriate software (e.g., LASERGENE NAVIGATOR software, DNASTAR) to determine regions s of high immunogenicity. The optimal sequences for immunization are selected from the C-terminus, the N-terminus, and those intervening, hydrophilic regions of the polypeptide which are likely to be exposed to the external environment when the polypeptide is in its natural conformation. Analysis used to select appropriate epitopes is also described by Ausubel (1997, supra, Chapter 11.7).
Peptides used for antibody induction do not need to have biological activity;
however, they must be to antigenic. Peptides used to induce specific antibodies may have an amino acid sequence consisting of at five amino acids, preferably at least 10 amino acids, and most preferably l5 amino acids. A
peptide which mimics an antigenic fragment of the natural polypeptide may be fused with another protein such as keyhole limpet cyanin (KLH; Sigma, St. Louis MO) for antibody production. A
peptide encompassing an antigenic region may be expressed from an sptm, synthesized as described 15 above, or purified from human cells.
Procedures well known in the art may be used for the production of antibodies.
Various hosts including mice, goats, and rabbits, may be immunized by injection with a peptide. Depending on the host species, various adjuvants may be used to increase immunological response.
In one procedure, peptides about 15 residues in length may be synthesized using an ABI
zo 431A peptide synthesizer (PE Biosystems) using fmoc-chemistry and coupled to KLH (Sigma) by reaction with M-maleimidobenzoyl-N-hydroxysuccinimide ester (Ausubel, 1995, su ra . Rabbits are immunized with the peptide-KLH complex in complete Freund's adjuvant. The resulting antisera are tested for antipeptide activity by binding the peptide to plastic, blocking with 1 % bovine serum albumin (BSA), reacting with rabbit antisera, washing, and reacting with radioiodinated goat anti-25 rabbit IgG. Antisera with antipeptide activity are tested for anti-SPTM
activity using protocols well known in the art, including ELISA, radioimmunoassay (RIA), and immunoblotting.
In another procedure, isolated and purified peptide may be used to immunize mice (about 100 pg of peptide) or rabbits (about 1 mg of peptide). Subsequently, the peptide is radioiodinated and used to screen the immunized animals' B-lymphocytes for production of antipeptide antibodies.
3o Positive cells are then used to produce hybridomas using standard techniques. About 20 mg of peptide is sufficient for labeling and screening several thousand clones.
Hybridomas of interest are detected by screening with radioiodinated peptide to identify those fusions producing peptide-specific monoclonal antibody. In a typical protocol, wells of a multi-well plate (FAST, Becton-Dickinson, Palo Alto, CA) are coated with affinity-purified, specific rabbit-anti-mouse (or suitable 35 anti-species IgG) antibodies at 10 mg/ml. The coated wells are blocked with 1 % BSA and washed and exposed to supernatants from hybridomas. After incubation, the wells are exposed to radiolabeled peptide at 1 mg/ml.
Clones producing antibodies bind a quantity of labeled peptide that is detectable above background. Such clones are expanded and subjected to 2 cycles of cloning.
Cloned hybridomas are injected into pristane-treated mice to produce ascites, and monoclonal antibody is purified from the ascitic fluid by affinity chromatography on protein A (Amersham Pharmacia Biotech). Several procedures for the production of monoclonal antibodies, including in vitro production, are described in Pound su ra). Monoclonal antibodies with antipeptide activity are tested for anti-SPTM activity using protocols well known in the art, including ELISA, RIA, and immunoblotting.
to Antibody fragments containing specific binding sites for an epitope may also be generated.
For example, such fragments include, but are not limited to, the F(ab~2 fragments produced by pepsin digestion of the antibody molecule, and the Fab fragments generated by reducing the disulfide bridges of the F(ab~2 fragments. Alternatively, construction of Fab expression libraries in filamentous bacteriophage allows rapid and easy identification of monoclonal fragments with desired specificity (Pound, supra, Chaps. 45-47). Antibodies generated against polypeptide encoded by sptm can be used to purify and characterize full-length SPTM protein and its activity, binding partners, etc.
Assays Using Antibodies Anti-SPTM antibodies may be used in assays to quantify the amount of SPTM
found in a 2o particular human cell. Such assays include methods utilizing the antibody and a label to detect expression level under normal or disease conditions. The peptides and antibodies of the invention may be used with or without modification or labeled by joining them, either covalently or noncovalently, with a reporter molecule.
Protocols for detecting and measuring protein expression using either polyclonal or monoclonal antibodies are well known in the art. Examples include ELISA, RIA, and fluorescent activated cell sorting (FACS). Such immunoassays typically involve the formation of complexes between the SPTM and its specific antibody and the measurement of such complexes. These and other assays are described in Pound (su ra).
Without further elaboration, it is believed that one skilled in the art can, using the preceding 3o description, utilize the present invention to its fullest extent. The following preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.
The disclosures of all patents, applications, and publications mentioned above and below, in particular U.S. Ser. No. 60/147,501, and U.S. Ser. No. 60/147,500 are hereby expressly incorporated by reference.
EXAMPLES
I. Construction of cDNA Libraries RNA was purchased from CLONTECH Laboratories, Inc. (Palo Alto CA) or isolated from various tissues. Some tissues were homogenized and lysed in guanidinium isothiocyanate, while others were homogenized and lysed in phenol or in a suitable mixture of denaturants, such as TRIZOL (Life Technologies), a monophasic solution of phenol and guanidine isothiocyanate. The resulting lysates were centrifuged over CsCI cushions or extracted with chloroform. RNA was precipitated with either isopropanol or sodium acetate and ethanol, or by other routine methods.
Phenol extraction and precipitation of RNA were repeated as necessary to increase RNA
to purity. In most cases, RNA was treated with DNase. For most libraries, poly(A+) RNA was isolated using oligo d(T)-coupled paramagnetic particles (Promega Corporation (Promega), Madison WI), OLIGOTEX latex particles (QIAGEN, Inc. (QIAGEN), Valencia CA), or an OLIGOTEX
mRNA
purification kit (QIAGEN). Alternatively, RNA was isolated directly from tissue lysates using other RNA isolation kits, e.g., the POLY(A)PURE mRNA purification kit (Ambion, Inc., Austin TX).
In some cases, Stratagene was provided with RNA and constructed the corresponding cDNA
libraries. Otherwise, cDNA was synthesized and cDNA libraries were constructed with the UNIZAP
vector system (Stratagene Cloning Systems, Inc. (Stratagene), La Jolla CA) or SUPERSCRIPT
plasmid system (Life Technologies), using the recommended procedures or similar methods known in the art. (See, e.g., Ausubel, 1997, supra, Chapters 5.1 through 6.6.) Reverse transcription was 2o initiated using oligo d(T) or random primers. Synthetic oligonucleotide adapters were ligated to double stranded cDNA, and the cDNA was digested with the appropriate restriction enzyme or enzymes. For most libraries, the cDNA was size-selected (300-1000 bp) using SEPHACRYL SI000, SEPHAROSE CL2B, or SEPHAROSE CL4B column chromatography (Amersham Pharmacia Biotech) or preparative agarose gel electrophoresis. cDNAs were ligated into compatible restriction enzyme sites of the polylinker of a suitable plasmid, e.g., PBLUESCRIPT
plasmid (Stratagene), pSPORTI plasmid (Life Technologies), or pINCY (Incyte). Recombinant plasmids were transformed into competent E. coli cells including XL1-Blue, XL1-BIueMRF, or SOLR from Stratagene or DHSa, DHlOB, or ElectroMAX DH10B from Life Technologies.
3 o II. Isolation of cDNA Clones Plasmids were recovered from host cells by in vivo excision using the UNIZAP
vector system (Stratagene) or by cell lysis. Plasmids were purified using at least one of the following: the Magic or WIZARD Minipreps DNA purification system (Promega); the AGTC Miniprep purification kit (Edge BioSystems, Gaithersburg MD); and the QIAWELL 8, QIAWELL 8 Plus, and QIAWELL 8 Ultra plasmid purification systems or the R.E.A.L. PREP 96 plasmid purification kit (QIAGEN). Following precipitation, plasmids were resuspended in 0.1 ml of distilled water and stored, with or without lyophilization, at 4°C.
Alternatively, plasmid DNA was amplified from host cell lysates using direct link PCR in a high-throughput format. (Rao, V.B. (1994) Anal. Biochem. 216:1-14.) Host cell lysis and thermal cycling steps were carried out in a single reaction mixture. Samples were processed and stored in 384-well plates, and the concentration of amplified plasmid DNA was quantified fluorometrically using PICOGREEN dye (Molecular Probes, Inc. (Molecular Probes), Eugene OR) and a FLUOROSKAN II fluorescence scanner (Labsystems Oy, Helsinki, Finland).
to III. Sequencing and Analysis cDNA sequencing reactions were processed using standard methods or high-throughput instrumentation such as the ABI CATALYST 800 thermal cycler (PE Biosystems) or the PTC-200 thermal cycler (MJ Research) in conjunction with the HYDRA microdispenser (Robbins Scientific Corp., Sunnyvale CA) or the MICROLAB 2200 liquid transfer system (Hamilton).
cDNA
i5 sequencing reactions were prepared using reagents provided by Amersham Pharmacia Biotech or supplied in ABI sequencing kits such as the ABI PRISM BIGDYE Terminator cycle sequencing ready reaction kit (PE Biosystems). Electrophoretic separation of cDNA
sequencing reactions and detection of labeled polynucleotides were carried out using the MEGABACE 1000 DNA sequencing system (Molecular Dynamics); the ABI PRISM 373 or 377 sequencing system (PE
Biosystems) in 2 o conjunction with standard ABI protocols and base calling software; or other sequence analysis systems known in the art. Reading frames within the cDNA sequences were identified using standard methods (reviewed in Ausubel, 1997, supra, Chapter 7.7). Some of the cDNA sequences were selected for extension using the techniques disclosed in Example VIII.
2 s IV. Assembly and Analysis of Sequences Component sequences from chromatograms were subject to PHRED analysis and assigned a quality score. The sequences having at least a required quality score were subject to various pre-processing editing pathways to eliminate, e.g., low quality 3' ends, vector and linker sequences, polyA tails, Alu repeats, mitochondrial and ribosomal sequences, bacterial contamination sequences, 3 o and sequences smaller than 50 base pairs. In particular, low-information sequences and repetitive elements (e.g., dinucleotide repeats, Alu repeats, etc.) were replaced by "n's", or masked, to prevent spurious matches.
Processed sequences were then subject to assembly procedures in which the sequences were assigned to gene bins (bins). Each sequence could only belong to one bin.
Sequences in each gene 35 bin were assembled to produce consensus sequences (templates). Subsequent new sequences were added to existing bins using BLASTn (v.1.4 WashU) and CROSSMATCH. Candidate pairs were identified as all BLAST hits having a quality score greater than or equal to 150. Alignments of at least 82% local identity were accepted into the bin. The component sequences from each bin were assembled using a version of PHRAP. Bins with several overlapping component sequences were assembled using DEEP PHRAP. The orientation (sense or antisense) of each assembled template was determined based on the number and orientation of its component sequences.
Template sequences as disclosed in the sequence listing correspond to sense strand sequences (the "forward"
reading frames), to the best determination. The complementary (antisense) strands are inherently disclosed herein. The component sequences which were used to assemble each template consensus sequence are listed in Table 3, along with their positions along the template nucleotide sequences.
to Bins were compared against each other and those having local similarity of at least 82%
were combined and reassembled. Reassembled bins having templates of insufficient overlap (less than 95% local identity) were re-split. Assembled templates were also subject to analysis by STITCHER/EXON MAPPER algorithms which analyze the probabilities of the presence of splice variants, alternatively spliced exons, splice junctions, differential expression of alternative spliced is genes across tissue types or disease states, etc. These resulting bins were subject to several rounds of the above assembly procedures.
Once gene bins were generated based upon sequence alignments, bins were clone joined based upon clone information. If the S' sequence of one clone was present in one bin and the 3' sequence from the same clone was present in a different bin, it was likely that the two bins actually 2 o belonged together in a single bin. The resulting combined bins underwent assembly procedures to regenerate the consensus sequences.
The final assembled templates were subsequently annotated using the following procedure.
Template sequences were analyzed using BLASTn (v2.0, NCBI) versus gbpri (GenBank version 116). "Hits" were defined as an exact match having from 95% local identity over 200 base pairs 25 through 100% local identity over 100 base pairs, or a homolog match having an E-value, i.e. a probability score, of s 1 x 10-g. The hits were subject to frameshift FASTx versus GENPEPT
(GenBank version 116). (See Table 4). In this analysis, a homolog match was defined as having an E-value of <_ 1 x 10-8. The assembly method used above was described in "System and Methods for Analyzing Biomolecular Sequences," U.S.S.N. 09/276,534, filed March 25, 1999, and the LIFESEQ
3 o Gold user manual (Incyte) both incorporated by reference herein.
Following assembly, template sequences were subjected to motif, BLAST, and functional analyses, and categorized in protein hierarchies using methods described in, e.g., "Database System Employing Protein Function Hierarchies for Viewing Biomolecular Sequence Data," U.S.S.N.
08/812,290, filed March 6, 1997; "Relational Database for Storing Biomolecule Information,"
35 U.S.S.N. 08/947,845, filed October 9, 1997; "Project-Based Full-Length Biomolecular Sequence Database," U.S.S.N. 08/811,758, filed March 6, 1997; and "Relational Database and System for Storing Information Relating to Biomolecular Sequences," U.S.S.N. 09/034,807, filed March 4, 1998, all of which are incorporated by reference herein.
The template sequences are further analyzed by translating each template in all three forward reading frames and searching each translation against the Pfam database of hidden Markov model-s based protein families and domains using the HMMER software package (available to the public from Washington University School of Medicine, St. Louis MO). (See also World Wide Web site http://pfam.wustl.edu/ for detailed descriptions of Pfam protein domains and families.) Additionally, the template sequences were translated in all three forward reading frames and each translation was searched against hidden Markov models for signal peptide and transmembrane to domains using the HMMER software package. Construction of hidden Markov models and their usage in sequence analysis has been described. (See, for example, Eddy, S.R.
(1996) Curr. Opin. Str.
Biol. 6:361-365.) Segments of templates which, when translated, contain similarity to signal peptide or transmembrane domain consensus sequences are reported in Table 2. Only those signal peptide or transmembrane hits with a cutoff score of 11 bits or greater are reported. A
cutoff score of 11 bits or 15 greater corresponds to at least about 91-94% true-positives in signal peptide prediction, and at least about 75% true-positives in transmembrane domain prediction.
The results of BLAST analysis as reported in Table 1 may support the results of HMMER
analysis as reported in Table 2 or may suggest alternative or additional properties of template-encoded secretory polypeptides not previously uncovered by HMMER or other analyses.
2o Template sequences are further analyzed using the bioinformatics tools listed in Table 4, or using sequence analysis software known in the art such as MACDNASIS PRO
software (Hitachi Software Engineering, South San Francisco CA) and LASERGENE software (DNASTAR).
Template sequences may be further queried against public databases such as the GenBank rodent, mammalian, vertebrate, prokaryote, and eukaryote databases.
V. Analysis of Polynucleotide Expression Northern analysis is a laboratory technique used to detect the presence of a transcript of a gene and involves the hybridization of a labeled nucleotide sequence to a membrane on which RNAs from a particular cell type or tissue have been bound. (See, e.g., Sambrook, s. unra, ch. 7; Ausubel, 1995, supra, ch. 4 and 16.) Analogous computer techniques applying BLAST are used to search for identical or related molecules in cDNA databases such as GenBank or LIFESEQ (Incyte Pharmaceuticals). This analysis is much faster than multiple membrane-based hybridizations. In addition, the sensitivity of the computer search can be modified to determine whether any particular match is categorized as exact or similar. The basis of the search is the product score, which is defined as:
BLAST Score x Percent Identity x minimum { length(Seq. 1 ), length(Seq. 2) }
The product score takes into account both the degree of similarity between two sequences and the 5 length of the sequence match. The product score is a normalized value between 0 and 100, and is calculated as follows: the BLAST score is multiplied by the percent nucleotide identity and the product is divided by (5 times the length of the shorter of the two sequences). The BLAST score is calculated by assigning a score of +5 for every base that matches in a high-scoring segment pair (HSP), and -4 for every mismatch. Two sequences may share more than one HSP
(separated by to gaps). If there is more than one HSP, then the pair with the highest BLAST
score is used to calculate the product score. The product score represents a balance between fractional overlap and quality in a BLAST alignment. For example, a product score of 100 is produced only for 100%
identity over the entire length of the shorter of the two sequences being compared. A product score of 70 is produced either by 100% identity and 70% overlap at one end, or by 88% identity and 100% overlap at the i5 other. A product score of 50 is produced either by 100% identity and SO%
overlap at one end, or 79% identity and 100% overlap.
VI. Tissue Distribution Profiling A tissue distribution profile is determined for each template by compiling the cDNA library 2o tissue classifications of its component cDNA sequences. Each component sequence, is derived from a cDNA library constructed from a human tissue. Each human tissue is classified into one of the following categories: cardiovascular system; connective tissue; digestive system; embryonic structures; endocrine system; exocrine glands; genitalia, female; genitalia, male; germ cells; heroic and immune system; liver; musculoskeletal system; nervous system; pancreas;
respiratory system;
25 sense organs; skin; stomatognathic system; unclassified/mixed; or urinary tract. Template sequences, component sequences, and cDNA library/tissue information are found in the LIFESEQ
GOLD database (Incyte Genomics, Palo Alto CA).
VII. Transcript Image Analysis 3o Transcript images are generated as described in Seilhamer et al., "Comparative Gene Transcript Analysis," U.S. Patent Number 5,840,484, incorporated herein by reference.
VIII. Extension of Polynucleotide Sequences and Isolation of a Full-length cDNA
Oligonucleotide primers designed using an sptm of the Sequence Listing are used to extend 35 the nucleic acid sequence. One primer is synthesized to initiate 5' extension of the template, and the other primer, to initiate 3' extension of the template. The initial primers may be designed using OLIGO 4.06 software (National Biosciences, Inc. (National Biosciences), Plymouth MN), or another appropriate program, to be about 22 to 30 nucleotides in length, to have a GC
content of about 50%
or more, and to anneal to the target sequence at temperatures of about 68°C to about 72°C. Any stretch of nucleotides which would result in hairpin structures and primer-primer dimerizations are avoided. Selected human cDNA libraries are used to extend the sequence. If more than one extension is necessary or desired, additional or nested sets of primers are designed.
High fidelity amplification is obtained by PCR using methods well known in the art. PCR is performed in 96-well plates using the PTC-200 thermal cycler (MJ Research).
The reaction mix contains DNA template, 200 nmol of each primer, reaction buffer containing Mg2+, (NH4)zS04, and to B-mercaptoethanol, Taq DNA polymerase (Amersham Pharmacia Biotech), ELONGASE enzyme (Life Technologies), and Pfu DNA polymerase (Stratagene), with the following parameters for primer pair PCI A and PCI B: Step 1: 94°C, 3 min; Step 2: 94°C, 15 sec; Step 3: 60°C, 1 min; Step 4: 68°C, 2 min; Step 5: Steps 2, 3, and 4 repeated 20 times; Step 6:
68°C, 5 min; Step 7: storage at 4°C. In the alternative, the parameters for primer pair T7 and SK+ are as follows: Step 1: 94°C, 3 15 min; Step 2: 94°C, 15 sec; Step 3: 57°C, 1 min; Step 4:
68°C, 2 min; Step 5: Steps 2, 3, and 4 repeated 20 times; Step 6: 68°C, 5 min; Step 7: storage at 4°C.
The concentration of DNA in each well is determined by dispensing 100 p1 PICOGREEN
quantitation reagent (0.25% (v/v); Molecular Probes) dissolved in 1X Tris-EDTA
(TE) and 0.5 p1 of undiluted PCR product into each well of an opaque fluorimeter plate (Corning Incorporated 20 (Corning), Corning NY), allowing the DNA to bind to the reagent. The plate is scanned in a FLUOROSKAN II (Labsystems Oy) to measure the fluorescence of the sample and to quantify the concentration of DNA. A 5 p1 to 10 p1 aliquot of the reaction nuxture is analyzed by electrophoresis on a 1 % agarose nuni-gel to determine which reactions are successful in extending the sequence.
The extended nucleotides are desalted and concentrated, transferred to 384-well plates, 2s digested with CviJI cholera virus endonuclease (Molecular Biology Research, Madison WI), and sonicated or sheared prior to religation into pUC 18 vector (Amersham Pharmacia Biotech). For shotgun sequencing, the digested nucleotides are separated on low concentration (0.6 to 0.8%) agarose gels, fragments are excised, and agar digested with AGAR ACE
(Promega). Extended clones are religated using T4 ligase (New England Biolabs, Inc., Beverly MA) into pUC 18 vector 30 (Amersham Pharmacia Biotech), treated with Pfu DNA polymerase (Stratagene) to fill-in restriction site overhangs, and transfected into competent E. coli cells. Transformed cells are selected on antibiotic-containing media, individual colonies are picked and cultured overnight at 37°C in 384-well plates in LB/2x carbenicillin liquid media.
The cells are lysed, and DNA is amplified by PCR using Taq DNA polymerase (Amersham 35 Pharmacia Biotech) and Pfu DNA polymerase (Stratagene) with the following parameters: Step 1:
94°C, 3 min; Step 2: 94°C, IS sec; Step 3: 60°C, 1 min;
Step 4: 72°C, 2 min; Step 5: steps 2, 3, and 4 repeated 29 times; Step 6: 72°C, 5 min; Step 7: storage at 4°C. DNA is quantified by PICOGREEN reagent (Molecular Probes) as described above. Samples with low DNA
recoveries are reamplified using the same conditions as described above. Samples are diluted with 20%
dimethysulfoxide (1:2, v/v), and sequenced using DYENAMIC energy transfer sequencing primers and the DYENAMIC DIRECT kit (Amersham Pharmacia Biotech) or the ABI PRISM
BIGDYE
Terminator cycle sequencing ready reaction kit (PE Biosystems).
In like manner, the sptm is used to obtain regulatory sequences (promoters, introns, and enhancers) using the procedure above, oligonucleotides designed for such extension, and an appropriate genomic library.
IX. Labeling of Probes and Southern Hybridization Analyses Hybridization probes derived from the sptm of the Sequence Listing are employed for screening cDNAs, mRNAs, or genomic DNA. The labeling of probe nucleotides between 100 and 1000 nucleotides in length is specifically described, but essentially the same procedure may be used is with larger cDNA fragments. Probe sequences are labeled at room temperature for 30 minutes using a T4 polynucleotide kinase, y3zP-ATP, and O.SX One-Phor-All Plus (Amersham Pharmacia Biotech) buffer and purified using a ProbeQuant G-50 Microcolumn (Amersham Pharmacia Biotech). The probe mixture is diluted to 10' dpm/pg/ml hybridization buffer and used in a typical membrane-based hybridization analysis.
2 o The DNA is digested with a restriction endonuclease such as Eco RV and is electrophoresed through a 0.7% agarose gel. The DNA fragments are transferred from the agarose to nylon membrane (NYTRAN Plus, Schleicher & Schuell, Inc., Keene NH) using procedures specified by the manufacturer of the membrane. Prehybridization is carried out for three or more hours at 68°C, and hybridization is carried out overnight at 68°C. To remove non-specific signals, blots are 25 sequentially washed at room temperature under increasingly stringent conditions, up to O. lx saline sodium citrate (SSC) and 0.5% sodium dodecyl sulfate. After the blots are placed in a PHOSPHORIMAGER cassette (Molecular Dynamics) or are exposed to autoradiography film, hybridization patterns of standard and experimental lanes are compared.
Essentially the same procedure is employed when screening RNA.
X. Chromosome Mapping of sptm The cDNA sequences which were used to assemble SEQ ID NO:1-26 are compared with sequences from the Incyte LIFESEQ database and public domain databases using BLAST and other implementations of the Smith-Waterman algorithm. Sequences from these databases that match SEQ
ID NO:1-26 are assembled into clusters of contiguous and overlapping sequences using assembly algorithms such as PHRAP (Table 4). Radiation hybrid and genetic mapping data available from public resources such as the Stanford Human Genome Center (SHGC), Whitehead Institute for Genome Research (WIGR), and Genethon are used to determine if any of the clustered sequences have been previously mapped. Inclusion of a mapped sequence in a cluster will result in the assignment of all sequences of that cluster, including its particular SEQ ID
NO:, to that map location.
The genetic map locations of SEQ ID NO:1-26 are described as ranges, or intervals, of human chromosomes. The map position of an interval, in centiMorgans, is measured relative to the terminus of the chromosome's p-arm. (The centiMorgan (cM) is a unit of measurement based on recombination frequencies between chromosomal markers. On average, 1 cM is roughly equivalent to 1 megabase (Mb) of DNA in humans, although this can vary widely due to hot and cold spots of to recombination.) The cM distances are based on genetic markers mapped by Genethon which provide boundaries for radiation hybrid markers whose sequences were included in each of the clusters.
XI. Microarray Analysis Probe Preparation from Tissue or Cell Samples is Total RNA is isolated from tissue samples using the guanidinium thiocyanate method and polyA+ RNA is purified using the oligo (dT) cellulose method. Each polyA+ RNA
sample is reverse transcribed using MMLV reverse-transcriptase, 0.05 pg/lrl oligo-dT primer (2lmer), 1X first strand buffer, 0.03 units/pl RNase inhibitor, 500 NM dATP, 500 pM dGTP, 5001rM dTTP, 40 pM dCTP, 40 pM dCTP-Cy3 (BDS) or dCTP-Cy5 (Amersham Pharmacia Biotech). The reverse transcription 2o reaction is performed in a 25 ml volume containing 200 ng polyA+ RNA with GEMBRIGHT kits (Incyte). Specific control polyA+ RNAs are synthesized by in vitro transcription from non-coding yeast genomic DNA (W. Lei, unpublished). As quantitative controls, the control mRNAs at 0.002 ng, 0.02 ng, 0.2 ng, and 2 ng are diluted into reverse transcription reaction at ratios of 1:100,000, 1:10,000, 1:1000, I :100 (w1w) to sample mRNA respectively. The control mRNAs are diluted into 25 reverse transcription reaction at ratios of 1:3, 3:1, 1:10, 10:1, 1:25, 25:1 (w/w) to sample mRNA
differential expression patterns. After incubation at 37° C for 2 hr, each reaction sample (one with Cy3 and another with Cy5 labeling) is treated with 2.5 ml of 0.5M sodium hydroxide and incubated for 20 minutes at 85°C to the stop the reaction and degrade the RNA.
Probes are purified using two successive CHROMA SPIN 30 gel filtration spin columns (CLONTECH Laboratories, Inc.
so (CLONTECH), Palo Alto CA) and after combining, both reaction samples are ethanol precipitated using 1 ml of glycogen (1 mg/ml), 60 ml sodium acetate, and 300 ml of 100%
ethanol. The probe is then dried to completion using a SpeedVAC (Savant Instruments Inc., Holbrook NY) and resuspended in 14 p1 5X SSC/0.2% SDS.
Microarray Preparation 35 Sequences of the present invention are used to generate array elements.
Each array element is amplified from bacterial cells containing vectors with cloned cDNA inserts.
PCR amplification uses primers complementary to the vector sequences flanking the cDNA insert.
Array elements are amplified in thirty cycles of PCR from an initial quantity of 1-2 ng to a final quantity greater than 5 pg. Amplified array elements are then purified using SEPHACRYL-400 (Amersham Pharmacia Biotech).
s Purified array elements are immobilized on polymer-coated glass slides.
Glass microscope slides (Corning) are cleaned by ultrasound in 0.1% SDS and acetone, with extensive distilled water washes between and after treatments. Glass slides are etched in 4%
hydrofluoric acid (VWR
Scientific Products Corporation (VWR), West Chester, PA), washed extensively in distilled water, and coated with 0.05% aminopropyl silane (Sigma) in 95% ethanol. Coated slides are cured in a l0 110°C oven.
Array elements are applied to the coated glass substrate using a procedure described in US
Patent No. 5,807,522, incorporated herein by reference. 1 p1 of the array element DNA, at an average concentration of 100 ng/pl, is loaded into the open capillary printing element by a high-speed robotic apparatus. The apparatus then deposits about 5 n1 of array element sample per slide.
15 Microarrays are UV-crosslinked using a STRATALINKER UV-crosslinker (Stratagene).
Microarrays are washed at room temperature once in 0.2% SDS and three times in distilled water.
Non-specific binding sites are blocked by incubation of microarrays in 0.2%
casein in phosphate buffered saline (PBS) (Tropix, Inc., Bedford, MA) for 30 minutes at 60°C followed by washes in 0.2% SDS and distilled water as before.
2 o Hybridization Hybridization reactions contain 9 p1 of probe mixture consisting of 0.2 pg each of Cy3 and Cy5 labeled cDNA synthesis products in 5X SSC, 0.2% SDS hybridization buffer.
The probe mixture is heated to 65°C for 5 minutes and is aliquoted onto the microarray surface and covered with an 1.8 cmz coverslip. The arrays are transferred to a waterproof chamber having a cavity just 25 slightly larger than a microscope slide. The chamber is kept at 100%
humidity internally by the addition of 140 p1 of Sx SSC in a comer of the chamber. The chamber containing the arrays is incubated for about 6.5 hours at 60° C. The arrays are washed for 10 min at 45° C in a first wash buffer (1X SSC, 0.1% SDS), three times for 10 minutes each at 45°C in a second wash buffer (0.1X
SSC), and dried.
3o Detection Reporter-labeled hybridization complexes are detected with a microscope equipped with an Innova 70 mixed gas 10 W laser (Coherent, Inc., Santa Clara CA) capable of generating spectral lines at 488 nm for excitation of Cy3 and at 632 nm for excitation of CyS. The excitation laser light is focused on the array using a 20X microscope objective (Nikon, Inc., Melville NY). The slide 35 containing the array is placed on a computer-controlled X-Y stage on the microscope and raster-scanned past the objective. The 1.8 cm x 1.8 cm array used in the present example is scanned with a resolution of 20 micrometers..
In two separate scans, a mixed gas multiline laser excites the two fluorophores sequentially.
Emitted light is split, based on wavelength, into two photomultiplier tube detectors (PMT 81477, s Hamamatsu Photonics Systems, Bridgewater NJ) corresponding to the two fluorophores.
Appropriate filters positioned between the array and the photomultiplier tubes are used to filter the signals. The emission maxima of the fluorophores used are 565 nm for Cy3 and 650 nm for CyS.
Each array is typically scanned twice, one scan per fluorophore using the appropriate filters at the laser source, although the apparatus is capable of recording the spectra from both fluorophores to simultaneously.
The sensitivity of the scans is typically calibrated using the signal intensity generated by a cDNA control species added to the probe mix at a known concentration. A
specific location on the array contains a complementary DNA sequence, allowing the intensity of the signal at that location to be correlated with a weight ratio of hybridizing species of 1:100,000. When two probes from 15 different sources (e.g., representing test and control cells), each labeled with a different fluorophore, are hybridized to a single array for the purpose of identifying genes that are differentially expressed, the calibration is done by labeling samples of the calibrating cDNA with the two fluorophores and adding identical amounts of each to the hybridization mixture.
The output of the photomultiplier tube is digitized using a 12-bit RTI-835H
analog-to-digital 20 (A/D) conversion board (Analog Devices, Inc., Norwood, MA) installed in an IBM-compatible PC
computer. The digitized data are displayed as an image where the signal intensity is mapped using a linear 20-color transformation to a pseudocolor scale ranging from blue (low signal) to red (high signal). The data is also analyzed quantitatively. Where two different fluorophores are excited and measured simultaneously, the data are first corrected for optical crosstalk (due to overlapping 2 s emission spectra) between the fluorophores using each fluorophore's emission spectrum.
A grid is superimposed over the fluorescence signal image such that the signal from each spot is centered in each element of the grid. The fluorescence signal within each element is then integrated to obtain a numerical value corresponding to the average intensity of the signal. The software used for signal analysis is the GEMTOOLS gene expression analysis program (Incyte).
XII. Complementary Nucleic Acids Sequences complementary to the sptm are used to detect, decrease, or inhibit expression of the naturally occurnng nucleotide. The use of oligonucleotides comprising from about 15 to 30 base pairs is typical in the art. However, smaller or larger sequence fragments can also be used.
Appropriate oligonucleotides are designed from the sptm using OLIGO 4.06 software (National Biosciences) or other appropriate programs and are synthesized using methods standard in the art or ordered from a commercial supplier. To inhibit transcription, a complementary oligonucleotide is designed from the most unique 5'sequence and used to prevent transcription factor binding to the promoter sequence. To inhibit translation, a complementary oligonucleotide is designed to prevent ribosomal binding and processing of the transcript.
XIII. Expression of SPTM
Expression and purification of SPTM is accomplished using bacterial or virus-based expression systems. For expression of SPTM in bacteria, cDNA is subcloned into an appropriate vector containing an antibiotic resistance gene and an inducible promoter that directs high levels of to cDNA transcription. Examples of such promoters include, but are not limited to, the trp-lac (tac) hybrid promoter and the TS or T7 bacteriophage promoter in conjunction with the lac operator regulatory element. Recombinant vectors are transformed into suitable bacterial hosts, e.g., BL21(DE3). Antibiotic resistant bacteria express SPTM upon induction with isopropyl beta-D-thiogalactopyranoside (IPTG). Expression of SPTM in eukaryotic cells is achieved by infecting 15 insect or mammalian cell lines with recombinant Autogranhica californica nuclear polyhedrosis virus (AcMNPV), commonly known as baculovirus. The nonessential polyhedrin gene of baculovirus is replaced with cDNA encoding SPTM by either homologous recombination or bacterial-mediated transposition involving transfer plasmid intermediates. Viral infectivity is maintained and the strong polyhedrin promoter drives high levels of cDNA transcription. Recombinant baculovirus is used to zo infect Spodoptera fru>yiperda (Sf9) insect cells in most cases, or human hepatocytes, in some cases.
Infection of the latter requires additional genetic modifications to baculovirus. (See e.g., Engelhard, suvra; and Sandig, supra.) In most expression systems, SPTM is synthesized as a fusion protein with, e.g., glutathione S-transferase (GST) or a peptide epitope tag, such as FLAG or 6-His, permitting rapid, single-step, zs affinity-based purification of recombinant fusion protein from crude cell lysates. GST, a 26 kilodalton enzyme from Schistosoma japonicum, enables the purification of fusion proteins on immobilized glutathione under conditions that maintain protein activity and antigenicity (Amersham Pharmacia Biotech). Following purification, the GST moiety can be proteolytically cleaved from SPTM at specifically engineered sites. FLAG, an 8-amino acid peptide, enables immunoaffinity 3o purification using commercially available monoclonal and polyclonal anti-FLAG antibodies (Eastman Kodak Company, Rochester NY). 6-His, a stretch of six consecutive histidine residues, enables purification on metal-chelate resins (QIAGEN). Methods for protein expression and purification are discussed in Ausubel (1995, su ra, Chapters 10 and 16).
Purified SPTM obtained by these methods can be used directly in the following activity assay.
XIV. Demonstration of SPTM Activity An assay for SPTM activity measures the expression of SPTM on the cell surface. cDNA
encoding SPTM is subcloned into an appropriate mammalian expression vector suitable for high levels of cDNA expression. The resulting construct is transfected into a nonhuman cell line such as s NIH3T3. Cell surface proteins are labeled with biotin using methods known in the art.
Immunoprecipitations are performed using SPTM-specific antibodies, and immunoprecipitated samples are analyzed using SDS-PAGE and immunoblotting techniques. The ratio of labeled immunoprecipitant to unlabeled immunoprecipitant is proportional to the amount of SPTM
expressed on the cell surface.
1o Alternatively, an assay for SPTM activity measures the amount of SPTM in secretory, membrane-bound organelles. Transfected cells as described above are harvested and lysed. The lysate is fractionated using methods known to those of skill in the art, for example, sucrose gradient ultracentrifugation. Such methods allow the isolation of subcellular components such as the Golgi apparatus, ER, small membrane-bound vesicles, and other secretory organelles.
is Immunoprecipitations from fractionated and total cell lysates are performed using SPTM-specific antibodies, and immunoprecipitated samples are analyzed using SDS-PAGE and immunoblotting techniques. The concentration of SPTM in secretory organelles relative to SPTM
in total cell lysate is proportional to the amount of SPTM in transit through the secretory pathway.
2 o XV. Functional Assays SPTM function is assessed by expressing sptm at physiologically elevated levels in manunalian cell culture systems. cDNA is subcloned into a mammalian expression vector containing a strong promoter that drives high levels of cDNA expression. Vectors of choice include pCMV
SPORT (Life Technologies) and pCR3.1 (Invitrogen Corporation, Carlsbad CA), both of which 2 s contain the cytomegalovirus promoter. 5-10 pg of recombinant vector are transiently transfected into a human cell line, preferably of endothelial or hematopoietic origin, using either liposome formulations or electroporation. 1-2 pg of an additional plasmid containing sequences encoding a marker protein are co-transfected.
Expression of a marker protein provides a means to distinguish transfected cells from s o nontransfected cells and is a reliable predictor of cDNA expression from the recombinant vector.
Marker proteins of choice include, e.g., Green Fluorescent Protein (GFP;
CLONTECH), CD64, or a CD64-GFP fusion protein. Flow cytometry (FCM), an automated laser optics-based technique, is used to identify transfected cells expressing GFP or CD64-GFP and to evaluate the apoptotic state of the cells and other cellular properties.
35 FCM detects and quantifies the uptake of fluorescent molecules that diagnose events preceding or coincident with cell death. These events include changes in nuclear DNA content as measured by staining of DNA with propidium iodide; changes in cell size and granularity as measured by forward light scatter and 90 degree side light scatter; down-regulation of DNA synthesis as measured by decrease in bromodeoxyuridine uptake; alterations in expression of cell surface and intracellular proteins as measured by reactivity with specific antibodies; and alterations in plasma membrane composition as measured by the binding of fluorescein-conjugated Annexin V protein to the cell surface. Methods in flow cytometry are discussed in Ormerod, M. G. ( 1994) Flow Ctometry, Oxford, New York NY.
The influence of SPTM on gene expression can be assessed using highly purified populations of cells transfected with sequences encoding SPTM and either CD64 or CD64-GFP.
to CD64 and CD64-GFP are expressed on the surface of transfected cells and bind to conserved regions of human immunoglobulin G (IgG). Transfected cells are efficiently separated from nontransfected cells using magnetic beads coated with either human IgG or antibody against CD64 (DYNAL, Inc., Lake Success NY). mRNA can be purified from the cells using methods well known by those of skill in the art. Expression of mRNA encoding SPTM and other genes of interest can be analyzed by northern analysis or microarray techniques.
XVI. Production of Antibodies SPTM substantially purified using polyacrylamide gel electrophoresis (PAGE;
see, e.g., Harrington, M.G. (1990) Methods Enzymol. 182:488-495), or other purification techniques, is used 2o to immunize rabbits and to produce antibodies using standard protocols.
Alternatively, the SPTM amino acid sequence is analyzed using LASERGENE
software (DNASTAR) to determine regions of high immunogenicity, and a corresponding peptide is synthesized and used to raise antibodies by means known to those of skill in the art. Methods for selection of appropriate epitopes, such as those near the C-terminus or in hydrophilic regions are well described in the art. (See, e.g., Ausubel, 1995, supra, Chapter 11.) Typically, peptides 15 residues in length are synthesized using an ABI 431A
peptide synthesizer (PE Biosystems) using fmoc-chemistry and coupled to KLH (Sigma) by reaction with N-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) to increase immunogenicity.
(See, e.g., Ausubel, supra.) Rabbits are immunized with the peptide-KL,H complex in complete Freund's 3 o adjuvant. Resulting antisera are tested for antipeptide activity by, for example, binding the peptide to plastic, blocking with 1 % BSA, reacting with rabbit antisera, washing, and reacting with radio-iodinated goat anti-rabbit IgG. Antisera with antipeptide activity are tested for anti-SPTM activity using protocols well known in the art, including ELISA, RIA, and immunoblotting.
XVII. Purification of Naturally Occurring SPTM Using Specific Antibodies Naturally occurring or recombinant SPTM is substantially purified by immunoaffinity chromatography using antibodies specific for SPTM. An immunoaffinity column is constructed by covalently coupling anti-SPTM antibody to an activated chromatographic resin, such as s CNBr-activated SEPHAROSE (Amersham Pharmacia Biotech). After the coupling, the resin is blocked and washed according to the manufacturer's instructions.
Media containing SPTM are passed over the immunoaffinity column, and the column is washed under conditions that allow the preferential absorbance of SPTM (e.g., high ionic strength buffers in the presence of detergent). The column is eluted under conditions that disrupt to antibody/SPTM binding (e.g., a buffer of pH 2 to pH 3, or a high concentration of a chaotrope, such as urea or thiocyanate ion), and SPTM is collected.
XVIII. Identification of Molecules Which Interact with SPTM
SPTM, or biologically active fragments thereof, are labeled with'ZSI Bolton-Hunter reagent.
is (See, e.g., Bolton, A.E. and W.M. Hunter (1973) Biochem. J. 133:529-539.) Candidate molecules previously arrayed in the wells of a multi-well plate are incubated with the labeled SPTM, washed, and any wells with labeled SPTM complex are assayed. Data obtained using different concentrations of SPTM are used to calculate values for the number, affinity, and association of SPTM with the candidate molecules.
2o Alternatively, molecules interacting with SPTM are analyzed using the yeast two-hybrid system as described in Fields, S. and O. Song (1989) Nature 340:245-246, or using commercially available kits based on the two-hybrid system, such as the MATCHMAKER system (CLONTECH).
SPTM may also be used in the PATHCALLING process (CuraGen Corp., New Haven CT) which employs the yeast two-hybrid system in a high-throughput manner to determine all 2 s interactions between the proteins encoded by two large libraries of genes (Nandabalan, K. et al.
(2000) U.S. Patent No. 6,057,101).
All publications and patents mentioned in the above specification are herein incorporated by reference. Various modifications and variations of the described method and system of the invention 3o will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the above-described modes for carrying out the invention which are obvious to those skilled in the field of molecular biology or 35 related fields are intended to be within the scope of the following claims.
o Q °' E za vU ,. °~~ o ~
Q r ~" c Q ~ C N ~E
O N M O N ~"
Y ~ ~ ~ O O O ~ N E !_ N C U ~ h Q ~ O ~
-O ~ N E Q O U ,c~
Q. _N p ~ 'O N p;
p o o ~ ~ a o ~ N 3 Y ~ ~n ~ -Q o vU ~ o a a ~ ~ p E
Q ~ o °' ~ ~ o ~? o ~ ~ v ~ aU
~n O 'D
"' LpU~ E ~ ~ Q O ~ "',~>. Q uyU
O v~~ ~ ~ ~ h Q ~ ~ . Z C p ~' E ~ M ~.~u O Q ~7 O
C v C ~ U ~ ~ Z ~ p ~ L" ~ U ~ vi .~ ~ U Q U p 'i' t O ~ pU n C U O E O N vi ~ 'O " N J z Q U ~ Q
Q N O ~ v U >- v~ M ~ U E C N U ~ U U M ~ m O Z
C ii Q C ~ Q d ~ ~ v~ C U ~ N p E ~ U Lv cY N o -~,~z ~ o a o 0 0~ ~ ~ a~ a~Q °~ ai E o,~~' o~~_a~ z o= o QQ ~ a~g a~ d~ ~ ~ a'~ a o--~ Z Qw N o o~ E N .C ~ s N ~ o o Q z Q ~ ~ ~ E M
U p U rn N = U C O Q p U ~ L" Z =' N ~n O V
C OZ~~~o°oC0 OUN~U~ Qp E~~ O~pMOQ
Qa~~°~pa~o°=~o c°_'Qa_Ez~ ~Q '~ ~o Q~NoN
O U ~ ° -o N U ~ N ~ c a N .Q N U N ~ C E ~ p ~ r- ~, ~ N o ~ Y
U ~ Q~ U ~ ~. ~ ~ w ~ ~ ~ p ~ j N E ~ ~ U QcG ~ ~ ~ ~ p ~ O
~ O O O ~ O ~ O ~ ~ D N m O ~ 0 ~ ° Z ~ N O O
~ o U~ o E a~ ° ~ ~ E a s N C O Q o o ~ ~ ~ C9 U~ o 0 E QU U~U ~~ >~-=~QO ~U o v~ > a_ E U ~~~c ~~~; E
Q c N c c c ~.~ ~z ~~oho a o C c C c c ~ c c ~ c -~ ~' ~ c p ~ "' c N N N Q O ~ ~ ~ r Z O N O N ~ N N (~ ~ ~ N Q N
-Q. -Q. 'a -Q. o U ~o D -o ~ -p E ~Q. ,o -a ~a -a -a o a ~ ~j L ~a Q- ~ z -a a~D~~~~?~~tNZ<~.,LDra~~~a~~°~mo~3~pUa or o 0 0 ~ aQ o o ~a~o 0 0 oQ ~ o o ao ~~ ~ o oQ o Eo E E E~~z ~Qo c~ > E~_ E EN aE E E E ~~ ~ E~z c E
z °m z z i ~ ~~ ~ ~ z ~ Y z z U z z ~ ~ z z ~ i aw U z ~
a~
M M N ~ ~ O O~ n ~ ~ r ~ N
i i i i i i i i i i ~ i UJ LV UJ UJ ' UJ UJ UJ UJ UJ UJ UJ UJ
- O O O O O O ~ O O O O O O O O O O O O O O O O
Q O O O O p O O O O O O O O
N ~O ~ ~ ~ ~ N r h U ~ ~O CV
O
d N O~ ~ ~ ~O c0 W M O O V c0 O, ~O ~_ N a0 V_ _ C~ O
O~ r ~O U_ O~ V ~O O N O ~ M ~_ ~O O~ U ~ c0 N
O~ ~ ~ h h N o0 ~ h N ~O ~O ~O u7 O~ ~O ~
E h h O~ O M h ~O h ~ O~ N h ~O U ~O O ~ U P O h O
7 O V N U N O ~ ~O ~ ~_ O O a0 O ~O a0 N h ~ h ~ c0 c0 U P ~O O~ h ~O CO ~O h h ~ ~O h ~ 00 U c~ ~O ~ CG ~
~O r V ~O ~f7 r X17 ~ r ~O M r V ~ ~O ~O V V M ~O M V
~ ~ ~ ° ° ~ ~ ~ ~ ° ~
D
M r M N ~ M N ~ Q M r ~O r N h ~O r N ~ ~ h U V O~ ~O V O M h ' ~O ~ u7 ~ M V V U V
O a0 a0 ~ a0 N ~ ~O V O- M ~ M ~ fw0 ~ ~ 00 c0 h d' V
h o0 h O ~ c0 c0 h N O N a0 O- r N ~ V ~ ~O
Q U ~ ~OO N M a0 U ~ ~ ~ tn N N h ~- ~ h U O
E~N°NNNN N NNNNNNNN NN c~c~ c~m'7c~M
N
Z
D ~ N M V ~ ~O h OD O~ ~ r ~ M ~ ~ ~ ~ M ~' O N M
N N N N
UJ
M
r:
O
Q
N
Y
N
C
O
U "' O 'd 47 ~ ~ U
a7 O Q
00 ~ E
C Q Q O
Q- ~ Z
Y
_C_ Q _N _O
O O_ U Q- Q
Z Q
C
U
Vl N fn N f~ N
O O O
O O O
O.
U
~O O O
O
.Q
O
d U N O O
~ c~ O
oD ~ CV
Z ~ ~ ~
D
M
P_ ~ n O r P N
O- O O
~ V d' H
O
Z
N N N
w TABLE 2.
SEQ Template Start Stop Frame Domain ID ID Type NO:
1 1978.1 401 478 forward TM
2 2588.4 362 454 forward SP
2 2588.4 1552 1626 forward TM
3 201759,3 926 1009 forward SP
4 208184,1 1438 1533 forward SP
4 208184.1 159 242 forward SP
4 208184,1 1194 1271 forward TM
212029,3 128 208 forward SP
b 213446,2 944 1021 forward SP
b 213446.2 614 718 forward SP
b 213446,2 934 1020 forward TM
7 228864,4 1600 1680 forward SP
7 228864.4 116 229 forward SP
7 228864.4 543 638 forward SP
8 229840.3 2861 2938 forward TM
9 231793.2 730 810 forward SP
234137.5 708 806 forward SP
11 234671.14 557 634 forward TM
12 241236.3 1397 1501 forward SP
13 245014.1 1326 1412 forward TM
14 245251.6 826 909 forward SP
252875.1 2388 2468 forward TM
16 252964.2 2954 3037 forward TM
17 267153.7 746 829 forward SP
18 331244.6 413 493 forward TM
19 335484.1 1977 2060 forward TM
19 335484.1 2805 2888 forward TM
337489.2 bbb 746 forward TM
21 359574.5 2571 2657 forward SP
21 359574.5 1845 1931 forward SP
21 359574.5 1665 1760 forward SP
22 360645.5 415 495 forward SP
23 404145.7 2141 2248 forward SP
23 404145.7 Ebb 785 forward SP
24 480119.1 1181 1267 forward SP
24 480119.1 413 499 forward SP
480951.5 2523 2606 forward TM
2b 481257.3 2774 2860 forward TM
S'7 SEQ ID NO: TemplateComponent Start Stop ID ID
1 1978.1 g 1855482 1 217 1 1978,1 3137104H1 1 272 1 1978.1 3137104F6 1 381 1 1978.1 3526040H1 11 304 1 1978.1 3523774H1 11 357 1 1978.1 g 1267790 148 605 1 1978.1 g1267782 148 522 1 1978.1 g1958606 164 580 1 1978.1 3031854H1 269 571 1 1978.1 4832441H1 339 597 1 1978,1 g1775794 353 418 1 1978.1 4142134H1 553 758 1 1978.1 1600481H1 605 800 1 1978.1 1600481F6 605 966 1 1978.1 4379163H1 653 915 1 1978.1 2901551H1 668 927 1 1978.1 1678677H1 677 909 1 1978.1 3842809H1 736 1043 1 1978.1 1793709H1 755 1050 1 1978.1 2773028H1 755 1009 1 1978.1 3602828H1 860 1155 1 1978.1 1610720H1 934 1142 1 1978,1 2366358H1 976 1193 1 1978.1 5497064H1 1036 1265 1 1978,1 3742273H1 1063 1273 1 1978.1 5261375H1 1113 1334 1 1978,1 1378352F1 1149 1688 1 1978.1 1378352H1 1149 1386 1 1978,1 1281776F6 1190 1796 1 1978,1 1281776H1 1190 1453 1 1978.1 2097593H1 1199 1380 1 1978.1 2098893H1 1199 1445 1 1978.1 g714966 1208 1550 1 1978.1 3929766H1 1219 1504 1 1978.1 g1425881 1230 1639 1 1978.1 g989565 1249 1465 1 1978.1 1369088H1 1249 1478 1 1978.1 627100H1 1249 1491 1 1978.1 815413H1 1269 1522 1 1978.1 4505379H1 1271 1473 1 1978.1 128177676 1348 1957 1 1978.1 g1860340 1388 1801 1 1978.1 g1959763 1438 1931 1 1978.1 160048176 1439 1962 1 1978.1 313710476 1467 1961 1 1978.1 g3231943 1542 1999 1 1978.1 5195075H1 1543 1772 1 1978.1 g3231851 1547 1999 1 1978.1 g3539313 1559 2000 1 1978.1 g3539311 1559 2001 SE6~ Template Component Start Stop ID NO: ID ID
1 1978.1 764088H1 1571 1866 1 1978.1 765817H1 1571 1820 1 1978.1 76581786 1571 1972 1 1978.1 765817T6 1571 1964 1 1978.1 81860995 1588 2012 1 1978.1 84068873 1592 2000 1 1978.1 82787512 1594 2000 1 1978.1 81202822 1605 2000 1 1978.1 g 1425795 1639 2004 1 1978.1 2202630T6 1656 1956 1 1978.1 2202630H1 1664 1911 1 1978.1 2202630F6 1664 1996 1 1978.1 g 1775688 1702 1969 1 1978.1 8714967 1724 2012 1 1978.1 2290116H1 1725 1992 1 1978.1 2127226H1 1725 1998 1 1978.1 3815472H1 1739 2000 1 1978.1 8989478 1752 1987 1 1978.1 83043215 1787 2005 1 1978.1 2413731H1 1868 2004 2 2588.4 3502438H1 2224 2533 2 2588.4 82786213 2248 2674 2 2588.4 83277689 2254 2669 2 2588.4 2366762H1 2248 2486 2 2588.4 1910722H1 2255 2499 2 2588.4 84286541 2256 2664 2 2588.4 83052444 2260 2670 2 2588.4 832051T6 2268 2624 2 2588.4 82873700 2274 2671 2 2588.4 82876032 2276 2668 2 2588.4 2663178H1 2278 2519 2 2588.4 81482457 2282 2670 2 2588.4 2868714H1 2290 2577 2 2588.4 83239166 2301 2671 2 2588.4 83700567 2302 2669 2 2588.4 4595434H1 2361 2549 2 2588.4 g 1118566 2382 2669 2 2588.4 81693563 2384 2670 2 2588.4 81920095 2390 2675 2 2588.4 2370688H1 2416 2519 2 2588.4 g 1952447 2420 2676 2 2588.4 81124041 2428 2669 2 2588.4 8787440 2432 2669 2 2588.4 82322889 2432 2803 2 2588.4 g 1885881 2434 2677 2 2588.4 81267377 2451 2817 2 2588.4 g 1119118 2466 2669 2 2588.4 81218402 2474 2669 2 2588.4 2768580Th 2481 2630 2 2588.4 82102824 2482 2892 SEQ ID Template Component Start Stop NO: ID ID
2 2588.4 1844326H1 2483 2669 2 2588.4 2768580H1 2488 2670 2 2588.4 2768580F6 2488 2670 2 2588.4 82457806 2514 2667 2 2588.4 1854244H1 2530 2669 2 2588.4 1830904Th 2533 2622 2 2588.4 1854244Th 2533 2630 2 2588.4 g 1484958 2560 2670 2 2588.4 35b5846H1 2565 2885 2 2588.4 8845861 2570 2688 2 2588.4 2094b84H1 2574 2669 2 2588.4 4157557H1 2598 2867 2 2588.4 3412843H1 2640 2859 2 2588.4 2467396Th 2734 3206 2 2588.4 2467396Fb 2741 . 3192 2 2588.4 2467396H1 2741 2978 2 2588.4 31486bOH1 2882 2992 2 2588.4 82435914 2884 3178 2 2588.4 2832630F6 2918 3237 2 2588.4 2832b30H1 2918 3174 2 2588.4 2832630Th 2922 3199 2 2588.4 81154518 2999 3296 2 2588.4 8845812 3031 3245 2 2588.4 4118483H1 3044 3213 2 2588.4 g 1123141 3054 3244 2 2588.4 2268209Th 761 1105 2 2588.4 2672328F6 1 357 2 2588.4 2590094H2 1 227 2 2588.4 2b72328H1 1 227 2 2588.4 2672248H1 1 227 2 2588.4 2159193H1 1 149 2 2588.4 2660709H1 5 253 2 2588.4 3046945H1 14 316 2 2588.4 20476b1H1 30 315 2 2588.4 81957845 31 476 2 2588.4 82210487 57 387 2 2588.4 3b98574H1 308 459 2 2588.4 5633547H1 440 637 2 2588.4 2892108H1 440 708 2 2588.4 3496131H1 490 777 2 2588.4 3111455H1 513 783 2 2588.4 2536480H1 550 792 2 2588.4 4971550H1 560 817 2 2588.4 226820986 570 955 2 2588.4 2268209H1 571 833 2 2588.4 1259305F1 611 1189 2 2588.4 3773508H1 612 930 2 2588.4 1259305H1 611 838 2 2588.4 82534bH1 685 983 2 2588.4 212237bH1 702 955 SE6~ Template Component Start Stop ID NO: ID ID
2 2588.4 3108360H1 743 1017 2 2588.4 g2210429 769 1039 2 2588.4 5188115H1 895 1068 2 2588.4 646258H1 907 1068 2 2588.4 4564951H1 961 1217 2 2588.4 661278H1 999 1263 2 2588.4 660712H1 999 1267 2 2588.4 634487H1 987 1238 2 2588.4 82037676 1040 1244 2 2588.4 5035180H1 1074 1347 2 2588.4 66127886 999 1563 2 2588.4 5035211H1 1074 1324 2 2588.4 81523090 1093 1462 2 2588.4 3523389H1 1113 1352 2 2588.4 81192612 1099 1470 2 2588.4 1450413H1 1129 1376 2 2588.4 4346111H1 1138 1389 2 2588.4 4346627H1 1138 1401 2 2588.4 3174422H1 1139 1381 2 2588.4 2645913H1 1158 1420 2 2588.4 4959350H1 1163 1408 2 2588.4 2632516H1 1170 1408 2 2588.4 2995782H1 1187 1446 2 2588.4 81950525 1257 1594 2 2588.4 5501962H1 1295 1527 2 2588.4 2866753H1 1313 1647 2 2588.4 81920346 1372 1779 2 2588.4 g 1950552 1426 1678 2 2588.4 1990742H1 1432 1677 2 2588.4 82102880 1453 1926 2 2588.4 2108316H1 1491 1762 2 2588.4 4323533H1 1493 1761 2 2588.4 2326875H1 1498 1749 2 2588.4 2326664H1 1498 1726 2 2588.4 5117484H1 1534 1793 2 2588.4 1794995H1 1560 1832 2 2588.4 3203064H1 1561 1846 2 2588.4 2406583H1 1576 1709 2 2588.4 4144701H1 1594 1773 2 2588.4 3605515H1 1621 1861 2 2588.4 2715994H1 1641 1885 2 2588.4 3141136H1 1644 1889 2 2588.4 3687001H1 1650 1947 2 2588.4 8900018 1654 1998 2 2588.4 81639521 1672 1916 2 2588.4 2860261H1 1690 1969 2 2588.4 3254658H1 1699 1932 2 2588.4 3095495H1 1712 1995 2 2588.4 2660751H1 1768 2016 2 2588.4 83205186 1804 2094 SE6~ Template Component Start Stop ID NO: ID ID
2 2588.4 1812964H1 1804 2036 2 2588.4 832051H1 1804 2072 2 2588.4 1812964F6 1805 2328 2 2588.4 2900724H1 1812 2115 2 2588.4 1496448H1 1817 2058 2 2588.4 g2912624 1840 2122 2 ' 2588.4 g2879636 1844 2122 2 2588.4 g2191548 1846 2122 2 2588.4 5506884H1 1863 2096 2 2588.4 2203126H1 1903 2157 2 2588.4 4159080H1 1906 2135 2 2588.4 1857148H1 1916 2161 2 2588.4 5099926H1 1925 2212 2 2588.4 g787181 1953 2177 2 2588.4 3327731H1 1983 2283 2 2588.4 5572386H1 1994 2106 2 2588.4 4986441H1 2004 2303 2 2588.4 3110534H1 2004 2279 2 2588.4 5396265T1 2047 2631 2 2588.4 2189071T6 2070 2626 2 2588.4 2189071H1 2072 2357 2 2588.4 2189071F6 2072 2492 2 2588.4 2783063H1 2074 2365 2 2588.4 539637571 2081 2633 2 2588.4 4862535H1 2082 2244 2 2588.4 267232876 2092 2636 2 2588.4 1972459H1 2094 2376 2 2588.4 3786773H1 2114 2409 2 2588.4 66127876 2145 2631 2 2588,4 3994175H 2158 2450 2 2588.4 3995990H1 2160 2411 2 2588.4 5137950H2 2208 2487 2 2588,4 g1523038 2213 2669 2 2588.4 2664705H1 2212 2338 2 2588.4 g3308729 2218 2673 3 201759.3 83662481 823 1315 3 201759,3 039821H1 861 1031 3 201759.3 5278457H1 871 1132 3 201759.3 836624H1 872 1143 3 201759.3 836632H1 873 1140 3 201759.3 4299787H1 879 1057 3 201759.3 263784H1 898 1265 3 201759.3 g2017411 900 1347 3 201759.3 82619981 904 1553 3 201759.3 826199H1 904 1190 3 201759,3 g1463426 908 1456 3 201759.3 2011073H1 914 1130 3 201759.3 4203594H1 917 1203 3 201759.3 2021844H1 918 1180 3 201759.3 4861150H1 919 1199 b2 SEQ ID Template Component Starf Stop NO: ID ID
3 201759.3 1494424H1 958 1173 3 201759.3 3697752H1 970 1290 3 201759.3 81049651 984 1332 3 201759.3 3015055H1 987 1320 3 201759.3 1857956H1 990 1165 3 201759.3 1857956F6 990 1530 3 201759.3 5112648H1 997 1334 3 201759.3 535858H1 1000 1099 3 201759.3 5091726H1 1015 1322 3 201759.3 1952952H1 1015 1309 3 201759.3 1257476H1 1016 1281 3 201759.3 4585955H1 1017 1309 3 201759.3 5836690H1 1018 1270 3 201759.3 4648947H1 1027 1197 3 201759.3 958699H1 1029 1339 3 201759.3 3960850H2 1028 1325 3 201759.3 691887H1 1030 1258 3 201759.3 g 1240155 1040 1284 3 201759.3 81025462 1053 1335 3 201759.3 g 1264434 1053 1450 3 201759.3 3354080H1 1065 1243 3 201759.3 8863516 1067 1324 3 201759.3 5428281H1 1073 1362 3 201759.3 1236418H1 1075 1290 3 201759.3 3525638H1 1085 1444 3 201759.3 4086966H1 1102 1398 3 201759,3 2921953H1 1116 1433 3 201759.3 2370849H1 1117 1402 3 201759.3 1649210H1 1117 1383 3 201759.3 4159589H1 1126 1416 3 201759.3 83919705 1134 1658 3 201759.3 2840735H1 1139 1417 3 201759.3 1401895H1 1140 1414 3 201759,3 82110825 1140 1652 3 201759.3 3807071H1 1141 1491 3 201759,3 4112417H1 1144 1251 3 201759.3 3843828H1 1143 1465 3 201759.3 83238572 1144 1668 3 201759.3 82347672 1147 1665 3 201759,3 82930046 1147 1665 3 201759,3 83238573 1150 1668 3 201759.3 82742072 1171 1658 3 201759.3 83595471 1176 1658 3 201759.3 83988715 1176 1658 3 201759.3 83644962 1177 1668 3 201759.3 3466714H1 1177 1467 3 201759.3 81384561 1180 1673 3 201759.3 83446683 1181 1670 3 201759.3 83679958 1184 1664 3 201759.3 g 13321 1190 1663 b5 b3 SE6~ Template Component Start Stop ID NO: ID ID
3 201759.3 3600088H1 1200 1528 3 201759.3 2542561T6 1207 1633 3 201759.3 900346H1 1225 1325 3 201759.3 90034681 1225 1658 3 201759.3 8848629 1225 1571 3 201759.3 5056168H1 1225 1530 3 201759.3 3112117H1 1233 1546 3 201759.3 82524963 1240 1658 3 201759.3 84332204 1241 1665 3 201759.3 3366929H1 1244 1517 3 201759.3 83432662 1244 1666 3 201759,3 82806722 1246 1661 3 201759.3 83931304 1247 1667 3 201759.3 83601403 1248 1663 3 201759.3 83238932 1252 1665 3 201759.3 83931309 1258 1667 3 201759.3 2293916H1 1261 1529 3 201759.3 2399275H1 1272 1541 3 201759.3 82557656 1281 1663 3 201759.3 82617892 1281 1659 3 201759.3 82463986 1286 1668 3 201759.3 82457535 1288 1646 3 201759.3 83416543 1292 1643 3 201759.3 83095258 1297 1665 3 201759.3 82669541 1297 1658 3 201759.3 3467486H1 1311 1579 3 201759.3 82198192 1314 1665 3 201759.3 g 749662 1313 1659 3 201759.3 8752157 1313 1580 3 201759.3 82188331 1324 1670 3 201759.3 83308655 1325 1658 3 201759.3 82156163 1331 1835 3 201759.3 83229304 1342 1668 3 201759.3 82969733 1349 1665 3 201759.3 2664494Th 1352 1622 3 201759.3 81049959 1369 1670 3 201759.3 82243211 1366 1668 3 201759.3 8863517 1371 1642 3 201759.3 8784617 1372 1665 3 201759.3 81614677 1368 1658 3 201759.3 84148476 1369 1665 3 201759.3 81294977 1369 1658 3 201759.3 82955119 1373 1667 3 201759.3 81448860 1373 1658 3 201759.3 g 29581 1395 1658 b 1 3 201759.3 83233016 1401 1663 3 201759.3 4640182H1 1401 1660 3 201759.3 83884622 1404 1670 3 201759.3 83431226 1406 1658 3 201759.3 83843156 1407 1658 b4 SEQ ID Template Component ~ Start Stop NO: ID ID
3 201759.3 2101118H1 1413 1655 3 201759.3 2044357H1 1428 1688 3 201759.3 3573519Th 1432 1996 3 201759.3 1695963T6 1432 1995 3 201759.3 2351137H1 1458 1662 3 201759.3 1901951H1 1468 1763 3 201759.3 2505488H2 1468 1721 3 201759.3 2052204H1 1486 1761 3 201759.3 2016130H1 1 95 3 201759.3 5373386H1 24 184 3 201759.3 6026840H1 51 139 3 201759.3 2598924H1 87 375 3 201759.3 2598924F6 88 598 3 201759.3 1318607H1 88 321 3 201759.3 3450621H1 93 257 3 201759.3 2664494H1 96 332 3 201759.3 2664494F6 96 652 3 201759.3 3573519F6 98 681 3 201759.3 3573519H1 98 405 3 201759.3 4177617H1 102 371 3 201759.3 4920283H1 101 194 3 201759.3 4843441H1 104 378 3 201759.3 3069036H1 104 395 3 201759.3 3374007H1 109 376 3 201759.3 4662762H1 109 366 3 201759.3 2160985H1 109 364 3 201759.3 2964373H1 109 423 3 201759,3 3561542H1 110 405 3 201759.3 3579440H1 110 414 3 201759.3 1571030H1 110 302 3 201759.3 3595416H1 112 234 3 201759.3 2133581H1 113 395 3 201759.3 3281108H1 112 376 3 201759.3 3658478H1 112 394 3 201759.3 3359378H1 117 395 3 201759.3 g1962636 119 523 3 201759.3 3373501H1 119 374 3 201759,3 899120H1 123 209 3 201759.3 2913242H1 123 383 3 201759.3 4974963H1 123 215 3 201759.3 81813092 125 514 3 201759.3 1531710H1 126 327 3 201759.3 4270743H1 163 428 3 201759.3 4522315H1 170 429 3 201759.3 2647741H1 176 428 3 201759.3 3031088H1 194 497 3 201759,3 82163335 192 565 3 201759.3 3895133H1 205 527 3 201759,3 3950958H1 272 434 3 201759,3 5538554H2 305 502 b5 SEQ ID Template Component Start Stop NO: ID ID
3 201759.3 1911718H1 323 482 3 201759.3 g4084676 346 828 3 201759.3 5713320H1 362 659 3 201759.3 583652bH1 363 651 3 201759.3 5833621H1 3b3 651 3 201759.3 2858391H1 367 b31 3 201759.3 2859193H1 367 b22 3 201759.3 g2255078 377 819 3 201759.3 273057bH1 423 698 3 ~ 201759.3 1695963Fb 433 907 3 201759.3 4548b39H1 433 676 3 201759.3 2674195H1 433 678 3 201759.3 1695963H1 433 685 3 201759.3 g21 b317b 461 890 3 201759.3 3422493H1 470 700 3 201759.3 597747H1 475 712 3 201759.3 436190H1 489 747 3 201759.3 g761512 496 878 3 201759.3 g 1799100 496 1022 3 201759.3 1707486H1 506 730 3 201759.3 3758616H1 511 639 3 201759.3 173498H1 523 720 3 201759.3 g883464 549 959 3 201759,3 4299747H1 566 794 3 201759.3 4301171H1 5bb 775 3 201759.3 g788509 576 853 3 201759.3 39b857bH1 586 911 3 201759.3 173498F1 593 1035 3 201759.3 3624367H1 611 886 3 201759.3 5811130H1 618 916 3 201759.3 2480172H1 620 957 3 201759.3 3233075H1 626 934 3 201759.3 1376454H1 629 872 3 201759.3 1376454F1 629 1103 3 201759.3 4824995H1 633 903 3 201759,3 1611033H1 638 856 3 201759.3 1b110b4H1 638 840 3 201759.3 85064981 639 1297 3 201759.3 850b49H1 639 901 3 201759,3 280397H1 640 1029 3 201759.3 3608679H1 639 848 3 201759.3 3502463H1 644 9bb 3 201759.3 4302480H1 646 950 3 201759.3 166390H1 652 925 3 201759,3 465154H1 675 922 3 201759,3 2471187H1 696 946 3 201759.3 81332164 698 1205 3 201759.3 81988555 704 1008 3 201759.3 167885H1 704 1055 3 201759.3 167849H1 705 1059 bb SE6~ Template Component Start Stop ID NO: ID ID
3 201759.3 087337H1 707 954 3 201759.3 1482767H1 724 988 3 201759.3 81614676 733 862 3 201759.3 8874674 740 1147 3 201759.3 8877795 740 1099 3 201759.3 668420H1 739 986 3 201759.3 061003H1 741 915 3 201759.3 81448859 753 1297 3 201759.3 5861969H1 754 1038 3 201759.3 2961324H1 754 1072 3 201759.3 2545528H1 760 1023 3 201759.3 030800H1 761 1060 3 201759.3 3599778H1 779 1014 3 201759.3 4886074H1 790 1073 3 201759.3 2702328H1 790 1054 3 201759.3 4724311H1 797 910 3 201759.3 1674833H1 802 1024 3 201759.3 81055891 803 1147 3 201759.3 4425751H1 817 1097 3 201759.3 700809H1 819 1111 3 201759.3 700858H1 819 1108 3 201759,3 81406784 1492 1915 3 201759.3 83307726 1501 1658 3 201759.3 83405773 1505 1969 3 201759.3 1007491H1 1541 1848 3 201759.3 83841579 1547 1665 3 201759.3 5906115H1 1549 1665 3 201759.3 83016169 1550 1658 3 201759.3 82967986 1558 1658 3 201759.3 1416494H1 1560 1811 3 201759.3 2111952H1 1560 1859 3 201759.3 82265647 1572 2043 3 201759.3 82106597 1571 1674 3 201759.3 040426H1 1577 1834 3 201759.3 8314936 1600 2038 3 201759.3 83872004 1609 2038 3 201759.3 82112437 1613 2047 3 201759.3 81382965 1616 2039 3 201759.3 82930234 1617 2039 3 201759.3 82559360 1619 2038 3 201759.3 1602514Th 1630 1972 3 201759.3 5022224H1 1637 1919 3 201759.3 1602514F6 1638 1821 3 201759.3 1602514H1 1638 1841 3 201759.3 g 1813014 1642 2039 3 201759.3 82107167 1647 2047 3 201759.3 1857956T6 1653 2000 3 201759.3 83770498 1655 2040 3 201759.3 8518019 1702 2038 3 201759.3 8883358 1708 2046 SEQ ID Template Component Start Stop NO: ID ID
3 201759.3 8678008 1717 2038 3 201759.3 83777972 1726 2041 3 201759.3 165551076 1743 1998 3 201759.3 1655510H1 1751 2003 3 201759.3 1655502H1 1751 1999 3 201759.3 81211514 1750 2039 3 201759.3 1655510F6 1751 2038 3 201759.3 84270201 1753 2046 3 201759.3 g 1025463 1758 2033 3 201759.3 2410391H1 1760 1986 3 201759.3 4565053H1 1763 2014 3 201759.3 8874588 - 1768 2062 3 201759.3 82836530 1783 2039 3 201759.3 82620460 1787 2038 3 201759.3 502222471 1794 1995 3 201759.3 8848545 1797 2010 3 201759.3 82269911 1826 2038 3 201759.3 81202659 1857 2052 3 201759.3 5597773H1 1869 2043 3 201759.3 8869167 1874 2062 3 201759.3 1818223H1 1896 2045 3 201759.3 82658131 1898 2347 3 201759.3 83595015 1910 2346 3 201759.3 5059857H1 1942 2004 3 201759.3 4654185H1 1959 2242 3 201759.3 3489630H1 1968 2039 3 201759.3 8750011 2022 2358 3 201759.3 84194527 2035 2346 3 201759.3 83843200 2039 2347 3 201759,3 82658236 2054 2347 3 201759.3 2844058F6 2078 2347 3 201759.3 2844058H1 2078 2350 3 201759.3 8752055 2137 2322 3 201759.3 83433471 2136 2345 4 208184.1 5329975H1 1526 1795 4 208184.1 3962839H1 1531 1848 4 208184.1 3963078H1 1531 1837 4 208184.1 832955H1 1393 1484 4 208184.1 150072176 1405 1942 4 208184.1 2360410H1 1406 1679 4 208184.1 2360557H1 1406 1539 4 208184.1 82023641 1411 1756 4 208184,1 2271884H1 1421 1705 4 208184.1 378111H1 1459 1630 4 208184.1 273132H1 1478 1606 4 208184.1 84313046 1518 1980 4 208184,1 2130933H1 1526 1810 4 208184.1 2833701H1 990 1243 4 208184.1 1357760H1 994 1258 4 208184.1 4753736H1 1001 1285 b8 SEQ ID Template Component Start Stop NO: ID ID
4 208184,1 84327798 1 405 4 208184.1 83146292 2 336 4 208184.1 1837725H1 44 324 4 208184.1 82466840 92 456 4 208184,1 467394H1 159 367 4 208184,1 2343544H1 267 506 4 208184.1 5942721H1 311 616 4 208184.1 2655870F6 521 1093 4 208184,1 1258044H1 521 758 4 208184.1 2655870H1 521 830 4 208184.1 1787374H1 560 844 4 208184.1 2479769H1 605 845 4 208184.1 3630251H1 607 894 4 208184.1 5589572H1 708 955 4 208184.1 2642468H1 777 1015 4 208184.1 2792888F6 782 1199 4 208184.1 3158506H1 869 1142 4 208184.1 830940H1 900 972 4 208184.1 2586835H ~ 928 1167 4 208184.1 3658943H1 938 1227 4 208184.1 647769H1 945 1164 4 208184.1 3330172H1 1542 1710 4 208184.1 82968814 1552 1974 4 208184.1 3663020H1 1592 1883 4 208184.1 3662752H1 1593 1893 4 208184.1 1629365H1 1628 1855 4 208184.1 1629361H1 1628 1841 4 208184.1 393609F1 1631 1981 4 208184.1 39360981 1631 1981 4 208184.1 83145605 1636 1983 4 208184.1 82318373 1640 1978 4 208184.1 2986775H1 1697 1990 4 208184.1 473722H1 1701 1933 4 208184.1 82941595 1703 2001 4 208184.1 888824H1 1706 1955 4 208184.1 4132772H2 1734 1979 4 208184.1 81378655 1744 1991 4 208184.1 83174115 1744 2011 4 208184.1 84327773 1775 1985 4 208184.1 8783328 1798 1975 4 208184.1 81444361 1802 1975 4 208184.1 2352377H1 1802 1985 4 208184.1 83837531 1924 1990 4 208184,1 700181H1 1378 1668 4 208184,1 2154043H1 1242 1524 4 208184.1 1500721H1 1248 1431 4 208184.1 1500721F6 1257 1748 4 208184,1 81378654 1267 1587 4 208184,1 3051269H1 1274 1560 4 208184.1 81296126 1279 1723 SEQ ID Template Component Start Stop NO: ID ID
4 208184.1 g842860 1356 1604 4 208184.1 372793471 1363 1936 4 208184.1 279288876 1362 1938 4 208184.1 265587076 1366 1922 4 208184.1 64296781 1368 1913 4 208184.1 642967H1 1369 1601 4 208184.1 645668H 1369 1615 4 208184,1 86932581 1143 1734 4 208184.1 73441481 1172 1674 4 208184.1 734414H1 1172 1393 4 208184.1 515633H1 1009 1322 4 208184.1 g783327 1028 1265 4 208184.1 3167476H1 1039 1316 4 208184.1 2726328H1 1048 1300 4 208184.1 3578247H1 1055 1320 4 208184.1 1330851H1 1055 1296 4 208184.1 g 1939112 1082 1314 4 208184.1 g1939111 1082 1322 4 208184,1 5426183H1 1105 1366 4 208184.1 1740885H1 1106 1341 4 208184,1 3727934H1 1117 1417 4 208184.1 869325H1 1143 1415 212029.3 1908946F6 1264 1619 5 212029.3 1908946H1 1264 1511 5 212029.3 g1958480 1322 1542 5 212029,3 227098486 1388 1847 5 212029.3 2270975H1 1388 1625 5 212029.3 2270984H1 1388 1617 5 212029.3 g850966 1509 1772 5 212029.3 987831 H 1587 1785 1, 5 212029.3 g2069455 1 405 5 212029.3 1597036H1 1 218 5 212029,3 4013148H1 178 464 5 212029.3 g2064597 257 606 5 212029.3 3296932H 313 565 5 212029.3 3296932F6 313 956 5 212029,3 5839392H1 316 547 5 212029.3 1254055H1 422 641 5 212029.3 3527901H1 436 710 5 212029.3 3402996H1 551 701 5 212029.3 3503954F6 617 1009 5 212029.3 3503954H1 618 921 5 212029.3 3985708H1 625 818 5 212029.3 3620240H1 773 982 5 212029,3 5912238H1 878 1073 5 212029.3 1961296H1 971 1244 5 212029.3 3406891F6 1033 1594 5 212029.3 3406891H1 1033 1273 5 212029.3 329693276 1256 1880 5 212029.3 4367370H2 1260 1508 SEQ ID Template Component Start Stop NO: ID ID
b 213446.2 4544305H1 1 149 b 213446.2 5522542H1 30 291 6 213446.2 5522550H1 30 292 b 213446.2 1750451H1 - 95 304 6 213446.2 5328728H1 94 357 b 213446.2 1750451F6 94 648 b 213446.2 3359386H1 96 358 b 213446.2 79633586 96 586 b 213446,2 3150909H1 97 331 b 213446.2 79633581 96 644 6 213446.2 796335H1 96 329 b 213446.2 5424323H1 98 249 b 213446.2 3057114H1 96 297 b 213446.2 4673642H1 99 375 b 213446.2 4675219H1 99 220 b 213446.2 4673443H1 99 230 6 213446.2 603462H1 103 357 6 213446.2 60346281 103 712 b 213446.2 4890190H1 144 432 b 213446.2 3456603H1 394 643 b 213446.2 5159788H1 438 bbl b 213446.2 5096622H2 502 780 6 213446.2 3369950H1 627 914 b 213446.2 1487733H1 632 923 b 213446.2 82321939 697 1107 6 213446,2 84080503 832 1304 b 213446.2 5182853F6 856 1172 6 213446.2 5182853H1 856 1015 6 213446.2 5182853T6 859 1342 6 213446.2 82656754 949 1317 6 213446.2 890504H1 1069 1263 6 213446.2 84123800 1095 1321 7 228864.4 5865075H1 109 391 7 228864.4 1616880H1 109 333 7 228864.4 8774507 118 458 7 228864,4 4155366H1 120 391 7 228864.4 2362950H1 120 282 7 228864.4 2106089H1 120 368 7 228864.4 2362976H1 120 279 7 228864.4 1444952H1 120 400 7 228864.4 5697362H1 123 391 7 228864.4 8830103 122 525 7 228864.4 2503761H1 145 416 7 228864.4 3796285H1 145 479 7 228864,4 3079081H1 147 235 7 228864.4 869160H1 159 421 7 228864.4 86916081 159 796 7 228864.4 3183023H1 177 496 7 228864.4 4560714H1 198 479 7 228864.4 1258418H1 207 449 SE6~ Template Component Start Stop ID NO: ID ID
7 228864.4 g389913 216 646 7 228864.4 3770688H1 222 367 7 228864.4 2533191H2 240 481 7 228864.4 3930940H1 268 571 7 228864.4 3537668H1 329 559 7 228864.4 2442003H1 ' 330 520 7 228864.4 1319657H1 347 595 7 228864.4 2629730H1 357 612 7 228864.4 3481103H1 371 651 7 228864.4 3497710H1 384 685 7 228864.4 1873990H1 390 677 7 228864.4 5161918H1 404 682 7 228864.4 5263240H1 407 478 7 228864.4 2308843H1 419 526 7 228864.4 2743121H1 419 684 7 228864.4 3080645H1 426 726 7 228864.4 g 1991438 427 704 7 228864.4 g 1990985 427 788 7 228864.4 4078219H1 429 727 7 228864.4 5386816H1 433 716 7 228864.4 g613059 433 723 7 228864.4 lb1bb45H1 435 683 7 228864,4 1616645F6 435 949 7 228864.4 g879155 457 630 7 228864,4 g907965 457 745 7 228864.4 698631H1 460 709 7 228864.4 495118H1 468 730 7 228864.4 495134H1 468 729 7 228864.4 1514782H1 485 705 7 228864.4 3296938H1 490 750 7 228864.4 4352776H1 494 706 7 228864.4 3480107H1 507 765 7 228864.4 1290794F6 517 877 7 228864.4 1290794H1 517 772 7 228864.4 4588579H1 521 805 7 228864,4 3107341H1 540 847 7 228864.4 4606551H1 541 812 7 228864,4 1463995H1 562 787 7 228864.4 8844939 592 867 7 228864,4 4752023H1 600 885 7 228864,4 2422049H1 603 836 7 228864,4 2620147H1 606 877 7 228864.4 739668H1 620 758 7 228864.4 1522232H1 618 812 7 228864.4 1519746H1 618 785 7 228864.4 73966881 629 1119 7 228864.4 2309713H1 630 883 7 228864.4 3146554H1 640 978 7 228864.4 878372H1 643 912 7 228864.4 3457194H1 649 909 SEQ ID Template Component Start Stop NO: ID ID
7 228864.4 3782086H1 661 989 7 228864.4 4567913H1 670 958 7 228864.4 1363758F1 670 1143 7 228864.4 4125731H1 670 950 7 228864.4 1363758H1 670 863 7 228864.4 1357005H1 670 951 7 228864.4 4045988H1 675 963 7 228864.4 g1886674 675 1127 7 228864.4 4775601H1 688 975 7 228864.4 5900350H1 717 870 7 228864.4 472426H1 734 904 7 228864.4 82206480 738 912 7 228864,4 3153075H1 741 1034 7 228864,4 5841024H2 745 1038 7 228864.4 4574294H1 751 1023 7 228864.4 3784538H1 783 1107 7 228864.4 81694080 789 1126 7 228864.4 4308240H1 788 1140 7 228864.4 3406691H1 789 1052 7 228864.4 3409828H1 803 1086 7 228864.4 82032612 810 1160 7 228864.4 4255552H1 824 ll04 7 228864.4 2956312H1 852 1180 7 228864,4 4379248H1 851 1140 7 228864.4 4378894H1 851 1027 7 228864.4 2411619H1 856 1103 7 228864,4 3504691H1 860 1153 7 228864.4 2642410H1 863 1121 7 228864.4 623141H1 868 1139 7 228864.4 2592655H1 867 1119 7 228864.4 4194450H1 867 1041 7 228864.4 2225947H1 867 1111 7 228864.4 81186186 872 1088 7 228864.4 81799037 874 1310 7 228864.4 1596221H1 874 1112 7 228864.4 4567877H1 878 1047 7 228864,4 2920003H1 876 1165 7 228864.4 2655503H1 880 1209 7 228864.4 264850H1 881 981 7 228864.4 6023806H1 883 1224 7 228864.4 1986159H1 883 1134 7 228864.4 1986159R6 883 1119 7 228864.4 2416335H1 883 1134 7 228864,4 3824142H1 894 1186 7 228864.4 5206556H1 895 1099 7 228864.4 4625676H1 901 1185 7 228864.4 171937H1 907 1124 7 228864.4 8888919 907 1190 7 228864,4 677587H1 918 1200 7 228864.4 2290038H1 919 1198 SE6Z Template Component Start Stop ID NO: ID ID ~
7 228864.4 5023768H1 928 1238 7 228864.4 82001495 928 1282 7 228864.4 5183168H1 937 1205 7 228864.4 5879286H1 945 1240 7 228864.4 4184443H1 945 1150 7 228864.4 4211129H1 944 1240 7 228864.4 3272214H1 968 1249 7 228864.4 2572116H1 981 1288 7 228864.4 5112704H1 985 1308 7 228864.4 1911846H1 1003 1113 7 228864.4 83307374 1444 1932 7 228864.4 84111085 1450 1961 7 228864.4 1368277H1 1454 1710 7 228864.4 5261924H1 1459 1712 7 228864.4 536879H1 1462 1752 7 228864.4 1959881T6 1458 1920 7 228864.4 82038223 1460 1768 7 228864.4 670986H1 1460 1801 7 228864.4 2372786H1 1460 1722 7 228864.4 1477817H1 1467 1738 7 228864.4 503758H1 1467 1751 7 228864.4 82139339 1472 1967 7 228864.4 2415457H1 1478 1767 7 228864.4 83429630 1483 1963 7 228864.4 1991354H1 1487 1804 7 228864.4 2508710H1 1499 1787 7 228864.4 83087298 1500 1968 7 228864.4 82354234 1502 1961 7 228864.4 83250205 1507 1973 7 228864.4 82264116 1507 1932 7 228864.4 83245152 1514 1970 7 228864,4 82526470 1515 1961 7 228864.4 81860066 1517 1958 7 228864.4 1906229H1 1520 1845 7 228864.4 82210895 1521 1947 7 228864,4 83593403 1521 1970 7 228864,4 3107177H1 1526 1866 7 228864.4 5978491H1 1529 1857 7 228864.4 3350739H1 1534 1854 7 228864.4 1341266H1 1534 1843 7 228864.4 82205403 1535 1974 7 228864.4 516461H1 1537 1798 7 228864.4 4253927H1 1544 1841 7 228864.4 82805846 1543 1963 7 228864.4 2413301H1 1543 1800 7 228864.4 82206749 1545 1964 7 228864.4 82881920 1553 1967 7 228864.4 83765236 1555 1972 7 228864.4 g 1693975 1561 1962 7 228864.4 81692741 1561 1973 SEQ ID Template Component Start Stop NO: ID ID
7 228864.4 83422186 1562 1968 7 228864,4 82206375 1569 1961 7 228864.4 82238997 1571 1984 7 228864.4 82269218 1571 1961 7 228864,4 81422987 1574 1958 ' 7 228864.4 1366917H1 1576 1829 7 228864.4 136691781 1576 1937 7 228864.4 136691771 1576 1930 7 228864.4 84509876 1576 1961 7 228864.4 82840643 1576 1969 7 228864.4 87327571 1577 1923 7 228864.4 873275H1 1577 1857 7 228864.4 87327581 1577 1961 7 228864.4 943941H1 1582 1944 7 228864.4 94394171 1581 1923 7 228864.4 553126H1 1590 1847 7 228864.4 82955909 1587 1969 7 228864.4 82141313 1592 1961 7 228864,4 841913H1 1595 1876 7 228864.4 1269237H1 1601 1895 7 228864.4 2240562H1 1600 1899 7 228864.4 1269229F6 1601 1961 7 228864,4 3173222H1 1601 1891 7 228864.4 126922976 1604 1921 7 228864.4 2569601H1 1605 1887 7 228864.4 008331H1 1607 1912 7 228864.4 82410907 1607 1967 7 228864.4 83870805 1607 1962 7 228864.4 8830045 1616 1978 7 228864.4 84110296 1612 1976 7 228864.4 4595257H1 1618 1841 7 228864.4 8825912 1622 1973 7 228864.4 g 1164606 1632 1961 7 228864.4 751050H1 1637 1898 7 228864.4 81479705 1638 1961 7 228864.4 1257103F1 1642 1967 7 228864.4 1257103H1 1642 1924 7 228864.4 8519500 1644 1967 7 228864.4 2915847H1 1642 1944 7 228864,4 5427111H1 1646 1939 7 228864,4 210895H1 1646 1898 7 228864.4 83050237 1647 1967 7 228864.4 2491624H1 1650 1906 7 228864,4 83754764 1654 1966 7 228864,4 8858236 1661 1945 7 228864,4 8888828 1663 1967 7 228864.4 8832518 1669 1974 7 228864.4 3793365H1 1666 1961 7 228864.4 4424104H1 1670 1953 7 228864.4 8907936 1673 1946 SEQ ID Template Component Start Stop NO: ID ID
7 228864.4 82264098 1673 1933 7 228864.4 82167663 1673 1966 7 228864.4 81886251 1684 1964 7 228864.4 83750664 1690 1961 7 228864.4 81443124 1693 1967 7 228864.4 8889394 1695 1979 7 228864.4 8519496 1697 1967 7 228864.4 8614232 1699 1967 7 228864,4 2101758H1 1700 1967 7 228864.4 8994586 1701 1957 7 228864.4 8845833 1701 1967 7 228864.4 8810610 1701 1960 7 228864.4 81067419 1701 1943 7 228864.4 1215929H1 1703 1857 7 228864.4 8872749 1706 1976 7 228864.4 8614200 1706 1961 7 228864.4 8566599 1710 1967 7 228864.4 8888655 1712 1968 7 228864.4 4425257H1 1715 1980 7 228864.4 240542H1 1716 1869 7 228864.4 82058861 1715 1967 7 228864.4 82335948 1720 1961 7 228864.4 82322019 1726 1966 7 228864.4 530442H1 1741 1961 7 228864.4 8670640 1752 1967 7 228864.4 2245477H1 1755 1961 7 228864,4 5580560H1 1766 1929 7 228864.4 g 1494073 1764 1961 7 228864.4 4194132H1 1766 1967 7 228864.4 82986422 1785 1967 7 228864.4 84123826 1797 1963 7 228864.4 1397558H1 1808 1961 7 228864.4 81479653 1806 1961 7 228864.4 2258238H1 1808 1961 7 228864.4 1370863H1 1809 1967 7 228864.4 82280375 1810 1967 7 228864,4 8916819 1817 1961 7 228864.4 82739855 1840 1965 7 228864.4 83038015 1842 1961 7 228864.4 82841777 1852 1961 7 228864,4 84372871 1855 1963 7 228864.4 1264942H1 1007 1273 7 228864.4 1264942R1 1007 1444 7 228864,4 405391R6 1014 1553 7 228864.4 5683210H1 1021 1289 7 228864.4 3541340H1 1019 1330 7 228864.4 215013H1 1035 1158 7 228864.4 81928459 1047 1478 7 228864.4 1228283H1 1058 1320 7 228864.4 531728R6 1066 1706 7b SEQ ID Template Component Start Stop NO: ID ID
7 228864.4 531728H1 1066 1371 7 228864.4 4092970H1 1066 1375 7 228864.4 5693116H1 1066 1331 7 228864.4 8614233 1077 1412 7 228864.4 5101746H1 1084 1332 7 228864,4 4642390H1 1105 1337 7 228864.4 866916H1 1109 1379 7 228864.4 866916R1 1109 1766 7 228864.4 1693363H1 1110 1207 7 228864.4 8810713 1114 1454 7 228864.4 8845887 1115 1544 7 228864.4 2214177H1 1118 1388 7 228864,4 1365249H1 1118 1190 7 228864.4 3853462H1 1118 1440 7 228864.4 81940874 1119 1688 7 228864,4 3493702H1 1124 1439 7 228864,4 5004632H1 1128 1400 7 228864.4 3992620H1 1132 1456 7 228864,4 2874610H1 1130 1466 7 228864,4 1340384H1 1134 1308 7 228864,4 5184044H1 1142 1429 7 228864.4 5107670H1 1141 1413 7 228864.4 4425962H1 1142 1416 7 228864.4 2246674H1 1144 1434 7 228864.4 82139112 1154 1646 7 228864.4 3663704H1 1155 1493 7 228864.4 2079688H1 1154 1447 7 228864.4 3591083H1 1154 1346 7 228864.4 3814383H1 1155 1476 7 228864.4 1681877H1 1154 1412 7 228864.4 2108278H1 1154 1458 7 228864.4 515405H1 1155 1403 7 228864.4 8858032 1157 1435 7 . 228864.41789187H1 1164 1422 7 228864.4 1788136H1 1164 1450 7 228864.4 4327161H1 1164 1437 7 228864.4 5832891H1 1184 1490 7 228864,4 276693H1 1181 1469 7 228864.4 81521765 1194 1542 7 228864.4 5404066H1 1195 1483 7 228864.4 5404004H1 1195 1317 7 228864.4 1394880H1 1199 1488 7 228864.4 8922893 1204 1539 7 228864.4 8889937 1204 1539 7 228864.4 8889393 1205 1573 7 228864.4 8888654 1205 1448 7 228864.4 1917625H1 1209 1482 7 228864.4 2630585H1 1211 1488 7 228864.4 133967H1 1218 1422 7 228864.4 1616645T6 1227 1921 SE9 ID Template Component Start Stop NO: ID ID
7 228864.4 8884600 1235 1593 7 228864.4 5840548H2 1241 1529 7 228864.4 4311468H1 1244 1447 7 228864.4 631129H1 1244 1534 7 228864.4 2130838H1 1244 1531 7 228864.4 81692842 1243 1822 7 228864.4 75204681 1254 1877 7 228864.4 2659504H1 1254 1562 7 228864.4 81954716 1264 1577 7 228864.4 1538114H1 1268 1454 7 228864.4 4852290H1 1279 1549 7 228864.4 1950908H1 1283 1565 7 228864.4 112889H1 1293 1544 7 228864.4 2707203H1 1297 1577 7 228864.4 4317110H1 1298 1622 7 228864.4 531728Th 1302 1923 7 228864.4 405391T6 1302 1921 7 228864.4 112890H1 1306 1522 7 228864.4 81961047 1306 1789 7 228864.4 6209217H1 1307 1670 7 228864.4 5106358H1 1308 1596 7 228864.4 1986159Th 1309 1922 7 228864,4 204430H1 1315 1474 7 228864.4 2220564H1 1317 1590 7 228864.4 81973608 1327 1661 7 228864,4 5100480H1 1337 1447 7 228864,4 1886806H1 1340 1662 7 228864.4 81576711 1341 1526 7 228864.4 82069223 1343 1823 7 228864.4 137261H1 1343 1539 7 228864.4 81423026 1343 1774 7 228864.4 604541H1 1343 1604 7 228864.4 3469340H1 1343 1631 7 228864.4 2438735H1 1351 1605 7 228864.4 82069954 1351 1817 7 228864.4 2438390H1 1351 1627 7 228864.4 3126373H1 1354 1711 7 228864.4 2422970H1 1361 1653 7 228864.4 82206156 1360 1739 7 228864.4 2316643H1 1370 1667 7 228864.4 2373160H1 1386 1695 7 228864.4 2364835H1 1386 1645 7 228864.4 1290794Th 1389 1952 7 228864.4 137894H1 1392 1604 7 228864.4 2627275H1 1392 1716 7 228864.4 4839445H1 1392 1726 7 228864.4 82930378 1395 1970 7 228864.4 739668F1 1400 1961 7 228864.4 3251281H1 1399 1792 7 228864.4 2666633H1 1404 1692 SE6~ Template Component Start Stop ID NO: ID ID
7 228864,4 5834458H1 1409 1606 7 228864.4 3692921H1 1412 1754 7 228864.4 g2360187 1411 1932 7 228864.4 g2953905 1412 1964 7 228864.4 1489882H1 1415 1731 7 228864.4 3269028H1 1419 1599 7 228864.4 g1960172 1419 1961 7 228864.4 1346630H1 1419 1703 7 228864.4 g2051175 1421 1872 7 228864.4 2561963H1 1422 1759 7 228864.4 566676H1 1426 1766 7 228864.4 g2728469 1424 1970 7 228864.4 g3162592 1421 1945 7 228864.4 4536759H1 1427 1718 7 228864.4 g3665710 1430 1965 7 228864.4 1453494H1 1432 1717 7 228864.4 g3162610 1435 1945 7 228864.4 g4313225 1442 1951 7 228864.4 g4328835 1440 1970 7 228864.4 g888982 1882 1968 7 228864.4 1443349F6 1 514 7 228864.4 1739557H1 55 293 7 228864.4 3541425H1 b3 374 7 228864.4 1594648H1 65 293 7 228864.4 868282H1 70 328 7 228864.4 4693320H2 76 177 7 228864.4 2437341H1 76 316 7 228864.4 1258508H1 79 348 7 228864.4 g677259 79 344 7 228864,4 2661646H1 82 327 7 228864.4 1992251H1 83 309 7 228864.4 2502018H1 83 356 7 228864.4 3700420H1 85 398 7 228864.4 1578634H1 87 320 7 228864.4 3601285H1 91 398 7 228864.4 3419979H1 91 366 7 228864.4 3394860H1 91 384 7 228864.4 3487463H1 91 397 7 228864.4 3323182H1 90 377 7 228864.4 3761644H1 92 455 7 228864.4 2190393H1 90 370 7 228864.4 2477729H1 91 320 7 228864.4 2925245H1 91 358 7 228864,4 3394839H1 91 359 7 228864.4 3394843H1 91 359 7 228864,4 660322H1 91 377 7 228864.4 2380023H1 91 329 7 228864.4 1687157H1 91 302 7 228864.4 3452490H1 91 264 7 228864,4 1959881H1 91 343 SEQ ID Template Component Start Stop NO: ID ID
7 228864.4 660994H1 91 375 7 228864.4 2663372H1 91 340 7 228864.4 3496054H1 91 407 7 228864.4 1749148H1 91 374 7 228864.4 2797721H1 91 351 7 228864,4 2370507H1 91 388 7 228864.4 8872854 87 439 7 228864.4 3251075H1 91 419 7 228864.4 195988186 91 406 7 228864.4 3359733H1 92 390 7 228864.4 3557086H1 93 408 7 228864.4 2660652H1 95 349 7 228864.4 1875407H1 95 381 7 228864.4 5778376H1 98 388 7 228864.4 4839236H1 96 410 7 228864.4 4873821H1 97 392 7 228864.4 2267072H1 98 373 7 228864.4 4563807H1 102 187 7 228864.4 4697375H1 101 328 7 228864.4 8574327 101 473 7 228864.4 2457949H1 101 355 7 228864.4 81959304 101 454 7 228864.4 4399256H1 101 258 7 228864.4 2525904H1 102 376 7 228864.4 750617H1 102 347 7 228864.4 4873985H1 102 367 7 228864.4 3296104H1 102 376 7 228864.4 2963248H1 101 426 7 228864.4 75061781 102 654 7 228864.4 8826028 103 438 7 228864.4 4753330H1 104 385 7 228864.4 3466388H1 104 374 7 228864.4 3372760H1 104 385 7 228864.4 8831794 103 419 7 228864,4 3581563H1 105 406 7 228864.4 835615H1 105 348 7 228864,4 3239308H1 105 373 7 228864,4 73272481 106 721 7 228864,4 732724H1 106 348 7 228864.4 3248690H1 106 424 .
7 228864,4 5919227H1 104 432 7 228864.4 5985820H1 108 389 8 229840.3 83921683 2848 3070 8 229840.3 82985904 2858 3072 8 229840.3 5909792H1 2693 2987 8 229840.3 84189001 2712 3069 8 229840.3 82882752 2717 3065 8 229840.3 84073312 2728 3073 8 229840.3 84264530 2733 3065 8 229840.3 84325751 2738 3069 SEQ ID Template Component Start Stop NO: ID ID
8 229840.3 81148915 2739 3065 8 229840.3 83836479 2744 3073 8 229840.3 145458076 2838 3037 8 229840.3 1454581H1 2838 3066 8 229840.3 1454581F1 2838 3065 8 229840.3 145458176 2838 3040 8 229840.3 82782503 2842 3069 8 229840.3 3034701H1 2838 3063 8 229840.3 3000391H1 1647 1951 8 229840.3 5375263H1 1665 1869 8 229840.3 5375650H1 1665 1924 8 229840.3 4140779H1 1675 1982 8 229840.3 288084576 1739 2019 8 229840.3 785393H1 1796 2090 8 229840.3 1664014H1 1827 2057 8 229840.3 83807773 1832 2305 8 229840.3 3323431H1 1888 2170 8 229840.3 4852173H1 3 263 8 229840.3 157321276 1903 2287 8 229840.3 4549830H1 1993 2265 8 229840.3 4995409H1 1944 2202 8 229840.3 2747040H1 1964 2208 .
8 229840.3 3878345H1 2032 2327 8 229840.3 3413323H1 2042 2290 8 229840.3 040203H1 2070 2308 8 229840.3 83094583 456 932 8 229840.3 83869975 473 933 8 229840.3 134898876 502 887 8 229840.3 82398144 503 931 8 229840.3 84069464 504 929 8 229840.3 300112276 565 905 8 229840.3 3001122H1 572 876 8 229840.3 3001122F6 573 932 8 229840.3 83213774 588 935 8 229840.3 82210579 6b2 941 8 229840.3 84190109 681 929 8 229840.3 3002524H1 692 886 8 229840.3 5637815H1 748 1014 8 229840.3 84327917 751 892 8 229840.3 3605342H1 760 1069 8 229840.3 1573212H1 872 1111 8 229840.3 1573212F6 872 1159 8 229840.3 5867496H1 913 1192 8 229840.3 5525935H2 972 1224 8 229840.3 5525917H2 972 1200 8 229840.3 82210630 52 237 8 229840.3 2882517H1 55 320 8 229840.3 1348984H1 132 393 8 229840.3 1348988F6 132 569 8 229840.3 230345776 338 895 SEQ ID Template Component Start Stop NO: ID ID
8 229840.3 252533776 394 899 8 229840.3 254803876 414 900 8 229840.3 4776015H1 16 291 8 229840.3 384074H1 22 310 8 229840.3 3201803H1 23 230 8 229840.3 2587779H1 34 280 8 229840.3 4358685H1 34 317 8 229840.3 4308bOlHl 34 325 8 229840.3 4308648H1 35 383 8 229840.3 426170H1 43 265 8 229840.3 828194H1 2400 2661 8 229840.3 138331876 2407 3027 8 229840.3 1487404H1 2412 2666 8 229840.3 87854281 2428 3032 8 229840.3 878542H1 2428 2664 8 229840.3 87854271 2428 3027 8 229840.3 2255908H1 2449 2735 8 229840.3 042254H1 2495 2695 8 229840.3 1676510H1 1463 1673 8 229840.3 3351180H1 1474 1763 8 229840.3 3164210H1 1482 1773 8 229840.3 6024893H1 1487 1789 8 229840.3 3294678H1 1513 1799 8 229840.3 3555380H1 1517 1822 8 229840.3 4370762H1 1551 1815 8 229840.3 3561882H1 1559 1860 8 229840.3 166401476 1570 2019 8 229840.3 2664716H1 1598 1827 8 229840.3 82553076 1599 2055 8 229840.3 1664014F6 1603 2057 8 229840.3 8843066 1608 1908 8 229840.3 2811115H1 1619 1892 8 229840.3 1383318F6 1630 2128 8 229840.3 1383318H1 1630 1873 8 229840.3 939387H1 2858 3065 8 229840.3 960688H1 2858 2999 8 229840.3 g 1784633 2858 3069 8 229840.3 82987896 2858 3072 8 229840.3 454983071 2858 3026 8 229840.3 83096610 2858 3069 8 229840.3 81761395 2866 3042 8 229840.3 902367H1 2878 3064 8 229840.3 90236771 2878 3036 8 229840.3 1370625H1 2883 3063 8 229840.3 1752509H1 2545 2763 8 229840.3 217456976 2550 3027 8 229840.3 3720838H1 2568 2887 8 229840.3 5680448H1 2580 2815 8 229840.3 84189079 2584 3067 8 229840.3 83927421 2595 3065 SEQ ID Template Component Start Stop NO; ID ID
8 229840.3 1903055H1 2609 2815 8 229840.3 83679709 2616 3074 8 229840.3 2133162H1 2660 2931 8 229840.3 779163H1 2685 2941 8 229840.3 4354675H1 2686 2815 8 229840.3 82264632 2495 2815 8 229840.3 82267837 2496 2838 8 229840.3 275005H1 2497 2653 8 229840.3 5076984H1 2508 2801 8 229840.3 1829765H1 2508 2744 8 229840.3 5076985H1 2509 2801 8 229840.3 1829765F6 2508 3038 8 229840.3 3995183H1 2514 2782 8 229840.3 1829765Th 2530 3023 8 229840.3 3519322H1 2082 2459 8 229840.3 2635539H1 2092 2363 8 229840.3 085879H1 2097 2364 8 229840.3 4852717H1 2096 2355 8 229840.3 3201459H1 2118 2314 8 229840.3 4980057H 2124 2385 8 229840.3 81785255 2144 2573 8 229840.3 3491811H1 2154 2423 8 229840.3 2471395H1 2215 2437 8 229840.3 3162006H1 2226 2511 8 229840.3 4996246H1 2229 2504 8 229840.3 81761571 2288 2651 8 229840.3 2694820H1 2308 2482 8 229840.3 2622173H1 2326 2606 8 229840.3 81925233 2364 2594 8 229840.3 828194T1 2400 3030 8 229840.3 82819481 2400 2953 8 229840.3 82540041 2946 3067 8 229840.3 82539934 2959 3067 8 229840.3 83055680 2978 3070 8 229840.3 2349363H1 2980 3069 8 229840.3 81925117 2981 3066 8 229840.3 2880845F6 1118 1558 8 229840.3 2880845H1 1118 1415 8 229840.3 2174569F6 1251 1727 8 229840.3 2174569H1 1251 1475 8 229840.3 4872808H1 1284 1561 8 229840.3 838790H1 1299 1568 8 229840.3 2845321H1 1333 1592 8 229840.3 3389695H1 1346 1632 8 229840.3 2267707H1 1380 1630 8 229840.3 1549249H1 1442 1632 8 229840.3 3749030H1 1 191 8 229840.3 2548038F6 10 548 8 229840.3 2539058F6 10 624 8 229840.3 4561642H1 10 264 SEQ ID Template Component Start Stop NO: ID ID
8 229840.3 2548038H1 10 261 8 229840.3 2303457H1 14 267 8 229840.3 230345786 14 487 8 229840.3 3714222H1 17 314 9 231793.2 3743582H1 1 301 9 231793.2 3490362H1 3 201 9 231793.2 3355002H1 21 304 9 231793.2 1522723H1 22 218 9 231793.2 2790244H2 30 337 9 231793.2 1866779F6 33 415 9 231793.2 1866779H1 33 315 9 231793.2 1311083H1 81 300 9 231793,2 3236153H1 112 360 9 231793.2 5158979H1 204 429 9 231793.2 1390212H1 289 447 9 231793.2 1390306H1 289 541 9 231793.2 100112686 326 885 9 231793.2 4049712H1 369 641 9 231793.2 3767101H1 536 651 9 231793.2 2791795H1 512 801 9 231793.2 4576054H1 565 824 9 231793.2 5593839H1 735 994 9 231793.2 5052279H1 837 971 9 231793.2 198660386 867 1390 9 231793.2 1986603H1 867 1148 9 231793.2 1991005H1 919 1076 9 231793.2 3962341H1 972 1262 9 231793.2 3673817H1 1007 1289 9 231793.2 2488457H1 1180 1409 9 231793,2 2623858H1 1187 1437 9 231793.2 262385886 1187 1501 9 231793.2 4650753H1 1351 1495 9 231793.2 2793766H1 1368 1667 9 231793,2 1803565H1 1553 1837 9 231793.2 5281570H2 1575 1847 9 231793.2 4731704H1 1578 1869 9 231793.2 158289H1 1659 1835 9 231793.2 4048712H1 1710 1992 9 231793.2 1707686H1 1780 1971 9 231793.2 5296093H1 1783 2004 9 231793.2 g 1979679 1792 2097 9 231793.2 g2277027 1844 2232 9 231793.2 2673033F6 1878 2419 9 231793.2 2673033H1 1878 2118 9 231793.2 977810H1 1886 2105 9 231793.2 5027277H1 1892 2169 9 231793.2 3803405H1 1935 2246 9 231793.2 5095560H1 1943 2126 9 231793.2 4213438H1 1971 2181 9 231793.2 198660376 1984 2479 SE9 ID Template Component Start Stop NO; ID ID
9 231793.2 100112676 1992 2477 9 231793.2 180356576 2006 2466 9 231793.2 4170673H1 2050 2319 9 231793.2 3406618H1 2052 2313 9 231793.2 186677977 2068 2484 9 231793.2 g3765637 2072 2541 9 231793.2 5094942H1 2071 2324 9 231793.2 121429376 2088 2483 9 231793,2 1214293R6 2089 2496 9 231793.2 1214293H1 2099 2319 9 231793.2 1214167H1 2100 2353 9 231793.2 g2347914 2126 2520 9 ~ 231793.25084768H1 2127 2351 9 231793.2 1914969H1 2130 2392 9 231793.2 g3049752 2143 2523 9 231793.2 170768676 2151 2476 9 231793.2 5048501H1 2163 2459 9 231793.2 267303376 2179 2484 9 231793.2 g2556740 2194 2521 9 231793.2 g4078219 2241 2545 9 231793.2 288397076 2276 2504 9 231793.2 3512992H1 2276 2482 9 231793.2 g2322181 2353 2523 9 231793.2 130206777 2358 2481 9 231793.2 1302517H1 2365 2521 9 231793.2 1302517F6 2365 2521 9 231793.2 134723H1 2380 2521 9 231793.2 g1195715 2479 2529 234137,5 1832689R6 409 751 10 234137.5 1711521H1 413 622 10 234137,5 3317846H1 475 733 10 234137.5 g1616066 508 785 10 234137.5 2185641H1 526 792 10 234137,5 1618067H1 569 786 10 234137.5 1255603F6 593 951 10 234137.5 1255603H1 593 840 10 234137.5 5518712H1 592 827 10 234137.5 1944240H1 206 468 10 234137.5 g814646 194 490 10 234137.5 3746685H1 207 493 10 234137.5 2486355H1 212 459 10 234137.5 2888507H1 194 257 10 234137.5 2500535H1 212 454 10 234137.5 3511080H1 198 505 10 234137.5 2503636H1 258 508 10 234137.5 698952H1 275 372 10 234137.5 699726H1 275 547 10 234137.5 699737H1 275 542 10 234137.5 5190833H2 287 547 10 234137.5 2723787H1 285 555 SEQ ID Template Component Start Stop NO: ID ID
234137.5 4880881H1 289 506 10 234137.5 1742695H1 1192 1399 10 234137.5 g1004759 1193 1454 10 234137.5 3051736H1 1198 1493 10 234137.5 3789688H1 1215 1430 10 234137.5 389357H1 1221 1370 10 234137.5 4000387H1 1237 1509 10 234137.5 535718H1 1253 1466 10 234137.5 45436581 1440 1754 10 234137.5 2419654H1 316 571 10 234137.5 1993760H1 317 548 10 234137.5 3506477H1 317 624 10 234137.5 g991858 324 495 10 234137.5 84152671 380 748 10 234137.5 3327435H1 381 647 10 234137.5 1832689H1 409 689 10 234137.5 211077786 1 348 10 234137.5 2110777H1 1 190 10 234137.5 714010H1 26 224 10 234137.5 8706051 26 417 10 234137.5 8674497 27 384 10 234137.5 6026756H1 34 308 10 234137.5 3530615H1 141 458 10 234137,5 4171108H1 155 454 10 234137.5 8615415 154 412 10 234137,5 3156905H1 lbl 328 10 234137.5 81815065 164 624 10 234137.5 8884950 1b8 595 10 234137.5 3331405H1 173 444 10 234137.5 3458347H1 183 429 10 234137.5 3672287H1 177 400 10 234137.5 2816025H1 181 495 10 234137.5 4077622H1 178 467 10 234137.5 905762H1 180 395 10 234137.5 8953765 180 561 10 234137.5 1602692H1 183 396 10 234137,5 1602692F6 183 487 10 234137,5 8775373 184 485 10 234137.5 1482169H1 182 462 10 234137.5 82141035 183 625 10 234137.5 4159960H1 186 452 10 234137.5 8616022 185 46b 10 234137.5 8705506 186 492 10 234137.5 8705505 186 460 10 234137.5 8868789 190 488 10 234137.5 8831177 190 564 10 234137.5 8574383 189 529 10 234137.5 81516946 192 619 10 234137.5 8390441 190 506 10 234137.5 3243071H1 194 448 SEQ ID Template Component Start Stop NO: ID ID
234137.5 2888320H1 194 481 10 234137.5 2180954H1 778 935 10 234137.5 90150081 614 1145 10 234137.5 4230253H1 1101 1384 10 234137.5 901600H1 614 922 10 234137.5 589607H1 1148 1398 10 234137.5 901500H1 614 907 10 234137.5 901744H1 614 815 10 234137.5 2287212H1 1189 1422 10 234137.5 5591962H1 633 765 10 234137.5 3424013H1 1190 1460 10 234137.5 1742570H1 1192 1478 10 234137.5 g4394560 1660 2001 10 234137.5 g4224234 1598 2008 11 234671.14 4638731H1 73 352 11 234671.14 2525135H1 71 327 11 234671.14 4510615H1 90 235 11 234671.14 2805957H1 91 423 11 234671.14 5912661H1 90 401 11 234671.14 2016655H1 93 419 11 234671.14 3202510H1 95 401 11 234671.14 4608993H1 95 350 11 234671.14 725bObHl 95 408 11 234671.14 5030359H1 94 349 11 234671.14 1499350H1 95 308 ~
11 234671.14 4849095H2 101 299 11 234671.14 2916364H1 100 405 11 234671.14 2071479H1 100 380 11 234671.14 4294695H1 105 191 11 234671.14 1480701H1 100 313 11 234671.14 2845388H1 103 388 11 234671.14 3916903H1 104 433 11 234671.14 4974316H1 104 402 11 234671.14 2865203H1 104 214 11 234671.14 916311H1 105 433 11 234671.14 915496H1 105 392 11 w 234671.14222004876 106 668 11 234671.14 g 1799327 103 346 11 234671.14 8735496 108 456 11 234671.14 2521203H1 108 377 11 234671.14 2820807H1 109 330 11 234671.14 5302702H1 111 380 11 234671.14 2367817H1 115 386 11 234671.14 2660131H1 116 374 11 234671.14 81962046 115 562 11 234671.14 2220048F6 118 622 11 234671.14 5622009H1 115 475 11 234671.14 088730H1 119 393 11 234671.14 82036474 120 433 11 234671.14 3978238H1 121 442 SE6~ ID NO. TemplateComponent Start Stop ID ID
11 234671,14 4744991H1 121 397 11 234671,14 3529614H1 122 458 11 234671.14 g1697240 122 306 11 234671.14 g1721900 122 613 11 234671.14 3928785H1 122 406 11 234671.14 4626904H1 122 396 11 234671.14 3928677H1 122 305 11 234671.14 g1516296 122 603 11 234671.14 2074823H1 122 270 11 234671.14 2135894H1 122 418 11 234671.14 3115158H1 123 430 11 234671.14 2135876H1 122 420 11 234671.14 575915H1 126 291 11 234671.14 4975637H1 126 419 11 234671.14 1463657H1 131 349 11 234671.14 g1317142 132 626 11 234671.14 146365771 131 669 11 234671.14 5278514H1 131 296 11 234671,14 1914942H1 132 399 11 234671.14 2479730H1 132 391 11 234671.14 3148758H1 132 461 11 234671.14 2912447H 132 425 11 234671.14 5857652H1 134 429 11 234671.14 2451454H1 134 392 11 234671.14 5664881H1 135 444 11 234671.14 4981466H1 136 420 11 234671.14 2968710H1 136 486 11 234671.14 4981166H1 136 419 11 234671.14 3013140H1 136 389 11 234671.14 2551737H1 136 422 11 234671.14 2284544H1 136 397 11 234671.14 102120H1 136 407 11 234671.14 3461073H1 136 399 11 234671.14 4822658H1 139 441 11 234671.14 4166805H1 136 467 11 234671.14 2707011H1 137 428 11 234671.14 4974307H1 139 436 11 234671.14 1468622H1 139 275 11 234671.14 1467020H1~ 139 345 11 234671.14 2541676H1 139 415 11 234671.14 1470317H1 139 341 11 234671.14 3733432H1 141 464 11 234671.14 g901576 143 487 11 234671.14 2766646H1 143 411 11 234671,14 082496H1 149 367 11 234671,14 2476615H1 148 390 11 234671.14 2905015H1 149 325 11 234671,14 3760125H1 156 272 11 234671,14 3297065H1 160 435 11 234671.14 6141029H1 159 505 SE6~ ID NO: TemplateComponent Start Stop ID ID
11 234671.14 2818173H1 161 414 11 234671.14 4701519H1 1b3 457 11 234671.14 2371480H1 165 412 11 234671.14 2448051H1 165 429 11 234671.14 2026733H1 165 446 11 234671.14 086299H1 165 447 11 234671.14 4553646H1 167 446 11 234671.14 3236203H1 170 447 11 234671.14 2625102H1 170 425 11 234671.14 g 1639954 171 396 11 234671.14 81447865 190 407 11 234671.14 8889618 204 571 11 234671.14 3292442F6 1 493 11 234671.14 3292442H1 1 261 11 234671.14 2787149H1 22 144 11 234671.14 4845874H1 64 251 11 234671.14 5217923H1 b9 348 11 234671.14 329244276 204 689 11 234671.14 8889628 204 548 11 234671.14 5509259H1 218 458 11 234671.14 3035317H1 223 544 11 234671.14 3035317F6 223 561 11 234671.14 84329558 240 715 11 234671.14 84111623 244 720 11 234671.14 83404679 245 707 11 234671.14 84112201 246 707 11 234671.14 82929715 248 707 11 234671.14 83401096 253 710 11 234671.14 4206791H1 273 465 11 234671,14 82268964 287 706 11 234671.14 419449H1 292 516 11 234671.14 276343376 293 678 11 234671.14 81516236 295 718 11 234671.14 1999242H1 310 512 11 234671.14 8504586 313 710 11 234671.14 81721788 314 716 11 234671.14 4372931H1 321 579 11 234671.14 1353392F1 323 760 11 234671.14 1353392H1 323 599 11 234671.14 83797245 334 707 11 234671.14 81728570 340 716 11 234671.14 4711787H1 383 484 11 234671.14 8735497 401 718 11 234671.14 2534033H1 406 647 11 234671.14 347531H1 412 659 11 234671.14 498396H1 419 637 11 234671.14 82327885 426 722 11 234671.14 83048289 426 915 11 234671.14 83756898 428 714 11 234671.14 5408101H1 428 529 SEQ ID Template Component Start Stop NO: ID ID
11 234671.14 83202140 430 720 11 234671.14 82875495 436 750 11 234671.14 84194406 439 715 11 234671.14 83600863 461 915 11 234671.14 548974H1 498 715 11 234671.14 83180704 511 572 11 234671.14 001841H1 517 911 11 234671.14 82904348 534 918 11 234671,14 81300605 535 712 11 234671,14 83843537 558 920 11 234671,14 82716778 564 715 11 234671.14 4704563H1 567 707 11 234671,14 5094769H1 613 856 1 1 234671,14 g 1147845 641 923 11 234671.14 3774346H1 676 970 11 234671,14 3237695H1 694 853 11 234671.14 3549570H1 731 986 11 234671.14 1306053F6 737 1223 11 234671.14 6104976H1 853 1149 11 234671.14 534062H1 914 1164 11 234671.14 2673834H1 931 1145 11 234671.14 84292281 998 1448 11 234671.14 1306053H1 994 1223 11 234671.14 83803923 1028 1448 11 234671.14 82768559 1065 1453 11 234671.14 83415483 1115 1459 11 234671.14 65982186 1144 1458 11 234671.14 65982176 1143 1410 11 234671.14 659821H1 1144 1407 11 234671.14 83659045 1159 1406 11 234671.14 82344002 1193 1447 11 234671.14 8889629 1209 1385 11 234671.14 8889619 1254 1401 11 234671.14 8901577 1258 1448 11 234671.14 8908490 1258 1402 11 234671.14 2374770H1 1344 1458 12 241236,3 84083561 1571 2017 12 241236,3 2491474H1 1570 1818 12 241236,3 84222338 1572 2016 12 241236.3 488351476 1574 1994 12 241236.3 84082140 1581 1953 12 241236.3 2129206H1 1590 1898 12 241236.3 82177776 1593 2016 12 241236.3 84077506 1605 2010 12 241236.3 145625381 1613 2014 12 241236.3 2752225H1 1623 1900 12 241236.3 84189365 1624 2019 12 241236.3 83144764 1626 2014 12 241236.3 82539525 1650 2013 12 241236.3 82986682 1666 2017 SE6~ Template Component Start Stop ID NO: ID ID
12 241236.3 g2273603 1701 2012 12 241236.3 2989623T6 1740 1966 12 241236.3 2625824H1 1750 1989 12 241236.3 2625824Th 1758 1956 12 241236.3 2625824F6 1750 2010 12 241236.3 g3756824 1 393 12 241236.3 5376769H1 1 249 12 241236.3 3473825H1 115 374 12 241236.3 1675287H1 134 303 12 241236.3 1675845H1 135 314 12 241236.3 2047281F6 271 810 12 241236.3 2047281H1 271 482 12 241236.3 3724339H1 352 632 12 241236.3 5733241H1 404 664 12 241236,3 4909488H1 408 664 12 241236.3 1857844H1 412 667 12 241236.3 3078885H1 467 776 12 241236.3 4883514F6 529 963 12 241236.3 4883514H1 529 815 12 241236.3 g1023658 566 798 12 241236.3 1222879H1 644 871 12 241236.3 3400427H1 661 890 12 241236.3 1702383H1 664 880 12 241236.3 4902281H1 687 953 12 241236.3 4380777H1 697 956 12 241236.3 868686H1 702 954 12 241236.3 2598561H1 706 994 12 241236.3 3672519H1 718 995 12 241236.3 5811931H1 729 1048 12 241236.3 4863967H 7b9 1059 12 241236.3 1534650H1 780 979 12 241236.3 4852733H1 780 1034 12 241236.3 1532438H1 780 987 12 241236.3 3407892H1 791 1049 12 241236,3 4173535H1 841 1129 12 241236.3 736762H1 845 1073 12 241236.3 987503H1 867 1107 12 241236,3 3591339H1 899 1203 12 241236.3 1600224H1 907 1096 12 241236,3 1680682H1 924 1117 12 241236.3 98487681 967 1431 12 241236.3 5022045H1 967 1235 12 241236.3 984876H1 967 1272 12 241236.3 2394790H1 995 1238 12 241236.3 3105586H1 1029 1318 12 241236.3 2116090H1 1029 1295 12 241236.3 g3894545 1045 1441 12 241236.3 1665126H1 1048 1280 12 241236.3 2812429H1 1096 1416 12 241236.3 3099677H1 1102 1419 SEQ ID Template Component Start Stop NO; ID ID
12 241236.3 3323472H1 1109 1397 12 241236,3 3806144H1 1111 1421 12 241236.3 1967610H1 1112 1402 12 241236.3 2967854H1 1112 1426 12 241236.3 g1627157 1114 1405 12 241236.3 3812578H1 1117 1273 12 241236.3 2808537H1 1122 1393 12 241236.3 2265394H1 1125 1400 12 241236.3 5573683H1 1130 1367 12 241236.3 603729H1 1139 1413 12 241236.3 2594490H1 1151 1408 12 241236.3 2083413H1 1153 1440 12 241236.3 606483H1 1210 1377 12 241236.3 336504H1 1227 1467 12 241236.3 g 1114699 1226 1411 12 241236.3 4903237H1 1276 1552 12 241236.3 1976619F6 1276 1737 12 241236.3 1976619H1 1276 1544 12 241236.3 1738833H1 1299 1487 12 241236.3 1738865F6 1299 1601 12 241236.3 4240709H1 1343 1407 12 241236.3 4240711H1 1343 1709 12 241236.3 g853461 1360 1657 12 241236.3 2123125H1 1368 1658 12 241236.3 5451102H1 1372 1637 12 241236.3 2191211H1 1382 1653 12 241236.3 g1792059 1408 1780 12 241236.3 543835H1 1412 1649 12 241236.3 197713076 1425 1965 12 241236.3 1633344H1 1427 1669 12 241236,3 4505552H1 1428 1707 12 241236.3 197661976 1433 1970 12 241236.3 502204571 1438 1972 12 241236.3 173886576 1441 1967 12 241236.3 1981924H1 1459 1759 12 241236.3 2803121H1 1495 1769 12 241236.3 2260917H1 1503 1771 .
12 241236.3 3014105H1 1509 1829 12 241236,3 1994356H1 1513 1799 12 241236.3 5568339H1 1525 1765 12 241236,3 3186679H1 1537 1873 12 241236,3 4828122H1 1544 1837 12 241236.3 4828623H1 1544 1807 12 241236.3 g3595120 1549 2018 12 241236,3 g2177775 1559 2016 12 241236,3 1456253H1 1562 1841 12 241236.3 1000028H1 1564 1808 12 241236.3 3791315H1 1567 1881 12 241236.3 g4392232 1568 2013 12 241236.3 g2968124 1767 2016 SEQ ID Template Component Start Stop NO: ID ID
12 241236.3 4115186H1 1773 2017 12 241236.3 3392646H1 1783 2058 12 241236.3 g3239075 1838 2014 12 241236.3 g3808002 1848 2016 12 241236.3 84072387 1848 2014 12 241236.3 3781961H1 1848 2169 12 241236.3 83754629 1851 2016 12 241236.3 84006032 1860 2015 12 241236.3 84073569 1860 2010 12 241236.3 84005900 1870 2007 12 241236.3 83321490 1862 2009 12 241236.3 84006303 1870 2007 12 241236.3 84087154 1871 2010 12 241236.3 83862359 1871 2010 12 241236.3 83322077 1862 2015 12 241236.3 84005537 1871 2010 12 241236.3 83846653 1871 2010 12 241236.3 84077466 1862 2010 12 241236.3 84080249 1871 2011 12 241236.3 83862436 1871 2010 12 241236.3 84018950 1863 2007 12 241236.3 84077665 1871 2010 12 241236.3 83989227 1871 2010 12 241236.3 83806894 1864 2014 12 241236.3 83932638 1871 2011 12 241236.3 83862447 1871 2010 12 241236.3 83847853 1871 2010 12 241236.3 83989984 1871 2010 12 241236.3 83890144 1871 2011 12 241236.3 83989001 1871 2010 12 241236.3 84071839 1871 2008 12 241236.3 83847054 1871 2008 12 241236.3 83989318 1871 2016 12 241236.3 83890413 1871 2016 12 241236.3 83848056 1871 2007 12 241236.3 84282452 1871 2007 12 241236.3 84018579 1871 2014 12 241236.3 83990148 1871 2014 12 241236.3 83890229 1871 2010 12 241236.3 83847713 1871 2010 12 241236.3 504961H1 1872 2018 12 241236.3 2475277H1 1872 2017 12 241236.3 83149294 1964 ~ 2016 13 245014.1 168004H1 1773 2112 13 245014.1 16800486 1777 2032 13 245014.1 3444984H1 1854 2115 13 245014.1 963645H1 1859 2101 13 245014.1 96364582 1859 2354 13 245014.1 83095484 1869 1985 13 245014.1 2278942H1 1903 2171 SEQ ID Template Component Start Stop NO: ID ID
13 245014.1 3993577H1 1907 2200 13 245014.1 3518094H1 1918 2179 13 245014.1 5696350H1 1918 2173 13 245014.1 4507976H1 1924 2192 13 245014.1 3020932H1 1924 2204 13 245014.1 4400157H1 1949 2191 13 245014.1 3248110H1 1949 2229 13 245014.1 2855006H1 1949 2041 13 245014.1 5399133H1 1 213 13 245014.1 345036186 68 543 13 245014.1 3450361H1 68 327 13 245014.1 2731452F6 81 421 13 245014.1 2731452H1 81 320 13 245014.1 263691H1 94 428 13 245014.1 5674201H1 106 347 13 245014.1 2645021H1 207 460 13 245014.1 8895569 346 512 13 245014.1 1923470Th 2455 2704 13 245014.1 192347086 2469 2742 13 245014.1 1923470H1 2469 2740 13 245014.1 81874511 2471 2748 13 245014.1 83179513 2407 2746 13 245014.1 g 1153232 241 b 2748 13 245014.1 2285748H1 2426 2679 13 245014.1 2875652H1 2477 2743 13 245014.1 8878521 2504 2740 13 245014.1 82810267 2508 2751 13 245014.1 84457618 2512 2745 13 245014.1 186006176 2430 2701 13 245014.1 1636359H1 2527 2620 13 245014.1 974331H1 2439 2619 13 245014.1 81548974 2445 2740 13 245014.1 4802874H1 2527 2633 13 245014.1 2785026H1 2528 2716 13 245014.1 82209561 2448 2743 13 245014.1 2862743H1 2558 2742 13 245014.1 82208300 2452 2740 13 245014.1 82987537 2624 2751 13 245014.1 3318766H1 1684 1957 13 245014.1 4825016H1 1699 1982 13 245014.1 3776745H1 1732 2032 13 245014.1 4368674H1 1746 2008 13 245014.1 2650579H1 1749 1945 13 245014.1 5062862H1 1764 2021 13 245014.1 5062961H2 1766 2004 13 245014.1 4089945H1 1770 1847 13 245014.1 263180276 2246 2706 13 245014.1 4863733H1 2264 2562 13 245014.1 5328806H1 2261 2544 13 245014.1 83917411 2269 2748 SEQ ID Template Component Start Stop NO. ID ID
13 245014.1 82838934 2255 2747 13 245014.1 3166548H1 2273 2559 13 245014.1 82818702 2280 2690 13 245014.1 83693781 2261 2742 13 245014.1 81068825 2306 2659 13 245014.1 83016160 2306 2749 13 245014.1 607473H1 2309 2584 13 245014.1 3558364H1 2329 2637 13 245014.1 84329144 2346 2738 13 245014.1 81941347 2347 2733 13 245014.1 4302681H1 2356 2591 13 245014.1 83182104 2369 2745 13 245014.1 1299474Th 2371 2705 13 245014.1 1299474F6 2377 2742 13 245014.1 82003283 2377 2742 13 245014.1 1302005H1 2380 2722 13 245014.1 81219422 2396 2743 13 245014.1 178082H1 1590 1829 13 245014.1 064892H1 1591 1750 13 245014.1 963385H1 1595 1896 13 245014.1 96338582 1595 1972 13 245014.1 81068873 1463 1775 13 245014.1 2280635H1 1470 1750 13 245014.1 14562381 1453 1886 13 245014.1 960167H1 1546 1671 13 245014.1 81166309 1456 1851 13 245014.1 3638263H1 1553 1845 13 245014.1 5423560H1 1615 1861 13 245014.1 1495185H1 1633 1857 13 245014.1 82209742 1636 2103 13 245014.1 927457H1 1650 1930 13 245014.1 722266H1 1650 1917 13 245014.1 929020H1 1650 1913 13 245014.1 92745781 1650 2180 13 245014.1 81874627 1666 1896 13 245014.1 81920695 1632 1830 13 245014.1 637604H1 1672 1906 13 245014.1 81958169 1678 1988 13 245014.1 8959179 1452 1761 13 245014.1 3038691H1 1453 1545 13 245014.1 3398816H1 1453 1567 13 245014.1 4212104H1 937 1209 13 245014.1 5500792H1 976 1201 13 245014.1 6012320H1 996 1270 13 245014.1 2675268H1 1000 1244 13 245014.1 2675268F6 1000 1405 13 245014.1 3724087H1 1035 1309 13 245014.1 3069566H1 1096 1395 13 245014.1 5508358H1 1126 1346 13 245014.1 5592345H1 1278 1487 SEQ ID Template Component Start Stop NO: ID ID
13 245014.1 141058H1 1278 1534 13 245014,1 3714983H1 1373 1661 13 245014.1 3515644H1 1417 1647 13 245014.1 4797535H1 360 650 13 245014.1 81128352 373 613 13 245014.1 82003284 456 712 13 245014.1 4164512H1 367 675 13 245014.1 8878573 547 871 13 245014.1 2749018H1 576 825 13 245014.1 3450361T6 593 1156 13 245014.1 2910268H1 610 873 13 245014.1 4372565H1 613 915 13 245014.1 133005H1 618 801 13 245014.1 13300586 618 1056 13 245014.1 4972429H1 693 985 13 245014.1 4435621H1 735 1012 13 245014.1 83446618 746 1207 13 245014.1 3275925H1 745 986 13 245014.1 5299476H1 746 899 13 245014.1 82541414 754 1204 13 245014,1 3629224H1 1987 2293 13 245014.1 160092H1 2017 2421 13 245014.1 3256601H1 2029 2284 13 245014.1 5091829H1 1988 2256 13 245014.1 3489772H1 2057 2357 13 245014.1 82057259 2087 2423 13 245014,1 8395755 2096 2414 13 245014.1 218809H1 2112 2381 13 245014.1 3493510H1 2011 2285 13 245014.1 217964H1 2112 2345 13 245014.1 1376993F1 2115 2581 13 245014.1 1376993H1 2115 2356 13 245014.1 113469H1 2014 2268 13 245014.1 1860061F6 2124 2549 13 245014.1 1860061H1 2124 2428 13 245014.1 3806342H1 2014 2255 13 245014.1 828638H1 2137 2406 13 245014,1 82863881 2137 2607 13 245014.1 5710216H2 2171 2422 13 245014,1 344609H1 2015 2226 13 245014.1 4121876H1 2174 2394 13 245014,1 4416742H1 2176 2434 13 245014.1 133005Th 2176 2707 13 245014,1 145623F1 2183 2740 13 245014,1 5500510H1 2192 2451 13 245014,1 82444538 2195 2559 13 245014.1 82163904 2198 2658 13 245014.1 004038H1 2203 2582 13 245014.1 003770H1 2203 2566 13 245014.1 003808H1 2203 2532 SE6~ Template Component Start Stop ID NO: ID ID
13 245014.1 4356958H1 2221 2498 13 245014,1 168004Th 2222 2703 13 245014.1 3858354H1 2235 2426 13 245014.1 3858174H1 2236 2531 13 245014.1 4602871H1 768 1018 13 245014.1 2884645H1 776 1041 13 245014.1 4196193H1 873 1007 13 245014.1 g2139409 887 1282 13 245014.1 2872604H1 890 1150 13 245014.1 4548678H1 890 1121 13 245014.1 g 1953042 915 11 b5 13 245014.1 3438285H1 1440 1656 13 245014.1 2462626H1 1448 1680 13 245014.1 3491523H1 1440 1685 14 245251.6 g3806445 1422 1590 14 245251.6 g3806467 1422 1590 14 245251,6 g3848606 1422 1590 14 245251.6 g3849478 1422 1590 14 245251.6 g3845826 1422 1590 14 245251.6 g3806471 1422 1590 14 245251.6 g3846603 1422 1590 14 245251.6 g4034496 1422 1594 14 245251.6 g3807003 1422 1591 14 245251.6 g3806382 1422 1593 14 245251.6 83847027 1422 1587 14 245251.6 83989330 1422 1587 14 245251.6 83861794 1422 1587 14 245251.6 84018012 1422 1593 14 245251.6 83847094 1422 1591 14 245251.6 83807437 1422 1593 14 245251.6 83846856 1422 1592 14 245251.6 84284777 1422 1586 14 245251.6 83847587 1422 1593 14 245251,6 84186360 1422 1593 14 245251.6 83990433 1422 1593 14 245251.6 83807539 1422 1593 14 245251,6 83990700 1422 1593 14 245251.6 84071417 1422 1593 ~
14 245251.6 83806276 1422 1592 14 245251,6 83806906 1422 1592 14 245251,6 83847511 1422 1592 14 245251,6 83842268 1422 1593 14 245251.6 83846164 1422 1592 14 245251.6 83846151 1422 1592 14 245251,6 84077836 1422 1594 14 245251.6 83862401 1422 1593 14 245251.6 84082235 1422 1593 14 245251.6 83847852 1422 1593 14 245251.6 83842306 1422 1591 14 245251.6 84074675 1422 1591 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 83861509 1422 1593 14 245251.6 83989299 1422 1593 14 245251.6 84074633 1422 1591 14 245251.6 83848075 1422 1593 14 245251,6 83847601 1422 1596 14 245251.6 83846659 1422 1591 14 245251.6 83807971 1422 1593 14 245251.6 83862373 1422 1592 14 245251.6 83846613 1422 1594 14 245251.6 83842371 1422 1593 14 245251.6 84150319 1422 1593 14 245251.6 83848195 1422 1593 14 245251.6 84186335 1422 1593 14 245251.6 84071420 1422 1590 14 245251.6 83845843 1422 1590 14 245251.6 271945H1 1423 1592 14 245251.6 4860092H1 1425 1549 14 245251.6 3025205H1 1425 1591 14 245251.6 81329015 1110 1592 14 245251.6 1708907H1 1110 1392 14 245251,6 2356035H1 1113 1395 14 245251.6 83321637 1412 1593 14 245251.6 83321397 1412 1591 14 245251.6 83990361 1412 1594 14 245251.6 83321297 1412 1594 14 245251.6 83321613 1412 1590 14 245251.6 83321619 1412 1590 14 245251,6 83321346 1412 1590 14 245251,6 83321642 1412 1592 14 245251,6 83322073 1412 1593 14 245251,6 83322037 1412 1579 14 245251,6 83321904 1412 1591 14 245251.6 83322057 1412 1594 14 245251,6 84086504 1412 1593 14 245251.6 83321689 1412 1593 14 245251.6 83322072 1412 1594 14 245251.6 290509H1 1413 1593 14 245251.6 83842429 1413 1595 14 245251.6 83321374 141 b 1590 14 245251.6 2715779H1 1417 1590 14 245251.6 83841465 1420 1590 14 245251.6 83847930 1421 1590 14 245251.6 83847580 1421 1592 14 245251.6 84187012 1421 1590 14 245251.6 83806657 1421 1586 14 245251.6 83846129 1421 1590 14 245251.6 84005749 1421 1592 14 245251.6 84005487 1421 1590 14 245251.6 83665836 1422 1590 14 245251.6 83848560 1422 1590 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 83845838 1422 1590 14 245251.6 83848559 1422 1590 14 245251.6 703105H1 1113 1417 14 245251.6 81501582 1117 1592 14 245251.6 83255080 1119 1602 14 245251.6 84081903 1119 1598 14 245251.6 81948394 1156 1590 14 245251.6 2411955H1 1117 1414 14 245251.6 4569146H1 1120 1459 14 245251.6 027069H1 1165 1412 14 245251.6 1538171H1 1120 1407 14 245251.6 83279555 1127 1593 14 245251.6 84114349 1128 1594 14 245251.6 83740354 1131 1592 14 245251.6 82279150 1132 1590 14 245251.6 84533152 1132 1592 14 245251.6 83962173 1132 1596 14 245251.6 887316H1 1138 1466 14 245251.6 82397876 1165 1592 14 245251.6 82360627 1138 1598 14 245251.6 82714133 1137 1590 14 245251.6 83016485 1165 1596 14 245251.6 82464368 1139 1594 14 245251.6 82552766 1146 1590 14 245251.6 2962133H1 1150 1496 14 245251.6 82464621 1152 1589 14 245251.6 537878H1 1150 1446 14 245251.6 1359957H1 1148 1419 14 245251.6 1963987H1 1155 1496 14 245251.6 83253832 1165 1593 14 245251.6 82913751 1168 1593 14 245251.6 82932949 1173 1602 14 245251.6 83735276 1178 1602 14 245251.6 863137H1 1181 1466 14 245251.6 84269459 1181 1590 14 245251.6 82563609 1183 1590 14 245251.6 2418779H1 1185 1471 14 245251.6 84113654 1188 1590 14 245251.6 81641703 1188 1586 14 245251.6 1551309H1 1190 1448 14 245251.6 83840122 1192 1597 14 245251.6 82705424 1200 1589 14 245251.6 2286469H1 1200 1498 14 245251.6 82566862 1209 1593 14 245251.6 82435745 1212 1361 14 245251.6 2088012H1 1215 1517 14 245251.6 1312225H1 1215 1472 14 245251.6 82270163 1215 1592 14 245251.6 2288870H1 1215 1497 14 245251.6 8864236 1220 1591 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 83597473 1220 1598 14 245251.6 81972695 1223 1595 14 245251.6 83322133 1231 1594 14 245251.6 81148477 1231 1598 14 245251.6 83960762 1244 1590 14 245251.6 272932H1 1248 1590 14 245251.6 3334564H1 1248 1581 14 245251.6 1355971H1 1248 1540 14 245251.6 1907330H1 1248 1548 14 245251.6 81774782 1253 ~ 1594 14 . 245251.6 8927896 1244 1592 14 245251.6 82279391 1256 1596 14 245251.6 83280855 1259 1597 14 245251.6 981518H1 1265 1598 14 245251.6 83070488 1267 1596 14 245251.6 84269675 1271 1593 14 245251.6 83127594 1273 1545 14 245251.6 84297922 1273 1593 14 245251.6 81527256 1274 1590 14 245251.6 83215022 1273 1593 14 245251.6 81927427 1278 1590 14 245251.6 81618008 1279 1599 14 245251.6 8651970 1270 1597 14 245251,6 1926049H1 1279 1543 14 245251.6 82053209 1281 1601 14 245251.6 770417H1 1425 1593 14 245251.6 83321693 1426 1590 14 245251.6 544220H1 1464 1596 14 245251.6 83886402 1465 1859 14 245251.6 422119H1 1493 1594 14 245251.6 4832225H1 721 877 14 245251.6 063120H1 727 876 14 245251,6 3228413H1 720 863 14 245251.6 81927545 717 883 14 245251.6 1255835H1 754 894 14 245251,6 3226250H1 699 837 14 245251,6 4323801H1 746 909 14 245251,6 4510868H1 704 796 14 245251.6 4800865H1 700 891 14 245251.6 3715312H1 697 900 14 245251.6 1428725H1 696 883 14 245251.6 2106521H1 480 642 14 245251.6 5100266H1 695 785 14 245251.6 1222560H1 693 907 14 245251.6 360061H1 701 914 14 245251.6 2388047H1 692 901 14 245251.6 81527303 817 919 14 245251.6 1708351H1 699 916 14 245251.6 4563631H1 839 920 14 245251.6 4337368H1 720 919 SEQ ID Template Component Start Stop NO; ID ID
14 245251.6 3284155H1 811 915 14 245251.6 1573816H1 427 644 14 245251.6 g2017060 687 914 14 245251.6 g2992991 687 808 14 245251.6 5945233H1 692 816 14 245251.6 142800H1 686 921 14 245251.6 1611073H1 686 892 14 245251.6 1612960H1 686 871 14 245251,6 5182909H1 686 922 14 245251.6 4675087H1 686 868 14 245251.6 2175031H1 686 917 14 245251.6 1674874H1 686 901 14 245251.6 748598H1 699 925 14 245251.6 g698473 1 375 14 245251.6 g2750955 3 322 14 245251.6 4711779H1 41 296 14 245251.6 2468527H1 173 531 14 245251.6 3674073H1 243 527 14 245251.6 g2015374 251 676 14 245251.6 4710904H1 283 582 14 245251.6 3674243H1 289 527 14 245251,6 5112393H1 314 606 14 245251.6 1960508H1 317 627 14 245251,6 4043372H1 322 607 14 245251.6 2017147H1 341 444 14 245251,6 1725960H1 376 , 592 14 245251,6 1573484H1 377 596 14 245251.6 310542H1 382 643 14 245251.6 3205850H1 400 693 14 245251.6 1726232H1 403 592 14 245251.6 310938H1 407 646 14 245251.6 1877685H1 417 704 14 245251.6 2598596H1 416 704 14 245251.6 3090278H1 416 704 14 245251.6 4128553H1 426 699 14 245251,6 g2030260 426 715 14 245251.6 5538163H1 448 647 14 245251.6 2502707H1 450 699 14 245251.6 1800655H1 462 705 14 245251.6 4899818H1 465 705 14 245251.6 3858619H1 464 724 14 245251.6 2111517H1 478 729 14 245251.6 310488H1 476 642 14 245251.6 1686443H1 491 731 14 245251.6 1425427H1 584 837 14 245251.6 1490475H1 584 812 14 245251.6 4853210H1 586 806 14 245251.6 g3846065 1396 1590 14 245251.6 g4304887 1396 1593 14 245251.6 g4006580 1396 1590 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 84085914 1396 1590 14 245251.6 84005760 1396 1592 14 245251,6 83931547 1396 1593 14 245251.6 83842208 1396 1590 14 245251.6 84082237 1399 1590 14 245251.6 83848014 1403 1590 14 245251.6 83322137 1406 1590 14 245251.6 83883898 1407 1587 14 245251.6 84086951 1407 1590 14 245251.6 84033921 1408 1590 14 245251.6 84077315 1409 1590 14 245251.6 83849422 1409 1587 14 245251.6 83322163 1409 1590 14 245251.6 84005466 1410 1596 14 245251.6 84189675 1409 1587 14 245251.6 83842222 1410 1593 14 245251.6 84073579 1410 1593 14 245251.6 84071991 1410 1593 14 245251.6 83848782 1410 1590 14 245251.6 83842461 1410 1590 14 245251.6 83890086 1410 1589 14 245251.6 84073751 1410 1587 14 245251.6 84072155 1410 1587 14 245251.6 84005762 1410 1587 14 245251.6 84017767 1410 1586 14 245251.6 84082225 1410 1633 14 245251.6 84150699 1410 1587 14 245251.6 83849075 1410 1590 14 245251.6 83842220 1410 1590 14 245251,6 84034488 1410 1592 14 245251,6 84018592 1410 1590 14 245251.6 84071488 1410 1590 14 245251,6 83990408 1410 1584 14 245251.6 84006140 1410 1587 14 245251,6 84148813 1410 1592 14 245251.6 83665905 1410 1591 14 245251.6 84189666 1410 1586 14 245251.6 83842450 1410 1590 14 245251.6 84006752 1410 1593 14 245251.6 83665891 1410 1595 14 245251.6 83848888 1410 1590 14 245251.6 84393782 1410 1590 14 245251.6 83927687 1410 1594 14 245251.6 83931504 1410 1589 14 245251.6 83922922 1411 1589 14 245251.6 83321965 1412 1590 14 245251.6 83321608 1412 1591 14 245251.6 83321192 1412 1590 14 245251.6 83321212 1412 1593 14 245251.6 83848884 1412 1631 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 83321780 1412 1590 14 245251.6 83321859 1412 1590 14 245251.6 83322187 1412 1596 14 245251,6 83846123 1412 1587 14 245251.6 83321441 1412 1590 14 245251.6 83322011 1412 1591 14 245251.6 83754224 1049 1606 14 245251,6 83425292 1050 1595 14 245251.6 4996361H1 1014 1361 14 245251.6 4546463H1 1019 1337 14 245251,6 83117255 1018 1545 14 245251.6 82357822 1020 1592 14 245251,6 1853257H1 1021 1384 14 245251.6 g 1722623 1022 1593 .
14 245251.6 82566601 1026 1486 14 245251,6 81328830 1031 1601 14 245251.6 82824176 1029 1592 14 245251.6 84124629 1041 1595 14 245251,6 82269348 1044 1592 14 245251.6 84217707 1045 1593 14 245251.6 84070671 1048 1601 14 245251.6 2240628H1 1047 1379 14 245251.6 84524298 3 185 14 245251.6 84005797 8 142 14 245251.6 813528H1 686 905 14 245251.6 83807474 1283 1416 14 245251.6 84327570 1238 1419 14, 245251.6 1645004H1 451 672 14 245251.6 1312584H1 697 963 14 245251.6 3471164H1 720 993 14 245251.6 4998559H1 722 1004 14 245251.6 83890267 1283 1418 14 245251.6 4351329H1 686 824 14 245251.6 1672134H1 1233 1423 14 245251.6 83848850 1283 1415 14 245251.6 1517530H1 462 672 14 245251,6 82037443 332 608 14 245251.6 3315274H1 739 996 14 245251.6 83990415 1283 1419 14 245251.6 83849121 1283 1415 14 245251.6 3272177H1 680 917 14 245251.6 5913406H1 686 954 14 245251.6 83848236 1283 1417 14 245251.6 052757H1 756 994 14 245251.6 4708284H1 686 930 14 245251.6 83848935 1283 1416 14 245251.6 83890340 8 142 14 245251.6 82025954 684 995 14 245251.6 1990122H1 581 672 14 245251.6 1436841H1 686 906 SEQ ID Template Component Start Stop NO: ID ID
14 245251,6 g 1301526 726 979 14 245251.6 83990448 1283 1417 14 245251.6 5902523H1 694 996 14 245251,6 2154086H1 740 1016 14 245251.6 917108H1 686 847 14 245251.6 2767517H1 686 922 14 245251.6 83862612 1283 1419 14 245251,6 83848684 6 142 14 245251.6 1814125H1 1258 1419 14 ~ 245251,6 3682120H1 697 991 14 245251.6 2053508H1 751 1005 14 245251,6 3291620H1 686 907 14 245251.6 83862415 1283 1419 14 245251.6 545078H1 734 994 14 245251.6 3280782H1 759 1005 14 245251.6 5376980H1 475 673 14 245251.6 3749492H1 686 950 14 245251.6 83847665 10 142 14 245251.6 1469717H1 864 1150 14 245251.6 2442618H1 869 1184 14 245251.6 516105076 873 1570 14 245251.6 281458376 874 1553 14 245251.6 5216384H1 888 1183 14 245251.6 g 1313327 885 1234 14 245251.6 506895H1 887 1161 14 245251.6 2246148H1 888 1183 14 245251.6 82032570 892 1215 14 245251.6 82033061 892 1312 14 245251.6 6105423H1 892 1228 14 245251.6 1212338H1 894 1249 14 245251.6 2681270H1 894 1239 14 245251.6 2408072H1 894 1201 14 245251.6 774022H1 894 1152 14 245251.6 4667376H1 894 1218 14 245251.6 2629364H1 894 1225 14 245251.6 2260118H1 894 1198 14 245251.6 4372704H1 895 1264 14 245251.6 464993H1 896 1176 14 245251.6 3027714H1 896 1274 14 245251.6 1856953H1 911 1241 14 245251.6 2410246H1 911 1181 14 245251,6 4750638H2 911 1243 14 245251.6 1294624H1 913 1179 14 245251,6 738970H1 921 1241 14 245251.6 g 1775058 924 1381 14 245251,6 81618108 929 1261 14 245251.6 82336997 938 1260 14 245251,6 1979648H1 940 1271 14 245251.6 1990936H1 941 1143 14 245251.6 966663H1 946 1300 104 .
SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 4371102H1 955 1331 14 245251.6 81315094 957 1239 14 245251.6 4369280H1 963 1293 14 245251.6 1905865H1 993 1281 14 245251.6 81972974 997 1364 14 245251.6 4068060H1 1006 1188 14 245251.6 83597449 1007 1595 14 245251.6 1657456H1 1009 1264 14 245251.6 4996367H1 1014 1326 14 245251.6 81758102 1094 1593 14 245251.6 81623171 1100 1594 14 245251.6 82824662 1099 1590 14 245251.6 82526734 1101 1590 14 245251.6 84108545 1103 1592 14 245251.6 82328692 1105 1593 14 245251.6 814904H1 1104 1425 14 245251.6 2870889H1 1108 1460 14 245251.6 5295918H1 686 922 14 245251.6 83890756 1283 1419 14 245251.6 3086975H1 686 955 14 245251.6 83990539 1283 1416 14 245251.6 83847105 1283 1417 14 245251.6 83989389 6 142 14 245251.6 1333963H1 686 884 14 245251.6 84077443 9 142 14 245251.6 3180014H1 686 913 14 245251.6 83849458 8 142 14 245251.6 4619650H1 686 907 14 245251.6 83989412 1283 1416 14 245251.6 491316H1 686 911 14 245251.6 84077428 7 142 14 245251.6 1647829H1 686 881 14 245251.6 83848848 1283 1416 14 245251.6 705929H1 686 889 14 245251.6 83806474 1283 1418 14 245251.6 2540850H1 686 937 14 245251.6 2301130H1 715 965 14 245251.6 83849235 1283 1411 14 245251.6 127489H1 686 893 14 245251.6 83848866 1283 1419 14 245251.6 1876624H1 383 664 14 245251.6 84085932 9 142 14 245251.6 84077334 1283 1419 14 245251.6 83890303 1283 1415 14 245251.6 3384767H1 725 969 14 245251.6 3688995H1 686 945 14 245251.6 1215027H1 839 975 14 245251.6 83847032 1283 1416 14 245251.6 83807516 8 142 14 245251.6 5102970H1 686 941 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 1802892H1 736 973 14 245251.6 g3842338 7 142 14 245251.6 3286343H2 719 969 14 245251.6 1874116H1 374 653 14 245251.6 g3806912 1283 1416 14 245251.6 g3847485 6 142 14 245251.6 619293H1 687 930 14 245251.6 1258505H1 720 968 14 245251.6 g3989388 1283 1411 14 245251.6 6007911H1 686 974 14 245251.6 2149173H1 686 956 14 245251.6 g3848208 1283 1419 14 245251.6 2992493H1 686 946 14 245251.6 650586H1 379 638 14 245251,6 g3849247 1283 1416 14 245251.6 5910613H1 686 972 14 245251,6 g4077711 1283 1419 14 245251.6 4510726H1 704 973 14 245251,6 g3848062 1283 1417 14 245251,6 6106933H1 686 919 14 245251,6 5115225H1 697 970 14 245251,6 g3846901 6 142 14 245251,6 2513695H2 686 907 14 245251,6 g4326234 1283 1419 14 245251.6 3158887H1 686 935 14 245251.6 2706363H1 756 1102 14 245251.6 g4535116 756 1070 14 245251,6 3883004H1 760 1087 14 245251.6 5301496H1 760 1055 14 245251.6 4096707H1 760 1122 14 245251.6 2863619H1 763 1162 14 245251.6 2867319H1 763 1102 14 245251.6 g1281850 767 1331 14 245251.6 g1576704 773 1232 14 245251.6 g1298432 777 1130 14 245251.6 3837476H1 784 1091 14 245251.6 3010150H1 785 1128 14 245251.6 3010801H1 785 1123 14 245251.6 g2204501 790 1201 14 245251.6 g2217814 791 1325 14 245251.6 g1060431 795 1137 14 245251.6 3918458H1 803 1125 14 245251.6 5697844H1 803 1122 14 245251.6 g2591145 815 1249 14 245251,6 4573806H1 818 1102 14 245251.6 4914643H1 820 1142 14 245251.6 908962H1 833 1192 14 245251.6 2132022T6 833 1548 14 245251.6 4628839H1 832 1120 14 245251.6 3550659H1 835 1213 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 g674861 839 1124 14 245251.6 706061H1 843 1165 14 245251,6 2061068H1 851 1161 14 245251.6 5264515F6 853 1331 14 245251.6 g2539208 854 1344 14 245251,6 2408850H1 856 1132 14 245251,6 6006938H1 863 1213 14 245251.6 6007037H1 863 1228 14 245251.6 3171466H1 866 1199 14 245251.6 g1124148 1283 1592 14 245251.6 g3803160 1285 1600 14 245251.6 g2942025 1286 1598 14 245251.6 3160175H1 1288 1592 14 245251.6 g1740568 1300 1593 14 245251.6 2300048H1 1302 1557 14 245251.6 82877399 1307 1594 14 245251.6 82728321 1309 1591 14 245251.6 1491834H1 1310 1593 14 245251.6 2862613H1 1317 1592 14 245251.6 945012H1 1322 1598 14 245251.6 88471 b8 1313 1593 14 245251.6 84327571 1325 1590 14 245251.6 1507186H1 1330 1569 14 245251,6 3970589H1 1334 1595 14 245251.6 209179H1 1334 1535 14 245251.6 207014H1 1334 1582 14 245251.6 3967178H1 1335 1590 14 245251.6 83058131 1337 1592 14 245251.6 3967462H1 1335 1591 14 245251.6 82787682 1337 1594 14 245251.6 83154417 1337 1594 14 245251.6 2361006H1 1338 1590 14 245251.6 2362930H1 1339 1590 14 245251.6 83001273 1339 1590 14 245251.6 83960768 1341 1592 14 245251.6 942262H1 1345 1592 14 245251.6 902954H1 1349 1593 14 245251.6 4506855H1 1353 1590 14 245251.6 81265337 1360 1599 14 245251.6 1419110H1 1365 1590 14 245251.6 81264701 1373 1599 14 245251.6 81227017 1374 1600 14 245251.6 83884934 1385 1589 14 245251.6 83884396 1388 1590 14 245251.6 83884926 1390 1587 14 245251.6 83846626 1390 1593 14 245251,6 83849105 1390 1541 14 245251.6 83884831 1391 1593 14 245251,6 83842214 1391 1590 14 245251.6 83846730 1393 1590 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 83846909 1393 1586 14 245251.6 82657904 1087 1590 14 245251.6 84525345 1090 1592 14 245251.6 83239030 1088 1599 14 245251.6 870032H1 1092 1407 14 245251.6 5597455H1 1093 1365 14 245251.6 1898558H1 697 967 14 245251.6 84071850 1283 1419 14 245251.6 2452174H1 686 897 14 245251.6 2842830H1 380 650 14 245251.6 3686824H1 686 972 14 245251.6 84077526 9 142 14 245251.6 3782176H1 686 945 14 245251.6 1535425H1 861 972 14 245251.6 83848055 1283 1419 14 245251.6 3119950H1 699 977 14 245251.6 3884464H1 686 806 14 245251.6 83842568 6 142 14 245251.6 3507042H1 695 977 14 245251.6 2512439H1 686 909 14 245251.6 84085946 1283 1416 14 245251.6 4405615H1 686 943 14 245251.6 5896519H1 694 977 14 245251.6 83845926 1283 1419 14 245251.6 3330695H1 686 929 14 245251.6 83847726 1283 1416 14 245251.6 3157747H1 693 975 14 245251.6 1622382H1 686 909 14 245251.6 83862513 1283 1419 14 245251,6 1656661H1 686 873 14 245251.6 83845948 8 142 14 245251.6 3028871H1 686 967 14 245251.6 3809687H1 686 977 14 245251.6 83990041 1283 1417 14 245251,6 2451959H1 573 669 14 245251.6 4551365H 699 976 1 .
14 245251.6 83847599 6 142 14 245251.6 5172386H1 721 980 14 245251.6 83845822 1283 1416 14 245251.6 4824541H1 726 980 14 245251.6 83931555 1283 1418 14 245251.6 84006049 9 142 14 245251.6 2481849H1 686 907 14 245251.6 6026544H1 686 978 14 245251.6 83862408 1283 1416 14 245251.6 5893562H1 694 984 14 245251.6 3141501H1 686 935 14 245251.6 82899544 48 137 14 245251.6 83842538 9 142 14 245251.6 1897745H1 686 935 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 g3807515 10 142 14 245251.6 3698231H1 686 964 14 245251.6 1680096H1 454 670 14 245251.6 3575006H1 686 976 14 245251.6 3945268H1 696 980 14 245251.6 g3990060 1283 1418 14 245251.6 1630619H1 740 961 14 245251.6 6026541H1 686 983 14 245251.6 282261H1 821 987 14 245251.6 83989332 1283 1416 14 245251.6 82714757 6 127 14 245251.6 83848017 1283 1418 14 245251.6 4909050H1 691 864 14 245251.6 84077616 1283 1419 14 245251.6 5016694H1 709 985 14 245251.6 82715675 1342 1421 14 245251.6 83890469 1283 1415 14 245251.6 82020485 727 976 14 245251.6 81548162 1304 1422 14 245251.6 84086845 1283 1419 14 245251.6 3095012H1 686 984 14 245251.6 83990363 1283 1416 14 245251.6 4012002H1 686 964 14 245251.6 82198225 1301 1421 14 245251.6 83989049 10 142 14 245251.6 2960954H1 686 985 14 245251.6 84189209 1283 1419 14 245251.6 4268413H1 686 983 14 245251.6 850512H1 756 961 14 245251.6 4238523H1 696 976 14 245251.6 83989140 1283 1419 14 245251.6 8715951 690 981 14 245251.6 83736535 1367 1423 14 245251.6 2512088H1 686 984 14 245251.6 84284258 9 142 14 245251.6 4379339H1 686 936 14 245251.6 83890461 1283 1419 14 245251.6 3182012H1 687 981 14 245251.6 4706886H1 686 932 14 245251.6 83846611 1283 1415 14 245251.6 2322530H1 736 987 14 245251.6 83990086 7 142 14 245251.6 3839096H1 686 938 14 245251.6 321302H1 765 984 14 245251.6 83989015 1283 1416 14 245251.6 1990623H1 686 928 14 245251.6 3683615H1 696 987 14 245251.6 84086491 1283 1416 14 245251.6 1619567H1 686 866 14 245251.6 3078410H1 686 986 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 84080312 9 142 14 245251.6 2908167H1 686 987 14 245251.6 3671767H1 686 892 14 245251.6 82037878 686 961 14 245251.6 84077435 1283 1416 14 245251.6 1603854H1 686 878 14 245251.6 81199063 686 987 14 245251.6 84017782 1283 1419 14 245251.6 1347327H1 686 907 14 245251.6 8927989 359 637 14 245251.6 3324035H1 697 990 14 245251.6 84086445 7 142 14 245251,6 2546965H2 686 862 14 245251.6 4343132H1 873 997 14 245251.6 84077453 1283 1419 14 245251.6 4334622H1 686 944 14 245251.6 8847231 356 637 14 245251.6 83846130 1283 1416 14 245251.6 84018630 1283 1416 14 245251.6 2101272H1 4 114 14 245251,6 2587234H1 686 903 14 245251.6 3574372H1 686 979 14 245251,6 83694286 1050 1590 14 245251,6 81315095 1061 1599 14 245251.6 210059H1 1053 1331 14 245251.6 83279541 1055 1598 14 245251.6 83736864 1055 1595 14 245251,6 4974349H1 1056 1417 14 245251.6 83665039 1061 1592 14 245251.6 3888183H1 1063 1401 14 245251.6 1530540H1 1063 1345 14 245251.6 81274050 1076 1590 14 245251.6 002239H1 1065 1548 14 245251.6 1297924H1 1065 1381 14 245251.6 3479370H1 1065 1328 14 245251.6 1312352H1 1068 1333 14 245251.6 506800H1 1068 1356 14 245251.6 81364437 1077 1592 14 245251.6 82214112 1072 1591 14 245251.6 1267456H1 1074 1366 14 245251.6 82820951 1079 1594 14 245251.6 1311167H1 1082 1398 14 245251.6 82401841 1080 1593 14 245251.6 83735785 1082 1596 14 245251.6 82217605 1083 1595 14 245251.6 g 1576739 1085 1592 14 245251.6 8674787 1092 1587 14 245251.6 4010641H1 697 1030 14 245251.6 2506513H1 697 956 14 245251.6 795092H1 697 957 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 5221852H2 697 979 14 245251.6 5687479H1 697 979 14 245251.6 1483887H1 697 973 14 245251.6 1449209H1 697 917 14 245251.6 3747027H1 697 1031 14 245251.6 1594015H1 697 942 14 245251.6 1455584H1 697 966 14 245251.6 1593886H1 697 922 14 245251.6 3379095H1 699 975 14 245251.6 526768H1 699 978 14 245251.6 g1970187 700 1120 14 245251.6 5913596H1 699 1013 14 245251.6 g1997336 702 1120 14 245251.6 g864282 704 1088 14 245251.6 4307655H1 702 1087 14 245251.6 3766134H1 702 1031 14 245251.6 4545031H1 705 1032 14 245251.6 g 1501684 705 1219 14 245251.6 g 1321292 707 1229 14 245251.6 2496344H1 705 1103 14 245251.6 4675111H1 705 964 14 245251.6 3482217H1 705 1067 14 245251.6 4070047H1 705 1031 14 245251.6 2997014H1 706 1031 14 245251.6 g1623223 711 1097 14 245251.6 5164521H1 709 999 14 245251.6 4196137H1 686 806 14 245251.6 358653H1 701 923 14 245251.6 1370775H1 686 823 14 245251.6 3759039H1 686 907 14 245251.6 600085H1 422 656 14 245251.6 1575013H1 686 897 14 245251.6 1000003H1 686 925 14 245251.6 2049730H1 686 925 14 245251.6 5282003H1 686 919 14 245251.6 5161050H1 557 657 14 245251.6 2134833H1 696 928 14 245251,6 4667193H1 689 928 14 245251,6 1593935H1 686 898 14 245251.6 1786467H1 686 919 14 245251,6 1299188H1 686 917 14 245251.6 2616796H1 686 913 14 245251,6 5699823H1 686 928 14 245251.6 4833390H1 691 907 14 245251.6 2450956H1 686 913 14 245251,6 1416169H1 686 927 14 245251.6 4902593H1 686 853 14 245251.6 685823H1 686 795 14 245251.6 1378622H1 686 892 14 245251.6 2203295H1 686 912 SEQ ID Template Component Start Stop NO: ID ID
14 245251,6 4873526H1 686 906 14 245251.6 1567661H1 686 889 14 245251.6 4265241H1 554 660 14 245251.6 4565002H1 686 930 14 245251.6 5028562H1 686 931 14 245251.6 3315321H2 686 916 14 245251.6 179704H1 686 857 14 245251.6 5043044H1 691 923 14 245251.6 3272310H1 686 923 14 245251.6 5590795H1 686 871 14 245251.6 4374880H1 686 930 14 245251.6 2942376H1 722 932 14 245251.6 2669414H1 686 932 14 245251.6 2051081H1 686 932 14 245251.6 778957H1 686 836 14 245251.6 3383437H1 686 924 14 245251.6 2502860H1 702 939 14 245251.6 g1548213 686 828 14 245251.6 1558658H1 686 895 14 245251.6 2742568H1 693 934 14 245251.6 5844527H1 686 928 14 245251.6 3237925H1 413 660 14 245251.6 1654956H1 686 903 14 245251.6 1212747H1 686 906 14 245251.6 2110510H1 695 937 14 245251,6 2670483H1 697 937 14 245251.6 3887565H1 686 937 14 245251.6 2278236H1 692 939 14 245251.6 1549915H1 686 880 14 245251.6 1915263H1 686 926 14 245251.6 3174435H1 686 912 14 245251,6 931246H1 686 925 14 245251.6 1524019H1 724 944 14 245251,6 2630203H1 686 914 14 245251.6 6063419H1 686 867 14 245251.6 1557962H1 686 876 14 245251,6 1519653H1 686 820 14 245251,6 g1970343 686 927 14 245251,6 1643982H1 686 870 14 245251.6 2636948H1 686 944 14 245251.6 3236095H1 686 910 14 ~ 245251.63290990H1 695 944 14 245251.6 2916653H1 439 664 14 245251.6 2347442H1 686 901 14 245251.6 2160657H1 705 942 14 245251.6 1612904H1 686 861 14 245251.6 1602311H1 686 865 14 245251.6 2479177H1 686 940 14 245251.6 3276325H1 686 942 14 245251,6 3342181H1 686 942 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 3414248H1 700 942 14 245251.6 4244690H1 424 664 14 245251.6 1657385H1 686 887 14 245251.6 2060168H1 686 942 14 245251.6 2724864H1 686 940 14 245251.6 2507348H1 718 943 14 245251.6 3439967H1 686 916 14 245251.6 3875717H1 712 946 14 245251.6 3930892H1 686 944 14 245251.6 2876429H1 686 930 14 245251.6 1663347H1 686 897 14 245251.6 745654H1 715 946 14 245251.6 5714032H1 402 bbl 14 245251.6 6013561H1 686 939 14 245251.6 3368428H1 687 945 14 245251.6 4673619H1 686 945 14 245251.6 4356555H1 686 921 14 245251.6 2984258H1 691 943 14 245251.6 6073987H1 686 945 14 245251.6 2435338H1 686 881 14 245251.6 3416993H1 698 943 14 245251.6 4108736H1 686 944 14 245251.6 1793902H1 686 938 14 245251.6 3429779H1 686 943 14 245251.6 1522075H1 468 664 14 245251.6 3282589H1 701 946 14 245251.6 5781877H1 686 925 14 245251.6 1311376H1 686 946 14 245251.6 2478308H1 686 912 14 245251.6 476523H1 1305 1419 14 245251.6 3406437H1 . 6 108 14 245251.6 4998161H1 686 936 14 245251.6 1759883H1 686 943 14 245251.6 2426656H1 686 918 14 245251.6 2357554H1 686 898 14 245251.6 911731H1 686 947 14 245251.6 3361812H1 686 947 14 245251.6 4349129H1 686 875 14 245251.6 4847891H1 686 922 14 245251.6 929615H1 686 943 14 245251.6 4593502H1 686 938 14 245251.6 g1956732 701 948 14 245251.6 3325687H2 554 664 14 245251.6 1504636H1 699 951 14 245251.6 3357413H1 686 931 14 245251.6 2093969H1 7 120 14 245251.6 3888045H1 686 917 14 245251.6 4400406H1 704 949 14 245251.6 4675188H1 686 895 14 245251.6 1833267H1 696 949 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 3531646H1 1290 1419 14 245251.6 4675103H1 686 823 14 245251.6 612029H1 686 948 14 245251.6 83861897 1283 1417 14 245251.6 83861915 10 142 14 245251.6 4585634H1 ' 686 807 14 245251.6 81187227 736 954 14 245251.6 83806416 6 142 14 245251.6 8809795 688 920 14 245251.6 83806236 1283 1417 14 245251.6 5184838H1 686 929 14 245251.6 83806383 9 142 14 245251.6 83862381 6 142 14 245251.6 5102972H1 686 938 14 245251.6 83806305 1283 1416 14 245251.6 4049171H1 686 952 14 245251.6 5399585H1 686 806 14 245251.6 83806377 8 142 14 245251.6 1609289H1 686 ' 861 14 245251.6 81985106 688 952 14 245251.6 1631116H1 740 958 14 245251.6 83846850 1283 1419 14 245251.6 3371627H1 686 934 14 245251.6 83842256 1283 1415 14 245251.6 81948393 686 952 14 245251.6 83849535 8 142 14 245251.6 1353725H1 686 906 14 245251.6 3811303H1 395 637 14 245251.6 83849274 1283 1417 14 245251.6 770658H1 692 958 14 245251.6 1709346H1 686 889 14 245251.6 83923055 1283 1416 14 245251.6 1351272H1 686 917 14 245251.6 2497443H1 686 952 14 245251.6 6007158H1 686 958 14 245251.6 84086359 1283 1419 14 245251.6 83849526 1283 1419 14 245251.6 5905094H1 686 959 14 245251.6 83847515 1283 1417 14 245251.6 3040561H1 686 954 14 245251.6 1886946H1 686 956 14 245251.6 4764852H1 686 958 14 245251.6 83847084 1283 1417 14 245251.6 83845943 1283 1419 14 245251.6 5685528H1 686 956 14 245251.6 83846660 9 142 14 245251.6 83845949 1283 1419 14 245251.6 3400315H1 688 927 14 245251.6 81953701 688 939 14 245251.6 5833060H1 686 954 SE6~ Template Component Start Stop ID NO: ID ID
14 245251.6 83989265 1283 1417 14 245251.6 4049178H1 686 954 14 245251.6 82038078 686 957 14 245251.6 212969H1 686 851 14 245251,6 84074607 9 142 14 245251.6 83990111 1283 1419 14 245251.6 4265942H1 688 945 14 245251.6 83990156 1283 1415 14 245251,6 1859765H1 446 666 14 245251.6 83847576 9 142 14 245251.6 81320366 594 1041 14 245251.6 2039935H1 596 882 14 245251.6 5299657H1 601 870 14 245251.6 4947763H1 623 800 14 245251.6 799795H1 640 890 14 245251.6 81957419 644 1200 14 245251.6 1503008H1 669 974 14 245251.6 1503133H1 669 1024 14 245251,6 1703102H1 670 907 14 245251.6 5945265H1 671 9b5 14 245251.6 4154972H1 672 973 14 245251.6 4783070H1 677 947 14 245251.6 2729061H1 680 956 14 245251.6 4817713H1 683 981 14 245251.6 2604603H1 685 958 14 245251,6 2300089H1 685 963 14 245251,6 3647926H1 689 1020 14 245251.6 5120725H1 690 1026 14 245251,6 083810H1 692 952 14 245251,6 4409416H1 694 881 14 245251,6 4057228H1 694 996 14 245251.6 5395048H1 696 1005 14 245251.6 3481334H1 693 1055 14 245251.6 4218418H1 694 988 14 245251.6 4820226H1 695 855 14 245251.6 4073954H1 694 1017 14 245251.6 1315458H1 695 975 14 245251.6 3600571H1 696 1025 14 245251.6 3776260H1 696 1029 14 245251.6 3588749H1 695 1055 14 245251,6 2814583F6 696 1360 14 245251.6 1229362H1 696 948 14 245251.6 5732270H1 695 982 14 245251.6 g 1727842 696 1088 14 245251.6 3660326H1 696 915 14 245251.6 4198443H1 697 808 14 245251.6 1455236H1 695 976 14 245251.6 2343111H1 696 992 14 245251.6 3513953H1 696 992 14 245251.6 4999458H1 696 993 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 2261362H1 696 975 14 245251.6 3029907H1 696 1017 14 245251.6 5121569H1 696 1011 14 245251.6 4537506H1 695 979 14 245251.6 3321759H1 696 1013 14 245251.6 2307802H1 697 981 14 245251.6 2307804H1 697 979 14 245251.6 3012456H1 697 951 14 245251.6 2504610H1 697 952 14 245251.6 3362687H1 697 990 14 245251.6 3748602H1 696 901 14 245251.6 3316419H1 697 990 14 245251,6 2814582H1 696 992 14 245251.6 2272892H1 697 993 14 245251.6 1807854H1 696 976 14 245251.6 g2466185 697 1219 14 245251.6 2132022H1 697 996 14 245251.6 213202286 697 1408 14 245251.6 3073883H1 697 997 14 245251.6 2125224H1 697 1003 14 245251.6 2269903H1 697 816 14 245251.6 1459722H1 697 922 14 245251.6 4562893H1 697 981 14 245251.6 1496792H1 696 922 14 245251.6 5221884H2 697 975 ~
14 245251.6 5572366H1 697 928 14 245251,6 2771241H1 697 967 14 245251.6 1573610H1 697 974 14 245251.6 1867126H1 697 1002 14 245251.6 1507375H1 697 928 14 245251,6 1573473H1 697 932 14 245251.6 3267774H1 697 1002 14 245251,6 3163705H1 697 973 14 245251,6 3272193H1 696 970 14 245251,6 2985313H1 697 1009 14 245251.6 3495519H1 697 1014 14 245251.6 3943155H1 697 981 14 245251.6 3812545H1 697 1032 14 245251.6 2708787H1 697 1024 14 24 ~51.b 3639075H 697 1030 14 245251.6 81940776 733 1099 14 245251.6 8908409 734 1122 14 245251.6 5865030H1 736 1078 14 245251.6 4050960H1 736 1049 14 245251.6 3819250H1 751 1088 14 245251.6 g 1761139 757 1219 14 245251.6 g 1967349 756 1382 14 245251.6 81618353 729 1108 14 245251.6 g 1364436 729 1251 14 245251.6 81727492 715 1095 SEQ ID Template Component Start Stop NO: ID ID
14 245251.6 g1968929 710 1184 14 245251.6 5161050F6 712 1306 14 245251.6 g1959923 712 1159 14 245251.6 g 1757908 715 1152 14 245251.6 1229535H1 721 817 14 245251.6 1844975H1 725 1044 14 245251.6 g1295958 729 1461 14 245251.6 358108H1 712 839 14 245251.6 2903511H1 712 1072 14 245251.6 3087812H1 712 1032 14 245251.6 g1440940 728 1227 15 252875.1 2931079H1 2777 3055 15 252875.1 1917962H1 2777 2996 15 252875.1 827946H1 2777 3031 15 252875.1 g 1494002 2777 2956 15 252875.1 1452450H1 2777 2989 15 252875.1 g28465 2777 2913 15 252875.1 g2046620 2785 3270 15 252875.1 g897974 2789 3046 15 252875.1 4584285H1 2789 3086 15 252875,1 g897962 2789 3132 15 252875.1 5518734H1 2797 3022 15 252875.1 g1157691 2797 3093 15 252875.1 5587262H1 2798 3081 15 252875.1 1547554H1 2800 2940 15 252875.1 2169571H1 2840 3091 15 252875.1 5449334H1 2849 3116 15 252875.1 4340677H1 2859 3171 15 252875.1 3015019H1 2858 3160 15 252875.1 406486H1 2859 3107 15 252875.1 3556907H1 2862 3187 15 252875.1 2651443H1 2871 3120 15 252875,1 2444851H1 2875 3115 15 252875.1 373627H1 2876 3096 15 252875.1 2172734H1 2879 3083 15 252875.1 5875371H1 2881 3171 15 252875.1 g 1690763 2890 3247 15 252875,1 g1506919 2890 3158 15 252875.1 3842658H1 2897 3209 15 252875.1 4435381H1 2895 3130 15 252875.1 2799807H1 2897 3164 15 252875.1 2909321H1 2904 3055 15 252875.1 3093958H1 2913 3222 15 252875.1 4644257H1 2913 3192 15 252875.1 2594951H1 2918 3182 15 252875.1 720109H1 2928 3197 15 252875.1 531590H1 2932 3153 15 252875.1 5497370H1 2938 3133 15 252875.1 4741744H1 2940 3237 15 252875.1 2850778H1 2951 3229 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 2420169H1 2950 3197 15 252875.1 2227025H1 2953 3202 15 252875.1 1948888H1 2953 3118 15 252875.1 96767181 2957 3598 15 252875.1 2682662H1 2956 3270 15 252875.1 967671H1 2957 3272 15 252875.1 g1303166 2964 3269 15 252875.1 4323462H1 2975 3231 15 252875.1 3774157H1 2982 3300 15 252875.1 2384295H2 2984 3216 15 252875.1 4156648H1 2992 3290 15 252875.1 5373633H1 2994 3209 15 252875.1 190297H1 3005 3261 15 252875.1 19029781 3005 3659 15 252875.1 3222225H1 3006 3362 15 252875.1 2197579H1 3012 3284 15 252875.1 4334641H1 3016 3321 15 252875.1 1739115H1 3031 3225 15 252875.1 2076112H1 3031 3345 15 252875.1 4588978H1 3031 3144 15 252875.1 1929325H1 3033 3287 15 252875.1 1698356H1 3044 3278 15 252875.1 774049H1 3044 3278 15 252875.1 3201988H1 3045 3229 15 252875.1 g 1165436 3045 3537 15 252875,1 4079815H1 3046 3338 15 252875.1 546658H1 3054 3386 15 252875,1 3243004H1 3061 3315 15 252875.1 2285730H1 3074 3327 15 252875.1 4957381H1 3075 3353 15 252875,1 g1165609 3101 3371 15 252875.1 548503H1 3112 3289 15 252875,1 434752H1 3117 3345 15 252875.1 1665374H1 3115 3374 15 252875,1 3766307H1 3116 3255 15 252875.1 5301677H1 3118 3294 15 252875.1 619409H1 3124 3411 15 252875.1 2134475H1 3129 3401 15 252875.1 1328119H1 3134 3432 15 252875.1 g835219 3135 3529 15 252875.1 3414825H1 3663 3915 15 252875.1 g4285757 3666 3843 15 252875.1 3992325H1 3673 3977 15 252875.1 1684593H1 3674 3906 15 252875.1 g1690764 3683 3831 15 252875.1 507054H1 3693 3932 15 252875.1 g 1493946 3705 3840 15 252875.1 2113227H1 3709 4000 15 252875.1 g4457753 3711 3844 15 252875.1 1601661H1 3712 3926 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 5860245H1 3714 4016 15 252875.1 g897528 3724 3841 15 252875,1 g1149324 3726 3877 15 252875.1 731353H1 3733 3998 15 252875,1 5219557H1 3737 3928 15 252875.1 g1194254 3752 4014 15 252875.1 g1976483 3768 4129 15 252875.1 g1194793 3775 3940 15 252875.1 3806345H1 3781 4050 15 252875.1 2603535H1 3783 4049 15 252875.1 47bb3bOH1 3785 4070 15 252875.1 1833291H1 3783 4043 15 252875.1 3450113H1 3790 4072 15 252875.1 5120311H1 634 940 15 252875.1 2866935H1 741 1043 15 252875.1 638818H1 752 1017 15 252875.1 3435566H1 812 1068 15 252875.1 2169234H1 833 1056 15 252875.1 2169234F6 833 1253 15 252875.1 5636183H1 906 1181 15 252875.1 4267043H1 961 1243 15 252875.1 3416556H1 985 1240 15 252875.1 5502666H1 1070 1287 15 252875.1 g1384448 1072 1421 15 252875.1 4b983bbHl 1099 1361 15 252875.1 2477291H1 1137 1358 15 252875.1 1274557F6 1172 1609 15 252875.1 1274557H1 1172 1419 15 252875.1 g3845885 1226 1585 15 252875.1 2746276H1 1241 1484 15 252875.1 3488583H1 1249 1508 15 252875.1 g2557990 1259 1550 15 252875.1 g3412243 1271 1590 15 252875,1 g2013979 1289 1524 15 252875.1 g2217748 4188 4593 15 252875.1 1336165H1 4186 4455 15 252875.1 2803030H1 4193 4486 15 252875.1 3728371H1 4193 4534 15 252875.1 g2195154 4193 4593 15 252875.1 372837171 4203 4554 15 252875.1 g1192650 4206 4590 15 252875,1 g2279223 4215 4590 15 252875.1 2718529H1 4217 4515 15 252875.1 83229683 4218 4587 15 252875.1 83144363 4227 4593 15 252875.1 81891729 4233 4590 15 252875.1 83666365 4234 4594 15 252875.1 83742308 4240 4593 15 252875.1 709764H1 4243 4529 15 252875.1 83237786 4245 4587 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 g1545463 4245 4602 15 252875.1 g2840952 4251 4587 15 252875.1 g2883750 4267 4608 15 252875.1 224311H1 4280 4486 15 252875.1 224311F1 4280 4587 15 252875.1 226928H1 4280 4545 15 252875.1 229979H1 4280 4508 15 252875.1 4091574H1 4282 4578 15 252875.1 2887836H1 4282 4576 15 252875.1 g4326366 4283 4593 15 252875.1 g 1139072 4293 4594 15 252875.1 g3434294 4294 4587 15 252875.1 174025986 4294 4587 15 252875.1 1740259H1 4294 4532 15 252875.1 1740259Th 4294 4553 15 252875.1 3470373H1 4300 4587 15 252875.1 g4149411 4304 4593 15 252875.1 659699H1 4310 4590 15 252875.1 731353F1 4156 4587 15 252875.1 g1846732 4157 4593 15 252875.1 g3214922 4160 4594 15 252875.1 g3416272 4325 4587 15 252875.1 g4525092 4330 4596 15 252875.1 4423707H1 4332 4587 15 252875.1 g3428976 4162 4595 15 252875.1 g3895874 4162 4596 15 252875.1 22431181 4177 4587 15 252875.1 g2753953 4168 4587 15 252875.1 g1626194 4171 4595 15 252875.1 g3146324 4171 4542 15 252875.1 g2779866 4172 4504 15 252875.1 g2054706 3495 3840 15 252875.1 3837481H1 3497 3712 15 252875.1 3512137H1 3510 3600 15 252875,1 g566011 3510 3833 15 252875.1 3325564H1 3518 3685 15 252875,1 g2537480 3527 4057 15 252875.1 2586362H1 3531 3819 15 252875.1 1265894H1 3534 3772 15 252875.1 1265894F1 3534 4149 15 252875.1 g1271274 3538 3812 15 252875.1 4339850H1 3540 3823 15 252875.1 5014329H1 3540 3807 15 252875.1 84333060 3540 3830 15 252875.1 83899484 3542 3840 15 252875.1 4019833H1 3553 3873 15 252875.1 3930433H1 3553 3868 15 252875.1 1394247H1 3557 3830 15 252875.1 8670185 3558 3833 15 252875.1 8897537 3565 3831 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 2313534H1 3569 3818 15 252875.1 1258470F1 3572 4196 15 252875.1 84304393 3571 3842 15 252875.1 2692250H1 3572 3831 15 252875.1 1258470H1 3572 3836 15 252875.1 81275416 3572 4230 15 252875.1 3809069H1 3582 3895 15 252875.1 81152594 3583 3840 15 252875.1 82321801 3588 3838 15 252875.1 8835206 3590 3840 15 252875.1 2808212H1 3607 3935 15 252875.1 1916784H1 3616 3905 15 252875.1 1251826H1 3619 3778 15 252875.1 1251826F1 3619 3830 15 252875.1 83920452 2265 2604 15 252875.1 2457404H1 2267 2520 15 252875.1 5216436H1 2268 2523 15 252875.1 8572819 2271 2614 15 252875.1 2685979H1 2291 2546 15 252875.1 4311421H1 2289 2413 15 252875.1 1387882H1 2291 2569 15 252875.1 1994174H1 2291 2402 15 252875.1 1386461H1 2291 2425 15 252875.1 3296980H1 2293 2560 15 252875.1 3742330H1 2307 2605 15 252875.1 2839295H1 2309 2585 15 252875.1 2615762H1 2321 2606 15 252875.1 2115669H1 2327 2594 15 252875.1 3248377H1 2331 2428 15 252875.1 1892380H1 2352 2493 15 252875.1 82217857 2382 2726 15 252875.1 3425510H1 2390 2665 15 252875.1 3666290H1 2391 2590 15 252875.1 3133325H1 2392 2667 15 252875.1 g 1897668 2395 2756 15 252875.1 034289H1 2400 2657 15 252875.1 g 1062015 2406 2733 15 252875.1 3542538H1 2407 2673 15 252875.1 3542586H1 2407 2668 15 252875.1 2969209H1 2424 2686 15 252875.1 4358014H1 2434 2716 15 252875.1 3657619H1 2435 2724 15 252875.1 82930924 2236 2642 15 252875.1 031953H1 2440 2723 15 252875.1 030691H1 2440 2652 15 252875.1 81154198 2441 2728 15 252875.1 2069257Th 2441 2867 15 252875.1 2744591H1 2441 2699 15 252875.1 81062277 2451 2739 15 252875.1 1945843H1 2476 2722 SE9 ID Template Component Start Stop NO: ID ID
15 252875.1 5135194H1 2479 2749 15 252875.1 4173923H1 2497 2797 15 252875.1 1853266H1 2497 2756 15 252875.1 5542442H1 2499 2719 15 252875.1 5497660H1 2514 2768 15 252875.1 84086589 2517 2925 15 252875.1 5878048H1 2521 2830 15 252875.1 81320612 2521 2852 15 252875.1 3891146H1 2524 2756 15 252875.1 2073038H1 2529 2756 15 252875.1 5834734H1 2544 2775 15 252875.1 5512348H1 2569 2872 15 252875.1 5512133H1 2569 2756 15 252875.1 199654386 2578 3088 15 252875.1 1996543H1 2578 2842 15 252875.1 3940668H1 2587 2874 15 252875.1 Ob0574H1 2591 2756 15 252875.1 4151473H1 2591 2870 15 252875.1 5196676H1 2591 2860 15 252875.1 030354H1 2599 2860 15 252875,1 4196058H1 2603 2923 15 252875.1 1450989F1 2621 2982 15 252875.1 1450989H1 2621 2901 15 252875.1 82218312 2632 3002 15 252875.1 g 1383259 2632 3083 15 252875.1 82617741 2633 2835 15 252875.1 8791689 2635 2874 15 252875.1 4933134H1 2648 2964 15 252875.1 2797213H1 2678 2953 15 252875.1 4864853H1 2678 2935 15 252875.1 2798634H1 2678 2946 15 252875.1 633892H1 2688 2918 15 252875.1 8880789 2705 3081 15 252875.1 2807841H1 2737 3068 15 252875,1 81182637 2746 3090 15 252875.1 81125575 2753 3131 15 252875.1 81295159 2765 3081 15 252875.1 4265522H1 2774 3018 15 25.2875.1 90022281 2775 3209 15 252875.1 900222H1 2775 3120 15 252875.1 4410765H1 2777 2983 15 252875.1 3468239H1 2777 2966 15 252875.1 2551180H1 2777 2970 15 252875.1 3813780H1 2777 3065 15 252875.1 81506871 3620 3830 15 252875.1 8791584 3621 3848 15 252875.1 2407631H1 3621 3840 15 252875.1 8835220 3629 3841 15 252875.1 83038977 3629 3783 15 252875.1 81062367 3637 3823 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 310441H1 3639 3825 15 252875.1 31044186 3640 3924 15 252875.1 4080535H1 3641 3961 15 252875.1 1740495H1 3641 3892 15 252875.1 4647311H1 3642 3919 15 252875.1 388848H1 3647 3848 15 252875.1 81332310 3651 4188 15 252875.1 81332258 3651 4126 15 252875.1 g 1524775 3653 4182 15 252875.1 81443183 3652 3840 15 252875.1 g 1891789 3654 4121 15 252875.1 400845H1 3659 3849 15 252875.1 2639596H1 1369 1429 15 252875.1 2874502F6 1406 1784 15 252875.1 2169234T6 1331 1696 15 252875.1 2874502H1 1407 1686 15 252875.1 2746872H1 1408 1674 15 252875.1 81984049 1443 1765 15 252875.1 5264513F6 1452 1772 15 252875.1 82526630 1461 1904 15 252875.1 2877577H1 1498 1668 15 252875.1 2871627H1 1498 1758 15 252875.1 4768331H1 1519 1790 15 252875.1 2762166H1 1536 1793 15 252875.1 82010681 1598 1898 15 252875.1 5370588H1 1609 1832 15 252875.1 3725509H1 1646 1936 15 252875.1 4714478H1 1664 1929 15 252875.1 1950683H1 1674 1901 15 252875.1 82006648 1675 1920 15 252875.1 82027521 1714 2070 15 252875.1 3825837H1 1735 2021 15 252875.1 84511067 1738 2020 15 252875.1 653234H1 1780 2029 15 252875.1 2170628H1 1806 2054 15 252875.1 2170628F6 1806 2302 15 252875.1 1665096H1 1845 2078 15 252875.1 5695708H1 1860 2097 15 252875.1 8573675 1919 2227 15 252875.1 5638872H1 1975 2241 15 252875.1 5086872H1 1983 2207 15 252875.1 1689519H1 1988 2112 15 252875.1 4833076H1 1999 2262 15 252875.1 3370367H1 2005 2286 15 252875.1 2354679H1 2006 2135 15 252875.1 82011403 2014 2239 15 252875.1 4820085H1 2037 2264 ' 15 252875.1 6063612H1 2037 2310 15 252875.1 2170628Th 2050 2471 15 252875.1 83676979 2051 2516 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 4346524H1 2081 2351 15 252875.1 2650068H1 2081 2333 15 252875.1 059589H1 2091 2303 15 252875.1 g2335474 2135 2520 15 252875.1 g616509 2166 2506 15 252875.1 4993749H1 2166 2461 15 252875.1 729898H1 2167 2371 15 252875.1 72989886 2167 2582 15 252875.1 73091586 2167 2686 15 252875.1 72989881 2167 2512 15 252875.1 350527H1 2181 2315 15 252875.1 1486345H1 2211 2463 15 252875.1 1486345F6 2211 2586 15 252875.1 5450622H1 2228 2489 15 252875.1 4553123H1 3172 3443 15 252875.1 3629790H1 3181 3496 15 252875.1 402268H1 3188 3407 15 252875.1 1509841H1 3195 3397 15 252875.1 1509833H1 3195 3399 15 252875.1 4919221H1 3206 3499 15 252875.1 g835205 3135 3437 15 252875.1 4073386H1 3142 3458 15 252875.1 2445427H1 3156 3414 15 252875.1 2041560H1 3157 3451 15 252875.1 5013650H1 3219 3526 15 252875.1 1876087H1 3222 3480 15 252875.1 2401949H1 3222 3494 15 252875.1 5875179H1 3223 3506 15 252875.1 5518081H1 3236 3414 15 252875.1 3163335H1 3239 3533 15 252875.1 5636648H1 3241 3536 15 252875.1 3076681H1 3247 3407 15 252875.1 g3850466 3246 3697 15 252875.1 1876575H1 3254 3547 15 252875.1 g1367750 3257 3843 15 252875.1 4931430H1 3264 3545 15 252875.1 1958432H1 3269 3585 15 252875.1 627261H1 3274 3529 15 252875.1 3786347H1 3281 3554 15 252875.1 1730878H1 3283 3539 15 252875.1 1730895H1 3283 3490 15 252875.1 1730824H1 3283 3492 15 252875.1 2874502T6 3290 3797 15 252875.1 469285H1 3293 3550 15 252875.1 2058867H1 3298 3571 15 252875.1 205886786 3298 3699 15 252875.1 5733018H1 3300 3592 15 252875.1 1261341H1 3301 3574 15 252875.1 2878759H1 3307 3607 15 252875.1 1398976H1 3310 3559 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 81751344 3316 3586 15 252875.1 720109F1 3317 3840 15 252875.1 82945397 3332 3840 15 252875.1 5778084H1 3336 3617 15 252875.1 8767808 3337 3845 15 252875.1 5777985H1 3337 3574 15 252875.1 1337062H1 3340 3594 15 252875.1 83280387 3347 3842 15 252875.1 2289425H1 3347 3610 15 252875.1 83675613 3354 3840 15 252875.1 3801180H1 3355 3524 15 252875.1 2876933H1 3367 3502 15 252875.1 84269890 3369 3846 15 252875.1 95279271 3382 3758 15 252875.1 2409980H1 3383 3623 15 252875.1 83446123 3389 3840 15 252875.1 82930114 3390 3850 15 252875.1 81157245 3394 3841 15 252875.1 1880890H1 3392 3654 15 252875.1 95279281 3394 3843 15 252875.1 952792H1 3396 3588 15 252875.1 83988283 3397 3840 15 252875.1 1813653H1 3396 3598 15 252875.1 1213928H1 3398 3638 15 252875,1 121392871 3398 3797 15 252875.1 83872611 3405 3840 15 252875.1 2505231H1 3406 3652 15 252875.1 84452830 3407 3840 15 252875.1 84523040 3407 3840 15 252875.1 81897843 3408 3844 15 252875.1 4715628H1 3411 3673 15 252875.1 2994530H1 3411 3680 15 252875.1 66100186 3412 3843 15 252875.1 83422408 3412 3840 15 252875,1 660905H1 3412 3685 15 252875.1 83870520 3412 3840 15 252875,1 66100176 3412 3798 15 252875.1 660690H1 3412 3692 15 252875.1 1740390H1 3414 3649 15 252875.1 3773806H1 3416 3738 15 252875.1 81324229 3421 3969 15 252875.1 83433983 3430 3849 15 252875,1 81440537 3440 3737 15 252875.1 81545520 3441 3877 15 252875.1 82264856 3445 3842 15 252875.1 82968893 3446 3844 15 252875.1 3972857H1 3449 3612 15 252875.1 3521680H1 3446 3813 15 252875.1 475000H1 3459 3741 15 252875.1 1369528H1 3462 3711 SEQ ID Template Component Start Stop NO: ID ID
15 252875.1 4716618H1 3464 3764 15 252875.1 5402888H1 3470 3744 15 252875.1 737350H1 3473 3678 15 252875.1 149929H1 3479 3686 15 252875.1 14992981 3478 4058 15 252875.1 2746121H1 3479 3733 15 252875.1 g 1060820 3490 3824 15 252875.1 86252381 3492 4121 15 252875.1 862523H1 3492 3770 15 252875.1 1741284H1 3492 3722 15 252875.1 1578142H1 3496 3744 15 252875.1 1962956H1 3795 4112 15 252875.1 5186635H1 3795 4047 15 252875.1 2110916H1 3795 3950 15 252875.1 2870075H1 3798 4092 15 252875.1 87279481 3800 4322 15 252875.1 872794H1 3800 4089 15 252875.1 3560953H1 3801 4004 15 252875.1 3623917H1 3811 3995 15 252875.1 4176710H1 3809 4014 15 252875.1 2364402H1 3813 3996 15 252875.1 2017186H1 3822 4091 15 252875.1 2806941H1 3825 4141 15 252875.1 136474881 3836 4363 15 252875.1 1364748H1 3836 4115 15 252875.1 2126618H1 3840 4142 15 252875.1 205886776 3849 4554 15 252875.1 1268579H1 3853 4104 15 252875.1 2420031H1 3861 4111 15 252875.1 867120H1 3861 4022 15 252875.1 3471449H1 3865 4144 15 252875.1 31044176 3890 4550 15 252875.1 687562H1 3894 4173 15 252875.1 502213071 3901 4543 15 252875.1 4995018H1 3907 4179 15 252875.1 5022130H1 3906 4031 15 252875.1 5401446H1 3913 4169 15 252875.1 3279479H1 3926 4204 15 252875.1 1517039H1 3926 4149 15 252875.1 1517087H1 3926 4130 15 252875.1 2072072H1 3934 4206 15 252875.1 3781502H1 3941 4286 15 252875.1 1548234H1 3941 4170 15 252875.1 5390212H1 3942 4216 15 252875.1 g 1321347 3949 4364 15 252875.1 3092282H1 3956 4209 15 252875.1 320547H1 3969 4394 15 252875.1 4436308H1 3979 4256 15 252875.1 1901926H1 3988 4270 15 252875.1 3051460H1 3988 4292 SE6~ Template Component Start Stop ID NO: ID ID
15 252875.1 3836484H1 4000 4290 15 252875.1 2423168H1 4010 4263 15 252875.1 4122620H1 4011 4292 15 252875.1 149929F1 4015 4587 15 252875.1 1590154H1 4014 4284 15 252875.1 779159H1 4016 4273 15 252875.1 77915981 4016 4586 ~
15 252875.1 4718944H1 4016 4296 15 252875.1 4981471H1 4019 4227 15 252875.1 2128923H1 4025 4308 15 252875.1 3859444H1 4027 4310 15 252875.1 3856453H1 4027 4286 15 252875,1 2564780H1 4029 4155 15 252875,1 5911630H1 4042 4395 15 252875.1 730915Th 4045 4555 15 252875.1 g2619417 4049 4327 15 252875,1 g2619632 4050 4332 15 252875,1 729898Th 4065 4551 15 252875.1 1667393H1 4074 4312 15 252875,1 4339273H1 4072 4385 15 252875,1 1666593H1 4074 4303 15 252875.1 1667396H1 4074 4312 15 252875,1 g 1846687 4080 4520 15 252875.1 g4108324 4089 4587 15 252875.1 2736196H1 4093 4366 15 252875,1 2736715H1 4093 4373 15 252875.1 3879868H1 4100 4235 15 252875.1 g3675575 4102 4587 15 252875.1 g1332311 4107 4604 15 252875.1 g4329975 4102 4587 15 252875.1 g1524714 4104 4600 15 252875.1 g3278422 4104 4587 15 252875.1 g3596503 4106 4587 15 252875.1 g2656299 4107 4592 15 252875.1 1759044H1 4108 4370 15 252875.1 3951189H1 4107 4428 15 252875.1 g4393268 4109 4596 15 252875.1 g3920837 4110 4593 15 252875.1 3559291H1 4111 4437 15 252875.1 g3644402 4116 4596 15 252875.1 5683481H1 4117 4371 15 252875.1 g3238075 4121 4587 15 252875.1 g1219850 4128 4589 15 252875.1 2599386H1 4126 4428 15 252875.1 g2217641 4128 4592 15 252875.1 g4394253 4129 4587 15 252875.1 g4267736 4136 4589 15 252875.1 g4453805 4139 4593 15 252875.1 g4522737 4140 4593 15 252875.1 g 1332201 4155 4593 SES~ Template -.Component Start Stop ID NO: ID ID
15 252875.1 g4509608 4154 4593 15 252875.1 5614003H1 4156 4396 15 252875.1 g4243557 4155 4593 15 252875.1 2754555H1 4338 4593 15 252875.1 g879867 4365 4600 15 252875.1 g1266259 4368 4594 15 252875.1 3327329H1 4370 4597 15 252875.1 4248607H1 4392 4609 15 252875.1 g4186572 4402 4587 15 252875.1 1351626H1 4411 4567 15 252875.1 1351626F1 4411 4587 15 252875.1 302767H1 4412 4588 15 252875.1 1968509H1 4412 4594 15 252875.1 5876201H1 4413 4603 15 252875.1 g2433592 4416 4598 15 252875.1 2969615H1 4419 4563 15 252875.1 g2942070 4469 4587 15 252875.1 g 1267224 4474 4593 15 252875.1 2043678H1 4475 4587 15 252875.1 g2986396 4477 4587 15 252875.1 3373314H1 1 112 15 252875.1 3077972H1 5 316 15 252875.1 2069257H1 42 277 15 252875.1 3073491H1 42 295 15 252875.1 2069257F6 47 450 15 252875.1 482316H1 49 258 15 252875.1 3036127H1 49 267 15 252875.1 3607250H1 49 197 15 252875.1 3343670H1 49 258 15 252875.1 3394626H1 49 291 15 252875.1 5522114H1 68 242 15 252875.1 3419860H1 176 401 15 252875.1 3199647H1 305 401 15 252875.1 g1984204 369 786 15 252875.1 3536255H1 386 662 15 252875.1 3528024H1 563 799 16 252964.2 4178741H1 3001 3238 16 252964.2 830538H1 3012 3108 16 252964.2 830538T1 3012 3198 16 252964.2 83053881 3012 3238 1b 252964.2 g3057275 3033 3241 1b 252964.2 g1164549 3040 3238 1b 252964.2 g1894136 3044 3243 16 252964.2 747073H1 3055 3313 16 252964.2 4074768H1 3099 3217 16 252964.2 g863600 3102 3226 16 252964.2 g1060375 3108 3215 16 252964.2 g1892056 3109 3241 16 252964.2 g2620960 3140 3245 1b 252964.2 g3805026 3150 3252 SE6~ Template Component Start Stop ID NO. ID ID
16 252964.2 2939591H1 2679 2990 16 252964.2 1993076T6 2681 3200 1b 252964.2 221873H1 2702 2925 16 252964.2 2853281H1 2711 3001 16 252964.2 2260511H1 2723 2995 16 . 252964.2 5289957H1 2723 3020 1 b 252964.2 8868647 2723 , 3063 16 252964.2 83108721 2731 3238 16 252964.2 4381077H1 2740 3027 16 252964.2 5272939H1 2740 3013 16 252964.2 82161092 2743 3241 16 252964.2 3223031H1 2758 2944 16 252964.2 1843518H1 2758 3072 16 252964.2 2245609H1 2779 3073 16 252964.2 88201 b2 2779 3063 16 252964.2 83033754 2784 3244 16 252964.2 4642653H1 2785 3057 16 252964.2 83900624 2787 3243 16 252964.2 84267231 2793 3238 16 252964.2 83919071 2794 3238 16 252964.2 2188192H1 2810 3110 16 252964.2 2369459Th 2816 3198 1b 252964.2 450871T6 2828 3200 1b 252964.2 661201H1 2842 3123 16 252964.2 5594903H1 2842 3112 16 252964.2 2736768H1 2850 3140 16 252964.2 83870375 2856 3243 16 252964.2 3805033H1 2856 3172 16 252964.2 84330626 2857 3238 16 252964.2 84112946 2862 3238 16 252964.2 4540882H1 2889 3156 16 252964.2 82207247 2889 3238 1b 252964.2 82218580 2889 3250 1b 252964.2 81719392 2892 3239 1b 252964.2 1833491H1 2896 3197 16 252964.2 911307H1 2899 3168 16 252964.2 619933H1 2906 3185 16 252964.2 83960791 2916 3238 16 252964.2 84391406 2917 3247 16 252964.2 82715745 2919 3238 16 252964.2 84268192 2920 3241 16 252964.2 84267270 2921 3244 16 252964.2 83644389 2922 3247 16 252964.2 928993H1 2924 3085 16 252964.2 82903695 2930 3238 16 252964.2 8566929 2935 3238 16 252964.2 81153963 2967 3238 1b 252964.2 3116982H1 2660 2957 16 252964.2 84070514 2973 3243 1b 252964.2 2792353H1 2660 2757 SE6~ Template Component Start Stop ID NO: ID ID
16 252964.2 g3778735 2983 3238 16 252964.2 053091H1 2997 3206 16 252964.2 497154H1 2999 3190 16 252964.2 500461H1 2999 3218 16 252964.2 2673105H1 1792 2031 16 252964.2 5855988H1 1793 2040 16 252964.2 5118330H1 1803 2082 16 252964.2 2866056H1 1860 2172 16 252964.2 4851249H1 1893 2144 16 252964.2 5007337H1 1898 2151 1 b 252964.2 g 1719391 1899 2291 1b 252964.2 2227319H1 1903 2148 16 252964.2 5926595H1 1920 2214 16 252964.2 g1060485 1945 2361 1b 252964.2 2845135H1 1958 2191 16 252964.2 1913383H1 2031 2290 16 252964.2 3481001H1 2073 2222 16 252964.2 5403224H1 2075 2379 16 252964.2 2370791H1 2076 2304 16 252964.2 2370791F6 2076 2562 1b 252964.2 3234460H1 2083 2331 16 252964.2 g1273052 2102 2564 1b 252964.2 4849809H1 2102 2386 16 252964.2 3551288H1 2110 2331 16 252964.2 6065193H1 2112 2375 16 252964.2 80568781 2130 2640 1b 252964.2 805687H1 2140 2339 16 252964.2 4818872H1 2168 2338 16 252964.2 445589H1 2169 2424 16 252964.2 3534641H1 2170 2472 16 252964.2 4932921H1 2228 2496 1 b 252964.2 g 1187975 2229 2592 1b 252964.2 925326H1 2237 2551 16 252964.2 925389H1 2237 2337 16 252964.2 92532681 2238 2597 16 252964.2 1984547H1 2246 2523 16 252964.2 198454786 2246 2718 16 252964.2 822651H1 2256 2524 16 252964.2 82265181 2256 2803 16 252964.2 2960302H1 2287 2582 16 252964.2 2745337H1 2311 2556 16 252964.2 2745683H1 2311 2554 16 252964.2 5015696H1 2321 2422 16 252964.2 5552559H1 2322 2586 16 252964.2 3469448H1 2323 2579 16 252964.2 4834907H1 2329 2586 16 252964.2 785664H1 2331 2633 16 252964.2 78566486 2331 2771 16 252964.2 78525781 2331 2862 16 252964.2 785257H1 2331 2582 SE6~ Template Component Start Stop ID NO. ID ID
16 252964.2 4266319H1 2385 2565 16 252964.2 g2161091 2394 2814 16 252964.2 3021996H1 2395 2694 16 252964.2 4795127H1 2428 2695 16 252964.2 1427976H1 2443 2707 16 252964.2 1427976F6 2443 3025 1b 252964.2 002126H1 2461 2923 16 252964.2 g1783079 2462 2847 1 b 252964.2 g 1892162 2462 2884 16 252964.2 4593447H1 2479 2737 16 252964.2 4416604H1 2486 2723 16 252964.2 313687H1 2491 2731 16 252964.2 374457H1 2492 2707 16 252964.2 1231088H1 2511 2737 16 252964,2 1427976T6 2510 3060 1b 252964.2 2421408H1 2535 2775 16 252964.2 1237191H1 2545 2782 16 252964.2 1237191F1 2545 3125 16 252964.2 2564135H1 2568 2835 16 252964.2 1364705H1 2569 2836 16 252964.2 1364705R1 2569 2936 16 252964,2 2570283H1 2569 2830 16 252964.2 3811167H1 2577 2851 16 252964,2 g3958470 2603 3096 1b 252964.2 785664T6 2611 3198 16 252964,2 6103263H1 2623 2913 16 252964,2 g2207504 2652 3049 16 252964.2 2820307H1 2657 3013 16 252964.2 2820510H1 2657 2994 16 252964.2 3620806H1 596 894 16 252964.2 450871R6 789 1191 16 252964.2 2367753T6 820 1282 16 252964.2 6336 11 831 1087 16 252964.2 2791431H1 860 1136 16 252964.2 3233115H1 649 894 16 252964.2 746957H1 919 1176 16 252964.2 1839028H1 1018 1185 16 252964.2 g4394691 686 1065 16 252964.2 1838057H1 1018 1320 16 252964.2 g1993698 1033 1347 16 252964.2 4292134H1 1058 1315 16 252964.2 g869109 1093 1386 1b 252964.2 g792911 1095 1358 16 252964.2 g2269330 700 1066 1b 252964.2 g2444529 1098 1482 1b 252964.2 452142H1 1120 1366 16 252964.2 4239190H1 740 1007 16 252964.2 4046046H1 1134 1403 16 252964.2 1993076F6 1136 1449 1b 252964.2 1993076H1 1136 1292 SEQ ID Template Component Start Stop NO: ID ID
16 252964.2 94548886 1173 1668 1b 252964.2 945488H1 1172 1463 16 252964.2 5434372H1 1176 1384 16 252964.2 2701918H1 1267 1540 16 252964.2 997219H1 1312 1504 16 252964.2 99721982 1312 1842 1b 252964.2 596014H1 1363 1597 16 252964.2 160577H1 1398 1597 16 252964.2 8573332 1426 1787 16 252964.2 8677613 1426 1779 16 252964.2 81998633 783 1161 16 252964.2 5193886H1 1448 1687 16 252964.2 82052933 1483 1589 16 252964.2 5192721H1 1589 1859 16 252964.2 82218358 1592 1916 16 252964.2 4108761H1 1608 1895 16 252964.2 81165576 1619 1872 16 252964.2 3285590H1 1701 1945 16 252964.2 5713371H1 1715 2000 16 252964.2 1877915H1 1767 1928 16 252964.2 450871H1 789 1015 16 252964.2 1877915F6 1767 2150 1b 252964.2 5615447H1 1 281 16 252964.2 1871935F6 8 479 1b 252964.2 1871935H1 8 ~ 263 16 252964.2 1871835H1 8 247 16 252964.2 2787027H1 101 429 16 252964.2 3770821H1 319 618 16 252964.2 5291758H1 346 547 16 252964,2 81545134 439 843 16 252964.2 81063095 439 811 16 252964,2 8272283 469 804 1b 252964.2 2670348T6 493 1024 16 252964.2 1871935Th 528 1019 1b 252964.2 2367753F6 563 974 1b 252964.2 2367753H1 563 788 17 267153.7 2580428F6 1 424 17 267153.7 5780256H1 7 197 17 267153.7 1927531H1 1 104 17 267153.7 5542321H1 1 86 17 267153.7 2580428H1 1 211 17 267153.7 82033888 656 925 17 267153.7 82033889 65b 842 17 267153.7 82034039 656 1001 17 267153.7 82034000 656 969 17 267153.7 82033922 656 925 17 267153.7 556169H1 663 808 17 267153.7 55616986 663 1220 17 267153.7 553115H1 663 885 17 267153.7 986072H1 693 802 SE9 ID Template Component Start Stop NO; ID ID
17 267153.7 4180466H1 1166 1393 17 267153.7 4180466F6 1166 1456 17 267153.7 1416069H1 1351 1620 17 267153.7 3047572F6 1402 1874 17 267153.7 3047572H1 1403 1708 17 267153,7 5422118H1 1463 1711 17 267153.7 3241209H1 1499 1736 17 267153.7 3577671H1 18 193 17 267153.7 5636615H1 18 164 17 267153.7 5322669H1 29 285 17 267153.7 5321675H1 29 298 17 267153.7 3227664F6 31 402 17 267153.7 3406115H1 31 290 17 267153.7 3799455H1 31 255 17 267153.7 3227664H1 33 322 17 267153.7 3146326H1 35 333 17 267153,7 4760440H1 45 149 17 267153.7 3378285H1 54 286 17 267153,7 3799580H1 69 370 17 267153.7 3366109H1 109 317 17 267153,7 g2229557 110 441 17 267153.7 6078201H1 381 715 17 267153.7 g923914 419 670 17 267153,7 g274698 464 842 17 267153.7 g781645 644 877 18 331244.6 g2037184 293 666 18 331244.6 3703079H1 295 604 18 331244.6 4355792H1 298 664 18 331244.6 5205414H2 299 581 18 331244.6 5662744H1 307 557 18 331244.6 1818166H1 312 602 18 331244.6 1428020F6 313 . 785 18 331244.6 2867856H1 314 547 18 331244.6 2534359H2 315 500 18 331244.6 2852946H1 315 629 18 331244.6 4909270H1 315 593 18 331244.6 5895948H1 321 625 18 331244.6 5902265H1 322 603 18 331244.6 g1970235 332 646 18 331244.6 4700222H1 335 620 18 331244.6 3367010H1 336 601 18 331244.6 g2103204 351 812 18 331244.6 3929559H1 352 Ebb 18 331244.6 036372H1 353 586 18 331244.6 058809H1 358 537 18 331244.6 2726788H1 358 614 18 331244.6 g 1110314 362 671 18 331244.6 351602H1 363 604 18 331244.6 1352253H1 1 254 18 331244.6 1352253F1 1 575 SE9 ID Template Component Start Stop NO: ID ID
18 331244.6 1352253F6 1 465 18 331244.6 2600773H1 363 680 18 331244.6 4718931H1 42 313 18 331244.6 2656868H1 363 576 18 331244.6 2605832H1 363 595 18 331244.6 3436228H1 363 598 18 331244.6 5118860H1 364 653 18 331244.6 2024732H1 366 624 18 331244.6 4371963H1 371 641 18 331244.6 100587H1 43 245 18 331244.6 1867334H1 49 224 18 331244.6 3597304H1 48 367 18 331244.6 2451902H1 50 289 18 331244.6 2738608H1 50 294 18 331244.6 g771569 51 434 18 331244.6 g1803076 53 131 18 331244.6 4718914H1 61 332 18 331244.6 4719022H 62 170 18 331244.6 4373837H1 371 652 18 331244.6 043783H1 381 689 18 331244.6 g1678313 381 800 18 331244.6 841019H1 387 650 18 331244.6 84101981 387 1002 18 331244.6 199510286 400 826 18 331244.6 1995102H1 400 695 18 331244.6 3855550H1 404 726 18 331244.6 g766559 115 361 18 331244,6 g2034844 121 481 18 331244.6 g880214 204 609 18 331244.6 g751349 253 587 18 331244.6 535267H1 280 511 18 331244.6 1428020H1 282 477 18 331244.6 1427648H1 282 560 18 331244.6 3450701H1 286 545 18 331244.6 1718398H1 455 670 18 331244.6 3025271H1 478 761 18 331244.6 3057108H1 481 665 18 331244.6 4773103H1 518 829 18 331244.6 94286281 528 983 18 331244.6 942862H1 528 778 18 331244.6 1302039H1 552 849 18 331244.6 4981303H1 560 837 18 331244.6 2101923H1 645 907 18 331244.6 3972632H1 696 975 18 331244.6 2327160H1 712 967 18 331244.6 2232654H1 731 975 18 331244.6 3818861H1 732 1029 18 331244.6 1609537H1 732 933 18 331244.6 1609517H1 732 920 18 331244.6 4710176H1 734 896 SE6~ Template Component Start Stop ID NO: ID ID
18 331244.6 4710284H1 734 1011 18 331244.6 82595082 755 945 18 331244.6 4049284H1 772 1069 18 331244.6 1538495H1 798 999 18 331244.6 1228870H1 844 1094 18 331244.6 2628877H1 861 1098 18 331244.6 4995618H1 875 1144 18 331244.6 199510276 877 1530 18 331244.6 2043991H1 884 1126 18 331244.6 3516482H1 915 1177 18 331244.6 199637476 922 1532 18 331244.6 199637486 939 1439 18 331244.6 1996374H1 939 1206 18 331244.6 1549444H1 939 1164 18 331244.6 4324734H1 945 1185 18 331244.6 336097H1 1003 1259 18 331244.6 82017702 1007 1387 18 331244.6 2425889H1 1035 1298 18 331244.6 3411191H1 1036 1202 18 331244.6 3078834H1 1103 1417 18 331244.6 480272H1 1113 1369 18 331244.6 82103137 1128 1585 18 331244.6 8712162 1138 1574 18 331244.6 84525329 1137 1571 18 331244.6 549094H1 1146 1442 18 331244.6 2579048H2 1154 1442 18 331244.6 1414589F6 1177 1583 18 331244.6 1414589H1 1177 1439 18 331244.6 83841570 1187 1575 18 331244.6 8794847 1206 1589 18 331244,6 4640449H1 1219 1507 18 331244.6 83840885 1222 1571 18 331244.6 8819967 1280 1581 18 331244.6 8751350 1272 1573 18 331244.6 4367801H1 1281 1528 18 331244.6 8519529 1293 1571 18 331244.6 8618115 1361 1575 19 335484,1 2626409H1 2774 3005 19 335484.1 2626409F6 2774 3290 19 335484.1 2626025H1 2774 3030 19 335484.1 1418291H1 . 2841 3077 19 335484.1 82397783 2874 3259 19 335484,1 2746883H1 2914 3175 19 335484.1 262640976 3031 3264 19 335484.1 84270950 3127 3574 19 335484.1 82899058 3132 3575 19 335484.1 2521894F6 148 bbl 19 335484.1 2521894H1 148 407 19 335484.1 5538378H1 264 471 19 335484.1 3465291H1 316 642 SEQ ID Template Component Start Stop NO: ID ID
19 335484.1 g1623573 318 650 19 335484.1 g715634 78 309 19 335484.1 5386328H1 330 594 19 335484.1 g764148 79 353 19 335484.1 g2012728 369 603 19 335484.1 5854480H1 414 711 19 335484.1 2671282F6 1138 1680 19 335484.1 3115951F6 1497 1895 19 335484.1 3115951H1 1498 1773 19 335484.1 g570994 1528 1910 19 335484.1 g672096 1529 1865 19 335484.1 g677051 1529 1830 19 335484.1 g781962 1542 1799 19 335484.1 g668551 1542 1803 19 335484.1 4010291H1 1563 1839 19 335484,1 2401422H1 1728 1969 19 335484.1 3695649H1 2034 2334 19 335484.1 g3240345 1869 2245 19 335484.1 3293772F6 2059 2440 19 335484.1 3293772H1 2059 2332 19 335484.1 116622H1 2085 2321 19 335484.1 11662281 2085 2558 19 335484,1 5171287H1 2170 2380 19 335484.1 5175487H1 2170 2442 19 335484.1 267128276 2172 2748 19 335484.1 5098225H1 419 697 19 335484.1 5677977H1 969 1230 19 335484.1 g1626824 970 1275 19 335484.1 5098225F6 419 691 19 335484.1 509822576 432 1048 19 335484.1 g2694430 439 905 19 335484.1 g2357857 995 1365 19 335484.1 g1289722 522 916 19 335484.1 5645168H1 633 884 19 335484.1 g715547 802 902 19 335484.1 g3239654 843 1073 19 335484.1 1978183H1 1014 1276 19 335484.1 5834795H1 1067 1-337 19 335484.1 2671282H1 1138 1379 19 335484.1 g1321140 1 418 19 335484.1 3448433H1 1 238 19 335484.1 4380511H1 16 285 19 335484,1 3576080H1 40 293 19 335484.1 3463823H1 64 314 19 335484.1 311595176 2174 2742 19 335484.1 116622F1 2216 2785 19 335484.1 4172444H1 2216 2512 19 335484.1 3721925H1 2298 2603 19 335484.1 g2902979 2336 2799 19 335484.1 g822642 2488 2802 SEQ ID Template Component Start Stop NO: ID ID
19 335484.1 g5b2bb2 2502 2785 19 335484.1 293b989H1 2520 2782 19 335484.1 867138b 2547 2785 19 335484.1 8646350 2577 2785 19 335484.1 864511b 2579 2785 19 335484.1 82805833 2664 2797 19 335484.1 3293772Tb 2748 3218 20 337489.2 49457b4H1 1 263 20 337489.2 81985316 1 217 20 337489.2 3247865H1 11 317 20 337489.2 4180529H1 15 112 20 337489.2 385371H1 166 429 20 337489.2 g 1624554 389 725 20 337489.2 3078832F6 392 796 20 337489.2 3078832H1 392 697 20 337489.2 3294510H1 650 824 20 337489.2 8395753 669 1006 20 337489.2 821843b4 816 1265 20 337489.2 b075740H1 885 1174 20 337489.2 6075772H1 903 1168 20 337489.2 3078832Tb 1009 1457 21 359574.5 82398327 1 343 21 359574.5 82629710 1 421 21 359574.5 3338142H1 1 233 21 359574.5 3b85831H1 30 171 21 359574.5 2993588H1 40 306 21 359574.5 1906768Fb 41 453 21 359574.5 190b7b8H1 41 118 21 359574.5 3172672H1 46 229 21 359574.5 3436865H1 47 289 21 359574.5 1818045H1 47 342 21 359574.5 81781952 bb 480 21 359574.5 3982668H1 72 264 21 359574.5 1b72722H1 75 282 21 359574.5 3036287H1 107 372 21 359574.5 81578363 103 345 21 359574.5 8827499 106 477 21 359574.5 4054942H1 123 423 21 359574.5 3340967H1 132 397 21 359574.5 3433495H1 132 218 21 359574.5 817357b9 158 554 21 359574.5 1390555H1 188 376 21 359574.5 1390555F6 188 565 21 359574.5 987088H1 190 476 21 359574.5 5850596H1 204 395 21 359574.5 2204622H1 326 591 21 359574.5 2204b22F6 326 853 21 359574.5 g 1961866 385 793 21 359574.5 1967881H1 396 690 21 359574.5 5059229H1 397 672 SEQ ID Template Component Start Stop NO: ID ID
21 359574.5 3199313H1 463 561 21 359574.5 1006996H1 511 748 21 359574.5 3054689H ' 547 838 21 359574.5 1965560H1 692 968 21 359574.5 5544945H1 716 949 21 359574.5 3376272H1 741 918 21 359574.5 8899846 882 1212 21 359574.5 8389140 910 1319 21 359574,5 8616300 914 1190 21 359574.5 5636083H1 920 1214 21 359574.5 83769768 924 1005 21 359574.5 3804657H1 943 1272 21 359574.5 1347412H1 967 1224 21 359574.5 270746H1 974 1326 21 359574.5 493004H1 977 1377 21 359574.5 4915149H1 979 1259 21 359574,5 3289817H1 1044 1181 21 359574.5 74741181 1057 1741 21 359574.5 747411H1 1057 1300 21 359574.5 1902775F6 1102 1593 21 359574,5 1902775H1 1102 1380 21 359574.5 3331792H1 1170 1463 21 359574.5 4787713H1 1231 1489 21 359574.5 5101264H1 1240 1501 21 359574.5 81578064 2292 2727 21 359574.5 045454H1 2294 2533 21 359574,5 82063879 2309 2770 21 359574.5 8848870 2314 2662 21 359574.5 8848899 2314 2632 21 359574.5 4731068H1 2312 2586 21 359574.5 8848913 2322 2712 21 359574.5 3494155H1 2327 2593 21 359574.5 4180013Th 2338 2792 21 359574.5 413579H1 2342 2590 21 359574.5 415164H1 2342 2589 21 359574.5 2905578Th 2345 2775 21 359574.5 1841356Th 2347 2748 21 359574.5 1713137Th 2345 2762 21 359574.5 83109931 2355 2819 21 359574.5 82705028 2359 2817 21 359574.5 82752959 2359 2815 21 359574.5 83752541 2360 2815 21 359574.5 81578272 2370 2817 21 359574.5 81941192 2370 2820 21 359574.5 82001627 2385 2815 21 359574.5 84114546 2380 2815 21 359574.5 3866784H1 2380 2664 21 359574.5 981891H1 2383 2661 21 359574.5 1500830Th 2387 2773 21 359574.5 82883824 2389 2818 SEQ ID Template Component Start Stop NO: ID ID
21 359574.5 g 1741113 2392 2814 21 359574.5 g 1815396 2394 2816 21 359574.5 83921165 2402 2815 21 359574.5 83277950 2404 2821 21 359574.5 83777806 2405 2780 21 359574.5 84389617 2405 2815 21 359574.5 84394654 2408 2816 21 359574.5 5161988H1 2412 2686 21 359574.5 819400b4 2414 2820 21 359574.5 831904b0 2418 2815 21 359574.5 82159890 2419 2819 21 359574.5 8848914 2422 2821 21 359574.5 83280154 2423 2818 21 359574.5 82063754 2428 2816 21 359574.5 81010758 2429 2828 21 359574.5 74413881 2433 2815 21 359574.5 81940045 2433 2820 21 359574.5 744138H1 2433 2681 21 359574.5 98558881 2441 2815 21 359574.5 98558871 2441 2772 21 359574.5 985588H1 2441 2703 21 359574.5 8848871 2450 2815 21 359574.5 8848900 2461 2792 21 359574.5 8519499 2467 2815 21 359574.5 83801239 2477 2818 21 359574.5 8890240 2479 2795 21 359574.5 83245088 2483 2820 21 359574.5 84308927 2485 2815 21 359574.5 8712131 2490 2816 21 359574.5 676177H1 2497 2753 21 359574,5 674403H1 2497 2775 21 359574,5 677641H1 2497 2780 21 359574.5 82955368 2508 2823 21 359574.5 1306109F6 2513 2815 21 359574.5 130610976 2515 2787 21 359574.5 82985090 2523 2815 21 359574.5 4509027H1 2523 2796 21 359574.5 3482667H1 2525 2773 21 359574.5 81781898 2533 2819 21 359574.5 83843043 2548 2816 21 359574.5 84088596 2553 2815 21 359574.5 3203278H1 2562 2772 21 359574.5 83862263 2579 2818 21 359574.5 82783892 2589 2813 21 359574.5 81241936 2605 2815 21 359574.5 82968846 2752 2815 21 359574.5 121182H1 1243 1366 21 359574.5 3929693H1 1258 1451 21 359574.5 3929728H1 1258 1553 21 359574.5 3929244H1 1258 1542 SEQ ID Template Component Start Stop NO: ID ID
21 359574.5 2583640H1 1299 1548 21 359574.5 3720446H1 1302 1550 21 359574.5 701602H1 1304 1583 21 359574.5 1533449H1 1349 1556 21 359574.5 3778291H1 1382 1674 21 359574.5 3444913H1 1400 1687 21 359574.5 3444961H1 1400 1679 21 359574.5 8958359 1426 1664 21 359574.5 4754535H1 1428 1647 21 359574.5 5413181H1 1438 1592 21 359574.5 4198550H1 1443 1721 21 359574.5 2310430H1 1479 1764 21 359574.5 4027760H1 1489 1759 21 359574.5 4016122H1 1535 1836 21 359574.5 8869879 1540 1599 21 359574.5 3442527H1 1567 1817 21 359574.5 4885815H1 1582 1849 21 359574.5 81275597 1609 1963 21 359574.5 4695180H1 1619 1885 21 359574.5 4695474H1 1620 1894 21 359574.5 8901597 1664 2045 21 359574.5 1007934H1 1689 2008 21 359574.5 4822784H1 1699 1898 21 359574.5 533880H1 1726 2009 21 359574.5 5273871H1 1733 1997 21 359574.5 1822559H1 1733 1991 21 359574.5 4771544H1 1736 2019 21 359574,5 957505H1 1739 1874 21 359574.5 1419462H1 1764 2012 21 359574.5 1419438H1 1764 2023 21 359574.5 5377747H1 1767 2042 21 359574,5 3090935H1 1767 2048 21 359574.5 2578414H1 1767 2041 ~
21 359574,5 3055886H 1777 1996 21 359574,5 4307872H1 1798 1913 21 359574.5 5888134H1 1809 2090 21 359574.5 5881810H1 1809 2029 21 359574.5 5881543H1 1809 2092 21 359574.5 5885336H1 1809 2092 21 359574.5 1756055H1 1832 2078 21 359574.5 175607086 1832 2190 21 359574.5 669694H1 1851 2139 21 359574.5 2819291H1 1851 2162 21 359574.5 669348H1 1851 2136 21 359574.5 4376341H1 1872 2139 21 359574.5 81815577 1876 2377 21 359574.5 5272067H1 1880 2149 21 359574.5 1713137F6 1887 2285 21 359574.5 1713137H1 1889 2114 21 359574.5 3457357H1 1894 2156 SEQ ID Template Component Start Stop NO: ID ID
21 359574.5 173730H1 1910 2114 21 359574.5 5897973H1 1917 2178 21 359574.5 5902784H1 1917 2216 21 359574.5 359622H1 1919 2162 21 359574.5 96061481 1945 2549 21 359574.5 960614H1 1945 2236 21 359574.5 1811654F6 1965 2504 21 359574.5 1811654H1 1965 2193 21 359574.5 2244848H1 2044 2311 21 359574.5 108439H 2050 2312 21 359574.5 5055320H1 2113 2403 21 359574.5 4168527H1 2115 2416 21 359574.5 993418H1 2116 2352 21 359574.5 4175578H1 2134 2428 21 359574.5 3121162H1 2142 2427 21 359574.5 1663986H1 2147 2381 21 359574.5 175607076 2173 2775 21 359574.5 2744396H1 2182 2464 21 359574.5 5052765H1 2187 2452 21 359574.5 269785776 2207 2773 21 359574.5 2597236H1 2219 2487 21 359574.5 g890239 2240 2516 21 359574.5 g944471 2245 2444 21 359574.5 g1940156 2246 2668 21 359574.5 g1940137 2246 2687 21 359574.5 345599H1 2246 2484 21 359574.5 g1941570 2246 2712 21 359574,5 34559981 2246 2815 21 359574.5 34559976 2246 2773 21 359574.5 34559986 2246 2711 21 359574,5 g944601 2257 2495 21 359574.5 337627276 2263 2783 21 359574.5 2875472H1 2286 2576 21 359574,5 5263385H1 2291 2476 21 359574,5 5263484H1 2291 2570 22 360645,5 3292408H1 459 712 22 360645.5 3316570H1 482 745 22 360645.5 2419778H1 627 854 22 360645.5 2069602F6 718 1133 22 360645.5 2069602H1 718 1005 22 360645.5 g1989917 895 1120 22 360645.5 2741388H1 919 1046 22 360645.5 3870739H1 928 1208 22 360645.5 g793668 936 1225 22 360645.5 4328833H1 949 1209 22 360645.5 g810427 1514 1829 22 360645.5 3337383H1 1563 1830 22 360645.5 4544819H1 1572 1859 22 360645.5 755269H1 1493 1731 22 360645.5 5674837H1 1503 1781 SE6~ Template Component Start Stop ID NO: ID ID
22 360645.5 4370282H1 1672 1936 22 360645,5 5622513H1 1718 1985 22 360645.5 1655614Th 1751 2297 22 360645.5 3943544H1 1865 2133 22 360645.5 5114825H1 2045 2300 22 360645.5 4003719H1 58 111 22 360645.5 3246721H1 68 332 22 360645.5 84307092 100 560 22 360645.5 1532088H1 108 298 22 360645,5 1532088F6 108 498 22 360645.5 5016056H1 116 341 22 360645.5 5730961H1 957 1236 22 360645.5 8928494 968 1138 22 360645.5 3945858H1 988 1262 22 360645.5 2757979H1 1000 1280 22 360645.5 853610H1 1008 1266 22 360645.5 858390H1 1008 1228 22 360645.5 83932189 137 556 22 360645.5 4862779H1 142 426 22 360645,5 4988340H1 237 514 22 360645.5 3460296H1 131 357 22 360645.5 750638H1 237 461 22 360645.5 4141768H1 386 657 22 360645,5 2607858Th 2162 2289 22 360645.5 492034H1 1 112 22 360645.5 3433917H1 1 243 22 360645.5 928400R6 9 371 22 360645.5 2607858H1 29 288 22 360645.5 2607858F6 29 372 22 360645.5 3111874H1 33 168 22 360645,5 3286166H2 33 137 22 360645.5 3346552H1 33 146 22 360645.5 928400H1 35 296 22 360645.5 3392281H1 40 321 22 360645.5 2562696H1 1447 1749 22 360645.5 2562696R6 1447 1930 22 360645.5 1655614F6 1468 2026 22 360645,5 1655614H1 1468 1602 22 360645.5 3780371H1 1479 1725 22 360645.5 3674986H1 1482 1626 22 360645.5 4294260H1 1490 1738 22 360645.5 5424404H1 1492 1695 22 360645,5 4118032H1 1010 1193 22 360645.5 3484111H1 1011 1329 22 360645.5 3749318H1 1089 1394 22 360645.5 82139442 1114 1465 22 360645.5 8813345 1194 1462 22 360645.5 2185958F6 1196 1667 22 360645.5 2185958H1 1196 1475 22 360645.5 5471220H1 1268 1469 SE9 ID Template Component Start Stop NO: ID ID
22 360645.5 4907477H1 1282 1514 22 360645.5 4931374H1 1291 1569 22 360645.5 5554128H1 1307 1579 22 360645.5 3852884H1 1316 1599 22 360645.5 2605946H1 1430 1682 22 360645.5 2605946F6 1430 1850 23 404145.7 1226940T6 2019 2668 23 404145.7 1384452H1 2040 2300 23 404145.7 g2849417 2162 2715 23 404145.7 g823503 2173 2683 23 404145.7 3406347H1 2172 2452 23 404145,7 999039Th 2184 2670 23 404145.7 1540442H1 2182 2421 23 404145.7 g982396 2199 2455 23 404145,7 g712667 2199 2485 23 404145.7 g1981065 2198 2524 23 404145.7 515954H1 2206 2479 23 404145.7 1422474H1 2212 2431 23 404145.7 1422482H1 2212 2425 23 404145.7 2059115H1 2218 2298 23 404145.7 5675554H1 2212 2487 23 404145.7 4296263H1 2231 2519 23 404145.7 g3958774 2305 2714 23 404145.7 g3848380 2304 2711 23 404145.7 g2254693 2310 2711 23 404145.7 3461604H1 1327 1395 23 404145.7 4695473H1 1331 1607 23 404145.7 4874584H1 1350 1628 23 404145.7 4787505H1 1176 1448 23 404145.7 255532H1 1351 1453 23 404145.7 2634636H1 1355 1622 23 404145.7 g832545 1379 1449 23 404145.7 4115082H1 1181 1460 23 404145.7 3782056H1 1386 1713 23 404145.7 g706330 1182 1437 23 404145,7 g2156249 1209 1450 23 404145.7 g567479 1209 1446 23 404145,7 g4327617 1215 1446 23 404145,7 3453995H1 1439 1718 23 404145.7 5085837H1 1440 1592 23 404145.7 g868972 1221 1465 23 404145.7 1623692H1 1263 1452 23 404145.7 388050H1 1276 1448 23 404145.7 494624H1 1454 1689 ' 23 404145.7 1209507H1 1458 1685 23 404145.7 g573709 1284 1576 23 404145.7 g872902 1297 1625 23 404145.7 g2156298 1300 1447 23 404145.7 120950781 1458 2035 23 404145.7 5849810H1 1322 1615 SEQ ID Template Component Start Stop NO: ID ID
23 404145.7 2716195H1 1460 1573 23 404145,7 4854635H1 1326 1576 23 404145.7 3875565H1 1477 1783 23 404145.7 4764440H1 1487 1750 23 404145,7 4764803H1 1487 1776 23 404145.7 504658H1 1492 1716 23 404145.7 2245901H1 1492 1745 23 404145.7 1554072H1 1522 1749 23 404145.7 4306748H1 1522 1648 23 404145.7 681646H1 1599 1730 23 404145.7 3397784H1 1660 1877 23 404145.7 4775418H1 1709 1991 23 404145.7 4320445H1 1743 2009 23 404145.7 5516752H1 1748 1890 23 404145.7 g1300713 1768 1930 23 404145.7 g2022370 1777 2020 23 404145.7 3573326H1 1779 2074 23 404145.7 2365670F6 983 1446 23 404145.7 4080981H1 990 1144 23 404145.7 g3694292 989 1450 23 404145.7 2365670H1 983 1211 23 404145.7 g4187437 990 1449 23 404145.7 197970176 989 1407 23 404145.7 g1941609 991 1450 23 404145.7 1979701H1 989 1100 23 404145.7 g2401947 999 1447 23 404145.7 g4175914 1010 1446 23 404145.7 g4186516 1012 1446 23 404145.7 5903586H1 243 372 23 404145.7 5895277H1 243 542 23 404145.7 713562H1 264 456 23 404145.7 1859327H1 283 553 23 404145.7 g2240756 298 640 23 404145.7 3802569H1 377 675 23 404145.7 3801769H1 376 685 23 404145.7 4160262H1 403 663 23 404145.7 3386012H1 417 669 23 404145.7 3672136H1 430 701 23 404145.7 3225464H1 446 551 23 404145.7 g1376475 496 934 23 404145,7 4125118H1 555 694 23 404145.7 2957060H1 594 885 23 404145.7 3615068H1 595 900 23 404145,7 5290436H1 596 868 23 404145.7 3035696F6 601 1194 23 404145.7 3035696H1 601 897 23 404145.7 2538441H1 650 866 23 404145.7 1927342H1 658 924 23 404145.7 3760928H1 664 986 23 404145.7 192734276 753 1404 SEQ ID Template Component Start Stop NO: ID ID
23 404145.7 4895377H1 762 1007 23 404145.7 2956245H1 792 1071 23 404145.7 3343627H1 800 1065 23 404145.7 3535153H1 804 1024 23 404145.7 g2558289 815 1224 23 404145.7 231872F1 894 1446 23 404145.7 g2080439 930 1431 23 404145.7 86685681 953 1577 23 404145.7 866856H1 954 1267 23 404145.7 g3230192 957 1458 23 404145.7 g4076020 965 1450 23 404145.7 g2080362 964 1449 23 404145.7 2775965H1 973 1254 23 404145.7 3729250H1 973 1309 23 404145.7 g4453632 976 1446 23 404145.7 g4137344 977 1446 23 404145.7 2365670T6 976 1402 23 404145.7 2208265H1 981 1247 23 404145.7 5067178H1 973 1228 23 404145.7 2258456H1 983 1254 23 404145.7 1809649F6 1 446 23 404145.7 1809649H1 1 236 23 404145.7 g868971 18 380 23 404145.7 g766530 18 261 23 404145,7 3753077H1 69 380 23 404145,7 3212973H1 103 385 23 404145,7 3504947H1 110 414 23 404145.7 5287655H1 184 359 23 404145.7 92991481 220 782 23 404145.7 929914H1 220 443 23 404145.7 4615617H1 1909 2168 23 404145,7 1304785H1 1912 2125 23 404145.7 5832281H1 1844 2103 23 404145.7 809035H1 1989 2155 23 404145.7 179371686 1996 2294 23 404145.7 1793716H1 1996 2260 23 404145.7 2562614H1 2007 2225 23 404145.7 2952424H1 1876 2161 23 404145.7 3282561H1 2012 2272 23 404145.7 2955893H1 1876 2137 23 404145.7 122694086 2014 2233 23 404145.7 1226940H1 2014 2270 23 404145.7 674047H 2017 2299 23 404145.7 675500H1 2017 2292 23 404145.7 g982397 2454 2704 23 404145.7 83003541 2472 2708 23 404145.7 8566129 2520 2706 23 404145.7 82022554 2549 2711 23 404145.7 808819H1 2625 2711 23 404145.7 1719821H1 2323 2479 SEQ ID Template Component Start Stop NO: ID ID
23 404145.7 83849700 2323 2720 23 404145.7 1652087Th 2323 2672 23 404145.7 1719821F6 2323 2673 23 404145.7 914198H1 2330 2630 23 404145.7 5779135H1 2329 2596 23 404145.7 83895240 2356 2712 23 404145.7 3410322H1 2369 2613 23 404145.7 82254107 2370 2712 23 404145.7 3035696Th 2372 2673 23 404145.7 8872903 2394 2719 23 404145.7 83899723 2414 2712 23 404145.7 81754350 2415 2704 23 404145.7 84451440 2429 2712 23 404145.7 3105351H1 2437 2704 23 404145.7 82278302 1017 1445 23 404145.7 84264482 1018 1446 23 404145.7 82167436 1016 1446 23 404145.7 82569624 1016 1446 23 404145.7 83785423 1022 1446 23 404145.7 83446161 1023 1446 23 404145.7 83757074 1031 1453 23 404145.7 4894986H1 1036 1338 23 404145.7 g 1332103 1031 1454 23 404145.7 84108387 1032 1446 23 404145.7 8674079 1041 1448 23 404145.7 4605744H1 1063 1335 23 404145.7 4605666H1 1063 1339 23 404145.7 3270540H1 1068 1326 23 404145.7 1624105H1 1083 1264 23 404145.7 81376427 1088 1447 23 404145.7 82809882 1103 1446 23 404145.7 1339468H1 1128 1390 23 404145.7 1340790H1 1128 1360 23 404145.7 3272590H1 1128 1397 23 404145.7 4583083H1 1135 1407 23 404145.7 84077930 1135 1453 23 404145.7 8817212 1153 1450 24 480119.1 2352304H1 739 946 24 480119.1 3758378H1 1117 1297 24 480119.1 2094276H1 900 1179 24 480119.1 3280967H1 806 1056 24 480119.1 342432H1 940 1165 24 480119.1 2082987H1 906 1175 24 480119.1 5499718H1 1123 1223 24 480119.1 3374480H1 972 1247 24 480119.1 2715270H1 734 1001 24 480119.1 670230H1 802 1052 24 480119.1 2860379H1 964 1231 24 480119.1 3792137H1 848 1151 24 480119.1 2860343H1 964 1210 SE9 ID Template Component Start Stop NO: ID ID
24 480119.1 997621H1 959 1209 24 480119.1 3055163H1 949 1191 24 480119.1 998148H1 1 280 24 480119.1 1908860F6 121 498 24 480119.1 1908860H1 121 226 24 480119.1 5639607H1 455 586 24 480119.1 3003224H1 516 790 24 480119.1 1229820H1 711 819 24 480119,1 g4307656 724 1062 24 480119.1 g3336553 744 1112 24 480119.1 3153981H1 806 1078 24 480119.1 669605H1 807 1071 24 480119.1 3376935H1 849 1097 24 480119.1 1636772F6 855 1316 24 480119.1 2579416H1 863 1102 24 480119,1 668857H1 967 1069 24 480119,1 4252513H1 968 1126 24 480119.1 163677276 1135 1336 24 480119.1 4066993H1 757 1016 24 480119,1 1945549H1 591 817 24 480119.1 1672355H1 994 1205 25 480951.5 3507776H1 1269 1599 25 480951.5 4822022H1 1279 1597 25 480951.5 g1980640 1281 1642 25 480951.5 g1227074 1282 1672 25 480951.5 635081H1 1281 1577 25 480951.5 g2525370 1282 1667 25 480951.5 g2224141 1287 1673 25 480951.5 633976H1 1295 1566 25 480951.5 g 1813260 1304 1683 25 480951.5 g3673968 1303 1667 25 480951.5 g1141351 1306 1674 25 480951.5 5733042H1 1306 1556 25 480951.5 4115350H1 1306 1589 25 480951.5 500639H1 1307 1589 25 480951.5 g3891298 1311 1670 25 480951.5 g1718633 1315 1675 25 480951.5 g1401801 1316 1669 25 480951.5 g989254 1317 1682 25 480951.5 g2070629 1318 1684 25 480951.5 g698987 1325 1714 25 480951.5 g698871 1325 1642 25 480951.5 g 1319182 1325 1781 25 480951.5 g2898680 1325 1767 25 480951.5 g2806772 1327 1547 25 480951.5 3359017H1 1249 1564 25 480951,5 g4089542 1255 1669 25 480951.5 765793H1 1260 1536 25 480951.5 3492863H1 1327 1629 25 480951.5 g2779619 1327 1667 SE9 ID Template Component Start Stop NO. ID ID
25 480951.5 686048H1 1327 1620 25 480951.5 g2617638 1261 1655 25 480951.5 g3677064 1263 1673 25 480951.5 3398923H1 1263 1523 25 480951.5 4729307H1 1267 1545 25 480951.5 5217308H1 1261 1532 25 480951.5 1221016H1 1328 1583 25 480951.5 2447883H1 1338 1603 25 480951.5 g1102813 1338 1697 25 480951.5 g2669446 1351 1670 25 480951.5 2048112H1 1369 1667 25 480951.5 2790672H1 1372 1695 25 480951.5 2234076H1 1375 1672 25 480951.5 3862273H1 1376 1622 25 480951.5 4247109H1 1377 1675 25 480951.5 4880414H1 1378 1671 25 480951.5 g1670201 1384 1667 25 480951.5 5077294H1 1391 1667 25 480951.5 g782958 1396 1672 25 480951.5 3142143H1 1393 1693 25 480951.5 Ob9b55H1 1400 1600 25 480951.5 g4089195 1401 1676 25 480951.5 2360852H1 1405 1684 25 480951,5 1220650H1 1416 1672 25 480951.5 g981974 1416 1648 25 480951.5 g2035110 1427 1667 25 480951,5 497474H1 1433 1647 25 480951,5 g2751121 1433 1670 25 480951.5 g 1998201 1463 1848 25 480951.5 g1996178 1463 1769 25 480951.5 2284547H1 1463 1725 25 480951.5 6013816H1 1488 1667 25 480951.5 g1067287 1496 1852 25 480951.5 g1401911 776 1312 25 480951,5 2423201H1 2372 2629 25 480951.5 g884922 2375 2737 25 480951.5 122603H1 2383 2588 25 480951.5 114097F1 2383 2736 25 480951.5 g1547877 2387 2736 25 480951.5 533580H1 2387 2655 25 480951.5 g1625895 2388 2744 25 480951.5 g892913 2389 2745 25 480951.5 4760035H1 2411 2725 25 480951.5 2029001H1 2411 2700 25 480951.5 5978765H1 2410 2729 25 480951.5 g3076031 2412 2739 25 480951.5 1288402H1 2417 2690 25 480951.5 g 1240606 2425 2736 25 480951,5 3729607H1 2426 2723 25 480951.5 g1740278 2437 2742 SEQ ID Template Component Start Stop NO: ID ID
25 480951.5 g 1690726 2453 2737 25 480951.5 g1070677 2455 2736 25 480951.5 g1505473 2455 2736 25 480951.5 565823H1 2457 2695 25 480951.5 564237H1 2457 2719 25 480951.5 g3784617 2458 2739 25 480951.5 g4292869 2458 2723 25 480951.5 501474H1 2457 2680 25 480951.5 532322H1 2463 2744 25 480951.5 g1114717 2474 2739 25 480951.5 g990510 2478 2730 25 480951.5 g 1271273 2490 2741 25 480951,5 g796298 2493 2745 25 480951.5 g4137432 2508 2737 25 480951,5 2907345H1 2514 2736 25 480951.5 g4389704 2523 2736 25 480951,5 865791T1 2543 3032 25 480951,5 865791H1 2543 2787 25 480951,5 2042379H1 2589 2733 25 480951.5 2412014H1 2608 2736 25 480951.5 3934970H1 2609 2742 25 480951.5 g4532798 2613 2736 25 480951.5 g3919950 2618 2736 25 480951.5 2108271H1 2638 2736 25 480951.5 5921804H1 2644 2736 25 480951.5 4020876H1 2665 2736 25 480951.5 g2070432 724 1019 25 480951.5 3579019H1 740 1053 25 480951.5 376204H1 747 1026 25 480951.5 1672679H1 751 878 25 480951.5 2839053H1 753 1032 25 480951,5 4192530H1 763 1028 25 480951.5 5283432H1 763 1029 25 480951.5 4575886H1 774 1052 25 480951.5 3750596H1 1 163 25 480951.5 g2056998 1 224 25 480951.5 2613688H1 9 250 25 480951.5 3541978H1 19 226 25 480951.5 3395818H1 39 330 25 480951.5 3395687H1 38 285 25 480951.5 3117868H1 70 261 25 480951.5 g2057109 161 443 25 480951.5 g2229512 237 678 25 480951.5 5542378H1 251 438 25 480951.5 3451601H1 298 471 25 480951.5 3243270H1 308 566 25 480951.5 4199125H1 308 bll 25 480951.5 466549H1 331 540 25 480951.5 3571943H1 331 479 25 480951.5 2943245H2 2145 2471 SEQ ID Template Component Start Stop NO: ID ID
25 480951.5 536022H1 2145 2426 25 480951.5 2961678H1 2154 2478 25 480951.5 2099720H1 2160 2467 25 480951.5 5875882H1 2164 2467 25 480951.5 2531822H1 2174 2510 25 480951.5 772953F1 2178 2736 25 480951.5 82820897 2184 2741 25 480951.5 1710502H1 2185 2468 25 480951.5 1291521H1 2190 2464 25 480951.5 8794676 2193 2517 25 480951.5 1916675H1 2191 2510 25 480951.5 8787672 2193 2560 25 480951.5 82204645 2197 2461 25 480951.5 82839081 2205 2711 ~
25 480951.5 2126621H1 2208 2531 25 480951.5 82156454 2210 2741 25 480951.5 82458421 2212 2739 25 480951.5 1834518H1 2217 2484 25 480951.5. 3816120H1 2219 2514 25 480951.5 82992797 2220 2736 25 480951.5 2158693H1 2224 2494 25 480951.5 81328891 2235 2746 25 480951.5 82221416 2227 2516 25 480951.5 81313752 2237 2746 25 480951.5 83648207 2237 2740 25 480951.5 708349H1 2241 2571 25 480951.5 5057841H1 2241 2545 25 480951,5 81313306 2257 2743 25 480951.5 81328885 2297 2746 25 480951,5 81319439 2304 2736 25 480951,5 82750733 2309 2725 25 480951,5 84308069 2319 2742 25 480951,5 82883660 2320 2743 25 480951,5 4698908H1 2320 2616 25 480951.5 83037326 2326 2738 25 480951.5 82162162 2337 2740 25 480951.5 3671211H1 2336 2687 25 480951.5 82051249 2337 2741 25 480951.5 3092677H1 2336 2643 25 480951.5 82841059 2337 2742 25 480951.5 5660220H1 2337 2544 25 480951.5 498999H1 2337 2551 25 480951.5 1633006H1 2337 2556 25 480951.5 3026659H1 2336 2662 25 480951.5 564552H1 2337 2576 25 480951.5 82177724 2337 2737 25 480951.5 82907272 2337 2738 25 480951.5 83427370 2337 2736 25 480951.5 83701416 2337 2735 25 480951.5 82713691 2337 2736 SEQ ID Template Component Start Stop NO: ID ID
25 480951.5 83677845 2337 2735.
25 480951.5 84137050 2337 2736 25 480951.5 84190652 2337 2736 25 480951.5 82410477 2337 2736 25 480951.5 82159482 2337 2725 25 480951.5 2024457H1 2337 2573 25 480951.5 497715H1 2338 2641 25 480951.5 4972011H1 2337 2572 25 480951.5 3889752H1 2337 2600 25 480951.5 84307373 2337 2737 25 480951.5 8923082 2341 2732 25 480951.5 g 1319066 2350 2742 25 480951.5 1369972H1 2367 2620 25 480951.5 168757H1 1502 1860 25 480951.5 146107H1 1517 1705 25 480951,5 4175742H1 1513 1829 25 480951.5 516463H1 1522 1773 25 480951.5 1837209H1 1541 1754 25 480951.5 5104267H1 1548 1851 25 480951.5 81493944 1549 1682 25 480951.5 4828067H1 1560 1843 25 480951.5 3626933H1 1560 1675 25 480951.5 4827669H1 1560 1763 25 480951.5 802254H1 1571 1839 25 480951.5 5733222H1 1573 1667 25 480951.5 1833804H1 1572 1840 25 480951.5 1834116H1 1599 1830 25 480951.5 1834116R6 1599 2021 25 480951.5 2267528H1 1600 1776 25 480951.5 82047293 1601 2121 25 480951.5 4316354H1 1601 1957 25 480951.5 2531080H1 1614 1859 25 480951.5 3549819H1 1626 1873 25 480951.5 4405261H1 1664 1936 25 480951.5 259520276 1667 2181 25 480951.5 2443532H1 1670 1916 25 480951.5 82205045 1689 2201 25 480951.5 4652128H1 1711 1862 25 480951.5 82178101 1716 2097 25 480951.5 4540165H1 1743 2004 25 480951.5 019674H1 1751 1969 25 480951.5 5777532H1 1751 2031 25 480951.5 4247819H1 1751 2025 25 480951.5 4244210H1 1751 2022 25 480951.5 139108H1 1751 2091 25 480951.5 136508781 1765 2020 25 480951.5 4872832H1 1766 2045 25 480951.5 4182858H1 1766 2029 25 480951.5 1365087H1 1766 2008 25 . 480951.5 2500845H1 1774 2016 SEB ID Template Component Start Stop NO; ID ID
25 480951.5 3270008H1 1787 2060 25 480951.5 3026939H1 1801 1902 25 480951.5 1970095F6 1808 2308 25 480951.5 1970095H1 1808 2104 25 480951.5 451299H1 1823 2050 25 480951.5 g 1367292 1825 2249 25 480951.5 3400713H1 1828 1918 25 480951.5 5035969H1 1856 2063 25 480951.5 g2986154 1859 2230 25 480951.5 77295381 1859 2460 25 480951.5 772953H1 1859 2099 25 480951.5 3478925H1 1862 2201 25 480951.5 499186H1 1864 1957 25 480951.5 497679H1 1871 2087 25 480951.5 499991H1 1871 2088 25 480951.5 5119583H1 1894 2180 25 480951.5 g3739696 1903 2235 25 480951.5 5013206H1 1910 2182 25 480951.5 2506884H1 1911 2150 25 480951.5 4728147H1 1911 2162 25 480951.5 2506516H1 1911 2154 25 480951.5 g922543 1923 2226 25 480951.5 g885013 1923 2312 25 480951.5 1220669H1 1928 2075 25 480951.5 3376313H1 1933 2196 25 480951.5 4816025H1 1934 2190 25 480951.5 g2208341 1941 2229 25 480951,5 633621H1 1947 2203 25 480951,5 g2005941 1953 2215 25 480951.5 3882972H1 1967 2274 25 480951,5 g3678005 1967 2227 25 480951,5 4881031H1 1967 2245 25 480951,5 g1102777 1976 2199 25 480951,5 2695882H1 1983 2290 25 480951.5 g2016849 1983 2261 25 480951.5 4607680H1 1986 2257 25 480951.5 3480738H1 1991 2125 25 480951.5 g1506305 2019 2162 25 480951.5 633694H1 2022 2300 25 480951.5 4210591H1 2027 2317 25 480951.5 4758948H1 2028 2334 25 480951.5 563634H1 2039 2256 25 480951.5 1541096H1 2049 2203 25 480951.5 4060004H1 2052 2340 25 480951.5 197009576 2057 2694 25 480951.5 183411676 2057 2689 25 480951.5 2594078H1 2062 2308 25 480951.5 2452635H1 2067 2319 25 480951,5 2134382H1 2082 2275 25 480951.5 4858857H1 2084 2408 SE6~ Template Component Start Stop ID NO: ID ID
25 480951.5 4767365H1 2083 2401 25 480951.5 2289353H1 2085 2322 25 480951.5 1818948H1 2085 2401 25 480951.5 1818322H1 2085 2308 25 480951.5 2972228H2 2086 2308 25 480951.5 2969484H1 2087 2415 25 480951.5 1720287H1 2095 2322 25 480951.5 81690725 2095 2526 25 480951.5 3702645H1 2105 2416 25 480951.5 625400H1 2105 2308 25 480951.5 3093179H1 2105 2407 25 480951.5 5375221H1 2142 2426 25 480951.5 3228787H1 2143 2261 25 480951.5 83959433 1122 1538 25 480951.5 5004750H1 1127 1317 25 480951.5 2508409H1 1131 1244 25 480951.5 2073090H1 1131 1460 25 480951.5 2875436H1 1130 1406 25 480951.5 5574295H1 1134 1401 25 480951.5 069957H1 1135 1359 25 480951.5 81720206 1141 1667 25 480951,5 82903027 1144 1664 25 480951.5 2964463H1 1147 1500 25 480951.5 81425708 1165 1667 25 480951.5 84152996 1175 1667 25 480951.5 83693187 1178 1667 25 480951.5 84152993 1178 1667 25 480951.5 679425H1 1181 1468 25 480951.5 630229H1 1186 1458 25 480951.5 82659963 1190 1609 25 480951.5 83678646 1190 1680 25 480951.5 4060761H1 1193 1488 25 480951,5 82161517 1193 1664 25 480951.5 2126237H1 1193 1470 25 480951.5 83366968 1197 1667 25 480951,5 84079071 1198 1676 25 480951.5 83675935 1199 1673 25 480951,5 83174345 1199 1672 25 480951,5 378369H1 1200 1467 25 480951,5 451941H1 1203 1427 25 480951.5 81126660 1203 1666 25 480951,5 82409946 1201 1665 25 480951.5 82836409 1204 1676 25 480951.5 4380896H1 1205 1426 25 480951.5 82167291 1205 1676 25 480951.5 8990603 1208 1624 25 480951.5 81721518 1208 1682 25 480951.5 82785589 1209 1667 25 480951.5 83884848 1214 1675 25 480951.5 82161366 1216 1667 SEQ ID Template Component Start Stop NO; ID ID
25 480951.5 82714918 1220 1607 25 480951.5 510978H1 1224 1467 25 480951.5 82741372 1226 1682 25 480951.5 1648008H1 1229 1467 25 480951.5 1648031H1 1229 1456 25 480951.5 2860452H1 1229 1532 25 480951.5 2044321H1 1230 1493 25 480951.5 4216861H1 1230 1528 25 480951.5 88026181 1246 1854 25 480951.5 880261H1 1246 1589 25 480951.5 497500H1 1247 1588 25 480951.5 562595H '\ 1247 1491 25 480951.5 390816H1 '1247 1513 25 480951.5 3336103H1 1248 1539 25 480951.5 85582881 655 1282 25 480951.5 855828H1 655 901 25 480951.5 l6bOl1bH1 662 903 25 480951.5 4459507H1 664 939 25 480951.5 8892912 664 1073 25 480951.5 1660036H1 662 807 25 480951.5 2737280H1 667 927 25 480951.5 2243455H1 666 953 25 480951.5 3051410H1 678 1002 25 480951.5 8892899 685 983 25 480951.5 1255907H1 715 969 25 480951.5 2687937H1 720 980 25 480951.5 2271346H1 722 999 25 480951,5 3373291H1 332 592 25 480951.5 5292779H2 332 602 25 480951.5 82013066 334 618 25 480951.5 2235148F6 335 829 25 480951.5 2235148H1 335 596 25 480951.5 82035111 335 522 25 480951.5 4891424H1 336 638 25 480951.5 5593759H1 338 591 25 480951.5 3390870H1 340 659 25 480951.5 1360005F1 342 875 25 480951.5 2913426H1 342 624 25 480951.5 4770833H1 341 626 25 480951.5 3250802H1 341 670 25 480951.5 1360005H1 342 601 25 480951.5 4023870H1 342 625 25 480951.5 81998895 343 510 25 480951.5 4161775H1 343 605 25 480951.5 4031302H1 342 614 25 480951.5 3778265H1 342 677 25 480951.5 4843784H1 345 640 25 480951.5 3533957H1 347 688 25 480951.5 451527H1 349 499 25 480951.5 4618672H1 349 614 SEQ ID Template Component Start Stop NO: ID ID
25 480951.5 g2669182 350 825 25 480951.5 g1277584 354 894 25 480951.5 3321371H1 354 659 25 480951.5 2581094H1 355 608 25 480951.5 4729423H1 355 520 25 480951.5 g1799076 359 866 25 480951.5 2457980H1 359 613 25 480951.5 5538138H1 361 523 25 480951.5 3123678H1 357 683 25 480951.5 3123878H1 357 553 25 480951.5 3591022H1 361 693 25 480951.5 3987391H1 362 656 25 480951.5 5391147H1 362 688 25 480951.5 3593512H1 362 715 25 480951.5 407591H1 363 527 25 480951.5 2650347H1 362 618 25 480951.5 1320037H1 362 652 25 480951.5 595420H1 362 628 25 480951.5 2719839H1 362 637 25 480951.5 2885143H1 364 649 25 480951.5 3538760H1 363 592 25 480951.5 4205158H1 362 667 25 480951.5 5064082H1 364 594 25 480951.5 4160969H1 364 672 25 480951.5 3394195H1 364 654 25 480951.5 5542680H1 363 598 25 480951.5 4067217H1 365 659 25 480951.5 1989538H1 367 723 25 480951.5 5395039H1 366 657 25 480951.5 3385558H1 367 659 25 480951.5 3574186H1 367 665 25 480951,5 3765155H1 367 711 25 480951.5 5538463H2 366 572 25 480951.5 1371886H1 367 607 25 480951,5 3291484H1 785 1029 25 480951,5 3984729H1 795 982 25 480951.5 g1303165 796 1092 25 480951,5 3678810H1 803 1029 25 480951.5 3441626H1 804 1029 25 480951.5 3674810H1 805 1005 25 480951.5 1909062H1 806 1029 25 480951.5 g782156 819 1142 25 480951.5 3322168H1 834 1141 25 480951.5 5661420H1 775 1049 25 480951.5 3825020H1 783 1029 25 480951.5 5538458H2 837 997 25 480951.5 754038H1 839 1029 25 480951.5 5516018H1 839 1029 25 480951.5 1727177H1 839 1029 25 480951.5 75403881 839 1469 SEQ ID Template Component Start Stop NO: ID ID
25 480951.5 999590H1 845 1029 25 480951.5 2780282H1 855 1029 25 480951.5 g2167709 862 1417 25 480951.5 2100719H1 876 1136 25 480951.5 3532184H1 890 1182 25 480951.5 2935763H1 890 1196 25 480951.5 g1844616 891 1232 25 480951.5 g1720287 892 1280 25 480951.5 5212745H1 895 1086 25 480951.5 g897017 902 1334 25 480951.5 341998H1 907 1167 25 480951.5 g2025152 911 1204 25 480951.5 083270H1 918 1140 25 480951,5 2435281H1 955 1204 25 480951.5 g1328982 969 1408 25 480951.5 3837044H1 970 1255 25 480951.5 1600531H1 973 1209 25 480951.5 2235148Th 1062 1629 25 480951.5 84234881 1062 1639 25 480951.5 2042383H1 1067 1375 25 480951.5 2376168H1 1069 1226 25 480951.5 2043947H1 1067 1363 25 480951.5 3217005H1 1069 1341 25 480951.5 2374982H1 1069 1266 25 480951.5 2376160H1 1069 1231 25 480951,5 5471168H1 1069 1273 25 480951,5 054106H1 1069 1255 25 480951,5 1719624H1 1069 1229 25 480951.5 842348H1 1069 1294 25 480951.5 2374615H1 1069 1261 25 480951,5 3170061H1 1069 1319 25 480951.5 5158959Th 1071 1642 25 480951.5 1330830H1 1090 1355 25 480951.5 2350109H1 1103 1315 25 480951,5 453412H1 1109 1211 25 480951.5 3421220H1 1115 1377 25 480951.5 507765H1 1118 1339 25 480951.5 1988757Th 1117 1617 25 480951.5 g1163670 451 632 25 480951.5 2779615H1 479 774 25 480951.5 3211910H1 481 620 25 480951.5 2232343H1 498 762 25 480951.5 g1494000 498 688 25 480951.5 g1670312 497 784 25 480951.5 2705619H1 498 797 25 480951.5 g1278591 498 665 25 480951.5 g1721860 498 940 25 480951.5 g989068 508 801 25 480951.5 g1809515 527 1029 25 480951.5 2944225H1 537 875 SE6~ Template Component Start Stop ID NO: ID ID
25 480951.5 2544567H2 534 828 25 480951.5 24994b8H1 541 840 25 480951.5 1592175H1 544 772 25 480951.5 1591703H1 544 770 25 480951.5 4176769H1 545 750 25 480951.5 8115b402 547 807 25 480951.5 3322962H1 554 866 25 480951.5 3331328H1 562 726 25 480951.5 3470714H1 560 853 25 480951.5 3214025H1 5b9 847 25 480951.5 037805H1 572 775 25 480951.5 5401247H1 576 884 25 480951.5 5410853H1 575 857 25 480951.5 5695792H1 620 892 25 480951.5 5294959H1 621 891 25 480951.5 84310946 625 1135 25 480951.5 83178543 627 1019 25 480951.5 452965H1 628 866 25 480951.5 3111016H1 632 748 25 480951.5 5208639H1 632 924 25 480951.5 84194092 641 990 25 480951.5 98678581 644 1138 25 480951.5 986785H1 644 883 25 480951.5 81687504 654 1111 25 480951.5 81064548 657 1032 25 480951.5 3504819H1 369 704 25 480951.5 3800372H1 3b7 682 25 480951.5 2448255H1 367 b21 25 480951.5 2599377H1 366 661 25 480951.5 274195bH1 367 640 25 480951.5 4374001H1 367 688 25 480951.5 2520140H1 369 622 25 480951.5 3751944H1 368 588 25 480951.5 4786273H2 368 5b1 25 480951:5 2878674H1 370 668 25 480951.5 3119978H1 370 667 25 480951.5 204764bH1 370 648 25 480951.5 4170133H1 370 679 25 480951.5 8981973 372 660 25 480951.5 2898280H1 371 596 25 480951,5 3363180H1 370 650 25 480951,5 82025536 372 690 25 480951,5 81198636 372 734 25 480951.5 3b49034H1 370 547 25 480951.5 3551711H1 372 703 25 480951.5 1346252H1 374 615 25 480951,5 2441829H1 375 601 25 480951.5 81974420 378 766 25 480951,5 81718741 379 696 25 480951.5 3745122H1 378 714 SE9 ID NO: Template Component Start Stop ID ID
25 480951.5 491592H1 380 540 25 480951.5 2921720H1 380 6b9 25 480951.5 650429H1 380 639 25 480951.5 5224b48H1 381 485 25 480951.5 3331491H1 382 646 25 480951.5 4770049H1 388 686 25 480951.5 82166364 390 811 25 480951.5 5589241H1 390 636 25 480951.5 5542605H1 392 629 25 480951.5 2742261H1 394 688 25 480951.5 5395040H1 393 688 25 480951.5 1579085H1 394 592 25 480951.5 81147442 397 762 25 480951.5 372b996H1 404 727 25 480951.5 81146694 404 792 25 480951.5 3647806H1 403 758 25 480951.5 2133705H1 402 688 25 480951.5 1423332H1 404 669 25 480951.5 2020306F6 404 842 25 480951.5 81978134 404 754 25 480951.5 81625996 404 807 25 480951.5 202030bH1 404 716 25 480951.5 810b8989 408 782 25 480951.5 3541b74H1 409 753 25 480951.5 2664883H1 407 682 25 480951.5 2535301H1 407 675 25 480951.5 81313751 408 760 25 480951.5 81367340 409 852 25 480951.5 81972153 411 675 25 480951.5 3247844H1 410 739 25 480951.5 5545462H1 410 629 25 480951.5 81425731 411 952 25 480951.5 3140608H1 410 727 25 480951.5 4415741H1 412 699 25 480951.5 5545632H1 413 665 25 480951.5 5041074H1 434 715 25 480951.5 1236401Fb 444 920 25 480951.5 123b075F1 444 1124 25 480951.5 123b075H1 444 724 25 480951.5 4747674H1 402 706 25 480951.5 35b5518H1 401 740 25 480951.5 4174839H1 402 717 25 480951.5 4418643H1 402 695 25 480951.5 2729711H1 403 690 25 480951.5 3326928H1 403 703 25 480951.5 4822b53H1 402 697 25 480951.5 198875786 404 842 25 480951.5 3758338H1 403 732 25 480951.5 1988757H1 404 722 25 480951.5 4842127H1 403 693 SEQ Template Component Start Stop ID ID ID
NO:
26 481257.3 5091990H1 1 268 26 481257.3 4179591F6 1 484 26 481257.3 35b1b77Fb 103 511 26 481257.3 35b1b77H1 105 308 26 481257.3 g1b24544 108 400 2b 481257.3 47b5172H1 138 377 26 481257.3 4766669H1 138 352 26 481257.3 4619167H1 243 524 ' 26 481257.3 2537458H1 295 568 26 481257,3 3228346H1 330 603 26 481257.3 g19854b7 349 684 26 481257.3 21b9847Fb 499 895 26 481257.3 2169847H1 499 719 26 481257.3 2527973H1 527 884 26 481257.3 4712652H1 554 800 26 481257.3 g1997026 580 924 2b 481257.3 g199b603 580 736 2b 481257.3 g707845 629 877 2b 481257.3 3438719H1 648 902 26 481257.3 3393125H1 675 922 26 481257.3 2443235H1 693 879 26 481257.3 g220bb83 692 1113 26 481257.3 g2183347 692 952 2b 481257.3 g2142295 707 1150 2b 481257.3 3039414H1 723 989 26 481257.3 2049674H1 748 1005 26 481257,3 3354726H1 748 1038 26 481257,3 5501685H1 785 . 1050 26 481257.3 5501786H1 785 996 26 481257.3 489168H 1 788 1038 26 481257.3 4802557H1 861 1118 26 481257.3 2550396H1 873 1120 26 481257.3 g838984 907 1182 2b 481257.3 3393352H1 914 1132 26 481257.3 2b45117Fb 936 1190 2b 481257.3 2645117H1 936 1189 26 481257.3 5507207H1 937 989 26 481257.3 g19b0242 952 1533 2b 481257.3 1839873H1 1083 1324 26 481257.3 3386853H1 1099 1393 26 481257.3 5538387H1 1101 1297 26 481257,3 5539981H2 1119 1255 26 481257.3 526475H1 1160 1441 26 481257.3 g70784b 1162 1504 26 481257.3 4230254H1 1171 1358 26 481257.3 1944021H1 1184 1441 26 481257.3 065494H1 1196 1375 26 481257.3 2443315H1 1209 1452 26 481257.3 4956366H1 1217 1434 26 481257.3 1626283H1 1219 1424 SEQ ID Template Component Start Stop NO: ID ID
26 481257.3 4803693H1 1231 1418 26 481257,3 4803661H1 1231 1463 26 481257.3 2490053H1 1284 1533 26 481257.3 77490081 1290 1870 26 481257.3 774900H1 1290 1521 26 481257.3 5544123H1 1332 1470 26 481257.3 5543325H2 1332 1537 2b 481257.3 882706H1 1373 1639 26 481257.3 2135058H1 1376 1660 26 481257.3 2135057H1 1376 1660 26 481257.3 4756042H1 1378 1638 26 481257.3 3224551H2 1385 1665 26 481257.3 1837721H1 1476 1754 26 481257.3 4700765H1 1496 1767 26 481257.3 5278213H1 1625 1796 26 481257.3 4605663H1 1509 1771 26 . 481257.31258053H1 1644 1882 26 481257.3 g1332248 1519 1971 2b 481257.3 3482768H1 1667 1986 26 481257.3 3117425H1 1674 1973 26 481257.3 g2162252 1679 2116 2b 481257.3 8773044 1708 1881 26 481257.3 8773045 1709 2008 26. 481257.3 8773043 1709 1958 26 481257.3 8776171 1709 2021 26 481257.3 5633438H1 1583 1813 26 481257.3 6063131H1 1710 2045 26 481257.3 4322029H1 1712 1984 26 481257.3 1293678H1 1731 2003 26 481257,3 5633470H1 1584 1851 26 481257,3 82138927 1742 2131 26 481257.3 5697876H1 1745 2017 26 481257.3 5424544H1 1599 1865 26 481257,3 4752662H1 1764 2045 26 481257.3 265691H1 1779 2037 26 481257.3 2570491H1 1777 2038 26 481257.3 81924668 1788 2046 26 481257,3 82155625 1796 2117 26 481257.3 681712H1 1800 2072 26 481257.3 5872540H1 1813 2117 26 481257.3 8840128 1828 2129 26 481257.3 5424549H1 1599 1865 26 481257.3 4114541H1 1600 1904 26 481257.3 8838985 1833 2082 .
26 481257.3 3113085H1 1839 2137 26 481257.3 81740712 1845 2006 26 481257.3 4434102H1 1851 2116 2b 481257.3 2818414H1 1611 1919 26 481257.3 2699486H1 1876 1990 26 481257.3 2705722H1 1877 2161 SE6~ Template Component Start Stop ID NO: ID ID
26 481257.3 4164453H1 1881 2158 26 481257.3 3485863H1 1906 2199 26 481257.3 5086162H1 1920 2106 26 481257.3 301.1128H 1625 1923 26 481257.3 1341459H1 1921 2164 26 481257.3 8879545 1936 2238 26 481257.3 5408150H1 1952 2059 26 481257.3 82206845 1971 2134 26 481257.3 018589H1 1977 2279 26 481257.3 82004226 1982 2334 26 481257.3 2474254H1 1988 2230 26 481257.3 1438403H1 1997 2261 26 481257.3 1437601H1 1997 2273 26 481257.3 5154866H1 1998 2251 26 481257.3 1738907F6 2021 2405 2b 481257.3 82031584 2022 2286 26 481257.3 1738907H1 2021 2268 26 481257.3 8873349 2043 2114 26 481257.3 2219963H1 2044 2310 26 481257.3 5546018H1 2057 2260 26 481257.3 4515045H1 2062 2322 26 481257.3 3377306H1 2074 2365 2b 481257.3 81860563 2075 2168 26 481257.3 3931048H1 2082 2386 26 481257.3 655184H1 2532 2780 26 481257.3 4759972H1 2535 2830 26 481257.3 3163986H1 2546 2816 26 481257.3 2425109H1 2548 2790 26 481257.3 1724276H1 2552 2776 26 481257.3 81887641 2557 2981 26 481257,3 82820788 2558 2990 26 481257,3 5677886H1 2559 2813 26 481257.3 4904046H2 2561 2845 26 481257.3 3563946H1 2562 2858 26 481257,3 1631524H1 2562 2794 26 481257.3 3563302H1 2562 2889 26 481257,3 81859585 2571 2997 26 481257.3 1846040H1 2574 2816 26 481257.3 2771788H1 2575 2822 26 481257.3 4802918H1 2576 2839 26 481257.3 350681H1 2581 2797 26 481257.3 2325487H1 2590 2841 26 481257.3 81977173 2593 2869 26 481257.3 81892411 2593 2864 26 481257.3 3473745H1 2595 2844 26 481257.3 1863330H1 2595 2846 26 481257.3 1863330F6 2595 3145 2b 481257.3 552764H1 2619 2851 26 481257.3 2362444H1 2632 2909 26 481257.3 1745503H1 2635 2883 SEQ ID Template Component Start Stop NO: ID ID
26 481257.3 4558555H1 2639 2891 26 481257.3 532059H1 2639 2854 26 481257.3 4555552H1 2639 2860 26 481257.3 4505643H1 2651 2943 26 481257.3 3068819H1 2656 2975 26 481257.3 3171027H1 2657 2944 26 481257.3 3171088H1 2657 2938 26 481257.3 3379612H1 2660 2928 26 481257.3 84395482 2684 3050 26 481257,3 1729555H1 2685 2905 26 481257.3 292475H1 2687 3033 26 481257.3 291878H1 2687 2952 26 481257.3 3950881H1 2693 2873 26 481257,3 3012122H1 2695 2981 26 481257.3 547518H1 2695 2933 26 481257,3 4211183H1 2695 2956 26 481257,3 1314982H1 2696 2940 26 481257.3 3946155H1 2700 2877 26 481257.3 6064507H1 2727 2975 26 481257.3 2600642H1 2727 3009 26 481257.3 6064407H1 2727 3024 26 481257.3 3886104H1 2738 3000 26 481257.3 g 1893892 2738 3076 26 481257.3 040482H1 2739 2939 26 481257.3 g 1892555 2742 3039 26 481257.3 1424170H1 2746 2986 26 481257.3 81398711 2751 2874 26 481257.3 1759965H1 2762 3034 26 481257.3 81919966 2768 3113 26 481257.3 696972H1 2768 3064 26 481257,3 3202809H1 2768 3059 26 481257.3 696677H1 2768 3005 26 481257.3 2158950H1 2768 3072 26 481257.3 5167705H1 2781 2881 26 481257.3 2022007H1 2789 3057 26 481257.3 3714681H1 2802 3077 26 481257.3 3761940H1 2802 3098 26 481257.3 3919253H1 2802 3050 26 481257.3 1318693H1 2805 2891 26 481257.3 2284086H1 2829 3055 26 481257.3 1420843H1 2835 3087 26 481257.3 4092117H1 2864 3094 26 481257.3 3366654H1 2203 2492 26 481257.3 82155929 2204 2638 26 481257.3 3076013H1 2210 2508 26 481257.3 3681116H1 2238 2555 26 481257.3 1747569H1 2272 2555 26 481257.3 1459994H1 2279 2530 26 481257,3 4321951H1 2280 2557 26 481257.3 3723672H1 2280 2463 SE6~ Template Component Start Stop ID NO: ID ID
26 481257.3 920433H1 2280 2595 26 481257.3 4622265H1 2285 2462 26 481257.3 338447H1 2287 2535 26 481257.3 8715010 2288 2600 26 481257.3 338842H1 2287 2501 26 481257.3 1351650H1 2288 2546 26 481257.3 1809511F6 2301 2879 2b 481257.3 1809511H1 2301 2557 26 481257.3 1553819H1 2306 2506 26 481257.3 3686776H1 2309 2607 26 481257.3 3089582H1 2315 2616 26 481257.3 4903640H1 2327 2616 26 481257.3 1807852H1 2334 2472 26 481257.3 1603388H1 2346 2556 26 481257.3 2585721H1 2346 2608 26 481257.3 490934H1 2347 2614 26 481257.3 4861461H1 2347 2602 26 481257.3 3738138H1 2362 2656 26 481257.3 3749039H1 2368 2654 26 481257.3 2411583H1 2383 2619 26 481257.3 1524008H1 2391 2650 26 481257.3 291952H1 2393 2726 26 481257.3 5569863H1 2396 2629 26 481257.3 658020H1 2399 2657 26 481257.3 2893849H1 2398 2615 26 481257.3 1544390H1 2400 2604 26 481257.3 2440744H1 2415 2645 26 481257.3 2185706H1 2427 2711 26 481257.3 81687360 2442 2876 26 481257.3 4904656H2 2457 2731 26 481257,3 3929576H1 2460 2755 26 481257,3 2743452H1 2479 2746 26 481257.3 2441476H1 2479 2708 26 481257,3 4558022H1 2511 2784 26 481257.3 4073134H1 2512 2712 26 481257.3 2188345H1 2519 2793 26 481257,3 4375649H1 2523 2788 26 481257.3 81860487 2524 2741 26 481257.3 2618351H1 2531 2774 26 481257.3 4880013H1 3083 3371 26 481257.3 3931126H1 2082 2372 26 481257.3 2156566H1 2092 2377 26 481257.3 3931010H1 2082 2262 26 481257.3 5156451H1 2112 2368 26 481257.3 5779103H1 2082 2363 26 481257.3 667400H1 2093 2357 26 481257.3 81898178 2093 2458 26 481257.3 663114H1 2123 2398 26 481257.3 663147H1 2123 2406 26 481257.3 4758209H1 2124 2413 SEQ ID Template Component Start Stop NO: ID ID
26 481257,3 2797741H1 2128 2388 26 481257,3 5205492H2 2135 2389 26 481257.3 528572H1 2138 2414 26 481257.3 2495479H1 2139 2385 26 481257.3 4513333H1 2154 2422 26 481257.3 3771907H1 2167 2496 26 481257.3 5208347H1 2180 2439 26 481257.3 1390911H1 2187 2445 i 4., ~ o ~>
w ~ , o ~ ~ ~ ~ o o ~
o II A, ~ b ~ ~ ~? II ~'? a Q' 'b ~ W
O
~
C 5 H y ~ ~ ~ A, ~ p O
' ~
~
L' ~ ~' y c C ~ ~
a~ ~ ~ .~ b ~ ~ y > w b >
"" t!
W m '' m w. O II ~
~ ~ O c ~ b C1 'fl ~ ~i eca O ~
~ ~ O
~ ~ v ~ ~ :e O ~ ~ p C ai .
E W > C
V ~ ,~ . O O , fi7 W c~ ~ ~ II O
tr .~ o cp ~ p c% ~ n ..: . ~ ~ c~ is ..
oa ~' ~'>', U ~' ~' ~ G7 > C O ~"~ m w cd W ~ ~ O
y:
fr .~ ~ N r ." O t-.
'" O y r.. ' y N ~
C, ~ W O fit,W ~ a ~ w~ W fx ~ W
> ~L 'w~ a. b w U
U G n .N C
~ z ~ ~
N
O ' N
yr O\ ~ w ~ .
c~ N ~l M
yy o N ~
0 O T ~ a O
U U U M ~ o ~ w 'a W f~
~ x', ~ W
a~ ~ r~~ a x ~,N
.~
V O C/7 ,~ N C C!j ~ N O
U U t~ ~ b M ~
~ _ M ~ ~ W ~ ~ x ~ ~ ~
g .~ x ? :3 ~ ~ N b ~ ~o ~ 3 ~
c v~ a ~ .r b ~ ~ ~
N b 0 ~ '~ ~ ~ ~ vi ,~ C ~ ~ Q ~
w w ~ ~x ~ a ~ ~ ~ ~ b~ "~
~
~ ~, ~ ~ _ r 'D _ Ov v ca ~a f3. o Qi U ~ ~ O M
. ~ .~
v~ ~. E- U _ U Y U O . Cn U
Y w U
~
. w , ~
w ao O O O U o a ~. ~ a x .~ ~
U O .
~ x o ~ ~
~
x W wa w a ~ . a~N~
z bb ~
:z3 ~a ~
xa~N
o . N o U
, .
v ~ ~ . ~ c ~ v ~
a ~p C V ~ ~ w n ~ o n p ~ W eC
y ~
~"
y G
~ .~
C "O 'O 4.C. U 'n ~ O U
N fti p 4. b "
, ~
ti ~ ~ C' C ~
y .b C :O c ~ pa ~ b C a C
O
C ~ ~'~' U O O U ~ U a "v~ c~ bQ ~
O" ~ cd ~ ~ U G ~
U C O ~i ~
E, _ [~ c0 c T
~ . ~ ~V7w _ a) ~ x~ O
U ~ ., ~ dp o .: .~ ~ c ~ ~ U ~ ~ C
y a :~ Q.
a~
~ vr~ ~ ~o~~ ~ ~, _o~u,~
~
J t-~ N p U ~ ~ ~ >~ ~ ~ . C
y C m G7 ~ O ~ , D
C
Uv~'~ ~ .. ~ " ~'~' V a a. c~
~ ~ U
~
U C ~ O b O c3 C _ c0 O U
y e~ 'n 4 y N C ~ U
p > '~ ~
b v' i . C v v' C O ~ ~ ~ O C ~
C ' O. ~ U N O it v~ O
a ~ O y O p C _ G , U
cd ~ ~ O n ~ 3 ,~.., G1r C_ w ~ ~ A ._ >
C ~
~ .~
y ~ ~ y V U w C ~ ~
' CC ~ O a.
GO
C p J r--~ ~
~
O ~ ~ ~ ~ ~ ~ y ~ aW C ~ ~."
.c O a~ v . c _ bD C .U O C O b0 C
a ~ ~ ~ C w U C ~. G
~
.
c~ O aG c~ O c N ~ _ C ~ a J ~ G~
~' O U i hp o-0 ~ ~
A a. ~ L~. a, U f L
C ~ ~~ . ~ o.., a~ ~
~ ~ ~ ~ ~
-a a a a a a ~a~. , ~
w a H a Q
w ~S w a Q ~ a w ~
..~ ... a Q ~ Q ~ w ~ x ci~
16~
U
~ O
, cC
W
L G]
"CI O C
~ N
O ~ id Y
, O :~
y >
. v~
O ~' O p cT~ O
O
O
CD
y ~ 'b O a c'~
>' _ c C~ ~ n 3 y U U w~ y v C O O
a: z ~ ~
t7 ~, Q
x ~.
~w= . ~ ~ o ~w~~ Wb a~~
G E" ,~ N 'C U y ~ a 01 o .y y 0.~ ' ~~ CG o' b ~ "' ~ o 'o 00 ~ ~ . C7 w C z ~ p 00 0. >, ~~ ~
a N 3 ~
~; ~ C~b N o0 ~ .~, ~ ~ '~" ~ ~v~
00 ~ s. ~ cd c0 >_ M
O Ova ~N~-. '~y ~ y ~ v '. r ct5 v G ~ 00 '~ ~ y ' ~
iC f.~ C ~ ~
y U
, _ E ~ ~v CL
o' ~3 _ 'D C N O ~ y > .
~ c" a ~ ~ .., W N y.
~ C7 v fl. ~ C G1 ~ U Q' N
-,' ' >
H
'~ ~ ~ '" 0 o ~ ~ t~
eo ,~ = 00 v ~ o.
w ~ o s ~ ~ 0.1 ' a y u ~ b U as s . . ~ ~; , c ~ r:; ~ ~ o o a '~
0 3 ~ '~ a. a~ ~ o ~ ~ ;
f1i ~ W oo ~ ~ C7 z - , C7 C7 '. rr~ a 3 u: U , ~ Z ca v~ Pa N
~ U
N c w b'' . '' s " o :3 w ~ o o .O ed ~ G ~ ~" G V N
~ ~
C
.b 0. . ~ O
a t, U G ' pr C ~' . ~ .~ ~ ~
~ O m .C
~ U ~ b 'O d " U
~ O 'b ~ U ~ G
, ~ y flJ
t" Q' U G ~ ~ ~ c~ G N
Gr ~ U
p ~p ~ ' bD C
s.
ii C cd ~ G-n 4 w b4 O O ' C N C D
U y t >, O. O
C b ~ p.
. ~ V U v N
~ O ~ ~ ~
U .C ~
O
~
N CL 4. y ~ ~ ~ W U U
U p. c0 ~
~ z ~
a~y ca w ~~ y c ~ .~ U p., ~ ~ c s ~ ., o .y ~ '_. >' .n ~ '~ E
o. ~ ~ .a ~
cG C U
~' U
au ~ .
C C ~ C ~ (~ G ~ b0 ~ ~ C
O ~ .~' ~ ~ N
L' b n N ~ 'Gr, ~ N U
p c~ c~ ~
N y ~ Q a ' a a ~ a Q~ ~ ~ ~ ~ a a ~ ~. ~ ~
U
~' .O d ~ U
O p t~. t~. ' G f~
0; w ate. 0.~ U
SEQUENCE LISTING
<110> INCYTE GENOMICS, INC.
Hodgson, David M.
Lincoln, Stephen E.
Russo, Frank D.
Spiro, Peter A.
Banville, Steve C.
Bratcher, Shawn R.
Dufour, Gerard E.
Cohen, Howard J.
Rosen, Bruce Chalup, Michael S.
Hillman, Jennifer L.
Jones, Anissa L.
Yu, Jimmy Y.
Greenawalt, Lila B.
Panzer, Scott R.
Roseberry, Ann M.
Wright, Rachel J.
Daniels, Susan E.
<120> SECRETORY MOLECULES
<130> PT-1064 PCT
<140> To Be Assigned <141> Herewith <150> 60/147,501; 60/147,500 <151> 1999-08-05; 1999-08-05 <160> 26 <170> PERL Program <210> 1 <211> 1973 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 001978.1 <400> 1 gcaggttcgg ggtcggccgg cctgcgcgtg ggcttgcgag gacgctgttc gtcccctgcg 60 ctggggtgtc cgacagcgag gaggagaacg acgcacggag cccgcgcgac tggaaccagc 120 aaagctccat ctgtcggcag aggagaaggg ggaggaggca cggccgaggc aaacgagcgg 180 acgcctcgtc gccgggtgcc ggtatcaccc cgctgcaacg ccttccagca aaagccaccg 240 cggcccgggt tgcagcagcc ggacggatgc caaggccaca cggcagccac gggggcagcc 300 gtcgcagtcg ccgtcccaca cgggctgcgg acaccaaggg ttgctaatga agtgattgag 360 aagaaacagt gaacatcctc atttcacaga taagacaaca tggatcagcc ttttactgtg 420 aattctctga aaaagttagc tgctatgcct gaccatacag atgtttccct aagcccagaa 480 gagcgagtcc gtgccctaag caagcttggt tgtaatatca ccatcagtga agacatcact 540 ccacgacgtt actttaggtc tggagtagag atggagaggt ggcgctgtgt atttggaaga 600 aggaaatttg gaaaatgcct ttgttcttta taataaattt ataaccttat ttgtagaaaa 660 gcttcctaac catcgagatt accagcaatg tgcagtacct gaaaagcagg atattatgaa 720 gaaactgaag gagattgcat tcccaaggac agatgaattg aaaaacgacc ttttaaagaa 780 atataacgta gaataccaag aatatttgca aagcaaaaac aaatataaag ctgaaattct 840 caaaaaattg gagcatcaga gattgataga ggcagaaagg aagcggattg ctcagatgcg 900 ccagcagcag ctagaatcgg agcagtttct gtttttcgaa gatcaactca agaagcaaga 960 gttagcccga ggtcaaatgc gaagtcagca aacctcaggg ctgtcagagc agattgatgg 1020 gagcgctttg tcctgctttt ccacacacca gaacaattcc ttgctgaatg tatttgcaga 1080 tcaacctaat aaaagtgatg caaccaatta tgctagccac tctcctcctg taaacagggc 1140 cttaacgcca gctgctactc taagtgctgt tcagaattta gtggttgaag gactgcgatg 1200 tgtagttttg ccagaagatc tttgccacaa atttctgcaa ctggcagaat ctaatacagt 1260 gagaggaata gaaacctgtg gaatactctg tggaaaactg acacataatg aatttactat 1320 tacccatgta attgtgccaa agcagtctgc gggaccagac tattgtgaca tggagaatgt 1380 agaggaatta ttcaatgttc aggatcaaca tgatctcctc actctaggat ggatccatac 1440 acatcccact caaactgcat ttttatccag cgttgatctt cacactcact gttcctatca 1500 actcatgttg ccagaggcca ttgccattgt ttgctcacca aagcataaag acactggcat 1560 cttcaggctc accaatgctg gcatgcttga ggtttctgct tgtaaaaaaa agggctttca 1620 tccacacacc aaggagccca ggctgttcag tatatgcaaa catgtgttgg taaaagacat 1680 aaaaataatt gtgttggatc tgaggtgata tgttctgaat gtaagcaccg tcaacatcag 1740 acacctactc atggacatgt ggttgccgga ttttcttaag atgtttccag aaatgactga 1800 tattttatat ttatacattt tagatgacaa agcttgatat ttattgctgt tgcacatttt 1860 aaagttttct ttttgggttg ctctgtgtca agagaggtta catggtgtta aatcggtacc 1920 tgataatgta cccaaatact atggccagat aataaattgt gctgcaaaca aca 1973 <210> 2 <211> 3199 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 002588.4 <400> 2 gtcccttccc ctcacccgct ccacgccctc ctgggccgag tggagttggg tggtgtcggg 60 agcctctccc tgaggggcac cgcgtcttca ggagctgggc ctccagtgcg gcgcgatgtc 120 aggcgcggtg acagctctgt gagtccgagg ccgcggccgt ggcgctgggc ggctgcgggg 180 cctgaccggt ccgctcatgg tgccgccacg acgccatcgc ggggcaggaa ggccaggggt 240 gctgagttct tcacctcctt ttagactgag atctgccaag ttttccggca ttgctcttga 300 ggatctcaga agggctctta agacaagact gcaaatggtg tgtgtatttg tcatgaaccg 360 aatgaattcc cagaacagtg gtttcactca gcgcaggcga atggctcttg ggattgttat 420 tcttctgctt gttgatgtga tatgggttgc ttcctctgaa cttacttcgt atgtttttac 480 ccagtacaac aaaccattct tcagcacctt tgcaaaaaca tctatgtttg ttttgtacct 540 tttgggcttt attatttgga agccatggag acaacagtgt acaagaggac ttcgcggaaa 600 gcatgctgct ttttttgcag atgctgaagg ttactttgct gcttgcacaa cagatacaac 660 tatgaatagt tctttgagtg aacctctgta tgtgcctgtg aaattccatg atcttccaag 720 tgaaaaacct gagagcacaa acattgatac tgaaaaaacc cccaaaaagt ctcgtgtgag 780 gttcagtaat atcatggaga ttcgacagct tccgtcaagt catgcattgg aagcaaagtt 840 gtctcgcatg tcatatcctg tgaaagaaca agaatccata ctgaaaactg tggggaaact 900 tactgcaact caagtagcga aaattagctt ttttttttgc tttgtgtggt ttttggcaaa 960 tttgtcatat caagaagcac tttcagacac acaagttgct atagttaata ttttatcttc 1020 aacttccgga ctttttacct taatccttgc tgcagtattt ccaagtaaca gtggagatag 1080 atttaccctt tctaaaacta ttagctgtaa ttttaagcat tggaggcgtt gtactggtaa 1140 acctgggcag ggtctgaaaa acctgctgga agagacacag taggttccat ttggtctctt 1200 gctggagcca tgctctatgc tgtctatatt gttatgatta agagaaaagt agatagagaa 1260 gacaagttgg atattccaat gttctttggt tttgtaggtt tgtttaatct gctgctctta 1320 tggccaggtt tctttttact tcattatact ggatttgagg acttcgagtt tcccaataaa 1380 gtagtattaa tgtgcattat cattaatggc cttattggaa cagtactctc agagttcctg 1440 tggttgtggg gctgctttct tacctcatca ttgataggca cacttgcact aagccttaca 1500 atacctctgt ccataatagc tgacatgtgt atgcaaaagg tgcagttttc ttggttattt 1560 tttgcaggag ctatccctgt atttttttca ttttttattg taactctcct atgccattat 1620 aataattggg atcctgtgat ggtgggaatc agaagaatat ttgcttttat atgcagaaaa 1680 Catcgaattc agagagttcc agaagacagc gaacagtgtg agagtctcat ttctatgcac 1740 agtgtttctc aggaggatgg agctagttag ctgtctgttg tctgtagccc agcttgataa 1800 tggaactata cagcgaagag acaatctctg gcaagttttt gtagaaaaaa tgtttcagtg 1860 cctagtctga aaaataacag tttgagttct ttgaaactct aaaatatatt tttctcatac 1920 ctgttttctt cattttcata atgaagcact ttgctatgta gctgtgtaca tatcactaca 1980 gttataggaa gtttcagtct acagtccatc caaaggacca acctgcctta cacatctcaa 2040 ggaattcagc tgttgaaatc atttgaacta atcaaggaat aaatcctaat gttctgggac 2100 tttattttca catgttaaat gctggaatat attatgaaaa tgttttcaag aaatcactta 2160 agtgttcata gaccagtatt tctgacaggt aaaatgctaa aataagctac ctgtaataag 2220 tgtggattat atttttgggt tttgtagaat attgcaaatt aaccacacaa aaaatgttta 2280 atttatgcaa caagcatgtt tgtgcaaatt tcatgggact ttaaaaagaa taagtatttg 2340 agaaaatatc tggttcactt acactacatt tactgtatta ttcttttata gcattaggtg 2400 ccttgtattt taaatctgtg acaaaccatg gcaaattttt aaaggggaag tattattata 2460 aaatgaagaa atatgtattt ctaaaggcta tattgctgta aacttaattg ataaagctct 252D
gtttaattta gagttttgaa gaaatagtct cccttcaatt aagaaatttt cataatggaa 2580 tgatttaaat tgaagtgaca aagagtatta ttaaaataca atgtttatac gtgtatttgt 2640 gtattgtaga tgtatcaagt gatttctaat ttttttcaca tatgaatgtg ccagattact 2700 ctagaactag atgtctcttc tttaaataat tttagttttc ctgaataaat ttgtaatggt 2760 taaagtacca agtaagtaag gcgagaaggg attctgtttt taaaatcaca tcagaacttt 2820 tcctctacta agattataaa ttaaatgtaa aatactccta attgcaattc ttaaacttag 2880 gccttacatg tacttattat gcaactgctc ctggactcta ttcaccatag atatcagtaa 2940 acgtatgtcc caggattcac aggcttttga ttaatcaata ttcttttcaa gtttgctgtg 3000 aagagtttag ttctcttcaa aatttcttaa ctaatctgat ttttaggaat tctctttgca 3060 gtgtttagct tcctattcac attcttaaaa ttgctttggt gttaccatga gtctaaaatg 3120 aagtttagcc ttccttttgt ttcattctga gaacttctat attatattac ctttaaaaat 3180 tgtttatgat attaaattt 3199 <210> 3 <211> 2235 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 201759.3 <400> 3 gcggcgacgg cggccgttgc tgcgccgggt actggggtcg ctgcctgagg cgcaggcgcc 60 gtggactcca cccgccccgg ggcctgggct cgctgtggac tcgtcatggc gaccgagcag 120 aggcctttcc acctggtggt gttcggcgcg tctggcttca ccggccagtt cgtgaccgag 180 gaggtggccc gggagcaggt ggacccggag cggagtcccg cctgccctgg gccgtggcgg 240 gccgctcccg ggagaagctg cagcgggtgc tggagaaggc ggccctgaag ctgggaagac 300 caacactgta catctgaagt tggaatcatc atctgtgata ttgctaatcc agcctcgctt 360 gatgaaatgg ctaaacaggc aacagttgtc ctcaattgcg taggaccata tcggttttat 420 ggagaacctg taataaaagc atgtattgaa aatggagcca gttgtatcga catcagtgga 480 gaacctcagt ttctggaact aatgcaactg aagtatcatg agaaagctgc agacaaaggg 540 gtttatatca ttggaagcag cggctttgac tccattccag cagatctggg agtaatatat 600 accagaaata aaatgaatgg tactttgact gctgtggaaa gtttcctgac tatacattca 660 ggacctgagg ggttgagcat tcatgatggt acctggaagt cagcaattta tggttttgga 720 gatcagagta atttgagaaa actaagaaat gtatcaaatc tgaaacctgt cccgctcatt 780 ggtccaaaat tgaagagaag gtggccaatt tcttattgtc gggaactcaa aggttattcc 840 attcctttta tgggatctga tgtgtctgtt gtaaggagga ctcaacgtta cttgtatgaa 900 aatttagagg aatcaccagt tcagtatgct gcgtatgtaa ctgtgggagg catcacctct 960 gttattaagc tgatgtttgc aggacttttc tttttgttct ttgtgaggtt tggaattgga 1020 aggcaacttc ctcataaaat tcccatggtt cttctccttt gggctatttt tcaaaacaag 1080 gcccaacaca aaaacagatt gatgctgcct cattcacgct gacattcttt ggtcaaggat 1140 acagccaagg cactggtaca gataagaaca aaccaaatat caaaatttgt actcaggtga 1200 aaggaccaga ggctggctat gtggctaccc ccatagctat ggttcaggca gccatgactc 1260 ttctaagtga tgcttctcat ctgcctaagg cgggcggggt cttcacacct ggagcagctt 1320 tttccaaaac aaagttgatt gacagactca acaaacacgg tattgagttt agtgttatta 1380 gcagctctga agtctaaaca ctggaagaat taactgaagt cataacgtgc gtgaattaac 1440 agcttctcta tttgatattt gaaattcttc tgtaagcctg tctgagtgta tgtggaaacg 1500 attgtcaaat ctaaaatatc tatatattaa aaagtaggaa attgtcctag cttaccctaa 1560 atttcaaatc tgagttgatt ttgtgatttt attgcttata acagagaact catatttgac 1620 atattttttt cattgatgtg ttcctggtag attttcacga atgagctggc aggtctaatg 1680 ggggaggcgg cgtcccagtc tgtgttgcag cagcattctc atcgggggtg cgcacaccat 1740 cgttactgtc gggcagtaac tgccgcttgc cttgccgcag taggagggaa atctcacctt 1800 ccttccacat actgtcttga gcctttgcta aattaaactg cactttttgc tatttttgcc 1860 tagtttttcg ccaatctaca ctgattttgg actgttacct aagttgaaaa ataaaaggtt 1920 gtcaatcgaa tggtggttta atgtttggac ctgccgatgt atttgtatag tggtagaaac 1980 atgctgctta agtggcctaa cctgtttctt gccaataagt aggcttatca ttttatcttt 2040 acgtaattct atatctgtga ctaggttttt aaggatacag cttataagtt gctatcaatt 2100 ttcactacct aagcagaatt tttctctaat ttactttttg tattttaact aggttttaca 2160 tggaagccct aaaataaggc aaaagacttt ttcttttgta ataagcatat aataaacacg 2220 tatatacata gcaaa 2235 <210> 4 <211> 1953 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 208184.1 <400> 4 gcggccgctg tagttgcggc ggtccagtcg tagcccggcc gcccgcgcct gtccggtccg 60 gtccggccac ggaggcagcg cagcggcggg actccgagcc taccccgccg agtgagctgc 120 gccgcaccgt gccgtcccac ccggcaccca ccagtccgat ggggccgcag cggcggctgt 180 cccctgccgg ggccgcccta ctctggggct tcctgctcca gctgacagcc gctcaggaag 240 caatcttgca tgcgtctgga aatggcacaa ccaaggacta ctgcatgctt tataaccctt 300 attggacagc tcttccaagt accctagaaa atgcaacttc cattagtttg atgaatctga 360 cttccacacc actatgcaac ctttctgata ttcctcctgt tggcataaag agcaaagcag 420 ttgtggttcc atggggaagc tgccattttc ttgaaaaagc cagaattgca cagaaaggag 480 gtgctgaagc aatgttagtt gtcaataaca gtgtcctatt tcctccctca ggtaacagat 540 ctgaatttcc tgatgtgaaa atactgattg catttataag ctacaaagac tttagagata 600 tgaaccagac tctaggagat aacattactg tgaaaatgta ttctccatcg tggcctaact 660 ttgattatac tatggtggtt atttttgtaa ttgcggtgtt cactgtggca ttaggtggat 720 actggagtgg actagttgaa ttggaaaact tgaaagcagt gacaactgaa gatagagaaa 780 tgaggaaaaa gaaggaagaa tatttaactt ttagtcctct tacagttgta atatttgtgg 840 tcatctgctg tgttatgatg gtcttacttt atttcttcta caaatggttg gtttatgtta 900 tgatagcaat tttctgcata gcatcagcaa tgagtctgta caactgtctt gctgcactaa 960 ttcataagat accatatgga caatgcacga ttgcatgtcg tggcaaaaac atggaagtga 1020 gacttatttt tctctctgga ctgtgcatag cagtagctgt tgtttgggct gtgtttcgaa 1080 atgaagacag gtgggcttgg attttacagg atatcttggg gattgctttc tgtctgaatt 1140 taattaaaac actgaagttg cccaacttca agtcatgtgt gatacttcta ggccttctcc 1200 tcctctatga tgtatttttt gttttcataa caccattcat cacaaagaat ggtgagagta 1260 tcatggttga actcgcagct ggaccttttg gaaataatga aaagttgcca gtagtcatca 1320 gagtaccaaa actgatctat ttctcagtaa tgagtgtgtg cctcatgcct gtttcaatat 1380 tgggttttgg agacattatt gtaccaggcc tgttgattgc atactgtaga agatttgatg 1440 ttcagactgg ttcttcttac atatactatg tttcgtctac agttgcctat gctattggca 1500 tgatacttac atttgttgtt ctggtgctga tgaaaaaggg gcaacctgct ctcctctatt 1560 tagtaccttg cacacttatt actgcctcag ttgttgcctg gagacgtaag gaaatgaaaa 1620 agttctggaa aggtaacagc tatcagatga tggaccattt ggattgtgca acaaatgaag 1680 aaaaccctgt gatatctggt gaacagattg tccagcaata atattatgtg gaactgctat 1740 aatgtgtcat tgattttcta caaatagact tcgacttttt aaattgactt ttgaattgac 1800 aatctgaaag agtcttcaat gatatgcttg caaaaatata tttttatgag ctggtactga 1860 cagttacatc ataaataact aaaacgcttt gcttttaatg ttaaagttgt gccttcacat 1920 taaataaaac atatggtctg tgtagtttcc gag ' 1953 <210> 5 <211> 1867 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 212029.3 <220>
<221> unsure <222> 54, 89, 1164, 1166-1187 <223> a, t, c, g, or other <400> 5 ctaccctgct cctcagcctg tgagaacaga tgtggccgtc ctgcggtacc agcnaccccc 60 tgagtatggg gtaacgagcc gcccatgcna acttccgttc ccatcaacca tgcagcagca 120 cagccccatg tcctcccaga cctcttccgc cagcgggcca ctgcactctg tctccctgcc 180 gcttccactc ccgatggccc tgggtgctcc acagcccccg cctgccgcct cccccagcca 240 gcagcttggt ccagatgcct ttgcgattgt ggagcgagcc cagcaaatgg tggagatatt 300 aacagaggag aaccgggtgc ttcaccagga acttcagggt tactacgaca atgccgacaa 360 gctccacaag tttgaaaaag aacttcagag aatttcggaa gcctatgaaa gtctggtcaa 420 gtctaccacc aagcgagaat cgctggacaa ggccatgaga aacaaattgg aaggcgagat 480 tagaagactt catgatttca acagagacct ccgagatcga ctagagactg ctaacaggca 540 actatccagc agggaatacg aagggcatga agacaaagct gcagaggggc attatgcttc 600 ccagaacaaa gaattcttga aggaaaagga gaaattagaa atggagttag cagcagtgcg 660 gactgcaagt gaggaccatc ggagacacat cgagatcctg gaccaggctt tgagcaacgc 720 ccaggccagg gtcatcaagc tggaagagga gttacgagag aagcaagcat atgttgagaa 780 agttgagaag ctgcagcagg ccctgaccca gctgcagtct gcatgtgaga agcgagaaca 840 gatggagcgg agactgcgga cttggctgga gagagagctg gatgcactga gaacccagca 900 gaaacatgga aatggccagc cagccaacat gccggaatac aatgccccag ccctcctgga 960 acttgtgcgg gagaaggagg agcggatcct ggccctggag gccgacatga caaagtggga 1020 gcagaagtac ctggaggaga gcaccatccg acactttgcc atgaatgccg cagccactgc 1080 agcagctgag agggacacca cgatcatcaa ccactcacgg aatggcagct acggagagag 1140 ctcgctggag gcccacatct ggcnannnnn nnnnnnnnnn nnnnnnncca acagaaggtg 1200 tcaggacatg gaatacacta ttaaaaatct ccatgccaaa atcatagaga aagatgctat 1260 gattaaggtc ctgcagcagc gatctcgtaa agatgccggg aagacagact cctccagcct 1320 acgtcctgcc cgctccgttc catccatagc agcagctact gggacacact ctcgccagac 1380 ctctcttacc agcagccagc tggctgagga aaagaaggaa gagaagacct ggaaggggag 1440 cataggattg ctgctgggga aggagcacca tgagcatgcc tctgccccac tgctgctacc 1500 cccacccacc tcagcactgt cctccatagc ctccactacg gcagccagca gtgcccacgc 1560 caagacaggc agcaaggaca gcagcacaca gactgacaag agtgccgagc tcttctggcc 1620 cagcatggcc tcccttccca gccgcggccg gctgagcacg acccctgctc acagccccgt 1680 cctgaaacac ccagcggcca aagggaccgc agagaaactg ggtatgtggg ctaccccacc 1740 ttgatgcccc tgaaaactgt ggaactgtct ggcctaagag aatcttttgt tgagctagag 1800 aggaagcagg ggcacccatc agctcttact ctatggggat gctattctaa tgcacttagg 1860 atatgtg 1867 <210> 6 <211> 1325 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 213446.2 <400> 6 cgggggctga tggaagtgca gtgggggctg gagagggcac cctagtgagt tggcttttct 60 ctccttcggt gcctttggtt gggctcgagg cccggggtcg gaggccatca ggacaagagt 120 gtgggacttg gaagggcagc cacctggagc ttggaagggg ctgtatccag catgctccaa 180 ggccacagct ctgtgttcca ggccttgctg gggaccttct tcacctgggg gatgacagca 240 gctggggcag ctctcgtgtt cgtattctct agtggacaga ggcggatctt agatggaagt 300 cttggctttg ctgcaggggt catgttggca gcttcctatt ggtctcttct ggccccagca 360 gttgagatgg ccacgtcctc tgggggcttc ggtgcctttg ccttcttccc tgtggctgtt 420 ggcttcaccc ttggagcggc ttttgtctac ttggctgacc tcctgatgcc tcacttgggt 480 gcagcagaag acccccagac ggccctggca ctgaacttcg gctctacgtt gatgaagaag 540 aagtctgatc ctgagggtcc cgcgctgctc ttccctgaga gtgaactttc catccggata 600 gacaagagtg agaatggtga ggcatatcag agaaagaagg cggcagccac tggccttcca 660 gagggtcctg ctgtccctgt gccttctcga gggaatctgg cacagcccgg cggcagcagc 720 tggaggagga tcgcactgct catcttggcc atcactatac acaacgttcc agagggtctc 780 gctgttggag ttggatttgg ggctatagaa aagacggcat ctgctacctt tgagagtgcc 840 aggaatttgg ccattggaat cgggatccag aatttccccg agggcctggc tgtcagcctt 900 cccttgcgag gggcaggctt ctccacctgg agagctttct ggtatgggca gctgagcggc 960 atggtggagc ccctggccgg ggtctttggt gcctttgccg tggtgctggc tgagcccatc 1020 ctgccctacg ctctggcctt tgctgccggt gccatggtct acgtggtcat ggacgacatc 1080 atccccgaag cccagatcag tggtaatggg aaactggcat cctgggcctc catcctggga 1140 tttgtagtga tgatgtcact ggacgttggc ctgggctagg gctgagacgc ttcggacccc 1200 gggaaaggcc atacgaagaa acagcagtgg ttggcttcta tgggacaaca agcttctttc 1260 ttcacattaa aacttttttc cttcctctct tcttcatctc attatcctga ttgactctaa 1320 ttata 1325 <210> 7 <211> 1808 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 228864.4 <400> 7 ggcgtggcct ccggccggct cctctgctgt tgccaaggga aactgccgcg aggaggcgga 60 aggagcagag gaccggcagc cggcgtcgag gcggggcgcg ggaacgacgg cggccatggc 120 ggcctcgggg cccgggtgtc gcagctggtg cttgtgtccc gaggtgccat ccgccacctt 180 cttcactgcg ctgctctcgc tgctggtttc cgggcctcgc ctgttcctgc tgcagcagcc 240 ccctggcgcc ctacgggcct cacgctgaag tccgaggccc ttcgcaactg gcaagtttac 300 aggctggtaa cctacatctt tgtctacgag aatcccatct ccctggctct gcggcgctat 360 catcatctgg cgctttgctg gcaatttcga gagaaccgtg ggcaccgtcc gccactgctt 420 cttcaccgtg atcttcgcca tcttctccgc tatcatcttc ctgtcattcg aggctgtgtc 480 atcactgtca aagctggggg aagtggagga tgccagaggt ttcaccccag tgggcctttg 540 ccatgctggg agtcaccacc gtccgttctc ggatgaggcg ggccctggtg tttggcatgg 600 ttgtgccctc agtcctggtt ccgtggctcc tgctgggtgc ctcgtggctc attccccaga 660 cctctttcct cagtaatgtc tgcgggctgt ccatcgggct ggcctatggc ctcacctact 720 gctattccat cgacctctca gagcgagtgg cgctgaagct cgatcagacc ttccccttca 780 gcctgatgag gaggatatcc gtgttcaagt acgtctcagg gtcttcagcc gagaggaggg 840 cagcccagag ccggaaactg aacccggtgc ctggctccta ccccacacag agctgccacc 900 ctcacctgtc cccaagccac cctgtgtccc agacgcagca cgccagtggt tcagaagctg 960 gcctcctggc cctccctggc acccccgggc acatgcccac cttgcctccg taccagcctg 1020 cctccggcct gtgctatgtg caagaaccac tttggtccaa accccacctc ctccagtgtc 1080 tacccagctt ctgcgggcac ctccctgggc atccagcccc ccacgcctgt gaacagccct 1140 ggcacggtgt attctggggc cttgggcaca ccaggggctg caggctccaa ggagtcctcc 1200 agggtcccca tgccctgaga gaatttctag ggaagtcatc tcacttggcc ttctgaaggt 1260 cctccctaag agtctcctga caaaagttac ttattgaaca cctctatgtg ccaggctctg 1320 tgttgggtac tttgatcaat gcccctgttt cagtctcatc tgtactcacg gcagccctgt 1380 ggagtacggt gtactggccc agcttacaga tgcagaaagc gagacgttct gccatcagat 1440 aaagtcacgt ggctctttag taacacggac aaggctcctc gccaaggaac tcgtggcaga 1500 agagggcagc agttggcagt agctgccgat gtctgtcccc agctccacca ttcctccctg 1560 tggctgtgcc atgctcgtgg tttcagtgtc cgtgtgtcca tgtgtctgcc cttcaggagc 1620 tcgcagctgg tgtgcttggc ggtcccaggc ctgtgtagtg tctctcccct gctgcgggcg 1680 cccccacccc gattcctctc cccagaagcg gtgggatggg cccccatgaa ctgcagcagc 1740 atgctgaggt gtccatgttg tctgcctttg tataaagaaa cagcctctga aaaaaaaaaa 1800 aaaaaaat 1808 <210> 8 <211> 2992 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 229840.3 <400> 8 aacacgagtc caagctgcag ctgggcaggg attgcggggt gccggccgtc tgagtttttt 60 taaaactgct tcgccgcgaa gtctgtctgc agccaaaatg tccaacagaa acaacaacaa 120 gcttcccagc aacctgccgc agttacagaa tctaatcaag cgagacccgc cggcctacat 180 cgaggagttt ctacagcagt ataatcacta caaatccaat gtggagattt tcaaattgca 240 accaaataaa cccagcaaag aactagcaga gctggtgatg tttatggcac agattagtca 300 ctgctaccca gagtacctaa gtaattttcc tcaagaggtg aaagatcttc tctcctgcaa 360 tcataccgta ttggatccag atctgcgaat gacattttgc aaagctttga tcttgctgag 420 aaataagaat ctcatcaatc catcaagcct gctagaactc ttctttgaac tttttcgttg 480 ccatgataaa cttctgcgaa agactttata cacacatatt gtgactgata tcaagaatat 540 aaatgcaaaa cacaagaaca ataaagtgaa tgtagtattg caaaatttca tgtacaccat 600 gttaagagat agcaatgcaa ccgcagccaa gatgtcttta gatgtaatga ttgaactcta 660 cagaaggaac atctggaatg atgcaaaaac tgtcaatgtt atcacaactg catgtttctc 720 taaggtcacc aagatattag ttgccgcttt gacattcttt cttgggaaag atgaagatga 780 aaaacaggac agtgactccg aatctgagga tgatggacca acagcaagag acctgctagt 840 acaatatgct acagggaaga aaagttccaa aaacaagaaa aagttggaaa aggcaatgaa 900 agtgctcaag aaacaaaaaa agaagaaaaa accagaggtg tttaactttt cagccattca 960 cttgattcat gatccccaag attttgcgga aaaactacta aagcagcttg agtgctgtaa 1020 ggagaggttt gaagtgaaga tgatgctcat gaaccttatc tccagattgg tgggaattca 1080 tgagcttttc ctcttcaatt tctatccctt tttgcaaagg tttctgcagc cccaccaaag 1140 agaagtaacc aagatccttc tgtttgctgc acaagcatct catcacctag tacccccaga 1200 gattattcaa tcattgctta tgactgtggc aaacaatttt gttaccgaca agaactctgg 1260 agaagtcatg acagtaggaa tcaatgctat aaaggagata acagctcgat gtcctctggc 1320 catgactgaa gaacttctcc aagacctggc tcagtataaa acacacaagg ataagaatgt 1380 aatgatgtct gctagaactt tgattcacct cttccgaaca ctgaatcctc agatgctgca 1440 gaagaaattc cggggtaagc ctacagaggc ctccatagaa gcaagagtac aagaatatgg 1500 agaattagat gctaaagatt acattccagg agcagaagtt ctggaagttg agaaagaaga 1560 gaatgctgaa aatgatgaag atggatggga aagtaccagt ctcagtgagg aggaggatgc 1620 tgatggtgaa tggattgatg tgcaacactc ttccgatgaa gaacagcaag aaatctccaa 1680 gaagctgaac agcatgccca tggaggagcg gaaggccaaa gctgcagcca tcagcactag 1740 ccgagtttta actcaggaag acttccagaa aatccgcatg gcccaaatga gaaaagaact 1800 tgatgctgcc cccgggaaat gccagaagag gaaatacatt gaaatagaca gtgatgaaga 1860 gcccaggggt gaattacttt ctcttcggga cattgaacgc cttcataaaa agccaaagtc 1920 tgacaaagag acaagactag caactgcaat ggctggaaag acagaccgaa aagaatttgt 1980 gaggaagaaa accaaaacaa atccattttc cagttcgaca aataaagaga agaaaaaaca 2040 gaagaacttt atgatgatgc ggtatagcca gaatgtccgg tcaaaaaata agcgttcctt 2100 ccgagaaaaa cagttggcac tacgagatgc acttttgaaa aagagaaaaa gaatgaagta 2160 acttcctggc aagttttcca ttcctagaag aatgctaagt ttgtgtcctt gctctgaaaa 2220 ttggtaaatc aagcatgttt gtttacatta aaaagtccag acacactgta ttgtgaaaac 2280 tgctgaacat gtggcagcaa ttttgtgttt ttattttgga gacggctaat ggtaggaatg 2340 ttaatgtaaa tagtggtggt aatgtaaaat catttcattt atcattcatg caaaaaaaag 2400 tatgtattga gtgcctattc attgtcactg tagatgcaaa acgaatgagc tgtaacccct 2460 tcactcaagg cattgacagc ttagctgtga gggtggacac acatatgtgt atttacagtg 2520 cagtgtaaat agttctgtag tagaggttaa ctccatattt ctgtgaggtc actgaggcct 2580 tatggactaa ctctgtgagg ataggagtta tatattctta taagacaaaa caaaacagga 2640 caatgttaca agagtaagag gttcttactt gtacataggc tttcctgctg aaaacaggcc 2700 cctgctgtac agattttggg tacataattt agctctttta gtcaatccaa gagatttaag 2760 tgaccccccc cccgtgtttt ttttgttttt gtttttgttt tgaatgccat gtaaaggctt 2820 tttggttaag acctcacttt taaaactgcc ttaagtataa atagtacctt tggaatatat 2880 ttagttcatc atttgagctg ccttcatact ggtttcctca gccttccttc agcctgtaat 2940 attttcagcc cactgtttac cttgtctcaa taaaaggttt ctaatgccaa at 2992 <210> 9 <211> 2513 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 231793.2 <400> 9 cccggaacta acctcggctc ccttgggaag gccgcgttgc atggccagga gcagcagtct 60 gggccgcgag tgcgggacac cgaggtcagg tctcggaaag ggaggacctc ctcgtcccca 120 ggggccccag gccaggtgca cccttggccg caggtgcacg gtctccggaa agtgcaggcg 180 cccacgtccc agctggacca tggcgcctcc gcggaacgtg gtgaagattg ccatccagat 240 gcgtgacgcc atcccgcagc tcatccagct ggaccaggcg aagccctggc cgctgtgctg 300 aaggaggtgt gcgacgcgtg gagcctgacg cactctgagc gttacgccct gcagtttgcg 360 gatgggcacc ggagatacat caccgagaat aaccgcgcgg agatcaagaa tggcagcatc 420 ctgtgcctca gcacggcccc agaccttgag gctgagcagc tcttgggtgg gctgcagagt 480 aacagtcctg aagggcgccg ggaagccctg aggcgccttg ttccgctggc ctcggacatg 540 atctttgcca gggaggtcat cagccgtaat gggctccaga tactaggcac catcattgaa 600 gatggggacg acctaggaga ggtgctggcc ctcagcctga gggccttctc agagctcatg 660 gagcacggcg tggtgtcctg ggagactctg agcatcccct ttgtgaggaa ggtggtgtgc 720 tacgtgaaca tgaacctcat ggatgcctcc gtgcctcccc tggcccttgg gctgctggag 780 agtgtgacct tgagcagccc agccctgggc cagctggtca agagcgaggt gcccctggat 840 aggctgctgg tgcacctaca ggtgatgaac cagcagctgc aaaccaaggc catggccctg 900 ctgacagcct tgctgcaggg ggccagccct gtggaacgca agcacatgct tgactatctt 960 tggcagagga accttcgcca gttcatctat aagaacatca tccacagtgc agcaccaatg 1020 ggcgacgaga tggctcatca cctgtacgta ctgcaggctc tcatgctggg gctgctggag 1080 ccgcgcatgc gaacgcccct ggacccctac agccaggagc agcgggagca gctgcaggtc 1140 ctacgccagg ctgccttcga ggtggagggg gagtcctcgg gtgccgggct aagtgctgac 1200 cgtcgccgtt ccctctgtgc ccgagagttc cgcaaactgg gcttttctaa cagcaaccca 1260 gcacaggacc tggagcgcgt gccccccggt ctgctggccc tggacaacat gttgtacttc 1320 tccagaaacg cgcccagcgc gtaacagccg gtttgtgttg gagaacagca gccgcgagga 1380 caagcacgag tgcccctttg cccggggcag catccagctg acggtgctgc tgtgtgagct 1440 gctccgtgtt ggggagccct gctctgagac agcccaggac ttctcaccca tgttcttcgg 1500 ccaagaccag agcttccacg agctcttctg tgtgggcatc cagctgttga ataagacctg 1560 gaaggagatg cgggctacac atggaggact tcgacaaggt catgcaggtg gtgcgggagc 1620 agctggcccg cactctggcc ctgaagccca cttccctgga gctcttccga accaaggtga 1680 atgcgctcac ttatggggag gtgctgcggc tgcggcagac tgaacggctg caccaggagg 1740 gcacactggc tccccctata ctggagctgc gggagaagct gaagccagag ctcatgggcc 1800 tgatccgcca gcagcgcttg ctccgcctct gtgaggggac gctcttccgc aagatcagca 1860 gccggcggcg ccaggataag ctgtggttct gctgcctgtc ccccaaccac aagctgctgc 1920 agtacggaga catggaggag ggcgccagcc cgcctaccct ggagagtctg cccgagcaac 1980 tccctgtggc cgacatgagg gcactcctga caggcaagga ctgcccccat gtccgggaga 2040 agggctccgg gaagcagaac aaggacctct atgagttggc cttctcaatc agctatgacc 2100 gtggggagga ggaagcgtac ctcaacttca ttgccccctc caagcgggag ttctacctgt 2160 ggacagatgg gctcagtgcc ttgctgggca gtcccatggg cagcgagcag acacggctgg 2220 acctggagca gctgctgacc atggagacca agctgcgtct gctggagctg gagaacgtgc 2280 ccatccccga gcggccaccc cctgtgcccc caccccccac caacttcaac ttctgctatg 2340 actgcagcat cgctgaacct tgacagtgtg gctggccatg ggccacagct gcggccactg 2400 cagcagccat gaagggcagt gggtagagga gtgcaggcac cctgaccagc agagattgct 2460 gcagaaataa agtctgcttg gctcttggga tatgttgagc cagctctgta aaa 2513 <210> 10 <211> 1976 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 234137.5 <220>
<221> unsure <222> 1035, 1039, 1051 <223> a, t, c, g, or other <400> 10 gggagtggta gtgggggctg cagctgccgg acccaggtgc ggaagtgcga gggcccaggt 60 ggctgaaggg gccgttagga acatccaagc ggtggggcac aggcagatcc ccgacctgac 120 ctggaccacc cttctcctct tggcccgccc cttcaactcg cctccgctta ggtctggatt 180 ggccccgccc cctgacctga gcctggtcct tcttcaggca ctgacccttg acctccggtg 240 gctcccccat ctctcaggcg cgatggctac gggcgcggat gtacgggaca ttctagaact 300 cgggggtcca gaaggggatg cagcctctgg gaccatcagc aagaaggaca ttatcaaccc 360 ggacaagaaa aaatccaaga agtcctctga gacactgact ttcaagaggc ccgagggcat 420 gcaccgggaa gtctatgcct tgctctactc tgacaagaag gatgcacccc cactgctacc 480 cagtgacact ggccagggat accgtacagt gaaggccaag ttgggctcca agaaggtgcg 540 gccttggaag tggatgccat tcaccaaccc ggcccgcaag gacggagcaa tgttcttcca 600 ctggcgacgt gcagcggagg agggcaagga ctaccccttt gccaggttca ataagactgt 660 gcaggtgcct gtgtactcgg agcaggagta ccagctttat ctccacgatg atgcttggac 720 taaggcagaa actgaccacc tctttgacct cagccgccge tttgacctgc gttttgttgt 780 tatccatgac cggtatgacc accagcagtt caagaagcgt tctgtggaag acctgaagga 840 gcggtactac cacatctgtg ctaagcttgc caacgtgcgg gctgtgccag gcacagacct 900 taagatacca gtatttgatg ctgggcacga acgacggcgg aaggaacagc ttgagcgtct 960 ctacaaccgg accccagagc aggtggcaga ggaggagtac ctggctacag gagctgcgca 1020 agattgatgc ccggnagang gagcgggaga nacgcagcca ggacctgcag aagctgatca 1080 cagcggcaga caccactgca gagcagcggc gcacggaacg caaggccccc aaaaagaagc 1140 taccccagaa aaaggaggct gagaagccgg ctgttcctga gactgcaggc atcaagtttc 1200 cagacttcaa gtctgcaggt gtcacgctgc ggagccaacg gatgaagctg ccaagctctg 1260 tgggacagaa gaagatcaag gccctggaac agatgctgct ggagcttggt gtggagctga 1320 gcccgacacc tacggaggag ctggtgcaca tgttcaatga gctgcgaacg acctggtgct 1380 gctctacgag ctcaagcagg cctgtgccaa ctgcgagtat gagctgcaga tgctgcggca 1440 ccgtcatgag gcactggccc gggctggtgt gctagggggc cctgccacac cagcatcagg 1500 cccaggcccg gcctctgctg agccggcagt gactgaaccc ggacttggtc ctgaccccaa 1560 ggacaccatc attgatgtgg tgggcgcacc cctcacgccc aattcggtaa gagtctggac 1620 aggctgggag gcacgcctgg gccctgcgag tgagcacatg cacatgggtg taggggctcc 1680 tctccctcta gtgcctgcag caggaacgat catcacttct gtgcgagtct gagactgagg 1740 gtaggagtgg gttgaccagt gggcgtcctt gtccctgagc gtgtgaagca catgcactaa 1800 gcctgactca ggccttgggg ggtcactgac ctcaatgcct tctgtgtatc ctcagagaaa 1860 gcgacgggag tcggcctcca gctcatcttc cgtgaagaaa gccaagaagc cgtgagaggc 1920 cccacggggt gtgggcgacg ctgttatgta aatagagctg ctgagttgga aaaaaa 1976 <210> 11 <211> 1400 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 234671.14 <220>
<221> unsure <222> 1397 <223> a, t, c, g, or other <40D> 11 ggcagttctc gtccagagcc caggtaatcc gggcgggatc agctagcgtc gcgatgtgat 60 gacgtcaggc cccggccagg ccgggagtgg cgtgctgggc cgtgcgcggc tgcggtacgg 120 cgtgttggtc ccagcggttc agctgaggta gggacgtgct gtaggccgga atgttaccgg 180 ctgttggatc tgtggatgag gaagaggatc ctgcggagga ggattgtcct gaattggttc 240 ccattgagac gacgcaaagc gaggaggagg aaaagtctgg cctcggcgcc aagatcccag 300 tcacaattat caccgggtat ttaggtgctg ggaagacaac acttctgaac tatattttga 360 cagagcaaca tagtaaaaga gtagcggtca ttttaaatga atctggggaa ggaagtgcgc 420 tggagaaatc cttagctgtc agccaaggtg gagagctcta tgaagagtgg ctggaactta 480 gaaacggttg cctctgctgt tcagtgaagt gaggaatgtg tttactgtgt acatggttta 540 ctagaaatgt ttattgatta tatttccagc tttaattttc ttgagtaatt taactgaatt 600 tacacagttt gcttcattgt attttcaaac aaatagaaaa taaacttatt aggaagcatt 660 ttcttaaagt gtttcttgct gtcttttcta tctgctctaa tgttttggtc cttttattga 720 gtttttattg cttttgatgt cagggcttat ttaatctcta gtgcatgaaa gtctcatatg 780 taaaaaatga ttattctgaa tttaatctgt cattggtcat atttctaagt gttcaacctt 840 ataaaaaaaa taaatgacta tcaaaaaaag aaaaacctta cattatgttc tactagttaa 900 gttttcaagg acagtgttca ctagtctacc atagacccta gaagagttac ccaacacata 960 gtagcactca aatatttgtt gaatgaatta taaaaatgac tacttgtatt gttaattttg 1020 tgtattctag tgaattaaat ctcttcggca tcatttactc ccttaggtat ttgactttgt 1080 gtcaaatgtt ttggcaagga taaaattata acagactttc ttgaacaacc aaaatataat 1140 ctattaagga ttttccttca cttttgataa aataagaaaa aaggaaatta aaaccttgca 1200 tcctaatgta aaatagaatt atatggtgtt taatatcagt gtccctttag ctattatatt 1260 aaactactat agttaataaa ttttatcatt attttgtatg ttggttttta aaaatttcat 1320 aaagctataa aaagatactt ggtcagataa agtttcctct gcttttaatt ttaataaagt 1380 attattatgt atatganaaa 1400 <210> 12 <211> 2126 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 241236.3 <220>
<221> unsure <222> 1157 <223> a, t, c, g, or other <40D> 12 tgacccccta ttgagagaga ttgctcctgg ccccctcacc acaccctctg tcccagattc 60 agatgtagcc tggtcttttt tggaaagatg ttccatctct cctgccctcc aggctccact 120 cctggtccct gcttcctctg tggttctgcc ccaggcacac tgcactgccc atcctgtcca 180 gaggagatct tctcggctct gcagtactcg ggcactgagg tgcctctgca gtggttgcgc 240 tcagaactgc cctacgtcct ggagatggtg gctgagctgg ctggacagca ggaccctggg 300 ctgggtgcct tttcctgtca ggaggcccgg agagcctggc tggatcgtca tggcaacctt 360 gatgaagctg tggaggagtg tgtgaggacc aggcgaagga aggtgcagga gctccagtct 420 ctaggctttg ggcctgagga ggggtctctc caggcattgt tccagcacgg aggtgatgtg 480 tcacgggccc tgactgagct acagcgccaa cgcctagagc ccttccgcca gcgcctctgg 540 gacagtggcc ctgagcccac cccttcctgg gatgggccag acaagcagag cctggtcagg 600 cggcttttgg cagtctacgc actccccagc tggggccggg cagagctggc actgtcactg 660 ctgcaggaga cacccaggaa ctatgagttg ggggatgtgg tagaagctgt gaggcacagc 720 caggaccggg ccttcctggc gccgcttgct tgcccaggag tgtgccgtgt gtggctgggc 780 cctgccccac aaccggatgc aggccctgac ttcctgtgag tgcaccatct gtcctgactg 840 cttccgccag cacttcacca tcgccttgaa ggagaagcac atcacagaca tggtgtgccc 90D
tgcctgtggc cgccccgacc tcaccgatga cacacagttg ctcagctact tctctaccct 960 tgacatccag cttcgcgaga gcctagagcc agatgcctat gcgttgttcc ataagaagct 1020 gaccgagggt gtgctgatgc gggaccccaa gttcttgtgg tgtgcccagt gctcctttgg 1080 cttcatatat gagcgtgagc agctggaggc aacttgtccc cagtgtcacc agaccttctg 1140 tgtgcgctgc aagcgcnagt gggaggagca gcaccgaggt cggagctgtg aggacttcca 1200 gaactggaaa cgcatgaacg acccagaata ccaggcccag ggcctaggca atgtatcttc 1260 aggaaaacgg cattgactgc cccaaatgca agttctcgta cgccctggcc cgaggaggct 1320 gcatgcactt tcactgtacc cagtgccgcc accagttctg cagcggctgc tacaatgcct 1380 tttacgccaa gaataaatgt ccagagccta actgcagggt gaaaaagtcc ctgcacggcc 1440 accaccctcg agactgcctc ttctacctgc gggactggac tgctctccgg cttcagaagc 1500 tgctacagga caataacgtc atgtttaata cagagcctcc agctggggcc cgggcagtcc 1560 ctggaggcgg ctgccgagtg atagagcaga aggaggttcc caatgggctc agggacgaag 1620 cttgtggcaa ggaaactcca gctggctatg ccggcctgtg ccaggcacac tacaaagagt 1680 atcttgtgag cctcatcaat gcccactcgc tggacccagc caccttgtat gaggtggaag 1740 agctggagac ggccactgag cgctacctgc acgtacgccc ccagcctttg gctggagagg 1800 atccccctgc ttaccaggcc cgcttgttac agaagctgac agaagaggta cccttgggac 1860 agagtatccc ccgcaggcgg aagtagctga gggcaagggt cccgatgagg gtcccatggc 1920 ctgctccctc aggaacagct ccagcaccaa taaagaggca tcttaccacc caggcttctt 1980 ggtggtcctt cttcctggtg ccaccatcta ggggcaccag ggaaagagcg gggtgaacag 2040 agctttgctg aaaagggccc cctgcaacct agtgcctgac cctccctgga ctcaggacca 2100 ggaaggagtt gacaccctgg atggtc 2126 <210> 13 <211> 2674 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 245014.1 <400> 13 gagtattgga agacttgcga tggaagaaat ctaccagaaa ccatttcaga cattaatgtt 60 tttgattcga gattggagct atccttatga acattcatat ggtttggaag gtggaaagca 120 atttcttgaa aagagattac aggtaaaaca aaatcaacat gaagagcttc agaatgtaag 180 gaagcacata cacaattgtt tctcaaatct tggttgcttc cttttgccac atcctggtct 240 taaagttgca actaatccta gttttgatgg gagattgaaa gatattgatg aagactttaa 300 acgagagctt cgaaatctgg ttccattgct gcttgcccct gaaaatttgg tagaaaaaga 360 gataagtgga tctaaagtca cttgtagaga tcttgtagaa tattttaagg cttacatcaa 420 aatctatcaa ggagaagaac ttccacatcc aaagtccatg cttcaggcaa cagctgaagc 480 taataatctt gctgcagtag caggagcaag agatacctat tgtaaaagta tggaacaggt 540 atgtggaggg gacaagcctt acattgcacc ttcagatctg gagcgaaaac acttggatct 600 caaggaagtg gcgataaaac aatttcgttc agtaaaaaag atgggtggag atgagttctg 660 ccgtcgttat caggaccagc ttgaagctga aattgaagaa acctatgcaa attttataaa 720 gcacaatgat ggcaaaaata tcttctatgc tgctcgtacc ccagccacac tgtttgcggt 780 catgtttgct atgtatataa tctcaggact gactggcttc attggcctaa actctatagc 840 tgtcttgtgt aaccttgtca tggggttagc actgatattt ctttgtactt gggcatatgt 900 taaatactct ggggagttca gagaaattgg aacagtgatt gatcagattg ctgaaacact 960 atgggaacag gtgttttcca aactgtttga agttactaga cgtcgaatgg ttcaccgtgc 1020 tctttcatca gcacagcgac agagactgtc atccaacaat aacaagaaga aaaattagac 1080 agtattttta acctttttcc tctatctgaa gtgttcacac ttacacatgt aggacaataa 1140 gcaggaccgt ctgggccggt ctgcataaat gctgtataca taccagattt gatgctgcat 1200 atagggtatg gaattgcaca tccatctcat aggaattgta aatggtttga ataagaggaa 1260 agtaattttt gttgcattat aaaatgtcta gtagcatcat aagttttttt gagagaagca 1320 tctttttatt tcccatattc ctggttattt tcatcattgc tttgaattga atttttatat 1380 ctatttttat atgtaactct ttttttacct catgtttttg tttgttttgc acatttctca 1440 taccacaggt attgaagccc ctgggtgata atttgatgga ggaaaacata aggcagtctg 1500 taacaaactc tatcaaagca ggcctgactg accaggtgtc tcatcatgcc agattaaaga 1560 cagactgaca gttcatctcc tcacggactc cactctcttt ttttttcatg cttgctgtac 1620 aatgagaact caaataaaaa taaaccaaag tttacaatca actgtagaag tagtttagtg 1680 taactggctt cacagatggc tgccacagag tgtgaagatt gtttgttagt tttaagcatt 1740 cttttaatgg gctcctaaga catgcagatg gactgaggag cattggttaa tcatgcacct 1800 ttgtgccatg tttaactctt ttatttcttt ttacttaatc taatgttagt gaatttgtct 1860 tatgtaaaag gatatttcag ggaaatattt tcagaaatct atttagagtc tctttaacac 1920 agtgtcccat tgaaatttta atttttagag aatttatgaa tcactgtttc aagaaccaga 1980 ttggaaagac aatgaagcct ttattgagcc actacattaa aagtatatat tgctttactg 2040 ccttcaatac cagtattaca taaatgcatg tatcagaaac ttcacagaaa ttacatggca 2100 actcttgtag ctaagaaagt aattctgagg tgtacatttg tcttgccttt ttaaatttat 2160 aaacttgccc taaaaggaga tgcatatctg ggaaactgaa ctgtcttttt gcagtttagc 2220 cttcatgtat ataaaatatg ccattaattt tattggggaa gaaattccat ccaaaaatgt 2280 tgcctacagc tatgagttaa gagtgtctgt acagtgtgta gcttttattt tctaaaatca 2340 cagatagggc atgtatatga cttataaata tataaatacg attttgtatt aaaagttttg 2400 tagtttatgg caaaatctgg tcctgtggta ggctaaataa gtactgtccc tgtgaaagga 2460 atgtttgtgg ctcatgtcag tgtgtgaatg catagacaat ttgaagtttt tgatatattt 2520 gtgatattta tcttgagcac tgcaatctca cccccccccc gcccaccaag ggaattcaat 2580 gggaatgttt attgtgactt tgtcctctgt tgcattttaa agttatttcc tgtaatttat 2640 tttcagtaca taattaaaaa tttgttgtat atat 2674 <210> 14 <211> 1427 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 245251.6 <400> 14 tggctgagtc aacacatctt tattaaacac ctgaagttac tgggaggagg ccatgatgct 60 ggacacactg tcaaagtcaa tcttctccac aatgttcttg ggtttaatgc tctcttcttg 120 gctacagatg aagatctgcc ccgactcgtc ggcactccag ccgtatttgc tcatccacac 180 ctttagctgg ctgtactttc ggacagagtc ttcaaagcca gttatacctt ccaagaggtc 240 catgttttca tccagggctt gccagaaggc ctggaaatgg caggtctcca gcaggtcccc 300 gaggtacaaa atctgtcgga ttggccgttc ttcttgatgt gcctggtcga tcatgcactt 360 gcacagggtg aagtctgtgt gcggcaagtt ggtgagggcc ttcagcagga tctgggcggt 420 gaccgtggtc tgaaagaagg ctgggttgaa ctggtacagc ttcaggacag ccaggttggc 480 ttccagatca taggcatttt ccttggcctg cgtctctaca tagcgctcca gggtggccag 540 gttctcagga ttgtaccctt gagcaacttg cccacgttgg ctctcatctg ctcaaacatc 600 gccatgactt ctgtcgcctt ccacaaccag ggctggaggc taacactgac ccggcacggc 660 gtcctcaagg acgggaacag gaagaggtca gtgttagcct ccagccctgg ttgtggaagg 720 cgacagaagt catggcgatg tttgagcaga tgagagccaa cgtgggcaag ttgctcaagg 780 gtatcgacag gtacaatcct gagaacctgg ccaccctgga gcgctatgta gagacgcagg 840 ccaaggaaaa tgcctatgat ctggaagcca acctggctgt cctgaagctg taccagttca 900 acccagcctt ctttcagacc acggtcaccg cccagatcct gctgaaggcc ctcaccaact 960 tgccgcacac agacttcacc ctgtgcaagt gcatgatcga ccaggcacat caagaagaac 1020 ggccaatccg acagattttg tacctcgggg acctgctgga gacctgccat ttccaggcct 1080 tctggcaagc cctggatgaa aacatggacc tcttggaagg tataactggc tttgaagact 1140 ctgtccgaaa gtttatctgc catgttgtgg gtatcactta ccagcacatt gaccgctggc 1200 tgctggccga gatgctcggg gatctgtcgg acagccagct aaaggtgtgg atgagcaaat 1260 acggctggag tgccgacgag tcggggcaga tcttcatctg tagccaagaa gagagcatta 1320 aacccaagaa cattgtggag aagattgact ttgacagtgt gtccagcatc atggcctcct 1380 cccagtaact tcaggtgttt aataaagatg tgttgactca gcccaaa 1427 <210> 15 <211> 4404 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 252875.1 <220>
<221> unsure <222> 9, 20, 26 <223> a, t, c, g, or other <400> 15 ctgtggcgnt ggcgctggtn gctgcngcgg cagccggcgg cacggcgctc gagcggttcc 60 tgtcagggtc agccggcggg ccccctgggt ggtccacctg caaatcgcgg agcggggccc 120 cagggatcga tggcgatgaa ctataacgcg aaggatgaag tggacggtgg gccccCgtgt 180 gctccggggg gcaccgcgaa gactcggaga ccggataaca cggccttcaa acagcaacgg 240 ctgccagctt ggcagcccat ccttacggct ggcacggtgc tacctatttt cttcatcatc 300 ggtctcatct tcattcccat cggcattggc atttttgtca cctccaacaa catccgcgag 360 atcgagattg attataccgg aacagagcct tccagtccct gtaataaatg tttatctccg 420 gatgtgacac cttgcttttg taccattaac ttcacactgg aaaagtcatt tgagggcaac 480 gtgtttatgt attatggact gtctaatttc tatcaaaacc atcgtcgtta cgtgaaatct 540 cgagatgata gtcaactaaa tggagattct agtgctttgc ttaatcccag taaggaatgt 600 gaaccttatc gaagaaatga agacaaacca attgctcctg tggagctatt gccaacagca 660 tgtttaatga tacattagaa ttgtttctca ttggcaatga ttcttatcct atacctatcg 720 ctttgaaaaa gaaaggtatt gcttggtgga cagataaaaa tgtgaaattc agaaatcccc 780 ctggaggaga caacctggaa gaacggttta aaggtacaac aaagcctgtg aactggctta 840 aaccagttta catgctggat tctgacccag ataataatgg attcataaat gaggatttta 900 ttgtttggat gcgtactgca gcattaccta cttttcgcaa gttgtatcgt cttatagaaa 960 ggaaaagtga tttacatcca acattaccag ctggccgata ctctttgaat gtcacataca 1020 attaccctgt acattatttt gatggacgaa aacggatgat cttgagcact atttcatgga 1080 tgggaggaaa aaatccattt ttggggattg cttacatcgc tgttggatcc atctccttcc 1140 ttctgggagt tgtactgcta gtaattaatc ataaatatag aaacagtagt aatacagctg 1200 acattaccat ttaattttat attatgaaag caaatcatct gcatgtgcat caaggccagt 1260 cctattcaac ctagctttcg aatgctgata tctggttagt atgtcatttt gaagttggca 1320 cataactttt ctaaaaaaaa gcagtctttg ttgtttgctt cttccctacg gatgacttct 1380 aaaaatatat gacgggtata aaaaaattag ctatattgat catatcaaca ctgtaactgc 1440 tgaaatggca ttctaatgtt tgctttttat tcggacaggc cacatgatgc atagagcctc 1500 tttcatgtga cttgtgtcta ctgcttaaat ctttatgctg tgttgatgat attatattga 1560 catatgaagc tgtatatgtg tatgtatttt gtggagaaag ggattacaag atgtatgagt 1620 ataatgactt gctaaccttt caggattcag agaaagatga agaaagacca tatctaaata 1680 atacacttca tcattttcat gtgtataaat gcttaaagta ccatctttgt tgaggtggtt 1740 catgtatcca gtttatccag tacagttatt tgtcaagctt agctttgatt tcaaaggaca 1800 cgcttacctt gtctggcata agaattaatg ctcatgtctg cagtggttgg gtaggtcctg 1860 cttaggagaa ttaaaaaatt cctctttccg tttggttgaa tgttgcagtc aggaacccca 1920 actcacttgg aatgttttta tatgtaatca tttcccttga agcttatact ttataaggga 1980 agaaagaatt caggtgatat gggaaaactg cttggcagac cttcatcttc tgcctcaact 2040 gtaaaccaca tgtaaatgct taatggagac tgttttcatt cttgtgatat ttaacattca 2100 gaaaattact tcagctttgg aaatactcag gctgttttta ttctgcaggt aagtgttttg 2160 acttaagtac taatattcca gaaatttttg aaagcagtaa ccttaatttc ctatgtattt 2220 cattccactt ttgcatatag gtcaaatagc aatgtgtatg cacattctct ttagttaagg 2280 caccaattgt tttggttggt tttcctaaga catactttaa aaagatgttc tataaatttc 2340 ctagttaaat tatggggatt ttggagtatg tacatgataa attataatac gtatatggtt 2400 gaagttattt tattttttac taatgaatta ttttaatatt ccttattgaa taaatgctgt 2460 aacttgtttg ctatggaact tattcttaaa gttctagtta aaaataattt ttccacatgc 2520 atgaaaatat gtattaatca gaggtggctt aattacattg aaattgcttt tttgttgttg 2580 tttttttact gaaataactc atgtttgtgt agaagaatgc ctgtttactc agagtttata 2640 ttttccttca gttatatttt aaatcaaaag gtctgggtaa tgtatacttt tgattaatat 2700 atactttttt taaaaaacaa aaaacaatgt aatggttaat agtagaaatg tgccacactt 2760 ttcaagtttt atataacata tgaaattcag ttaaaagaat gtgtgtttca taatgacttt 2820 taactggtaa aaatattact tgcacgaagt aacttgatgt atggttatcc tgaaatttcg 2880 gagtatttgg tgtgttcttt gtctaaaaat agtctgtttt gtcagtcctt cagaatatta 2940 tttattctga agattgtccc tcttgcactt gggcagttta ttttcgggga tacattgttg 3000 ggggagaggg gtttctgcca ctctttccag attgagtctg tgctgtttaa ggaggactac 3060 catcctgcaa ctctttttct aattggggca cagaggatgt cgctaaagaa aagttgaaga 3120 gccctttcag cactttctca tctgtggaga agatggaatc ttaaaataca tttggagttt 3180 tatctgtttt acaagtccat tgatggccta agttcctcct gttttctgct gtttgatctc 3240 taaggaactc ctgttgctaa atatgaagag tatggaacat tcatatagtc tctgtgaagc 3300 atggggggag ggaagacatt tctttttctt ataggcttta tgctcaaatg tcatagtctc 3360 ctttcaaaga attgtgttgc attttaaatg cacccagctt aagtagaaga cattgaagga 3420 tgcattaatt ttcaggaact attttgaatt atgaaaagat tcccaattga aaaaattatt 3480 caacaagtaa aagctaagaa atttcattga aatcataagg cagtttaagc ataaattgat 3540 aaaaatagct gtgtactact aattaataga aaatcattca accaagagaa gagtcaagtg 3600 aatatcgttt gtttatttgc tagtgagttt ctttgtaacg ttgattttat taaatgataa 3660 tatttggtta gtatgtccta tgttaataaa aatgaacaaa attaattttg ctatgttcag 3720 gtgtcttgat aaaataacaa tgctccagtg ttgttgctta catttagcac taaattttaa 3780 cacagggtca gtgagtccag gttttaactt cttcatgcct ggatgggata aaatgtaatt 3840 cattgttaaa ttaattcata tttgtattta ttaatcactg tgaccaacat taaccatttg 3900 ttcttaccag gaagtggtca gattatcatc tgagttacag ttagactggc taagtttggt 3960 attagatcaa ggggaatgtc cagtaaacag agaggtaagc atgatggaaa taatgaagtg 4020 gggtacacag gaaaaacctg actagtgagg aggagcagct gagagatagg gtcagtgaat 4080 gtggttcagc ctgctacctc tcctgtcttc atagaaccat tgccttagaa ttattgtatg 4140 acacgttttt tgttggttaa gctgtaaggt tttgttcttt gtgaacatgg gtattttgag 4200 gggagggtgg agggagtagg gaagtggtcc ttttacaaga attttgatgc ataagtgtct 4260 attgtagggt ttggatgatc tagtaaagtg ttttagaacc cctttttatc ccatgcacca 4320 ttcagtaaac ataaaaatca caattctgct aatgtcattt ggaacttcaa aataaatatc 4380 ttgtctaaaa acaagaaaaa aaaa 4404 <210> 16 <211> 3150 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 252964.2 <400> 16 cctttctcct cacccagccc cttgctcttc ccttttgaaa ggcccgtgtg ttttctttcc 60 ttaccctgtg cttgctcatg tctactccgg ttttctctac cacatcctta gagccatcac 120 ctggcacgca ggcgccttac attctacggt agaacgtggg gtactgtgtg tgcacataga 180 cacacttacg tggaattaca gttgtgggtt tatccaagat gaggaagatt tcacctgctg 240 tttaatagac ttggggccat gtgcctcccc acacatgggc aaggacaggt ggaatgtcgg 300 gaccacactg tgcggcttct cggcacaaag cggagggagg ctgtggtcgc tgccggccta 360 ggtgtcccag gtgccccgcc tttctctggg acacagttgg gggctggctt ctgagggatt 420 cctttctccc ctctttgtgt ggccccagcc agggcggtgg gcagtcctgg tgtagagcac 480 aagcctctcc accctagaga aatgcctctg taccacggct accatgtgga accttaactt 540 gcagaaggct tgttaacaat tgttttgaga gagatggctg gtcatgccac agctgctggg 600 gactccgcct actccagccc tcttgggaca cactgtggga tttgtggccc ttccccagag 660 gaattgtgga gactgtccca tggaacaaac cctcaggcac cagcacaggg ctctgggtga 720 ctcagtaaaa ctaacgtttg tctctgacaa gatcagctgt aggctcaccg gccagagaag 780 accactgtga gcattttgcc gtatatcctg ccctgccatt tgttcacttt ttaaactaaa 840 ataggaacat ccgacacaca ccgtttgcat cgtcttctcc cttgatattt taagcatttt 900 cccatgtcat gagtttctca gaaacatgtt tttaacaatt gtactattta gtcattgtcc 960 atttactata atttatctga ccatttccct actgtaaaat acttaagacg gtttctgatt 1020 tttccactat ttaaataatg ctgtgatgaa tatctttaaa atcttctgat ttcttacttt 1080 tttccccctt agatgcctgg aagtggtatt ttgaggtgaa agagtttgtt cattttgaag 1140 atatttctgt ctctctctcg acctgatgtg tagacgctca cttccagtag cagaaccacc 1200 ttagttgtgt cttacagatt ctgaacaaat cggtttctga taagccatgt gttccaaaga 1260 atgtctgaat aagaccgctc tttatttaaa tgctaagagg atgtcactac tgcaatccat 1320 ctgtggccga ttttttccaa gagccaattt ccttgttttg gttgcaagaa cctggctctg 1380 cctgcatgtc agctctctgc cctccctgct gccgtggctt tcaagcgctt ggcagaatct 1440 tgtacttcgt gtccacaatg gtactgaatt tgcatctgca cagtcagcag agataacaag 1500 tgttgaactg accttgccac atgcttagtg agtgatttgt aattaagttt atagactcag 1560 aaggtatatt aggacatttg gaatcagtag cagagcaaag cctctttgaa'aaaaaccacg 1620 tagactgatt gggttttaca agagtgcatt tgtctccccc ttccaccccc ccaccttcag 1680 gtcttagtgg ttcacaagag cccagcagcc aggctggctt tttcattgta gggcgtggtt 1740 gtcccagctg gtgtagattt caggccgccc cccccaactc cctgcccaca gtgttgcaga 1800 ttgcctggct ggcagcaagt ccagaccacc caaatttggt tggattcttc atttctccac 1860 tgtagttggg gtccattgat tgtgcagggg aacgtgcagg aggtttttct aggcaccgtg 1920 ttcagtgctg cttcactcta ccagagatta tggccaaatt gcacggaatt tggtttcttg 1980 ccctctgaag cctgagggcc cccccttgcc tggctggttg acagacccgg ggtggtcact 2040 gctgagactt cagagatcgc agctgctgtg agaatacggt gaaggtactt tgttctggaa 2100 gatgttgtca tacacttttc cccagttatt ttcaaacttg acatgagcct atgttgactc 2160 actgggtggg ggtcccttct tacgcagcac acgtggcaag tgcctgaatc ggggctggag 2220 gcacttcaga gcctctgagg ggccaccact tctggcccaa aattgcaggg ttgtagatga 2280 ggctgcctgt ggagaactgg tgtgaggagg aagctgtttc caacaaagag cactttcatc 2340 tgttgagatg gctgtggtga gcaactgaac gagcctacgt gtgtacctga aattttcccc 2400 gtaactcatt tcttccatat gaagaaacac caaactatgt acagagaact ttttacaaaa 2460 gggcagacct tttttaagct gtgtaaccca catagcctaa ccacctggca gaatgactac 2520 gaataggggt cattgtgctg gtaaaagcct ctattacgac tgtaagtaag ttggatgttg 2580 gcaaaattaa attgttacag tatttagagc tgctgtagct gttccttcac aacataaaat 2640 aggataaatg actagtacgt ctttcaggtg ggtggcaagc agaacatgcg taatattctc 2700 tacctggtct gtagctgtaa ctgtgatgta cagacaaagc aaaaattaaa agaacttatg 2760 aaaacaaatg caatgatact aggatataca cttttgtatt tttattctta tataaggtta 2820 tttgctggct attgttggcc tctagttcag tctgtgttat ttaaattcta atatatgaat 2880 tatttgaatt gaattcatgt tcggggccac gttgttgtat gtattgatgt acagccttga 2940 atgtgaataa ttattgtaaa ctatatttta caactttttt tctggcttta ttatataaat 3000 tttctattgg gtcagtgatt taatcatata atttaatgaa tctgtttatc cttttttttt 3060 ttccaaatac ttgtgcttta ggtgtagtta ccagatgatg aattttcctc gtatggtcag 3120 tagtcttgta ataaaaagca tgtagagtgt 3150 <210> 17 <211> 1852 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 267153.7 <220>
<221> unsure <222> 551, 1151, 1200, 1257, 1823 <223> a, t, c, g, or other <400> 17 ccggcgccga ggttcttgac tgctgtgccg gacgccaggt gtagccatgc agcgagccga 60 ttccgagcag ccctccaagc gtccccgttg cgatgacagc ccgagaaccc cctcaaacac 120 cccttccgca gaggcagact ggtccccggg cctggaactc catcccgact acaagacatg 180 gggtccggag caggtgtgct ccttcctcag gcgcggtggc tttgaagagc cggtgctgct 240 gaagaacatc cgagaaaatg aaatcacagg cgcattactg ccttgtcttg atgagtctcg 300 ttttgaaaat cttggagtaa gttccttggg ggagaggaag aagctgctta gttatatccc 360 agcgattggt tcaaatccac gttgatacaa tgaaggtaat taatgatcct atccatggcc 420 acattgagct ccaccctctc ctcgtccgaa tcattgatac acctcaattt caacgtcttc 480 gatacatcaa acagctagga ggtggttact atgtttttcc aggagcttca cacaatctac 540 gagcttgata ntctaggggt ggggtatcta gcaggatgtc tagttcacgc actgggtgaa 600 aaacaaccag agctgcagat aagtgaacga gatgttctct gtgttcagat tgctggactt 660 tgtcatgatc tcggtcatgg gccattttct cacatgtttg atggacgatt tattccactt 720 gctcgcccgg aggtgaaatg gacgcatgaa caaggctcag ttatgatgtt tgagcacctt 780 attaattcta atggaattaa gcctgtcatg gaacaatatg gtctcatccc tgaagaagat 840 atttgcttta taaaggaaca aattgtagga ccacttgaat cacctgtcga agattcattg 900 atttggtgcc tatcctaaaa cttccagtgg gttttcttgc cttccagtgg ccatataaag 960 ggcgtcctga aaacaaaagc ttcctttatg agatagtatc taataaaaga aatggcattg 1020 atgtggacaa atgggattat tttgccaggg actgccatca tcttggaatc caaaataatt 1080 ttgattacaa gcgctttatt aagtttgccc gtgtctgtga agtagacaat gagttgcgta 1140 tttgtgctag ngataaggaa gttggaaatc tgtatgacat gttccacact cgcaactctn 1200 ggacaccgta gagcttatca acacaaagtt ggcaacatta ttgatacaat gtaaganact 1260 tgattgtcat ttccctataa aattttcctt gatacttggc tagagtatca tactaggctc 1320 aactagacat ttctagatga gttcaagtga atattaagtg attaaattga aaatggtttc 1380 cttaaagaaa aaaaatctag cataaagtta atttagttgg aggaaaagga gggaagtgga 1440 taaaggggca gatggaggga agtggataaa ggggcagatg aagggaagaa gagctggctt 1500 aggccagacg tgaagcggca gtgctgagat cactcaggac ctcggcacag gtagtcactt 1560 acacaccatt ctcatcagga gaatgggagg taggacatga atatttaaat tctgagatta 1620 atgacaaaag ttaactttaa ggattaagat taatgtctat ttgtatcctt tcaaatattt 1680 atcaaaatta gtaccaaatg gtaaaaccaa caggaatttt acctcttcct gacccagtca 1740 gaaccatagc agaaaactgt acagccaggt ctctccgtga ctcaaagatc cataaggagt 1800 tatcaaacac tgggtgtgag tcnagttact tcttccatgt ctctaaaata gc 1852 <210> 18 <211> 1513 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 331244.6 <400> 18 ggtaaagtgg cttctgggcg gaaggtacac tataggctcg gggaggtaag cggcggcagg 60 ccggcggttg gtgtgtcccg ggtgtgggga ggcgacagag ccctggcact tgagggttga 120 gggggcctcc ccagccgcgg cgaaaccgtc tagcctccgg aggccaggcc gtgagtgcgg 180 gaggtatacg ccaaggcgga agaattttgc cactcactac ctgtgtgacc tcgggtaaat 240 tagccttgga acgtcagttt cttcgtctct ataattgaaa taataatagt acctctctca 300 ggattgttgt gagccgtcag tgaaacactt agagcagttt ctggcacatg gtagaattgg 360 gctatttgct gaagcttctt ggtggccctt gctagcccag gaagaaactt acattttgat 420 ttttttgtac catggctttg gttcacaaat tgctgcgtgg tacttatttt ctcagaaaat 480 tctctaagcc aacttctgcc ttgtatccat ttttgggtat tcgctttgca gagtattcca 540 gtagtcttca gaaaccagtg gcttctcctg gcaaagcctc cctcacagag gaagactgaa 600 ggggatttgc aaggagatca ccagaaagaa gttgctttgg atataacttc ttctgaggag 660 aagcctgatg ttagtttcga taaagcaatt agagatgaag caatatacca ttttaggctt 720 ttgaaggatg aaattgtgga tcattggaga ggaccggaag gccaccctct gcatgaggtc 780 ttgctggaac aagccaaggt tgtctggcaa ttccggggga aagaagattt ggataagtgg 840 acagtgactt ctgataagac gattggaggc agaagtgaag tgtttttgaa aatgggcaag 900 aataaccaaa gtgcactgct atatggaact ctgagctctg aggcgcctca ggacggggag 960 tctacccgaa gtgggtactg tgcaatgata tccaggattc caaggggtgc ttttgagagg 1020 aagatgtctt acgattggtc ccagttcaat actctgtatc tccgtgtacg tggggatggt 1080 cggccttgga tggtgaatat caaggaggac acagatttct tccagaggac gaatcagatg 1140 tatagttact tcatgttcac ccgcggggga ccctactggc aggaggtcaa gattcctttt 1200 tccaaatttt tcttctctaa tcgaggaaga atccgggatg ttcagcatga gcttccgctt 1260 gataagatct cttctatagg attcaccttg gctgataaag tggatggtcc attcttcctg 1320 gagatagatt ttattggcgt gtttactgat ccagctcata cagaagaatt tgcctatgaa 1380 aattctccag agcttaaccc aaggcttttt aaataaagat catatggtag ttttgtttta 1440 ctaatctaag ggtactagca tctacaatga tatagacaaa ataaaatatt tctttaatgg 1500 catccaacca aaa 1513 <210> 19 <211> 3243 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 335484.1 <220>
<221> unsure <222> 3222 <223> a, t, c, g, or other <400> 19 gagggagagg ccgagagaaa tttcggtact gcgcatgaac cgagcgtgac gttgaggttt 60 gaaataaccg gcaaagagta aaggctgaaa ctagcttcct gaaagcttcg tagggcccga 120 gccctgtgag cccaggttct gcgcccacta ggaggtgtca tgctgactgc tttttttaaa 180 gccctagaat cttggcttcg gcgtttgggg taagctccgt tctcgttctc aagcgcgttt 240 ccgcgaactc tcgcgggatt gacgggccgt ctcgagagcc ggcatctcct aggagctagt 300 cctggtcctc ggctaggcgg cttggggtcg cggcgtaact ggggagccag cctgacgccg 360 gcggaccccg cctgtgatcc tggcaacgat ggatgatgac ttgatgttgg cactgcggct 420 tcaggaggag tggaacttgc aggaggcgga gcgcgatcat gcccaggagt ccctgtcgct 480 agtggacgcg tcgtgggagt tggtggaccc cacaccggac ttgcaggcac tgtttgttca 540 gtttaacgac caattcttct ggggccagct ggaggccgtc gaggtgaagt ggagcgtgcg 600 aatgaccctg tgtgctggga tatgcagcta tgaagggaag ggtggaatgt gttccatccg 660 tctcagcgaa ccccttttga agttgaggcc aagaaaggat cttgtagaga ccctcctgca 720 tgaaatgata catgcctatt tatttgtcac taataacgac aaagaccgag aagggcatgg 780 tccagaattt tgtaaacata tgcatcgcat caacagcctg actggagcca atataacggt 840 ataccatact tttcacgatg aggtggatga gtatcggcga cactggtggc gctgcaatgg 900 gccgtgccag cacaggccac cgtattacgg ctatgtcaaa cgagctacta acagggaacc 960 ctctgctcat gactattggt gggctgagca ccagaaaacc tgtggaggca cttacataaa 1020 aatcaaggaa ccagagaatt actcaaaaaa aggcaaagga aaggcaaaac taggaaagga 1080 accagtattg gccgcagaga ataaagataa acccaacaga ggtgaggccc agctagtaat 1140 cccttttagt gggaaaggat atgttctagg agaaacaagc aatttacctt cacctgggaa 1200 actgatcact tcacatgcca ttaataaaac ccaagatctt ttaaatcaaa accattcagc 1260 aaatgctgta agacttaatt ctaaaatcaa ggtgaaattt gaacagaatg gttcaagtaa 1320 aaattctcat ctggtctccc ctgctgttag taacagtcac caaaatgttc taagcaacta 1380 ctttcctaga gtatcatttg ccaaccaaaa ggctttcaga ggtgtgaatg gatctccaag 1440 gataagtgta acagttggca acatccctaa aaactcagtc tcttctagtt ctcagagaag 1500 ggtttcatct tctaagatat ccctaagaaa ttcttcaaaa gtaacggaat cagcatctgt 1560 gatgccatcc caggatgtga gtgggtctga agatacattc ccaaataaac gacctaggct 1620 agaagataag actgtttttg acaatttttt tatcaagaaa gagcaaataa aaagcagtgg 1680 taatgatcca aagtatagta caaccacagc tcagaattcc agcagttcat ccagtcagag 1740 caaaatggtt aattgcccag tttgtcagaa tgaagttctg gagtctcaga ttaatgagca 1800 cttggactgg tgccttgaag gtgacagcat caaagtcaaa agcgaagaaa gtctttgaaa 1860 aaggtttcaa agtctcaagt accacctgta ttatctcact aatgtgctat gtcagccagt 1920 caggaagttc tggttaatac taagatttgt aggttataat ctagttcaca taaccaatag 1980 aaagtgtcct attttatata tacgcatata agattgtaat tttaagatgt tttgtgtctc 2040 agggtgctac attcactctt gccttaggta tactgtaacc caggttctgc ctgtcgtgta 2100 taatttttag atacttttgt tctttcttgc tcttaaggat tttaaaaacc tgttaatctt 2160 tttatttgta tactttccta aaaatattca tatggggaat cctgtcaggt gtttggttat 2220 attgactatt tattaatagt attagaactc attccctgaa ctgatgtaaa tcttcatagt 2280 gtcagacata ctgaccaaaa ccacaatcta gactacaaag tatattgttt tagagtactc 2340 aaattgtatt atttattaat ttttttgttt gcaaaatctt aacaggaact gtattttcta 2400 tattttaaag aattttattt gtcccacttt tactaaacag tggcagcaga ttttaagtta 2460 aagaatatgg aatatagtaa aataagtaaa tttcttttgg aatattttta gtaacaaata 2520 gccactataa ttctgtaggc caaattttat attgagttta gctgttttct caaaatttag 2580 cagagtggtt aaaattctgt gctgataagt aactgataca tataacataa acataacaaa 2640 gttgcctagt tgatgtaaca gtggaaagtt atctggaaat agtattttga actttaagcc 2700 aagtttaaaa cattataata aaaggaatac catttgtgca ttttaagtaa tcttttttaa 2760 aaaaaatatt ttccatgtta tagggaaagg acaaagagac ttttatcagt ttgctttttg 2820 tcttgtggct gtacatgctg ttggcatagc cctaatacag ttgttcacaa gttttctttt 2880 ttcttgttgc aattttcctt cactttgttg taatacaggt gcacaaatct taagtgcaca 2940 gctgggtaaa cttttacagt gttcacctgt gtaactacca cccggatcaa gttagagaac 3000 acttccattg ccacagaagg cttcctatag gtgtctgttc ccagttgata cccatgaccc 3060 tcaccacctc cagaggtccc cactgttttc accccatcgt cgcagattat tttttaattt 3120 tataatgtag tatctttgtt cctatgtata gcaggagttc attttcattg ctcttgcatt 3180 tgtatgaata tactagaatt tattcatcat ctatgtaatg gncattgaat attccagttt 3240 ggg 3243 <210> 20 <211> 1451 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 337489.2 <220>
<221> unsure <222> 281, 291, 830, 845 <223> a, t, c, g, or other <400> 20 acagtggcgt gttcctagaa gccgctttcg gcatcagtag gcggcggcgt ggggtctggc 60 agcgtgggga gagggaccaa ccgacgccac ttcgtgttgg gaagtgggag cgggagggcc 120 gggcaattcc cgaccgaacc aaacggtttc catggatctc aatagtgcca gcactgttgt 180 tcttcaggtg ttaacacagg ccaccagtca ggatactgct gtgttaaaac cagctgagga 240 gcagttgaag cagtgggaga cacagccagg tttctattca ntgttgctga ntattttcac 300 caaccacact ttggatataa atgtaaggtg gcttgctgta ctgtatttta aacatggaat 360 tgatcgctac tggagacgtg tagcacctca tgctctctca gaggaggaga aaactactct 420 gcgtgcaggg ctcatcacca acttcaatga accaataaac cagattgcaa ctcagattgc 480 agtgctcatt gcaaaagttg ctagattgga ttgtcccaga cagtggcctg aactaattcc 540 cactcttata gagtctgtta aagtccagga tgatcttcga cagcacagag cattacttac 600 cttctatcat gttaccaaga cactggcatc taaacgactt gctgctgata gaaaactatt 660 ttatgattta gcttctggaa tttataattt tgcctgctct ctgtggaatc accacacaga 720 cacattcctg caagaagttt cttctggcaa tgaagctgca attttgagtt cactagaacg 780 aacactgcta tcattgaaag tgctgcgtaa gttaactgtt aatggatttn tggacctcat 840 aagantatgg aggtgatggg ttttttacat ggaatatttg aacgtctaaa acagtttctg 900 gaatgcagta gaagtatagg tacagataat gtgtgtagag atagactgga aaagaccatc 960 attcttttta ctaaagtgct tttggacttc ttggatcagc atcctttttc atttactcct 1020 ctaattcaga gatcactgga attttctgta agctatgttt ttacagaagt tggtgaaggc 1080 gttacatttg aacgattcat tgtccaatgt atgaatctta ttaagatgat tgtcaaaaat 1140 tatgcttata agccatccaa aaattttgaa ggtaattcct ttattggcag tttaaaagaa 1200 ttattttaat cttaagtgtg atataattgc tataattaca aactttttaa aaaatgtcat 1260 tttagtctga aaaataaatt gttgctggga catgaaaaag atataaggat tataggcttt 1320 agtatgttta tactagcttt taaaaacaac atagtgcatt taataagcca ttttttgtag 1380 cacaaattgg ttgaagctta gggactttaa gaattaggta ctatagtcat cactgcagct 1440 catattgtag g 1451 <210> 21 <211> 2710 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 359574.5 <400> 21 ccacgctgct gcatgggcca cgtgagctca ggctgtggga gcggatggag ctgctacagt 60 cagcgcttgg ggctggcctc agcttgtaga cccgagccct gcagaacaac cccccgtggc 120 gcaggagagc agaagaaagg gggcctttat gcccttttga gggaagcaca cattctgcaa 180 ggccgtggaa acaaagggag gaactgtttg tagccctcgt ccagacgccc caaacaaaca 240 gagccaagtt acaccctgtt taaccctgcc ttcaaaggga cgactctgta agattctctg 300 ctacttattc aagttgacac gatgcccttc acactccacc tgaggtcccg ccttccctct 360 gccataagga gtttgattct acaaaagaaa ccaaacatca gaaatacatc cagcatggct 420 ggagagctcc gaccagccag cctggtggtc ctgcccaggt cccttgctcc agcttttgaa 480 agattctgcc aggtcaacac tggtcctcta cccctgctgg gccagagtga gccagaaaag 540 tggatgctgc cccctcaagg tgctatctca gagaccagga tgggccatcc ccagttctgg 600 aaatacgagt tcggtgcctg caccggcagc ctggcttcgc tggagcagta ctcggagcag 660 ctgaaggaca tggtggcctt cttcctgggc tgcagcttct ccctggagga ggccttggag 720 aaagcggggc tcccccagaa gagacccagc aggtcacagc caggcgggtg catacaagac 780 aacagtgcct tgtgttaccc atgctggctt ctgctgccct ctggtggtca cgatgaggcc 840 cattcccaag gacaagctgg aagggctggt gcgggcctgc tgctccctcg gaggtgagca 900 ggggcaacct gttcacatgg gcgacccaga actgttggga atcaaagagc tttccaaacc 960 tgcctacggg gatgccatgg tgtgtccccc aggggaggtt ccagtgttct ggccttctcc 1020 gctgaccagt ctcggagctg tcagcagctg tgagacccca ctgggctttt gccagcatcc 1080 caggctgcac agttatgact gacctgaagg atgcaaaggc tccacctggt tgtctcaccc 1140 cagagagaat tccagaggtc catcacattt cccaagatcc tctgcactac agcatcgcgt 1200 acagtctctg cttctcagaa gatcagagaa ctagagtcta tgatcggcat agacccaggg 1260 aaccggggga ttgggcacct gctctgtaaa gatgagctgc tgaaggcctc tctctcgctg 1320 tcccatgccc gctcagtgct catcaccact gggttcccca cacatttcaa tcatgagcct 1380 ccagaagaga cagatggccc accaggagct gttgctctgg ttgccttcct gcaggccttg 1440 gagaaggagg tcgccataat cgttgaccag agagcctgga acttgcacca gaagattgtt 1500 gaagatgctg ttgagcaagg tgttctgaag acgcagatcc cgatattaac ttaccaaggt 1560 ggatcagtgg aagctgctca ggcattcctg tggcaaaaat ggggacccgc agacacctag 1620 atttgaccac ctggtggcca tagagcgtgc cggaagagct gctgatggca attactacaa 1680 tgcaaggaag atgaacatca agcacttggt tgaccccatt gacgatcttt ttcttgctgc 1740 gaagaagatt cctggaatct catcaactgg agtcggtgat ggaggcaacg agcttgggat 1800 gggtaaagtc aaggaggctg tgaggaggca catacggcac ggggatgtca tcgcctgcga 1860 cgtggaggct gactttgccg tcattgctgg tgtttctaac tggggaggct atgccctggc 1920 ctgcgcactc tacatcctgt actcatgtgc tgtccacagt cagtacctga ggaaagcagt 1980 cggaccctcc agggcacctg gagatcaggc ctggactcag gccctcccgt cggtcattaa 2040 ggaagaaaaa atgctgggca tcttggtgca gcacaaagtc cggagtggcg tctcgggcat 2100 cgtgggcatg gaggtggatg ggctgccctt ccacaacacc cacgccgaga tgatccagaa 2160 gctggtggac gtcaccacgg cacaggtgta accgtccatg ttccgtgtga gcagagtccc 2220 taccaacggg caggtctgca tccggggaga atgcagctgc ttctggcgac aatcctgcta 2280 gtaaacactg gtcttcggtg agcaacgaac actcgcctgg cctgggaaac tgcatgccca 2340 ctttctggga ggggttagtg caggtgccgt ggacaaagga caacatttct ctggggcttt 2400 ttaactttta ttcctaagac tctaaaggcg ttgatttcaa ccctccttca ctctggcttc 2460 ttcaggcaac ccacgtggtc tcctgtgaga atcttctcga cagttactta tggggacact 2520 tgtgaacaat taactgccag gcagagcatg agaacaaaca ttcccaggcc atgtaggata 2580 ggatactcca gactccagtc atcctccccc atccatggtt tctgttactc atggtttcag 2640 ttactcatag ccaactgcag accgaaaata ctaaatgaaa aatttcagaa ataaacaact 2700 cttaagtttt 2710 <210> 22 <211> 2271 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 360645.5 <220>
<221> unsure <222> 2002 <223> a, t, c, g, or other <400> 22 cggaggcgag cggagggttt cccgcggcgg atttctgaca gtcagacttg tccacaagaa 60 ctcaactggc aaggctgctt ttctgtgcta aaactgggga gctagtgggc accatgaaga 120 tcttctgcag tcgggccaat ccgaccacgg ggtctgtgga gtggctggag gaggatgaac 180 actatgatta ccaccaggag attgcaaggt catcttatgc agatatgcta catgacaaag 240 acagaaatgt aaaatactac caaggtatcc gggctgccgt gagcagggtg aaggacagag 300 gacagaaggc cttggttctc gacattggca ctggcacggg actcttgtca atgatggcgg 360 tcacagcagg tgccgacttc tgctatgcca tcgaggtttt caagcctatg gctgatgctg 420 ctgtgaagat tgtggagaaa aatggcttta gtgataagat taaggttatc aacaagcatt 480 ccaccgaggt gactgtaggt ccagagggtg acatgccatg ccgtgccaac atcctggtca 540 cagagttgtt tgacacagag ctgatcgggg agggggcgct gccctcctat gagcacgcac 600 acaggcatct cgtggaggaa aattgtgagg ccgtgcccca cagagccacc gtctatgcac 660 agctggtgga gtccgggagg atgtggtcgt ggaacaagct atttcccatc cacgtgcaga 720 ccagcctcgg agagcaggtc atcgtccctc ccgttgacgt ggagagctgc cctggcgcac 780 cctctgtctg tgacattcag ctgaaccagg tgtcaccagc cgactttaca gtcctcagcg 840 atgtgctgcc catgttcagc atagacttca gcaagcaagt cagtagctca gcagcctgcc 900 atagcaggcg gtttgaacct ctgacatctg gccgagctca ggtggttctc tcgtggtggg 960 acattgaaat ggaccctgag gggaagatca agtgcaccat ggcccccttc tgggcacact 1020 cagacccaga ggagatgcag tggcgggacc actggatgca gtgtgtgtac ttcctgccac 1080 aagaggagcc tgtggtgcag ggctcagcgc ttctatctgg tagcccacca cgatgactac 1140 tgcgtatggt acagcctgca gaggaccagc cctgaaaaga atgagagagt ccgccagatg 1200 cgccccgtgt gtgactgcca ggctcacctg ctctggaacc ggcctcggtt tggagagatc 1260 aatgaccagg acagaactga tcgatacgtc caggctctga ggaccgtgct gaagccagac 1320 agcgtgtgcc tgtgtgtcag cgatggcagc ctgctctccg tgctggccca tcacctgggg 1380 gtggagcagg tgtttacagt cgagagttca gcagcttctc acaaactgtt gagaaaaatc 1440 ttcaaggcta accacttgga agataaaatt aacatcatag agaaacggcc ggaattatta 1500 acaaatgagg acctacaggg cagaaaggtc tctctcctcc tgggcgagcc gttcttcact 1560 accagcctgc tgccgtggca caacctctac ttctggtacg tgcggaccgc tgtggaccag 1620 cacctggggc caggtgccat ggtgatgccc caggcagcct cgctgcacgc tgtggttgtg 1680 gagttcaggg acctgtggcg gatccggagc ccctgtggtg actgcgaagg cttcgacgtg 1740 cacatcatgg acgacatgat taagcgtgcc ctggacttca gggagagcag ggaagctgag 1800 ccccacccgc tgtgggagta cccatgccgc agcctctccg agccctggca gatcctgacc 1860 tttgacttcc agcagccggt gcccctgcag cccctgtgtg ccgagggcac tgtggagctc 1920 agaagctcag gaagatggga gcttacttcc tgtggtcacc gatgcaccat tttcctgaac 1980 cctcctggga gctggagcag gnccgggcag agccacgcag cggtgctatg gatggagtac 2040 cacctgaccc cggagtgcac gctcagcact ggcctcctgg agcctgcaga ccccgagggg 2100 ggctgctgct ggaaccccca ctgcaagcag gccgtctact tcttcagccc tgccccagat 2160 cccagagcac tgctgggtgg cccacggact gtcagctatg cagtggagtt tcaccccgac 2220 acaggcgaca tcatcatgga gttcaggcat gcagataccc cagactgacc a 2271 <210> 23 <211> 2611 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 404145.7 <400> 23 gctgtggggt ttttctgtaa gactgaagat gacttcaatg attggtgcca gcaagtcaaa 60 aagctgtctc tgctcggagg tgccctgccc atgtttgagc tggtggagca gcagccttca 120 catctgggcc tgccccgacg tcctgaacct gtccctaggt gagagctgcc aagtccaggt 180 ggggtccctc ggaggtacga tctgtgccct tgcttcccca gtcctggccc ccttggtttt 240 gaccattaag gtgtgtgtga gcctgagccg tgagcacttg gcagtggttc gcctgtgaga 300 ccaggtatgg agtggagcgt cccctcctcc aagcttgcgc ccagcagccc aggacccacc 360 tcgtcttccc caccagcgct gcctgcccgg gcgctgtgga gctgggcgtg ctaccatgga 420 gtcctcaggg gtctggagca gacagaacat gcaggctctg tggtgacgca gtcctgggtg 480 ggggactggt tcacttgggc accactggcc atgggtggcg tagacccctc ggaccatggc 540 cagcgtgccg caggagccgg cctgggctcg tgcagtgaag tgagtggccg tgagcgcgtc 600 ctcctcatct ctgtctccct gtgggaaact ctacaaacaa ggcaatggca atggaaccac 660 tcctgatgac cacgagggtc agacgcggga cagaggcccc tcagggcctg agattgtgcc 720 ggccgccccc tgccctcctc accctgccct gctcctcttc tctgctccct ccccccatat 780 tcgcaggtct gcacaacccc cggacctgtt cacacccgca tggggacagc tgtctgtggg 840 ctgcagagca ggcactgctc agtctgcccc acgccaaggg cccttgactc acacccaggt 900 ggcccaccca agatgcctga tgcgctatgt cctgttcctt ctagattctt ctgatgtaga 960 gcgactggaa agattcttcg actcagaaga tgaagacttt gaaatcctgt ccctttgaaa 1020 atcctggggt cgggggtggc acctgtgaga gcctggggct cctggtgccg ctgcgtttca 1080 tccatcccgc ccgctcgcct gccgagggct gcgccccgtg ctgcctcccc ccagagggcc 1140 acccgctgtg ctcgtggact gaggctgcgc tgcccgggag gccttactgc ttggtgtcag 1200 actgcccagc tcagagtgcc cgtcagggcc tgtgcatccg cacgcggagc cgtctgttag 1260 gagcttccag agtgttctct cgacactgcc agccccgtgt tagcacctgg gcctcagtcc 1320 cacttgctcc caggcgccgg ttctgtggtt ggtttggaat taaagtcctg tttgaagttg 1380 tcagacacag acatgaattt ctggggcgct ccctgagtca gagtctcaga agacctgtgc 1440 aggctggcgt gagaggagcg gcagccacac tgcggcccca cgcccaagga ctgggctgct 1500 ctcgaggggg gcgcgcccac cgctgtgtcc tctctgccca gcctggctta ccaagggcta 1560 cctcagtggg agatgaggtt ggaggaacga aggcgaggtt cctccttgct ttggggagaa 1620 aagtattcag gaagtgggtg tgtgggaaac ctgaagatgg cgtgcacagg acacagcgtg 1680 ggcggcctgg gcagaagggc ggctggctgt cctggagctg ctgctggagc ctgccctcag 1740 agtgtccctt tccagtgctg tggcattctg tggcagcttc cccaggtgtg gtgacggggg 1800 ggggcggggc ctccacctgt gacagccagg cttgagggtg gacggcgtgc ctctcccagg 1860 agccttcccc atgtccttgc cttgctgaga attgccctcc catgccgctg aggtgttagg 1920 tggtttaggg ccaaaagggg aaaaccactt gagtcttgtg gtgtgtggtg ggcagacacc 1980 acagggtggc atcacctggt ggcatttcca gaacctcagc cccgattcca gcacccacca 2040 ccgcctgacc ctgtgtaacc tgctgtcccg ggtcccagag tgcactctgc cccgctgctc 2100 tgctgcctgt cctgggaaag tagctttgcc ccactaggaa atgtaaacag gagggcttgg 2160 ggagcgtggg cacttttctc atgagcagct actgcggcgt tggcaggact cgctgctgct 2220 gctgctgctg cttgtgtagg tcggggagcc ggagatcccc gaggacgcgc gccggacagt 2280 cggcactgac cggcccacct ggtagcagag gacaccccca gccccccaag cattgaagac 2340 atagtgtatt tcctcgtatc ctttctccct tgggtgtagt tggggtgggg aagcagggaa 2400 ggctggtgcg atctccattc cttgggctcc acgtccgagt tcatggtgcg ccgctgtgct 2460 gggagctgca gtggtaatgt gtgggacacc ttgaccaaag gggagctttg tctcgtgtgt 2520 tttgaaaaag gcttaatgaa gagaatgttg ttcattctta gtagtatagt ttgcaattct 2580 taatggcaaa taataagttt cagtagaaaa c 2611 <210> 24 <211> 1331 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 480119.1 <220>
<221> unsure <222> 605, 733, 1319, 1325 <223> a, t, c, g, or other <400> 24 gagaaagctt aatattgaag tatctctcct atgaggtgtt agaactattt gcctacaatt 60 tattggggaa aaaattgctc atttgtgtac ataaacctag gacagagcac atagggaaaa 120 taacattcca acacagggga attttgccca aggctcatga aagaacccaa gccagttttc 180 tcaagacttg acctcaggcc tactggaata.tttctctcaa agtctcctgt tctcacactg 240 acaagactga tgtccctgtg ttaggattgg acagaggaat gtttctgtgt gcaaggaaga 300 actgcttaat gtaagagggc ccatctgaat ttatttgcag gacatcggtg ggatcaagtg 360 aaaaaggagg accacgaggc aacaggtccc aggctcagca gagagctgct ggatgagaaa 420 gggcctgaag tcttgcagga ctcactggat agatgttatt caactccttc aggttgtctt 480 gaactgactg actcatgcca gccctacaga agtgcctttt atgtattgga gcaacagcgt 540 gttggcttgg ctgttgacat ggatgaaatt gaaaagaagg ggaagaagat caaagaagga 600 aagangaagg ggaagaaaag aaggggaaga agatcaaaac ccaccatgcc ccaggctcag 660 cagggagctg ctggatgaga aagggcctga agtcttgcag gactcactgg atagatgtta 720 ttcgactcct cangttatct tgaactgcct gacttaggcc agccctacag cagtgctgtt 780 tactcattgg aggaacagta ccttggcttg gctcttgacg tggacagaat taaaaaggac 840 caagaagagg aagaagacca aggcccacca tgccccaggc tcagcaggga gctgctggag 900 gtagtagagc ctgaagtctt gcaggactca ctggatagat gttattcaac tccttccagt 960 tgtcttgaac agcctgactc ctgccagccc tatggaagtt ccttttatgc attggaggaa 1020 aaacatgttg gcttttctct tgacgtggga gaaattgaaa agaaggggaa ggggaagaaa 1080 agaaggggaa gaagatcaaa gaaggaaaga agaaggggaa gaaaagaagg ggaagaagat 1140 caaaacccac catgccccag gctcagcagg gagctgctgg atgagaaagg gcctgaagtc 1200 ttgcaggact cactggatag atgttattca actccttcca gttgtcttga acagcctgac 1260 tcctgccagc cctatggaag ttccttttat gcattggagg aaaaacatgt tggcttttnt 1320 cttgncgtgg g <210> 25 <211> 2813 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 480951.5 <220>
<221> unsure <222> 13, 981, 992, 2807 <223> a, t, c, g, or other <400> 25 cctggagact cgngtggccg aggggcttca taccagctga agagcgacaa gccgctggca 60 gccgcggatc tcaccgccgc tcaggagatc tgttggtaat ctgaggattt ttattctacg 120 tcgtcttgac agatggaaaa cctgaagtaa cttcgggcta accttgtgtt tttggaaaat 180 tagtagactt ggtggtgaag aaactgggag gagtaggata ttagctaact ttgcatagcc 240 acatatagag cgtcgcagct gcattccacc aaagaggaac caaaaggcct gtggtgttcc 300 cagggtacat attcatgcca gaagtgaagt gccttggtga attcgtttcc tgaaagttta 360 tcgcatactt gtactgggtt agccttatgc cagcctggac catcttggag gcagtgtagg 420 atcatggaag aactttgaat taggttttta gaacttcagc cataaaaatg ggcagaattt 480 tccttgatca tatcggtggt acccgtctgt tttcttgtgc aaactgtgat acgatcctga 540 ccaaccgctc agaactcatc tccactcgtt tcacaggcgc cactggcaga gcatttcttt 600 ttaacaaggt agttaacctg cagtacagtg aagttcaaga tcgggtcatg ctcactggcc 660 gccacatggt tcgagatgtg agctgcaaaa actgcaatag caaactggga tggatctatg 720 agtttgccac tgaagacagc cagcgatata aggaaggccg cgtgatcctg gaacgtgctc 780 tagttcgaga gagtgagggc tttgaggagc atgtaccatc tgataactct tgaagataca 840 gagagaaatc catcttttcc caggtctcct tcactgaaaa caaaaatcta cttacataca 900 ctgtcacctt agcatcagag tcggattaat gaactgcgga acaagaggtt gtgagaatct 960 aagatggaac ctttctttct ntctttcttt tnttttaaat tttgtatttt ccatccaaca 1020 gcagtgtgta gagagaatat tatgcagatg ccgttaattt tttaccctat gtttacgtct 1080 tgaggcagca gagtctgtct gcagctatgt ggtgagctat gtaaggaaaa aaatctgggc 1140 tgttagagtg aaaaagtgtg ttttatgtca attgtgaaag gaaaatgtta ggagtatggt 1200 ttttaaactt gggcttcatt ttaaactttt ttttttaaac ccagttattt cacttgattt 1260 gctagcttca gagaagagat ccgaatctgt gcccagcgct aaaggctcag tgttagcatg 1320 gcttgtgctg gccggtgtgc catattcttg ttggagatga accgtagcac cagagcccat 1380 tcttccttgt cagtcttggc ccaaagatgt caccattcct agttatttgt caccacataa 1440 ttggtgttga ttggaaactt tttctgagat gggacagaac tgctgggttg tctttttcca 1500 tgtaacttaa gcatagtaat ataaataaag taatagttgg atgcttttgg tcctgtgttg 1560 cttttaaaaa caccttataa aagaggagag tatttgataa gcaattttca tagtagtaaa 1620 gttttttttc atctcttaaa ctaaattgac catgcatata atattctttg tttaaatgaa 1680 agcatactgt tgaaacccgc agtgttgcat ttagaaaaca gttgaacaga atgtcaatgt 1740 gcattcatgc aaaaaaacat ttaatctgca tctgttttag aaaaggggga aatgaagcaa 1800 cttgtctaaa aatactgctt tacaaagcat ttcagccttt ccccctcagt tttgcattga 1860 ttttttgaca agtctgtaga gcctaatagt ttccatcaaa ggcctagatc tcttatttag 1920 catttttttc agctcttctc tcagaagttc agctgttgaa acgaaaactg tactttgtac 1980 cctcacatac aaagggatca aatttgacct ggtgttattt tagccccaaa tttatgacat 2040 tacacaatat taaaatgtaa atgtttcttt acccaaacta cttctagata ttctagtatt 2100 tgcttctggt ggaattaaat gacggtaaaa ttggctaatt atttgaatga atgaatggat 2160 ggatgttttg catgctcaat ttctaggtcc tttgtctaga aaggaaattt gcctcagttg 2220 aattagtgaa atatttctgt cgttgatatt aaaagtgact tctgagtaca gttaagttcc 2280 tcctatttgc cactgggctg ttggttagaa gcataggtaa ctgattaagt aggtatgata 2340 ctgcatttga aataagtgga cacaaactat cctttctcca ccatggactc aatctgagaa 2400 caacagcatt catttccatt catttccata ctggcttttg attatatgca gattcctagt 2460 agcatgcctt acctacagca ctatgtgcat ttgctgtcac aataaagtat attttgtctt 2520 gcattgatgc agtactgctg cttattttcc actgatcttg tctagtgatc atcttaattt 2580 ttatctctga acacatactt ggtatctttg agtacctgta gctttcttca tttggcaatg 2640 atagtgatgt ctgacttgat taactgccta attcacacat gaagacattg actttgccag 2700 tattaacttc tctgagatca ttttgcctta gatactgata actatagttc agtatatata 2760 aacaaaaaaa tttcatatta ctaggttaac ttttaggtaa ctggcangta cca 2813 <210> 26 <211> 3281 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 481257.3 <400> 26 cagcgacgac gcggaggcag agaaaggaac gcccggccca gccccgtagc acaggcggag 60 tgcagcggag ggcccctgcc gctgccgtca tgccgttccc gtttgggaag tctcacaaat 120 ctccagcaga cattgtgaag aatctgaagg agagcatggc tgttctggaa aagcaagaca 180 tttctgataa aaaagcagaa aaggctacag aagaagtttc caaaaatctg gttgccatga 240 aagaaattct gtatggcaca aatgaaaaag agcctcagac agaagcagta gctcaacttg 300 ctcaagaact ctataatagt gggctcctta gcaccctggt agctgattta cagctcattg 360 actttgaggg caaaaaagac gtggctcaaa ttttcaacaa tattctcaga agacaaattg 420 gtacgagaac tcctactgtt gaatacatct gcacccaaca gaatattttg ttcatgttat 480 tgaaagggta tgaatctcca gaaatagctc taaattgtgg aataatgtta agagaatgca 540 tcagacatga accacttgca aaaatcattt tgtggtcgga acagttttat gatttcttca 600 gatatgtcga aatgtcaaca tttgacatag cttcagatgc atttgccaca ttcaaggatt 660 tacttacaag acataaattg ctcagtgcag aatttttgga acagcattat gatagatttt 720 tcagtgaata tgagaagtta cttcattcag aaaattatgt gacaaaaaga cagtcactga 780 agcttctcgg tgaactacta ctagatagac acaacttcac aattatgaca aaatacatca 840 gtaaacctga gaacctcaaa ttaatgatga acctgctgcg agacaaaagt cgcaacatcc 900 agtttgaggc ctttcacgtt tttaaggtgt ttgtagccaa tcctaacaag acgcagccca 960 tcctagacat cctcctcaag aaccaggcca aactcataga gttcctcagc aagtttcaga 1020 acgacaggac ggaggatgag cagtttaacg acgagaagac ctatttagtt aaacagatca 1080 gggatttgaa gagaccagct cagcaagaag cttaatctcc aataaacatc tatgttaaat 1140 ccaaattcag catttgctgt tagctattca gcatcaggca ctcttattga ttcatgagga 1200 acattactgc taatctgctg ttaagtgaac ggtttttcat tttacccttt tgtttttcag 1260 tccaggttgg agatcgtagc tgctgctgct tgcacactag ggcacatgtg ggctttctct 1320 tgatctttgt gtcatttcag aattcaaaga ctgtgctacg ggagttctga acatggctgg 1380 gttcatgaag gcaaatgtat ggatgagagt gtggtttagg aaagagggca ctgatatcag 1440 attagaccta tgtgtttgca cccatctttg ttggcgatct gagtgcagtg tggcaagtgc 1500 acacctggca tccctgcgtc agatcgcgca ccttcaggtc gcgcaccttg cgctgaagga 1560 agatgacgca gagctttatc tgaaatcaga ggggagctat ccaaaatggg agtttggggg 1620 cagctaaagt tgacatgcga ataaattgat actgaaactt agcaacttct taaaagtgta 1680 aagaagcctc ataagatcat aaggaaaatg tatatatgct tttcacagct ttctagaatt 1740 ttttgacatt tgattttctt gagacttgta aacctggata tgttgaaggg tatttgttaa 1800 ttttactttt caaagatact ttaaaacagt agagctagca atgacacctt gcatttcatt 1860 tcaacactgc ttcaaggttt cttttgtata taattcttag aatgctcatt tcttttaaat 1920 ggtttaattt gtacagcaga ggaatgttat tgtagtagta tgtaactatt acctaatact 1980 gagtttttgc aaaaaacaat gaatgctcat atgtaattga aatacttcag atcacatgaa 2040 aatgctgatt taacatttaa gtatcacagc attaaaagaa aaagaaagta aaccagtcct 2100 ttgtattcag ttacctaatg gggtgccatc aataagctgc gatacagccc tggagctcag 2160 tcagccacac cttcctgcat cctattggcc ttattcattt taaatgagtt aatgaatctg 2220 ccagatctgt gaatgataga gattatgcta aattaatgct gattctttgt gtgtgtggga 2280 aatctctgta gagcaccttt tctttcttag actaagtaac ccagtacaat agttgtgaac 2340 tgaataatta aaactttggc ttctcttagg aaaagacgac ttcctagtca taggtgtcct 2400 atggggaaat ttattttttt ttaatgtcct gttccttaat gctgcaaatt atcagtattt 2460 ataaagtaac tgattttgca ccactttttt gttactgtga ccacggcaga acaatgtctt 2520 ctagactata tctatgtaaa gttattagaa tggtatctgt tcattttagt gatatgaaga 2580 tcacaactaa caactgacaa atcagagttt gccagttcaa attcagcatg gctgcagctg 2640 attaagaaat tgatatgatt attctttgct agcctctctt actaatggaa ttatatactg 2700 gccagtaaaa tgggcctccc aattgctgtt tcagcaggtt ttaaaccttc aggaacacca 2760 gttaggaaaa tagctccaga aaatatagat atattttatt tttattaaaa tggcagtcta 2820 catcataatt ggcatttctc aagactgtct ttaccagaat ctgtgtgaaa taaggcaatc 2880 tagtctcctt gaaaagaaaa tcccttggga tgtttaggaa ggaagacttg gccgtgatgt 2940 ggtgtcctgg ctttgtggtg tagtgctgtg tgtatggagt tagtgtaaaa acatggatta 3000 caccaagtgg aagaaacgtc ttcttgccaa gctcattctt agaacttaca catctagaac 3060 agcttccact ttggcagtga ggtcgtagcc tttcaggtgg aagaagtgag ggtgcagcgt 3120 gtcagacaca acattcatgt tactcttaca ttggaatctg aaggtagttc agacttcgtg 3180 ggtttgtttt taagcaaaac aatgtgaaaa catttaagtt tgaaatgttg catttgaagt 3240 tatgatcatt taatatatca tattaccaag actattatct g 3281
26 481257.3 4803693H1 1231 1418 26 481257,3 4803661H1 1231 1463 26 481257.3 2490053H1 1284 1533 26 481257.3 77490081 1290 1870 26 481257.3 774900H1 1290 1521 26 481257.3 5544123H1 1332 1470 26 481257.3 5543325H2 1332 1537 2b 481257.3 882706H1 1373 1639 26 481257.3 2135058H1 1376 1660 26 481257.3 2135057H1 1376 1660 26 481257.3 4756042H1 1378 1638 26 481257.3 3224551H2 1385 1665 26 481257.3 1837721H1 1476 1754 26 481257.3 4700765H1 1496 1767 26 481257.3 5278213H1 1625 1796 26 481257.3 4605663H1 1509 1771 26 . 481257.31258053H1 1644 1882 26 481257.3 g1332248 1519 1971 2b 481257.3 3482768H1 1667 1986 26 481257.3 3117425H1 1674 1973 26 481257.3 g2162252 1679 2116 2b 481257.3 8773044 1708 1881 26 481257.3 8773045 1709 2008 26. 481257.3 8773043 1709 1958 26 481257.3 8776171 1709 2021 26 481257.3 5633438H1 1583 1813 26 481257.3 6063131H1 1710 2045 26 481257.3 4322029H1 1712 1984 26 481257.3 1293678H1 1731 2003 26 481257,3 5633470H1 1584 1851 26 481257,3 82138927 1742 2131 26 481257.3 5697876H1 1745 2017 26 481257.3 5424544H1 1599 1865 26 481257,3 4752662H1 1764 2045 26 481257.3 265691H1 1779 2037 26 481257.3 2570491H1 1777 2038 26 481257.3 81924668 1788 2046 26 481257,3 82155625 1796 2117 26 481257.3 681712H1 1800 2072 26 481257.3 5872540H1 1813 2117 26 481257.3 8840128 1828 2129 26 481257.3 5424549H1 1599 1865 26 481257.3 4114541H1 1600 1904 26 481257.3 8838985 1833 2082 .
26 481257.3 3113085H1 1839 2137 26 481257.3 81740712 1845 2006 26 481257.3 4434102H1 1851 2116 2b 481257.3 2818414H1 1611 1919 26 481257.3 2699486H1 1876 1990 26 481257.3 2705722H1 1877 2161 SE6~ Template Component Start Stop ID NO: ID ID
26 481257.3 4164453H1 1881 2158 26 481257.3 3485863H1 1906 2199 26 481257.3 5086162H1 1920 2106 26 481257.3 301.1128H 1625 1923 26 481257.3 1341459H1 1921 2164 26 481257.3 8879545 1936 2238 26 481257.3 5408150H1 1952 2059 26 481257.3 82206845 1971 2134 26 481257.3 018589H1 1977 2279 26 481257.3 82004226 1982 2334 26 481257.3 2474254H1 1988 2230 26 481257.3 1438403H1 1997 2261 26 481257.3 1437601H1 1997 2273 26 481257.3 5154866H1 1998 2251 26 481257.3 1738907F6 2021 2405 2b 481257.3 82031584 2022 2286 26 481257.3 1738907H1 2021 2268 26 481257.3 8873349 2043 2114 26 481257.3 2219963H1 2044 2310 26 481257.3 5546018H1 2057 2260 26 481257.3 4515045H1 2062 2322 26 481257.3 3377306H1 2074 2365 2b 481257.3 81860563 2075 2168 26 481257.3 3931048H1 2082 2386 26 481257.3 655184H1 2532 2780 26 481257.3 4759972H1 2535 2830 26 481257.3 3163986H1 2546 2816 26 481257.3 2425109H1 2548 2790 26 481257.3 1724276H1 2552 2776 26 481257.3 81887641 2557 2981 26 481257,3 82820788 2558 2990 26 481257,3 5677886H1 2559 2813 26 481257.3 4904046H2 2561 2845 26 481257.3 3563946H1 2562 2858 26 481257,3 1631524H1 2562 2794 26 481257.3 3563302H1 2562 2889 26 481257,3 81859585 2571 2997 26 481257.3 1846040H1 2574 2816 26 481257.3 2771788H1 2575 2822 26 481257.3 4802918H1 2576 2839 26 481257.3 350681H1 2581 2797 26 481257.3 2325487H1 2590 2841 26 481257.3 81977173 2593 2869 26 481257.3 81892411 2593 2864 26 481257.3 3473745H1 2595 2844 26 481257.3 1863330H1 2595 2846 26 481257.3 1863330F6 2595 3145 2b 481257.3 552764H1 2619 2851 26 481257.3 2362444H1 2632 2909 26 481257.3 1745503H1 2635 2883 SEQ ID Template Component Start Stop NO: ID ID
26 481257.3 4558555H1 2639 2891 26 481257.3 532059H1 2639 2854 26 481257.3 4555552H1 2639 2860 26 481257.3 4505643H1 2651 2943 26 481257.3 3068819H1 2656 2975 26 481257.3 3171027H1 2657 2944 26 481257.3 3171088H1 2657 2938 26 481257.3 3379612H1 2660 2928 26 481257.3 84395482 2684 3050 26 481257,3 1729555H1 2685 2905 26 481257.3 292475H1 2687 3033 26 481257.3 291878H1 2687 2952 26 481257.3 3950881H1 2693 2873 26 481257,3 3012122H1 2695 2981 26 481257.3 547518H1 2695 2933 26 481257,3 4211183H1 2695 2956 26 481257,3 1314982H1 2696 2940 26 481257.3 3946155H1 2700 2877 26 481257.3 6064507H1 2727 2975 26 481257.3 2600642H1 2727 3009 26 481257.3 6064407H1 2727 3024 26 481257.3 3886104H1 2738 3000 26 481257.3 g 1893892 2738 3076 26 481257.3 040482H1 2739 2939 26 481257.3 g 1892555 2742 3039 26 481257.3 1424170H1 2746 2986 26 481257.3 81398711 2751 2874 26 481257.3 1759965H1 2762 3034 26 481257.3 81919966 2768 3113 26 481257.3 696972H1 2768 3064 26 481257,3 3202809H1 2768 3059 26 481257.3 696677H1 2768 3005 26 481257.3 2158950H1 2768 3072 26 481257.3 5167705H1 2781 2881 26 481257.3 2022007H1 2789 3057 26 481257.3 3714681H1 2802 3077 26 481257.3 3761940H1 2802 3098 26 481257.3 3919253H1 2802 3050 26 481257.3 1318693H1 2805 2891 26 481257.3 2284086H1 2829 3055 26 481257.3 1420843H1 2835 3087 26 481257.3 4092117H1 2864 3094 26 481257.3 3366654H1 2203 2492 26 481257.3 82155929 2204 2638 26 481257.3 3076013H1 2210 2508 26 481257.3 3681116H1 2238 2555 26 481257.3 1747569H1 2272 2555 26 481257.3 1459994H1 2279 2530 26 481257,3 4321951H1 2280 2557 26 481257.3 3723672H1 2280 2463 SE6~ Template Component Start Stop ID NO: ID ID
26 481257.3 920433H1 2280 2595 26 481257.3 4622265H1 2285 2462 26 481257.3 338447H1 2287 2535 26 481257.3 8715010 2288 2600 26 481257.3 338842H1 2287 2501 26 481257.3 1351650H1 2288 2546 26 481257.3 1809511F6 2301 2879 2b 481257.3 1809511H1 2301 2557 26 481257.3 1553819H1 2306 2506 26 481257.3 3686776H1 2309 2607 26 481257.3 3089582H1 2315 2616 26 481257.3 4903640H1 2327 2616 26 481257.3 1807852H1 2334 2472 26 481257.3 1603388H1 2346 2556 26 481257.3 2585721H1 2346 2608 26 481257.3 490934H1 2347 2614 26 481257.3 4861461H1 2347 2602 26 481257.3 3738138H1 2362 2656 26 481257.3 3749039H1 2368 2654 26 481257.3 2411583H1 2383 2619 26 481257.3 1524008H1 2391 2650 26 481257.3 291952H1 2393 2726 26 481257.3 5569863H1 2396 2629 26 481257.3 658020H1 2399 2657 26 481257.3 2893849H1 2398 2615 26 481257.3 1544390H1 2400 2604 26 481257.3 2440744H1 2415 2645 26 481257.3 2185706H1 2427 2711 26 481257.3 81687360 2442 2876 26 481257.3 4904656H2 2457 2731 26 481257,3 3929576H1 2460 2755 26 481257,3 2743452H1 2479 2746 26 481257.3 2441476H1 2479 2708 26 481257,3 4558022H1 2511 2784 26 481257.3 4073134H1 2512 2712 26 481257.3 2188345H1 2519 2793 26 481257,3 4375649H1 2523 2788 26 481257.3 81860487 2524 2741 26 481257.3 2618351H1 2531 2774 26 481257.3 4880013H1 3083 3371 26 481257.3 3931126H1 2082 2372 26 481257.3 2156566H1 2092 2377 26 481257.3 3931010H1 2082 2262 26 481257.3 5156451H1 2112 2368 26 481257.3 5779103H1 2082 2363 26 481257.3 667400H1 2093 2357 26 481257.3 81898178 2093 2458 26 481257.3 663114H1 2123 2398 26 481257.3 663147H1 2123 2406 26 481257.3 4758209H1 2124 2413 SEQ ID Template Component Start Stop NO: ID ID
26 481257,3 2797741H1 2128 2388 26 481257,3 5205492H2 2135 2389 26 481257.3 528572H1 2138 2414 26 481257.3 2495479H1 2139 2385 26 481257.3 4513333H1 2154 2422 26 481257.3 3771907H1 2167 2496 26 481257.3 5208347H1 2180 2439 26 481257.3 1390911H1 2187 2445 i 4., ~ o ~>
w ~ , o ~ ~ ~ ~ o o ~
o II A, ~ b ~ ~ ~? II ~'? a Q' 'b ~ W
O
~
C 5 H y ~ ~ ~ A, ~ p O
' ~
~
L' ~ ~' y c C ~ ~
a~ ~ ~ .~ b ~ ~ y > w b >
"" t!
W m '' m w. O II ~
~ ~ O c ~ b C1 'fl ~ ~i eca O ~
~ ~ O
~ ~ v ~ ~ :e O ~ ~ p C ai .
E W > C
V ~ ,~ . O O , fi7 W c~ ~ ~ II O
tr .~ o cp ~ p c% ~ n ..: . ~ ~ c~ is ..
oa ~' ~'>', U ~' ~' ~ G7 > C O ~"~ m w cd W ~ ~ O
y:
fr .~ ~ N r ." O t-.
'" O y r.. ' y N ~
C, ~ W O fit,W ~ a ~ w~ W fx ~ W
> ~L 'w~ a. b w U
U G n .N C
~ z ~ ~
N
O ' N
yr O\ ~ w ~ .
c~ N ~l M
yy o N ~
0 O T ~ a O
U U U M ~ o ~ w 'a W f~
~ x', ~ W
a~ ~ r~~ a x ~,N
.~
V O C/7 ,~ N C C!j ~ N O
U U t~ ~ b M ~
~ _ M ~ ~ W ~ ~ x ~ ~ ~
g .~ x ? :3 ~ ~ N b ~ ~o ~ 3 ~
c v~ a ~ .r b ~ ~ ~
N b 0 ~ '~ ~ ~ ~ vi ,~ C ~ ~ Q ~
w w ~ ~x ~ a ~ ~ ~ ~ b~ "~
~
~ ~, ~ ~ _ r 'D _ Ov v ca ~a f3. o Qi U ~ ~ O M
. ~ .~
v~ ~. E- U _ U Y U O . Cn U
Y w U
~
. w , ~
w ao O O O U o a ~. ~ a x .~ ~
U O .
~ x o ~ ~
~
x W wa w a ~ . a~N~
z bb ~
:z3 ~a ~
xa~N
o . N o U
, .
v ~ ~ . ~ c ~ v ~
a ~p C V ~ ~ w n ~ o n p ~ W eC
y ~
~"
y G
~ .~
C "O 'O 4.C. U 'n ~ O U
N fti p 4. b "
, ~
ti ~ ~ C' C ~
y .b C :O c ~ pa ~ b C a C
O
C ~ ~'~' U O O U ~ U a "v~ c~ bQ ~
O" ~ cd ~ ~ U G ~
U C O ~i ~
E, _ [~ c0 c T
~ . ~ ~V7w _ a) ~ x~ O
U ~ ., ~ dp o .: .~ ~ c ~ ~ U ~ ~ C
y a :~ Q.
a~
~ vr~ ~ ~o~~ ~ ~, _o~u,~
~
J t-~ N p U ~ ~ ~ >~ ~ ~ . C
y C m G7 ~ O ~ , D
C
Uv~'~ ~ .. ~ " ~'~' V a a. c~
~ ~ U
~
U C ~ O b O c3 C _ c0 O U
y e~ 'n 4 y N C ~ U
p > '~ ~
b v' i . C v v' C O ~ ~ ~ O C ~
C ' O. ~ U N O it v~ O
a ~ O y O p C _ G , U
cd ~ ~ O n ~ 3 ,~.., G1r C_ w ~ ~ A ._ >
C ~
~ .~
y ~ ~ y V U w C ~ ~
' CC ~ O a.
GO
C p J r--~ ~
~
O ~ ~ ~ ~ ~ ~ y ~ aW C ~ ~."
.c O a~ v . c _ bD C .U O C O b0 C
a ~ ~ ~ C w U C ~. G
~
.
c~ O aG c~ O c N ~ _ C ~ a J ~ G~
~' O U i hp o-0 ~ ~
A a. ~ L~. a, U f L
C ~ ~~ . ~ o.., a~ ~
~ ~ ~ ~ ~
-a a a a a a ~a~. , ~
w a H a Q
w ~S w a Q ~ a w ~
..~ ... a Q ~ Q ~ w ~ x ci~
16~
U
~ O
, cC
W
L G]
"CI O C
~ N
O ~ id Y
, O :~
y >
. v~
O ~' O p cT~ O
O
O
CD
y ~ 'b O a c'~
>' _ c C~ ~ n 3 y U U w~ y v C O O
a: z ~ ~
t7 ~, Q
x ~.
~w= . ~ ~ o ~w~~ Wb a~~
G E" ,~ N 'C U y ~ a 01 o .y y 0.~ ' ~~ CG o' b ~ "' ~ o 'o 00 ~ ~ . C7 w C z ~ p 00 0. >, ~~ ~
a N 3 ~
~; ~ C~b N o0 ~ .~, ~ ~ '~" ~ ~v~
00 ~ s. ~ cd c0 >_ M
O Ova ~N~-. '~y ~ y ~ v '. r ct5 v G ~ 00 '~ ~ y ' ~
iC f.~ C ~ ~
y U
, _ E ~ ~v CL
o' ~3 _ 'D C N O ~ y > .
~ c" a ~ ~ .., W N y.
~ C7 v fl. ~ C G1 ~ U Q' N
-,' ' >
H
'~ ~ ~ '" 0 o ~ ~ t~
eo ,~ = 00 v ~ o.
w ~ o s ~ ~ 0.1 ' a y u ~ b U as s . . ~ ~; , c ~ r:; ~ ~ o o a '~
0 3 ~ '~ a. a~ ~ o ~ ~ ;
f1i ~ W oo ~ ~ C7 z - , C7 C7 '. rr~ a 3 u: U , ~ Z ca v~ Pa N
~ U
N c w b'' . '' s " o :3 w ~ o o .O ed ~ G ~ ~" G V N
~ ~
C
.b 0. . ~ O
a t, U G ' pr C ~' . ~ .~ ~ ~
~ O m .C
~ U ~ b 'O d " U
~ O 'b ~ U ~ G
, ~ y flJ
t" Q' U G ~ ~ ~ c~ G N
Gr ~ U
p ~p ~ ' bD C
s.
ii C cd ~ G-n 4 w b4 O O ' C N C D
U y t >, O. O
C b ~ p.
. ~ V U v N
~ O ~ ~ ~
U .C ~
O
~
N CL 4. y ~ ~ ~ W U U
U p. c0 ~
~ z ~
a~y ca w ~~ y c ~ .~ U p., ~ ~ c s ~ ., o .y ~ '_. >' .n ~ '~ E
o. ~ ~ .a ~
cG C U
~' U
au ~ .
C C ~ C ~ (~ G ~ b0 ~ ~ C
O ~ .~' ~ ~ N
L' b n N ~ 'Gr, ~ N U
p c~ c~ ~
N y ~ Q a ' a a ~ a Q~ ~ ~ ~ ~ a a ~ ~. ~ ~
U
~' .O d ~ U
O p t~. t~. ' G f~
0; w ate. 0.~ U
SEQUENCE LISTING
<110> INCYTE GENOMICS, INC.
Hodgson, David M.
Lincoln, Stephen E.
Russo, Frank D.
Spiro, Peter A.
Banville, Steve C.
Bratcher, Shawn R.
Dufour, Gerard E.
Cohen, Howard J.
Rosen, Bruce Chalup, Michael S.
Hillman, Jennifer L.
Jones, Anissa L.
Yu, Jimmy Y.
Greenawalt, Lila B.
Panzer, Scott R.
Roseberry, Ann M.
Wright, Rachel J.
Daniels, Susan E.
<120> SECRETORY MOLECULES
<130> PT-1064 PCT
<140> To Be Assigned <141> Herewith <150> 60/147,501; 60/147,500 <151> 1999-08-05; 1999-08-05 <160> 26 <170> PERL Program <210> 1 <211> 1973 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 001978.1 <400> 1 gcaggttcgg ggtcggccgg cctgcgcgtg ggcttgcgag gacgctgttc gtcccctgcg 60 ctggggtgtc cgacagcgag gaggagaacg acgcacggag cccgcgcgac tggaaccagc 120 aaagctccat ctgtcggcag aggagaaggg ggaggaggca cggccgaggc aaacgagcgg 180 acgcctcgtc gccgggtgcc ggtatcaccc cgctgcaacg ccttccagca aaagccaccg 240 cggcccgggt tgcagcagcc ggacggatgc caaggccaca cggcagccac gggggcagcc 300 gtcgcagtcg ccgtcccaca cgggctgcgg acaccaaggg ttgctaatga agtgattgag 360 aagaaacagt gaacatcctc atttcacaga taagacaaca tggatcagcc ttttactgtg 420 aattctctga aaaagttagc tgctatgcct gaccatacag atgtttccct aagcccagaa 480 gagcgagtcc gtgccctaag caagcttggt tgtaatatca ccatcagtga agacatcact 540 ccacgacgtt actttaggtc tggagtagag atggagaggt ggcgctgtgt atttggaaga 600 aggaaatttg gaaaatgcct ttgttcttta taataaattt ataaccttat ttgtagaaaa 660 gcttcctaac catcgagatt accagcaatg tgcagtacct gaaaagcagg atattatgaa 720 gaaactgaag gagattgcat tcccaaggac agatgaattg aaaaacgacc ttttaaagaa 780 atataacgta gaataccaag aatatttgca aagcaaaaac aaatataaag ctgaaattct 840 caaaaaattg gagcatcaga gattgataga ggcagaaagg aagcggattg ctcagatgcg 900 ccagcagcag ctagaatcgg agcagtttct gtttttcgaa gatcaactca agaagcaaga 960 gttagcccga ggtcaaatgc gaagtcagca aacctcaggg ctgtcagagc agattgatgg 1020 gagcgctttg tcctgctttt ccacacacca gaacaattcc ttgctgaatg tatttgcaga 1080 tcaacctaat aaaagtgatg caaccaatta tgctagccac tctcctcctg taaacagggc 1140 cttaacgcca gctgctactc taagtgctgt tcagaattta gtggttgaag gactgcgatg 1200 tgtagttttg ccagaagatc tttgccacaa atttctgcaa ctggcagaat ctaatacagt 1260 gagaggaata gaaacctgtg gaatactctg tggaaaactg acacataatg aatttactat 1320 tacccatgta attgtgccaa agcagtctgc gggaccagac tattgtgaca tggagaatgt 1380 agaggaatta ttcaatgttc aggatcaaca tgatctcctc actctaggat ggatccatac 1440 acatcccact caaactgcat ttttatccag cgttgatctt cacactcact gttcctatca 1500 actcatgttg ccagaggcca ttgccattgt ttgctcacca aagcataaag acactggcat 1560 cttcaggctc accaatgctg gcatgcttga ggtttctgct tgtaaaaaaa agggctttca 1620 tccacacacc aaggagccca ggctgttcag tatatgcaaa catgtgttgg taaaagacat 1680 aaaaataatt gtgttggatc tgaggtgata tgttctgaat gtaagcaccg tcaacatcag 1740 acacctactc atggacatgt ggttgccgga ttttcttaag atgtttccag aaatgactga 1800 tattttatat ttatacattt tagatgacaa agcttgatat ttattgctgt tgcacatttt 1860 aaagttttct ttttgggttg ctctgtgtca agagaggtta catggtgtta aatcggtacc 1920 tgataatgta cccaaatact atggccagat aataaattgt gctgcaaaca aca 1973 <210> 2 <211> 3199 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 002588.4 <400> 2 gtcccttccc ctcacccgct ccacgccctc ctgggccgag tggagttggg tggtgtcggg 60 agcctctccc tgaggggcac cgcgtcttca ggagctgggc ctccagtgcg gcgcgatgtc 120 aggcgcggtg acagctctgt gagtccgagg ccgcggccgt ggcgctgggc ggctgcgggg 180 cctgaccggt ccgctcatgg tgccgccacg acgccatcgc ggggcaggaa ggccaggggt 240 gctgagttct tcacctcctt ttagactgag atctgccaag ttttccggca ttgctcttga 300 ggatctcaga agggctctta agacaagact gcaaatggtg tgtgtatttg tcatgaaccg 360 aatgaattcc cagaacagtg gtttcactca gcgcaggcga atggctcttg ggattgttat 420 tcttctgctt gttgatgtga tatgggttgc ttcctctgaa cttacttcgt atgtttttac 480 ccagtacaac aaaccattct tcagcacctt tgcaaaaaca tctatgtttg ttttgtacct 540 tttgggcttt attatttgga agccatggag acaacagtgt acaagaggac ttcgcggaaa 600 gcatgctgct ttttttgcag atgctgaagg ttactttgct gcttgcacaa cagatacaac 660 tatgaatagt tctttgagtg aacctctgta tgtgcctgtg aaattccatg atcttccaag 720 tgaaaaacct gagagcacaa acattgatac tgaaaaaacc cccaaaaagt ctcgtgtgag 780 gttcagtaat atcatggaga ttcgacagct tccgtcaagt catgcattgg aagcaaagtt 840 gtctcgcatg tcatatcctg tgaaagaaca agaatccata ctgaaaactg tggggaaact 900 tactgcaact caagtagcga aaattagctt ttttttttgc tttgtgtggt ttttggcaaa 960 tttgtcatat caagaagcac tttcagacac acaagttgct atagttaata ttttatcttc 1020 aacttccgga ctttttacct taatccttgc tgcagtattt ccaagtaaca gtggagatag 1080 atttaccctt tctaaaacta ttagctgtaa ttttaagcat tggaggcgtt gtactggtaa 1140 acctgggcag ggtctgaaaa acctgctgga agagacacag taggttccat ttggtctctt 1200 gctggagcca tgctctatgc tgtctatatt gttatgatta agagaaaagt agatagagaa 1260 gacaagttgg atattccaat gttctttggt tttgtaggtt tgtttaatct gctgctctta 1320 tggccaggtt tctttttact tcattatact ggatttgagg acttcgagtt tcccaataaa 1380 gtagtattaa tgtgcattat cattaatggc cttattggaa cagtactctc agagttcctg 1440 tggttgtggg gctgctttct tacctcatca ttgataggca cacttgcact aagccttaca 1500 atacctctgt ccataatagc tgacatgtgt atgcaaaagg tgcagttttc ttggttattt 1560 tttgcaggag ctatccctgt atttttttca ttttttattg taactctcct atgccattat 1620 aataattggg atcctgtgat ggtgggaatc agaagaatat ttgcttttat atgcagaaaa 1680 Catcgaattc agagagttcc agaagacagc gaacagtgtg agagtctcat ttctatgcac 1740 agtgtttctc aggaggatgg agctagttag ctgtctgttg tctgtagccc agcttgataa 1800 tggaactata cagcgaagag acaatctctg gcaagttttt gtagaaaaaa tgtttcagtg 1860 cctagtctga aaaataacag tttgagttct ttgaaactct aaaatatatt tttctcatac 1920 ctgttttctt cattttcata atgaagcact ttgctatgta gctgtgtaca tatcactaca 1980 gttataggaa gtttcagtct acagtccatc caaaggacca acctgcctta cacatctcaa 2040 ggaattcagc tgttgaaatc atttgaacta atcaaggaat aaatcctaat gttctgggac 2100 tttattttca catgttaaat gctggaatat attatgaaaa tgttttcaag aaatcactta 2160 agtgttcata gaccagtatt tctgacaggt aaaatgctaa aataagctac ctgtaataag 2220 tgtggattat atttttgggt tttgtagaat attgcaaatt aaccacacaa aaaatgttta 2280 atttatgcaa caagcatgtt tgtgcaaatt tcatgggact ttaaaaagaa taagtatttg 2340 agaaaatatc tggttcactt acactacatt tactgtatta ttcttttata gcattaggtg 2400 ccttgtattt taaatctgtg acaaaccatg gcaaattttt aaaggggaag tattattata 2460 aaatgaagaa atatgtattt ctaaaggcta tattgctgta aacttaattg ataaagctct 252D
gtttaattta gagttttgaa gaaatagtct cccttcaatt aagaaatttt cataatggaa 2580 tgatttaaat tgaagtgaca aagagtatta ttaaaataca atgtttatac gtgtatttgt 2640 gtattgtaga tgtatcaagt gatttctaat ttttttcaca tatgaatgtg ccagattact 2700 ctagaactag atgtctcttc tttaaataat tttagttttc ctgaataaat ttgtaatggt 2760 taaagtacca agtaagtaag gcgagaaggg attctgtttt taaaatcaca tcagaacttt 2820 tcctctacta agattataaa ttaaatgtaa aatactccta attgcaattc ttaaacttag 2880 gccttacatg tacttattat gcaactgctc ctggactcta ttcaccatag atatcagtaa 2940 acgtatgtcc caggattcac aggcttttga ttaatcaata ttcttttcaa gtttgctgtg 3000 aagagtttag ttctcttcaa aatttcttaa ctaatctgat ttttaggaat tctctttgca 3060 gtgtttagct tcctattcac attcttaaaa ttgctttggt gttaccatga gtctaaaatg 3120 aagtttagcc ttccttttgt ttcattctga gaacttctat attatattac ctttaaaaat 3180 tgtttatgat attaaattt 3199 <210> 3 <211> 2235 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 201759.3 <400> 3 gcggcgacgg cggccgttgc tgcgccgggt actggggtcg ctgcctgagg cgcaggcgcc 60 gtggactcca cccgccccgg ggcctgggct cgctgtggac tcgtcatggc gaccgagcag 120 aggcctttcc acctggtggt gttcggcgcg tctggcttca ccggccagtt cgtgaccgag 180 gaggtggccc gggagcaggt ggacccggag cggagtcccg cctgccctgg gccgtggcgg 240 gccgctcccg ggagaagctg cagcgggtgc tggagaaggc ggccctgaag ctgggaagac 300 caacactgta catctgaagt tggaatcatc atctgtgata ttgctaatcc agcctcgctt 360 gatgaaatgg ctaaacaggc aacagttgtc ctcaattgcg taggaccata tcggttttat 420 ggagaacctg taataaaagc atgtattgaa aatggagcca gttgtatcga catcagtgga 480 gaacctcagt ttctggaact aatgcaactg aagtatcatg agaaagctgc agacaaaggg 540 gtttatatca ttggaagcag cggctttgac tccattccag cagatctggg agtaatatat 600 accagaaata aaatgaatgg tactttgact gctgtggaaa gtttcctgac tatacattca 660 ggacctgagg ggttgagcat tcatgatggt acctggaagt cagcaattta tggttttgga 720 gatcagagta atttgagaaa actaagaaat gtatcaaatc tgaaacctgt cccgctcatt 780 ggtccaaaat tgaagagaag gtggccaatt tcttattgtc gggaactcaa aggttattcc 840 attcctttta tgggatctga tgtgtctgtt gtaaggagga ctcaacgtta cttgtatgaa 900 aatttagagg aatcaccagt tcagtatgct gcgtatgtaa ctgtgggagg catcacctct 960 gttattaagc tgatgtttgc aggacttttc tttttgttct ttgtgaggtt tggaattgga 1020 aggcaacttc ctcataaaat tcccatggtt cttctccttt gggctatttt tcaaaacaag 1080 gcccaacaca aaaacagatt gatgctgcct cattcacgct gacattcttt ggtcaaggat 1140 acagccaagg cactggtaca gataagaaca aaccaaatat caaaatttgt actcaggtga 1200 aaggaccaga ggctggctat gtggctaccc ccatagctat ggttcaggca gccatgactc 1260 ttctaagtga tgcttctcat ctgcctaagg cgggcggggt cttcacacct ggagcagctt 1320 tttccaaaac aaagttgatt gacagactca acaaacacgg tattgagttt agtgttatta 1380 gcagctctga agtctaaaca ctggaagaat taactgaagt cataacgtgc gtgaattaac 1440 agcttctcta tttgatattt gaaattcttc tgtaagcctg tctgagtgta tgtggaaacg 1500 attgtcaaat ctaaaatatc tatatattaa aaagtaggaa attgtcctag cttaccctaa 1560 atttcaaatc tgagttgatt ttgtgatttt attgcttata acagagaact catatttgac 1620 atattttttt cattgatgtg ttcctggtag attttcacga atgagctggc aggtctaatg 1680 ggggaggcgg cgtcccagtc tgtgttgcag cagcattctc atcgggggtg cgcacaccat 1740 cgttactgtc gggcagtaac tgccgcttgc cttgccgcag taggagggaa atctcacctt 1800 ccttccacat actgtcttga gcctttgcta aattaaactg cactttttgc tatttttgcc 1860 tagtttttcg ccaatctaca ctgattttgg actgttacct aagttgaaaa ataaaaggtt 1920 gtcaatcgaa tggtggttta atgtttggac ctgccgatgt atttgtatag tggtagaaac 1980 atgctgctta agtggcctaa cctgtttctt gccaataagt aggcttatca ttttatcttt 2040 acgtaattct atatctgtga ctaggttttt aaggatacag cttataagtt gctatcaatt 2100 ttcactacct aagcagaatt tttctctaat ttactttttg tattttaact aggttttaca 2160 tggaagccct aaaataaggc aaaagacttt ttcttttgta ataagcatat aataaacacg 2220 tatatacata gcaaa 2235 <210> 4 <211> 1953 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 208184.1 <400> 4 gcggccgctg tagttgcggc ggtccagtcg tagcccggcc gcccgcgcct gtccggtccg 60 gtccggccac ggaggcagcg cagcggcggg actccgagcc taccccgccg agtgagctgc 120 gccgcaccgt gccgtcccac ccggcaccca ccagtccgat ggggccgcag cggcggctgt 180 cccctgccgg ggccgcccta ctctggggct tcctgctcca gctgacagcc gctcaggaag 240 caatcttgca tgcgtctgga aatggcacaa ccaaggacta ctgcatgctt tataaccctt 300 attggacagc tcttccaagt accctagaaa atgcaacttc cattagtttg atgaatctga 360 cttccacacc actatgcaac ctttctgata ttcctcctgt tggcataaag agcaaagcag 420 ttgtggttcc atggggaagc tgccattttc ttgaaaaagc cagaattgca cagaaaggag 480 gtgctgaagc aatgttagtt gtcaataaca gtgtcctatt tcctccctca ggtaacagat 540 ctgaatttcc tgatgtgaaa atactgattg catttataag ctacaaagac tttagagata 600 tgaaccagac tctaggagat aacattactg tgaaaatgta ttctccatcg tggcctaact 660 ttgattatac tatggtggtt atttttgtaa ttgcggtgtt cactgtggca ttaggtggat 720 actggagtgg actagttgaa ttggaaaact tgaaagcagt gacaactgaa gatagagaaa 780 tgaggaaaaa gaaggaagaa tatttaactt ttagtcctct tacagttgta atatttgtgg 840 tcatctgctg tgttatgatg gtcttacttt atttcttcta caaatggttg gtttatgtta 900 tgatagcaat tttctgcata gcatcagcaa tgagtctgta caactgtctt gctgcactaa 960 ttcataagat accatatgga caatgcacga ttgcatgtcg tggcaaaaac atggaagtga 1020 gacttatttt tctctctgga ctgtgcatag cagtagctgt tgtttgggct gtgtttcgaa 1080 atgaagacag gtgggcttgg attttacagg atatcttggg gattgctttc tgtctgaatt 1140 taattaaaac actgaagttg cccaacttca agtcatgtgt gatacttcta ggccttctcc 1200 tcctctatga tgtatttttt gttttcataa caccattcat cacaaagaat ggtgagagta 1260 tcatggttga actcgcagct ggaccttttg gaaataatga aaagttgcca gtagtcatca 1320 gagtaccaaa actgatctat ttctcagtaa tgagtgtgtg cctcatgcct gtttcaatat 1380 tgggttttgg agacattatt gtaccaggcc tgttgattgc atactgtaga agatttgatg 1440 ttcagactgg ttcttcttac atatactatg tttcgtctac agttgcctat gctattggca 1500 tgatacttac atttgttgtt ctggtgctga tgaaaaaggg gcaacctgct ctcctctatt 1560 tagtaccttg cacacttatt actgcctcag ttgttgcctg gagacgtaag gaaatgaaaa 1620 agttctggaa aggtaacagc tatcagatga tggaccattt ggattgtgca acaaatgaag 1680 aaaaccctgt gatatctggt gaacagattg tccagcaata atattatgtg gaactgctat 1740 aatgtgtcat tgattttcta caaatagact tcgacttttt aaattgactt ttgaattgac 1800 aatctgaaag agtcttcaat gatatgcttg caaaaatata tttttatgag ctggtactga 1860 cagttacatc ataaataact aaaacgcttt gcttttaatg ttaaagttgt gccttcacat 1920 taaataaaac atatggtctg tgtagtttcc gag ' 1953 <210> 5 <211> 1867 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 212029.3 <220>
<221> unsure <222> 54, 89, 1164, 1166-1187 <223> a, t, c, g, or other <400> 5 ctaccctgct cctcagcctg tgagaacaga tgtggccgtc ctgcggtacc agcnaccccc 60 tgagtatggg gtaacgagcc gcccatgcna acttccgttc ccatcaacca tgcagcagca 120 cagccccatg tcctcccaga cctcttccgc cagcgggcca ctgcactctg tctccctgcc 180 gcttccactc ccgatggccc tgggtgctcc acagcccccg cctgccgcct cccccagcca 240 gcagcttggt ccagatgcct ttgcgattgt ggagcgagcc cagcaaatgg tggagatatt 300 aacagaggag aaccgggtgc ttcaccagga acttcagggt tactacgaca atgccgacaa 360 gctccacaag tttgaaaaag aacttcagag aatttcggaa gcctatgaaa gtctggtcaa 420 gtctaccacc aagcgagaat cgctggacaa ggccatgaga aacaaattgg aaggcgagat 480 tagaagactt catgatttca acagagacct ccgagatcga ctagagactg ctaacaggca 540 actatccagc agggaatacg aagggcatga agacaaagct gcagaggggc attatgcttc 600 ccagaacaaa gaattcttga aggaaaagga gaaattagaa atggagttag cagcagtgcg 660 gactgcaagt gaggaccatc ggagacacat cgagatcctg gaccaggctt tgagcaacgc 720 ccaggccagg gtcatcaagc tggaagagga gttacgagag aagcaagcat atgttgagaa 780 agttgagaag ctgcagcagg ccctgaccca gctgcagtct gcatgtgaga agcgagaaca 840 gatggagcgg agactgcgga cttggctgga gagagagctg gatgcactga gaacccagca 900 gaaacatgga aatggccagc cagccaacat gccggaatac aatgccccag ccctcctgga 960 acttgtgcgg gagaaggagg agcggatcct ggccctggag gccgacatga caaagtggga 1020 gcagaagtac ctggaggaga gcaccatccg acactttgcc atgaatgccg cagccactgc 1080 agcagctgag agggacacca cgatcatcaa ccactcacgg aatggcagct acggagagag 1140 ctcgctggag gcccacatct ggcnannnnn nnnnnnnnnn nnnnnnncca acagaaggtg 1200 tcaggacatg gaatacacta ttaaaaatct ccatgccaaa atcatagaga aagatgctat 1260 gattaaggtc ctgcagcagc gatctcgtaa agatgccggg aagacagact cctccagcct 1320 acgtcctgcc cgctccgttc catccatagc agcagctact gggacacact ctcgccagac 1380 ctctcttacc agcagccagc tggctgagga aaagaaggaa gagaagacct ggaaggggag 1440 cataggattg ctgctgggga aggagcacca tgagcatgcc tctgccccac tgctgctacc 1500 cccacccacc tcagcactgt cctccatagc ctccactacg gcagccagca gtgcccacgc 1560 caagacaggc agcaaggaca gcagcacaca gactgacaag agtgccgagc tcttctggcc 1620 cagcatggcc tcccttccca gccgcggccg gctgagcacg acccctgctc acagccccgt 1680 cctgaaacac ccagcggcca aagggaccgc agagaaactg ggtatgtggg ctaccccacc 1740 ttgatgcccc tgaaaactgt ggaactgtct ggcctaagag aatcttttgt tgagctagag 1800 aggaagcagg ggcacccatc agctcttact ctatggggat gctattctaa tgcacttagg 1860 atatgtg 1867 <210> 6 <211> 1325 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 213446.2 <400> 6 cgggggctga tggaagtgca gtgggggctg gagagggcac cctagtgagt tggcttttct 60 ctccttcggt gcctttggtt gggctcgagg cccggggtcg gaggccatca ggacaagagt 120 gtgggacttg gaagggcagc cacctggagc ttggaagggg ctgtatccag catgctccaa 180 ggccacagct ctgtgttcca ggccttgctg gggaccttct tcacctgggg gatgacagca 240 gctggggcag ctctcgtgtt cgtattctct agtggacaga ggcggatctt agatggaagt 300 cttggctttg ctgcaggggt catgttggca gcttcctatt ggtctcttct ggccccagca 360 gttgagatgg ccacgtcctc tgggggcttc ggtgcctttg ccttcttccc tgtggctgtt 420 ggcttcaccc ttggagcggc ttttgtctac ttggctgacc tcctgatgcc tcacttgggt 480 gcagcagaag acccccagac ggccctggca ctgaacttcg gctctacgtt gatgaagaag 540 aagtctgatc ctgagggtcc cgcgctgctc ttccctgaga gtgaactttc catccggata 600 gacaagagtg agaatggtga ggcatatcag agaaagaagg cggcagccac tggccttcca 660 gagggtcctg ctgtccctgt gccttctcga gggaatctgg cacagcccgg cggcagcagc 720 tggaggagga tcgcactgct catcttggcc atcactatac acaacgttcc agagggtctc 780 gctgttggag ttggatttgg ggctatagaa aagacggcat ctgctacctt tgagagtgcc 840 aggaatttgg ccattggaat cgggatccag aatttccccg agggcctggc tgtcagcctt 900 cccttgcgag gggcaggctt ctccacctgg agagctttct ggtatgggca gctgagcggc 960 atggtggagc ccctggccgg ggtctttggt gcctttgccg tggtgctggc tgagcccatc 1020 ctgccctacg ctctggcctt tgctgccggt gccatggtct acgtggtcat ggacgacatc 1080 atccccgaag cccagatcag tggtaatggg aaactggcat cctgggcctc catcctggga 1140 tttgtagtga tgatgtcact ggacgttggc ctgggctagg gctgagacgc ttcggacccc 1200 gggaaaggcc atacgaagaa acagcagtgg ttggcttcta tgggacaaca agcttctttc 1260 ttcacattaa aacttttttc cttcctctct tcttcatctc attatcctga ttgactctaa 1320 ttata 1325 <210> 7 <211> 1808 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 228864.4 <400> 7 ggcgtggcct ccggccggct cctctgctgt tgccaaggga aactgccgcg aggaggcgga 60 aggagcagag gaccggcagc cggcgtcgag gcggggcgcg ggaacgacgg cggccatggc 120 ggcctcgggg cccgggtgtc gcagctggtg cttgtgtccc gaggtgccat ccgccacctt 180 cttcactgcg ctgctctcgc tgctggtttc cgggcctcgc ctgttcctgc tgcagcagcc 240 ccctggcgcc ctacgggcct cacgctgaag tccgaggccc ttcgcaactg gcaagtttac 300 aggctggtaa cctacatctt tgtctacgag aatcccatct ccctggctct gcggcgctat 360 catcatctgg cgctttgctg gcaatttcga gagaaccgtg ggcaccgtcc gccactgctt 420 cttcaccgtg atcttcgcca tcttctccgc tatcatcttc ctgtcattcg aggctgtgtc 480 atcactgtca aagctggggg aagtggagga tgccagaggt ttcaccccag tgggcctttg 540 ccatgctggg agtcaccacc gtccgttctc ggatgaggcg ggccctggtg tttggcatgg 600 ttgtgccctc agtcctggtt ccgtggctcc tgctgggtgc ctcgtggctc attccccaga 660 cctctttcct cagtaatgtc tgcgggctgt ccatcgggct ggcctatggc ctcacctact 720 gctattccat cgacctctca gagcgagtgg cgctgaagct cgatcagacc ttccccttca 780 gcctgatgag gaggatatcc gtgttcaagt acgtctcagg gtcttcagcc gagaggaggg 840 cagcccagag ccggaaactg aacccggtgc ctggctccta ccccacacag agctgccacc 900 ctcacctgtc cccaagccac cctgtgtccc agacgcagca cgccagtggt tcagaagctg 960 gcctcctggc cctccctggc acccccgggc acatgcccac cttgcctccg taccagcctg 1020 cctccggcct gtgctatgtg caagaaccac tttggtccaa accccacctc ctccagtgtc 1080 tacccagctt ctgcgggcac ctccctgggc atccagcccc ccacgcctgt gaacagccct 1140 ggcacggtgt attctggggc cttgggcaca ccaggggctg caggctccaa ggagtcctcc 1200 agggtcccca tgccctgaga gaatttctag ggaagtcatc tcacttggcc ttctgaaggt 1260 cctccctaag agtctcctga caaaagttac ttattgaaca cctctatgtg ccaggctctg 1320 tgttgggtac tttgatcaat gcccctgttt cagtctcatc tgtactcacg gcagccctgt 1380 ggagtacggt gtactggccc agcttacaga tgcagaaagc gagacgttct gccatcagat 1440 aaagtcacgt ggctctttag taacacggac aaggctcctc gccaaggaac tcgtggcaga 1500 agagggcagc agttggcagt agctgccgat gtctgtcccc agctccacca ttcctccctg 1560 tggctgtgcc atgctcgtgg tttcagtgtc cgtgtgtcca tgtgtctgcc cttcaggagc 1620 tcgcagctgg tgtgcttggc ggtcccaggc ctgtgtagtg tctctcccct gctgcgggcg 1680 cccccacccc gattcctctc cccagaagcg gtgggatggg cccccatgaa ctgcagcagc 1740 atgctgaggt gtccatgttg tctgcctttg tataaagaaa cagcctctga aaaaaaaaaa 1800 aaaaaaat 1808 <210> 8 <211> 2992 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 229840.3 <400> 8 aacacgagtc caagctgcag ctgggcaggg attgcggggt gccggccgtc tgagtttttt 60 taaaactgct tcgccgcgaa gtctgtctgc agccaaaatg tccaacagaa acaacaacaa 120 gcttcccagc aacctgccgc agttacagaa tctaatcaag cgagacccgc cggcctacat 180 cgaggagttt ctacagcagt ataatcacta caaatccaat gtggagattt tcaaattgca 240 accaaataaa cccagcaaag aactagcaga gctggtgatg tttatggcac agattagtca 300 ctgctaccca gagtacctaa gtaattttcc tcaagaggtg aaagatcttc tctcctgcaa 360 tcataccgta ttggatccag atctgcgaat gacattttgc aaagctttga tcttgctgag 420 aaataagaat ctcatcaatc catcaagcct gctagaactc ttctttgaac tttttcgttg 480 ccatgataaa cttctgcgaa agactttata cacacatatt gtgactgata tcaagaatat 540 aaatgcaaaa cacaagaaca ataaagtgaa tgtagtattg caaaatttca tgtacaccat 600 gttaagagat agcaatgcaa ccgcagccaa gatgtcttta gatgtaatga ttgaactcta 660 cagaaggaac atctggaatg atgcaaaaac tgtcaatgtt atcacaactg catgtttctc 720 taaggtcacc aagatattag ttgccgcttt gacattcttt cttgggaaag atgaagatga 780 aaaacaggac agtgactccg aatctgagga tgatggacca acagcaagag acctgctagt 840 acaatatgct acagggaaga aaagttccaa aaacaagaaa aagttggaaa aggcaatgaa 900 agtgctcaag aaacaaaaaa agaagaaaaa accagaggtg tttaactttt cagccattca 960 cttgattcat gatccccaag attttgcgga aaaactacta aagcagcttg agtgctgtaa 1020 ggagaggttt gaagtgaaga tgatgctcat gaaccttatc tccagattgg tgggaattca 1080 tgagcttttc ctcttcaatt tctatccctt tttgcaaagg tttctgcagc cccaccaaag 1140 agaagtaacc aagatccttc tgtttgctgc acaagcatct catcacctag tacccccaga 1200 gattattcaa tcattgctta tgactgtggc aaacaatttt gttaccgaca agaactctgg 1260 agaagtcatg acagtaggaa tcaatgctat aaaggagata acagctcgat gtcctctggc 1320 catgactgaa gaacttctcc aagacctggc tcagtataaa acacacaagg ataagaatgt 1380 aatgatgtct gctagaactt tgattcacct cttccgaaca ctgaatcctc agatgctgca 1440 gaagaaattc cggggtaagc ctacagaggc ctccatagaa gcaagagtac aagaatatgg 1500 agaattagat gctaaagatt acattccagg agcagaagtt ctggaagttg agaaagaaga 1560 gaatgctgaa aatgatgaag atggatggga aagtaccagt ctcagtgagg aggaggatgc 1620 tgatggtgaa tggattgatg tgcaacactc ttccgatgaa gaacagcaag aaatctccaa 1680 gaagctgaac agcatgccca tggaggagcg gaaggccaaa gctgcagcca tcagcactag 1740 ccgagtttta actcaggaag acttccagaa aatccgcatg gcccaaatga gaaaagaact 1800 tgatgctgcc cccgggaaat gccagaagag gaaatacatt gaaatagaca gtgatgaaga 1860 gcccaggggt gaattacttt ctcttcggga cattgaacgc cttcataaaa agccaaagtc 1920 tgacaaagag acaagactag caactgcaat ggctggaaag acagaccgaa aagaatttgt 1980 gaggaagaaa accaaaacaa atccattttc cagttcgaca aataaagaga agaaaaaaca 2040 gaagaacttt atgatgatgc ggtatagcca gaatgtccgg tcaaaaaata agcgttcctt 2100 ccgagaaaaa cagttggcac tacgagatgc acttttgaaa aagagaaaaa gaatgaagta 2160 acttcctggc aagttttcca ttcctagaag aatgctaagt ttgtgtcctt gctctgaaaa 2220 ttggtaaatc aagcatgttt gtttacatta aaaagtccag acacactgta ttgtgaaaac 2280 tgctgaacat gtggcagcaa ttttgtgttt ttattttgga gacggctaat ggtaggaatg 2340 ttaatgtaaa tagtggtggt aatgtaaaat catttcattt atcattcatg caaaaaaaag 2400 tatgtattga gtgcctattc attgtcactg tagatgcaaa acgaatgagc tgtaacccct 2460 tcactcaagg cattgacagc ttagctgtga gggtggacac acatatgtgt atttacagtg 2520 cagtgtaaat agttctgtag tagaggttaa ctccatattt ctgtgaggtc actgaggcct 2580 tatggactaa ctctgtgagg ataggagtta tatattctta taagacaaaa caaaacagga 2640 caatgttaca agagtaagag gttcttactt gtacataggc tttcctgctg aaaacaggcc 2700 cctgctgtac agattttggg tacataattt agctctttta gtcaatccaa gagatttaag 2760 tgaccccccc cccgtgtttt ttttgttttt gtttttgttt tgaatgccat gtaaaggctt 2820 tttggttaag acctcacttt taaaactgcc ttaagtataa atagtacctt tggaatatat 2880 ttagttcatc atttgagctg ccttcatact ggtttcctca gccttccttc agcctgtaat 2940 attttcagcc cactgtttac cttgtctcaa taaaaggttt ctaatgccaa at 2992 <210> 9 <211> 2513 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 231793.2 <400> 9 cccggaacta acctcggctc ccttgggaag gccgcgttgc atggccagga gcagcagtct 60 gggccgcgag tgcgggacac cgaggtcagg tctcggaaag ggaggacctc ctcgtcccca 120 ggggccccag gccaggtgca cccttggccg caggtgcacg gtctccggaa agtgcaggcg 180 cccacgtccc agctggacca tggcgcctcc gcggaacgtg gtgaagattg ccatccagat 240 gcgtgacgcc atcccgcagc tcatccagct ggaccaggcg aagccctggc cgctgtgctg 300 aaggaggtgt gcgacgcgtg gagcctgacg cactctgagc gttacgccct gcagtttgcg 360 gatgggcacc ggagatacat caccgagaat aaccgcgcgg agatcaagaa tggcagcatc 420 ctgtgcctca gcacggcccc agaccttgag gctgagcagc tcttgggtgg gctgcagagt 480 aacagtcctg aagggcgccg ggaagccctg aggcgccttg ttccgctggc ctcggacatg 540 atctttgcca gggaggtcat cagccgtaat gggctccaga tactaggcac catcattgaa 600 gatggggacg acctaggaga ggtgctggcc ctcagcctga gggccttctc agagctcatg 660 gagcacggcg tggtgtcctg ggagactctg agcatcccct ttgtgaggaa ggtggtgtgc 720 tacgtgaaca tgaacctcat ggatgcctcc gtgcctcccc tggcccttgg gctgctggag 780 agtgtgacct tgagcagccc agccctgggc cagctggtca agagcgaggt gcccctggat 840 aggctgctgg tgcacctaca ggtgatgaac cagcagctgc aaaccaaggc catggccctg 900 ctgacagcct tgctgcaggg ggccagccct gtggaacgca agcacatgct tgactatctt 960 tggcagagga accttcgcca gttcatctat aagaacatca tccacagtgc agcaccaatg 1020 ggcgacgaga tggctcatca cctgtacgta ctgcaggctc tcatgctggg gctgctggag 1080 ccgcgcatgc gaacgcccct ggacccctac agccaggagc agcgggagca gctgcaggtc 1140 ctacgccagg ctgccttcga ggtggagggg gagtcctcgg gtgccgggct aagtgctgac 1200 cgtcgccgtt ccctctgtgc ccgagagttc cgcaaactgg gcttttctaa cagcaaccca 1260 gcacaggacc tggagcgcgt gccccccggt ctgctggccc tggacaacat gttgtacttc 1320 tccagaaacg cgcccagcgc gtaacagccg gtttgtgttg gagaacagca gccgcgagga 1380 caagcacgag tgcccctttg cccggggcag catccagctg acggtgctgc tgtgtgagct 1440 gctccgtgtt ggggagccct gctctgagac agcccaggac ttctcaccca tgttcttcgg 1500 ccaagaccag agcttccacg agctcttctg tgtgggcatc cagctgttga ataagacctg 1560 gaaggagatg cgggctacac atggaggact tcgacaaggt catgcaggtg gtgcgggagc 1620 agctggcccg cactctggcc ctgaagccca cttccctgga gctcttccga accaaggtga 1680 atgcgctcac ttatggggag gtgctgcggc tgcggcagac tgaacggctg caccaggagg 1740 gcacactggc tccccctata ctggagctgc gggagaagct gaagccagag ctcatgggcc 1800 tgatccgcca gcagcgcttg ctccgcctct gtgaggggac gctcttccgc aagatcagca 1860 gccggcggcg ccaggataag ctgtggttct gctgcctgtc ccccaaccac aagctgctgc 1920 agtacggaga catggaggag ggcgccagcc cgcctaccct ggagagtctg cccgagcaac 1980 tccctgtggc cgacatgagg gcactcctga caggcaagga ctgcccccat gtccgggaga 2040 agggctccgg gaagcagaac aaggacctct atgagttggc cttctcaatc agctatgacc 2100 gtggggagga ggaagcgtac ctcaacttca ttgccccctc caagcgggag ttctacctgt 2160 ggacagatgg gctcagtgcc ttgctgggca gtcccatggg cagcgagcag acacggctgg 2220 acctggagca gctgctgacc atggagacca agctgcgtct gctggagctg gagaacgtgc 2280 ccatccccga gcggccaccc cctgtgcccc caccccccac caacttcaac ttctgctatg 2340 actgcagcat cgctgaacct tgacagtgtg gctggccatg ggccacagct gcggccactg 2400 cagcagccat gaagggcagt gggtagagga gtgcaggcac cctgaccagc agagattgct 2460 gcagaaataa agtctgcttg gctcttggga tatgttgagc cagctctgta aaa 2513 <210> 10 <211> 1976 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 234137.5 <220>
<221> unsure <222> 1035, 1039, 1051 <223> a, t, c, g, or other <400> 10 gggagtggta gtgggggctg cagctgccgg acccaggtgc ggaagtgcga gggcccaggt 60 ggctgaaggg gccgttagga acatccaagc ggtggggcac aggcagatcc ccgacctgac 120 ctggaccacc cttctcctct tggcccgccc cttcaactcg cctccgctta ggtctggatt 180 ggccccgccc cctgacctga gcctggtcct tcttcaggca ctgacccttg acctccggtg 240 gctcccccat ctctcaggcg cgatggctac gggcgcggat gtacgggaca ttctagaact 300 cgggggtcca gaaggggatg cagcctctgg gaccatcagc aagaaggaca ttatcaaccc 360 ggacaagaaa aaatccaaga agtcctctga gacactgact ttcaagaggc ccgagggcat 420 gcaccgggaa gtctatgcct tgctctactc tgacaagaag gatgcacccc cactgctacc 480 cagtgacact ggccagggat accgtacagt gaaggccaag ttgggctcca agaaggtgcg 540 gccttggaag tggatgccat tcaccaaccc ggcccgcaag gacggagcaa tgttcttcca 600 ctggcgacgt gcagcggagg agggcaagga ctaccccttt gccaggttca ataagactgt 660 gcaggtgcct gtgtactcgg agcaggagta ccagctttat ctccacgatg atgcttggac 720 taaggcagaa actgaccacc tctttgacct cagccgccge tttgacctgc gttttgttgt 780 tatccatgac cggtatgacc accagcagtt caagaagcgt tctgtggaag acctgaagga 840 gcggtactac cacatctgtg ctaagcttgc caacgtgcgg gctgtgccag gcacagacct 900 taagatacca gtatttgatg ctgggcacga acgacggcgg aaggaacagc ttgagcgtct 960 ctacaaccgg accccagagc aggtggcaga ggaggagtac ctggctacag gagctgcgca 1020 agattgatgc ccggnagang gagcgggaga nacgcagcca ggacctgcag aagctgatca 1080 cagcggcaga caccactgca gagcagcggc gcacggaacg caaggccccc aaaaagaagc 1140 taccccagaa aaaggaggct gagaagccgg ctgttcctga gactgcaggc atcaagtttc 1200 cagacttcaa gtctgcaggt gtcacgctgc ggagccaacg gatgaagctg ccaagctctg 1260 tgggacagaa gaagatcaag gccctggaac agatgctgct ggagcttggt gtggagctga 1320 gcccgacacc tacggaggag ctggtgcaca tgttcaatga gctgcgaacg acctggtgct 1380 gctctacgag ctcaagcagg cctgtgccaa ctgcgagtat gagctgcaga tgctgcggca 1440 ccgtcatgag gcactggccc gggctggtgt gctagggggc cctgccacac cagcatcagg 1500 cccaggcccg gcctctgctg agccggcagt gactgaaccc ggacttggtc ctgaccccaa 1560 ggacaccatc attgatgtgg tgggcgcacc cctcacgccc aattcggtaa gagtctggac 1620 aggctgggag gcacgcctgg gccctgcgag tgagcacatg cacatgggtg taggggctcc 1680 tctccctcta gtgcctgcag caggaacgat catcacttct gtgcgagtct gagactgagg 1740 gtaggagtgg gttgaccagt gggcgtcctt gtccctgagc gtgtgaagca catgcactaa 1800 gcctgactca ggccttgggg ggtcactgac ctcaatgcct tctgtgtatc ctcagagaaa 1860 gcgacgggag tcggcctcca gctcatcttc cgtgaagaaa gccaagaagc cgtgagaggc 1920 cccacggggt gtgggcgacg ctgttatgta aatagagctg ctgagttgga aaaaaa 1976 <210> 11 <211> 1400 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 234671.14 <220>
<221> unsure <222> 1397 <223> a, t, c, g, or other <40D> 11 ggcagttctc gtccagagcc caggtaatcc gggcgggatc agctagcgtc gcgatgtgat 60 gacgtcaggc cccggccagg ccgggagtgg cgtgctgggc cgtgcgcggc tgcggtacgg 120 cgtgttggtc ccagcggttc agctgaggta gggacgtgct gtaggccgga atgttaccgg 180 ctgttggatc tgtggatgag gaagaggatc ctgcggagga ggattgtcct gaattggttc 240 ccattgagac gacgcaaagc gaggaggagg aaaagtctgg cctcggcgcc aagatcccag 300 tcacaattat caccgggtat ttaggtgctg ggaagacaac acttctgaac tatattttga 360 cagagcaaca tagtaaaaga gtagcggtca ttttaaatga atctggggaa ggaagtgcgc 420 tggagaaatc cttagctgtc agccaaggtg gagagctcta tgaagagtgg ctggaactta 480 gaaacggttg cctctgctgt tcagtgaagt gaggaatgtg tttactgtgt acatggttta 540 ctagaaatgt ttattgatta tatttccagc tttaattttc ttgagtaatt taactgaatt 600 tacacagttt gcttcattgt attttcaaac aaatagaaaa taaacttatt aggaagcatt 660 ttcttaaagt gtttcttgct gtcttttcta tctgctctaa tgttttggtc cttttattga 720 gtttttattg cttttgatgt cagggcttat ttaatctcta gtgcatgaaa gtctcatatg 780 taaaaaatga ttattctgaa tttaatctgt cattggtcat atttctaagt gttcaacctt 840 ataaaaaaaa taaatgacta tcaaaaaaag aaaaacctta cattatgttc tactagttaa 900 gttttcaagg acagtgttca ctagtctacc atagacccta gaagagttac ccaacacata 960 gtagcactca aatatttgtt gaatgaatta taaaaatgac tacttgtatt gttaattttg 1020 tgtattctag tgaattaaat ctcttcggca tcatttactc ccttaggtat ttgactttgt 1080 gtcaaatgtt ttggcaagga taaaattata acagactttc ttgaacaacc aaaatataat 1140 ctattaagga ttttccttca cttttgataa aataagaaaa aaggaaatta aaaccttgca 1200 tcctaatgta aaatagaatt atatggtgtt taatatcagt gtccctttag ctattatatt 1260 aaactactat agttaataaa ttttatcatt attttgtatg ttggttttta aaaatttcat 1320 aaagctataa aaagatactt ggtcagataa agtttcctct gcttttaatt ttaataaagt 1380 attattatgt atatganaaa 1400 <210> 12 <211> 2126 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 241236.3 <220>
<221> unsure <222> 1157 <223> a, t, c, g, or other <40D> 12 tgacccccta ttgagagaga ttgctcctgg ccccctcacc acaccctctg tcccagattc 60 agatgtagcc tggtcttttt tggaaagatg ttccatctct cctgccctcc aggctccact 120 cctggtccct gcttcctctg tggttctgcc ccaggcacac tgcactgccc atcctgtcca 180 gaggagatct tctcggctct gcagtactcg ggcactgagg tgcctctgca gtggttgcgc 240 tcagaactgc cctacgtcct ggagatggtg gctgagctgg ctggacagca ggaccctggg 300 ctgggtgcct tttcctgtca ggaggcccgg agagcctggc tggatcgtca tggcaacctt 360 gatgaagctg tggaggagtg tgtgaggacc aggcgaagga aggtgcagga gctccagtct 420 ctaggctttg ggcctgagga ggggtctctc caggcattgt tccagcacgg aggtgatgtg 480 tcacgggccc tgactgagct acagcgccaa cgcctagagc ccttccgcca gcgcctctgg 540 gacagtggcc ctgagcccac cccttcctgg gatgggccag acaagcagag cctggtcagg 600 cggcttttgg cagtctacgc actccccagc tggggccggg cagagctggc actgtcactg 660 ctgcaggaga cacccaggaa ctatgagttg ggggatgtgg tagaagctgt gaggcacagc 720 caggaccggg ccttcctggc gccgcttgct tgcccaggag tgtgccgtgt gtggctgggc 780 cctgccccac aaccggatgc aggccctgac ttcctgtgag tgcaccatct gtcctgactg 840 cttccgccag cacttcacca tcgccttgaa ggagaagcac atcacagaca tggtgtgccc 90D
tgcctgtggc cgccccgacc tcaccgatga cacacagttg ctcagctact tctctaccct 960 tgacatccag cttcgcgaga gcctagagcc agatgcctat gcgttgttcc ataagaagct 1020 gaccgagggt gtgctgatgc gggaccccaa gttcttgtgg tgtgcccagt gctcctttgg 1080 cttcatatat gagcgtgagc agctggaggc aacttgtccc cagtgtcacc agaccttctg 1140 tgtgcgctgc aagcgcnagt gggaggagca gcaccgaggt cggagctgtg aggacttcca 1200 gaactggaaa cgcatgaacg acccagaata ccaggcccag ggcctaggca atgtatcttc 1260 aggaaaacgg cattgactgc cccaaatgca agttctcgta cgccctggcc cgaggaggct 1320 gcatgcactt tcactgtacc cagtgccgcc accagttctg cagcggctgc tacaatgcct 1380 tttacgccaa gaataaatgt ccagagccta actgcagggt gaaaaagtcc ctgcacggcc 1440 accaccctcg agactgcctc ttctacctgc gggactggac tgctctccgg cttcagaagc 1500 tgctacagga caataacgtc atgtttaata cagagcctcc agctggggcc cgggcagtcc 1560 ctggaggcgg ctgccgagtg atagagcaga aggaggttcc caatgggctc agggacgaag 1620 cttgtggcaa ggaaactcca gctggctatg ccggcctgtg ccaggcacac tacaaagagt 1680 atcttgtgag cctcatcaat gcccactcgc tggacccagc caccttgtat gaggtggaag 1740 agctggagac ggccactgag cgctacctgc acgtacgccc ccagcctttg gctggagagg 1800 atccccctgc ttaccaggcc cgcttgttac agaagctgac agaagaggta cccttgggac 1860 agagtatccc ccgcaggcgg aagtagctga gggcaagggt cccgatgagg gtcccatggc 1920 ctgctccctc aggaacagct ccagcaccaa taaagaggca tcttaccacc caggcttctt 1980 ggtggtcctt cttcctggtg ccaccatcta ggggcaccag ggaaagagcg gggtgaacag 2040 agctttgctg aaaagggccc cctgcaacct agtgcctgac cctccctgga ctcaggacca 2100 ggaaggagtt gacaccctgg atggtc 2126 <210> 13 <211> 2674 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 245014.1 <400> 13 gagtattgga agacttgcga tggaagaaat ctaccagaaa ccatttcaga cattaatgtt 60 tttgattcga gattggagct atccttatga acattcatat ggtttggaag gtggaaagca 120 atttcttgaa aagagattac aggtaaaaca aaatcaacat gaagagcttc agaatgtaag 180 gaagcacata cacaattgtt tctcaaatct tggttgcttc cttttgccac atcctggtct 240 taaagttgca actaatccta gttttgatgg gagattgaaa gatattgatg aagactttaa 300 acgagagctt cgaaatctgg ttccattgct gcttgcccct gaaaatttgg tagaaaaaga 360 gataagtgga tctaaagtca cttgtagaga tcttgtagaa tattttaagg cttacatcaa 420 aatctatcaa ggagaagaac ttccacatcc aaagtccatg cttcaggcaa cagctgaagc 480 taataatctt gctgcagtag caggagcaag agatacctat tgtaaaagta tggaacaggt 540 atgtggaggg gacaagcctt acattgcacc ttcagatctg gagcgaaaac acttggatct 600 caaggaagtg gcgataaaac aatttcgttc agtaaaaaag atgggtggag atgagttctg 660 ccgtcgttat caggaccagc ttgaagctga aattgaagaa acctatgcaa attttataaa 720 gcacaatgat ggcaaaaata tcttctatgc tgctcgtacc ccagccacac tgtttgcggt 780 catgtttgct atgtatataa tctcaggact gactggcttc attggcctaa actctatagc 840 tgtcttgtgt aaccttgtca tggggttagc actgatattt ctttgtactt gggcatatgt 900 taaatactct ggggagttca gagaaattgg aacagtgatt gatcagattg ctgaaacact 960 atgggaacag gtgttttcca aactgtttga agttactaga cgtcgaatgg ttcaccgtgc 1020 tctttcatca gcacagcgac agagactgtc atccaacaat aacaagaaga aaaattagac 1080 agtattttta acctttttcc tctatctgaa gtgttcacac ttacacatgt aggacaataa 1140 gcaggaccgt ctgggccggt ctgcataaat gctgtataca taccagattt gatgctgcat 1200 atagggtatg gaattgcaca tccatctcat aggaattgta aatggtttga ataagaggaa 1260 agtaattttt gttgcattat aaaatgtcta gtagcatcat aagttttttt gagagaagca 1320 tctttttatt tcccatattc ctggttattt tcatcattgc tttgaattga atttttatat 1380 ctatttttat atgtaactct ttttttacct catgtttttg tttgttttgc acatttctca 1440 taccacaggt attgaagccc ctgggtgata atttgatgga ggaaaacata aggcagtctg 1500 taacaaactc tatcaaagca ggcctgactg accaggtgtc tcatcatgcc agattaaaga 1560 cagactgaca gttcatctcc tcacggactc cactctcttt ttttttcatg cttgctgtac 1620 aatgagaact caaataaaaa taaaccaaag tttacaatca actgtagaag tagtttagtg 1680 taactggctt cacagatggc tgccacagag tgtgaagatt gtttgttagt tttaagcatt 1740 cttttaatgg gctcctaaga catgcagatg gactgaggag cattggttaa tcatgcacct 1800 ttgtgccatg tttaactctt ttatttcttt ttacttaatc taatgttagt gaatttgtct 1860 tatgtaaaag gatatttcag ggaaatattt tcagaaatct atttagagtc tctttaacac 1920 agtgtcccat tgaaatttta atttttagag aatttatgaa tcactgtttc aagaaccaga 1980 ttggaaagac aatgaagcct ttattgagcc actacattaa aagtatatat tgctttactg 2040 ccttcaatac cagtattaca taaatgcatg tatcagaaac ttcacagaaa ttacatggca 2100 actcttgtag ctaagaaagt aattctgagg tgtacatttg tcttgccttt ttaaatttat 2160 aaacttgccc taaaaggaga tgcatatctg ggaaactgaa ctgtcttttt gcagtttagc 2220 cttcatgtat ataaaatatg ccattaattt tattggggaa gaaattccat ccaaaaatgt 2280 tgcctacagc tatgagttaa gagtgtctgt acagtgtgta gcttttattt tctaaaatca 2340 cagatagggc atgtatatga cttataaata tataaatacg attttgtatt aaaagttttg 2400 tagtttatgg caaaatctgg tcctgtggta ggctaaataa gtactgtccc tgtgaaagga 2460 atgtttgtgg ctcatgtcag tgtgtgaatg catagacaat ttgaagtttt tgatatattt 2520 gtgatattta tcttgagcac tgcaatctca cccccccccc gcccaccaag ggaattcaat 2580 gggaatgttt attgtgactt tgtcctctgt tgcattttaa agttatttcc tgtaatttat 2640 tttcagtaca taattaaaaa tttgttgtat atat 2674 <210> 14 <211> 1427 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 245251.6 <400> 14 tggctgagtc aacacatctt tattaaacac ctgaagttac tgggaggagg ccatgatgct 60 ggacacactg tcaaagtcaa tcttctccac aatgttcttg ggtttaatgc tctcttcttg 120 gctacagatg aagatctgcc ccgactcgtc ggcactccag ccgtatttgc tcatccacac 180 ctttagctgg ctgtactttc ggacagagtc ttcaaagcca gttatacctt ccaagaggtc 240 catgttttca tccagggctt gccagaaggc ctggaaatgg caggtctcca gcaggtcccc 300 gaggtacaaa atctgtcgga ttggccgttc ttcttgatgt gcctggtcga tcatgcactt 360 gcacagggtg aagtctgtgt gcggcaagtt ggtgagggcc ttcagcagga tctgggcggt 420 gaccgtggtc tgaaagaagg ctgggttgaa ctggtacagc ttcaggacag ccaggttggc 480 ttccagatca taggcatttt ccttggcctg cgtctctaca tagcgctcca gggtggccag 540 gttctcagga ttgtaccctt gagcaacttg cccacgttgg ctctcatctg ctcaaacatc 600 gccatgactt ctgtcgcctt ccacaaccag ggctggaggc taacactgac ccggcacggc 660 gtcctcaagg acgggaacag gaagaggtca gtgttagcct ccagccctgg ttgtggaagg 720 cgacagaagt catggcgatg tttgagcaga tgagagccaa cgtgggcaag ttgctcaagg 780 gtatcgacag gtacaatcct gagaacctgg ccaccctgga gcgctatgta gagacgcagg 840 ccaaggaaaa tgcctatgat ctggaagcca acctggctgt cctgaagctg taccagttca 900 acccagcctt ctttcagacc acggtcaccg cccagatcct gctgaaggcc ctcaccaact 960 tgccgcacac agacttcacc ctgtgcaagt gcatgatcga ccaggcacat caagaagaac 1020 ggccaatccg acagattttg tacctcgggg acctgctgga gacctgccat ttccaggcct 1080 tctggcaagc cctggatgaa aacatggacc tcttggaagg tataactggc tttgaagact 1140 ctgtccgaaa gtttatctgc catgttgtgg gtatcactta ccagcacatt gaccgctggc 1200 tgctggccga gatgctcggg gatctgtcgg acagccagct aaaggtgtgg atgagcaaat 1260 acggctggag tgccgacgag tcggggcaga tcttcatctg tagccaagaa gagagcatta 1320 aacccaagaa cattgtggag aagattgact ttgacagtgt gtccagcatc atggcctcct 1380 cccagtaact tcaggtgttt aataaagatg tgttgactca gcccaaa 1427 <210> 15 <211> 4404 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 252875.1 <220>
<221> unsure <222> 9, 20, 26 <223> a, t, c, g, or other <400> 15 ctgtggcgnt ggcgctggtn gctgcngcgg cagccggcgg cacggcgctc gagcggttcc 60 tgtcagggtc agccggcggg ccccctgggt ggtccacctg caaatcgcgg agcggggccc 120 cagggatcga tggcgatgaa ctataacgcg aaggatgaag tggacggtgg gccccCgtgt 180 gctccggggg gcaccgcgaa gactcggaga ccggataaca cggccttcaa acagcaacgg 240 ctgccagctt ggcagcccat ccttacggct ggcacggtgc tacctatttt cttcatcatc 300 ggtctcatct tcattcccat cggcattggc atttttgtca cctccaacaa catccgcgag 360 atcgagattg attataccgg aacagagcct tccagtccct gtaataaatg tttatctccg 420 gatgtgacac cttgcttttg taccattaac ttcacactgg aaaagtcatt tgagggcaac 480 gtgtttatgt attatggact gtctaatttc tatcaaaacc atcgtcgtta cgtgaaatct 540 cgagatgata gtcaactaaa tggagattct agtgctttgc ttaatcccag taaggaatgt 600 gaaccttatc gaagaaatga agacaaacca attgctcctg tggagctatt gccaacagca 660 tgtttaatga tacattagaa ttgtttctca ttggcaatga ttcttatcct atacctatcg 720 ctttgaaaaa gaaaggtatt gcttggtgga cagataaaaa tgtgaaattc agaaatcccc 780 ctggaggaga caacctggaa gaacggttta aaggtacaac aaagcctgtg aactggctta 840 aaccagttta catgctggat tctgacccag ataataatgg attcataaat gaggatttta 900 ttgtttggat gcgtactgca gcattaccta cttttcgcaa gttgtatcgt cttatagaaa 960 ggaaaagtga tttacatcca acattaccag ctggccgata ctctttgaat gtcacataca 1020 attaccctgt acattatttt gatggacgaa aacggatgat cttgagcact atttcatgga 1080 tgggaggaaa aaatccattt ttggggattg cttacatcgc tgttggatcc atctccttcc 1140 ttctgggagt tgtactgcta gtaattaatc ataaatatag aaacagtagt aatacagctg 1200 acattaccat ttaattttat attatgaaag caaatcatct gcatgtgcat caaggccagt 1260 cctattcaac ctagctttcg aatgctgata tctggttagt atgtcatttt gaagttggca 1320 cataactttt ctaaaaaaaa gcagtctttg ttgtttgctt cttccctacg gatgacttct 1380 aaaaatatat gacgggtata aaaaaattag ctatattgat catatcaaca ctgtaactgc 1440 tgaaatggca ttctaatgtt tgctttttat tcggacaggc cacatgatgc atagagcctc 1500 tttcatgtga cttgtgtcta ctgcttaaat ctttatgctg tgttgatgat attatattga 1560 catatgaagc tgtatatgtg tatgtatttt gtggagaaag ggattacaag atgtatgagt 1620 ataatgactt gctaaccttt caggattcag agaaagatga agaaagacca tatctaaata 1680 atacacttca tcattttcat gtgtataaat gcttaaagta ccatctttgt tgaggtggtt 1740 catgtatcca gtttatccag tacagttatt tgtcaagctt agctttgatt tcaaaggaca 1800 cgcttacctt gtctggcata agaattaatg ctcatgtctg cagtggttgg gtaggtcctg 1860 cttaggagaa ttaaaaaatt cctctttccg tttggttgaa tgttgcagtc aggaacccca 1920 actcacttgg aatgttttta tatgtaatca tttcccttga agcttatact ttataaggga 1980 agaaagaatt caggtgatat gggaaaactg cttggcagac cttcatcttc tgcctcaact 2040 gtaaaccaca tgtaaatgct taatggagac tgttttcatt cttgtgatat ttaacattca 2100 gaaaattact tcagctttgg aaatactcag gctgttttta ttctgcaggt aagtgttttg 2160 acttaagtac taatattcca gaaatttttg aaagcagtaa ccttaatttc ctatgtattt 2220 cattccactt ttgcatatag gtcaaatagc aatgtgtatg cacattctct ttagttaagg 2280 caccaattgt tttggttggt tttcctaaga catactttaa aaagatgttc tataaatttc 2340 ctagttaaat tatggggatt ttggagtatg tacatgataa attataatac gtatatggtt 2400 gaagttattt tattttttac taatgaatta ttttaatatt ccttattgaa taaatgctgt 2460 aacttgtttg ctatggaact tattcttaaa gttctagtta aaaataattt ttccacatgc 2520 atgaaaatat gtattaatca gaggtggctt aattacattg aaattgcttt tttgttgttg 2580 tttttttact gaaataactc atgtttgtgt agaagaatgc ctgtttactc agagtttata 2640 ttttccttca gttatatttt aaatcaaaag gtctgggtaa tgtatacttt tgattaatat 2700 atactttttt taaaaaacaa aaaacaatgt aatggttaat agtagaaatg tgccacactt 2760 ttcaagtttt atataacata tgaaattcag ttaaaagaat gtgtgtttca taatgacttt 2820 taactggtaa aaatattact tgcacgaagt aacttgatgt atggttatcc tgaaatttcg 2880 gagtatttgg tgtgttcttt gtctaaaaat agtctgtttt gtcagtcctt cagaatatta 2940 tttattctga agattgtccc tcttgcactt gggcagttta ttttcgggga tacattgttg 3000 ggggagaggg gtttctgcca ctctttccag attgagtctg tgctgtttaa ggaggactac 3060 catcctgcaa ctctttttct aattggggca cagaggatgt cgctaaagaa aagttgaaga 3120 gccctttcag cactttctca tctgtggaga agatggaatc ttaaaataca tttggagttt 3180 tatctgtttt acaagtccat tgatggccta agttcctcct gttttctgct gtttgatctc 3240 taaggaactc ctgttgctaa atatgaagag tatggaacat tcatatagtc tctgtgaagc 3300 atggggggag ggaagacatt tctttttctt ataggcttta tgctcaaatg tcatagtctc 3360 ctttcaaaga attgtgttgc attttaaatg cacccagctt aagtagaaga cattgaagga 3420 tgcattaatt ttcaggaact attttgaatt atgaaaagat tcccaattga aaaaattatt 3480 caacaagtaa aagctaagaa atttcattga aatcataagg cagtttaagc ataaattgat 3540 aaaaatagct gtgtactact aattaataga aaatcattca accaagagaa gagtcaagtg 3600 aatatcgttt gtttatttgc tagtgagttt ctttgtaacg ttgattttat taaatgataa 3660 tatttggtta gtatgtccta tgttaataaa aatgaacaaa attaattttg ctatgttcag 3720 gtgtcttgat aaaataacaa tgctccagtg ttgttgctta catttagcac taaattttaa 3780 cacagggtca gtgagtccag gttttaactt cttcatgcct ggatgggata aaatgtaatt 3840 cattgttaaa ttaattcata tttgtattta ttaatcactg tgaccaacat taaccatttg 3900 ttcttaccag gaagtggtca gattatcatc tgagttacag ttagactggc taagtttggt 3960 attagatcaa ggggaatgtc cagtaaacag agaggtaagc atgatggaaa taatgaagtg 4020 gggtacacag gaaaaacctg actagtgagg aggagcagct gagagatagg gtcagtgaat 4080 gtggttcagc ctgctacctc tcctgtcttc atagaaccat tgccttagaa ttattgtatg 4140 acacgttttt tgttggttaa gctgtaaggt tttgttcttt gtgaacatgg gtattttgag 4200 gggagggtgg agggagtagg gaagtggtcc ttttacaaga attttgatgc ataagtgtct 4260 attgtagggt ttggatgatc tagtaaagtg ttttagaacc cctttttatc ccatgcacca 4320 ttcagtaaac ataaaaatca caattctgct aatgtcattt ggaacttcaa aataaatatc 4380 ttgtctaaaa acaagaaaaa aaaa 4404 <210> 16 <211> 3150 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 252964.2 <400> 16 cctttctcct cacccagccc cttgctcttc ccttttgaaa ggcccgtgtg ttttctttcc 60 ttaccctgtg cttgctcatg tctactccgg ttttctctac cacatcctta gagccatcac 120 ctggcacgca ggcgccttac attctacggt agaacgtggg gtactgtgtg tgcacataga 180 cacacttacg tggaattaca gttgtgggtt tatccaagat gaggaagatt tcacctgctg 240 tttaatagac ttggggccat gtgcctcccc acacatgggc aaggacaggt ggaatgtcgg 300 gaccacactg tgcggcttct cggcacaaag cggagggagg ctgtggtcgc tgccggccta 360 ggtgtcccag gtgccccgcc tttctctggg acacagttgg gggctggctt ctgagggatt 420 cctttctccc ctctttgtgt ggccccagcc agggcggtgg gcagtcctgg tgtagagcac 480 aagcctctcc accctagaga aatgcctctg taccacggct accatgtgga accttaactt 540 gcagaaggct tgttaacaat tgttttgaga gagatggctg gtcatgccac agctgctggg 600 gactccgcct actccagccc tcttgggaca cactgtggga tttgtggccc ttccccagag 660 gaattgtgga gactgtccca tggaacaaac cctcaggcac cagcacaggg ctctgggtga 720 ctcagtaaaa ctaacgtttg tctctgacaa gatcagctgt aggctcaccg gccagagaag 780 accactgtga gcattttgcc gtatatcctg ccctgccatt tgttcacttt ttaaactaaa 840 ataggaacat ccgacacaca ccgtttgcat cgtcttctcc cttgatattt taagcatttt 900 cccatgtcat gagtttctca gaaacatgtt tttaacaatt gtactattta gtcattgtcc 960 atttactata atttatctga ccatttccct actgtaaaat acttaagacg gtttctgatt 1020 tttccactat ttaaataatg ctgtgatgaa tatctttaaa atcttctgat ttcttacttt 1080 tttccccctt agatgcctgg aagtggtatt ttgaggtgaa agagtttgtt cattttgaag 1140 atatttctgt ctctctctcg acctgatgtg tagacgctca cttccagtag cagaaccacc 1200 ttagttgtgt cttacagatt ctgaacaaat cggtttctga taagccatgt gttccaaaga 1260 atgtctgaat aagaccgctc tttatttaaa tgctaagagg atgtcactac tgcaatccat 1320 ctgtggccga ttttttccaa gagccaattt ccttgttttg gttgcaagaa cctggctctg 1380 cctgcatgtc agctctctgc cctccctgct gccgtggctt tcaagcgctt ggcagaatct 1440 tgtacttcgt gtccacaatg gtactgaatt tgcatctgca cagtcagcag agataacaag 1500 tgttgaactg accttgccac atgcttagtg agtgatttgt aattaagttt atagactcag 1560 aaggtatatt aggacatttg gaatcagtag cagagcaaag cctctttgaa'aaaaaccacg 1620 tagactgatt gggttttaca agagtgcatt tgtctccccc ttccaccccc ccaccttcag 1680 gtcttagtgg ttcacaagag cccagcagcc aggctggctt tttcattgta gggcgtggtt 1740 gtcccagctg gtgtagattt caggccgccc cccccaactc cctgcccaca gtgttgcaga 1800 ttgcctggct ggcagcaagt ccagaccacc caaatttggt tggattcttc atttctccac 1860 tgtagttggg gtccattgat tgtgcagggg aacgtgcagg aggtttttct aggcaccgtg 1920 ttcagtgctg cttcactcta ccagagatta tggccaaatt gcacggaatt tggtttcttg 1980 ccctctgaag cctgagggcc cccccttgcc tggctggttg acagacccgg ggtggtcact 2040 gctgagactt cagagatcgc agctgctgtg agaatacggt gaaggtactt tgttctggaa 2100 gatgttgtca tacacttttc cccagttatt ttcaaacttg acatgagcct atgttgactc 2160 actgggtggg ggtcccttct tacgcagcac acgtggcaag tgcctgaatc ggggctggag 2220 gcacttcaga gcctctgagg ggccaccact tctggcccaa aattgcaggg ttgtagatga 2280 ggctgcctgt ggagaactgg tgtgaggagg aagctgtttc caacaaagag cactttcatc 2340 tgttgagatg gctgtggtga gcaactgaac gagcctacgt gtgtacctga aattttcccc 2400 gtaactcatt tcttccatat gaagaaacac caaactatgt acagagaact ttttacaaaa 2460 gggcagacct tttttaagct gtgtaaccca catagcctaa ccacctggca gaatgactac 2520 gaataggggt cattgtgctg gtaaaagcct ctattacgac tgtaagtaag ttggatgttg 2580 gcaaaattaa attgttacag tatttagagc tgctgtagct gttccttcac aacataaaat 2640 aggataaatg actagtacgt ctttcaggtg ggtggcaagc agaacatgcg taatattctc 2700 tacctggtct gtagctgtaa ctgtgatgta cagacaaagc aaaaattaaa agaacttatg 2760 aaaacaaatg caatgatact aggatataca cttttgtatt tttattctta tataaggtta 2820 tttgctggct attgttggcc tctagttcag tctgtgttat ttaaattcta atatatgaat 2880 tatttgaatt gaattcatgt tcggggccac gttgttgtat gtattgatgt acagccttga 2940 atgtgaataa ttattgtaaa ctatatttta caactttttt tctggcttta ttatataaat 3000 tttctattgg gtcagtgatt taatcatata atttaatgaa tctgtttatc cttttttttt 3060 ttccaaatac ttgtgcttta ggtgtagtta ccagatgatg aattttcctc gtatggtcag 3120 tagtcttgta ataaaaagca tgtagagtgt 3150 <210> 17 <211> 1852 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 267153.7 <220>
<221> unsure <222> 551, 1151, 1200, 1257, 1823 <223> a, t, c, g, or other <400> 17 ccggcgccga ggttcttgac tgctgtgccg gacgccaggt gtagccatgc agcgagccga 60 ttccgagcag ccctccaagc gtccccgttg cgatgacagc ccgagaaccc cctcaaacac 120 cccttccgca gaggcagact ggtccccggg cctggaactc catcccgact acaagacatg 180 gggtccggag caggtgtgct ccttcctcag gcgcggtggc tttgaagagc cggtgctgct 240 gaagaacatc cgagaaaatg aaatcacagg cgcattactg ccttgtcttg atgagtctcg 300 ttttgaaaat cttggagtaa gttccttggg ggagaggaag aagctgctta gttatatccc 360 agcgattggt tcaaatccac gttgatacaa tgaaggtaat taatgatcct atccatggcc 420 acattgagct ccaccctctc ctcgtccgaa tcattgatac acctcaattt caacgtcttc 480 gatacatcaa acagctagga ggtggttact atgtttttcc aggagcttca cacaatctac 540 gagcttgata ntctaggggt ggggtatcta gcaggatgtc tagttcacgc actgggtgaa 600 aaacaaccag agctgcagat aagtgaacga gatgttctct gtgttcagat tgctggactt 660 tgtcatgatc tcggtcatgg gccattttct cacatgtttg atggacgatt tattccactt 720 gctcgcccgg aggtgaaatg gacgcatgaa caaggctcag ttatgatgtt tgagcacctt 780 attaattcta atggaattaa gcctgtcatg gaacaatatg gtctcatccc tgaagaagat 840 atttgcttta taaaggaaca aattgtagga ccacttgaat cacctgtcga agattcattg 900 atttggtgcc tatcctaaaa cttccagtgg gttttcttgc cttccagtgg ccatataaag 960 ggcgtcctga aaacaaaagc ttcctttatg agatagtatc taataaaaga aatggcattg 1020 atgtggacaa atgggattat tttgccaggg actgccatca tcttggaatc caaaataatt 1080 ttgattacaa gcgctttatt aagtttgccc gtgtctgtga agtagacaat gagttgcgta 1140 tttgtgctag ngataaggaa gttggaaatc tgtatgacat gttccacact cgcaactctn 1200 ggacaccgta gagcttatca acacaaagtt ggcaacatta ttgatacaat gtaaganact 1260 tgattgtcat ttccctataa aattttcctt gatacttggc tagagtatca tactaggctc 1320 aactagacat ttctagatga gttcaagtga atattaagtg attaaattga aaatggtttc 1380 cttaaagaaa aaaaatctag cataaagtta atttagttgg aggaaaagga gggaagtgga 1440 taaaggggca gatggaggga agtggataaa ggggcagatg aagggaagaa gagctggctt 1500 aggccagacg tgaagcggca gtgctgagat cactcaggac ctcggcacag gtagtcactt 1560 acacaccatt ctcatcagga gaatgggagg taggacatga atatttaaat tctgagatta 1620 atgacaaaag ttaactttaa ggattaagat taatgtctat ttgtatcctt tcaaatattt 1680 atcaaaatta gtaccaaatg gtaaaaccaa caggaatttt acctcttcct gacccagtca 1740 gaaccatagc agaaaactgt acagccaggt ctctccgtga ctcaaagatc cataaggagt 1800 tatcaaacac tgggtgtgag tcnagttact tcttccatgt ctctaaaata gc 1852 <210> 18 <211> 1513 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 331244.6 <400> 18 ggtaaagtgg cttctgggcg gaaggtacac tataggctcg gggaggtaag cggcggcagg 60 ccggcggttg gtgtgtcccg ggtgtgggga ggcgacagag ccctggcact tgagggttga 120 gggggcctcc ccagccgcgg cgaaaccgtc tagcctccgg aggccaggcc gtgagtgcgg 180 gaggtatacg ccaaggcgga agaattttgc cactcactac ctgtgtgacc tcgggtaaat 240 tagccttgga acgtcagttt cttcgtctct ataattgaaa taataatagt acctctctca 300 ggattgttgt gagccgtcag tgaaacactt agagcagttt ctggcacatg gtagaattgg 360 gctatttgct gaagcttctt ggtggccctt gctagcccag gaagaaactt acattttgat 420 ttttttgtac catggctttg gttcacaaat tgctgcgtgg tacttatttt ctcagaaaat 480 tctctaagcc aacttctgcc ttgtatccat ttttgggtat tcgctttgca gagtattcca 540 gtagtcttca gaaaccagtg gcttctcctg gcaaagcctc cctcacagag gaagactgaa 600 ggggatttgc aaggagatca ccagaaagaa gttgctttgg atataacttc ttctgaggag 660 aagcctgatg ttagtttcga taaagcaatt agagatgaag caatatacca ttttaggctt 720 ttgaaggatg aaattgtgga tcattggaga ggaccggaag gccaccctct gcatgaggtc 780 ttgctggaac aagccaaggt tgtctggcaa ttccggggga aagaagattt ggataagtgg 840 acagtgactt ctgataagac gattggaggc agaagtgaag tgtttttgaa aatgggcaag 900 aataaccaaa gtgcactgct atatggaact ctgagctctg aggcgcctca ggacggggag 960 tctacccgaa gtgggtactg tgcaatgata tccaggattc caaggggtgc ttttgagagg 1020 aagatgtctt acgattggtc ccagttcaat actctgtatc tccgtgtacg tggggatggt 1080 cggccttgga tggtgaatat caaggaggac acagatttct tccagaggac gaatcagatg 1140 tatagttact tcatgttcac ccgcggggga ccctactggc aggaggtcaa gattcctttt 1200 tccaaatttt tcttctctaa tcgaggaaga atccgggatg ttcagcatga gcttccgctt 1260 gataagatct cttctatagg attcaccttg gctgataaag tggatggtcc attcttcctg 1320 gagatagatt ttattggcgt gtttactgat ccagctcata cagaagaatt tgcctatgaa 1380 aattctccag agcttaaccc aaggcttttt aaataaagat catatggtag ttttgtttta 1440 ctaatctaag ggtactagca tctacaatga tatagacaaa ataaaatatt tctttaatgg 1500 catccaacca aaa 1513 <210> 19 <211> 3243 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 335484.1 <220>
<221> unsure <222> 3222 <223> a, t, c, g, or other <400> 19 gagggagagg ccgagagaaa tttcggtact gcgcatgaac cgagcgtgac gttgaggttt 60 gaaataaccg gcaaagagta aaggctgaaa ctagcttcct gaaagcttcg tagggcccga 120 gccctgtgag cccaggttct gcgcccacta ggaggtgtca tgctgactgc tttttttaaa 180 gccctagaat cttggcttcg gcgtttgggg taagctccgt tctcgttctc aagcgcgttt 240 ccgcgaactc tcgcgggatt gacgggccgt ctcgagagcc ggcatctcct aggagctagt 300 cctggtcctc ggctaggcgg cttggggtcg cggcgtaact ggggagccag cctgacgccg 360 gcggaccccg cctgtgatcc tggcaacgat ggatgatgac ttgatgttgg cactgcggct 420 tcaggaggag tggaacttgc aggaggcgga gcgcgatcat gcccaggagt ccctgtcgct 480 agtggacgcg tcgtgggagt tggtggaccc cacaccggac ttgcaggcac tgtttgttca 540 gtttaacgac caattcttct ggggccagct ggaggccgtc gaggtgaagt ggagcgtgcg 600 aatgaccctg tgtgctggga tatgcagcta tgaagggaag ggtggaatgt gttccatccg 660 tctcagcgaa ccccttttga agttgaggcc aagaaaggat cttgtagaga ccctcctgca 720 tgaaatgata catgcctatt tatttgtcac taataacgac aaagaccgag aagggcatgg 780 tccagaattt tgtaaacata tgcatcgcat caacagcctg actggagcca atataacggt 840 ataccatact tttcacgatg aggtggatga gtatcggcga cactggtggc gctgcaatgg 900 gccgtgccag cacaggccac cgtattacgg ctatgtcaaa cgagctacta acagggaacc 960 ctctgctcat gactattggt gggctgagca ccagaaaacc tgtggaggca cttacataaa 1020 aatcaaggaa ccagagaatt actcaaaaaa aggcaaagga aaggcaaaac taggaaagga 1080 accagtattg gccgcagaga ataaagataa acccaacaga ggtgaggccc agctagtaat 1140 cccttttagt gggaaaggat atgttctagg agaaacaagc aatttacctt cacctgggaa 1200 actgatcact tcacatgcca ttaataaaac ccaagatctt ttaaatcaaa accattcagc 1260 aaatgctgta agacttaatt ctaaaatcaa ggtgaaattt gaacagaatg gttcaagtaa 1320 aaattctcat ctggtctccc ctgctgttag taacagtcac caaaatgttc taagcaacta 1380 ctttcctaga gtatcatttg ccaaccaaaa ggctttcaga ggtgtgaatg gatctccaag 1440 gataagtgta acagttggca acatccctaa aaactcagtc tcttctagtt ctcagagaag 1500 ggtttcatct tctaagatat ccctaagaaa ttcttcaaaa gtaacggaat cagcatctgt 1560 gatgccatcc caggatgtga gtgggtctga agatacattc ccaaataaac gacctaggct 1620 agaagataag actgtttttg acaatttttt tatcaagaaa gagcaaataa aaagcagtgg 1680 taatgatcca aagtatagta caaccacagc tcagaattcc agcagttcat ccagtcagag 1740 caaaatggtt aattgcccag tttgtcagaa tgaagttctg gagtctcaga ttaatgagca 1800 cttggactgg tgccttgaag gtgacagcat caaagtcaaa agcgaagaaa gtctttgaaa 1860 aaggtttcaa agtctcaagt accacctgta ttatctcact aatgtgctat gtcagccagt 1920 caggaagttc tggttaatac taagatttgt aggttataat ctagttcaca taaccaatag 1980 aaagtgtcct attttatata tacgcatata agattgtaat tttaagatgt tttgtgtctc 2040 agggtgctac attcactctt gccttaggta tactgtaacc caggttctgc ctgtcgtgta 2100 taatttttag atacttttgt tctttcttgc tcttaaggat tttaaaaacc tgttaatctt 2160 tttatttgta tactttccta aaaatattca tatggggaat cctgtcaggt gtttggttat 2220 attgactatt tattaatagt attagaactc attccctgaa ctgatgtaaa tcttcatagt 2280 gtcagacata ctgaccaaaa ccacaatcta gactacaaag tatattgttt tagagtactc 2340 aaattgtatt atttattaat ttttttgttt gcaaaatctt aacaggaact gtattttcta 2400 tattttaaag aattttattt gtcccacttt tactaaacag tggcagcaga ttttaagtta 2460 aagaatatgg aatatagtaa aataagtaaa tttcttttgg aatattttta gtaacaaata 2520 gccactataa ttctgtaggc caaattttat attgagttta gctgttttct caaaatttag 2580 cagagtggtt aaaattctgt gctgataagt aactgataca tataacataa acataacaaa 2640 gttgcctagt tgatgtaaca gtggaaagtt atctggaaat agtattttga actttaagcc 2700 aagtttaaaa cattataata aaaggaatac catttgtgca ttttaagtaa tcttttttaa 2760 aaaaaatatt ttccatgtta tagggaaagg acaaagagac ttttatcagt ttgctttttg 2820 tcttgtggct gtacatgctg ttggcatagc cctaatacag ttgttcacaa gttttctttt 2880 ttcttgttgc aattttcctt cactttgttg taatacaggt gcacaaatct taagtgcaca 2940 gctgggtaaa cttttacagt gttcacctgt gtaactacca cccggatcaa gttagagaac 3000 acttccattg ccacagaagg cttcctatag gtgtctgttc ccagttgata cccatgaccc 3060 tcaccacctc cagaggtccc cactgttttc accccatcgt cgcagattat tttttaattt 3120 tataatgtag tatctttgtt cctatgtata gcaggagttc attttcattg ctcttgcatt 3180 tgtatgaata tactagaatt tattcatcat ctatgtaatg gncattgaat attccagttt 3240 ggg 3243 <210> 20 <211> 1451 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 337489.2 <220>
<221> unsure <222> 281, 291, 830, 845 <223> a, t, c, g, or other <400> 20 acagtggcgt gttcctagaa gccgctttcg gcatcagtag gcggcggcgt ggggtctggc 60 agcgtgggga gagggaccaa ccgacgccac ttcgtgttgg gaagtgggag cgggagggcc 120 gggcaattcc cgaccgaacc aaacggtttc catggatctc aatagtgcca gcactgttgt 180 tcttcaggtg ttaacacagg ccaccagtca ggatactgct gtgttaaaac cagctgagga 240 gcagttgaag cagtgggaga cacagccagg tttctattca ntgttgctga ntattttcac 300 caaccacact ttggatataa atgtaaggtg gcttgctgta ctgtatttta aacatggaat 360 tgatcgctac tggagacgtg tagcacctca tgctctctca gaggaggaga aaactactct 420 gcgtgcaggg ctcatcacca acttcaatga accaataaac cagattgcaa ctcagattgc 480 agtgctcatt gcaaaagttg ctagattgga ttgtcccaga cagtggcctg aactaattcc 540 cactcttata gagtctgtta aagtccagga tgatcttcga cagcacagag cattacttac 600 cttctatcat gttaccaaga cactggcatc taaacgactt gctgctgata gaaaactatt 660 ttatgattta gcttctggaa tttataattt tgcctgctct ctgtggaatc accacacaga 720 cacattcctg caagaagttt cttctggcaa tgaagctgca attttgagtt cactagaacg 780 aacactgcta tcattgaaag tgctgcgtaa gttaactgtt aatggatttn tggacctcat 840 aagantatgg aggtgatggg ttttttacat ggaatatttg aacgtctaaa acagtttctg 900 gaatgcagta gaagtatagg tacagataat gtgtgtagag atagactgga aaagaccatc 960 attcttttta ctaaagtgct tttggacttc ttggatcagc atcctttttc atttactcct 1020 ctaattcaga gatcactgga attttctgta agctatgttt ttacagaagt tggtgaaggc 1080 gttacatttg aacgattcat tgtccaatgt atgaatctta ttaagatgat tgtcaaaaat 1140 tatgcttata agccatccaa aaattttgaa ggtaattcct ttattggcag tttaaaagaa 1200 ttattttaat cttaagtgtg atataattgc tataattaca aactttttaa aaaatgtcat 1260 tttagtctga aaaataaatt gttgctggga catgaaaaag atataaggat tataggcttt 1320 agtatgttta tactagcttt taaaaacaac atagtgcatt taataagcca ttttttgtag 1380 cacaaattgg ttgaagctta gggactttaa gaattaggta ctatagtcat cactgcagct 1440 catattgtag g 1451 <210> 21 <211> 2710 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 359574.5 <400> 21 ccacgctgct gcatgggcca cgtgagctca ggctgtggga gcggatggag ctgctacagt 60 cagcgcttgg ggctggcctc agcttgtaga cccgagccct gcagaacaac cccccgtggc 120 gcaggagagc agaagaaagg gggcctttat gcccttttga gggaagcaca cattctgcaa 180 ggccgtggaa acaaagggag gaactgtttg tagccctcgt ccagacgccc caaacaaaca 240 gagccaagtt acaccctgtt taaccctgcc ttcaaaggga cgactctgta agattctctg 300 ctacttattc aagttgacac gatgcccttc acactccacc tgaggtcccg ccttccctct 360 gccataagga gtttgattct acaaaagaaa ccaaacatca gaaatacatc cagcatggct 420 ggagagctcc gaccagccag cctggtggtc ctgcccaggt cccttgctcc agcttttgaa 480 agattctgcc aggtcaacac tggtcctcta cccctgctgg gccagagtga gccagaaaag 540 tggatgctgc cccctcaagg tgctatctca gagaccagga tgggccatcc ccagttctgg 600 aaatacgagt tcggtgcctg caccggcagc ctggcttcgc tggagcagta ctcggagcag 660 ctgaaggaca tggtggcctt cttcctgggc tgcagcttct ccctggagga ggccttggag 720 aaagcggggc tcccccagaa gagacccagc aggtcacagc caggcgggtg catacaagac 780 aacagtgcct tgtgttaccc atgctggctt ctgctgccct ctggtggtca cgatgaggcc 840 cattcccaag gacaagctgg aagggctggt gcgggcctgc tgctccctcg gaggtgagca 900 ggggcaacct gttcacatgg gcgacccaga actgttggga atcaaagagc tttccaaacc 960 tgcctacggg gatgccatgg tgtgtccccc aggggaggtt ccagtgttct ggccttctcc 1020 gctgaccagt ctcggagctg tcagcagctg tgagacccca ctgggctttt gccagcatcc 1080 caggctgcac agttatgact gacctgaagg atgcaaaggc tccacctggt tgtctcaccc 1140 cagagagaat tccagaggtc catcacattt cccaagatcc tctgcactac agcatcgcgt 1200 acagtctctg cttctcagaa gatcagagaa ctagagtcta tgatcggcat agacccaggg 1260 aaccggggga ttgggcacct gctctgtaaa gatgagctgc tgaaggcctc tctctcgctg 1320 tcccatgccc gctcagtgct catcaccact gggttcccca cacatttcaa tcatgagcct 1380 ccagaagaga cagatggccc accaggagct gttgctctgg ttgccttcct gcaggccttg 1440 gagaaggagg tcgccataat cgttgaccag agagcctgga acttgcacca gaagattgtt 1500 gaagatgctg ttgagcaagg tgttctgaag acgcagatcc cgatattaac ttaccaaggt 1560 ggatcagtgg aagctgctca ggcattcctg tggcaaaaat ggggacccgc agacacctag 1620 atttgaccac ctggtggcca tagagcgtgc cggaagagct gctgatggca attactacaa 1680 tgcaaggaag atgaacatca agcacttggt tgaccccatt gacgatcttt ttcttgctgc 1740 gaagaagatt cctggaatct catcaactgg agtcggtgat ggaggcaacg agcttgggat 1800 gggtaaagtc aaggaggctg tgaggaggca catacggcac ggggatgtca tcgcctgcga 1860 cgtggaggct gactttgccg tcattgctgg tgtttctaac tggggaggct atgccctggc 1920 ctgcgcactc tacatcctgt actcatgtgc tgtccacagt cagtacctga ggaaagcagt 1980 cggaccctcc agggcacctg gagatcaggc ctggactcag gccctcccgt cggtcattaa 2040 ggaagaaaaa atgctgggca tcttggtgca gcacaaagtc cggagtggcg tctcgggcat 2100 cgtgggcatg gaggtggatg ggctgccctt ccacaacacc cacgccgaga tgatccagaa 2160 gctggtggac gtcaccacgg cacaggtgta accgtccatg ttccgtgtga gcagagtccc 2220 taccaacggg caggtctgca tccggggaga atgcagctgc ttctggcgac aatcctgcta 2280 gtaaacactg gtcttcggtg agcaacgaac actcgcctgg cctgggaaac tgcatgccca 2340 ctttctggga ggggttagtg caggtgccgt ggacaaagga caacatttct ctggggcttt 2400 ttaactttta ttcctaagac tctaaaggcg ttgatttcaa ccctccttca ctctggcttc 2460 ttcaggcaac ccacgtggtc tcctgtgaga atcttctcga cagttactta tggggacact 2520 tgtgaacaat taactgccag gcagagcatg agaacaaaca ttcccaggcc atgtaggata 2580 ggatactcca gactccagtc atcctccccc atccatggtt tctgttactc atggtttcag 2640 ttactcatag ccaactgcag accgaaaata ctaaatgaaa aatttcagaa ataaacaact 2700 cttaagtttt 2710 <210> 22 <211> 2271 <212> DNA
<213> Homo Sapiens <220>
<221> misc_feature <223> Incyte ID No: 360645.5 <220>
<221> unsure <222> 2002 <223> a, t, c, g, or other <400> 22 cggaggcgag cggagggttt cccgcggcgg atttctgaca gtcagacttg tccacaagaa 60 ctcaactggc aaggctgctt ttctgtgcta aaactgggga gctagtgggc accatgaaga 120 tcttctgcag tcgggccaat ccgaccacgg ggtctgtgga gtggctggag gaggatgaac 180 actatgatta ccaccaggag attgcaaggt catcttatgc agatatgcta catgacaaag 240 acagaaatgt aaaatactac caaggtatcc gggctgccgt gagcagggtg aaggacagag 300 gacagaaggc cttggttctc gacattggca ctggcacggg actcttgtca atgatggcgg 360 tcacagcagg tgccgacttc tgctatgcca tcgaggtttt caagcctatg gctgatgctg 420 ctgtgaagat tgtggagaaa aatggcttta gtgataagat taaggttatc aacaagcatt 480 ccaccgaggt gactgtaggt ccagagggtg acatgccatg ccgtgccaac atcctggtca 540 cagagttgtt tgacacagag ctgatcgggg agggggcgct gccctcctat gagcacgcac 600 acaggcatct cgtggaggaa aattgtgagg ccgtgcccca cagagccacc gtctatgcac 660 agctggtgga gtccgggagg atgtggtcgt ggaacaagct atttcccatc cacgtgcaga 720 ccagcctcgg agagcaggtc atcgtccctc ccgttgacgt ggagagctgc cctggcgcac 780 cctctgtctg tgacattcag ctgaaccagg tgtcaccagc cgactttaca gtcctcagcg 840 atgtgctgcc catgttcagc atagacttca gcaagcaagt cagtagctca gcagcctgcc 900 atagcaggcg gtttgaacct ctgacatctg gccgagctca ggtggttctc tcgtggtggg 960 acattgaaat ggaccctgag gggaagatca agtgcaccat ggcccccttc tgggcacact 1020 cagacccaga ggagatgcag tggcgggacc actggatgca gtgtgtgtac ttcctgccac 1080 aagaggagcc tgtggtgcag ggctcagcgc ttctatctgg tagcccacca cgatgactac 1140 tgcgtatggt acagcctgca gaggaccagc cctgaaaaga atgagagagt ccgccagatg 1200 cgccccgtgt gtgactgcca ggctcacctg ctctggaacc ggcctcggtt tggagagatc 1260 aatgaccagg acagaactga tcgatacgtc caggctctga ggaccgtgct gaagccagac 1320 agcgtgtgcc tgtgtgtcag cgatggcagc ctgctctccg tgctggccca tcacctgggg 1380 gtggagcagg tgtttacagt cgagagttca gcagcttctc acaaactgtt gagaaaaatc 1440 ttcaaggcta accacttgga agataaaatt aacatcatag agaaacggcc ggaattatta 1500 acaaatgagg acctacaggg cagaaaggtc tctctcctcc tgggcgagcc gttcttcact 1560 accagcctgc tgccgtggca caacctctac ttctggtacg tgcggaccgc tgtggaccag 1620 cacctggggc caggtgccat ggtgatgccc caggcagcct cgctgcacgc tgtggttgtg 1680 gagttcaggg acctgtggcg gatccggagc ccctgtggtg actgcgaagg cttcgacgtg 1740 cacatcatgg acgacatgat taagcgtgcc ctggacttca gggagagcag ggaagctgag 1800 ccccacccgc tgtgggagta cccatgccgc agcctctccg agccctggca gatcctgacc 1860 tttgacttcc agcagccggt gcccctgcag cccctgtgtg ccgagggcac tgtggagctc 1920 agaagctcag gaagatggga gcttacttcc tgtggtcacc gatgcaccat tttcctgaac 1980 cctcctggga gctggagcag gnccgggcag agccacgcag cggtgctatg gatggagtac 2040 cacctgaccc cggagtgcac gctcagcact ggcctcctgg agcctgcaga ccccgagggg 2100 ggctgctgct ggaaccccca ctgcaagcag gccgtctact tcttcagccc tgccccagat 2160 cccagagcac tgctgggtgg cccacggact gtcagctatg cagtggagtt tcaccccgac 2220 acaggcgaca tcatcatgga gttcaggcat gcagataccc cagactgacc a 2271 <210> 23 <211> 2611 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 404145.7 <400> 23 gctgtggggt ttttctgtaa gactgaagat gacttcaatg attggtgcca gcaagtcaaa 60 aagctgtctc tgctcggagg tgccctgccc atgtttgagc tggtggagca gcagccttca 120 catctgggcc tgccccgacg tcctgaacct gtccctaggt gagagctgcc aagtccaggt 180 ggggtccctc ggaggtacga tctgtgccct tgcttcccca gtcctggccc ccttggtttt 240 gaccattaag gtgtgtgtga gcctgagccg tgagcacttg gcagtggttc gcctgtgaga 300 ccaggtatgg agtggagcgt cccctcctcc aagcttgcgc ccagcagccc aggacccacc 360 tcgtcttccc caccagcgct gcctgcccgg gcgctgtgga gctgggcgtg ctaccatgga 420 gtcctcaggg gtctggagca gacagaacat gcaggctctg tggtgacgca gtcctgggtg 480 ggggactggt tcacttgggc accactggcc atgggtggcg tagacccctc ggaccatggc 540 cagcgtgccg caggagccgg cctgggctcg tgcagtgaag tgagtggccg tgagcgcgtc 600 ctcctcatct ctgtctccct gtgggaaact ctacaaacaa ggcaatggca atggaaccac 660 tcctgatgac cacgagggtc agacgcggga cagaggcccc tcagggcctg agattgtgcc 720 ggccgccccc tgccctcctc accctgccct gctcctcttc tctgctccct ccccccatat 780 tcgcaggtct gcacaacccc cggacctgtt cacacccgca tggggacagc tgtctgtggg 840 ctgcagagca ggcactgctc agtctgcccc acgccaaggg cccttgactc acacccaggt 900 ggcccaccca agatgcctga tgcgctatgt cctgttcctt ctagattctt ctgatgtaga 960 gcgactggaa agattcttcg actcagaaga tgaagacttt gaaatcctgt ccctttgaaa 1020 atcctggggt cgggggtggc acctgtgaga gcctggggct cctggtgccg ctgcgtttca 1080 tccatcccgc ccgctcgcct gccgagggct gcgccccgtg ctgcctcccc ccagagggcc 1140 acccgctgtg ctcgtggact gaggctgcgc tgcccgggag gccttactgc ttggtgtcag 1200 actgcccagc tcagagtgcc cgtcagggcc tgtgcatccg cacgcggagc cgtctgttag 1260 gagcttccag agtgttctct cgacactgcc agccccgtgt tagcacctgg gcctcagtcc 1320 cacttgctcc caggcgccgg ttctgtggtt ggtttggaat taaagtcctg tttgaagttg 1380 tcagacacag acatgaattt ctggggcgct ccctgagtca gagtctcaga agacctgtgc 1440 aggctggcgt gagaggagcg gcagccacac tgcggcccca cgcccaagga ctgggctgct 1500 ctcgaggggg gcgcgcccac cgctgtgtcc tctctgccca gcctggctta ccaagggcta 1560 cctcagtggg agatgaggtt ggaggaacga aggcgaggtt cctccttgct ttggggagaa 1620 aagtattcag gaagtgggtg tgtgggaaac ctgaagatgg cgtgcacagg acacagcgtg 1680 ggcggcctgg gcagaagggc ggctggctgt cctggagctg ctgctggagc ctgccctcag 1740 agtgtccctt tccagtgctg tggcattctg tggcagcttc cccaggtgtg gtgacggggg 1800 ggggcggggc ctccacctgt gacagccagg cttgagggtg gacggcgtgc ctctcccagg 1860 agccttcccc atgtccttgc cttgctgaga attgccctcc catgccgctg aggtgttagg 1920 tggtttaggg ccaaaagggg aaaaccactt gagtcttgtg gtgtgtggtg ggcagacacc 1980 acagggtggc atcacctggt ggcatttcca gaacctcagc cccgattcca gcacccacca 2040 ccgcctgacc ctgtgtaacc tgctgtcccg ggtcccagag tgcactctgc cccgctgctc 2100 tgctgcctgt cctgggaaag tagctttgcc ccactaggaa atgtaaacag gagggcttgg 2160 ggagcgtggg cacttttctc atgagcagct actgcggcgt tggcaggact cgctgctgct 2220 gctgctgctg cttgtgtagg tcggggagcc ggagatcccc gaggacgcgc gccggacagt 2280 cggcactgac cggcccacct ggtagcagag gacaccccca gccccccaag cattgaagac 2340 atagtgtatt tcctcgtatc ctttctccct tgggtgtagt tggggtgggg aagcagggaa 2400 ggctggtgcg atctccattc cttgggctcc acgtccgagt tcatggtgcg ccgctgtgct 2460 gggagctgca gtggtaatgt gtgggacacc ttgaccaaag gggagctttg tctcgtgtgt 2520 tttgaaaaag gcttaatgaa gagaatgttg ttcattctta gtagtatagt ttgcaattct 2580 taatggcaaa taataagttt cagtagaaaa c 2611 <210> 24 <211> 1331 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 480119.1 <220>
<221> unsure <222> 605, 733, 1319, 1325 <223> a, t, c, g, or other <400> 24 gagaaagctt aatattgaag tatctctcct atgaggtgtt agaactattt gcctacaatt 60 tattggggaa aaaattgctc atttgtgtac ataaacctag gacagagcac atagggaaaa 120 taacattcca acacagggga attttgccca aggctcatga aagaacccaa gccagttttc 180 tcaagacttg acctcaggcc tactggaata.tttctctcaa agtctcctgt tctcacactg 240 acaagactga tgtccctgtg ttaggattgg acagaggaat gtttctgtgt gcaaggaaga 300 actgcttaat gtaagagggc ccatctgaat ttatttgcag gacatcggtg ggatcaagtg 360 aaaaaggagg accacgaggc aacaggtccc aggctcagca gagagctgct ggatgagaaa 420 gggcctgaag tcttgcagga ctcactggat agatgttatt caactccttc aggttgtctt 480 gaactgactg actcatgcca gccctacaga agtgcctttt atgtattgga gcaacagcgt 540 gttggcttgg ctgttgacat ggatgaaatt gaaaagaagg ggaagaagat caaagaagga 600 aagangaagg ggaagaaaag aaggggaaga agatcaaaac ccaccatgcc ccaggctcag 660 cagggagctg ctggatgaga aagggcctga agtcttgcag gactcactgg atagatgtta 720 ttcgactcct cangttatct tgaactgcct gacttaggcc agccctacag cagtgctgtt 780 tactcattgg aggaacagta ccttggcttg gctcttgacg tggacagaat taaaaaggac 840 caagaagagg aagaagacca aggcccacca tgccccaggc tcagcaggga gctgctggag 900 gtagtagagc ctgaagtctt gcaggactca ctggatagat gttattcaac tccttccagt 960 tgtcttgaac agcctgactc ctgccagccc tatggaagtt ccttttatgc attggaggaa 1020 aaacatgttg gcttttctct tgacgtggga gaaattgaaa agaaggggaa ggggaagaaa 1080 agaaggggaa gaagatcaaa gaaggaaaga agaaggggaa gaaaagaagg ggaagaagat 1140 caaaacccac catgccccag gctcagcagg gagctgctgg atgagaaagg gcctgaagtc 1200 ttgcaggact cactggatag atgttattca actccttcca gttgtcttga acagcctgac 1260 tcctgccagc cctatggaag ttccttttat gcattggagg aaaaacatgt tggcttttnt 1320 cttgncgtgg g <210> 25 <211> 2813 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 480951.5 <220>
<221> unsure <222> 13, 981, 992, 2807 <223> a, t, c, g, or other <400> 25 cctggagact cgngtggccg aggggcttca taccagctga agagcgacaa gccgctggca 60 gccgcggatc tcaccgccgc tcaggagatc tgttggtaat ctgaggattt ttattctacg 120 tcgtcttgac agatggaaaa cctgaagtaa cttcgggcta accttgtgtt tttggaaaat 180 tagtagactt ggtggtgaag aaactgggag gagtaggata ttagctaact ttgcatagcc 240 acatatagag cgtcgcagct gcattccacc aaagaggaac caaaaggcct gtggtgttcc 300 cagggtacat attcatgcca gaagtgaagt gccttggtga attcgtttcc tgaaagttta 360 tcgcatactt gtactgggtt agccttatgc cagcctggac catcttggag gcagtgtagg 420 atcatggaag aactttgaat taggttttta gaacttcagc cataaaaatg ggcagaattt 480 tccttgatca tatcggtggt acccgtctgt tttcttgtgc aaactgtgat acgatcctga 540 ccaaccgctc agaactcatc tccactcgtt tcacaggcgc cactggcaga gcatttcttt 600 ttaacaaggt agttaacctg cagtacagtg aagttcaaga tcgggtcatg ctcactggcc 660 gccacatggt tcgagatgtg agctgcaaaa actgcaatag caaactggga tggatctatg 720 agtttgccac tgaagacagc cagcgatata aggaaggccg cgtgatcctg gaacgtgctc 780 tagttcgaga gagtgagggc tttgaggagc atgtaccatc tgataactct tgaagataca 840 gagagaaatc catcttttcc caggtctcct tcactgaaaa caaaaatcta cttacataca 900 ctgtcacctt agcatcagag tcggattaat gaactgcgga acaagaggtt gtgagaatct 960 aagatggaac ctttctttct ntctttcttt tnttttaaat tttgtatttt ccatccaaca 1020 gcagtgtgta gagagaatat tatgcagatg ccgttaattt tttaccctat gtttacgtct 1080 tgaggcagca gagtctgtct gcagctatgt ggtgagctat gtaaggaaaa aaatctgggc 1140 tgttagagtg aaaaagtgtg ttttatgtca attgtgaaag gaaaatgtta ggagtatggt 1200 ttttaaactt gggcttcatt ttaaactttt ttttttaaac ccagttattt cacttgattt 1260 gctagcttca gagaagagat ccgaatctgt gcccagcgct aaaggctcag tgttagcatg 1320 gcttgtgctg gccggtgtgc catattcttg ttggagatga accgtagcac cagagcccat 1380 tcttccttgt cagtcttggc ccaaagatgt caccattcct agttatttgt caccacataa 1440 ttggtgttga ttggaaactt tttctgagat gggacagaac tgctgggttg tctttttcca 1500 tgtaacttaa gcatagtaat ataaataaag taatagttgg atgcttttgg tcctgtgttg 1560 cttttaaaaa caccttataa aagaggagag tatttgataa gcaattttca tagtagtaaa 1620 gttttttttc atctcttaaa ctaaattgac catgcatata atattctttg tttaaatgaa 1680 agcatactgt tgaaacccgc agtgttgcat ttagaaaaca gttgaacaga atgtcaatgt 1740 gcattcatgc aaaaaaacat ttaatctgca tctgttttag aaaaggggga aatgaagcaa 1800 cttgtctaaa aatactgctt tacaaagcat ttcagccttt ccccctcagt tttgcattga 1860 ttttttgaca agtctgtaga gcctaatagt ttccatcaaa ggcctagatc tcttatttag 1920 catttttttc agctcttctc tcagaagttc agctgttgaa acgaaaactg tactttgtac 1980 cctcacatac aaagggatca aatttgacct ggtgttattt tagccccaaa tttatgacat 2040 tacacaatat taaaatgtaa atgtttcttt acccaaacta cttctagata ttctagtatt 2100 tgcttctggt ggaattaaat gacggtaaaa ttggctaatt atttgaatga atgaatggat 2160 ggatgttttg catgctcaat ttctaggtcc tttgtctaga aaggaaattt gcctcagttg 2220 aattagtgaa atatttctgt cgttgatatt aaaagtgact tctgagtaca gttaagttcc 2280 tcctatttgc cactgggctg ttggttagaa gcataggtaa ctgattaagt aggtatgata 2340 ctgcatttga aataagtgga cacaaactat cctttctcca ccatggactc aatctgagaa 2400 caacagcatt catttccatt catttccata ctggcttttg attatatgca gattcctagt 2460 agcatgcctt acctacagca ctatgtgcat ttgctgtcac aataaagtat attttgtctt 2520 gcattgatgc agtactgctg cttattttcc actgatcttg tctagtgatc atcttaattt 2580 ttatctctga acacatactt ggtatctttg agtacctgta gctttcttca tttggcaatg 2640 atagtgatgt ctgacttgat taactgccta attcacacat gaagacattg actttgccag 2700 tattaacttc tctgagatca ttttgcctta gatactgata actatagttc agtatatata 2760 aacaaaaaaa tttcatatta ctaggttaac ttttaggtaa ctggcangta cca 2813 <210> 26 <211> 3281 <212> DNA
<213> Homo sapiens <220>
<221> misc_feature <223> Incyte ID No: 481257.3 <400> 26 cagcgacgac gcggaggcag agaaaggaac gcccggccca gccccgtagc acaggcggag 60 tgcagcggag ggcccctgcc gctgccgtca tgccgttccc gtttgggaag tctcacaaat 120 ctccagcaga cattgtgaag aatctgaagg agagcatggc tgttctggaa aagcaagaca 180 tttctgataa aaaagcagaa aaggctacag aagaagtttc caaaaatctg gttgccatga 240 aagaaattct gtatggcaca aatgaaaaag agcctcagac agaagcagta gctcaacttg 300 ctcaagaact ctataatagt gggctcctta gcaccctggt agctgattta cagctcattg 360 actttgaggg caaaaaagac gtggctcaaa ttttcaacaa tattctcaga agacaaattg 420 gtacgagaac tcctactgtt gaatacatct gcacccaaca gaatattttg ttcatgttat 480 tgaaagggta tgaatctcca gaaatagctc taaattgtgg aataatgtta agagaatgca 540 tcagacatga accacttgca aaaatcattt tgtggtcgga acagttttat gatttcttca 600 gatatgtcga aatgtcaaca tttgacatag cttcagatgc atttgccaca ttcaaggatt 660 tacttacaag acataaattg ctcagtgcag aatttttgga acagcattat gatagatttt 720 tcagtgaata tgagaagtta cttcattcag aaaattatgt gacaaaaaga cagtcactga 780 agcttctcgg tgaactacta ctagatagac acaacttcac aattatgaca aaatacatca 840 gtaaacctga gaacctcaaa ttaatgatga acctgctgcg agacaaaagt cgcaacatcc 900 agtttgaggc ctttcacgtt tttaaggtgt ttgtagccaa tcctaacaag acgcagccca 960 tcctagacat cctcctcaag aaccaggcca aactcataga gttcctcagc aagtttcaga 1020 acgacaggac ggaggatgag cagtttaacg acgagaagac ctatttagtt aaacagatca 1080 gggatttgaa gagaccagct cagcaagaag cttaatctcc aataaacatc tatgttaaat 1140 ccaaattcag catttgctgt tagctattca gcatcaggca ctcttattga ttcatgagga 1200 acattactgc taatctgctg ttaagtgaac ggtttttcat tttacccttt tgtttttcag 1260 tccaggttgg agatcgtagc tgctgctgct tgcacactag ggcacatgtg ggctttctct 1320 tgatctttgt gtcatttcag aattcaaaga ctgtgctacg ggagttctga acatggctgg 1380 gttcatgaag gcaaatgtat ggatgagagt gtggtttagg aaagagggca ctgatatcag 1440 attagaccta tgtgtttgca cccatctttg ttggcgatct gagtgcagtg tggcaagtgc 1500 acacctggca tccctgcgtc agatcgcgca ccttcaggtc gcgcaccttg cgctgaagga 1560 agatgacgca gagctttatc tgaaatcaga ggggagctat ccaaaatggg agtttggggg 1620 cagctaaagt tgacatgcga ataaattgat actgaaactt agcaacttct taaaagtgta 1680 aagaagcctc ataagatcat aaggaaaatg tatatatgct tttcacagct ttctagaatt 1740 ttttgacatt tgattttctt gagacttgta aacctggata tgttgaaggg tatttgttaa 1800 ttttactttt caaagatact ttaaaacagt agagctagca atgacacctt gcatttcatt 1860 tcaacactgc ttcaaggttt cttttgtata taattcttag aatgctcatt tcttttaaat 1920 ggtttaattt gtacagcaga ggaatgttat tgtagtagta tgtaactatt acctaatact 1980 gagtttttgc aaaaaacaat gaatgctcat atgtaattga aatacttcag atcacatgaa 2040 aatgctgatt taacatttaa gtatcacagc attaaaagaa aaagaaagta aaccagtcct 2100 ttgtattcag ttacctaatg gggtgccatc aataagctgc gatacagccc tggagctcag 2160 tcagccacac cttcctgcat cctattggcc ttattcattt taaatgagtt aatgaatctg 2220 ccagatctgt gaatgataga gattatgcta aattaatgct gattctttgt gtgtgtggga 2280 aatctctgta gagcaccttt tctttcttag actaagtaac ccagtacaat agttgtgaac 2340 tgaataatta aaactttggc ttctcttagg aaaagacgac ttcctagtca taggtgtcct 2400 atggggaaat ttattttttt ttaatgtcct gttccttaat gctgcaaatt atcagtattt 2460 ataaagtaac tgattttgca ccactttttt gttactgtga ccacggcaga acaatgtctt 2520 ctagactata tctatgtaaa gttattagaa tggtatctgt tcattttagt gatatgaaga 2580 tcacaactaa caactgacaa atcagagttt gccagttcaa attcagcatg gctgcagctg 2640 attaagaaat tgatatgatt attctttgct agcctctctt actaatggaa ttatatactg 2700 gccagtaaaa tgggcctccc aattgctgtt tcagcaggtt ttaaaccttc aggaacacca 2760 gttaggaaaa tagctccaga aaatatagat atattttatt tttattaaaa tggcagtcta 2820 catcataatt ggcatttctc aagactgtct ttaccagaat ctgtgtgaaa taaggcaatc 2880 tagtctcctt gaaaagaaaa tcccttggga tgtttaggaa ggaagacttg gccgtgatgt 2940 ggtgtcctgg ctttgtggtg tagtgctgtg tgtatggagt tagtgtaaaa acatggatta 3000 caccaagtgg aagaaacgtc ttcttgccaa gctcattctt agaacttaca catctagaac 3060 agcttccact ttggcagtga ggtcgtagcc tttcaggtgg aagaagtgag ggtgcagcgt 3120 gtcagacaca acattcatgt tactcttaca ttggaatctg aaggtagttc agacttcgtg 3180 ggtttgtttt taagcaaaac aatgtgaaaa catttaagtt tgaaatgttg catttgaagt 3240 tatgatcatt taatatatca tattaccaag actattatct g 3281
Claims (19)
1. An isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of:
a) a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26, b) a naturally occurring polynucleotide sequence having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26, c) a polynucleotide sequence complementary to a), d) a polynucleotide sequence complementary to b), and e) an RNA equivalent of a) through d).
a) a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26, b) a naturally occurring polynucleotide sequence having at least 90% sequence identity to a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26, c) a polynucleotide sequence complementary to a), d) a polynucleotide sequence complementary to b), and e) an RNA equivalent of a) through d).
2. An isolated polynucleotide of claim 1, comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:1-26.
3. An isolated polynucleotide comprising at least 60 contiguous nucleotides of a polynucleotide of claim 1.
4. A composition for the detection of expression of secretory polynucleotides comprising at least one of the polynucleotides of claim 1 and a detectable label.
5. A method for detecting a target polynucleotide in a sample, said target polynucleotide having a sequence of a polynucleotide of claim 1, the method comprising:
a) amplifying said target polynucleotide or fragment thereof using polymerase chain reaction amplification, and b) detecting the presence or absence of said amplified target polynucleotide or fragment thereof, and, optionally, if present, the amount thereof.
a) amplifying said target polynucleotide or fragment thereof using polymerase chain reaction amplification, and b) detecting the presence or absence of said amplified target polynucleotide or fragment thereof, and, optionally, if present, the amount thereof.
6. A method for detecting a target polynucleotide in a sample, said target polynucleotide comprising a sequence of a polynucleotide of claim 1, the method comprising:
a) hybridizing the sample with a probe comprising at least 20 contiguous nucleotides comprising a sequence complementary to said target polynucleotide in the sample, and which probe specifically hybridizes to said target polynucleotide, under conditions whereby a hybridization complex is formed between said probe and said target polynucleotide, and b) detecting the presence or absence of said hybridization complex, and, optionally, if present, the amount thereof.
a) hybridizing the sample with a probe comprising at least 20 contiguous nucleotides comprising a sequence complementary to said target polynucleotide in the sample, and which probe specifically hybridizes to said target polynucleotide, under conditions whereby a hybridization complex is formed between said probe and said target polynucleotide, and b) detecting the presence or absence of said hybridization complex, and, optionally, if present, the amount thereof.
7. A method of claim 5, wherein the probe comprises at least 30 contiguous nucleotides.
8. A method of claim 5, wherein the probe comprises at least 60 contiguous nucleotides.
9. A recombinant polynucleotide comprising a promoter sequence operably linked to a polynucleotide of claim 1.
10. A cell transformed with a recombinant polynucleotide of claim 9.
11. A transgenic organism comprising a recombinant polynucleotide of claim 9.
12. A method for producing a secretory polypeptide, the method comprising:
a) culturing a cell under conditions suitable for expression of the secretory polypeptide, wherein said cell is transformed with a recombinant polynucleotide of claim 9, and b) recovering the secretory polypeptide so expressed.
a) culturing a cell under conditions suitable for expression of the secretory polypeptide, wherein said cell is transformed with a recombinant polynucleotide of claim 9, and b) recovering the secretory polypeptide so expressed.
13. A purified secretory polypeptide (SPTM) encoded by at least one of the polynucleotides of claim 2.
14. An isolated antibody which specifically binds to a secretory polypeptide of claim 13.
15. A method of identifying a test compound which specifically binds to the secretory polypeptide of claim 13, the method comprising the steps of:
a) providing a test compound;
b) combining the secretory polypeptide with the test compound for a sufficient time and under suitable conditions for binding; and c) detecting binding of the secretory polypeptide to the test compound, thereby identifying the test compound which specifically binds the secretory polypeptide.
a) providing a test compound;
b) combining the secretory polypeptide with the test compound for a sufficient time and under suitable conditions for binding; and c) detecting binding of the secretory polypeptide to the test compound, thereby identifying the test compound which specifically binds the secretory polypeptide.
16. A microarray wherein at least one element of the microarray is a polynucleotide of claim 3.
17. A method for generating a transcript image of a sample which contains polynucleotides, the method comprising the steps of:
a) labeling the polynucleotides of the sample, b) contacting the elements of the microarray of claim 16 with the labeled polynucleotides of the sample under conditions suitable for the formation of a hybridization complex, and c) quantifying the expression of the polynucleotides in the sample.
a) labeling the polynucleotides of the sample, b) contacting the elements of the microarray of claim 16 with the labeled polynucleotides of the sample under conditions suitable for the formation of a hybridization complex, and c) quantifying the expression of the polynucleotides in the sample.
18. A method for screening a compound for effectiveness in altering expression of a target polynucleotide, wherein said target polynucleotide comprises a polynucleotide sequence of claim 1, the method comprising:
a) exposing a sample comprising the target polynucleotide to a compound, and b) detecting altered expression of the target polynucleotide.
a) exposing a sample comprising the target polynucleotide to a compound, and b) detecting altered expression of the target polynucleotide.
19. A method of claim 6 for toxicity testing of a compound, further comprising:
c) comparing the presence, absence or amount of said target polynucleotide in a first biological sample and a second biological sample, wherein said first biological sample has been contacted with said compound, and said second sample is a control, whereby a change in presence, absence or amount of said target polynucleotide in said first sample, as compared with said second sample, is indicative of toxic response to said compound.
c) comparing the presence, absence or amount of said target polynucleotide in a first biological sample and a second biological sample, wherein said first biological sample has been contacted with said compound, and said second sample is a control, whereby a change in presence, absence or amount of said target polynucleotide in said first sample, as compared with said second sample, is indicative of toxic response to said compound.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14750099P | 1999-08-05 | 1999-08-05 | |
| US14750199P | 1999-08-05 | 1999-08-05 | |
| US60/147,500 | 1999-08-05 | ||
| US60/147,501 | 1999-08-05 | ||
| PCT/US2000/015246 WO2001011032A1 (en) | 1999-08-05 | 2000-06-01 | Secretory molecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2380549A1 true CA2380549A1 (en) | 2001-02-15 |
Family
ID=26844995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002380549A Abandoned CA2380549A1 (en) | 1999-08-05 | 2000-06-01 | Secretory molecules |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1200571A1 (en) |
| AU (1) | AU5316800A (en) |
| CA (1) | CA2380549A1 (en) |
| WO (1) | WO2001011032A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7611892B2 (en) | 2000-03-24 | 2009-11-03 | President And Fellows Of Harvard College | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| EP1440089A2 (en) * | 2001-11-01 | 2004-07-28 | Amersham plc | Human angiomotin-like protein 1 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6114114A (en) * | 1992-07-17 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
| JP2001505783A (en) * | 1996-12-11 | 2001-05-08 | カイロン コーポレイション | Secreted human protein |
| WO1999003990A1 (en) * | 1997-07-16 | 1999-01-28 | Human Genome Sciences, Inc. | 64 human secreted proteins |
| WO1999005256A2 (en) * | 1997-07-24 | 1999-02-04 | President And Fellows Of Harvard College | Method for cloning secreted proteins |
-
2000
- 2000-06-01 CA CA002380549A patent/CA2380549A1/en not_active Abandoned
- 2000-06-01 AU AU53168/00A patent/AU5316800A/en not_active Abandoned
- 2000-06-01 EP EP00938080A patent/EP1200571A1/en not_active Withdrawn
- 2000-06-01 WO PCT/US2000/015246 patent/WO2001011032A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU5316800A (en) | 2001-03-05 |
| WO2001011032A1 (en) | 2001-02-15 |
| EP1200571A1 (en) | 2002-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2447183A1 (en) | Molecules for disease detection and treatment | |
| CA2447212A1 (en) | Secretory molecules | |
| US20040048253A1 (en) | Molecules for diagnostics and therapeutics | |
| CA2419943A1 (en) | Secretory molecules | |
| CA2449440A1 (en) | Structural and cytoskeleton-associated proteins | |
| CA2420983A1 (en) | Molecules for disease detection and treatment | |
| US20050095587A1 (en) | Molecules for disease detection and treatment | |
| US20040138414A1 (en) | Secreted proteins | |
| WO2003062385A2 (en) | Secretory molecules | |
| EP1263949A2 (en) | Secretory polypeptides and corresponding polynucleotides | |
| WO2002055738A2 (en) | Molecules for disease detection and treatment | |
| CA2380549A1 (en) | Secretory molecules | |
| US20030124569A1 (en) | Secretory molecules | |
| US20040171012A1 (en) | Nucleic acid-associated proteins | |
| CA2374822A1 (en) | Molecules for disease detection and treatment | |
| CA2394049A1 (en) | Vesicle trafficking proteins | |
| US20040101884A1 (en) | Molecules for disease detection and treatment | |
| CA2460480A1 (en) | Molecules for disease detection and treatment | |
| JP2003533975A (en) | Secreted protein | |
| CA2429195A1 (en) | Immunoglobulin superfamily proteins | |
| CA2433802A1 (en) | Secretory molecules | |
| US20040142331A1 (en) | Molecules for disease detection and treatment | |
| US20030220240A1 (en) | Vesicle trafficking proteins | |
| WO2002078420A2 (en) | Molecules for disease detection and treatment | |
| CA2446292A1 (en) | Nucleic acid-associated proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |